data_1kzx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kzx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.26 77.4 m-85 . . . . . 0 N--CA 1.508 2.463 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.23 105.62 1.46 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.946 1.298 . . . . 0.0 114.186 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 m 178.04 169.65 0.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 125.253 1.421 . . . . 0.0 111.412 -172.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.1 m -97.06 128.42 43.99 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.734 -1.229 . . . . 0.0 110.789 171.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -131.22 95.51 3.8 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.306 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -77.56 139.78 39.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -70.25 124.05 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 112.454 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.64 -57.58 3.07 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.278 163.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -136.2 156.82 48.12 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 122.294 1.045 . . . . 0.0 112.589 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.9 m -136.2 94.51 3.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.596 -1.315 . . . . 0.0 110.067 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -93.06 118.84 31.65 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.616 -159.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.274 51.5 t30 64.11 17.92 10.93 Favored 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.19 -33.16 74.81 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -50.52 71.98 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -63.86 -41.49 97.77 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -49.58 -51.11 39.43 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.751 1.759 . . . . 0.0 115.751 163.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.5 mtp -65.84 -32.29 73.72 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.04 -48.54 75.82 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 160.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.16 -32.86 74.59 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.9 mmt -58.09 -53.9 53.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.075 1.307 . . . . 0.0 114.202 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.36 52.94 0.12 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.79 167.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 118.457 1.128 . . . . 0.0 112.756 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -79.52 166.56 21.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.756 -1.215 . . . . 0.0 113.032 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.285 13.3 tt -75.63 59.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 123.534 1.635 . . . . 0.0 114.72 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.17 -65.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -60.15 -33.75 72.61 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -50.45 -52.12 40.76 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 162.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.59 -52.29 18.87 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.41 -50.25 68.34 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.53 58.04 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.46 94.01 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -110.1 39.24 2.2 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -80.0 0.29 32.26 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.253 62.3 m-80 62.18 52.28 3.25 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.0 tp -76.77 121.87 23.94 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-O 122.085 0.945 . . . . 0.0 113.096 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -109.92 122.21 47.01 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.682 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.18 103.01 14.46 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.898 0.479 . . . . 0.0 109.723 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -91.4 100.07 12.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.119 -0.988 . . . . 0.0 108.735 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.5 mt -90.15 124.68 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.1 p -135.03 115.84 13.95 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -99.26 105.4 17.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.626 -1.296 . . . . 0.0 111.39 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.92 -52.01 9.52 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.27 87.88 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.105 -0.997 . . . . 0.0 111.086 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.316 25.8 t30 69.55 -48.65 0.61 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -165.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.62 121.39 14.85 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -85.42 114.54 22.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.057 0.543 . . . . 0.0 110.321 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -90.44 102.57 15.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.7 t -105.36 101.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -79.86 105.06 10.86 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 123.362 0.665 . . . . 0.0 109.867 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.89 99.52 9.73 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.155 0.982 . . . . 0.0 109.146 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.0 t -111.77 109.16 18.86 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.815 0.446 . . . . 0.0 112.174 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -135.27 178.74 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.3 m -54.64 -37.45 65.68 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -69.74 -53.24 19.35 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -148.32 143.71 27.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.302 0.955 . . . . 0.0 112.842 -168.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -121.87 95.23 4.58 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.596 0.759 . . . . 0.0 109.425 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.08 152.89 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 123.317 0.647 . . . . 0.0 111.026 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.27 115.82 30.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.708 -1.245 . . . . 0.0 112.505 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -86.48 101.09 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.32 107.15 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -126.5 130.68 51.09 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -83.51 147.56 27.72 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.452 1.12 . . . . 0.0 111.478 161.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.57 111.08 4.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.64 -6.99 52.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 119.019 2.367 . . . . 0.0 119.019 -167.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.9 t -85.78 130.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.822 2.311 . . . . 0.0 110.511 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 107.54 10.68 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.559 0.744 . . . . 0.0 111.919 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -126.9 157.71 38.69 Favored 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.42 0.688 . . . . 0.0 112.426 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -82.95 113.93 20.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 111.844 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -92.44 116.76 29.27 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.503 0.721 . . . . 0.0 109.405 167.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -96.96 124.35 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.25 0.548 . . . . 0.0 111.155 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.449 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -110.28 142.97 41.15 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 122.368 1.08 . . . . 0.0 111.639 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.8 mt -114.58 116.22 28.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.736 0.814 . . . . 0.0 110.13 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -93.69 120.49 34.02 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 121.674 -0.641 . . . . 0.0 111.103 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.55 -161.67 35.12 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 117.651 1.82 . . . . 0.0 117.651 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.8 p -123.84 121.48 35.5 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.579 -160.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -79.25 114.15 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.938 0.79 . . . . 0.0 109.908 155.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -114.35 142.9 45.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.38 0.672 . . . . 0.0 110.973 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 tp -91.41 103.41 16.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.687 -1.258 . . . . 0.0 111.768 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -83.55 83.95 7.71 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.144 0.974 . . . . 0.0 110.127 166.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.57 -88.38 0.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -118.32 13.05 13.57 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.82 128.51 49.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.153 1.797 . . . . 0.0 109.473 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 mt -85.8 101.11 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.48 110.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-O 122.481 1.134 . . . . 0.0 109.335 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.87 103.12 3.01 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.731 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -90.06 90.47 8.14 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.23 161.16 19.39 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 122.844 1.306 . . . . 0.0 111.773 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -150.05 155.17 39.4 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.992 . . . . 0.0 110.724 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -68.21 131.78 45.98 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 113.858 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.3 p -55.46 -43.62 75.64 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 164.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -45.25 4.57 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.895 0.878 . . . . 0.0 111.698 -161.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -65.32 -42.74 92.67 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.73 -9.89 72.17 Favored Glycine 0 CA--C 1.558 2.732 0 N-CA-C 119.136 2.414 . . . . 0.0 119.136 -161.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -78.02 138.75 38.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.326 1.563 . . . . 0.0 112.894 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -73.45 148.06 43.58 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 tt -137.6 121.2 17.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.67 0.747 . . . . 0.0 110.227 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -93.59 120.18 33.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.982 -0.449 . . . . 0.0 110.112 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -125.02 124.8 42.75 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.668 0.387 . . . . 0.0 111.67 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.01 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -96.04 120.7 36.79 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.093 0.557 . . . . 0.0 110.458 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.87 153.79 31.68 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.523 0.729 . . . . 0.0 111.931 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.97 115.93 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.827 -1.17 . . . . 0.0 108.252 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tp -89.34 81.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.126 0.965 . . . . 0.0 110.67 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.0 -84.44 1.13 Allowed Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.905 -1.122 . . . . 0.0 114.976 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -128.8 26.01 5.59 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.66 125.79 31.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.901 -1.125 . . . . 0.0 109.906 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 tp -77.93 117.75 19.58 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.352 -0.843 . . . . 0.0 111.007 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -97.77 125.52 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.81 104.04 14.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 162.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -98.93 91.87 5.25 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.35 0.66 . . . . 0.0 109.248 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.27 113.44 25.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.96 0.904 . . . . 0.0 111.402 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.52 108.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -122.28 124.82 44.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.129 0.572 . . . . 0.0 110.872 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 57.1 37.68 28.7 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.12 26.39 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 119.801 2.68 . . . . 0.0 119.801 -163.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.28 107.26 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 119.942 1.871 . . . . 0.0 108.08 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 118.81 28.17 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.449 0.7 . . . . 0.0 111.948 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.88 125.12 53.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.222 0.609 . . . . 0.0 112.195 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.68 106.21 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.863 -0.523 . . . . 0.0 110.395 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -85.58 117.99 24.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.919 -1.113 . . . . 0.0 109.225 164.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.7 mt -115.02 117.42 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -164.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -116.55 117.47 29.97 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.34 0.656 . . . . 0.0 109.683 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.67 152.31 28.51 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 112.08 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -63.2 100.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.05 -1.031 . . . . 0.0 112.751 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.41 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -116.37 88.53 2.91 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 120.221 -1.549 . . . . 0.0 111.252 -150.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -164.77 -178.94 5.55 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.687 1.195 . . . . 0.0 110.88 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -92.22 106.99 18.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.614 -1.304 . . . . 0.0 109.192 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -109.54 100.5 9.55 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -168.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -95.94 139.06 32.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.199 -0.938 . . . . 0.0 112.754 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.64 115.57 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.61 -61.45 1.91 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.151 0.58 . . . . 0.0 111.395 164.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -140.13 146.54 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.197 0.999 . . . . 0.0 112.948 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 108.07 8.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.56 -49.85 24.24 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -162.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -138.66 41.29 2.18 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -84.39 48.66 1.53 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 119.469 -2.02 . . . . 0.0 114.513 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -149.02 -47.57 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.415 1.486 . . . . 0.0 111.682 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.89 -37.97 89.35 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.942 1.701 . . . . 0.0 114.834 160.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -49.4 -57.93 6.05 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 159.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -45.29 76.95 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 168.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -50.59 -49.35 56.66 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -62.8 -37.73 87.88 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.7 mtm -62.91 -52.25 63.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.05 70.53 0.09 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 145.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-O 122.708 1.242 . . . . 0.0 111.276 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -63.92 156.34 28.0 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.258 14.0 tt -56.66 -40.11 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.47 -53.14 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.34 0.973 . . . . 0.0 113.067 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.78 -30.03 67.5 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -52.3 -46.41 65.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 159.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -57.53 -48.38 79.44 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.17 -34.65 75.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.27 75.28 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.94 -50.83 30.33 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 162.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.46 58.56 4.93 Favored 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 119.807 1.185 . . . . 0.0 112.917 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -95.97 -28.04 14.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 65.31 49.88 1.85 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.625 1.17 . . . . 0.0 114.041 -168.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -77.08 124.67 28.14 Favored 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.765 -1.21 . . . . 0.0 113.741 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -120.94 111.65 17.77 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.828 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 mt -91.38 100.23 13.05 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -91.65 101.05 13.68 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.97 -1.081 . . . . 0.0 109.116 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.19 107.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -104.03 104.15 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -92.45 127.52 37.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.668 -0.645 . . . . 0.0 110.984 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -125.74 76.92 1.62 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.734 1.254 . . . . 0.0 111.265 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 -95.23 1.36 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.055 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -97.19 -23.37 16.22 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -91.15 155.31 18.71 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 120.182 1.355 . . . . 0.0 112.621 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -124.6 112.49 16.88 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.955 0.902 . . . . 0.0 109.449 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.4 m -96.41 94.28 7.32 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.82 107.17 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.83 94.31 9.27 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.08 97.86 10.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.621 0.769 . . . . 0.0 108.934 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -113.62 115.53 28.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.324 0.65 . . . . 0.0 111.507 -162.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -144.66 168.57 19.85 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 0.0 113.127 -170.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -58.9 -34.64 71.91 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 160.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -50.08 67.74 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.25 11.66 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.35 1.06 . . . . 0.0 111.839 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -118.19 101.21 8.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.42 120.17 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.633 -0.667 . . . . 0.0 110.799 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.88 102.81 14.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.941 -1.099 . . . . 0.0 111.46 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.5 97.4 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.01 111.0 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -138.58 142.49 39.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.79 150.42 25.06 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.15 0.976 . . . . 0.0 111.648 164.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.08 102.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.053 -1.029 . . . . 0.0 113.099 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.81 -4.01 36.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 118.931 2.333 . . . . 0.0 118.931 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.79 135.23 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 121.376 2.588 . . . . 0.0 112.263 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.8 p -84.22 96.69 9.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 110.75 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -122.96 154.98 37.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.407 0.683 . . . . 0.0 112.693 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -83.38 105.71 14.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.654 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -96.87 101.72 13.36 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.047 0.939 . . . . 0.0 110.638 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -87.35 109.33 19.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.056 -1.028 . . . . 0.0 111.061 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -166.557 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -68.28 140.12 55.97 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 25.2 mt -134.76 100.24 4.55 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.328 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -84.51 107.25 16.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.913 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -154.55 23.97 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.506 0.963 . . . . 0.0 115.506 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.2 p -124.33 122.35 37.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.773 -155.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -82.27 107.51 15.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 155.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.5 m -108.69 149.96 28.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.6 -0.687 . . . . 0.0 112.322 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 105.28 17.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.877 -1.139 . . . . 0.0 110.91 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.05 79.85 1.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.955 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.51 -92.83 0.89 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 121.128 -0.982 . . . . 0.0 114.04 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.69 52.37 1.93 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.401 0.62 . . . . 0.0 111.188 160.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -141.04 120.06 12.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -83.04 99.2 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.358 -1.464 . . . . 0.0 109.446 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 tp -90.17 111.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.693 0.797 . . . . 0.0 110.033 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.28 92.8 1.36 Allowed Glycine 0 N--CA 1.482 1.734 0 C-N-CA 123.793 0.711 . . . . 0.0 113.172 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.21 111.25 22.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -134.86 111.16 9.65 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -156.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -84.79 120.64 26.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.697 -1.252 . . . . 0.0 111.855 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -54.97 120.21 6.56 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.9 p -64.17 -43.07 96.26 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.25 -44.24 76.08 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.92 -47.66 8.4 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.48 54.66 3.06 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 -157.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -138.52 124.22 19.75 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.335 1.067 . . . . 0.0 110.24 -172.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -83.75 99.51 10.32 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.115 1.436 . . . . 0.0 113.774 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.5 132.46 34.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.715 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -106.71 110.19 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.734 -0.604 . . . . 0.0 110.192 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -111.05 112.34 24.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.799 -0.563 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.66 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.154 -0.966 . . . . 0.0 108.784 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 mtm-85 -90.46 116.08 28.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.847 168.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -144.39 159.45 42.7 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.656 0.782 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.3 mt -126.14 121.43 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.423 -1.423 . . . . 0.0 109.494 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.13 83.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.12 -80.59 0.96 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.89 -50.41 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -94.22 148.16 22.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 120.212 1.369 . . . . 0.0 114.329 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 tp -86.93 120.75 28.53 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.127 0.571 . . . . 0.0 111.411 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 m -106.77 121.38 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.5 ' NE2' ' HH ' ' A' ' 117' ' ' TYR . 16.0 tt0 -107.97 103.18 12.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.54 -0.725 . . . . 0.0 109.751 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.4 m -97.8 100.49 11.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.584 0.753 . . . . 0.0 109.356 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.5 ' HH ' ' NE2' ' A' ' 115' ' ' GLN . 78.7 m-85 -90.04 117.71 29.04 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.023 0.929 . . . . 0.0 111.424 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.92 115.64 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -110.84 107.56 17.09 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.67 0.668 . . . . 0.0 109.647 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER 54.64 32.4 17.1 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 175.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.01 -40.5 2.5 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -162.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.69 112.67 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 120.538 2.169 . . . . 0.0 112.361 -168.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.77 130.07 39.9 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.08 0.552 . . . . 0.0 112.342 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.69 112.46 13.68 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.846 0.858 . . . . 0.0 110.996 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -103.31 116.29 32.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -0.804 . . . . 0.0 110.679 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -106.14 114.07 27.98 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.041 0.448 . . . . 0.0 109.83 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.1 mt -101.23 121.19 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.97 124.87 51.61 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.326 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -82.65 142.35 31.78 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.887 0.851 . . . . 0.0 111.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -79.97 105.5 11.3 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 124.924 1.29 . . . . 0.0 113.669 174.485 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.277 87.8 m-85 . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 122.815 1.293 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.92 -36.15 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -137.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -122.82 -172.32 2.46 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 123.327 1.537 . . . . 0.0 112.918 -158.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.8 m -78.03 118.97 20.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.16 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -122.71 108.1 12.69 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -109.94 139.52 44.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.099 -1.001 . . . . 0.0 113.307 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.62 117.75 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -102.28 -56.97 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.691 0.797 . . . . 0.0 111.438 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 110.77 11.93 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.467 0.707 . . . . 0.0 112.032 -166.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.1 p -106.86 127.31 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 112.512 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -73.94 -46.65 42.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -147.03 45.59 1.17 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -83.9 52.44 2.29 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 119.332 -2.105 . . . . 0.0 113.955 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -152.26 -51.76 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.157 1.383 . . . . 0.0 110.349 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.95 -30.75 70.12 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 163.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -50.94 -40.47 57.46 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 154.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -70.39 -34.23 72.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -50.95 -52.68 39.96 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 121.009 1.731 . . . . 0.0 115.318 159.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.09 -34.14 74.46 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.28 -51.52 69.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 162.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 68.27 0.48 Allowed Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.015 0.825 . . . . 0.0 114.094 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.66 149.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.462 0.649 . . . . 0.0 112.489 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -78.89 153.03 30.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.769 -1.207 . . . . 0.0 113.68 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.311 10.7 tt -59.61 -39.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 118.483 2.771 . . . . 0.0 118.483 -170.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.6 m -59.11 -42.43 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -67.14 -35.18 79.15 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -55.72 -50.73 69.56 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.387 1.903 . . . . 0.0 114.151 164.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -56.38 -54.68 42.69 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.94 48.58 0.85 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.96 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.059 1.344 . . . . 0.0 111.963 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.28 93.85 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -83.97 67.75 9.75 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 122.283 1.04 . . . . 0.0 111.403 171.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -92.51 -33.55 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.84 50.58 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.521 1.129 . . . . 0.0 113.532 -166.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.88 124.19 26.91 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.493 1.14 . . . . 0.0 113.632 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -108.71 100.05 9.33 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.054 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.83 102.73 11.01 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.132 0.573 . . . . 0.0 109.491 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.1 m -99.51 105.59 17.52 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -107.22 118.23 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -161.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 p -123.96 126.53 46.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.72 -0.612 . . . . 0.0 110.492 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.17 119.95 37.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.631 -0.668 . . . . 0.0 110.933 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.08 -49.83 14.42 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.36 -91.42 0.08 OUTLIER Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -74.7 -24.6 58.79 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 157.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -87.62 129.5 35.1 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 119.894 1.225 . . . . 0.0 111.954 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -109.83 134.7 51.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.358 1.063 . . . . 0.0 110.581 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.5 m -107.59 111.93 24.42 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -104.76 105.63 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -80.88 110.02 16.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 110.335 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.16 82.52 4.16 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.175 0.59 . . . . 0.0 110.525 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 t -96.66 111.09 23.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.002 -1.061 . . . . 0.0 112.752 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 p -131.94 -169.72 2.26 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.376 0.671 . . . . 0.0 112.069 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -70.45 -1.59 11.25 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 159.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -126.91 -38.36 2.04 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.675 1.19 . . . . 0.0 114.008 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -90.4 -90.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 119.79 1.177 . . . . 0.0 111.781 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.287 70.4 m-80 60.96 60.28 1.87 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 pt -134.14 135.2 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 123.121 0.568 . . . . 0.0 110.595 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.79 103.05 14.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 111.868 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 t -88.13 98.28 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.0 113.61 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.99 140.64 45.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.689 0.757 . . . . 0.0 112.734 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.36 142.71 41.09 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 111.982 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 100.69 0.89 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 112.891 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.81 -12.42 24.94 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.103 2.401 . . . . 0.0 119.103 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.26 134.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 121.247 2.524 . . . . 0.0 112.61 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.6 t -82.08 92.8 6.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 111.984 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -119.15 170.27 9.22 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.956 0.902 . . . . 0.0 113.036 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -88.61 99.13 12.08 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 121.723 -0.611 . . . . 0.0 110.613 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -87.1 87.1 7.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.835 170.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -71.18 142.75 50.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 177.522 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 121.665 0.745 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -85.68 118.56 25.26 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 110.794 151.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -92.66 116.63 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.929 -1.107 . . . . 0.0 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -94.58 114.63 26.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.721 . . . . 0.0 110.649 -174.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.77 -153.7 24.98 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 p -119.86 140.77 50.31 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -160.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.16 109.64 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 108.913 155.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.3 m -104.58 139.19 39.81 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.181 0.592 . . . . 0.0 111.484 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.1 tp -88.17 107.47 18.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.118 -0.989 . . . . 0.0 109.959 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.85 -53.59 17.41 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.79 -71.07 0.28 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -162.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.15 -39.8 39.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 160.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.04 145.26 35.88 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.959 0.904 . . . . 0.0 112.882 -164.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.06 101.53 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 146.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.2 110.42 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.797 0.808 . . . . 0.0 109.485 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.76 94.68 2.02 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.8 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.02 95.61 9.89 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.534 0.683 . . . . 0.0 109.18 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.48 164.96 20.77 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 122.561 1.172 . . . . 0.0 111.835 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.79 155.01 46.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.849 -1.157 . . . . 0.0 112.072 165.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -67.84 139.02 56.53 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.8 m -77.91 -51.87 9.74 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.17 0.588 . . . . 0.0 112.062 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.97 -41.38 74.66 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.0 -31.63 7.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.15 38.56 29.48 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 118.556 2.182 . . . . 0.0 118.556 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -144.08 157.54 44.25 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.92 1.36 . . . . 0.0 111.916 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -80.54 129.68 34.66 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -159.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.79 124.08 51.77 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.029 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -107.24 107.22 18.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -107.27 99.32 8.86 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.58 119.91 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -103.62 124.49 48.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.748 0.704 . . . . 0.0 110.398 170.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.28 146.27 40.17 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.53 0.732 . . . . 0.0 111.114 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -89.71 115.16 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.322 -1.486 . . . . 0.0 108.676 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -99.74 88.93 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.31 -88.51 0.8 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.486 -0.759 . . . . 0.0 113.953 -174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -136.88 50.41 2.01 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 161.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -137.57 122.05 18.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.23 109.25 15.58 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 123.549 0.74 . . . . 0.0 110.786 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.69 98.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 109.951 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -84.59 96.26 9.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.033 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.2 m -96.34 92.6 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.524 0.73 . . . . 0.0 109.709 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.9 105.78 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.964 0.906 . . . . 0.0 111.438 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.6 t -109.48 109.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -127.18 119.46 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 110.078 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.8 OUTLIER 48.75 63.64 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.18 -31.72 2.58 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 119.211 2.444 . . . . 0.0 119.211 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.54 121.78 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.662 1.731 . . . . 0.0 110.698 -159.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.43 143.6 27.15 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 123.81 0.844 . . . . 0.0 112.953 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.29 109.39 6.1 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 121.56 -0.713 . . . . 0.0 110.689 164.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -101.16 96.98 7.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.257 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -87.46 111.41 21.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.259 0.624 . . . . 0.0 110.231 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.09 111.59 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -170.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -103.68 113.82 27.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.41 0.684 . . . . 0.0 109.602 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -77.11 162.75 27.22 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.35 110.25 4.01 Favored 'General case' 0 CA--C 1.57 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 112.361 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 C-N-CA 125.039 1.335 . . . . 0.0 112.38 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -69.13 94.42 0.67 Allowed 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -168.05 173.18 8.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.619 1.168 . . . . 0.0 110.999 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 m -88.97 117.79 28.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.001 . . . . 0.0 109.499 166.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -120.43 113.0 19.68 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.986 0.514 . . . . 0.0 109.876 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 142.45 27.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.267 -0.896 . . . . 0.0 112.754 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.72 115.94 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.573 -0.705 . . . . 0.0 111.923 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.21 -53.38 6.72 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.334 0.654 . . . . 0.0 112.074 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.12 143.23 25.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.667 0.746 . . . . 0.0 112.839 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -109.3 88.39 2.72 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.995 0.902 . . . . 0.0 110.446 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.31 118.89 25.13 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.632 0.773 . . . . 0.0 110.969 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.291 22.9 t30 67.25 11.71 8.53 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 118.105 2.631 . . . . 0.0 118.105 -173.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -64.77 -37.64 88.27 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -63.05 -42.84 99.82 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -71.39 -39.87 70.89 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -46.51 -55.88 6.85 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 158.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtp -63.17 -39.25 94.12 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.18 -43.87 95.52 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -38.02 66.26 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 163.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.4 mtt -59.56 -36.94 77.16 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.311 2.338 . . . . 0.0 117.311 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.6 63.12 0.89 Allowed Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.779 0.718 . . . . 0.0 114.147 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.91 -171.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.481 0.658 . . . . 0.0 112.479 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -65.36 173.41 2.62 Favored 'General case' 0 CA--C 1.583 2.231 0 O-C-N 119.899 -1.751 . . . . 0.0 113.976 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.4 tt -94.8 -45.39 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.333 -1.479 . . . . 0.0 114.381 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.2 -60.03 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.686 1.13 . . . . 0.0 112.239 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -55.08 -49.6 71.26 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -34.49 -51.37 0.47 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 118.668 2.84 . . . . 0.0 118.668 160.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -73.2 -39.67 65.37 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.53 95.99 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 168.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.04 -44.59 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -114.02 54.33 0.76 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 118.505 0.593 . . . . 0.0 112.086 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -83.63 -13.77 53.51 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 59.9 m-80 64.89 61.15 0.8 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.736 1.153 . . . . 0.0 113.136 -167.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 tp -83.32 120.86 26.38 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.607 1.194 . . . . 0.0 113.357 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -102.69 118.35 36.65 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.941 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.19 100.41 12.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 m -91.54 102.92 15.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.842 0.83 . . . . 0.0 108.878 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.21 124.04 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -117.98 107.75 14.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -87.22 91.17 8.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.51 0.671 . . . . 0.0 111.323 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -89.46 68.16 7.79 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.463 0.649 . . . . 0.0 112.158 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 78.66 0.15 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 116.86 1.504 . . . . 0.0 116.86 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.328 24.0 m120 72.27 -34.32 0.29 Allowed 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -166.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.79 148.98 34.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.477 1.035 . . . . 0.0 112.971 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -132.19 116.88 17.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.389 1.076 . . . . 0.0 108.116 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.9 m -102.38 100.64 10.81 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.9 t -105.87 104.57 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -83.32 104.47 13.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.27 96.39 8.46 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -115.09 114.53 25.46 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.573 0.749 . . . . 0.0 110.944 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 p -141.62 -177.64 5.27 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.301 1.048 . . . . 0.0 113.765 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 159.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -90.58 -48.51 7.04 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -130.32 152.14 50.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 119.997 1.271 . . . . 0.0 112.918 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.01 93.43 2.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.981 . . . . 0.0 109.799 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 pt -136.38 130.31 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.632 -0.668 . . . . 0.0 111.245 -172.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -88.32 105.81 17.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.379 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.72 101.46 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.61 121.7 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 123.385 0.674 . . . . 0.0 109.365 -171.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.55 148.96 23.42 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.396 0.679 . . . . 0.0 111.628 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.88 155.98 17.38 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 120.555 -1.341 . . . . 0.0 113.052 162.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.64 124.4 20.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.65 62.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.536 2.574 . . . . 0.0 119.536 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.86 141.94 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 120.488 2.144 . . . . 0.0 110.741 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 t -73.08 124.43 25.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -137.01 165.0 27.05 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 121.814 0.816 . . . . 0.0 111.246 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -91.39 110.04 21.33 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 110.424 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -84.61 -50.14 7.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.264 5.8 m120 75.65 133.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 122.593 1.187 . . . . 0.0 113.598 175.629 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 CA--C 1.573 1.862 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -94.09 126.49 39.34 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.053 1.406 . . . . 0.0 113.022 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.01 123.99 46.85 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.218 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -135.95 131.44 35.12 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.86 -148.06 16.55 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.477 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.7 p -120.51 123.04 41.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.026 -0.691 . . . . 0.0 112.104 -156.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -80.9 107.15 13.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.65 0.659 . . . . 0.0 109.734 153.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.6 m -95.39 172.34 8.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 111.24 162.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.41 116.79 14.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.409 -1.432 . . . . 0.0 109.978 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.3 88.04 5.01 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.007 0.908 . . . . 0.0 111.795 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.98 -84.17 0.59 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -126.81 32.45 5.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 170.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -141.11 123.66 15.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.482 -1.387 . . . . 0.0 109.096 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.48 127.61 33.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.16 124.18 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.685 0.755 . . . . 0.0 109.945 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.85 103.37 1.41 Allowed Glycine 0 N--CA 1.479 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 113.538 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -95.51 96.78 9.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.4 119.23 31.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.521 -170.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -87.4 139.58 30.4 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.533 1.159 . . . . 0.0 112.512 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -63.86 139.19 58.74 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 168.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -52.37 -43.25 64.59 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 152.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.96 -55.37 3.79 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.508 0.723 . . . . 0.0 111.876 -157.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.17 -32.39 13.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.45 90.04 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 119.042 2.377 . . . . 0.0 119.042 -163.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.09 -3.36 57.22 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -164.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.333 4.7 tt0 72.57 118.3 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 tt -90.34 137.68 32.15 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.137 0.975 . . . . 0.0 111.441 162.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.1 108.09 16.18 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.094 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.261 9.9 t -113.32 114.55 26.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 0.0 112.278 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.07 134.24 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -112.8 121.16 43.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 0.0 110.529 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.99 172.65 12.08 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 121.679 0.752 . . . . 0.0 111.766 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.59 108.36 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.053 . . . . 0.0 109.481 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.263 11.1 tp -96.98 88.09 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.812 0.815 . . . . 0.0 109.717 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.27 -90.31 1.01 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.121 -0.987 . . . . 0.0 114.125 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.83 52.48 1.94 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 165.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -132.87 121.99 23.73 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.181 0.992 . . . . 0.0 108.375 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.2 101.97 11.58 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.775 -0.578 . . . . 0.0 109.908 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.81 83.46 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.093 0.949 . . . . 0.0 110.476 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.39 100.05 10.45 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.238 1.018 . . . . 0.0 109.984 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.4 m -110.68 90.44 3.32 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.005 -151.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.42 114.02 24.61 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.978 0.911 . . . . 0.0 110.89 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -108.71 124.26 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -141.34 128.15 20.46 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 121.355 0.597 . . . . 0.0 111.649 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 3.9 mm-40 48.96 44.35 22.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -167.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.04 -25.3 1.87 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 119.31 2.484 . . . . 0.0 119.31 -165.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.3 t -82.85 117.31 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 120.317 2.058 . . . . 0.0 110.03 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -91.67 140.76 29.4 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.97 0.908 . . . . 0.0 112.659 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.59 32.58 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 165.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -103.32 106.19 16.65 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.959 -0.463 . . . . 0.0 110.388 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -83.8 102.59 12.44 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.22 115.16 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -106.96 115.62 30.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.241 0.543 . . . . 0.0 109.576 -173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -84.16 149.29 26.26 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.421 0.689 . . . . 0.0 111.924 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -62.17 112.1 2.24 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 125.235 1.414 . . . . 0.0 112.827 -173.658 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.252 5.5 p-10 -74.55 80.89 1.97 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 120.234 1.379 . . . . 0.0 114.205 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -146.93 -166.35 2.48 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.135 0.969 . . . . 0.0 111.573 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.5 m -94.55 127.56 40.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.654 -1.279 . . . . 0.0 109.985 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -136.63 105.53 5.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.966 -0.459 . . . . 0.0 110.509 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -98.97 137.39 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.212 0.915 . . . . 0.0 111.339 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.6 120.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.801 0.81 . . . . 0.0 112.693 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.17 -54.64 5.79 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.065 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -147.25 160.77 42.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 121.765 0.793 . . . . 0.0 112.677 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -136.54 118.27 15.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 111.445 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -70.46 -60.35 2.32 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -165.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -130.33 51.13 2.13 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.32 1.057 . . . . 0.0 112.944 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -74.89 -36.8 62.25 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.0 -50.56 72.34 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.13 -36.79 77.86 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.53 -52.44 38.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 160.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 mtp -61.22 -48.97 79.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -43.02 64.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -54.69 -30.14 54.93 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtm -70.98 -11.46 60.98 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.69 64.54 1.74 Allowed Glycine 0 N--CA 1.495 2.583 0 CA-C-N 122.265 2.302 . . . . 0.0 114.67 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -119.55 170.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 122.821 1.296 . . . . 0.0 113.092 -164.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.2 108.0 16.84 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 120.877 -1.139 . . . . 0.0 110.531 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.3 12.7 tt -49.25 -44.53 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 119.808 3.262 . . . . 0.0 119.808 -164.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.07 -46.94 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 170.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -68.66 -31.13 70.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -51.22 -45.58 61.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.91 -52.24 66.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.79 -36.29 82.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.89 91.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.12 75.18 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -92.47 62.48 3.95 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 163.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER -83.03 -17.36 43.56 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 60.28 50.88 5.85 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -84.22 149.62 26.01 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -111.59 114.48 27.57 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.771 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.11 103.28 11.61 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.2 m -91.73 99.0 11.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 168.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -99.94 124.22 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.9 p -129.76 119.45 23.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.649 -0.657 . . . . 0.0 109.921 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -88.72 119.2 28.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.901 0.773 . . . . 0.0 111.96 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.81 76.9 1.82 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 123.112 0.565 . . . . 0.0 109.856 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.54 80.49 0.1 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 20.0 m120 71.62 -50.4 0.69 Allowed 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -166.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -73.95 121.84 21.64 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.981 0.912 . . . . 0.0 112.929 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -99.69 134.78 42.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.56 -0.712 . . . . 0.0 111.481 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 m -102.27 111.06 23.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 161.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.04 105.49 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -86.01 95.8 9.63 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.954 0.502 . . . . 0.0 110.218 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.0 t -98.76 110.28 22.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.875 0.47 . . . . 0.0 110.336 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.83 170.35 15.91 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -68.82 -6.54 27.5 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -100.03 -46.03 5.47 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.499 1.045 . . . . 0.0 113.206 168.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.87 154.5 40.5 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.035 1.288 . . . . 0.0 112.205 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -112.58 105.94 14.25 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 161.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.2 pt -123.51 127.6 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.248 0.547 . . . . 0.0 111.3 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -99.71 100.67 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.759 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.17 98.11 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.0 109.582 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.19 128.9 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.194 0.598 . . . . 0.0 110.346 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -148.66 147.78 29.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.456 0.646 . . . . 0.0 112.729 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 157.06 16.47 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.318 1.056 . . . . 0.0 110.785 164.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.78 80.89 3.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 112.436 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.02 -38.3 1.83 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -162.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.53 121.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.072 1.436 . . . . 0.0 110.091 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -68.19 127.69 33.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.39 165.43 22.57 Favored 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 123.896 0.879 . . . . 0.0 111.579 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -96.26 108.16 20.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -92.15 97.62 11.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.489 -0.757 . . . . 0.0 110.135 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -75.67 115.24 15.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.778 -0.576 . . . . 0.0 112.409 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.563 1.454 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -172.751 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.19 114.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.366 0.603 . . . . 0.0 109.651 160.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.18 117.11 27.92 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.448 0.642 . . . . 0.0 110.494 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -91.27 109.45 20.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.39 0.676 . . . . 0.0 109.998 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.94 -149.84 14.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.8 p -138.92 142.65 38.47 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.076 0.551 . . . . 0.0 110.851 -170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -85.32 89.18 7.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.998 -1.064 . . . . 0.0 108.319 153.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -76.69 138.06 39.77 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.984 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.97 105.74 13.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 110.857 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.24 -35.39 73.8 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.73 -79.21 0.2 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.91 -24.25 41.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 160.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -120.79 149.15 43.01 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.263 1.392 . . . . 0.0 111.921 -160.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -94.94 108.88 20.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.925 -1.11 . . . . 0.0 108.993 162.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.19 112.43 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 CA-C-O 122.317 1.056 . . . . 0.0 109.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.01 92.88 0.74 Allowed Glycine 0 N--CA 1.479 1.519 0 C-N-CA 124.265 0.936 . . . . 0.0 113.746 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.09 91.33 8.67 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.41 152.25 37.14 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.101 0.953 . . . . 0.0 112.386 -168.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -121.61 139.43 53.55 Favored 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.549 0.74 . . . . 0.0 110.023 169.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -63.38 131.16 47.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.862 -1.149 . . . . 0.0 113.607 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.7 m -66.59 -47.21 73.46 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 167.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.66 -51.87 37.21 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.72 -45.94 27.38 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.75 -8.34 79.66 Favored Glycine 0 CA--C 1.558 2.781 0 N-CA-C 118.543 2.177 . . . . 0.0 118.543 -153.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.53 152.12 24.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.648 1.724 . . . . 0.0 112.724 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -70.81 141.63 51.35 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.92 126.16 40.95 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -100.51 146.73 26.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 111.15 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 m -148.35 109.73 4.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.159 -1.588 . . . . 0.0 111.69 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.1 t -97.07 122.87 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.227 . . . . 0.0 109.966 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.41 127.62 44.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 111.198 163.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.61 146.01 27.08 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.337 0.655 . . . . 0.0 110.872 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.36 102.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.26 11.3 tp -98.68 75.19 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.039 0.923 . . . . 0.0 111.27 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.83 62.4 3.83 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 116.164 1.226 . . . . 0.0 116.164 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.317 9.1 t70 81.9 -41.1 0.13 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -167.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.74 107.75 7.04 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.97 0.908 . . . . 0.0 113.324 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.3 tp -76.07 102.42 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.655 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -91.72 82.5 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.111 0.482 . . . . 0.0 110.447 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.496 ' NE2' ' HH ' ' A' ' 117' ' ' TYR . 16.8 tt0 -73.8 97.93 2.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.955 -1.091 . . . . 0.0 110.921 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.7 m -106.08 89.52 3.09 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 -157.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.496 ' HH ' ' NE2' ' A' ' 115' ' ' GLN . 73.4 m-85 -81.96 137.96 35.04 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.146 0.978 . . . . 0.0 111.977 -176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.64 120.62 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -131.71 122.59 26.16 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 55.92 36.8 28.0 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.83 -17.15 17.16 Favored Glycine 0 CA--C 1.557 2.689 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 -163.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.37 116.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.009 1.904 . . . . 0.0 109.23 -172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.15 147.37 23.11 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.57 123.49 15.36 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.894 0.877 . . . . 0.0 111.681 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -110.72 98.4 7.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.061 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -86.69 108.83 18.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.2 mt -106.91 126.34 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -115.67 128.7 56.1 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.516 0.674 . . . . 0.0 111.447 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -80.79 155.03 26.86 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 121.672 0.749 . . . . 0.0 111.396 165.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -68.45 114.22 6.69 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.15 -0.969 . . . . 0.0 111.7 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 125.253 1.421 . . . . 0.0 112.531 -173.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -82.35 90.55 6.68 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 120.747 1.612 . . . . 0.0 113.466 -165.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -162.37 179.0 8.16 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 122.209 1.004 . . . . 0.0 112.188 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 m -83.04 125.2 31.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 110.222 163.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.91 106.39 9.28 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.183 0.593 . . . . 0.0 109.727 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -97.74 138.39 35.19 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.919 -1.113 . . . . 0.0 112.605 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.85 112.05 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 113.326 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.71 -59.52 2.22 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.087 0.555 . . . . 0.0 111.828 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -134.78 124.48 25.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.0 p -103.72 129.26 51.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.454 0.702 . . . . 0.0 112.034 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.332 0.1 OUTLIER -72.75 -72.81 0.23 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 177.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -121.48 39.5 3.83 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.804 1.184 . . . . 0.0 114.069 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.74 -40.83 75.93 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -64.54 -30.77 71.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -79.0 -40.12 32.34 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -48.27 -50.44 29.76 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 158.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.406 ' SD ' HG22 ' A' ' 23' ' ' VAL . 12.4 mmt -50.12 -50.8 47.34 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 163.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -52.66 -46.51 67.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -57.67 -41.83 82.36 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.61 -33.82 74.58 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.77 67.9 0.83 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-N 119.55 1.068 . . . . 0.0 113.904 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 HG22 ' SD ' ' A' ' 18' ' ' MET . 11.5 m -126.2 170.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.466 1.127 . . . . 0.0 112.51 -165.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -64.22 178.74 0.65 Allowed 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.4 tt -108.53 167.4 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 157.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.383 46.2 t 80.85 -68.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 120.392 -1.443 . . . . 0.0 111.691 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -65.87 -38.86 89.91 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 119.802 1.183 . . . . 0.0 113.811 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -44.23 -42.84 6.83 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 161.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -69.69 -51.23 36.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.179 -0.951 . . . . 0.0 113.538 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -55.51 -33.65 63.93 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.2 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.24 94.34 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 161.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -103.8 51.74 0.78 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.85 -7.58 59.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 7.3 m-80 67.07 49.29 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.787 1.235 . . . . 0.0 114.229 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.9 tp -72.36 117.25 13.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.08 103.64 10.08 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.713 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.98 100.75 13.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.46 0.704 . . . . 0.0 110.072 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -90.57 101.92 14.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.966 -1.084 . . . . 0.0 109.551 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -94.34 113.45 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.4 p -107.8 110.08 21.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.46 91.61 5.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.665 1.221 . . . . 0.0 111.281 -167.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.63 80.39 9.14 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.746 1.26 . . . . 0.0 113.817 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 -100.02 1.56 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.322 -0.861 . . . . 0.0 114.937 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.08 -4.47 56.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 162.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -114.27 162.83 16.08 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-O 122.224 1.011 . . . . 0.0 111.998 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.46 112.19 10.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.94 -1.1 . . . . 0.0 109.223 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.5 m -95.74 100.7 12.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 164.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -99.26 100.71 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -86.62 98.69 11.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.76 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.44 99.01 10.14 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -97.73 116.51 30.08 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -142.76 176.55 8.96 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.196 0.998 . . . . 0.0 113.394 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -55.09 -37.11 66.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 164.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.91 -46.8 14.64 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -147.02 144.27 29.02 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.539 1.518 . . . . 0.0 112.897 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -126.78 96.29 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 167.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.92 148.78 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.651 1.215 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.39 109.07 18.77 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.409 -0.807 . . . . 0.0 111.219 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.43 96.41 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.59 112.41 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -140.18 144.36 36.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.176 0.591 . . . . 0.0 111.925 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.69 153.2 18.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.365 1.079 . . . . 0.0 111.083 162.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.31 117.73 6.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.57 -9.68 68.96 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 -168.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -77.65 130.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 120.772 2.286 . . . . 0.0 110.691 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -80.15 122.31 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.658 -0.651 . . . . 0.0 112.341 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -148.44 165.98 29.52 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 121.552 0.692 . . . . 0.0 111.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.88 101.17 13.46 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 110.822 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -75.77 -55.69 5.4 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.262 9.3 m-20 73.12 137.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.872 1.269 . . . . 0.0 114.013 172.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.853 178.584 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.31 148.76 44.05 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 120.76 -1.212 . . . . 0.0 114.09 148.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.1 mt -140.35 100.78 3.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.61 0.764 . . . . 0.0 111.676 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -86.53 121.43 29.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.576 1.15 . . . . 0.0 111.917 171.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.59 -163.11 34.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.9 p -120.05 125.06 47.39 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.081 0.553 . . . . 0.0 111.907 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -80.42 106.93 12.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.792 -0.568 . . . . 0.0 110.21 155.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -98.12 170.01 9.21 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.965 0.888 . . . . 0.0 111.711 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.3 117.48 29.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.916 -1.115 . . . . 0.0 108.803 172.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -71.85 -43.77 64.94 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.2 -81.83 0.06 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -78.65 -31.29 46.74 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 157.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -86.75 132.04 33.97 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.688 1.131 . . . . 0.0 112.239 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.21 120.56 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 157.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.03 111.21 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.876 0.846 . . . . 0.0 108.783 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -106.24 105.93 2.48 Favored Glycine 0 N--CA 1.482 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 113.02 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -100.56 98.13 8.75 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -124.15 118.91 27.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.274 0.629 . . . . 0.0 111.561 -165.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -95.68 148.18 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 111.967 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -66.68 138.94 57.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.424 -1.422 . . . . 0.0 113.179 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.269 32.2 p -70.55 -33.44 71.14 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.55 -71.22 0.07 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.83 -50.58 3.15 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.346 1.058 . . . . 0.0 113.768 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.36 51.95 0.42 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -95.54 134.09 38.8 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.34 1.07 . . . . 0.0 110.151 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.88 118.05 12.23 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -108.9 115.66 30.5 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.81 104.92 17.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 109.642 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.3 p -99.2 102.75 14.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.8 134.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.619 1.1 . . . . 0.0 108.42 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -134.06 138.21 45.16 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.84 157.68 38.24 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.47 1.128 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.58 119.22 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.956 -1.09 . . . . 0.0 110.075 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -89.79 66.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 121.121 -0.987 . . . . 0.0 111.817 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.95 -77.87 0.95 Allowed Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.742 -1.224 . . . . 0.0 114.858 -168.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.63 -49.29 4.05 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.05 153.46 20.55 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 120.186 1.357 . . . . 0.0 114.122 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.23 108.59 20.06 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.506 -0.746 . . . . 0.0 110.562 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.17 139.66 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 169.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -130.2 101.88 5.98 Favored 'General case' 0 CA--C 1.563 1.465 0 O-C-N 121.675 -0.64 . . . . 0.0 109.867 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 119.1 23.52 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.131 0.972 . . . . 0.0 109.733 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -106.81 109.08 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 164.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.74 132.47 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -127.62 113.4 16.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 163.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.46 62.39 2.65 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.7 -44.98 3.38 Favored Glycine 0 CA--C 1.552 2.352 0 N-CA-C 118.115 2.006 . . . . 0.0 118.115 -166.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.59 123.81 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.402 1.601 . . . . 0.0 113.834 -162.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -80.24 150.63 29.98 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.506 1.146 . . . . 0.0 113.298 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.26 118.37 19.4 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.57 152.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -107.1 104.14 13.72 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -169.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -102.58 115.89 31.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.7 mt -101.98 113.74 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -98.72 130.73 45.21 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.049 1.404 . . . . 0.0 110.173 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -97.26 153.06 18.27 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.18 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.66 121.56 14.77 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 112.936 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.386 2.6 p30 . . . . . 0 N--CA 1.488 1.466 0 C-N-CA 125.463 1.505 . . . . 0.0 114.667 -175.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -159.35 83.8 0.77 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.165 -0.959 . . . . 0.0 110.126 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -166.48 175.82 7.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.284 -0.885 . . . . 0.0 111.915 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.9 m -81.84 124.78 29.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.964 -1.085 . . . . 0.0 110.482 160.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -124.98 104.09 8.38 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.304 0.641 . . . . 0.0 109.937 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -86.03 137.66 32.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.123 -0.986 . . . . 0.0 112.623 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.84 120.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.121 -0.987 . . . . 0.0 113.012 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -105.86 -64.83 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.78 0.832 . . . . 0.0 110.725 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.79 149.85 37.88 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 122.229 1.014 . . . . 0.0 111.402 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.0 m -157.86 106.11 2.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.101 -1.624 . . . . 0.0 109.692 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.24 -76.6 0.2 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -149.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.35 52.91 2.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.547 -1.346 . . . . 0.0 113.137 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.01 64.29 8.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 119.776 -1.828 . . . . 0.0 113.245 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.99 -49.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.374 1.07 . . . . 0.0 112.961 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -69.91 -39.39 76.21 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -45.23 -54.11 7.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 155.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.3 mtp -67.2 -40.62 86.48 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.92 -45.05 82.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 165.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -64.13 -34.89 79.1 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.39 -52.08 65.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 121.017 1.735 . . . . 0.0 115.535 166.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.17 65.96 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.8 p -148.44 128.68 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -77.56 158.66 29.75 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.292 10.1 tp -50.6 -41.03 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 118.853 2.909 . . . . 0.0 118.853 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -55.73 -46.09 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.98 -34.12 61.95 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -61.39 -38.97 88.98 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 165.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.81 -51.13 64.47 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-N 120.401 1.455 . . . . 0.0 114.694 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.07 -42.48 85.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.82 70.25 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.15 -50.92 66.29 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 164.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -88.53 55.1 3.27 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 119.444 1.02 . . . . 0.0 113.203 171.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -94.14 -7.47 42.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -173.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 60.08 42.28 15.93 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 114.99 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -74.54 117.44 16.36 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 122.691 1.234 . . . . 0.0 112.051 -172.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.601 ' NZ ' ' HG ' ' A' ' 52' ' ' SER . 7.2 ttpm? -117.46 112.58 20.83 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.898 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -96.02 103.04 14.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.884 -0.51 . . . . 0.0 110.306 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.5 m -91.03 97.89 11.44 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.96 124.1 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -135.73 114.62 12.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.04 115.85 28.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 112.638 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -83.76 76.68 9.98 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.11 0.957 . . . . 0.0 110.877 171.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.68 -81.02 0.53 Allowed Glycine 0 N--CA 1.492 2.378 0 O-C-N 121.144 -0.973 . . . . 0.0 115.141 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -100.07 -38.1 8.7 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 165.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -85.51 118.68 25.19 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.291 1.405 . . . . 0.0 113.05 -163.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -86.38 115.56 23.97 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.461 0.704 . . . . 0.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.1 m -86.78 104.44 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 162.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 t -106.45 116.67 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -84.73 99.49 10.87 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -75.03 91.07 2.5 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.601 ' HG ' ' NZ ' ' A' ' 37' ' ' LYS . 34.3 t -106.76 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.646 0.779 . . . . 0.0 110.789 -168.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.7 p -148.95 172.81 14.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.1 m -60.02 -49.09 79.05 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.36 -43.73 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -154.46 139.24 17.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.747 1.158 . . . . 0.0 111.889 -165.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -125.76 92.03 3.52 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -132.68 124.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.058 0.456 . . . . 0.0 111.153 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.49 102.9 10.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 112.135 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.91 103.78 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.36 106.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -129.59 138.56 51.34 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.6 0.76 . . . . 0.0 111.823 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.34 159.22 15.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.644 1.212 . . . . 0.0 111.86 167.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.5 113.3 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.68 75.91 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.0 126.4 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 121.013 2.407 . . . . 0.0 110.767 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -82.21 106.25 13.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.142 0.577 . . . . 0.0 111.871 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.48 154.3 48.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.732 -0.605 . . . . 0.0 112.384 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.36 89.54 7.7 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 122.709 1.242 . . . . 0.0 112.013 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -75.53 163.46 27.35 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.704 1.202 . . . . 0.0 112.523 168.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER -159.01 140.07 12.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.055 -1.653 . . . . 0.0 112.036 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -168.817 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.04 132.36 37.21 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 121.721 0.772 . . . . 0.0 112.919 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -136.49 103.72 5.35 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.747 0.819 . . . . 0.0 111.629 -159.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 127.38 35.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.166 -1.584 . . . . 0.0 111.623 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.68 174.47 46.91 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.226 2.451 . . . . 0.0 119.226 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.9 p -118.19 108.61 15.37 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.989 -1.106 . . . . 0.0 112.203 -169.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.73 107.54 5.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.612 -1.305 . . . . 0.0 109.989 166.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.5 m -110.07 -29.67 8.11 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -156.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.277 35.7 tp 69.08 103.31 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.312 1.445 . . . . 0.0 114.159 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.52 129.19 55.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.24 -108.82 1.42 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -118.3 45.33 2.03 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 163.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -141.99 114.68 8.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.13 95.77 5.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.839 -1.163 . . . . 0.0 110.187 170.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.5 tp -83.24 113.99 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 123.366 0.666 . . . . 0.0 110.606 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.89 2.47 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 123.834 0.731 . . . . 0.0 112.649 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -84.39 93.0 8.17 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -103.87 103.94 13.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.912 -0.492 . . . . 0.0 112.072 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -87.4 137.22 32.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.077 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -66.43 141.41 57.93 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.4 p -67.11 -32.69 74.0 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -63.86 -67.07 0.46 Allowed 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -109.4 -23.6 11.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 46.84 7.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.04 -16.1 55.79 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.317 6.3 tt0 69.36 87.88 0.12 Allowed 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.07 100.6 11.49 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -88.96 110.07 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.534 -0.729 . . . . 0.0 111.177 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -104.85 107.28 18.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.17 100.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.943 -1.098 . . . . 0.0 108.231 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -83.24 116.29 22.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.854 -0.529 . . . . 0.0 110.309 167.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -135.13 141.78 46.05 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.141 0.976 . . . . 0.0 110.294 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 105.41 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.32 -1.488 . . . . 0.0 107.022 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.251 14.7 tt -87.82 71.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.338 1.066 . . . . 0.0 110.714 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.12 1.54 Allowed Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.046 -1.034 . . . . 0.0 114.691 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.422 ' OD2' ' OE2' ' A' ' 112' ' ' GLU . 7.5 p-10 -105.12 -53.56 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.422 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 2.7 mt-10 -86.73 148.75 25.29 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 122.09 0.948 . . . . 0.0 112.914 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.3 tp -79.24 110.33 14.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.549 -0.719 . . . . 0.0 109.638 167.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.55 118.62 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -96.68 100.9 12.43 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 165.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 128.36 39.52 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.443 0.697 . . . . 0.0 109.759 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -135.31 119.1 17.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.845 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -87.16 144.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.012 0.525 . . . . 0.0 111.595 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -136.3 108.24 7.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 156.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.257 3.3 tm-20 49.19 70.03 0.52 Allowed 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.08 -42.73 2.76 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -169.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.63 119.71 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.708 1.254 . . . . 0.0 109.932 -165.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -98.41 140.2 33.03 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.854 0.835 . . . . 0.0 112.484 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.46 168.04 19.66 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.352 1.072 . . . . 0.0 112.497 162.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.69 150.05 51.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 111.599 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -122.99 117.0 24.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 157.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.4 109.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.34 127.5 47.94 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.959 0.903 . . . . 0.0 110.762 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -78.44 150.74 32.98 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.889 0.852 . . . . 0.0 112.62 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.43 122.23 14.06 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 113.155 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.489 1.492 0 C-N-CA 125.318 1.447 . . . . 0.0 111.501 -176.231 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.33 90.86 7.21 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 120.153 -1.592 . . . . 0.0 114.532 -161.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.8 m -167.26 174.19 8.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.761 1.224 . . . . 0.0 111.336 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.87 130.79 34.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -136.02 112.44 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -103.7 138.49 40.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 120.099 1.318 . . . . 0.0 113.453 -175.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.26 116.91 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -173.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -110.14 -48.29 3.2 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 123.949 0.899 . . . . 0.0 112.495 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 93.87 3.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.524 -0.735 . . . . 0.0 111.155 172.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -84.7 95.59 8.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.556 -1.34 . . . . 0.0 112.483 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.1 127.04 37.43 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.699 0.761 . . . . 0.0 111.11 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.303 6.7 t30 64.6 17.76 11.05 Favored 'General case' 0 CA--C 1.584 2.281 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 -171.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.52 -45.48 79.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -52.13 -41.39 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -42.56 61.92 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -46.78 -54.39 9.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 161.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.5 mmt -60.83 -48.12 83.23 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -60.55 -34.69 74.51 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -61.31 -40.79 95.48 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.0 mtp -58.46 -22.26 54.06 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 119.501 3.149 . . . . 0.0 119.501 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.93 49.67 3.28 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-N 120.246 1.384 . . . . 0.0 116.429 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.22 -30.87 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 17.8 m120 79.08 152.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.1 1.36 . . . . 0.0 112.444 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.17 75.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 122.89 1.329 . . . . 0.0 110.109 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.14 -68.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.877 1.271 . . . . 0.0 107.682 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -75.27 -38.57 60.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -61.51 -22.81 65.45 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -61.19 -55.71 29.1 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.361 0.982 . . . . 0.0 113.313 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -56.93 -29.01 62.74 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.43 -54.93 13.81 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.865 1.666 . . . . 0.0 113.885 162.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.15 -43.52 61.25 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -99.81 55.06 0.94 Allowed 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 161.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -70.45 -35.12 73.15 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 60.99 45.01 9.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.336 1.054 . . . . 0.0 113.751 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 tp -72.65 128.84 36.76 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.913 0.863 . . . . 0.0 113.038 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -126.44 118.36 24.8 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.777 0.831 . . . . 0.0 109.972 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.53 100.55 12.13 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.448 0.699 . . . . 0.0 109.787 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -95.28 96.86 9.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 109.054 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.8 mt -86.59 124.3 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.908 0.883 . . . . 0.0 109.321 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.8 p -122.04 109.61 14.78 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -113.74 126.05 54.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 112.258 -165.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.86 132.71 19.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 122.848 0.459 . . . . 0.0 110.156 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.11 61.99 4.97 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.306 31.7 m120 69.51 -28.2 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -168.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.88 128.57 34.81 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.409 1.459 . . . . 0.0 112.572 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -102.93 108.24 19.36 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 163.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 m -95.27 98.33 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 t -108.59 113.21 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -169.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 99.25 7.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.648 -0.658 . . . . 0.0 109.589 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.01 97.97 10.01 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.1 t -107.5 124.21 49.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 112.389 -161.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.6 p -146.14 169.02 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.822 0.849 . . . . 0.0 112.889 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -58.86 -38.5 78.9 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 167.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -64.89 -54.51 29.75 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -151.81 140.91 21.24 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.598 1.09 . . . . 0.0 112.332 -162.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.98 103.48 9.97 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.0 pt -125.33 127.78 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.946 -0.471 . . . . 0.0 111.241 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 96.52 8.52 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.192 -0.942 . . . . 0.0 111.486 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.64 100.3 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.54 110.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -127.76 124.09 36.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.348 0.594 . . . . 0.0 112.075 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -81.26 140.11 35.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.531 0.682 . . . . 0.0 111.382 166.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.93 120.72 11.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.75 -0.09 86.93 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.6 t -95.14 139.21 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.295 2.047 . . . . 0.0 110.122 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -76.81 110.11 11.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 112.135 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -134.52 169.39 17.35 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 123.699 0.8 . . . . 0.0 111.513 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -97.62 121.95 40.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 112.539 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -93.0 -66.56 0.91 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.341 16.0 m-80 92.55 129.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 125.732 1.613 . . . . 0.0 113.285 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.7 mt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.306 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.62 128.25 35.27 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.597 0.713 . . . . 0.0 111.049 167.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.12 111.86 24.1 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.081 0.952 . . . . 0.0 111.656 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.55 113.59 25.26 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.36 1.064 . . . . 0.0 110.948 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.51 -152.69 21.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -125.47 124.16 40.78 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 122.939 0.496 . . . . 0.0 111.937 -158.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -84.64 106.05 15.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.181 -0.949 . . . . 0.0 109.582 158.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -105.11 131.39 52.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.04 0.536 . . . . 0.0 110.6 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -82.57 98.0 8.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.869 -1.144 . . . . 0.0 110.639 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.41 83.85 7.57 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.685 0.755 . . . . 0.0 109.514 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -78.83 0.3 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 115.494 0.958 . . . . 0.0 115.494 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -112.28 -29.0 7.7 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -97.02 136.96 36.83 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 121.533 1.97 . . . . 0.0 111.973 -169.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.81 101.61 11.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -92.1 110.98 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 CA-C-O 122.2 1.0 . . . . 0.0 109.858 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.04 96.75 2.24 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 124.381 0.991 . . . . 0.0 112.884 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -91.99 94.84 9.47 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -119.21 107.28 13.24 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.891 0.476 . . . . 0.0 111.814 -163.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -73.21 141.15 47.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.81 -1.181 . . . . 0.0 112.054 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -69.14 132.81 47.15 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.175 0.988 . . . . 0.0 112.321 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.9 p -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 164.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -61.65 -74.58 0.08 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -89.1 -31.1 18.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.44 3.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -130.48 139.81 50.53 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 118.027 0.913 . . . . 0.0 109.764 171.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -72.4 102.52 3.19 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 123.497 1.618 . . . . 0.0 114.036 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -78.63 121.05 24.18 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.348 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -96.5 120.46 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 122.088 -0.382 . . . . 0.0 110.427 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -119.51 109.39 15.67 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.966 0.507 . . . . 0.0 110.001 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.15 108.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 120.358 -1.464 . . . . 0.0 109.267 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -88.59 119.75 29.34 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.425 0.69 . . . . 0.0 109.739 166.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -141.12 139.45 33.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 0.0 110.807 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.37 120.41 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.818 -1.176 . . . . 0.0 110.073 170.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.4 mt -116.09 94.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.17 -101.23 1.11 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.459 -0.776 . . . . 0.0 114.638 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -123.66 43.28 3.01 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 165.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.25 125.2 27.28 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.343 1.057 . . . . 0.0 108.683 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -86.48 105.99 17.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 m -88.89 115.7 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 109.225 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -107.64 95.99 6.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.418 -0.801 . . . . 0.0 110.067 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 86.2 m -91.11 96.76 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.035 0.534 . . . . 0.0 110.86 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -81.61 129.7 34.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.91 0.884 . . . . 0.0 111.323 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -126.31 115.55 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -120.9 117.96 28.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 118.545 0.611 . . . . 0.0 111.875 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 55.14 26.58 8.44 Favored 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.17 -32.28 7.73 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 -160.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.39 130.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.651 2.225 . . . . 0.0 113.48 -166.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.1 142.45 28.68 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.94 123.23 14.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.06 -1.025 . . . . 0.0 111.232 153.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -110.03 87.39 2.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -70.02 99.21 1.41 Allowed 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 170.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.3 mt -101.07 115.99 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -108.27 111.82 23.97 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.402 0.681 . . . . 0.0 110.715 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -78.17 146.03 35.28 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 121.607 0.717 . . . . 0.0 112.285 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -66.3 128.91 38.0 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.257 11.4 t70 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.909 1.684 . . . . 0.0 110.34 -165.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -94.42 82.17 4.02 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 120.067 -1.646 . . . . 0.0 114.491 -163.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -152.42 178.61 9.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.917 -1.114 . . . . 0.0 112.824 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 m -82.83 101.52 11.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.0 -1.063 . . . . 0.0 110.123 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -100.21 97.49 8.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.431 0.692 . . . . 0.0 110.067 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -97.96 139.24 34.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.603 . . . . 0.0 111.711 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 8.5 p -70.89 115.23 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.46 -60.83 2.2 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.64 0.776 . . . . 0.0 111.985 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -134.5 158.95 42.63 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 122.567 1.175 . . . . 0.0 111.094 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -156.97 143.44 18.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 119.397 -2.064 . . . . 0.0 112.025 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.49 139.19 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.235 0.541 . . . . 0.0 111.526 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.305 57.0 t30 53.99 38.92 29.91 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -81.05 -47.3 13.76 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.98 -37.42 74.19 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -51.61 66.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.528 1.058 . . . . 0.0 113.771 170.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -48.8 -53.44 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 mmt -55.06 -43.33 73.75 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -43.67 98.44 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 165.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.3 mtm -60.39 -61.51 2.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.71 56.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.347 0 CA-C-N 118.832 0.742 . . . . 0.0 114.925 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.96 127.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -76.71 163.16 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -50.88 -44.88 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -169.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 -46.94 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 119.795 1.18 . . . . 0.0 113.052 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -57.79 -39.67 78.08 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 mtm105 -60.39 -29.05 68.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 167.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 121.258 1.845 . . . . 0.0 114.524 164.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.68 -38.43 84.92 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 165.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.07 -58.54 7.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.58 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -89.69 52.39 2.31 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 118.881 0.764 . . . . 0.0 112.252 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -77.39 -51.58 10.57 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.375 -1.453 . . . . 0.0 113.743 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 37.4 m-80 66.19 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.179 0.992 . . . . 0.0 111.646 -163.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -72.28 120.66 18.2 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -119.16 114.25 22.16 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.373 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.08 101.01 11.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.839 0.456 . . . . 0.0 109.806 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -87.02 105.92 17.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.98 -1.075 . . . . 0.0 109.22 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.9 mt -102.61 130.36 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 C-N-CA 123.211 0.605 . . . . 0.0 109.417 -168.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -114.9 134.36 55.22 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.184 0.594 . . . . 0.0 109.678 160.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -96.24 96.93 9.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 109.852 155.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -83.56 78.47 9.67 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 122.69 1.234 . . . . 0.0 112.024 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.26 -96.17 2.04 Favored Glycine 0 N--CA 1.488 2.124 0 O-C-N 121.568 -0.708 . . . . 0.0 113.002 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -99.08 -47.57 5.18 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.22 134.24 56.79 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -97.04 108.51 21.25 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.011 0.924 . . . . 0.0 109.316 174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.4 m -90.07 100.13 13.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 164.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -94.93 102.9 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -88.04 93.01 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.616 -0.677 . . . . 0.0 109.282 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.59 120.73 24.92 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.592 0.357 . . . . 0.0 111.527 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -122.63 116.83 24.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.479 0.712 . . . . 0.0 109.396 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -149.03 168.83 22.09 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 122.364 1.078 . . . . 0.0 112.76 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 m -60.16 -37.85 81.38 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.84 -43.88 62.09 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.65 153.56 31.54 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.74 1.154 . . . . 0.0 111.36 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.13 104.14 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.554 -0.716 . . . . 0.0 110.298 166.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.49 159.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.043 0.925 . . . . 0.0 112.07 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -99.75 110.4 22.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.605 -1.309 . . . . 0.0 110.064 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.04 100.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.69 126.34 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.25 0.62 . . . . 0.0 109.794 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.55 141.88 21.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.73 -0.606 . . . . 0.0 111.982 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -92.02 147.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 112.084 170.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.86 91.47 5.37 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.07 -47.6 1.0 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 116.261 1.264 . . . . 0.0 116.261 -160.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -85.25 127.14 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.008 1.404 . . . . 0.0 109.912 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 t -74.41 142.27 45.02 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -141.83 166.48 24.62 Favored 'General case' 0 CA--C 1.572 1.807 0 C-N-CA 123.815 0.846 . . . . 0.0 112.253 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.85 104.46 16.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.382 0.61 . . . . 0.0 110.516 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -89.08 83.13 6.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 112.01 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -86.12 132.6 33.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.915 -1.115 . . . . 0.0 112.669 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.562 1.41 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.14 84.68 4.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 111.346 -158.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.5 95.56 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.327 -0.858 . . . . 0.0 113.214 -162.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -78.81 116.11 18.94 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.463 0.705 . . . . 0.0 110.837 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' C ' ' HG1' ' A' ' 81' ' ' THR . . . 176.2 -149.32 9.77 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 115.539 0.976 . . . . 0.0 115.539 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.446 ' HG1' ' C ' ' A' ' 80' ' ' GLY . 4.1 m -160.72 144.97 13.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.874 -0.78 . . . . 0.0 110.39 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.17 102.72 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 162.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -97.75 140.51 32.02 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.355 0.662 . . . . 0.0 111.864 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.79 102.15 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.819 -1.176 . . . . 0.0 111.016 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.15 84.94 4.92 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.004 0.906 . . . . 0.0 110.203 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.69 -81.99 0.61 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -119.38 -5.26 10.37 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -114.11 137.86 51.19 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 121.087 1.767 . . . . 0.0 110.237 -171.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.5 mt -82.54 106.42 14.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.45 -1.406 . . . . 0.0 110.105 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 tt -92.25 111.55 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 CA-C-O 122.399 1.095 . . . . 0.0 109.752 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.39 94.09 1.96 Allowed Glycine 0 N--CA 1.478 1.475 0 C-N-CA 123.878 0.751 . . . . 0.0 113.232 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -90.29 109.84 20.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -133.84 145.64 49.89 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.896 0.855 . . . . 0.0 111.512 -168.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -124.76 132.8 53.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.421 -0.799 . . . . 0.0 109.503 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -64.25 127.4 31.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 112.44 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.32 0.4 OUTLIER -82.8 -27.39 30.97 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -57.39 -54.82 42.44 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 164.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -93.47 -39.77 10.7 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.32 -13.59 51.52 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -158.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -96.03 153.66 17.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.383 1.592 . . . . 0.0 113.669 -160.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.48 134.56 34.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -166.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -119.47 129.65 54.84 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.7 1.2 . . . . 0.0 110.435 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -118.73 108.87 15.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.685 . . . . 0.0 109.491 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -115.47 112.95 23.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.916 -0.49 . . . . 0.0 111.981 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.29 116.12 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.984 -1.072 . . . . 0.0 109.215 -173.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -91.58 117.36 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.765 -0.585 . . . . 0.0 109.66 166.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.55 149.71 37.82 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.112 0.958 . . . . 0.0 112.478 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -89.51 103.87 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.395 -0.816 . . . . 0.0 109.354 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.6 tt -95.6 72.26 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.05 0.928 . . . . 0.0 110.96 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.88 59.75 6.74 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.353 24.8 m-20 79.59 -34.37 0.14 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.92 130.77 42.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 120.01 1.277 . . . . 0.0 113.034 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 46.7 tp -87.72 105.48 17.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.887 -1.133 . . . . 0.0 110.101 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.81 109.71 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.903 0.859 . . . . 0.0 110.295 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.11 104.53 17.09 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -106.93 91.11 3.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.216 0.607 . . . . 0.0 110.046 -162.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -81.87 102.04 10.6 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.456 0.703 . . . . 0.0 112.083 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.2 t -98.94 107.03 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -122.16 114.58 21.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.83 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 51.7 39.03 24.39 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 -32.86 5.89 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 118.673 2.229 . . . . 0.0 118.673 -165.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.15 110.27 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 120.578 2.189 . . . . 0.0 112.238 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -86.84 117.95 25.91 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.97 0.508 . . . . 0.0 111.662 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.11 118.44 32.85 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.537 0.684 . . . . 0.0 111.949 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -100.42 122.61 43.45 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.081 0.552 . . . . 0.0 110.815 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -108.39 111.91 24.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 167.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.91 112.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -105.55 135.62 46.62 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 121.383 0.611 . . . . 0.0 112.249 -170.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.44 146.81 25.02 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 122.003 0.906 . . . . 0.0 111.515 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -81.01 90.4 5.97 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 121.445 0.641 . . . . 0.0 112.637 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 5.3 t0 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.21 1.404 . . . . 0.0 113.821 172.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 . . . . . 0 CA--C 1.576 1.975 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.25 3.4 p-10 -95.83 88.32 4.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.93 -1.731 . . . . 0.0 114.171 -158.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 p -148.2 -170.81 3.69 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 122.292 1.044 . . . . 0.0 112.309 170.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -87.16 114.92 24.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.938 -1.101 . . . . 0.0 109.373 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -119.73 106.24 11.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.74 136.84 42.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.178 -0.951 . . . . 0.0 112.814 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.61 117.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 113.566 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -101.11 -55.84 2.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.1 0.56 . . . . 0.0 111.588 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -85.56 -78.66 0.26 Allowed 'General case' 0 CA--C 1.57 1.722 0 O-C-N 121.757 -0.589 . . . . 0.0 112.248 -162.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.268 16.1 m 57.66 95.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.287 13.5 tm-20 -87.12 -110.19 0.06 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.938 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -86.27 58.9 5.32 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-N 121.474 1.943 . . . . 0.0 115.136 -169.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -70.12 -31.82 69.54 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 165.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -48.61 -54.09 15.94 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 169.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.26 -31.93 68.11 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -55.88 -52.85 62.63 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 164.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.419 ' SD ' ' HA ' ' A' ' 28' ' ' ARG . 74.7 mtm -54.64 -46.55 73.96 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -55.72 -47.66 76.52 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.29 -44.25 75.54 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.3 mtt -65.78 -35.25 80.18 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.56 61.32 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 CA-C-N 119.703 1.138 . . . . 0.0 115.029 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.29 145.37 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.285 0.564 . . . . 0.0 111.447 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -80.83 156.57 26.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.594 -1.316 . . . . 0.0 114.126 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.273 14.8 tt -53.66 -42.22 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.44 -45.23 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -58.26 -46.35 86.18 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 76.2 mtt180 -52.12 -51.6 56.84 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 171.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.86 -49.09 77.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -58.5 -37.79 76.31 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.16 -38.45 31.36 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.3 -53.1 54.26 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 163.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -88.95 53.92 2.84 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 119.362 0.983 . . . . 0.0 113.181 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.11 -31.99 26.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 66.53 49.68 1.33 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 124.663 1.185 . . . . 0.0 113.383 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.9 121.54 23.58 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 122.682 1.229 . . . . 0.0 113.363 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -111.46 106.31 15.17 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.364 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.05 94.72 7.85 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.3 m -87.06 100.19 12.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.6 mt -93.87 127.85 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -171.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 p -129.11 110.74 12.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -91.44 101.09 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.9 . . . . 0.0 109.951 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.52 -35.5 30.28 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.3 81.77 0.04 OUTLIER Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.336 -0.853 . . . . 0.0 111.292 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 6.7 t-20 70.18 -52.48 0.64 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -159.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -62.8 137.92 58.39 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -112.61 109.45 19.0 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -84.23 103.1 13.14 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.543 0.737 . . . . 0.0 109.107 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.89 108.27 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.73 89.74 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.527 -0.733 . . . . 0.0 109.568 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.66 85.4 6.05 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.912 0.863 . . . . 0.0 111.872 -163.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.4 m -101.84 98.19 8.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.707 -0.621 . . . . 0.0 111.527 -154.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.7 p -127.44 171.03 11.92 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.65 0.78 . . . . 0.0 112.926 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -75.05 66.05 1.55 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.829 -1.169 . . . . 0.0 110.95 163.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.36 -62.18 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 123.949 0.899 . . . . 0.0 111.416 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.291 42.1 ptt85 -138.55 -62.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.268 30.8 t-20 66.0 91.07 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.42 1.463 . . . . 0.0 113.944 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.7 143.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.436 0.636 . . . . 0.0 110.762 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -80.92 101.4 9.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.476 0.655 . . . . 0.0 112.005 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.12 106.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.6 97.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -109.18 126.98 53.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.21 148.97 21.98 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.782 0.801 . . . . 0.0 111.7 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.49 119.77 15.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 113.813 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.63 1.46 89.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -91.77 132.81 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 120.144 1.972 . . . . 0.0 109.872 -173.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -78.28 110.74 13.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 112.155 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -132.75 159.64 39.12 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.636 0.731 . . . . 0.0 112.549 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.88 105.75 17.95 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.512 -0.742 . . . . 0.0 111.302 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -93.08 116.2 28.82 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.081 0.952 . . . . 0.0 110.559 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -89.91 131.0 36.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.009 -1.057 . . . . 0.0 111.558 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.498 1.935 0 O-C-N 120.646 -1.284 . . . . 0.0 114.242 176.685 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.7 m . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 122.014 0.912 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -117.54 124.94 49.93 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -155.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.96 109.42 8.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.836 -1.165 . . . . 0.0 112.09 -162.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.52 112.64 24.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.057 -1.027 . . . . 0.0 111.141 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.39 -149.91 15.81 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 117.209 1.644 . . . . 0.0 117.209 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -133.8 123.38 24.74 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.438 -152.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -82.53 116.23 21.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.942 -0.474 . . . . 0.0 110.233 158.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.2 m -113.63 134.63 54.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 111.248 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 tp -85.66 115.55 23.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 110.689 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.71 -93.41 0.1 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 123.089 0.555 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.49 -86.18 1.9 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 119.432 1.014 . . . . 0.0 111.49 169.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -110.95 47.01 1.02 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 117.047 0.424 . . . . 0.0 111.901 161.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -140.82 122.27 15.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.858 -1.151 . . . . 0.0 108.394 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.29 105.09 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.93 112.13 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.33 95.87 1.51 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -85.3 113.6 21.75 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -137.67 111.35 8.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.08 0.552 . . . . 0.0 111.053 -165.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -87.2 129.98 34.74 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 120.489 -1.382 . . . . 0.0 112.919 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -62.02 139.35 58.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 163.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.0 p -72.02 -51.22 22.82 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 -49.81 64.44 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -86.91 -36.95 18.08 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.03 12.08 79.16 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -173.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.41 -18.66 44.64 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.752 3.242 . . . . 0.0 119.752 -165.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.346 5.4 tt0 67.14 100.97 0.05 OUTLIER 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.95 132.29 41.31 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.735 0.814 . . . . 0.0 110.703 160.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -112.72 97.4 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 t -92.64 110.15 21.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.498 0.666 . . . . 0.0 110.177 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.56 117.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -103.05 119.32 38.64 Favored 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.663 0.785 . . . . 0.0 110.612 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -144.08 142.43 30.62 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.774 0.83 . . . . 0.0 110.477 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -84.43 111.69 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 108.155 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.26 98.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.25 -106.27 2.78 Favored Glycine 0 N--CA 1.488 2.116 0 O-C-N 121.847 -0.533 . . . . 0.0 112.927 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.4 ' OD1' ' OE2' ' A' ' 112' ' ' GLU . 3.3 p-10 -92.97 -30.31 15.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE2' ' OD1' ' A' ' 111' ' ' ASP . 3.9 mt-10 -102.19 141.33 35.2 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.149 0.975 . . . . 0.0 112.975 -160.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.59 104.8 5.42 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.003 164.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.34 103.82 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 95.13 5.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -105.61 111.1 23.66 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.751 0.421 . . . . 0.0 110.473 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.75 112.4 18.87 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.718 0.407 . . . . 0.0 110.284 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.83 114.72 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -139.43 108.1 5.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.204 0.602 . . . . 0.0 109.768 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 54.98 50.88 14.53 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.32 -27.75 4.5 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.939 2.335 . . . . 0.0 118.939 -166.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.72 130.06 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.722 1.761 . . . . 0.0 110.485 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -101.29 107.96 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.05 0.54 . . . . 0.0 109.968 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.21 98.75 9.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -93.84 87.83 5.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.732 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -90.99 104.42 17.02 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.69 121.32 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.721 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -109.32 119.37 39.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.601 0.76 . . . . 0.0 110.504 -166.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -76.27 147.88 37.97 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 122.152 0.977 . . . . 0.0 113.43 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -68.13 109.53 3.57 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 123.804 0.842 . . . . 0.0 112.829 175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 125.118 1.367 . . . . 0.0 112.569 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.36 174.09 5.16 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.392 37.0 p 86.83 -177.79 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.625 1.57 . . . . 0.0 114.075 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.9 m -96.92 129.07 44.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.654 -1.279 . . . . 0.0 111.405 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -122.26 102.73 8.3 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -100.53 144.66 29.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.54 0.686 . . . . 0.0 112.268 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.77 122.8 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.58 -68.05 0.78 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.795 163.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.17 128.17 44.29 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.556 0.693 . . . . 0.0 111.585 -172.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -109.44 120.48 42.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.654 0.782 . . . . 0.0 111.028 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.26 130.39 47.39 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.386 0.675 . . . . 0.0 110.538 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 18.7 t30 53.74 21.63 2.77 Favored 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 119.48 3.141 . . . . 0.0 119.48 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.44 -42.24 71.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -59.08 -38.91 80.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.75 -48.41 81.78 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 120.602 1.546 . . . . 0.0 114.837 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -48.13 -61.02 2.19 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 mtt -66.94 -35.75 80.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -63.83 -42.86 97.55 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 167.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -56.78 -42.98 80.4 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 164.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtp -51.34 -30.5 18.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 164.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.46 47.68 4.24 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 116.165 1.226 . . . . 0.0 116.165 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.43 163.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 122.197 0.998 . . . . 0.0 112.188 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -66.84 144.38 56.32 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.694 -1.254 . . . . 0.0 112.804 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.281 15.4 tt -56.89 -40.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.01 -44.68 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 119.554 1.07 . . . . 0.0 113.28 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -58.96 -40.99 86.38 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -35.35 79.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -67.11 -48.37 68.33 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 114.157 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -53.64 -24.92 15.67 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 165.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.76 -51.44 59.17 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 120.955 1.707 . . . . 0.0 114.602 164.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.74 -44.32 63.25 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -106.52 61.14 0.64 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 167.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.3 5.6 p30 -82.08 -35.5 28.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.304 -1.498 . . . . 0.0 114.698 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 54.95 44.44 28.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -76.3 122.08 23.9 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -111.28 133.77 53.37 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.551 0.74 . . . . 0.0 111.745 166.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.53 102.75 10.59 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -85.78 100.93 12.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.304 -0.872 . . . . 0.0 109.403 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -93.83 127.94 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -141.29 125.39 17.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.131 -0.981 . . . . 0.0 110.207 171.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -95.03 122.98 38.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.687 -0.633 . . . . 0.0 111.396 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -105.45 76.41 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.571 0.7 . . . . 0.0 109.895 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.13 78.05 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 115.994 1.157 . . . . 0.0 115.994 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 4.3 m-80 70.26 -50.27 0.65 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -167.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -73.64 120.74 19.65 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.017 0.927 . . . . 0.0 112.726 -172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -98.85 125.26 44.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.223 0.609 . . . . 0.0 111.919 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.6 m -94.78 108.13 20.14 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 165.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -105.29 101.47 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.16 104.87 17.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.16 145.03 35.88 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 121.936 0.874 . . . . 0.0 112.473 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -149.49 117.98 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.844 -1.16 . . . . 0.0 110.068 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 t -150.33 167.21 27.68 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 124.541 1.136 . . . . 0.0 111.26 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -51.9 -29.7 21.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -63.06 -53.86 47.15 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -171.78 171.29 5.26 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.226 1.01 . . . . 0.0 112.312 -162.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -133.26 119.58 19.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.731 -1.23 . . . . 0.0 111.129 161.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.4 pt -140.02 150.22 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-O 122.171 0.986 . . . . 0.0 111.521 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.12 106.63 18.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.7 t -95.59 93.61 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 t -93.91 120.77 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -135.51 139.48 44.02 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.145 0.974 . . . . 0.0 113.311 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.15 142.4 27.54 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 121.853 0.835 . . . . 0.0 110.858 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.22 92.79 1.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.397 -0.814 . . . . 0.0 112.84 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.37 -27.44 5.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.659 1.823 . . . . 0.0 117.659 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.08 127.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.036 1.918 . . . . 0.0 110.422 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -75.07 102.23 4.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.236 0.615 . . . . 0.0 111.309 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -112.27 150.6 30.73 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.754 0.822 . . . . 0.0 112.069 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -90.97 101.48 14.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.689 -0.632 . . . . 0.0 110.661 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.31 104.72 17.02 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.48 -0.762 . . . . 0.0 110.529 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -72.49 114.86 11.07 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.699 0.761 . . . . 0.0 111.769 168.22 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -75.65 107.19 7.65 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.586 0.707 . . . . 0.0 112.536 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.3 mt -84.24 104.36 14.21 Favored 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.427 -0.795 . . . . 0.0 110.536 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -87.17 110.35 20.09 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.448 1.099 . . . . 0.0 110.758 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.8 -157.87 30.39 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -128.37 136.18 50.57 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 122.903 0.481 . . . . 0.0 111.957 -165.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -91.56 114.93 27.59 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 153.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -107.19 136.9 46.25 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.084 0.554 . . . . 0.0 111.176 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.8 tp -89.31 104.39 16.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.972 -1.08 . . . . 0.0 110.987 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -78.09 -42.74 31.11 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.53 -92.27 0.08 OUTLIER Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -74.77 3.45 7.99 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 156.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -126.62 119.47 27.12 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.802 1.183 . . . . 0.0 108.772 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.07 102.34 13.76 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 160.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.88 113.55 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 C-N-CA 124.093 0.957 . . . . 0.0 109.25 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.8 104.1 3.01 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.044 0.83 . . . . 0.0 113.164 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.07 99.96 11.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.51 152.36 41.83 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.285 1.04 . . . . 0.0 112.121 -172.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -125.48 146.03 49.82 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.765 0.793 . . . . 0.0 110.056 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -65.41 129.57 40.23 Favored 'General case' 0 CA--C 1.565 1.556 0 O-C-N 120.827 -1.171 . . . . 0.0 112.11 170.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -85.63 38.17 0.73 Allowed 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 122.122 0.963 . . . . 0.0 112.298 158.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -160.74 45.35 0.2 Allowed 'General case' 0 CA--C 1.585 2.314 0 C-N-CA 124.845 1.258 . . . . 0.0 110.314 -157.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.38 51.6 p30 138.11 -50.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.763 2.425 . . . . 0.0 111.469 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.8 2.14 27.12 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -90.48 145.61 24.77 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.514 2.157 . . . . 0.0 112.649 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -70.49 151.06 45.51 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.87 113.89 12.02 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -104.61 132.19 51.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.618 -0.676 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -142.85 139.2 30.77 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.8 t -120.92 118.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -96.54 120.94 37.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 162.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -146.34 165.28 29.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.82 111.58 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.634 -1.291 . . . . 0.0 109.307 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.19 85.99 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.046 0.927 . . . . 0.0 110.204 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.95 -84.31 1.02 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.079 -1.013 . . . . 0.0 114.622 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -141.62 48.07 1.64 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 163.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -142.75 136.91 29.37 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -81.49 105.7 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.478 -1.389 . . . . 0.0 111.177 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.33 109.76 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.749 0.785 . . . . 0.0 110.442 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -98.13 104.43 16.46 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -91.47 142.6 27.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 123.257 0.623 . . . . 0.0 109.61 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -151.2 116.88 5.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.789 -1.194 . . . . 0.0 110.513 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.72 125.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.359 1.064 . . . . 0.0 108.505 -171.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 110.97 10.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.969 0.507 . . . . 0.0 109.791 173.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 68.02 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 175.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 -31.19 1.92 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.826 2.291 . . . . 0.0 118.826 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.98 102.72 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 119.311 1.556 . . . . 0.0 109.189 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.66 133.41 33.7 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.197 0.998 . . . . 0.0 111.104 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.24 156.25 47.86 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.108 0.956 . . . . 0.0 111.722 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -133.89 149.84 51.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.939 0.876 . . . . 0.0 111.855 -170.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -141.1 119.39 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.019 -1.051 . . . . 0.0 108.54 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt -101.52 108.02 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -94.3 123.23 37.56 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.629 0.772 . . . . 0.0 110.015 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -79.57 165.47 22.91 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.06 112.76 6.67 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.802 -1.186 . . . . 0.0 112.859 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 125.151 1.38 . . . . 0.0 113.372 178.361 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.12 101.61 2.29 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.232 1.378 . . . . 0.0 112.756 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.5 m 179.61 165.56 1.1 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.145 1.378 . . . . 0.0 110.518 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.1 m -96.33 111.98 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 167.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -108.8 114.25 27.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.776 -0.578 . . . . 0.0 110.509 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -92.74 135.29 34.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.105 -0.997 . . . . 0.0 112.559 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.3 129.22 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.885 -1.134 . . . . 0.0 113.61 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -119.0 -65.17 1.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.168 0.987 . . . . 0.0 110.998 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 75.46 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.345 0.658 . . . . 0.0 111.494 -165.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 p -85.89 139.59 31.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.341 2.5 tm-20 -94.06 -97.78 0.15 Allowed 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.542 -166.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.255 19.3 t30 -100.0 50.22 0.91 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.143 -1.598 . . . . 0.0 113.345 -167.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -76.84 -39.73 50.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.06 -40.55 98.04 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -67.19 -43.79 81.25 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -47.02 -54.97 9.06 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 161.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtp -65.32 -34.11 77.55 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -53.79 -46.36 71.0 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 163.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.66 -41.31 98.22 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.9 mmm -54.11 -48.95 70.19 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.06 65.72 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 123.536 0.589 . . . . 0.0 114.209 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.41 131.51 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.749 0.785 . . . . 0.0 110.701 -174.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.67 161.86 24.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.9 tt -58.23 158.03 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.384 42.3 t 82.14 -73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 C-N-CA 124.573 1.149 . . . . 0.0 109.267 -161.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -53.51 -50.68 64.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -64.07 -24.82 67.85 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -71.14 -48.54 51.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 121.67 2.032 . . . . 0.0 113.545 167.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.6 mt -56.0 -48.69 75.44 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 165.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.08 81.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -49.22 78.32 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.103 1.774 . . . . 0.0 115.355 165.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -92.3 59.95 3.57 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 121.79 -0.569 . . . . 0.0 111.439 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -74.3 -27.64 60.81 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.75 38.2 11.98 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.308 1.5 pt? -81.16 151.45 28.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -169.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -127.75 114.31 17.12 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.822 -173.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.8 mt -97.39 99.15 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.82 -1.175 . . . . 0.0 111.236 -170.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.2 m -85.71 95.02 9.25 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.886 0.851 . . . . 0.0 109.818 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.0 mt -95.71 121.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -133.6 69.57 1.47 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.606 0.639 . . . . 0.0 111.973 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -58.36 110.64 1.0 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -165.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.15 62.29 2.15 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.47 84.69 0.17 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.312 -0.867 . . . . 0.0 114.76 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.32 -66.21 0.29 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.546 1.173 . . . . 0.0 112.651 -160.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -67.93 123.69 21.29 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.347 1.059 . . . . 0.0 113.676 -161.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.21 107.9 19.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.265 -0.897 . . . . 0.0 110.825 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -90.9 101.99 14.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -112.11 102.36 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -85.42 97.34 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.04 93.29 9.33 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.734 0.778 . . . . 0.0 108.964 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.6 t -91.99 89.39 6.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.359 0.599 . . . . 0.0 111.8 -164.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.2 p -100.61 162.64 12.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -51.68 -36.63 47.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 163.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.09 -46.92 63.87 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -162.81 137.96 6.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.962 0.905 . . . . 0.0 111.342 -161.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -100.75 101.88 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 163.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 pt -103.89 113.45 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.107 0.563 . . . . 0.0 110.105 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -77.9 89.42 4.1 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.768 0.794 . . . . 0.0 112.024 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.88 106.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.95 104.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -117.85 132.28 56.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.925 -0.484 . . . . 0.0 112.255 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 157.45 24.66 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.778 1.275 . . . . 0.0 111.304 159.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.53 102.27 8.73 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.679 -1.263 . . . . 0.0 111.386 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.1 3.08 51.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 119.026 2.371 . . . . 0.0 119.026 -162.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.54 132.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 121.55 2.675 . . . . 0.0 112.222 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -82.99 102.9 12.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.283 -0.885 . . . . 0.0 110.768 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -139.13 157.58 45.71 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 112.997 -171.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.33 110.55 19.18 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.224 0.609 . . . . 0.0 111.533 173.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -100.61 113.66 26.68 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.122 0.969 . . . . 0.0 110.8 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.61 128.67 35.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 112.321 167.678 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 97' ' ' ASP 0.389 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 . . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.06 119.19 22.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-O 122.327 1.061 . . . . 0.0 111.322 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.38 111.32 23.58 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.689 0.796 . . . . 0.0 110.418 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -95.32 116.89 29.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 112.294 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.22 -150.58 18.59 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -133.48 116.63 16.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.274 -0.545 . . . . 0.0 112.278 -160.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.59 119.79 20.12 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.55 0.614 . . . . 0.0 111.036 158.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -132.21 150.81 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.701 0.8 . . . . 0.0 111.419 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -98.92 103.57 15.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.658 -1.276 . . . . 0.0 112.019 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -91.69 81.81 5.27 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.01 0.91 . . . . 0.0 110.083 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.9 -105.89 1.84 Allowed Glycine 0 N--CA 1.491 2.303 0 O-C-N 121.411 -0.806 . . . . 0.0 114.777 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.62 10.72 37.71 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -113.54 116.75 30.03 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.836 1.198 . . . . 0.0 110.005 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -77.25 96.75 4.63 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.971 -1.08 . . . . 0.0 109.22 163.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.58 111.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.994 0.918 . . . . 0.0 108.89 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.99 98.06 1.85 Allowed Glycine 0 N--CA 1.475 1.284 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -78.52 105.07 9.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.36 134.11 47.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 111.306 -165.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -106.29 140.59 38.99 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 111.257 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -66.71 122.95 18.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.566 -1.334 . . . . 0.0 112.366 167.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -63.45 -25.74 68.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.445 ' CG ' ' HG1' ' A' ' 76' ' ' THR . 5.5 m-20 -62.58 -44.98 94.97 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.95 -4.93 0.21 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -160.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.8 7.17 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 118.596 2.198 . . . . 0.0 118.596 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.87 -29.47 12.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -172.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.328 1.8 mt-10 71.46 112.98 0.06 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 124.73 1.212 . . . . 0.0 113.296 -160.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 114.78 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 164.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.68 134.7 35.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 111.522 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.2 p -131.3 116.37 17.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.962 -0.461 . . . . 0.0 110.654 -167.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -114.36 106.62 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 120.854 -1.154 . . . . 0.0 108.458 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -90.54 122.23 33.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.217 162.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.33 144.18 31.33 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.76 1.164 . . . . 0.0 113.882 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -96.56 104.61 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.85 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 174.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.11 -97.56 0.14 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -99.78 25.19 7.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.98 149.18 41.45 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.265 1.031 . . . . 0.0 110.213 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.7 tp -100.22 112.64 24.96 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 168.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.12 120.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -110.15 91.62 3.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.7 m -89.13 101.96 14.62 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.964 0.905 . . . . 0.0 109.413 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -103.25 116.07 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.827 -0.546 . . . . 0.0 110.162 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.92 123.95 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -126.06 111.81 15.13 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.36 0.664 . . . . 0.0 110.544 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.3 OUTLIER 52.79 53.98 11.26 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.14 -25.36 1.58 Allowed Glycine 0 CA--C 1.556 2.616 0 N-CA-C 119.292 2.477 . . . . 0.0 119.292 -165.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.47 109.48 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 119.362 1.581 . . . . 0.0 109.246 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -85.04 143.98 28.55 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.914 0.885 . . . . 0.0 112.807 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.36 121.17 17.51 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.472 -0.768 . . . . 0.0 110.813 162.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -100.44 110.01 22.18 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -90.23 109.57 20.64 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.4 mt -109.67 117.52 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.099 -1.0 . . . . 0.0 108.352 -167.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.64 144.77 42.36 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 121.692 0.758 . . . . 0.0 112.179 -167.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -114.34 138.86 49.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.942 0.897 . . . . 0.0 110.205 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -67.78 118.0 10.43 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -174.381 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.326 50.8 m-85 . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 116.288 1.959 . . . . 0.0 116.288 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -79.19 98.01 6.43 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.365 0.984 . . . . 0.0 112.471 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 m -168.65 -176.95 2.93 Favored 'General case' 0 CA--C 1.573 1.843 0 C-N-CA 124.95 1.3 . . . . 0.0 110.064 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.0 m -93.16 130.12 38.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.643 -1.286 . . . . 0.0 109.615 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -135.9 112.97 10.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.229 -0.919 . . . . 0.0 111.552 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -102.51 143.21 32.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 112.268 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.252 8.6 p -76.41 90.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.339 1.066 . . . . 0.0 113.319 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -46.17 18.45 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -141.35 79.51 1.69 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.92 1.236 . . . . 0.0 113.16 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -79.75 139.53 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.817 -1.177 . . . . 0.0 114.163 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.343 0.9 OUTLIER -86.87 -91.26 0.11 Allowed 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 123.989 0.916 . . . . 0.0 111.702 -177.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -107.0 43.7 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 121.116 1.78 . . . . 0.0 114.634 -166.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.79 -32.14 63.62 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.52 -44.56 80.91 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -69.1 -38.51 78.97 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.72 -54.09 38.59 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 162.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.422 ' SD ' HG13 ' A' ' 23' ' ' VAL . 8.1 mmt -48.06 -50.98 26.24 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 164.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -56.56 -45.92 81.02 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.2 -38.99 91.22 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.8 mtm -62.16 -35.02 77.54 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 167.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.83 62.63 0.54 Allowed Glycine 0 N--CA 1.49 2.26 0 CA-C-N 119.046 0.839 . . . . 0.0 114.96 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG13 ' SD ' ' A' ' 18' ' ' MET . 16.1 m -118.91 145.6 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.395 0.616 . . . . 0.0 111.175 -170.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -66.7 156.29 35.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.881 -1.137 . . . . 0.0 113.673 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.07 -43.72 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -57.92 -51.64 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -59.95 -44.88 94.12 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -51.6 -48.24 63.29 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -70.56 -58.53 3.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 168.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.15 -32.84 69.43 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.91 65.57 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 121.598 1.999 . . . . 0.0 115.598 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.76 85.25 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 156.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -100.45 49.15 0.9 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -85.47 -7.22 59.02 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 58.87 38.26 24.57 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.288 1.3 pt? -74.28 139.23 44.12 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.698 1.237 . . . . 0.0 113.059 -172.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -136.9 89.1 2.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -155.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.1 mt -89.35 110.16 20.98 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.148 0.579 . . . . 0.0 110.985 -160.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.4 m -89.0 106.71 18.6 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 164.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.01 124.19 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 60.5 p -139.63 118.56 12.52 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.966 -0.459 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -77.5 96.7 4.79 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.646 0.778 . . . . 0.0 111.158 167.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.24 83.57 7.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.688 1.232 . . . . 0.0 111.116 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.51 1.57 Allowed Glycine 0 N--CA 1.489 2.19 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.704 -165.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -131.98 -22.44 2.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.36 115.46 12.74 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 120.282 1.401 . . . . 0.0 112.723 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -78.64 106.13 10.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.477 -0.764 . . . . 0.0 110.025 171.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -88.15 103.64 15.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -104.54 107.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.28 96.15 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.62 90.55 3.95 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -89.77 95.45 10.25 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -129.25 173.06 10.85 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 0.0 112.955 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -58.88 -40.32 84.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.24 -40.17 52.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 151.21 31.08 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 121.677 2.035 . . . . 0.0 113.456 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -111.02 96.15 5.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.83 132.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.591 -0.693 . . . . 0.0 112.443 -168.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.23 109.36 18.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.006 -1.059 . . . . 0.0 111.773 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -95.36 101.0 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.4 t -100.15 116.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -141.51 123.02 15.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -174.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.69 152.93 31.34 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 112.611 166.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.33 106.47 1.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 113.558 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 CA--C 1.552 2.385 0 N-CA-C 118.846 2.299 . . . . 0.0 118.846 -169.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.09 135.67 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 121.127 2.464 . . . . 0.0 112.654 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.7 p -84.42 105.16 15.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.315 -0.865 . . . . 0.0 110.925 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.27 163.04 31.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -100.33 110.11 22.33 Favored 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 123.155 0.582 . . . . 0.0 110.37 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -73.56 -61.7 1.74 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.261 39.2 m-80 77.91 100.95 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.778 1.172 . . . . 0.0 114.055 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 CA--C 1.577 2.011 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.608 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.84 127.94 34.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.481 0.712 . . . . 0.0 109.912 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -137.05 97.97 3.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.765 -1.209 . . . . 0.0 111.806 -157.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.481 HH21 ' NZ ' ' A' ' 94' ' ' LYS . 32.3 ptt180 -91.37 115.63 28.19 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.415 0.686 . . . . 0.0 111.843 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.34 -154.07 23.12 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -127.48 145.58 50.79 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.37 116.36 29.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.131 -0.981 . . . . 0.0 108.995 150.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -106.67 174.7 5.77 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 121.158 0.504 . . . . 0.0 111.462 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -124.29 120.91 33.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.149 -1.594 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.43 83.46 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 109.972 169.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.86 -93.21 0.39 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.266 -0.896 . . . . 0.0 115.227 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -117.69 39.39 3.35 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 166.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.97 110.69 9.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.799 -1.188 . . . . 0.0 108.092 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -82.48 118.27 23.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 109.685 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -111.88 105.84 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.404 0.682 . . . . 0.0 110.219 -167.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.41 95.8 2.11 Favored Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 113.098 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -102.62 102.54 12.77 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.36 134.17 51.14 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.431 0.692 . . . . 0.0 110.911 -168.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.481 ' NZ ' HH21 ' A' ' 79' ' ' ARG . 0.2 OUTLIER -104.42 127.65 52.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.14 115.23 13.39 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.388 -0.82 . . . . 0.0 112.835 -170.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -59.14 -44.84 92.08 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.96 -39.47 78.18 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -125.48 -28.15 3.35 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -161.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.46 65.95 1.49 Allowed Glycine 0 N--CA 1.492 2.37 0 CA-C-N 120.615 1.552 . . . . 0.0 114.777 -172.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -152.89 137.43 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 117.512 0.656 . . . . 0.0 111.869 -164.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -77.66 122.16 24.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 113.391 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.05 120.19 41.6 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.717 0.807 . . . . 0.0 109.602 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -113.01 108.05 16.81 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.259 15.3 t -115.94 102.26 9.51 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.175 0.59 . . . . 0.0 112.255 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.93 121.08 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.181 -0.949 . . . . 0.0 109.855 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -96.17 125.62 40.82 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.932 0.893 . . . . 0.0 111.423 170.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -149.83 159.77 44.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.989 0.899 . . . . 0.0 112.224 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.29 117.61 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.552 -1.342 . . . . 0.0 109.352 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.73 -51.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.57 77.37 0.08 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.48 0.0 OUTLIER 78.09 -45.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -159.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -78.44 143.73 36.46 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.03 116.94 29.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.91 0.884 . . . . 0.0 110.427 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.35 107.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.761 -0.587 . . . . 0.0 109.521 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.48 103.29 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.0 m -101.47 91.5 4.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.313 0.645 . . . . 0.0 109.993 -161.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.55 109.89 18.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.339 1.056 . . . . 0.0 112.892 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.15 119.12 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -124.48 113.25 17.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 50.36 55.33 9.64 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.03 -21.12 1.38 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.36 102.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.739 1.769 . . . . 0.0 108.946 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.84 141.36 28.71 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.71 0.804 . . . . 0.0 112.883 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.98 116.0 12.39 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.493 0.717 . . . . 0.0 111.403 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.35 101.94 13.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 0.0 108.632 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -82.91 101.86 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.7 mt -95.08 106.81 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.41 130.37 43.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.093 0.557 . . . . 0.0 110.945 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -85.47 148.16 26.11 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.459 0.647 . . . . 0.0 111.424 169.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -80.53 90.01 5.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 122.137 0.97 . . . . 0.0 112.035 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -174.03 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 116.728 2.122 . . . . 0.0 116.728 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.58 94.78 5.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.48 1.133 . . . . 0.0 112.244 -163.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -167.21 173.11 9.3 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.745 1.26 . . . . 0.0 111.346 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 m -84.8 129.6 34.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.056 . . . . 0.0 110.613 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -136.24 99.99 4.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.912 -0.493 . . . . 0.0 111.366 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -87.84 136.38 32.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.092 -1.005 . . . . 0.0 112.653 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -65.83 119.89 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.69 -62.75 1.2 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.643 0.777 . . . . 0.0 111.219 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -133.69 103.03 5.7 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.163 0.585 . . . . 0.0 110.985 -160.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -96.56 100.12 11.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.36 -0.837 . . . . 0.0 112.334 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.35 122.46 24.49 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.053 0.541 . . . . 0.0 110.849 -174.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.253 23.8 t30 64.09 12.5 7.05 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -65.76 -43.17 89.68 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.57 -35.95 77.3 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.93 -41.73 50.89 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -45.93 -52.1 12.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 158.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mtt -68.6 -28.94 67.37 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -55.75 -47.07 77.59 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-N 120.871 1.669 . . . . 0.0 114.825 158.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -59.47 -41.4 89.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 167.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.4 mtp -60.91 -39.02 87.76 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 167.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.03 65.29 0.64 Allowed Glycine 0 N--CA 1.486 2.01 0 CA-C-N 118.926 0.784 . . . . 0.0 114.186 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.79 131.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.353 0.596 . . . . 0.0 110.611 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -74.64 153.78 38.8 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 14.1 tt -48.16 -39.4 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -172.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.45 -59.45 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 120.29 1.405 . . . . 0.0 113.024 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -68.0 -37.84 81.92 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.17 -40.99 82.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -60.5 -44.56 95.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 163.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.44 -40.6 75.05 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.17 77.18 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 171.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.96 68.06 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 166.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -94.0 58.31 2.55 Favored 'General case' 0 CA--C 1.575 1.912 0 C-N-CA 123.832 0.853 . . . . 0.0 111.947 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.42 -23.04 18.55 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 61.01 52.33 4.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.693 1.197 . . . . 0.0 114.222 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.0 tp -82.24 114.06 20.48 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.401 -0.812 . . . . 0.0 112.639 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -100.16 105.05 16.61 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.05 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.34 102.32 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.2 m -92.45 105.42 17.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.1 mt -96.57 124.56 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -170.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -147.9 107.67 3.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.699 -0.625 . . . . 0.0 111.323 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.01 147.43 26.21 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 171.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.38 -48.53 12.79 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 164.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.84 -68.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.172 -0.955 . . . . 0.0 113.386 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -123.33 48.84 1.77 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.767 -0.843 . . . . 0.0 112.449 164.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -154.14 109.96 3.22 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.033 -1.042 . . . . 0.0 108.318 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -86.08 118.48 25.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.902 0.481 . . . . 0.0 111.752 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.5 m -84.67 102.99 13.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 165.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.8 m -100.25 108.63 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.35 99.5 12.3 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.69 74.53 3.69 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.885 -161.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 t -87.99 109.7 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.737 -1.227 . . . . 0.0 113.227 -166.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -139.71 163.55 32.31 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.936 1.294 . . . . 0.0 109.405 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 m -75.57 51.95 0.62 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 119.687 -1.883 . . . . 0.0 112.336 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -174.73 -53.84 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.809 0 C-N-CA 125.06 1.344 . . . . 0.0 111.78 -164.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -93.63 -91.58 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.189 1.359 . . . . 0.0 110.023 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.303 2.1 t30 51.71 57.74 6.22 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.0 pt -119.53 -35.61 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.273 35.0 mt-10 76.98 99.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.086 1.312 . . . . 0.0 112.135 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.66 113.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.15 97.35 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -106.93 136.43 46.78 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -86.4 149.71 24.82 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.201 1.001 . . . . 0.0 112.427 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -80.47 75.23 7.33 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 110.347 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.14 -60.23 0.26 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 -161.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.18 140.59 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 118.402 1.101 . . . . 0.0 112.287 -172.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 p -86.95 118.6 26.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.986 -1.071 . . . . 0.0 110.459 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -140.21 162.23 35.76 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.837 0.827 . . . . 0.0 112.643 -166.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.23 103.55 10.18 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 111.692 167.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -81.77 -48.16 11.97 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 168.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.255 15.4 m-20 69.19 168.05 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.872 1.269 . . . . 0.0 114.168 172.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.571 1.763 0 O-C-N 120.914 -1.117 . . . . 0.0 109.003 167.784 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -84.65 151.96 24.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -141.39 109.81 5.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.873 -0.517 . . . . 0.0 110.134 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -97.35 122.43 40.38 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.238 1.015 . . . . 0.0 110.817 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.61 -160.07 33.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.6 m -140.69 142.26 34.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.391 -0.476 . . . . 0.0 110.007 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -89.31 109.6 20.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 163.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -96.76 135.24 38.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.293 0.637 . . . . 0.0 111.17 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.45 105.35 17.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.858 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -78.71 -41.59 30.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.15 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -85.1 5.24 30.52 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 159.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -121.47 123.57 42.36 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.964 1.256 . . . . 0.0 109.508 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.58 100.9 12.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 159.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 tp -89.03 107.27 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-O 122.005 0.907 . . . . 0.0 109.289 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.53 100.89 1.87 Allowed Glycine 0 N--CA 1.475 1.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.334 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.08 96.06 10.57 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -113.63 154.47 27.16 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.991 . . . . 0.0 111.702 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -146.1 147.35 31.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.71 -1.244 . . . . 0.0 111.767 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -72.44 149.43 44.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p -72.92 -46.62 51.6 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.007 -1.058 . . . . 0.0 112.969 152.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -50.01 5.59 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -174.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.52 20.89 5.15 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.63 -16.18 3.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 120.434 2.934 . . . . 0.0 120.434 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -83.29 146.28 28.62 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 118.717 1.259 . . . . 0.0 113.982 -157.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -69.69 130.85 43.48 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.34 111.62 23.29 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.77 162.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -91.23 112.58 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 109.936 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -114.75 136.24 53.29 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.413 0.685 . . . . 0.0 111.135 -170.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.66 114.11 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.868 -1.145 . . . . 0.0 108.838 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -96.53 112.85 24.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.913 -1.117 . . . . 0.0 109.725 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.83 140.52 32.97 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-O 121.221 0.534 . . . . 0.0 112.322 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.9 120.16 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.45 -1.406 . . . . 0.0 109.594 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -97.88 75.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 123.93 0.892 . . . . 0.0 110.737 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.65 -89.51 1.24 Allowed Glycine 0 N--CA 1.492 2.41 0 O-C-N 120.523 -1.361 . . . . 0.0 114.453 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -126.1 36.2 4.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 170.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -136.09 121.33 19.09 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.299 1.039 . . . . 0.0 108.227 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -78.63 108.63 12.18 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.216 0.607 . . . . 0.0 109.423 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.4 m -90.69 114.07 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -95.38 99.31 11.24 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.2 m -92.17 96.75 10.49 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 -167.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -100.66 115.58 30.55 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.863 0.865 . . . . 0.0 110.834 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -113.99 115.78 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -118.46 117.93 30.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.725 -0.609 . . . . 0.0 109.445 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.1 OUTLIER 41.62 66.06 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.4 -35.25 2.43 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.1 118.49 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.294 1.547 . . . . 0.0 109.609 -164.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.71 146.04 24.32 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.223 1.011 . . . . 0.0 112.663 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.26 146.23 44.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.735 0.779 . . . . 0.0 111.663 156.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -118.86 101.99 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -82.71 102.81 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.7 mt -100.17 115.96 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -108.27 120.47 42.47 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.335 0.654 . . . . 0.0 110.044 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -81.48 156.5 25.29 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.954 0.883 . . . . 0.0 112.774 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -65.17 122.61 17.48 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 112.869 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.265 10.7 t70 . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 125.403 1.481 . . . . 0.0 110.529 -167.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.72 83.91 7.74 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -163.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 t -148.91 -173.11 4.27 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 122.794 1.283 . . . . 0.0 111.119 168.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -91.3 123.78 35.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.018 -1.051 . . . . 0.0 109.614 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -132.95 115.83 15.69 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.011 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -112.56 146.17 39.01 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 120.256 1.389 . . . . 0.0 112.993 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.99 115.12 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.17 -64.42 1.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.771 0.829 . . . . 0.0 111.454 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -138.61 118.9 13.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.255 0.622 . . . . 0.0 111.177 -169.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.6 p -102.59 121.06 41.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.373 0.669 . . . . 0.0 111.412 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -103.89 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.495 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -77.27 38.09 0.22 Allowed 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 121.26 1.846 . . . . 0.0 115.816 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.0 -42.66 37.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -64.31 -27.9 69.35 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -78.99 -42.65 26.14 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -45.81 -51.21 13.22 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 161.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.2 mtp -66.88 -30.44 70.61 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.92 -49.57 76.31 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 165.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -57.03 -33.69 67.45 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 166.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.9 mtp -64.71 -50.66 66.08 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 165.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.97 67.72 0.27 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 119.029 0.831 . . . . 0.0 114.407 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.45 149.82 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.867 0.841 . . . . 0.0 110.789 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -79.73 159.95 26.43 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 10.8 tp -49.44 -47.35 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.73 -46.67 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -76.45 -37.78 56.42 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -49.57 -46.13 48.59 Favored 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 121.287 1.858 . . . . 0.0 115.355 161.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.27 -57.17 10.2 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -56.75 -35.05 68.17 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.78 97.8 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.74 93.34 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 164.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -93.17 42.02 1.09 Allowed 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -77.89 -23.88 48.6 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 60.71 47.06 8.46 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.79 108.07 4.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 111.826 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -99.5 108.2 20.58 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.347 0.659 . . . . 0.0 109.343 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.25 100.83 12.04 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.703 0.801 . . . . 0.0 109.07 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.0 m -93.98 98.04 10.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.9 mt -97.79 122.72 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -165.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -117.89 106.84 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.86 88.44 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.952 0.882 . . . . 0.0 111.264 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -80.12 46.21 0.79 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.6 83.3 0.49 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.732 -1.23 . . . . 0.0 114.719 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.317 24.7 m120 72.08 -40.4 0.47 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 -174.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -74.41 145.72 43.49 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.498 1.142 . . . . 0.0 113.081 164.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.03 109.95 13.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 0.0 108.595 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.8 m -89.51 99.97 12.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.32 104.12 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -85.6 104.37 15.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.613 -0.679 . . . . 0.0 109.779 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -93.7 99.24 11.69 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.943 0.897 . . . . 0.0 109.383 -173.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 t -104.7 114.03 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.1 0.56 . . . . 0.0 111.505 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -143.78 175.71 9.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -59.62 -33.12 71.09 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 163.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -85.56 -46.58 10.69 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -143.74 142.69 31.05 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.786 0.834 . . . . 0.0 111.875 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -126.48 92.4 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.73 144.46 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -164.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 112.25 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.913 -1.117 . . . . 0.0 112.065 171.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -99.15 105.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.22 115.21 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -135.78 146.9 48.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.702 -0.624 . . . . 0.0 112.504 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -99.51 151.95 20.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.136 0.969 . . . . 0.0 111.591 164.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.22 122.99 16.45 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.99 85.22 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.27 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.581 2.191 . . . . 0.0 110.637 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.7 p -75.04 106.81 6.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.584 -0.698 . . . . 0.0 111.122 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -140.17 161.61 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.643 0.735 . . . . 0.0 112.487 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.93 104.13 12.07 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 111.775 170.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -86.77 -177.36 6.09 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 122.06 0.933 . . . . 0.0 111.775 164.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.29 152.16 51.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 CA--C 1.571 1.788 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 146.61 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 93.41 4.33 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 125.947 1.699 . . . . 0.0 113.161 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt -100.4 99.53 10.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 112.328 -171.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -85.54 117.8 24.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.878 -1.139 . . . . 0.0 113.283 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.56 -171.25 44.35 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 116.969 1.548 . . . . 0.0 116.969 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -115.28 117.81 31.52 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 118.595 -0.716 . . . . 0.0 111.652 -170.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -74.53 107.14 6.47 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.155 0.889 . . . . 0.0 110.784 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -119.58 135.82 54.63 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.591 0.756 . . . . 0.0 111.324 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.59 107.46 18.16 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.801 -1.187 . . . . 0.0 111.691 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.44 80.42 2.23 Favored 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.602 1.161 . . . . 0.0 109.915 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.85 0.83 Allowed Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.511 -0.743 . . . . 0.0 113.772 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -88.05 -35.77 17.35 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -75.73 121.82 23.09 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.197 0.908 . . . . 0.0 112.409 -164.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mt -80.6 96.85 6.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.0 109.169 166.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.59 116.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.102 0.961 . . . . 0.0 109.491 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.0 100.48 1.58 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.667 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.4 86.71 7.24 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -109.47 112.96 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.237 0.615 . . . . 0.0 111.942 -164.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -89.37 130.97 35.66 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.195 -0.941 . . . . 0.0 111.293 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.89 114.3 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.975 . . . . 0.0 110.477 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.8 m -59.56 -49.97 75.71 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -162.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.295 3.4 t70 -72.76 -17.29 61.61 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.61 -58.79 3.02 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.691 1.587 . . . . 0.0 114.545 162.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.52 44.13 9.72 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 -146.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -142.94 139.48 30.72 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.175 1.487 . . . . 0.0 111.357 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.14 138.96 31.1 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.665 2.469 . . . . 0.0 117.665 -163.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.36 111.86 16.28 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.591 1.556 . . . . 0.0 108.253 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -100.35 115.97 31.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 110.987 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.4 p -109.83 115.19 29.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.594 0.758 . . . . 0.0 111.003 -169.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.73 116.9 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 119.467 1.03 . . . . 0.0 109.266 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -94.35 124.86 38.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.195 0.598 . . . . 0.0 110.908 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.48 42.08 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.508 0.671 . . . . 0.0 111.0 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.4 mm -95.92 109.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.691 -1.256 . . . . 0.0 108.571 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.258 10.3 tp -79.71 63.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 122.439 1.114 . . . . 0.0 112.904 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.04 -77.88 1.12 Allowed Glycine 0 N--CA 1.49 2.238 0 O-C-N 120.556 -1.34 . . . . 0.0 115.07 -170.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -97.14 -45.19 6.63 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -96.95 148.63 22.77 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 112.956 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.6 tp -85.56 114.71 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.901 -1.124 . . . . 0.0 110.411 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.3 m -87.8 123.93 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.784 . . . . 0.0 109.776 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -104.94 98.69 8.37 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 164.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.2 m -95.05 106.76 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -109.07 115.61 30.38 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.596 0.758 . . . . 0.0 110.273 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.18 110.06 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -98.5 105.98 18.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.942 1.246 . . . . 0.0 109.682 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 46.89 50.2 13.84 Favored 'General case' 0 CA--C 1.58 2.101 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.96 -40.49 2.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.16 116.34 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.48 2.14 . . . . 0.0 112.373 -170.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -92.32 138.68 31.31 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 121.729 0.776 . . . . 0.0 112.921 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.37 142.31 47.15 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.678 0.791 . . . . 0.0 111.609 164.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -123.43 101.94 7.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -83.06 117.65 22.99 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 166.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -104.82 123.09 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -108.8 127.64 54.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.965 0.906 . . . . 0.0 111.151 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -85.26 148.74 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.997 0.903 . . . . 0.0 112.899 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.89 123.95 31.81 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.196 0.598 . . . . 0.0 112.338 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 125.088 1.355 . . . . 0.0 112.592 174.121 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.353 82.2 m-85 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.72 72.96 5.27 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 119.949 1.249 . . . . 0.0 113.269 -171.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.9 p -156.43 -178.01 7.02 Favored 'General case' 0 CA--C 1.573 1.856 0 C-N-CA 124.42 1.088 . . . . 0.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.26 128.75 34.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.94 -1.1 . . . . 0.0 110.915 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -129.39 114.55 16.31 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -101.86 141.37 34.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.286 -0.884 . . . . 0.0 112.394 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.69 93.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.873 -1.142 . . . . 0.0 113.916 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.88 -45.74 9.48 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -143.64 152.72 41.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 111.354 -167.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.5 m -159.65 150.77 19.62 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.362 -2.086 . . . . 0.0 112.994 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -123.76 0.06 Allowed 'General case' 0 CA--C 1.578 2.045 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.22 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.295 0.1 OUTLIER -77.22 49.8 0.72 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 122.448 2.385 . . . . 0.0 116.776 -174.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -47.72 83.58 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.449 1.5 . . . . 0.0 114.745 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.92 -36.84 84.49 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.72 -44.18 74.4 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 120.177 1.353 . . . . 0.0 114.496 170.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -46.8 -56.73 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.9 mtt -67.21 -28.63 68.24 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -59.09 -48.27 82.2 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.82 1.645 . . . . 0.0 115.145 161.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -62.53 -36.2 81.85 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 mtp -59.09 -59.38 5.57 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.29 69.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.5 0.591 . . . . 0.0 114.456 171.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.3 p -148.43 136.56 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.932 0 CA-C-O 121.92 0.867 . . . . 0.0 110.17 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -82.42 164.65 20.86 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 33.1 pt -55.59 -40.17 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -169.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -48.9 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -70.67 -36.03 73.13 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -65.45 -42.3 92.48 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 167.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -55.53 -39.74 70.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.01 -60.93 2.78 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.508 160.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.75 74.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -173.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.37 71.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 161.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -124.52 41.9 3.39 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 123.741 0.816 . . . . 0.0 112.903 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.12 11.31 4.26 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 20.0 m-80 56.1 49.63 15.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -168.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.93 113.97 14.03 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.252 1.025 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -112.82 118.61 35.42 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.683 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -101.6 97.45 7.88 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.9 m -95.01 115.02 26.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -110.36 127.09 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -164.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -140.07 116.52 10.7 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.585 -0.697 . . . . 0.0 111.139 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -71.54 114.55 9.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -90.75 86.47 6.35 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.447 0.642 . . . . 0.0 109.292 165.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.79 23.23 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 117.431 1.732 . . . . 0.0 117.431 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.346 33.1 m120 65.59 -0.5 1.22 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -164.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -95.7 107.56 19.78 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 120.484 1.493 . . . . 0.0 109.384 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.38 105.69 8.66 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.047 0.939 . . . . 0.0 111.515 -169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.0 m -79.86 95.51 6.08 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.14 112.38 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.62 74.58 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.731 -169.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -84.68 101.42 12.16 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.56 0.695 . . . . 0.0 109.665 -158.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.6 m -114.91 101.96 9.53 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.872 -156.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -137.13 176.06 9.05 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.6 t -66.98 -9.68 41.28 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 168.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.26 -55.71 4.18 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.589 1.541 . . . . 0.0 113.156 166.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -155.42 140.65 17.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 118.703 0.683 . . . . 0.0 110.662 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -108.51 93.28 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -116.83 115.6 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.249 0.547 . . . . 0.0 110.501 -163.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.69 90.2 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.13 116.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -166.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.03 92.83 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -104.58 134.07 48.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.02 153.0 41.07 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 112.435 166.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.7 mt -73.71 73.94 1.53 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 120.966 -1.084 . . . . 0.0 111.845 164.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.39 -63.18 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -167.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.36 146.06 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 p -83.1 106.2 14.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.4 -0.813 . . . . 0.0 110.925 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -129.87 154.98 46.75 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.466 0.706 . . . . 0.0 112.612 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -82.01 119.92 24.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 111.579 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -94.11 -40.62 9.95 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.266 5.6 m120 76.8 99.07 0.07 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 168.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.149 -0.969 . . . . 0.0 112.346 175.398 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.501 2.075 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.303 22.8 pt-20 -86.7 95.95 9.97 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-O 123.104 1.43 . . . . 0.0 112.371 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.92 111.94 8.5 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.73 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -94.37 122.18 36.66 Favored 'General case' 0 CA--C 1.559 1.32 0 O-C-N 121.951 -0.468 . . . . 0.0 111.625 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.83 -152.38 21.6 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 115.573 0.989 . . . . 0.0 115.573 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.3 p -130.52 115.57 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.741 -155.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -80.42 142.42 34.35 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.509 0.671 . . . . 0.0 110.456 157.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.7 m -153.05 146.31 24.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.58 -1.325 . . . . 0.0 110.826 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.7 tp -88.24 102.61 14.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.89 -1.131 . . . . 0.0 111.36 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.0 93.77 7.59 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.324 0.65 . . . . 0.0 109.455 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -100.99 0.76 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 121.368 -0.833 . . . . 0.0 113.668 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -89.95 -33.07 16.54 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 161.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -80.76 133.19 35.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.845 1.657 . . . . 0.0 112.554 -161.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.14 101.07 7.71 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.721 -1.237 . . . . 0.0 109.562 163.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.84 111.81 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.737 0.815 . . . . 0.0 109.866 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.89 98.18 2.12 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 123.924 0.773 . . . . 0.0 113.06 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.48 103.58 16.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -121.52 150.5 41.52 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.235 1.017 . . . . 0.0 112.409 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -118.37 140.27 50.1 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.642 0.777 . . . . 0.0 109.487 169.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -66.11 125.2 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.722 -1.236 . . . . 0.0 112.049 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 m -70.89 -43.31 68.6 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.46 -0.775 . . . . 0.0 113.022 171.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -51.05 -56.92 10.2 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 165.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.75 -40.23 9.46 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.62 -9.78 60.65 Favored Glycine 0 CA--C 1.556 2.595 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.79 150.07 28.07 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 119.689 1.744 . . . . 0.0 112.841 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -85.46 143.7 28.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -173.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -131.92 134.87 46.15 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.48 1.112 . . . . 0.0 110.179 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -119.5 109.16 15.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.68 120.33 41.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.627 -0.67 . . . . 0.0 112.119 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.43 110.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.266 -0.896 . . . . 0.0 109.002 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 mtm-85 -92.75 116.38 28.97 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 121.586 -0.696 . . . . 0.0 110.766 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -137.51 149.43 46.77 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.769 0.828 . . . . 0.0 111.601 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -99.76 115.14 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.79 -1.194 . . . . 0.0 108.391 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 pt -80.73 -27.96 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.31 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.11 34.88 2.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 159.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -145.15 128.87 17.21 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.114 0.966 . . . . 0.0 109.865 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.98 110.05 20.29 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.742 0.817 . . . . 0.0 109.641 170.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.17 114.08 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -109.45 91.64 3.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -93.98 98.38 10.99 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.403 0.681 . . . . 0.0 110.073 -166.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.12 98.78 11.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.732 0.813 . . . . 0.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.12 106.88 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -120.3 109.7 15.69 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 53.61 50.5 17.05 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.86 -27.8 4.25 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 -167.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.0 t -87.74 113.92 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.694 1.747 . . . . 0.0 109.524 -170.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -104.87 101.53 11.12 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.398 0.679 . . . . 0.0 111.978 -169.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.31 102.97 14.84 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 112.377 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -81.48 99.22 8.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.097 0.559 . . . . 0.0 110.226 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -99.71 109.87 22.31 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.93 120.1 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.673 -1.267 . . . . 0.0 108.768 -159.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.2 123.65 48.31 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.517 0.727 . . . . 0.0 110.014 -168.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.06 156.8 31.5 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.986 1.266 . . . . 0.0 113.526 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -64.49 99.98 0.34 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 123.845 0.858 . . . . 0.0 113.147 174.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 4.8 t0 . . . . . 0 C--O 1.256 1.399 0 C-N-CA 125.407 1.483 . . . . 0.0 114.355 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.322 86.3 m-85 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -71.24 92.49 1.02 Allowed 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.083 1.311 . . . . 0.0 113.522 -164.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -177.04 171.21 2.14 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 125.211 1.405 . . . . 0.0 110.877 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -90.02 126.83 35.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.941 -1.099 . . . . 0.0 110.7 171.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -128.62 109.32 11.25 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.123 0.569 . . . . 0.0 110.07 -173.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -104.18 143.72 32.55 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.233 0.924 . . . . 0.0 113.067 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.43 120.56 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.402 ' CG ' HH21 ' A' ' 10' ' ' ARG . 10.7 t0 -86.72 -66.08 0.94 Allowed 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 123.486 0.715 . . . . 0.0 110.683 170.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.402 HH21 ' CG ' ' A' ' 9' ' ' ASP . 3.1 ptp85 -137.14 117.98 14.14 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.936 0.494 . . . . 0.0 111.223 -168.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.1 p -93.1 100.13 12.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.704 -0.622 . . . . 0.0 110.176 166.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.74 -80.4 0.07 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -155.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -88.29 44.36 1.19 Allowed 'General case' 0 CA--C 1.579 2.081 0 CA-C-N 120.32 1.418 . . . . 0.0 113.451 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -80.33 -45.29 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.387 -1.446 . . . . 0.0 114.827 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.71 -21.16 65.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.36 -40.95 17.24 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 120.331 1.423 . . . . 0.0 114.799 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -47.43 -49.98 23.89 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.971 1.714 . . . . 0.0 115.534 158.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 165.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -54.17 -44.43 71.48 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -58.16 -40.63 81.89 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 165.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -40.17 95.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 169.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.35 65.37 0.63 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 119.055 0.843 . . . . 0.0 114.177 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -128.13 148.38 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 122.274 1.035 . . . . 0.0 112.511 -167.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.91 159.2 33.14 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 14.2 tt -53.3 -38.67 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.93 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.264 0.938 . . . . 0.0 113.198 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -56.27 -43.81 79.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -60.33 -38.63 84.35 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -67.95 -54.93 14.87 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 166.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.38 -36.04 77.13 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.73 74.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.68 81.36 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 163.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -97.92 49.47 1.02 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 119.288 0.949 . . . . 0.0 113.532 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -83.31 -12.25 56.84 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.34 36.06 25.27 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.91 122.94 20.88 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 122.288 1.042 . . . . 0.0 112.674 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -118.42 111.79 19.13 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.032 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.61 98.98 10.07 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 m -92.04 100.24 12.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.835 . . . . 0.0 109.007 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.56 122.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.1 p -130.48 109.73 10.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -94.69 102.68 14.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.825 -1.172 . . . . 0.0 110.918 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.1 pm0 -75.09 -34.87 61.8 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.54 81.42 0.05 OUTLIER Glycine 0 N--CA 1.486 2.003 0 CA-C-N 119.18 0.9 . . . . 0.0 111.83 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER 74.32 -56.41 0.64 Allowed 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -160.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -60.53 139.54 57.72 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.62 114.47 28.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.823 0.449 . . . . 0.0 109.855 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.0 m -88.55 96.75 10.75 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.03 112.04 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.35 102.31 11.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.47 -0.769 . . . . 0.0 109.069 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -97.05 101.18 12.7 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -174.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.1 t -116.11 115.51 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.072 0.549 . . . . 0.0 112.412 -165.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -150.04 179.03 8.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -166.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -62.45 -43.69 98.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 164.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.1 -42.1 69.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 172.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -149.16 130.02 14.25 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.415 1.007 . . . . 0.0 111.209 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -119.99 86.99 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.22 144.74 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.676 -0.64 . . . . 0.0 111.657 -158.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.68 116.03 28.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.706 -1.246 . . . . 0.0 111.902 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.34 99.59 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.67 95.73 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.88 130.18 53.07 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.268 0.556 . . . . 0.0 112.477 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -92.22 145.51 24.44 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-O 122.353 1.073 . . . . 0.0 111.062 166.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.23 128.05 32.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.163 -0.961 . . . . 0.0 112.234 -168.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 -8.66 59.25 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 119.161 2.424 . . . . 0.0 119.161 -167.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.21 137.14 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 119.904 1.852 . . . . 0.0 110.813 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 95.62 5.68 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 121.711 0.767 . . . . 0.0 111.77 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -120.9 165.18 15.56 Favored 'General case' 0 CA--C 1.573 1.852 0 C-N-CA 124.401 1.08 . . . . 0.0 111.851 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -82.06 125.68 31.11 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.863 -1.148 . . . . 0.0 113.011 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -139.69 72.12 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.819 -0.55 . . . . 0.0 110.763 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -77.75 146.45 35.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.938 . . . . 0.0 113.086 -172.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 CA--C 1.574 1.871 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 178.69 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.503 2.193 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -94.14 120.21 34.07 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 125.19 1.396 . . . . 0.0 109.744 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.1 mt -127.88 131.14 49.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 112.164 -164.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -120.17 134.24 55.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.577 -0.702 . . . . 0.0 110.711 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.73 -178.62 43.81 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 118.944 2.337 . . . . 0.0 118.944 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.1 p -118.3 120.09 36.6 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.408 -1.396 . . . . 0.0 110.992 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.25 111.45 20.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -87.51 -38.37 16.1 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.267 39.3 tp 62.01 86.74 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.957 1.303 . . . . 0.0 113.586 -167.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -86.45 83.57 7.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.18 0.99 . . . . 0.0 109.956 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.98 -96.14 0.59 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -98.26 -9.43 25.55 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -108.7 122.31 46.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.13 1.786 . . . . 0.0 110.383 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -73.44 102.02 3.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.809 -1.182 . . . . 0.0 109.84 168.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -97.27 123.3 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-O 121.523 0.677 . . . . 0.0 109.761 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.98 102.22 0.67 Allowed Glycine 0 N--CA 1.481 1.655 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.11 -170.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -84.29 98.92 10.26 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.301 0.551 . . . . 0.0 110.301 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -107.09 105.91 16.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.157 0.98 . . . . 0.0 110.019 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -90.01 133.1 35.01 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 121.639 -0.663 . . . . 0.0 110.938 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -62.38 122.7 16.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.3 p -71.19 -26.6 63.03 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -64.98 -57.47 8.63 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 164.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -111.35 -46.77 3.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 38.71 6.14 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 118.562 2.185 . . . . 0.0 118.562 -165.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.82 -8.04 59.31 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.301 4.9 tt0 72.18 99.49 0.07 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 175.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 tt -99.86 114.88 28.38 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.871 0.868 . . . . 0.0 110.229 172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -99.71 113.33 25.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.0 m -103.42 122.4 44.79 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 122.832 0.453 . . . . 0.0 110.759 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.57 111.06 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -105.29 113.05 26.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.375 0.67 . . . . 0.0 109.739 171.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.91 158.38 44.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.442 -0.786 . . . . 0.0 112.634 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.98 111.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.993 -1.067 . . . . 0.0 108.261 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 10.9 tp -85.5 68.26 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 CA-C-O 122.341 1.067 . . . . 0.0 111.744 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.77 -84.55 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 120.795 -1.191 . . . . 0.0 114.698 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.35 -17.39 18.05 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -118.46 131.34 56.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.336 1.425 . . . . 0.0 111.334 -168.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.8 tp -79.63 109.88 14.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 110.209 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.4 114.04 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.57 99.29 9.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.0 109.231 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.581 ' HG1' ' NZ ' ' A' ' 125' ' ' LYS . 30.4 m -100.01 105.67 17.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -172.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -84.18 102.3 12.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.198 0.599 . . . . 0.0 110.561 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.83 112.12 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -128.89 107.03 9.31 Favored 'General case' 0 CA--C 1.564 1.497 0 O-C-N 121.779 -0.576 . . . . 0.0 110.818 -176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.406 15.4 pt-20 39.56 64.57 0.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.56 -33.13 4.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -168.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.61 117.81 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 119.341 1.57 . . . . 0.0 109.758 -162.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.21 144.95 25.97 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.84 144.29 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 161.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.581 ' NZ ' ' HG1' ' A' ' 116' ' ' THR . 60.7 mttm -122.98 104.01 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 109.226 -174.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -80.7 105.44 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 162.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.91 123.26 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -109.44 125.37 52.35 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.441 0.696 . . . . 0.0 110.218 -171.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -81.39 165.54 21.22 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.573 0.701 . . . . 0.0 112.248 169.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -71.54 100.45 2.25 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 120.869 -1.144 . . . . 0.0 112.09 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 7.3 t0 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 125.2 1.4 . . . . 0.0 114.012 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -155.69 81.87 1.03 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.022 . . . . 0.0 109.884 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -167.74 171.19 10.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.126 -0.984 . . . . 0.0 112.052 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -71.84 117.29 13.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.92 . . . . 0.0 111.138 161.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -114.64 101.87 9.5 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.69 135.99 33.62 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.476 0.711 . . . . 0.0 112.685 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.22 117.58 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.57 -62.88 1.19 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.723 0.809 . . . . 0.0 111.302 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.73 129.59 47.36 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.02 0.914 . . . . 0.0 110.946 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m -113.27 115.32 28.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -87.71 -57.78 2.82 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.894 0.478 . . . . 0.0 112.27 -165.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -121.15 145.83 47.41 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -163.21 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.077 0.951 . . . . 0.0 111.305 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -35.48 80.65 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -67.29 -37.14 82.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 165.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.6 -52.09 63.27 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.6 mtp -58.54 -37.44 75.68 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.4 -43.9 75.68 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.55 -44.84 95.35 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 166.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.0 mtm -58.22 -44.1 88.04 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.508 2.04 . . . . 0.0 116.508 175.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.17 63.02 0.1 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.6 143.59 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-O 122.483 1.135 . . . . 0.0 111.139 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -82.05 163.11 22.3 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 120.853 -1.155 . . . . 0.0 113.742 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.8 tp -64.0 157.46 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 O-C-N 121.03 -1.044 . . . . 0.0 113.24 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.389 21.8 t 80.48 -61.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 124.346 1.058 . . . . 0.0 110.7 -162.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -56.2 -47.42 78.4 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 162.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -61.83 -16.6 51.45 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 164.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.67 -44.31 12.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.21 1.368 . . . . 0.0 113.462 164.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.96 -48.89 69.84 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 166.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.76 -18.66 62.11 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.09 -58.51 3.98 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.912 1.233 . . . . 0.0 113.019 158.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.1 49.39 1.79 Allowed 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' CG ' ' HG ' ' A' ' 53' ' ' SER . 31.0 t0 -79.78 -30.43 40.64 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 63.91 55.41 1.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.713 1.142 . . . . 0.0 112.547 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.3 tp -79.81 113.25 17.82 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.957 0.884 . . . . 0.0 111.658 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -107.15 101.36 10.77 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.048 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.34 93.85 8.81 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.4 m -90.37 94.34 9.7 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.59 0.709 . . . . 0.0 110.336 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mt -80.77 124.47 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.674 0.79 . . . . 0.0 109.389 -175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.5 p -133.12 104.54 6.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -92.24 115.87 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.65 -1.281 . . . . 0.0 112.274 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.92 -41.29 59.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.7 -84.09 0.05 OUTLIER Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.126 -0.984 . . . . 0.0 111.42 171.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -82.02 -49.73 9.91 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 157.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.87 119.71 11.17 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -85.58 115.95 23.58 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -95.86 99.44 11.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -96.53 103.89 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.32 100.38 8.36 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 123.297 0.639 . . . . 0.0 110.062 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -86.92 97.3 10.61 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.419 0.688 . . . . 0.0 109.433 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -107.03 113.11 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.075 0.55 . . . . 0.0 110.317 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HG ' ' CG ' ' A' ' 34' ' ' ASP . 4.1 p -145.49 -170.45 3.45 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.21 1.005 . . . . 0.0 113.292 -174.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -62.0 -47.31 85.38 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.901 -1.125 . . . . 0.0 113.441 165.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -63.17 -48.77 76.99 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -142.09 163.05 33.92 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -160.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -143.43 88.68 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.111 163.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 141.62 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.261 -0.9 . . . . 0.0 112.429 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -84.72 115.31 22.61 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 121.398 -0.814 . . . . 0.0 112.708 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.24 98.32 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -87.39 114.07 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -127.44 124.1 37.64 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.757 0.789 . . . . 0.0 112.824 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.29 148.44 29.42 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 121.683 0.754 . . . . 0.0 111.478 164.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.52 88.46 2.68 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.758 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.07 -47.38 0.69 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -160.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.9 t -75.7 136.88 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 118.716 1.258 . . . . 0.0 112.264 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.3 p -89.84 120.12 30.8 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.304 -0.872 . . . . 0.0 110.35 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.82 156.8 47.03 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 121.971 0.891 . . . . 0.0 112.737 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.26 97.78 10.97 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.519 0.676 . . . . 0.0 110.479 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -84.31 97.94 9.73 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.531 -0.731 . . . . 0.0 110.299 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.41 133.07 39.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.579 -0.7 . . . . 0.0 112.057 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -174.643 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.39 130.12 35.03 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.42 120.46 38.21 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.705 1.202 . . . . 0.0 108.876 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -113.4 108.79 17.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.389 -1.444 . . . . 0.0 111.1 -159.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.22 -149.19 18.97 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 -172.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.9 m -140.78 147.26 38.82 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.01 0.91 . . . . 0.0 112.314 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -92.45 117.61 30.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.014 163.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -111.74 144.34 41.18 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.375 0.67 . . . . 0.0 111.586 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.3 tp -87.77 103.36 15.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.732 -1.23 . . . . 0.0 110.861 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.92 84.86 4.99 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.966 0.888 . . . . 0.0 108.848 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.34 -97.05 0.44 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -95.28 -19.97 19.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -89.17 124.24 34.17 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.639 1.563 . . . . 0.0 111.19 -172.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -82.54 100.07 9.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.772 -1.205 . . . . 0.0 108.967 164.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -95.79 110.32 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-O 122.131 0.967 . . . . 0.0 109.893 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.7 93.15 1.85 Allowed Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.005 0.812 . . . . 0.0 112.363 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.41 94.65 9.44 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.41 131.18 56.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.277 0.631 . . . . 0.0 109.719 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -90.41 134.72 34.15 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.953 -1.092 . . . . 0.0 110.131 164.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.23 105.88 1.52 Allowed 'General case' 0 CA--C 1.566 1.573 0 O-C-N 120.824 -1.173 . . . . 0.0 110.653 169.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -42.93 -59.63 1.92 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -163.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.69 67.42 0.67 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 123.568 1.651 . . . . 0.0 107.497 -169.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.71 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.068 -162.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.27 45.37 5.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 116.182 1.233 . . . . 0.0 116.182 -171.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -139.81 126.3 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 117.843 0.821 . . . . 0.0 109.883 -166.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -76.74 127.12 32.16 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.91 109.58 21.51 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.557 0.743 . . . . 0.0 109.281 161.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -98.77 122.38 41.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.02 94.17 4.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.02 -0.425 . . . . 0.0 110.217 -159.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.94 105.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 119.764 -1.835 . . . . 0.0 108.99 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -102.89 113.34 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.834 0.743 . . . . 0.0 110.506 170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -135.2 154.03 51.75 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 123.946 0.899 . . . . 0.0 111.06 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -86.57 108.71 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.692 -1.255 . . . . 0.0 109.627 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.7 tp -88.68 72.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.997 0.903 . . . . 0.0 111.117 172.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.59 0.5 Allowed Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.06 -1.025 . . . . 0.0 115.122 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -91.15 -14.07 31.81 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -134.3 145.57 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 119.443 1.019 . . . . 0.0 112.283 -161.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.2 tp -82.4 105.97 13.9 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.722 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.1 p -87.5 108.15 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -0.778 . . . . 0.0 110.209 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -98.96 106.25 18.48 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.114 0.566 . . . . 0.0 110.278 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.7 m -98.1 110.73 23.26 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.83 0.852 . . . . 0.0 109.78 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -98.9 105.99 18.2 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.542 1.137 . . . . 0.0 108.373 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.92 110.12 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -139.23 127.08 22.11 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.543 0.737 . . . . 0.0 110.86 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 50.66 45.17 27.23 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.63 -15.5 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 119.688 2.635 . . . . 0.0 119.688 -166.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.87 119.46 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 CA-C-N 119.618 1.709 . . . . 0.0 108.958 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.96 120.89 33.04 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.32 0.648 . . . . 0.0 110.565 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.92 136.31 54.81 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.53 0.732 . . . . 0.0 112.306 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -126.53 117.99 23.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 109.912 -172.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -109.96 116.75 32.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.06 120.03 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -108.95 126.21 52.85 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.842 0.857 . . . . 0.0 110.172 -171.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -91.85 153.92 19.23 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.174 0.988 . . . . 0.0 113.125 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -63.34 112.93 2.93 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.289 5.3 m-20 . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 126.221 1.809 . . . . 0.0 108.436 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.317 73.9 m-85 . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.11 94.63 2.44 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 -170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 m -173.73 177.53 2.45 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.581 1.552 . . . . 0.0 110.532 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.6 m -92.96 129.07 39.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.915 -1.741 . . . . 0.0 111.05 168.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -124.18 104.76 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.236 0.614 . . . . 0.0 109.871 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -89.82 133.37 34.76 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.511 0.724 . . . . 0.0 111.238 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.34 111.91 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.382 -0.823 . . . . 0.0 112.444 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.64 -62.79 1.51 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.276 0.631 . . . . 0.0 111.747 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -143.52 116.29 8.74 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.75 0.786 . . . . 0.0 109.788 -168.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.3 m -99.57 127.65 45.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.271 0.628 . . . . 0.0 110.729 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.317 5.7 tm-20 -74.82 -93.59 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -167.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -96.82 39.25 1.18 Allowed 'General case' 0 CA--C 1.577 1.982 0 O-C-N 120.477 -1.389 . . . . 0.0 113.72 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.27 -36.99 58.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.91 -35.64 78.99 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 166.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -71.28 -40.07 71.15 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 167.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -47.44 -50.45 22.87 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 157.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.476 ' SD ' HG12 ' A' ' 23' ' ' VAL . 6.5 mmt -59.3 -42.39 91.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 169.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.09 -44.67 91.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 166.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -55.91 -43.89 77.73 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.9 mmt -58.51 -37.65 76.06 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 167.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.3 46.01 2.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.476 HG12 ' SD ' ' A' ' 18' ' ' MET . 7.1 p -108.73 142.76 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 C-N-CA 123.841 0.856 . . . . 0.0 110.518 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -69.76 165.56 21.15 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.299 12.5 tt -73.63 53.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.78 -67.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -67.67 -25.95 65.96 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -42.9 -42.47 3.7 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 153.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.42 -52.01 5.61 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.291 -0.862 . . . . 0.0 112.364 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -57.86 -40.11 79.36 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.53 -35.03 60.81 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.88 88.36 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 163.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -103.43 47.67 0.87 Allowed 'General case' 0 CA--C 1.577 1.994 0 C-N-CA 123.867 0.867 . . . . 0.0 112.895 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -83.78 -11.56 56.91 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 59.27 46.21 13.09 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.311 -1.493 . . . . 0.0 114.185 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tt -85.32 108.65 17.9 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 121.379 -0.825 . . . . 0.0 111.914 -166.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -94.82 111.19 22.99 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.448 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.82 101.67 13.77 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.369 0.668 . . . . 0.0 110.256 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -81.48 101.15 9.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.168 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.7 mt -90.38 119.58 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 p -128.79 108.68 10.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -88.44 84.58 6.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 111.527 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.41 76.25 5.92 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 121.92 0.866 . . . . 0.0 111.563 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.95 77.23 0.7 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 115.812 1.085 . . . . 0.0 115.812 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.292 18.1 t-20 70.9 -57.87 0.58 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.25 119.01 9.45 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -86.42 106.37 17.4 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.502 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.4 m -87.64 97.35 10.82 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -104.23 107.79 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -94.63 106.02 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -78.78 111.86 15.34 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.237 0.615 . . . . 0.0 110.801 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 t -113.02 106.07 14.24 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.047 0.539 . . . . 0.0 109.558 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -142.86 178.43 7.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -58.83 -39.63 81.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -60.65 -52.12 66.5 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 165.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -158.3 151.45 22.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -159.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -122.91 90.92 3.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.789 0.836 . . . . 0.0 109.675 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.29 148.8 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.233 -0.917 . . . . 0.0 112.785 -167.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.86 116.88 33.77 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.109 0.964 . . . . 0.0 112.609 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.01 104.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.45 114.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -123.12 124.57 43.36 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.86 145.87 29.21 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.818 0.818 . . . . 0.0 111.263 166.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.73 117.5 11.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.33 0.11 85.05 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 119.537 2.575 . . . . 0.0 119.537 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.7 t -95.95 137.1 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 120.526 2.163 . . . . 0.0 110.374 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.0 p -75.28 121.83 22.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.728 . . . . 0.0 112.651 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -137.97 158.6 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.644 -0.66 . . . . 0.0 112.455 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.51 107.28 18.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.71 -0.619 . . . . 0.0 110.304 173.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -95.46 110.13 22.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -75.18 126.8 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.631 -0.668 . . . . 0.0 110.62 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.498 1.941 0 O-C-N 120.757 -1.214 . . . . 0.0 113.88 172.189 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.24 101.35 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.3 115.49 24.74 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -98.08 109.6 22.33 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.621 0.769 . . . . 0.0 110.409 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.59 -176.52 46.54 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -120.94 119.56 32.95 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.093 -1.553 . . . . 0.0 110.565 -166.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -79.47 112.19 16.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.905 0.775 . . . . 0.0 110.202 159.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.2 m -106.62 138.09 43.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.278 0.631 . . . . 0.0 110.983 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 tp -88.43 108.44 19.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.782 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -67.72 -42.56 81.74 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 171.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.28 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -79.77 -22.07 43.62 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 157.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -105.97 134.42 49.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.284 1.402 . . . . 0.0 111.341 -167.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.5 mt -94.35 111.35 23.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 108.78 167.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -105.36 120.11 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.784 1.234 . . . . 0.0 109.184 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.02 111.83 2.48 Favored Glycine 0 N--CA 1.483 1.805 0 O-C-N 121.839 -0.538 . . . . 0.0 113.94 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -97.59 107.97 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.136 0.575 . . . . 0.0 109.556 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -127.14 107.25 9.86 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.399 0.618 . . . . 0.0 112.618 -164.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.72 124.71 31.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -61.24 150.53 34.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.829 -1.17 . . . . 0.0 113.875 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.6 m -80.67 68.23 6.82 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-O 123.508 1.623 . . . . 0.0 111.011 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -152.23 -85.04 0.07 Allowed 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -115.72 -22.87 8.94 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 50.81 2.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 -167.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -82.03 -30.78 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.383 10.7 tt0 74.99 97.83 0.07 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 126.001 1.72 . . . . 0.0 114.707 -168.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 tt -89.58 116.32 27.64 Favored 'General case' 0 CA--C 1.563 1.442 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.526 165.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -92.07 117.02 29.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.762 . . . . 0.0 110.764 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -114.02 112.97 24.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.825 0.85 . . . . 0.0 109.157 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.8 t -105.85 113.52 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -110.32 117.93 34.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.219 0.918 . . . . 0.0 109.566 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.16 144.53 38.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.998 0.904 . . . . 0.0 112.045 -169.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -91.31 108.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.68 -47.57 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.763 -0.585 . . . . 0.0 111.542 168.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.84 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.485 1.917 0 CA-C-N 119.185 0.902 . . . . 0.0 111.247 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.35 -30.02 47.82 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.08 144.2 34.1 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 122.425 1.107 . . . . 0.0 112.516 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 tp -95.13 115.2 27.12 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.756 0.822 . . . . 0.0 109.186 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.4 121.43 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.805 -0.559 . . . . 0.0 109.83 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.37 99.14 7.99 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.689 0.796 . . . . 0.0 109.85 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -98.17 111.01 23.49 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.725 0.81 . . . . 0.0 110.915 -169.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -100.91 112.08 24.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.928 0.891 . . . . 0.0 110.723 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.27 113.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -123.96 110.0 14.25 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 122.997 0.519 . . . . 0.0 112.209 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.275 43.6 mt-10 47.22 34.5 3.1 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 119.53 -44.26 1.43 Allowed Glycine 0 CA--C 1.553 2.418 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -162.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.74 121.76 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 119.304 1.552 . . . . 0.0 113.33 -163.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.02 133.74 34.65 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.841 -0.537 . . . . 0.0 111.689 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.69 117.33 9.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.436 0.694 . . . . 0.0 111.571 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.297 1.1 pptp? -114.64 126.22 54.64 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -105.23 115.33 30.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 110.365 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mt -98.78 120.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.89 130.28 55.63 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.342 0.657 . . . . 0.0 110.896 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.61 149.07 21.83 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.97 0.89 . . . . 0.0 112.053 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -84.89 113.03 21.08 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 112.689 -174.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.65 0 C-N-CA 124.802 1.241 . . . . 0.0 113.896 172.222 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.575 1.92 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -141.74 91.11 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.367 -1.458 . . . . 0.0 107.746 166.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -174.87 167.5 3.63 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.54 1.162 . . . . 0.0 111.899 -171.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -101.3 141.78 33.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 111.662 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -141.84 121.81 13.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.477 -165.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -112.11 142.47 44.52 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 120.502 1.501 . . . . 0.0 112.52 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.279 7.7 p -80.5 91.09 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 122.769 1.271 . . . . 0.0 114.059 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.55 -36.26 29.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -122.52 145.7 48.08 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.082 -1.011 . . . . 0.0 112.189 -172.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 p -152.46 159.5 43.35 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.271 1.6 tm-20 -106.57 -137.28 0.36 Allowed 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.736 171.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.286 8.8 p30 -80.99 58.72 3.53 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 118.917 -2.364 . . . . 0.0 117.159 -167.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CE2' ' SD ' ' A' ' 18' ' ' MET . 31.6 t80 -61.14 -40.44 93.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.719 -1.863 . . . . 0.0 115.159 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.64 -43.05 68.45 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 165.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.91 -45.12 52.58 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.596 1.543 . . . . 0.0 115.024 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -45.55 -51.61 11.65 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 160.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.45 ' SD ' ' HA ' ' A' ' 28' ' ' ARG . 43.4 mtp -62.01 -45.4 93.77 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -43.04 72.21 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-N 120.373 1.442 . . . . 0.0 114.733 168.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -40.34 89.15 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 166.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.466 ' SD ' HG22 ' A' ' 76' ' ' THR . 72.9 mtm -62.98 -45.37 92.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 169.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.82 68.61 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 CA-C-N 118.841 0.746 . . . . 0.0 114.633 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.42 174.39 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.311 1.053 . . . . 0.0 113.267 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.16 159.8 21.97 Favored 'General case' 0 CA--C 1.577 2.009 0 O-C-N 120.712 -1.243 . . . . 0.0 113.338 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.264 14.7 tt -59.67 -44.49 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.66 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 CA-C-O 123.715 1.721 . . . . 0.0 112.088 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -149.77 -52.28 0.15 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 127.749 2.419 . . . . 0.0 106.169 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 12.0 mtm105 -42.95 -55.11 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 161.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -62.28 -41.44 98.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.09 -51.85 66.28 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.29 36.65 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.61 -56.07 25.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 119.674 -1.891 . . . . 0.0 113.162 156.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -86.28 48.56 1.64 Allowed 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -80.41 -16.13 55.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 58.69 21.24 8.61 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.27 1.3 pt? -77.2 145.53 37.57 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -157.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.03 119.07 34.69 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.396 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -99.19 109.76 22.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.559 0.744 . . . . 0.0 109.615 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 m -90.19 101.62 14.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.92 125.38 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.253 12.8 t -133.37 143.05 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.062 0.934 . . . . 0.0 111.705 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -110.1 110.36 21.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.866 0.866 . . . . 0.0 110.858 -172.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -88.8 77.17 7.87 Favored 'General case' 0 CA--C 1.57 1.73 0 CA-C-O 121.723 0.773 . . . . 0.0 110.149 165.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.46 -95.25 0.14 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -91.97 -8.47 46.11 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 168.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -113.38 118.55 34.88 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 121.121 1.782 . . . . 0.0 111.213 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.44 129.81 38.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.555 -0.716 . . . . 0.0 111.709 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -100.37 109.84 22.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 163.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.13 103.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -88.5 99.37 12.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.863 . . . . 0.0 109.734 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.26 100.08 12.2 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.287 0.635 . . . . 0.0 112.431 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.4 t -95.08 94.81 8.18 Favored 'General case' 0 CA--C 1.56 1.331 0 O-C-N 122.126 -0.359 . . . . 0.0 111.024 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.8 p -114.61 167.5 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.148 0.979 . . . . 0.0 113.361 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.6 m -56.96 -42.62 80.45 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 166.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -68.04 -49.33 62.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -148.95 145.76 27.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.498 1.044 . . . . 0.0 112.16 -169.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.06 102.11 8.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.646 . . . . 0.0 109.59 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -139.93 149.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.787 0.803 . . . . 0.0 112.145 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.87 105.54 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.491 -0.755 . . . . 0.0 110.416 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.65 99.03 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.2 t -96.83 123.43 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -144.33 146.83 32.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -99.66 143.3 30.05 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.023 0.916 . . . . 0.0 111.906 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.18 109.34 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.461 0.704 . . . . 0.0 112.898 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.92 -38.12 3.4 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.7 t -73.79 132.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 118.847 1.323 . . . . 0.0 110.329 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -98.21 102.99 14.89 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.315 1.055 . . . . 0.0 110.715 -171.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.41 163.73 14.92 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.973 1.309 . . . . 0.0 112.06 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -87.12 112.15 21.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.643 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -80.54 -65.93 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.536 -0.728 . . . . 0.0 112.135 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 73.03 122.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.386 1.074 . . . . 0.0 113.029 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.9 mt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.466 HG22 ' SD ' ' A' ' 21' ' ' MET . 91.7 m . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.75 117.33 20.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.766 -0.584 . . . . 0.0 111.703 -173.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.6 mt -141.02 117.81 11.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.974 0.91 . . . . 0.0 110.612 -164.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.264 2.6 ptm85 -131.89 138.84 48.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.33 -172.93 40.24 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.248 0.927 . . . . 0.0 112.189 -167.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -110.2 -179.08 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.888 -1.36 . . . . 0.0 112.72 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -122.67 107.23 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 p -85.17 128.96 34.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -0.975 . . . . 0.0 113.356 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 tp -85.31 104.49 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.298 0.639 . . . . 0.0 111.148 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.22 97.37 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.864 0.84 . . . . 0.0 109.201 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.5 -100.25 1.17 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.589 -0.694 . . . . 0.0 113.652 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -113.63 8.6 17.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 163.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -103.23 127.49 50.53 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.804 1.638 . . . . 0.0 110.528 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.62 99.02 11.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 151.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.21 114.17 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.789 0.804 . . . . 0.0 109.169 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.19 99.97 1.4 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 121.79 -0.569 . . . . 0.0 114.04 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -87.46 100.26 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.452 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.6 116.32 31.52 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.613 0.765 . . . . 0.0 109.435 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -76.36 124.63 27.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.137 -0.977 . . . . 0.0 111.726 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.1 100.36 12.59 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 -171.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.5 p -68.45 -21.68 64.63 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -56.74 -23.46 42.85 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 163.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.45 -49.54 0.36 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.428 1.091 . . . . 0.0 113.681 -157.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.92 60.36 0.93 Allowed Glycine 0 N--CA 1.49 2.246 0 CA-C-N 119.172 0.896 . . . . 0.0 115.051 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -144.0 141.63 30.25 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.465 0.706 . . . . 0.0 110.635 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.28 103.28 6.22 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.025 0.917 . . . . 0.0 111.575 167.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.98 123.58 25.97 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 121.796 -0.565 . . . . 0.0 109.804 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -107.59 100.17 9.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -108.02 118.7 37.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.357 0.663 . . . . 0.0 110.91 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.87 113.57 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -100.59 118.53 36.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.079 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.65 145.86 31.97 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 123.591 0.756 . . . . 0.0 110.809 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.31 110.89 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.535 -1.353 . . . . 0.0 108.006 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER -91.78 85.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.272 1.034 . . . . 0.0 109.005 171.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.46 -91.05 1.04 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 120.77 -1.206 . . . . 0.0 114.205 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -130.93 42.92 3.17 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.687 -0.89 . . . . 0.0 112.945 165.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -136.23 119.79 17.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.817 -1.177 . . . . 0.0 109.716 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.65 108.23 13.04 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.407 0.683 . . . . 0.0 110.614 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -89.9 71.63 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 123.318 0.647 . . . . 0.0 112.027 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -69.56 97.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.821 -1.174 . . . . 0.0 112.048 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -109.58 98.05 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -160.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.12 106.23 18.22 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.501 1.12 . . . . 0.0 111.942 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.14 123.1 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.54 -0.725 . . . . 0.0 109.308 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -136.32 124.02 22.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.102 0.561 . . . . 0.0 110.716 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.253 48.2 mt-10 46.62 54.72 8.48 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.78 24.63 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.3 t -114.45 129.33 70.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 120.294 2.047 . . . . 0.0 108.966 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -114.83 127.2 55.58 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.776 0.83 . . . . 0.0 111.525 -171.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.52 115.16 25.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.923 0.868 . . . . 0.0 112.54 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -87.46 122.79 31.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -104.88 102.71 12.23 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.41 107.4 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.99 123.92 42.22 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.856 0.462 . . . . 0.0 110.463 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -78.0 167.93 20.68 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.66 0.743 . . . . 0.0 112.025 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.77 103.89 1.88 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.88 -1.138 . . . . 0.0 113.028 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 125.623 1.569 . . . . 0.0 113.978 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.301 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.26 77.4 m-85 69.86 -21.92 0.17 Allowed 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.23 105.62 1.46 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.946 1.298 . . . . 0.0 114.186 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 m 178.04 169.65 0.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 125.253 1.421 . . . . 0.0 111.412 -172.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.1 m -97.06 128.42 43.99 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.734 -1.229 . . . . 0.0 110.789 171.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -131.22 95.51 3.8 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.306 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -77.56 139.78 39.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -70.25 124.05 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 112.454 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.64 -57.58 3.07 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.278 163.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -136.2 156.82 48.12 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 122.294 1.045 . . . . 0.0 112.589 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.9 m -136.2 94.51 3.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.596 -1.315 . . . . 0.0 110.067 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -93.06 118.84 31.65 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.616 -159.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.274 51.5 t30 64.11 17.92 10.93 Favored 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.19 -33.16 74.81 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -50.52 71.98 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -63.86 -41.49 97.77 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -49.58 -51.11 39.43 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.751 1.759 . . . . 0.0 115.751 163.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.5 mtp -65.84 -32.29 73.72 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.04 -48.54 75.82 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 160.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.16 -32.86 74.59 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.9 mmt -58.09 -53.9 53.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.075 1.307 . . . . 0.0 114.202 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.36 52.94 0.12 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.79 167.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 118.457 1.128 . . . . 0.0 112.756 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -79.52 166.56 21.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.756 -1.215 . . . . 0.0 113.032 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.285 13.3 tt -75.63 59.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 123.534 1.635 . . . . 0.0 114.72 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.17 -65.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -60.15 -33.75 72.61 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -50.45 -52.12 40.76 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 162.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.59 -52.29 18.87 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.41 -50.25 68.34 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.53 58.04 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.46 94.01 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -110.1 39.24 2.2 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -80.0 0.29 32.26 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.253 62.3 m-80 62.18 52.28 3.25 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.0 tp -76.77 121.87 23.94 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-O 122.085 0.945 . . . . 0.0 113.096 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -109.92 122.21 47.01 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.682 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.18 103.01 14.46 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.898 0.479 . . . . 0.0 109.723 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -91.4 100.07 12.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.119 -0.988 . . . . 0.0 108.735 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.5 mt -90.15 124.68 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.1 p -135.03 115.84 13.95 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -99.26 105.4 17.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.626 -1.296 . . . . 0.0 111.39 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.92 -52.01 9.52 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.27 87.88 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.105 -0.997 . . . . 0.0 111.086 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.316 25.8 t30 69.55 -48.65 0.61 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -165.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.62 121.39 14.85 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -85.42 114.54 22.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.057 0.543 . . . . 0.0 110.321 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -90.44 102.57 15.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.7 t -105.36 101.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -79.86 105.06 10.86 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 123.362 0.665 . . . . 0.0 109.867 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.89 99.52 9.73 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.155 0.982 . . . . 0.0 109.146 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.0 t -111.77 109.16 18.86 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.815 0.446 . . . . 0.0 112.174 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -135.27 178.74 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.3 m -54.64 -37.45 65.68 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -69.74 -53.24 19.35 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -148.32 143.71 27.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.302 0.955 . . . . 0.0 112.842 -168.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -121.87 95.23 4.58 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.596 0.759 . . . . 0.0 109.425 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.08 152.89 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 123.317 0.647 . . . . 0.0 111.026 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.27 115.82 30.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.708 -1.245 . . . . 0.0 112.505 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -86.48 101.09 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.32 107.15 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -126.5 130.68 51.09 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -83.51 147.56 27.72 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.452 1.12 . . . . 0.0 111.478 161.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.57 111.08 4.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.64 -6.99 52.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 119.019 2.367 . . . . 0.0 119.019 -167.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.9 t -85.78 130.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.822 2.311 . . . . 0.0 110.511 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 107.54 10.68 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.559 0.744 . . . . 0.0 111.919 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -126.9 157.71 38.69 Favored 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.42 0.688 . . . . 0.0 112.426 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -82.95 113.93 20.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 111.844 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -92.44 116.76 29.27 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.503 0.721 . . . . 0.0 109.405 167.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -96.96 124.35 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.25 0.548 . . . . 0.0 111.155 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.77 -11.3 59.96 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.289 . . 68.6 61.68 0.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -174.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -172.57 -59.96 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 124.637 1.175 . . . . 0.0 110.474 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.57 58.87 0.01 OUTLIER Glycine 0 CA--C 1.549 2.156 0 C-N-CA 125.154 1.359 . . . . 0.0 110.899 -170.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -172.44 114.76 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -166.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -110.28 142.97 41.15 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 122.368 1.08 . . . . 0.0 111.639 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.8 mt -114.58 116.22 28.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.736 0.814 . . . . 0.0 110.13 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -93.69 120.49 34.02 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 121.674 -0.641 . . . . 0.0 111.103 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.55 -161.67 35.12 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 117.651 1.82 . . . . 0.0 117.651 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.8 p -123.84 121.48 35.5 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.579 -160.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -79.25 114.15 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.938 0.79 . . . . 0.0 109.908 155.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -114.35 142.9 45.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.38 0.672 . . . . 0.0 110.973 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 tp -91.41 103.41 16.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.687 -1.258 . . . . 0.0 111.768 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -83.55 83.95 7.71 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.144 0.974 . . . . 0.0 110.127 166.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.57 -88.38 0.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -118.32 13.05 13.57 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.82 128.51 49.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.153 1.797 . . . . 0.0 109.473 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 mt -85.8 101.11 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.48 110.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-O 122.481 1.134 . . . . 0.0 109.335 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.87 103.12 3.01 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.731 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -90.06 90.47 8.14 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.23 161.16 19.39 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 122.844 1.306 . . . . 0.0 111.773 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -150.05 155.17 39.4 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.992 . . . . 0.0 110.724 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -68.21 131.78 45.98 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 113.858 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.3 p -55.46 -43.62 75.64 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 164.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -45.25 4.57 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.895 0.878 . . . . 0.0 111.698 -161.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -65.32 -42.74 92.67 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.73 -9.89 72.17 Favored Glycine 0 CA--C 1.558 2.732 0 N-CA-C 119.136 2.414 . . . . 0.0 119.136 -161.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -78.02 138.75 38.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.326 1.563 . . . . 0.0 112.894 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -73.45 148.06 43.58 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 tt -137.6 121.2 17.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.67 0.747 . . . . 0.0 110.227 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -93.59 120.18 33.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.982 -0.449 . . . . 0.0 110.112 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -125.02 124.8 42.75 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.668 0.387 . . . . 0.0 111.67 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.01 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -96.04 120.7 36.79 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.093 0.557 . . . . 0.0 110.458 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.87 153.79 31.68 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.523 0.729 . . . . 0.0 111.931 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.97 115.93 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.827 -1.17 . . . . 0.0 108.252 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tp -89.34 81.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.126 0.965 . . . . 0.0 110.67 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.0 -84.44 1.13 Allowed Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.905 -1.122 . . . . 0.0 114.976 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -128.8 26.01 5.59 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.66 125.79 31.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.901 -1.125 . . . . 0.0 109.906 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 tp -77.93 117.75 19.58 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.352 -0.843 . . . . 0.0 111.007 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -97.77 125.52 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.81 104.04 14.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 162.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -98.93 91.87 5.25 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.35 0.66 . . . . 0.0 109.248 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.27 113.44 25.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.96 0.904 . . . . 0.0 111.402 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.52 108.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -122.28 124.82 44.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.129 0.572 . . . . 0.0 110.872 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 57.1 37.68 28.7 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.12 26.39 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 119.801 2.68 . . . . 0.0 119.801 -163.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.28 107.26 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 119.942 1.871 . . . . 0.0 108.08 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 118.81 28.17 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.449 0.7 . . . . 0.0 111.948 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.88 125.12 53.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.222 0.609 . . . . 0.0 112.195 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.68 106.21 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.863 -0.523 . . . . 0.0 110.395 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -85.58 117.99 24.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.919 -1.113 . . . . 0.0 109.225 164.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.7 mt -115.02 117.42 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -164.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -116.55 117.47 29.97 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.34 0.656 . . . . 0.0 109.683 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.67 152.31 28.51 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 112.08 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -63.2 100.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.05 -1.031 . . . . 0.0 112.751 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.41 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.245 0 CA-C-O 120.945 0.403 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.29 11.73 3.27 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -116.37 88.53 2.91 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 120.221 -1.549 . . . . 0.0 111.252 -150.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -164.77 -178.94 5.55 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.687 1.195 . . . . 0.0 110.88 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -92.22 106.99 18.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.614 -1.304 . . . . 0.0 109.192 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -109.54 100.5 9.55 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -168.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -95.94 139.06 32.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.199 -0.938 . . . . 0.0 112.754 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.64 115.57 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.61 -61.45 1.91 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.151 0.58 . . . . 0.0 111.395 164.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -140.13 146.54 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.197 0.999 . . . . 0.0 112.948 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 108.07 8.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.56 -49.85 24.24 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -162.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -138.66 41.29 2.18 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -84.39 48.66 1.53 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 119.469 -2.02 . . . . 0.0 114.513 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -149.02 -47.57 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.415 1.486 . . . . 0.0 111.682 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.89 -37.97 89.35 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.942 1.701 . . . . 0.0 114.834 160.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -49.4 -57.93 6.05 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 159.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -45.29 76.95 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 168.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -50.59 -49.35 56.66 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -62.8 -37.73 87.88 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.7 mtm -62.91 -52.25 63.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.05 70.53 0.09 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 145.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-O 122.708 1.242 . . . . 0.0 111.276 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -63.92 156.34 28.0 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.258 14.0 tt -56.66 -40.11 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.47 -53.14 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.34 0.973 . . . . 0.0 113.067 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.78 -30.03 67.5 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -52.3 -46.41 65.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 159.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -57.53 -48.38 79.44 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.17 -34.65 75.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.27 75.28 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.94 -50.83 30.33 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 162.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.46 58.56 4.93 Favored 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 119.807 1.185 . . . . 0.0 112.917 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -95.97 -28.04 14.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 65.31 49.88 1.85 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.625 1.17 . . . . 0.0 114.041 -168.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -77.08 124.67 28.14 Favored 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.765 -1.21 . . . . 0.0 113.741 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -120.94 111.65 17.77 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.828 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 mt -91.38 100.23 13.05 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -91.65 101.05 13.68 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.97 -1.081 . . . . 0.0 109.116 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.19 107.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -104.03 104.15 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -92.45 127.52 37.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.668 -0.645 . . . . 0.0 110.984 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -125.74 76.92 1.62 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.734 1.254 . . . . 0.0 111.265 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 -95.23 1.36 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.055 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -97.19 -23.37 16.22 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -91.15 155.31 18.71 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 120.182 1.355 . . . . 0.0 112.621 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -124.6 112.49 16.88 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.955 0.902 . . . . 0.0 109.449 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.4 m -96.41 94.28 7.32 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.82 107.17 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.83 94.31 9.27 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.08 97.86 10.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.621 0.769 . . . . 0.0 108.934 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -113.62 115.53 28.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.324 0.65 . . . . 0.0 111.507 -162.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -144.66 168.57 19.85 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 0.0 113.127 -170.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -58.9 -34.64 71.91 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 160.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -50.08 67.74 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.25 11.66 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.35 1.06 . . . . 0.0 111.839 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -118.19 101.21 8.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.42 120.17 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.633 -0.667 . . . . 0.0 110.799 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.88 102.81 14.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.941 -1.099 . . . . 0.0 111.46 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.5 97.4 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.01 111.0 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -138.58 142.49 39.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.79 150.42 25.06 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.15 0.976 . . . . 0.0 111.648 164.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.08 102.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.053 -1.029 . . . . 0.0 113.099 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.81 -4.01 36.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 118.931 2.333 . . . . 0.0 118.931 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.79 135.23 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 121.376 2.588 . . . . 0.0 112.263 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.8 p -84.22 96.69 9.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 110.75 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -122.96 154.98 37.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.407 0.683 . . . . 0.0 112.693 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -83.38 105.71 14.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.654 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -96.87 101.72 13.36 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.047 0.939 . . . . 0.0 110.638 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -87.35 109.33 19.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.056 -1.028 . . . . 0.0 111.061 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.94 -82.99 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -166.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.29 -74.68 0.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.909 1.231 . . . . 0.0 111.585 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -71.9 -56.3 5.95 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 119.793 1.178 . . . . 0.0 114.098 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.03 48.53 0.12 Allowed Glycine 0 N--CA 1.485 1.912 0 CA-C-O 119.34 -0.7 . . . . 0.0 114.082 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -109.51 97.25 6.85 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 118.72 1.26 . . . . 0.0 109.417 -167.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -68.28 140.12 55.97 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 25.2 mt -134.76 100.24 4.55 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.328 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -84.51 107.25 16.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.913 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -154.55 23.97 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.506 0.963 . . . . 0.0 115.506 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.2 p -124.33 122.35 37.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.773 -155.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -82.27 107.51 15.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 155.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.5 m -108.69 149.96 28.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.6 -0.687 . . . . 0.0 112.322 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 105.28 17.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.877 -1.139 . . . . 0.0 110.91 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.05 79.85 1.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.955 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.51 -92.83 0.89 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 121.128 -0.982 . . . . 0.0 114.04 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.69 52.37 1.93 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.401 0.62 . . . . 0.0 111.188 160.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -141.04 120.06 12.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -83.04 99.2 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.358 -1.464 . . . . 0.0 109.446 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 tp -90.17 111.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.693 0.797 . . . . 0.0 110.033 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.28 92.8 1.36 Allowed Glycine 0 N--CA 1.482 1.734 0 C-N-CA 123.793 0.711 . . . . 0.0 113.172 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.21 111.25 22.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -134.86 111.16 9.65 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -156.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -84.79 120.64 26.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.697 -1.252 . . . . 0.0 111.855 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -54.97 120.21 6.56 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.9 p -64.17 -43.07 96.26 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.25 -44.24 76.08 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.92 -47.66 8.4 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.48 54.66 3.06 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 -157.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -138.52 124.22 19.75 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.335 1.067 . . . . 0.0 110.24 -172.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -83.75 99.51 10.32 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.115 1.436 . . . . 0.0 113.774 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.5 132.46 34.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.715 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -106.71 110.19 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.734 -0.604 . . . . 0.0 110.192 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -111.05 112.34 24.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.799 -0.563 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.66 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.154 -0.966 . . . . 0.0 108.784 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 mtm-85 -90.46 116.08 28.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.847 168.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -144.39 159.45 42.7 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.656 0.782 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.3 mt -126.14 121.43 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.423 -1.423 . . . . 0.0 109.494 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.13 83.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.12 -80.59 0.96 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.89 -50.41 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -94.22 148.16 22.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 120.212 1.369 . . . . 0.0 114.329 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 tp -86.93 120.75 28.53 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.127 0.571 . . . . 0.0 111.411 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 m -106.77 121.38 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.5 ' NE2' ' HH ' ' A' ' 117' ' ' TYR . 16.0 tt0 -107.97 103.18 12.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.54 -0.725 . . . . 0.0 109.751 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.4 m -97.8 100.49 11.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.584 0.753 . . . . 0.0 109.356 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.5 ' HH ' ' NE2' ' A' ' 115' ' ' GLN . 78.7 m-85 -90.04 117.71 29.04 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.023 0.929 . . . . 0.0 111.424 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.92 115.64 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -110.84 107.56 17.09 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.67 0.668 . . . . 0.0 109.647 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER 54.64 32.4 17.1 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 175.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.01 -40.5 2.5 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -162.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.69 112.67 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 120.538 2.169 . . . . 0.0 112.361 -168.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.77 130.07 39.9 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.08 0.552 . . . . 0.0 112.342 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.69 112.46 13.68 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.846 0.858 . . . . 0.0 110.996 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -103.31 116.29 32.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -0.804 . . . . 0.0 110.679 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -106.14 114.07 27.98 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.041 0.448 . . . . 0.0 109.83 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.1 mt -101.23 121.19 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.97 124.87 51.61 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.326 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -82.65 142.35 31.78 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.887 0.851 . . . . 0.0 111.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -79.97 105.5 11.3 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 124.924 1.29 . . . . 0.0 113.669 174.485 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.277 87.8 m-85 76.96 78.52 0.08 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.815 1.293 . . . . 0.0 110.413 -176.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.92 -36.15 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -137.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -122.82 -172.32 2.46 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 123.327 1.537 . . . . 0.0 112.918 -158.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.8 m -78.03 118.97 20.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.16 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -122.71 108.1 12.69 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -109.94 139.52 44.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.099 -1.001 . . . . 0.0 113.307 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.62 117.75 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -102.28 -56.97 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.691 0.797 . . . . 0.0 111.438 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 110.77 11.93 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.467 0.707 . . . . 0.0 112.032 -166.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.1 p -106.86 127.31 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 112.512 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -73.94 -46.65 42.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -147.03 45.59 1.17 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -83.9 52.44 2.29 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 119.332 -2.105 . . . . 0.0 113.955 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -152.26 -51.76 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.157 1.383 . . . . 0.0 110.349 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.95 -30.75 70.12 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 163.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -50.94 -40.47 57.46 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 154.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -70.39 -34.23 72.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -50.95 -52.68 39.96 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 121.009 1.731 . . . . 0.0 115.318 159.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.09 -34.14 74.46 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.28 -51.52 69.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 162.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 68.27 0.48 Allowed Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.015 0.825 . . . . 0.0 114.094 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.66 149.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.462 0.649 . . . . 0.0 112.489 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -78.89 153.03 30.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.769 -1.207 . . . . 0.0 113.68 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.311 10.7 tt -59.61 -39.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 118.483 2.771 . . . . 0.0 118.483 -170.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.6 m -59.11 -42.43 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -67.14 -35.18 79.15 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -55.72 -50.73 69.56 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.387 1.903 . . . . 0.0 114.151 164.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -56.38 -54.68 42.69 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.94 48.58 0.85 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.96 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.059 1.344 . . . . 0.0 111.963 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.28 93.85 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -83.97 67.75 9.75 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 122.283 1.04 . . . . 0.0 111.403 171.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -92.51 -33.55 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.84 50.58 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.521 1.129 . . . . 0.0 113.532 -166.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.88 124.19 26.91 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.493 1.14 . . . . 0.0 113.632 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -108.71 100.05 9.33 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.054 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.83 102.73 11.01 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.132 0.573 . . . . 0.0 109.491 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.1 m -99.51 105.59 17.52 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -107.22 118.23 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -161.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 p -123.96 126.53 46.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.72 -0.612 . . . . 0.0 110.492 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.17 119.95 37.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.631 -0.668 . . . . 0.0 110.933 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.08 -49.83 14.42 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.36 -91.42 0.08 OUTLIER Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -74.7 -24.6 58.79 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 157.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -87.62 129.5 35.1 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 119.894 1.225 . . . . 0.0 111.954 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -109.83 134.7 51.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.358 1.063 . . . . 0.0 110.581 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.5 m -107.59 111.93 24.42 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -104.76 105.63 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -80.88 110.02 16.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 110.335 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.16 82.52 4.16 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.175 0.59 . . . . 0.0 110.525 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 t -96.66 111.09 23.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.002 -1.061 . . . . 0.0 112.752 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 p -131.94 -169.72 2.26 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.376 0.671 . . . . 0.0 112.069 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -70.45 -1.59 11.25 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 159.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -126.91 -38.36 2.04 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.675 1.19 . . . . 0.0 114.008 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -90.4 -90.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 119.79 1.177 . . . . 0.0 111.781 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.287 70.4 m-80 60.96 60.28 1.87 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 pt -134.14 135.2 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 123.121 0.568 . . . . 0.0 110.595 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.79 103.05 14.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 111.868 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 t -88.13 98.28 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.0 113.61 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.99 140.64 45.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.689 0.757 . . . . 0.0 112.734 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.36 142.71 41.09 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 111.982 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 100.69 0.89 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 112.891 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.81 -12.42 24.94 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.103 2.401 . . . . 0.0 119.103 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.26 134.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 121.247 2.524 . . . . 0.0 112.61 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.6 t -82.08 92.8 6.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 111.984 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -119.15 170.27 9.22 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.956 0.902 . . . . 0.0 113.036 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -88.61 99.13 12.08 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 121.723 -0.611 . . . . 0.0 110.613 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -87.1 87.1 7.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.835 170.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -71.18 142.75 50.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.58 5.68 50.88 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.352 . . 72.03 -79.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.278 1.399 . . . . 0.0 113.554 -170.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.89 -19.83 31.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.63 -64.08 1.39 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 117.028 1.571 . . . . 0.0 117.028 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -171.21 171.84 5.53 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 124.352 1.061 . . . . 0.0 111.472 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -85.68 118.56 25.26 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 110.794 151.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -92.66 116.63 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.929 -1.107 . . . . 0.0 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -94.58 114.63 26.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.721 . . . . 0.0 110.649 -174.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.77 -153.7 24.98 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 p -119.86 140.77 50.31 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -160.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.16 109.64 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 108.913 155.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.3 m -104.58 139.19 39.81 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.181 0.592 . . . . 0.0 111.484 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.1 tp -88.17 107.47 18.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.118 -0.989 . . . . 0.0 109.959 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.85 -53.59 17.41 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.79 -71.07 0.28 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -162.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.15 -39.8 39.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 160.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.04 145.26 35.88 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.959 0.904 . . . . 0.0 112.882 -164.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.06 101.53 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 146.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.2 110.42 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.797 0.808 . . . . 0.0 109.485 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.76 94.68 2.02 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.8 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.02 95.61 9.89 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.534 0.683 . . . . 0.0 109.18 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.48 164.96 20.77 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 122.561 1.172 . . . . 0.0 111.835 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.79 155.01 46.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.849 -1.157 . . . . 0.0 112.072 165.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -67.84 139.02 56.53 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.8 m -77.91 -51.87 9.74 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.17 0.588 . . . . 0.0 112.062 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.97 -41.38 74.66 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.0 -31.63 7.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.15 38.56 29.48 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 118.556 2.182 . . . . 0.0 118.556 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -144.08 157.54 44.25 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.92 1.36 . . . . 0.0 111.916 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -80.54 129.68 34.66 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -159.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.79 124.08 51.77 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.029 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -107.24 107.22 18.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -107.27 99.32 8.86 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.58 119.91 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -103.62 124.49 48.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.748 0.704 . . . . 0.0 110.398 170.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.28 146.27 40.17 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.53 0.732 . . . . 0.0 111.114 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -89.71 115.16 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.322 -1.486 . . . . 0.0 108.676 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -99.74 88.93 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.31 -88.51 0.8 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.486 -0.759 . . . . 0.0 113.953 -174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -136.88 50.41 2.01 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 161.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -137.57 122.05 18.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.23 109.25 15.58 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 123.549 0.74 . . . . 0.0 110.786 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.69 98.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 109.951 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -84.59 96.26 9.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.033 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.2 m -96.34 92.6 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.524 0.73 . . . . 0.0 109.709 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.9 105.78 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.964 0.906 . . . . 0.0 111.438 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.6 t -109.48 109.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -127.18 119.46 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 110.078 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.8 OUTLIER 48.75 63.64 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.18 -31.72 2.58 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 119.211 2.444 . . . . 0.0 119.211 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.54 121.78 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.662 1.731 . . . . 0.0 110.698 -159.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.43 143.6 27.15 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 123.81 0.844 . . . . 0.0 112.953 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.29 109.39 6.1 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 121.56 -0.713 . . . . 0.0 110.689 164.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -101.16 96.98 7.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.257 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -87.46 111.41 21.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.259 0.624 . . . . 0.0 110.231 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.09 111.59 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -170.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -103.68 113.82 27.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.41 0.684 . . . . 0.0 109.602 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -77.11 162.75 27.22 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.35 110.25 4.01 Favored 'General case' 0 CA--C 1.57 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 112.361 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 C-N-CA 125.039 1.335 . . . . 0.0 112.38 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.321 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -134.07 -48.76 0.8 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.843 1.201 . . . . 0.0 112.379 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -69.13 94.42 0.67 Allowed 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -168.05 173.18 8.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.619 1.168 . . . . 0.0 110.999 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 m -88.97 117.79 28.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.001 . . . . 0.0 109.499 166.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -120.43 113.0 19.68 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.986 0.514 . . . . 0.0 109.876 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 142.45 27.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.267 -0.896 . . . . 0.0 112.754 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.72 115.94 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.573 -0.705 . . . . 0.0 111.923 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.21 -53.38 6.72 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.334 0.654 . . . . 0.0 112.074 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.12 143.23 25.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.667 0.746 . . . . 0.0 112.839 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -109.3 88.39 2.72 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.995 0.902 . . . . 0.0 110.446 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.31 118.89 25.13 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.632 0.773 . . . . 0.0 110.969 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.291 22.9 t30 67.25 11.71 8.53 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 118.105 2.631 . . . . 0.0 118.105 -173.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -64.77 -37.64 88.27 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -63.05 -42.84 99.82 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -71.39 -39.87 70.89 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -46.51 -55.88 6.85 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 158.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtp -63.17 -39.25 94.12 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.18 -43.87 95.52 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -38.02 66.26 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 163.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.4 mtt -59.56 -36.94 77.16 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.311 2.338 . . . . 0.0 117.311 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.6 63.12 0.89 Allowed Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.779 0.718 . . . . 0.0 114.147 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.91 -171.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.481 0.658 . . . . 0.0 112.479 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -65.36 173.41 2.62 Favored 'General case' 0 CA--C 1.583 2.231 0 O-C-N 119.899 -1.751 . . . . 0.0 113.976 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.4 tt -94.8 -45.39 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.333 -1.479 . . . . 0.0 114.381 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.2 -60.03 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.686 1.13 . . . . 0.0 112.239 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -55.08 -49.6 71.26 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -34.49 -51.37 0.47 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 118.668 2.84 . . . . 0.0 118.668 160.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -73.2 -39.67 65.37 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.53 95.99 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 168.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.04 -44.59 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -114.02 54.33 0.76 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 118.505 0.593 . . . . 0.0 112.086 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -83.63 -13.77 53.51 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 59.9 m-80 64.89 61.15 0.8 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.736 1.153 . . . . 0.0 113.136 -167.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 tp -83.32 120.86 26.38 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.607 1.194 . . . . 0.0 113.357 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -102.69 118.35 36.65 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.941 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.19 100.41 12.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 m -91.54 102.92 15.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.842 0.83 . . . . 0.0 108.878 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.21 124.04 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -117.98 107.75 14.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -87.22 91.17 8.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.51 0.671 . . . . 0.0 111.323 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -89.46 68.16 7.79 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.463 0.649 . . . . 0.0 112.158 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 78.66 0.15 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 116.86 1.504 . . . . 0.0 116.86 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.328 24.0 m120 72.27 -34.32 0.29 Allowed 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -166.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.79 148.98 34.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.477 1.035 . . . . 0.0 112.971 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -132.19 116.88 17.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.389 1.076 . . . . 0.0 108.116 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.9 m -102.38 100.64 10.81 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.9 t -105.87 104.57 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -83.32 104.47 13.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.27 96.39 8.46 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -115.09 114.53 25.46 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.573 0.749 . . . . 0.0 110.944 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 p -141.62 -177.64 5.27 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.301 1.048 . . . . 0.0 113.765 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 159.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -90.58 -48.51 7.04 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -130.32 152.14 50.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 119.997 1.271 . . . . 0.0 112.918 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.01 93.43 2.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.981 . . . . 0.0 109.799 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 pt -136.38 130.31 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.632 -0.668 . . . . 0.0 111.245 -172.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -88.32 105.81 17.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.379 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.72 101.46 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.61 121.7 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 123.385 0.674 . . . . 0.0 109.365 -171.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.55 148.96 23.42 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.396 0.679 . . . . 0.0 111.628 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.88 155.98 17.38 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 120.555 -1.341 . . . . 0.0 113.052 162.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.64 124.4 20.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.65 62.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.536 2.574 . . . . 0.0 119.536 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.86 141.94 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 120.488 2.144 . . . . 0.0 110.741 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 t -73.08 124.43 25.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -137.01 165.0 27.05 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 121.814 0.816 . . . . 0.0 111.246 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -91.39 110.04 21.33 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 110.424 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -84.61 -50.14 7.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.264 5.8 m120 75.65 133.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -77.2 156.42 31.53 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.593 1.187 . . . . 0.0 113.598 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 66.05 8.53 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -168.45 -62.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.038 1.335 . . . . 0.0 108.606 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.66 -52.76 0.02 OUTLIER Glycine 0 CA--C 1.55 2.281 0 N-CA-C 115.649 1.02 . . . . 0.0 115.649 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -62.41 146.71 50.67 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -94.09 126.49 39.34 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.053 1.406 . . . . 0.0 113.022 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.01 123.99 46.85 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.218 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -135.95 131.44 35.12 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.86 -148.06 16.55 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.477 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.7 p -120.51 123.04 41.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.026 -0.691 . . . . 0.0 112.104 -156.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -80.9 107.15 13.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.65 0.659 . . . . 0.0 109.734 153.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.6 m -95.39 172.34 8.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 111.24 162.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.41 116.79 14.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.409 -1.432 . . . . 0.0 109.978 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.3 88.04 5.01 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.007 0.908 . . . . 0.0 111.795 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.98 -84.17 0.59 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -126.81 32.45 5.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 170.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -141.11 123.66 15.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.482 -1.387 . . . . 0.0 109.096 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.48 127.61 33.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.16 124.18 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.685 0.755 . . . . 0.0 109.945 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.85 103.37 1.41 Allowed Glycine 0 N--CA 1.479 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 113.538 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -95.51 96.78 9.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.4 119.23 31.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.521 -170.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -87.4 139.58 30.4 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.533 1.159 . . . . 0.0 112.512 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -63.86 139.19 58.74 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 168.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -52.37 -43.25 64.59 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 152.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.96 -55.37 3.79 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.508 0.723 . . . . 0.0 111.876 -157.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.17 -32.39 13.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.45 90.04 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 119.042 2.377 . . . . 0.0 119.042 -163.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.09 -3.36 57.22 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -164.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.333 4.7 tt0 72.57 118.3 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 tt -90.34 137.68 32.15 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.137 0.975 . . . . 0.0 111.441 162.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.1 108.09 16.18 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.094 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.261 9.9 t -113.32 114.55 26.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 0.0 112.278 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.07 134.24 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -112.8 121.16 43.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 0.0 110.529 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.99 172.65 12.08 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 121.679 0.752 . . . . 0.0 111.766 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.59 108.36 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.053 . . . . 0.0 109.481 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.263 11.1 tp -96.98 88.09 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.812 0.815 . . . . 0.0 109.717 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.27 -90.31 1.01 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.121 -0.987 . . . . 0.0 114.125 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.83 52.48 1.94 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 165.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -132.87 121.99 23.73 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.181 0.992 . . . . 0.0 108.375 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.2 101.97 11.58 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.775 -0.578 . . . . 0.0 109.908 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.81 83.46 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.093 0.949 . . . . 0.0 110.476 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.39 100.05 10.45 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.238 1.018 . . . . 0.0 109.984 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.4 m -110.68 90.44 3.32 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.005 -151.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.42 114.02 24.61 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.978 0.911 . . . . 0.0 110.89 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -108.71 124.26 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -141.34 128.15 20.46 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 121.355 0.597 . . . . 0.0 111.649 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 3.9 mm-40 48.96 44.35 22.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -167.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.04 -25.3 1.87 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 119.31 2.484 . . . . 0.0 119.31 -165.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.3 t -82.85 117.31 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 120.317 2.058 . . . . 0.0 110.03 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -91.67 140.76 29.4 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.97 0.908 . . . . 0.0 112.659 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.59 32.58 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 165.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -103.32 106.19 16.65 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.959 -0.463 . . . . 0.0 110.388 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -83.8 102.59 12.44 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.22 115.16 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -106.96 115.62 30.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.241 0.543 . . . . 0.0 109.576 -173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -84.16 149.29 26.26 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.421 0.689 . . . . 0.0 111.924 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -62.17 112.1 2.24 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 125.235 1.414 . . . . 0.0 112.827 -173.658 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.24 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -110.49 -47.99 3.21 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.252 5.5 p-10 -74.55 80.89 1.97 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 120.234 1.379 . . . . 0.0 114.205 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -146.93 -166.35 2.48 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.135 0.969 . . . . 0.0 111.573 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.5 m -94.55 127.56 40.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.654 -1.279 . . . . 0.0 109.985 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -136.63 105.53 5.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.966 -0.459 . . . . 0.0 110.509 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -98.97 137.39 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.212 0.915 . . . . 0.0 111.339 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.6 120.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.801 0.81 . . . . 0.0 112.693 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.17 -54.64 5.79 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.065 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -147.25 160.77 42.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 121.765 0.793 . . . . 0.0 112.677 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -136.54 118.27 15.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 111.445 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -70.46 -60.35 2.32 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -165.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -130.33 51.13 2.13 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.32 1.057 . . . . 0.0 112.944 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -74.89 -36.8 62.25 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.0 -50.56 72.34 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.13 -36.79 77.86 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.53 -52.44 38.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 160.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 mtp -61.22 -48.97 79.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -43.02 64.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -54.69 -30.14 54.93 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtm -70.98 -11.46 60.98 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.69 64.54 1.74 Allowed Glycine 0 N--CA 1.495 2.583 0 CA-C-N 122.265 2.302 . . . . 0.0 114.67 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -119.55 170.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 122.821 1.296 . . . . 0.0 113.092 -164.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.2 108.0 16.84 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 120.877 -1.139 . . . . 0.0 110.531 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.3 12.7 tt -49.25 -44.53 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 119.808 3.262 . . . . 0.0 119.808 -164.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.07 -46.94 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 170.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -68.66 -31.13 70.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -51.22 -45.58 61.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.91 -52.24 66.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.79 -36.29 82.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.89 91.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.12 75.18 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -92.47 62.48 3.95 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 163.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER -83.03 -17.36 43.56 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 60.28 50.88 5.85 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -84.22 149.62 26.01 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -111.59 114.48 27.57 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.771 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.11 103.28 11.61 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.2 m -91.73 99.0 11.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 168.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -99.94 124.22 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.9 p -129.76 119.45 23.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.649 -0.657 . . . . 0.0 109.921 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -88.72 119.2 28.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.901 0.773 . . . . 0.0 111.96 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.81 76.9 1.82 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 123.112 0.565 . . . . 0.0 109.856 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.54 80.49 0.1 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 20.0 m120 71.62 -50.4 0.69 Allowed 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -166.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -73.95 121.84 21.64 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.981 0.912 . . . . 0.0 112.929 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -99.69 134.78 42.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.56 -0.712 . . . . 0.0 111.481 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 m -102.27 111.06 23.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 161.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.04 105.49 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -86.01 95.8 9.63 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.954 0.502 . . . . 0.0 110.218 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.0 t -98.76 110.28 22.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.875 0.47 . . . . 0.0 110.336 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.83 170.35 15.91 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -68.82 -6.54 27.5 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -100.03 -46.03 5.47 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.499 1.045 . . . . 0.0 113.206 168.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.87 154.5 40.5 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.035 1.288 . . . . 0.0 112.205 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -112.58 105.94 14.25 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 161.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.2 pt -123.51 127.6 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.248 0.547 . . . . 0.0 111.3 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -99.71 100.67 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.759 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.17 98.11 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.0 109.582 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.19 128.9 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.194 0.598 . . . . 0.0 110.346 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -148.66 147.78 29.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.456 0.646 . . . . 0.0 112.729 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 157.06 16.47 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.318 1.056 . . . . 0.0 110.785 164.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.78 80.89 3.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 112.436 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.02 -38.3 1.83 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -162.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.53 121.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.072 1.436 . . . . 0.0 110.091 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -68.19 127.69 33.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.39 165.43 22.57 Favored 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 123.896 0.879 . . . . 0.0 111.579 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -96.26 108.16 20.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -92.15 97.62 11.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.489 -0.757 . . . . 0.0 110.135 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -75.67 115.24 15.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.778 -0.576 . . . . 0.0 112.409 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.0 -69.57 0.39 Allowed 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.37 -68.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.687 1.131 . . . . 0.0 111.263 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -66.73 -55.5 14.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.27 67.12 0.07 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.0 m -152.12 106.73 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.953 . . . . 0.0 109.298 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.19 114.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.366 0.603 . . . . 0.0 109.651 160.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.18 117.11 27.92 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.448 0.642 . . . . 0.0 110.494 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -91.27 109.45 20.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.39 0.676 . . . . 0.0 109.998 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.94 -149.84 14.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.8 p -138.92 142.65 38.47 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.076 0.551 . . . . 0.0 110.851 -170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -85.32 89.18 7.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.998 -1.064 . . . . 0.0 108.319 153.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -76.69 138.06 39.77 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.984 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.97 105.74 13.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 110.857 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.24 -35.39 73.8 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.73 -79.21 0.2 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.91 -24.25 41.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 160.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -120.79 149.15 43.01 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.263 1.392 . . . . 0.0 111.921 -160.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -94.94 108.88 20.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.925 -1.11 . . . . 0.0 108.993 162.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.19 112.43 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 CA-C-O 122.317 1.056 . . . . 0.0 109.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.01 92.88 0.74 Allowed Glycine 0 N--CA 1.479 1.519 0 C-N-CA 124.265 0.936 . . . . 0.0 113.746 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.09 91.33 8.67 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.41 152.25 37.14 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.101 0.953 . . . . 0.0 112.386 -168.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -121.61 139.43 53.55 Favored 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.549 0.74 . . . . 0.0 110.023 169.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -63.38 131.16 47.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.862 -1.149 . . . . 0.0 113.607 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.7 m -66.59 -47.21 73.46 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 167.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.66 -51.87 37.21 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.72 -45.94 27.38 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.75 -8.34 79.66 Favored Glycine 0 CA--C 1.558 2.781 0 N-CA-C 118.543 2.177 . . . . 0.0 118.543 -153.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.53 152.12 24.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.648 1.724 . . . . 0.0 112.724 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -70.81 141.63 51.35 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.92 126.16 40.95 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -100.51 146.73 26.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 111.15 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 m -148.35 109.73 4.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.159 -1.588 . . . . 0.0 111.69 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.1 t -97.07 122.87 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.227 . . . . 0.0 109.966 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.41 127.62 44.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 111.198 163.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.61 146.01 27.08 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.337 0.655 . . . . 0.0 110.872 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.36 102.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.26 11.3 tp -98.68 75.19 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.039 0.923 . . . . 0.0 111.27 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.83 62.4 3.83 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 116.164 1.226 . . . . 0.0 116.164 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.317 9.1 t70 81.9 -41.1 0.13 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -167.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.74 107.75 7.04 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.97 0.908 . . . . 0.0 113.324 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.3 tp -76.07 102.42 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.655 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -91.72 82.5 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.111 0.482 . . . . 0.0 110.447 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.496 ' NE2' ' HH ' ' A' ' 117' ' ' TYR . 16.8 tt0 -73.8 97.93 2.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.955 -1.091 . . . . 0.0 110.921 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.7 m -106.08 89.52 3.09 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 -157.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.496 ' HH ' ' NE2' ' A' ' 115' ' ' GLN . 73.4 m-85 -81.96 137.96 35.04 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.146 0.978 . . . . 0.0 111.977 -176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.64 120.62 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -131.71 122.59 26.16 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 55.92 36.8 28.0 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.83 -17.15 17.16 Favored Glycine 0 CA--C 1.557 2.689 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 -163.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.37 116.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.009 1.904 . . . . 0.0 109.23 -172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.15 147.37 23.11 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.57 123.49 15.36 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.894 0.877 . . . . 0.0 111.681 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -110.72 98.4 7.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.061 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -86.69 108.83 18.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.2 mt -106.91 126.34 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -115.67 128.7 56.1 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.516 0.674 . . . . 0.0 111.447 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -80.79 155.03 26.86 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 121.672 0.749 . . . . 0.0 111.396 165.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -68.45 114.22 6.69 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.15 -0.969 . . . . 0.0 111.7 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 125.253 1.421 . . . . 0.0 112.531 -173.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -109.42 -1.96 18.05 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 -171.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -82.35 90.55 6.68 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 120.747 1.612 . . . . 0.0 113.466 -165.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -162.37 179.0 8.16 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 122.209 1.004 . . . . 0.0 112.188 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 m -83.04 125.2 31.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 110.222 163.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.91 106.39 9.28 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.183 0.593 . . . . 0.0 109.727 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -97.74 138.39 35.19 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.919 -1.113 . . . . 0.0 112.605 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.85 112.05 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 113.326 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.71 -59.52 2.22 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.087 0.555 . . . . 0.0 111.828 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -134.78 124.48 25.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.0 p -103.72 129.26 51.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.454 0.702 . . . . 0.0 112.034 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.332 0.1 OUTLIER -72.75 -72.81 0.23 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 177.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -121.48 39.5 3.83 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.804 1.184 . . . . 0.0 114.069 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.74 -40.83 75.93 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -64.54 -30.77 71.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -79.0 -40.12 32.34 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -48.27 -50.44 29.76 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 158.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.406 ' SD ' HG22 ' A' ' 23' ' ' VAL . 12.4 mmt -50.12 -50.8 47.34 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 163.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -52.66 -46.51 67.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -57.67 -41.83 82.36 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.61 -33.82 74.58 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.77 67.9 0.83 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-N 119.55 1.068 . . . . 0.0 113.904 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 HG22 ' SD ' ' A' ' 18' ' ' MET . 11.5 m -126.2 170.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.466 1.127 . . . . 0.0 112.51 -165.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -64.22 178.74 0.65 Allowed 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.4 tt -108.53 167.4 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 157.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.383 46.2 t 80.85 -68.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 120.392 -1.443 . . . . 0.0 111.691 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -65.87 -38.86 89.91 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 119.802 1.183 . . . . 0.0 113.811 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -44.23 -42.84 6.83 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 161.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -69.69 -51.23 36.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.179 -0.951 . . . . 0.0 113.538 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -55.51 -33.65 63.93 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.2 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.24 94.34 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 161.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -103.8 51.74 0.78 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.85 -7.58 59.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 7.3 m-80 67.07 49.29 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.787 1.235 . . . . 0.0 114.229 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.9 tp -72.36 117.25 13.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.08 103.64 10.08 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.713 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.98 100.75 13.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.46 0.704 . . . . 0.0 110.072 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -90.57 101.92 14.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.966 -1.084 . . . . 0.0 109.551 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -94.34 113.45 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.4 p -107.8 110.08 21.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.46 91.61 5.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.665 1.221 . . . . 0.0 111.281 -167.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.63 80.39 9.14 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.746 1.26 . . . . 0.0 113.817 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 -100.02 1.56 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.322 -0.861 . . . . 0.0 114.937 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.08 -4.47 56.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 162.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -114.27 162.83 16.08 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-O 122.224 1.011 . . . . 0.0 111.998 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.46 112.19 10.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.94 -1.1 . . . . 0.0 109.223 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.5 m -95.74 100.7 12.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 164.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -99.26 100.71 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -86.62 98.69 11.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.76 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.44 99.01 10.14 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -97.73 116.51 30.08 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -142.76 176.55 8.96 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.196 0.998 . . . . 0.0 113.394 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -55.09 -37.11 66.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 164.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.91 -46.8 14.64 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -147.02 144.27 29.02 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.539 1.518 . . . . 0.0 112.897 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -126.78 96.29 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 167.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.92 148.78 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.651 1.215 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.39 109.07 18.77 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.409 -0.807 . . . . 0.0 111.219 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.43 96.41 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.59 112.41 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -140.18 144.36 36.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.176 0.591 . . . . 0.0 111.925 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.69 153.2 18.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.365 1.079 . . . . 0.0 111.083 162.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.31 117.73 6.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.57 -9.68 68.96 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 -168.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -77.65 130.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 120.772 2.286 . . . . 0.0 110.691 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -80.15 122.31 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.658 -0.651 . . . . 0.0 112.341 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -148.44 165.98 29.52 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 121.552 0.692 . . . . 0.0 111.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.88 101.17 13.46 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 110.822 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -75.77 -55.69 5.4 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.262 9.3 m-20 73.12 137.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.872 1.269 . . . . 0.0 114.013 172.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.3 mt -110.97 127.48 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.853 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.35 124.58 21.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.283 38.1 m-20 71.97 -29.91 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -160.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.19 -66.29 1.58 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 116.991 1.557 . . . . 0.0 116.991 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -174.89 156.44 2.23 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.0 110.345 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.31 148.76 44.05 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 120.76 -1.212 . . . . 0.0 114.09 148.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.1 mt -140.35 100.78 3.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.61 0.764 . . . . 0.0 111.676 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -86.53 121.43 29.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.576 1.15 . . . . 0.0 111.917 171.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.59 -163.11 34.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.9 p -120.05 125.06 47.39 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.081 0.553 . . . . 0.0 111.907 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -80.42 106.93 12.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.792 -0.568 . . . . 0.0 110.21 155.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -98.12 170.01 9.21 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.965 0.888 . . . . 0.0 111.711 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.3 117.48 29.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.916 -1.115 . . . . 0.0 108.803 172.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -71.85 -43.77 64.94 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.2 -81.83 0.06 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -78.65 -31.29 46.74 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 157.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -86.75 132.04 33.97 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.688 1.131 . . . . 0.0 112.239 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.21 120.56 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 157.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.03 111.21 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.876 0.846 . . . . 0.0 108.783 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -106.24 105.93 2.48 Favored Glycine 0 N--CA 1.482 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 113.02 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -100.56 98.13 8.75 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -124.15 118.91 27.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.274 0.629 . . . . 0.0 111.561 -165.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -95.68 148.18 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 111.967 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -66.68 138.94 57.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.424 -1.422 . . . . 0.0 113.179 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.269 32.2 p -70.55 -33.44 71.14 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.55 -71.22 0.07 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.83 -50.58 3.15 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.346 1.058 . . . . 0.0 113.768 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.36 51.95 0.42 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -95.54 134.09 38.8 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.34 1.07 . . . . 0.0 110.151 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.88 118.05 12.23 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -108.9 115.66 30.5 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.81 104.92 17.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 109.642 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.3 p -99.2 102.75 14.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.8 134.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.619 1.1 . . . . 0.0 108.42 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -134.06 138.21 45.16 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.84 157.68 38.24 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.47 1.128 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.58 119.22 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.956 -1.09 . . . . 0.0 110.075 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -89.79 66.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 121.121 -0.987 . . . . 0.0 111.817 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.95 -77.87 0.95 Allowed Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.742 -1.224 . . . . 0.0 114.858 -168.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.63 -49.29 4.05 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.05 153.46 20.55 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 120.186 1.357 . . . . 0.0 114.122 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.23 108.59 20.06 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.506 -0.746 . . . . 0.0 110.562 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.17 139.66 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 169.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -130.2 101.88 5.98 Favored 'General case' 0 CA--C 1.563 1.465 0 O-C-N 121.675 -0.64 . . . . 0.0 109.867 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 119.1 23.52 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.131 0.972 . . . . 0.0 109.733 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -106.81 109.08 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 164.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.74 132.47 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -127.62 113.4 16.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 163.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.46 62.39 2.65 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.7 -44.98 3.38 Favored Glycine 0 CA--C 1.552 2.352 0 N-CA-C 118.115 2.006 . . . . 0.0 118.115 -166.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.59 123.81 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.402 1.601 . . . . 0.0 113.834 -162.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -80.24 150.63 29.98 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.506 1.146 . . . . 0.0 113.298 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.26 118.37 19.4 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.57 152.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -107.1 104.14 13.72 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -169.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -102.58 115.89 31.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.7 mt -101.98 113.74 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -98.72 130.73 45.21 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.049 1.404 . . . . 0.0 110.173 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -97.26 153.06 18.27 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.18 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.66 121.56 14.77 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 112.936 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.386 2.6 p30 . . . . . 0 N--CA 1.488 1.466 0 C-N-CA 125.463 1.505 . . . . 0.0 114.667 -175.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.437 0 CA-C-O 121.833 0.825 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -97.49 68.48 2.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.243 -0.911 . . . . 0.0 112.73 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -159.35 83.8 0.77 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.165 -0.959 . . . . 0.0 110.126 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -166.48 175.82 7.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.284 -0.885 . . . . 0.0 111.915 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.9 m -81.84 124.78 29.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.964 -1.085 . . . . 0.0 110.482 160.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -124.98 104.09 8.38 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.304 0.641 . . . . 0.0 109.937 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -86.03 137.66 32.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.123 -0.986 . . . . 0.0 112.623 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.84 120.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.121 -0.987 . . . . 0.0 113.012 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -105.86 -64.83 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.78 0.832 . . . . 0.0 110.725 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.79 149.85 37.88 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 122.229 1.014 . . . . 0.0 111.402 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.0 m -157.86 106.11 2.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.101 -1.624 . . . . 0.0 109.692 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.24 -76.6 0.2 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -149.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.35 52.91 2.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.547 -1.346 . . . . 0.0 113.137 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.01 64.29 8.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 119.776 -1.828 . . . . 0.0 113.245 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.99 -49.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.374 1.07 . . . . 0.0 112.961 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -69.91 -39.39 76.21 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -45.23 -54.11 7.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 155.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.3 mtp -67.2 -40.62 86.48 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.92 -45.05 82.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 165.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -64.13 -34.89 79.1 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.39 -52.08 65.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 121.017 1.735 . . . . 0.0 115.535 166.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.17 65.96 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.8 p -148.44 128.68 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -77.56 158.66 29.75 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.292 10.1 tp -50.6 -41.03 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 118.853 2.909 . . . . 0.0 118.853 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -55.73 -46.09 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.98 -34.12 61.95 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -61.39 -38.97 88.98 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 165.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.81 -51.13 64.47 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-N 120.401 1.455 . . . . 0.0 114.694 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.07 -42.48 85.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.82 70.25 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.15 -50.92 66.29 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 164.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -88.53 55.1 3.27 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 119.444 1.02 . . . . 0.0 113.203 171.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -94.14 -7.47 42.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -173.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 60.08 42.28 15.93 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 114.99 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -74.54 117.44 16.36 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 122.691 1.234 . . . . 0.0 112.051 -172.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.601 ' NZ ' ' HG ' ' A' ' 52' ' ' SER . 7.2 ttpm? -117.46 112.58 20.83 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.898 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -96.02 103.04 14.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.884 -0.51 . . . . 0.0 110.306 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.5 m -91.03 97.89 11.44 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.96 124.1 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -135.73 114.62 12.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.04 115.85 28.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 112.638 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -83.76 76.68 9.98 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.11 0.957 . . . . 0.0 110.877 171.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.68 -81.02 0.53 Allowed Glycine 0 N--CA 1.492 2.378 0 O-C-N 121.144 -0.973 . . . . 0.0 115.141 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -100.07 -38.1 8.7 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 165.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -85.51 118.68 25.19 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.291 1.405 . . . . 0.0 113.05 -163.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -86.38 115.56 23.97 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.461 0.704 . . . . 0.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.1 m -86.78 104.44 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 162.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 t -106.45 116.67 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -84.73 99.49 10.87 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -75.03 91.07 2.5 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.601 ' HG ' ' NZ ' ' A' ' 37' ' ' LYS . 34.3 t -106.76 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.646 0.779 . . . . 0.0 110.789 -168.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.7 p -148.95 172.81 14.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.1 m -60.02 -49.09 79.05 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.36 -43.73 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -154.46 139.24 17.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.747 1.158 . . . . 0.0 111.889 -165.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -125.76 92.03 3.52 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -132.68 124.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.058 0.456 . . . . 0.0 111.153 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.49 102.9 10.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 112.135 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.91 103.78 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.36 106.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -129.59 138.56 51.34 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.6 0.76 . . . . 0.0 111.823 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.34 159.22 15.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.644 1.212 . . . . 0.0 111.86 167.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.5 113.3 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.68 75.91 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.0 126.4 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 121.013 2.407 . . . . 0.0 110.767 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -82.21 106.25 13.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.142 0.577 . . . . 0.0 111.871 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.48 154.3 48.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.732 -0.605 . . . . 0.0 112.384 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.36 89.54 7.7 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 122.709 1.242 . . . . 0.0 112.013 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -75.53 163.46 27.35 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.704 1.202 . . . . 0.0 112.523 168.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER -159.01 140.07 12.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.055 -1.653 . . . . 0.0 112.036 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.6 mt -93.9 176.56 6.3 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.71 65.27 0.49 Allowed 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -173.01 -55.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.46 1.104 . . . . 0.0 111.823 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.13 2.45 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 117.093 1.597 . . . . 0.0 117.093 -159.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -70.22 114.88 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 119.729 1.765 . . . . 0.0 112.232 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.04 132.36 37.21 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 121.721 0.772 . . . . 0.0 112.919 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -136.49 103.72 5.35 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.747 0.819 . . . . 0.0 111.629 -159.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 127.38 35.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.166 -1.584 . . . . 0.0 111.623 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.68 174.47 46.91 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.226 2.451 . . . . 0.0 119.226 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.9 p -118.19 108.61 15.37 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.989 -1.106 . . . . 0.0 112.203 -169.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.73 107.54 5.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.612 -1.305 . . . . 0.0 109.989 166.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.5 m -110.07 -29.67 8.11 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -156.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.277 35.7 tp 69.08 103.31 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.312 1.445 . . . . 0.0 114.159 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.52 129.19 55.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.24 -108.82 1.42 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -118.3 45.33 2.03 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 163.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -141.99 114.68 8.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.13 95.77 5.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.839 -1.163 . . . . 0.0 110.187 170.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.5 tp -83.24 113.99 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 123.366 0.666 . . . . 0.0 110.606 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.89 2.47 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 123.834 0.731 . . . . 0.0 112.649 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -84.39 93.0 8.17 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -103.87 103.94 13.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.912 -0.492 . . . . 0.0 112.072 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -87.4 137.22 32.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.077 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -66.43 141.41 57.93 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.4 p -67.11 -32.69 74.0 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -63.86 -67.07 0.46 Allowed 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -109.4 -23.6 11.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 46.84 7.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.04 -16.1 55.79 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.317 6.3 tt0 69.36 87.88 0.12 Allowed 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.07 100.6 11.49 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -88.96 110.07 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.534 -0.729 . . . . 0.0 111.177 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -104.85 107.28 18.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.17 100.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.943 -1.098 . . . . 0.0 108.231 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -83.24 116.29 22.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.854 -0.529 . . . . 0.0 110.309 167.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -135.13 141.78 46.05 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.141 0.976 . . . . 0.0 110.294 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 105.41 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.32 -1.488 . . . . 0.0 107.022 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.251 14.7 tt -87.82 71.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.338 1.066 . . . . 0.0 110.714 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.12 1.54 Allowed Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.046 -1.034 . . . . 0.0 114.691 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.422 ' OD2' ' OE2' ' A' ' 112' ' ' GLU . 7.5 p-10 -105.12 -53.56 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.422 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 2.7 mt-10 -86.73 148.75 25.29 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 122.09 0.948 . . . . 0.0 112.914 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.3 tp -79.24 110.33 14.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.549 -0.719 . . . . 0.0 109.638 167.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.55 118.62 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -96.68 100.9 12.43 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 165.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 128.36 39.52 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.443 0.697 . . . . 0.0 109.759 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -135.31 119.1 17.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.845 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -87.16 144.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.012 0.525 . . . . 0.0 111.595 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -136.3 108.24 7.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 156.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.257 3.3 tm-20 49.19 70.03 0.52 Allowed 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.08 -42.73 2.76 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -169.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.63 119.71 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.708 1.254 . . . . 0.0 109.932 -165.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -98.41 140.2 33.03 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.854 0.835 . . . . 0.0 112.484 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.46 168.04 19.66 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.352 1.072 . . . . 0.0 112.497 162.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.69 150.05 51.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 111.599 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -122.99 117.0 24.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 157.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.4 109.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.34 127.5 47.94 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.959 0.903 . . . . 0.0 110.762 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -78.44 150.74 32.98 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.889 0.852 . . . . 0.0 112.62 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.43 122.23 14.06 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 113.155 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.489 1.492 0 C-N-CA 125.318 1.447 . . . . 0.0 111.501 -176.231 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.359 0 CA-C-O 121.152 0.501 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -112.83 48.65 1.0 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.508 -0.745 . . . . 0.0 112.458 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.33 90.86 7.21 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 120.153 -1.592 . . . . 0.0 114.532 -161.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.8 m -167.26 174.19 8.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.761 1.224 . . . . 0.0 111.336 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.87 130.79 34.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -136.02 112.44 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -103.7 138.49 40.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 120.099 1.318 . . . . 0.0 113.453 -175.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.26 116.91 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -173.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -110.14 -48.29 3.2 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 123.949 0.899 . . . . 0.0 112.495 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 93.87 3.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.524 -0.735 . . . . 0.0 111.155 172.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -84.7 95.59 8.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.556 -1.34 . . . . 0.0 112.483 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.1 127.04 37.43 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.699 0.761 . . . . 0.0 111.11 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.303 6.7 t30 64.6 17.76 11.05 Favored 'General case' 0 CA--C 1.584 2.281 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 -171.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.52 -45.48 79.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -52.13 -41.39 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -42.56 61.92 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -46.78 -54.39 9.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 161.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.5 mmt -60.83 -48.12 83.23 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -60.55 -34.69 74.51 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -61.31 -40.79 95.48 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.0 mtp -58.46 -22.26 54.06 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 119.501 3.149 . . . . 0.0 119.501 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.93 49.67 3.28 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-N 120.246 1.384 . . . . 0.0 116.429 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.22 -30.87 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 17.8 m120 79.08 152.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.1 1.36 . . . . 0.0 112.444 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.17 75.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 122.89 1.329 . . . . 0.0 110.109 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.14 -68.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.877 1.271 . . . . 0.0 107.682 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -75.27 -38.57 60.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -61.51 -22.81 65.45 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -61.19 -55.71 29.1 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.361 0.982 . . . . 0.0 113.313 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -56.93 -29.01 62.74 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.43 -54.93 13.81 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.865 1.666 . . . . 0.0 113.885 162.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.15 -43.52 61.25 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -99.81 55.06 0.94 Allowed 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 161.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -70.45 -35.12 73.15 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 60.99 45.01 9.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.336 1.054 . . . . 0.0 113.751 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 tp -72.65 128.84 36.76 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.913 0.863 . . . . 0.0 113.038 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -126.44 118.36 24.8 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.777 0.831 . . . . 0.0 109.972 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.53 100.55 12.13 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.448 0.699 . . . . 0.0 109.787 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -95.28 96.86 9.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 109.054 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.8 mt -86.59 124.3 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.908 0.883 . . . . 0.0 109.321 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.8 p -122.04 109.61 14.78 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -113.74 126.05 54.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 112.258 -165.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.86 132.71 19.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 122.848 0.459 . . . . 0.0 110.156 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.11 61.99 4.97 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.306 31.7 m120 69.51 -28.2 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -168.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.88 128.57 34.81 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.409 1.459 . . . . 0.0 112.572 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -102.93 108.24 19.36 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 163.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 m -95.27 98.33 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 t -108.59 113.21 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -169.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 99.25 7.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.648 -0.658 . . . . 0.0 109.589 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.01 97.97 10.01 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.1 t -107.5 124.21 49.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 112.389 -161.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.6 p -146.14 169.02 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.822 0.849 . . . . 0.0 112.889 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -58.86 -38.5 78.9 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 167.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -64.89 -54.51 29.75 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -151.81 140.91 21.24 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.598 1.09 . . . . 0.0 112.332 -162.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.98 103.48 9.97 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.0 pt -125.33 127.78 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.946 -0.471 . . . . 0.0 111.241 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 96.52 8.52 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.192 -0.942 . . . . 0.0 111.486 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.64 100.3 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.54 110.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -127.76 124.09 36.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.348 0.594 . . . . 0.0 112.075 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -81.26 140.11 35.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.531 0.682 . . . . 0.0 111.382 166.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.93 120.72 11.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.75 -0.09 86.93 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.6 t -95.14 139.21 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.295 2.047 . . . . 0.0 110.122 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -76.81 110.11 11.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 112.135 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -134.52 169.39 17.35 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 123.699 0.8 . . . . 0.0 111.513 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -97.62 121.95 40.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 112.539 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -93.0 -66.56 0.91 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.341 16.0 m-80 92.55 129.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 125.732 1.613 . . . . 0.0 113.285 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.7 mt -74.12 -67.06 0.65 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 179.23 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 125.493 1.517 . . . . 0.0 109.359 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -66.6 -47.01 74.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.99 70.31 0.1 OUTLIER Glycine 0 N--CA 1.484 1.878 0 CA-C-N 118.744 0.702 . . . . 0.0 114.079 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 m -163.08 116.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.719 -0.871 . . . . 0.0 108.931 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.62 128.25 35.27 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.597 0.713 . . . . 0.0 111.049 167.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.12 111.86 24.1 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.081 0.952 . . . . 0.0 111.656 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.55 113.59 25.26 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.36 1.064 . . . . 0.0 110.948 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.51 -152.69 21.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -125.47 124.16 40.78 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 122.939 0.496 . . . . 0.0 111.937 -158.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -84.64 106.05 15.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.181 -0.949 . . . . 0.0 109.582 158.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -105.11 131.39 52.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.04 0.536 . . . . 0.0 110.6 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -82.57 98.0 8.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.869 -1.144 . . . . 0.0 110.639 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.41 83.85 7.57 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.685 0.755 . . . . 0.0 109.514 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -78.83 0.3 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 115.494 0.958 . . . . 0.0 115.494 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -112.28 -29.0 7.7 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -97.02 136.96 36.83 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 121.533 1.97 . . . . 0.0 111.973 -169.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.81 101.61 11.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -92.1 110.98 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 CA-C-O 122.2 1.0 . . . . 0.0 109.858 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.04 96.75 2.24 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 124.381 0.991 . . . . 0.0 112.884 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -91.99 94.84 9.47 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -119.21 107.28 13.24 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.891 0.476 . . . . 0.0 111.814 -163.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -73.21 141.15 47.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.81 -1.181 . . . . 0.0 112.054 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -69.14 132.81 47.15 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.175 0.988 . . . . 0.0 112.321 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.9 p -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 164.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -61.65 -74.58 0.08 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -89.1 -31.1 18.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.44 3.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -130.48 139.81 50.53 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 118.027 0.913 . . . . 0.0 109.764 171.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -72.4 102.52 3.19 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 123.497 1.618 . . . . 0.0 114.036 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -78.63 121.05 24.18 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.348 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -96.5 120.46 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 122.088 -0.382 . . . . 0.0 110.427 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -119.51 109.39 15.67 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.966 0.507 . . . . 0.0 110.001 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.15 108.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 120.358 -1.464 . . . . 0.0 109.267 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -88.59 119.75 29.34 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.425 0.69 . . . . 0.0 109.739 166.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -141.12 139.45 33.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 0.0 110.807 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.37 120.41 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.818 -1.176 . . . . 0.0 110.073 170.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.4 mt -116.09 94.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.17 -101.23 1.11 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.459 -0.776 . . . . 0.0 114.638 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -123.66 43.28 3.01 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 165.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.25 125.2 27.28 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.343 1.057 . . . . 0.0 108.683 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -86.48 105.99 17.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 m -88.89 115.7 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 109.225 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -107.64 95.99 6.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.418 -0.801 . . . . 0.0 110.067 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 86.2 m -91.11 96.76 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.035 0.534 . . . . 0.0 110.86 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -81.61 129.7 34.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.91 0.884 . . . . 0.0 111.323 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -126.31 115.55 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -120.9 117.96 28.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 118.545 0.611 . . . . 0.0 111.875 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 55.14 26.58 8.44 Favored 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.17 -32.28 7.73 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 -160.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.39 130.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.651 2.225 . . . . 0.0 113.48 -166.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.1 142.45 28.68 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.94 123.23 14.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.06 -1.025 . . . . 0.0 111.232 153.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -110.03 87.39 2.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -70.02 99.21 1.41 Allowed 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 170.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.3 mt -101.07 115.99 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -108.27 111.82 23.97 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.402 0.681 . . . . 0.0 110.715 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -78.17 146.03 35.28 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 121.607 0.717 . . . . 0.0 112.285 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -66.3 128.91 38.0 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.257 11.4 t70 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.909 1.684 . . . . 0.0 110.34 -165.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.42 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.69 55.1 1.04 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 119.403 1.002 . . . . 0.0 111.71 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -94.42 82.17 4.02 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 120.067 -1.646 . . . . 0.0 114.491 -163.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -152.42 178.61 9.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.917 -1.114 . . . . 0.0 112.824 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 m -82.83 101.52 11.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.0 -1.063 . . . . 0.0 110.123 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -100.21 97.49 8.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.431 0.692 . . . . 0.0 110.067 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -97.96 139.24 34.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.603 . . . . 0.0 111.711 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 8.5 p -70.89 115.23 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.46 -60.83 2.2 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.64 0.776 . . . . 0.0 111.985 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -134.5 158.95 42.63 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 122.567 1.175 . . . . 0.0 111.094 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -156.97 143.44 18.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 119.397 -2.064 . . . . 0.0 112.025 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.49 139.19 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.235 0.541 . . . . 0.0 111.526 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.305 57.0 t30 53.99 38.92 29.91 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -81.05 -47.3 13.76 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.98 -37.42 74.19 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -51.61 66.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.528 1.058 . . . . 0.0 113.771 170.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -48.8 -53.44 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.8 mmt -55.06 -43.33 73.75 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -43.67 98.44 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 165.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.3 mtm -60.39 -61.51 2.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.71 56.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.347 0 CA-C-N 118.832 0.742 . . . . 0.0 114.925 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.96 127.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -76.71 163.16 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -50.88 -44.88 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -169.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 -46.94 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 119.795 1.18 . . . . 0.0 113.052 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -57.79 -39.67 78.08 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 mtm105 -60.39 -29.05 68.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 167.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 121.258 1.845 . . . . 0.0 114.524 164.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.68 -38.43 84.92 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 165.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.07 -58.54 7.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.58 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -89.69 52.39 2.31 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 118.881 0.764 . . . . 0.0 112.252 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -77.39 -51.58 10.57 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.375 -1.453 . . . . 0.0 113.743 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 37.4 m-80 66.19 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.179 0.992 . . . . 0.0 111.646 -163.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -72.28 120.66 18.2 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -119.16 114.25 22.16 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.373 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.08 101.01 11.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.839 0.456 . . . . 0.0 109.806 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -87.02 105.92 17.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.98 -1.075 . . . . 0.0 109.22 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.9 mt -102.61 130.36 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 C-N-CA 123.211 0.605 . . . . 0.0 109.417 -168.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -114.9 134.36 55.22 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.184 0.594 . . . . 0.0 109.678 160.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -96.24 96.93 9.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 109.852 155.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -83.56 78.47 9.67 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 122.69 1.234 . . . . 0.0 112.024 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.26 -96.17 2.04 Favored Glycine 0 N--CA 1.488 2.124 0 O-C-N 121.568 -0.708 . . . . 0.0 113.002 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -99.08 -47.57 5.18 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.22 134.24 56.79 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -97.04 108.51 21.25 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.011 0.924 . . . . 0.0 109.316 174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.4 m -90.07 100.13 13.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 164.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -94.93 102.9 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -88.04 93.01 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.616 -0.677 . . . . 0.0 109.282 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.59 120.73 24.92 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.592 0.357 . . . . 0.0 111.527 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -122.63 116.83 24.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.479 0.712 . . . . 0.0 109.396 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -149.03 168.83 22.09 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 122.364 1.078 . . . . 0.0 112.76 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 m -60.16 -37.85 81.38 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.84 -43.88 62.09 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.65 153.56 31.54 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.74 1.154 . . . . 0.0 111.36 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.13 104.14 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.554 -0.716 . . . . 0.0 110.298 166.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.49 159.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.043 0.925 . . . . 0.0 112.07 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -99.75 110.4 22.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.605 -1.309 . . . . 0.0 110.064 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.04 100.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.69 126.34 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.25 0.62 . . . . 0.0 109.794 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.55 141.88 21.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.73 -0.606 . . . . 0.0 111.982 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -92.02 147.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 112.084 170.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.86 91.47 5.37 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.07 -47.6 1.0 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 116.261 1.264 . . . . 0.0 116.261 -160.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -85.25 127.14 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.008 1.404 . . . . 0.0 109.912 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 t -74.41 142.27 45.02 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -141.83 166.48 24.62 Favored 'General case' 0 CA--C 1.572 1.807 0 C-N-CA 123.815 0.846 . . . . 0.0 112.253 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.85 104.46 16.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.382 0.61 . . . . 0.0 110.516 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -89.08 83.13 6.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 112.01 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -86.12 132.6 33.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.915 -1.115 . . . . 0.0 112.669 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.27 -69.72 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -166.06 -57.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 119.57 1.077 . . . . 0.0 111.722 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -45.24 -71.5 0.07 Allowed 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 165.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.98 45.61 0.02 OUTLIER Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.887 1.232 . . . . 0.0 112.872 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 m -99.84 103.54 15.16 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.14 84.68 4.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 111.346 -158.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.5 95.56 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.327 -0.858 . . . . 0.0 113.214 -162.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -78.81 116.11 18.94 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.463 0.705 . . . . 0.0 110.837 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' C ' ' HG1' ' A' ' 81' ' ' THR . . . 176.2 -149.32 9.77 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 115.539 0.976 . . . . 0.0 115.539 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.446 ' HG1' ' C ' ' A' ' 80' ' ' GLY . 4.1 m -160.72 144.97 13.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.874 -0.78 . . . . 0.0 110.39 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.17 102.72 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 162.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -97.75 140.51 32.02 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.355 0.662 . . . . 0.0 111.864 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.79 102.15 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.819 -1.176 . . . . 0.0 111.016 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.15 84.94 4.92 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.004 0.906 . . . . 0.0 110.203 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.69 -81.99 0.61 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -119.38 -5.26 10.37 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -114.11 137.86 51.19 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 121.087 1.767 . . . . 0.0 110.237 -171.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.5 mt -82.54 106.42 14.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.45 -1.406 . . . . 0.0 110.105 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 tt -92.25 111.55 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 CA-C-O 122.399 1.095 . . . . 0.0 109.752 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.39 94.09 1.96 Allowed Glycine 0 N--CA 1.478 1.475 0 C-N-CA 123.878 0.751 . . . . 0.0 113.232 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -90.29 109.84 20.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -133.84 145.64 49.89 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.896 0.855 . . . . 0.0 111.512 -168.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -124.76 132.8 53.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.421 -0.799 . . . . 0.0 109.503 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -64.25 127.4 31.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 112.44 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.32 0.4 OUTLIER -82.8 -27.39 30.97 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -57.39 -54.82 42.44 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 164.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -93.47 -39.77 10.7 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.32 -13.59 51.52 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -158.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -96.03 153.66 17.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.383 1.592 . . . . 0.0 113.669 -160.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.48 134.56 34.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -166.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -119.47 129.65 54.84 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.7 1.2 . . . . 0.0 110.435 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -118.73 108.87 15.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.685 . . . . 0.0 109.491 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -115.47 112.95 23.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.916 -0.49 . . . . 0.0 111.981 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.29 116.12 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.984 -1.072 . . . . 0.0 109.215 -173.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -91.58 117.36 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.765 -0.585 . . . . 0.0 109.66 166.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.55 149.71 37.82 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.112 0.958 . . . . 0.0 112.478 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -89.51 103.87 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.395 -0.816 . . . . 0.0 109.354 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.6 tt -95.6 72.26 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.05 0.928 . . . . 0.0 110.96 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.88 59.75 6.74 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.353 24.8 m-20 79.59 -34.37 0.14 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.92 130.77 42.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 120.01 1.277 . . . . 0.0 113.034 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 46.7 tp -87.72 105.48 17.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.887 -1.133 . . . . 0.0 110.101 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.81 109.71 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.903 0.859 . . . . 0.0 110.295 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.11 104.53 17.09 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -106.93 91.11 3.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.216 0.607 . . . . 0.0 110.046 -162.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -81.87 102.04 10.6 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.456 0.703 . . . . 0.0 112.083 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.2 t -98.94 107.03 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -122.16 114.58 21.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.83 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 51.7 39.03 24.39 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 -32.86 5.89 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 118.673 2.229 . . . . 0.0 118.673 -165.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.15 110.27 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 120.578 2.189 . . . . 0.0 112.238 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -86.84 117.95 25.91 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.97 0.508 . . . . 0.0 111.662 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.11 118.44 32.85 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.537 0.684 . . . . 0.0 111.949 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -100.42 122.61 43.45 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.081 0.552 . . . . 0.0 110.815 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -108.39 111.91 24.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 167.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.91 112.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -105.55 135.62 46.62 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 121.383 0.611 . . . . 0.0 112.249 -170.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.44 146.81 25.02 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 122.003 0.906 . . . . 0.0 111.515 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -81.01 90.4 5.97 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 121.445 0.641 . . . . 0.0 112.637 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 5.3 t0 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.21 1.404 . . . . 0.0 113.821 172.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 122.118 0.961 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -105.13 40.52 1.5 Allowed 'General case' 0 CA--C 1.576 1.975 0 O-C-N 121.565 -0.709 . . . . 0.0 112.273 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.25 3.4 p-10 -95.83 88.32 4.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.93 -1.731 . . . . 0.0 114.171 -158.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 p -148.2 -170.81 3.69 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 122.292 1.044 . . . . 0.0 112.309 170.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -87.16 114.92 24.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.938 -1.101 . . . . 0.0 109.373 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -119.73 106.24 11.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.74 136.84 42.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.178 -0.951 . . . . 0.0 112.814 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.61 117.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 113.566 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -101.11 -55.84 2.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.1 0.56 . . . . 0.0 111.588 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -85.56 -78.66 0.26 Allowed 'General case' 0 CA--C 1.57 1.722 0 O-C-N 121.757 -0.589 . . . . 0.0 112.248 -162.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.268 16.1 m 57.66 95.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.287 13.5 tm-20 -87.12 -110.19 0.06 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.938 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -86.27 58.9 5.32 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-N 121.474 1.943 . . . . 0.0 115.136 -169.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -70.12 -31.82 69.54 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 165.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -48.61 -54.09 15.94 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 169.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.26 -31.93 68.11 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -55.88 -52.85 62.63 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 164.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.419 ' SD ' ' HA ' ' A' ' 28' ' ' ARG . 74.7 mtm -54.64 -46.55 73.96 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -55.72 -47.66 76.52 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.29 -44.25 75.54 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.3 mtt -65.78 -35.25 80.18 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.56 61.32 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 CA-C-N 119.703 1.138 . . . . 0.0 115.029 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.29 145.37 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.285 0.564 . . . . 0.0 111.447 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -80.83 156.57 26.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.594 -1.316 . . . . 0.0 114.126 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.273 14.8 tt -53.66 -42.22 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.44 -45.23 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -58.26 -46.35 86.18 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 76.2 mtt180 -52.12 -51.6 56.84 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 171.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.86 -49.09 77.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -58.5 -37.79 76.31 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.16 -38.45 31.36 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.3 -53.1 54.26 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 163.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -88.95 53.92 2.84 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 119.362 0.983 . . . . 0.0 113.181 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.11 -31.99 26.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 66.53 49.68 1.33 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 124.663 1.185 . . . . 0.0 113.383 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.9 121.54 23.58 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 122.682 1.229 . . . . 0.0 113.363 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -111.46 106.31 15.17 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.364 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.05 94.72 7.85 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.3 m -87.06 100.19 12.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.6 mt -93.87 127.85 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -171.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 p -129.11 110.74 12.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -91.44 101.09 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.9 . . . . 0.0 109.951 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.52 -35.5 30.28 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.3 81.77 0.04 OUTLIER Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.336 -0.853 . . . . 0.0 111.292 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 6.7 t-20 70.18 -52.48 0.64 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -159.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -62.8 137.92 58.39 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -112.61 109.45 19.0 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -84.23 103.1 13.14 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.543 0.737 . . . . 0.0 109.107 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.89 108.27 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.73 89.74 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.527 -0.733 . . . . 0.0 109.568 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.66 85.4 6.05 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.912 0.863 . . . . 0.0 111.872 -163.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.4 m -101.84 98.19 8.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.707 -0.621 . . . . 0.0 111.527 -154.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.7 p -127.44 171.03 11.92 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.65 0.78 . . . . 0.0 112.926 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -75.05 66.05 1.55 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.829 -1.169 . . . . 0.0 110.95 163.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.36 -62.18 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 123.949 0.899 . . . . 0.0 111.416 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.291 42.1 ptt85 -138.55 -62.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.268 30.8 t-20 66.0 91.07 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.42 1.463 . . . . 0.0 113.944 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.7 143.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.436 0.636 . . . . 0.0 110.762 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -80.92 101.4 9.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.476 0.655 . . . . 0.0 112.005 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.12 106.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.6 97.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -109.18 126.98 53.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.21 148.97 21.98 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.782 0.801 . . . . 0.0 111.7 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.49 119.77 15.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 113.813 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.63 1.46 89.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -91.77 132.81 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 120.144 1.972 . . . . 0.0 109.872 -173.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -78.28 110.74 13.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 112.155 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -132.75 159.64 39.12 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.636 0.731 . . . . 0.0 112.549 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.88 105.75 17.95 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.512 -0.742 . . . . 0.0 111.302 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -93.08 116.2 28.82 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.081 0.952 . . . . 0.0 110.559 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -89.91 131.0 36.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.009 -1.057 . . . . 0.0 111.558 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt -73.75 -177.22 2.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.646 -1.284 . . . . 0.0 114.242 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -58.5 4.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.244 -1.535 . . . . 0.0 113.566 167.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -41.19 -44.64 2.64 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.28 71.37 0.39 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 123.914 0.768 . . . . 0.0 111.429 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.7 m -157.34 141.32 16.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.59 -0.947 . . . . 0.0 109.846 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -117.54 124.94 49.93 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -155.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.96 109.42 8.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.836 -1.165 . . . . 0.0 112.09 -162.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.52 112.64 24.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.057 -1.027 . . . . 0.0 111.141 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.39 -149.91 15.81 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 117.209 1.644 . . . . 0.0 117.209 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -133.8 123.38 24.74 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.438 -152.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -82.53 116.23 21.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.942 -0.474 . . . . 0.0 110.233 158.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.2 m -113.63 134.63 54.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 111.248 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 tp -85.66 115.55 23.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 110.689 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.71 -93.41 0.1 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 123.089 0.555 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.49 -86.18 1.9 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 119.432 1.014 . . . . 0.0 111.49 169.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -110.95 47.01 1.02 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 117.047 0.424 . . . . 0.0 111.901 161.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -140.82 122.27 15.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.858 -1.151 . . . . 0.0 108.394 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.29 105.09 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.93 112.13 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.33 95.87 1.51 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -85.3 113.6 21.75 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -137.67 111.35 8.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.08 0.552 . . . . 0.0 111.053 -165.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -87.2 129.98 34.74 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 120.489 -1.382 . . . . 0.0 112.919 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -62.02 139.35 58.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 163.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.0 p -72.02 -51.22 22.82 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 -49.81 64.44 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -86.91 -36.95 18.08 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.03 12.08 79.16 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -173.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.41 -18.66 44.64 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.752 3.242 . . . . 0.0 119.752 -165.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.346 5.4 tt0 67.14 100.97 0.05 OUTLIER 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.95 132.29 41.31 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.735 0.814 . . . . 0.0 110.703 160.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -112.72 97.4 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 t -92.64 110.15 21.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.498 0.666 . . . . 0.0 110.177 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.56 117.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -103.05 119.32 38.64 Favored 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.663 0.785 . . . . 0.0 110.612 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -144.08 142.43 30.62 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.774 0.83 . . . . 0.0 110.477 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -84.43 111.69 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 108.155 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.26 98.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.25 -106.27 2.78 Favored Glycine 0 N--CA 1.488 2.116 0 O-C-N 121.847 -0.533 . . . . 0.0 112.927 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.4 ' OD1' ' OE2' ' A' ' 112' ' ' GLU . 3.3 p-10 -92.97 -30.31 15.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE2' ' OD1' ' A' ' 111' ' ' ASP . 3.9 mt-10 -102.19 141.33 35.2 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.149 0.975 . . . . 0.0 112.975 -160.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.59 104.8 5.42 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.003 164.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.34 103.82 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 95.13 5.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -105.61 111.1 23.66 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.751 0.421 . . . . 0.0 110.473 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.75 112.4 18.87 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.718 0.407 . . . . 0.0 110.284 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.83 114.72 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -139.43 108.1 5.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.204 0.602 . . . . 0.0 109.768 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 54.98 50.88 14.53 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.32 -27.75 4.5 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.939 2.335 . . . . 0.0 118.939 -166.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.72 130.06 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.722 1.761 . . . . 0.0 110.485 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -101.29 107.96 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.05 0.54 . . . . 0.0 109.968 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.21 98.75 9.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -93.84 87.83 5.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.732 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -90.99 104.42 17.02 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.69 121.32 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.721 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -109.32 119.37 39.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.601 0.76 . . . . 0.0 110.504 -166.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -76.27 147.88 37.97 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 122.152 0.977 . . . . 0.0 113.43 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -68.13 109.53 3.57 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 123.804 0.842 . . . . 0.0 112.829 175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 125.118 1.367 . . . . 0.0 112.569 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.49 -26.99 22.92 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -165.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.36 174.09 5.16 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.392 37.0 p 86.83 -177.79 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.625 1.57 . . . . 0.0 114.075 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.9 m -96.92 129.07 44.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.654 -1.279 . . . . 0.0 111.405 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -122.26 102.73 8.3 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -100.53 144.66 29.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.54 0.686 . . . . 0.0 112.268 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.77 122.8 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.58 -68.05 0.78 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.795 163.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.17 128.17 44.29 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.556 0.693 . . . . 0.0 111.585 -172.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -109.44 120.48 42.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.654 0.782 . . . . 0.0 111.028 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.26 130.39 47.39 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.386 0.675 . . . . 0.0 110.538 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 18.7 t30 53.74 21.63 2.77 Favored 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 119.48 3.141 . . . . 0.0 119.48 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.44 -42.24 71.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -59.08 -38.91 80.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.75 -48.41 81.78 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 120.602 1.546 . . . . 0.0 114.837 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -48.13 -61.02 2.19 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 mtt -66.94 -35.75 80.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -63.83 -42.86 97.55 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 167.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -56.78 -42.98 80.4 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 164.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtp -51.34 -30.5 18.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 164.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.46 47.68 4.24 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 116.165 1.226 . . . . 0.0 116.165 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.43 163.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 122.197 0.998 . . . . 0.0 112.188 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -66.84 144.38 56.32 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.694 -1.254 . . . . 0.0 112.804 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.281 15.4 tt -56.89 -40.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.01 -44.68 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 119.554 1.07 . . . . 0.0 113.28 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -58.96 -40.99 86.38 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -35.35 79.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -67.11 -48.37 68.33 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 114.157 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -53.64 -24.92 15.67 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 165.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.76 -51.44 59.17 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 120.955 1.707 . . . . 0.0 114.602 164.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.74 -44.32 63.25 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -106.52 61.14 0.64 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 167.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.3 5.6 p30 -82.08 -35.5 28.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.304 -1.498 . . . . 0.0 114.698 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 54.95 44.44 28.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -76.3 122.08 23.9 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -111.28 133.77 53.37 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.551 0.74 . . . . 0.0 111.745 166.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.53 102.75 10.59 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -85.78 100.93 12.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.304 -0.872 . . . . 0.0 109.403 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -93.83 127.94 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -141.29 125.39 17.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.131 -0.981 . . . . 0.0 110.207 171.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -95.03 122.98 38.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.687 -0.633 . . . . 0.0 111.396 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -105.45 76.41 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.571 0.7 . . . . 0.0 109.895 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.13 78.05 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 115.994 1.157 . . . . 0.0 115.994 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 4.3 m-80 70.26 -50.27 0.65 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -167.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -73.64 120.74 19.65 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.017 0.927 . . . . 0.0 112.726 -172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -98.85 125.26 44.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.223 0.609 . . . . 0.0 111.919 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.6 m -94.78 108.13 20.14 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 165.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -105.29 101.47 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.16 104.87 17.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.16 145.03 35.88 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 121.936 0.874 . . . . 0.0 112.473 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -149.49 117.98 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.844 -1.16 . . . . 0.0 110.068 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 t -150.33 167.21 27.68 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 124.541 1.136 . . . . 0.0 111.26 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -51.9 -29.7 21.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -63.06 -53.86 47.15 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -171.78 171.29 5.26 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.226 1.01 . . . . 0.0 112.312 -162.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -133.26 119.58 19.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.731 -1.23 . . . . 0.0 111.129 161.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.4 pt -140.02 150.22 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-O 122.171 0.986 . . . . 0.0 111.521 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.12 106.63 18.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.7 t -95.59 93.61 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 t -93.91 120.77 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -135.51 139.48 44.02 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.145 0.974 . . . . 0.0 113.311 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.15 142.4 27.54 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 121.853 0.835 . . . . 0.0 110.858 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.22 92.79 1.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.397 -0.814 . . . . 0.0 112.84 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.37 -27.44 5.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.659 1.823 . . . . 0.0 117.659 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.08 127.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.036 1.918 . . . . 0.0 110.422 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -75.07 102.23 4.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.236 0.615 . . . . 0.0 111.309 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -112.27 150.6 30.73 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.754 0.822 . . . . 0.0 112.069 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -90.97 101.48 14.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.689 -0.632 . . . . 0.0 110.661 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.31 104.72 17.02 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.48 -0.762 . . . . 0.0 110.529 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -72.49 114.86 11.07 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.65 150.33 39.62 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.699 0.761 . . . . 0.0 111.769 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.39 0.03 7.35 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 121.683 3.957 . . . . 0.0 121.683 -160.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.05 -79.68 0.19 Allowed 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.3 1.409 . . . . 0.0 109.474 157.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.71 63.88 0.15 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 119.108 0.867 . . . . 0.0 115.163 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.8 m -134.39 103.33 5.67 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 117.561 0.68 . . . . 0.0 109.657 -172.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -75.65 107.19 7.65 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.586 0.707 . . . . 0.0 112.536 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.3 mt -84.24 104.36 14.21 Favored 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.427 -0.795 . . . . 0.0 110.536 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -87.17 110.35 20.09 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.448 1.099 . . . . 0.0 110.758 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.8 -157.87 30.39 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -128.37 136.18 50.57 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 122.903 0.481 . . . . 0.0 111.957 -165.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -91.56 114.93 27.59 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 153.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -107.19 136.9 46.25 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.084 0.554 . . . . 0.0 111.176 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.8 tp -89.31 104.39 16.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.972 -1.08 . . . . 0.0 110.987 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -78.09 -42.74 31.11 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.53 -92.27 0.08 OUTLIER Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -74.77 3.45 7.99 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 156.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -126.62 119.47 27.12 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.802 1.183 . . . . 0.0 108.772 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.07 102.34 13.76 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 160.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.88 113.55 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 C-N-CA 124.093 0.957 . . . . 0.0 109.25 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.8 104.1 3.01 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.044 0.83 . . . . 0.0 113.164 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.07 99.96 11.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.51 152.36 41.83 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.285 1.04 . . . . 0.0 112.121 -172.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -125.48 146.03 49.82 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.765 0.793 . . . . 0.0 110.056 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -65.41 129.57 40.23 Favored 'General case' 0 CA--C 1.565 1.556 0 O-C-N 120.827 -1.171 . . . . 0.0 112.11 170.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -85.63 38.17 0.73 Allowed 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 122.122 0.963 . . . . 0.0 112.298 158.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -160.74 45.35 0.2 Allowed 'General case' 0 CA--C 1.585 2.314 0 C-N-CA 124.845 1.258 . . . . 0.0 110.314 -157.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.38 51.6 p30 138.11 -50.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.763 2.425 . . . . 0.0 111.469 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.8 2.14 27.12 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -90.48 145.61 24.77 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.514 2.157 . . . . 0.0 112.649 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -70.49 151.06 45.51 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.87 113.89 12.02 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -104.61 132.19 51.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.618 -0.676 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -142.85 139.2 30.77 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.8 t -120.92 118.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -96.54 120.94 37.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 162.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -146.34 165.28 29.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.82 111.58 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.634 -1.291 . . . . 0.0 109.307 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.19 85.99 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.046 0.927 . . . . 0.0 110.204 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.95 -84.31 1.02 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.079 -1.013 . . . . 0.0 114.622 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -141.62 48.07 1.64 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 163.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -142.75 136.91 29.37 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -81.49 105.7 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.478 -1.389 . . . . 0.0 111.177 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.33 109.76 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.749 0.785 . . . . 0.0 110.442 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -98.13 104.43 16.46 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -91.47 142.6 27.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 123.257 0.623 . . . . 0.0 109.61 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -151.2 116.88 5.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.789 -1.194 . . . . 0.0 110.513 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.72 125.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.359 1.064 . . . . 0.0 108.505 -171.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 110.97 10.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.969 0.507 . . . . 0.0 109.791 173.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 68.02 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 175.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 -31.19 1.92 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.826 2.291 . . . . 0.0 118.826 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.98 102.72 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 119.311 1.556 . . . . 0.0 109.189 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.66 133.41 33.7 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.197 0.998 . . . . 0.0 111.104 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.24 156.25 47.86 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.108 0.956 . . . . 0.0 111.722 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -133.89 149.84 51.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.939 0.876 . . . . 0.0 111.855 -170.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -141.1 119.39 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.019 -1.051 . . . . 0.0 108.54 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt -101.52 108.02 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -94.3 123.23 37.56 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.629 0.772 . . . . 0.0 110.015 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -79.57 165.47 22.91 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.06 112.76 6.67 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.802 -1.186 . . . . 0.0 112.859 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 125.151 1.38 . . . . 0.0 113.372 178.361 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.306 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 67.61 -1.75 1.53 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.12 101.61 2.29 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.232 1.378 . . . . 0.0 112.756 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.5 m 179.61 165.56 1.1 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.145 1.378 . . . . 0.0 110.518 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.1 m -96.33 111.98 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 167.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -108.8 114.25 27.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.776 -0.578 . . . . 0.0 110.509 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -92.74 135.29 34.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.105 -0.997 . . . . 0.0 112.559 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.3 129.22 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.885 -1.134 . . . . 0.0 113.61 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -119.0 -65.17 1.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.168 0.987 . . . . 0.0 110.998 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 75.46 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.345 0.658 . . . . 0.0 111.494 -165.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 p -85.89 139.59 31.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.341 2.5 tm-20 -94.06 -97.78 0.15 Allowed 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.542 -166.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.255 19.3 t30 -100.0 50.22 0.91 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.143 -1.598 . . . . 0.0 113.345 -167.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -76.84 -39.73 50.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.06 -40.55 98.04 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -67.19 -43.79 81.25 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -47.02 -54.97 9.06 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 161.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtp -65.32 -34.11 77.55 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -53.79 -46.36 71.0 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 163.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.66 -41.31 98.22 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.9 mmm -54.11 -48.95 70.19 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.06 65.72 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 123.536 0.589 . . . . 0.0 114.209 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.41 131.51 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.749 0.785 . . . . 0.0 110.701 -174.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.67 161.86 24.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.9 tt -58.23 158.03 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.384 42.3 t 82.14 -73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 C-N-CA 124.573 1.149 . . . . 0.0 109.267 -161.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -53.51 -50.68 64.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -64.07 -24.82 67.85 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -71.14 -48.54 51.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 121.67 2.032 . . . . 0.0 113.545 167.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.6 mt -56.0 -48.69 75.44 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 165.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.08 81.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -49.22 78.32 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.103 1.774 . . . . 0.0 115.355 165.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -92.3 59.95 3.57 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 121.79 -0.569 . . . . 0.0 111.439 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -74.3 -27.64 60.81 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.75 38.2 11.98 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.308 1.5 pt? -81.16 151.45 28.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -169.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -127.75 114.31 17.12 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.822 -173.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.8 mt -97.39 99.15 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.82 -1.175 . . . . 0.0 111.236 -170.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.2 m -85.71 95.02 9.25 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.886 0.851 . . . . 0.0 109.818 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.0 mt -95.71 121.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -133.6 69.57 1.47 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.606 0.639 . . . . 0.0 111.973 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -58.36 110.64 1.0 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -165.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.15 62.29 2.15 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.47 84.69 0.17 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.312 -0.867 . . . . 0.0 114.76 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.32 -66.21 0.29 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.546 1.173 . . . . 0.0 112.651 -160.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -67.93 123.69 21.29 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.347 1.059 . . . . 0.0 113.676 -161.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.21 107.9 19.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.265 -0.897 . . . . 0.0 110.825 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -90.9 101.99 14.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -112.11 102.36 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -85.42 97.34 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.04 93.29 9.33 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.734 0.778 . . . . 0.0 108.964 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.6 t -91.99 89.39 6.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.359 0.599 . . . . 0.0 111.8 -164.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.2 p -100.61 162.64 12.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -51.68 -36.63 47.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 163.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.09 -46.92 63.87 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -162.81 137.96 6.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.962 0.905 . . . . 0.0 111.342 -161.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -100.75 101.88 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 163.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 pt -103.89 113.45 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.107 0.563 . . . . 0.0 110.105 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -77.9 89.42 4.1 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.768 0.794 . . . . 0.0 112.024 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.88 106.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.95 104.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -117.85 132.28 56.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.925 -0.484 . . . . 0.0 112.255 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 157.45 24.66 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.778 1.275 . . . . 0.0 111.304 159.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.53 102.27 8.73 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.679 -1.263 . . . . 0.0 111.386 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.1 3.08 51.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 119.026 2.371 . . . . 0.0 119.026 -162.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.54 132.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 121.55 2.675 . . . . 0.0 112.222 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -82.99 102.9 12.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.283 -0.885 . . . . 0.0 110.768 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -139.13 157.58 45.71 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 112.997 -171.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.33 110.55 19.18 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.224 0.609 . . . . 0.0 111.533 173.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -100.61 113.66 26.68 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.122 0.969 . . . . 0.0 110.8 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.61 128.67 35.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 mt -84.8 165.97 17.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 112.321 167.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.16 -73.51 0.05 Allowed 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -114.43 59.13 0.69 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 120.397 1.453 . . . . 0.0 111.096 158.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.5 41.68 0.66 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 97' ' ' ASP 0.389 0.6 OUTLIER 75.91 163.67 0.25 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 163.731 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.06 119.19 22.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-O 122.327 1.061 . . . . 0.0 111.322 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.38 111.32 23.58 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.689 0.796 . . . . 0.0 110.418 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -95.32 116.89 29.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 112.294 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.22 -150.58 18.59 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -133.48 116.63 16.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.274 -0.545 . . . . 0.0 112.278 -160.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.59 119.79 20.12 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.55 0.614 . . . . 0.0 111.036 158.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -132.21 150.81 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.701 0.8 . . . . 0.0 111.419 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -98.92 103.57 15.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.658 -1.276 . . . . 0.0 112.019 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -91.69 81.81 5.27 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.01 0.91 . . . . 0.0 110.083 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.9 -105.89 1.84 Allowed Glycine 0 N--CA 1.491 2.303 0 O-C-N 121.411 -0.806 . . . . 0.0 114.777 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.62 10.72 37.71 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -113.54 116.75 30.03 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.836 1.198 . . . . 0.0 110.005 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -77.25 96.75 4.63 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.971 -1.08 . . . . 0.0 109.22 163.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.58 111.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.994 0.918 . . . . 0.0 108.89 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.99 98.06 1.85 Allowed Glycine 0 N--CA 1.475 1.284 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -78.52 105.07 9.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.36 134.11 47.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 111.306 -165.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -106.29 140.59 38.99 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 111.257 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -66.71 122.95 18.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.566 -1.334 . . . . 0.0 112.366 167.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -63.45 -25.74 68.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.445 ' CG ' ' HG1' ' A' ' 76' ' ' THR . 5.5 m-20 -62.58 -44.98 94.97 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.95 -4.93 0.21 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -160.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.8 7.17 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 118.596 2.198 . . . . 0.0 118.596 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.87 -29.47 12.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -172.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.328 1.8 mt-10 71.46 112.98 0.06 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 124.73 1.212 . . . . 0.0 113.296 -160.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 114.78 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 164.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.68 134.7 35.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 111.522 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.2 p -131.3 116.37 17.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.962 -0.461 . . . . 0.0 110.654 -167.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -114.36 106.62 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 120.854 -1.154 . . . . 0.0 108.458 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -90.54 122.23 33.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.217 162.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.33 144.18 31.33 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.76 1.164 . . . . 0.0 113.882 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -96.56 104.61 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.85 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 174.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.11 -97.56 0.14 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -99.78 25.19 7.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.98 149.18 41.45 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.265 1.031 . . . . 0.0 110.213 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.7 tp -100.22 112.64 24.96 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 168.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.12 120.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -110.15 91.62 3.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.7 m -89.13 101.96 14.62 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.964 0.905 . . . . 0.0 109.413 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -103.25 116.07 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.827 -0.546 . . . . 0.0 110.162 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.92 123.95 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -126.06 111.81 15.13 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.36 0.664 . . . . 0.0 110.544 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.3 OUTLIER 52.79 53.98 11.26 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.14 -25.36 1.58 Allowed Glycine 0 CA--C 1.556 2.616 0 N-CA-C 119.292 2.477 . . . . 0.0 119.292 -165.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.47 109.48 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 119.362 1.581 . . . . 0.0 109.246 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -85.04 143.98 28.55 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.914 0.885 . . . . 0.0 112.807 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.36 121.17 17.51 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.472 -0.768 . . . . 0.0 110.813 162.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -100.44 110.01 22.18 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -90.23 109.57 20.64 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.4 mt -109.67 117.52 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.099 -1.0 . . . . 0.0 108.352 -167.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.64 144.77 42.36 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 121.692 0.758 . . . . 0.0 112.179 -167.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -114.34 138.86 49.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.942 0.897 . . . . 0.0 110.205 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -67.78 118.0 10.43 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -174.381 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.304 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.326 50.8 m-85 74.96 -53.15 0.67 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.288 1.959 . . . . 0.0 116.288 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -79.19 98.01 6.43 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.365 0.984 . . . . 0.0 112.471 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 m -168.65 -176.95 2.93 Favored 'General case' 0 CA--C 1.573 1.843 0 C-N-CA 124.95 1.3 . . . . 0.0 110.064 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.0 m -93.16 130.12 38.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.643 -1.286 . . . . 0.0 109.615 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -135.9 112.97 10.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.229 -0.919 . . . . 0.0 111.552 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -102.51 143.21 32.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 112.268 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.252 8.6 p -76.41 90.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.339 1.066 . . . . 0.0 113.319 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -46.17 18.45 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -141.35 79.51 1.69 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.92 1.236 . . . . 0.0 113.16 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -79.75 139.53 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.817 -1.177 . . . . 0.0 114.163 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.343 0.9 OUTLIER -86.87 -91.26 0.11 Allowed 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 123.989 0.916 . . . . 0.0 111.702 -177.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -107.0 43.7 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 121.116 1.78 . . . . 0.0 114.634 -166.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.79 -32.14 63.62 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.52 -44.56 80.91 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -69.1 -38.51 78.97 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.72 -54.09 38.59 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 162.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.422 ' SD ' HG13 ' A' ' 23' ' ' VAL . 8.1 mmt -48.06 -50.98 26.24 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 164.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -56.56 -45.92 81.02 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.2 -38.99 91.22 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.8 mtm -62.16 -35.02 77.54 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 167.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.83 62.63 0.54 Allowed Glycine 0 N--CA 1.49 2.26 0 CA-C-N 119.046 0.839 . . . . 0.0 114.96 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG13 ' SD ' ' A' ' 18' ' ' MET . 16.1 m -118.91 145.6 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.395 0.616 . . . . 0.0 111.175 -170.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -66.7 156.29 35.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.881 -1.137 . . . . 0.0 113.673 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.07 -43.72 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -57.92 -51.64 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -59.95 -44.88 94.12 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -51.6 -48.24 63.29 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -70.56 -58.53 3.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 168.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.15 -32.84 69.43 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.91 65.57 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 121.598 1.999 . . . . 0.0 115.598 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.76 85.25 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 156.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -100.45 49.15 0.9 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -85.47 -7.22 59.02 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 58.87 38.26 24.57 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.288 1.3 pt? -74.28 139.23 44.12 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.698 1.237 . . . . 0.0 113.059 -172.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -136.9 89.1 2.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -155.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.1 mt -89.35 110.16 20.98 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.148 0.579 . . . . 0.0 110.985 -160.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.4 m -89.0 106.71 18.6 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 164.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.01 124.19 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 60.5 p -139.63 118.56 12.52 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.966 -0.459 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -77.5 96.7 4.79 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.646 0.778 . . . . 0.0 111.158 167.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.24 83.57 7.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.688 1.232 . . . . 0.0 111.116 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.51 1.57 Allowed Glycine 0 N--CA 1.489 2.19 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.704 -165.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -131.98 -22.44 2.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.36 115.46 12.74 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 120.282 1.401 . . . . 0.0 112.723 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -78.64 106.13 10.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.477 -0.764 . . . . 0.0 110.025 171.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -88.15 103.64 15.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -104.54 107.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.28 96.15 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.62 90.55 3.95 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -89.77 95.45 10.25 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -129.25 173.06 10.85 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 0.0 112.955 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -58.88 -40.32 84.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.24 -40.17 52.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 151.21 31.08 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 121.677 2.035 . . . . 0.0 113.456 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -111.02 96.15 5.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.83 132.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.591 -0.693 . . . . 0.0 112.443 -168.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.23 109.36 18.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.006 -1.059 . . . . 0.0 111.773 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -95.36 101.0 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.4 t -100.15 116.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -141.51 123.02 15.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -174.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.69 152.93 31.34 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 112.611 166.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.33 106.47 1.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 113.558 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 CA--C 1.552 2.385 0 N-CA-C 118.846 2.299 . . . . 0.0 118.846 -169.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.09 135.67 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 121.127 2.464 . . . . 0.0 112.654 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.7 p -84.42 105.16 15.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.315 -0.865 . . . . 0.0 110.925 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.27 163.04 31.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -100.33 110.11 22.33 Favored 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 123.155 0.582 . . . . 0.0 110.37 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -73.56 -61.7 1.74 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.261 39.2 m-80 77.91 100.95 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.778 1.172 . . . . 0.0 114.055 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.75 176.83 9.17 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.27 68.5 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' CG ' ' HG1' ' A' ' 76' ' ' THR . 50.3 p-10 -72.89 -58.64 3.18 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 171.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.0 58.42 0.04 OUTLIER Glycine 0 CA--C 1.546 2.007 0 C-N-CA 124.288 0.947 . . . . 0.0 110.965 -161.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.446 ' HG1' ' CG ' ' A' ' 74' ' ' ASP . 91.0 m -130.79 96.45 4.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.84 127.94 34.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.481 0.712 . . . . 0.0 109.912 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -137.05 97.97 3.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.765 -1.209 . . . . 0.0 111.806 -157.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.481 HH21 ' NZ ' ' A' ' 94' ' ' LYS . 32.3 ptt180 -91.37 115.63 28.19 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.415 0.686 . . . . 0.0 111.843 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.34 -154.07 23.12 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -127.48 145.58 50.79 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.37 116.36 29.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.131 -0.981 . . . . 0.0 108.995 150.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -106.67 174.7 5.77 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 121.158 0.504 . . . . 0.0 111.462 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -124.29 120.91 33.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.149 -1.594 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.43 83.46 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 109.972 169.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.86 -93.21 0.39 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.266 -0.896 . . . . 0.0 115.227 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -117.69 39.39 3.35 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 166.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.97 110.69 9.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.799 -1.188 . . . . 0.0 108.092 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -82.48 118.27 23.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 109.685 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -111.88 105.84 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.404 0.682 . . . . 0.0 110.219 -167.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.41 95.8 2.11 Favored Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 113.098 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -102.62 102.54 12.77 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.36 134.17 51.14 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.431 0.692 . . . . 0.0 110.911 -168.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.481 ' NZ ' HH21 ' A' ' 79' ' ' ARG . 0.2 OUTLIER -104.42 127.65 52.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.14 115.23 13.39 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.388 -0.82 . . . . 0.0 112.835 -170.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -59.14 -44.84 92.08 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.96 -39.47 78.18 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -125.48 -28.15 3.35 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -161.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.46 65.95 1.49 Allowed Glycine 0 N--CA 1.492 2.37 0 CA-C-N 120.615 1.552 . . . . 0.0 114.777 -172.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -152.89 137.43 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 117.512 0.656 . . . . 0.0 111.869 -164.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -77.66 122.16 24.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 113.391 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.05 120.19 41.6 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.717 0.807 . . . . 0.0 109.602 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -113.01 108.05 16.81 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.259 15.3 t -115.94 102.26 9.51 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.175 0.59 . . . . 0.0 112.255 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.93 121.08 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.181 -0.949 . . . . 0.0 109.855 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -96.17 125.62 40.82 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.932 0.893 . . . . 0.0 111.423 170.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -149.83 159.77 44.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.989 0.899 . . . . 0.0 112.224 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.29 117.61 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.552 -1.342 . . . . 0.0 109.352 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.73 -51.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.57 77.37 0.08 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.48 0.0 OUTLIER 78.09 -45.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -159.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -78.44 143.73 36.46 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.03 116.94 29.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.91 0.884 . . . . 0.0 110.427 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.35 107.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.761 -0.587 . . . . 0.0 109.521 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.48 103.29 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.0 m -101.47 91.5 4.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.313 0.645 . . . . 0.0 109.993 -161.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.55 109.89 18.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.339 1.056 . . . . 0.0 112.892 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.15 119.12 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -124.48 113.25 17.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 50.36 55.33 9.64 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.03 -21.12 1.38 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.36 102.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.739 1.769 . . . . 0.0 108.946 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.84 141.36 28.71 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.71 0.804 . . . . 0.0 112.883 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.98 116.0 12.39 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.493 0.717 . . . . 0.0 111.403 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.35 101.94 13.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 0.0 108.632 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -82.91 101.86 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.7 mt -95.08 106.81 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.41 130.37 43.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.093 0.557 . . . . 0.0 110.945 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -85.47 148.16 26.11 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.459 0.647 . . . . 0.0 111.424 169.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -80.53 90.01 5.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 122.137 0.97 . . . . 0.0 112.035 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -174.03 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 121.443 0.64 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.6 -47.31 14.33 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.728 2.122 . . . . 0.0 116.728 -170.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.58 94.78 5.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.48 1.133 . . . . 0.0 112.244 -163.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -167.21 173.11 9.3 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.745 1.26 . . . . 0.0 111.346 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 m -84.8 129.6 34.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.056 . . . . 0.0 110.613 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -136.24 99.99 4.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.912 -0.493 . . . . 0.0 111.366 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -87.84 136.38 32.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.092 -1.005 . . . . 0.0 112.653 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -65.83 119.89 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.69 -62.75 1.2 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.643 0.777 . . . . 0.0 111.219 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -133.69 103.03 5.7 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.163 0.585 . . . . 0.0 110.985 -160.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -96.56 100.12 11.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.36 -0.837 . . . . 0.0 112.334 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.35 122.46 24.49 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.053 0.541 . . . . 0.0 110.849 -174.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.253 23.8 t30 64.09 12.5 7.05 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -65.76 -43.17 89.68 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.57 -35.95 77.3 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.93 -41.73 50.89 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -45.93 -52.1 12.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 158.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mtt -68.6 -28.94 67.37 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -55.75 -47.07 77.59 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-N 120.871 1.669 . . . . 0.0 114.825 158.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -59.47 -41.4 89.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 167.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.4 mtp -60.91 -39.02 87.76 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 167.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.03 65.29 0.64 Allowed Glycine 0 N--CA 1.486 2.01 0 CA-C-N 118.926 0.784 . . . . 0.0 114.186 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.79 131.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.353 0.596 . . . . 0.0 110.611 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -74.64 153.78 38.8 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 14.1 tt -48.16 -39.4 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -172.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.45 -59.45 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 120.29 1.405 . . . . 0.0 113.024 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -68.0 -37.84 81.92 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.17 -40.99 82.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -60.5 -44.56 95.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 163.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.44 -40.6 75.05 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.17 77.18 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 171.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.96 68.06 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 166.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -94.0 58.31 2.55 Favored 'General case' 0 CA--C 1.575 1.912 0 C-N-CA 123.832 0.853 . . . . 0.0 111.947 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.42 -23.04 18.55 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 61.01 52.33 4.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.693 1.197 . . . . 0.0 114.222 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.0 tp -82.24 114.06 20.48 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.401 -0.812 . . . . 0.0 112.639 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -100.16 105.05 16.61 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.05 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.34 102.32 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.2 m -92.45 105.42 17.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.1 mt -96.57 124.56 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -170.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -147.9 107.67 3.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.699 -0.625 . . . . 0.0 111.323 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.01 147.43 26.21 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 171.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.38 -48.53 12.79 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 164.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.84 -68.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.172 -0.955 . . . . 0.0 113.386 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -123.33 48.84 1.77 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.767 -0.843 . . . . 0.0 112.449 164.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -154.14 109.96 3.22 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.033 -1.042 . . . . 0.0 108.318 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -86.08 118.48 25.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.902 0.481 . . . . 0.0 111.752 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.5 m -84.67 102.99 13.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 165.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.8 m -100.25 108.63 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.35 99.5 12.3 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.69 74.53 3.69 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.885 -161.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 t -87.99 109.7 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.737 -1.227 . . . . 0.0 113.227 -166.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -139.71 163.55 32.31 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.936 1.294 . . . . 0.0 109.405 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 m -75.57 51.95 0.62 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 119.687 -1.883 . . . . 0.0 112.336 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -174.73 -53.84 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.809 0 C-N-CA 125.06 1.344 . . . . 0.0 111.78 -164.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -93.63 -91.58 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.189 1.359 . . . . 0.0 110.023 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.303 2.1 t30 51.71 57.74 6.22 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.0 pt -119.53 -35.61 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.273 35.0 mt-10 76.98 99.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.086 1.312 . . . . 0.0 112.135 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.66 113.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.15 97.35 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -106.93 136.43 46.78 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -86.4 149.71 24.82 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.201 1.001 . . . . 0.0 112.427 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -80.47 75.23 7.33 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 110.347 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.14 -60.23 0.26 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 -161.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.18 140.59 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 118.402 1.101 . . . . 0.0 112.287 -172.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 p -86.95 118.6 26.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.986 -1.071 . . . . 0.0 110.459 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -140.21 162.23 35.76 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.837 0.827 . . . . 0.0 112.643 -166.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.23 103.55 10.18 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 111.692 167.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -81.77 -48.16 11.97 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 168.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.255 15.4 m-20 69.19 168.05 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.872 1.269 . . . . 0.0 114.168 172.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -101.14 -130.07 0.23 Allowed 'General case' 0 CA--C 1.571 1.763 0 O-C-N 120.914 -1.117 . . . . 0.0 109.003 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.29 -29.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -47.97 83.38 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 168.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.48 71.29 0.01 OUTLIER Glycine 0 CA--C 1.543 1.796 0 C-N-CA 124.306 0.955 . . . . 0.0 110.761 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 m -162.21 119.61 2.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -84.65 151.96 24.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -141.39 109.81 5.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.873 -0.517 . . . . 0.0 110.134 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -97.35 122.43 40.38 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.238 1.015 . . . . 0.0 110.817 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.61 -160.07 33.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.6 m -140.69 142.26 34.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.391 -0.476 . . . . 0.0 110.007 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -89.31 109.6 20.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 163.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -96.76 135.24 38.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.293 0.637 . . . . 0.0 111.17 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.45 105.35 17.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.858 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -78.71 -41.59 30.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.15 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -85.1 5.24 30.52 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 159.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -121.47 123.57 42.36 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.964 1.256 . . . . 0.0 109.508 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.58 100.9 12.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 159.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 tp -89.03 107.27 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-O 122.005 0.907 . . . . 0.0 109.289 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.53 100.89 1.87 Allowed Glycine 0 N--CA 1.475 1.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.334 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.08 96.06 10.57 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -113.63 154.47 27.16 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.991 . . . . 0.0 111.702 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -146.1 147.35 31.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.71 -1.244 . . . . 0.0 111.767 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -72.44 149.43 44.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p -72.92 -46.62 51.6 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.007 -1.058 . . . . 0.0 112.969 152.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -50.01 5.59 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -174.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.52 20.89 5.15 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.63 -16.18 3.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 120.434 2.934 . . . . 0.0 120.434 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -83.29 146.28 28.62 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 118.717 1.259 . . . . 0.0 113.982 -157.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -69.69 130.85 43.48 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.34 111.62 23.29 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.77 162.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -91.23 112.58 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 109.936 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -114.75 136.24 53.29 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.413 0.685 . . . . 0.0 111.135 -170.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.66 114.11 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.868 -1.145 . . . . 0.0 108.838 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -96.53 112.85 24.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.913 -1.117 . . . . 0.0 109.725 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.83 140.52 32.97 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-O 121.221 0.534 . . . . 0.0 112.322 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.9 120.16 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.45 -1.406 . . . . 0.0 109.594 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -97.88 75.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 123.93 0.892 . . . . 0.0 110.737 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.65 -89.51 1.24 Allowed Glycine 0 N--CA 1.492 2.41 0 O-C-N 120.523 -1.361 . . . . 0.0 114.453 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -126.1 36.2 4.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 170.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -136.09 121.33 19.09 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.299 1.039 . . . . 0.0 108.227 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -78.63 108.63 12.18 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.216 0.607 . . . . 0.0 109.423 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.4 m -90.69 114.07 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -95.38 99.31 11.24 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.2 m -92.17 96.75 10.49 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 -167.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -100.66 115.58 30.55 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.863 0.865 . . . . 0.0 110.834 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -113.99 115.78 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -118.46 117.93 30.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.725 -0.609 . . . . 0.0 109.445 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.1 OUTLIER 41.62 66.06 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.4 -35.25 2.43 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.1 118.49 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.294 1.547 . . . . 0.0 109.609 -164.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.71 146.04 24.32 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.223 1.011 . . . . 0.0 112.663 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.26 146.23 44.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.735 0.779 . . . . 0.0 111.663 156.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -118.86 101.99 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -82.71 102.81 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.7 mt -100.17 115.96 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -108.27 120.47 42.47 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.335 0.654 . . . . 0.0 110.044 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -81.48 156.5 25.29 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.954 0.883 . . . . 0.0 112.774 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -65.17 122.61 17.48 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 112.869 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.265 10.7 t70 . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 125.403 1.481 . . . . 0.0 110.529 -167.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 121.65 0.738 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.88 12.65 7.3 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.72 83.91 7.74 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -163.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 t -148.91 -173.11 4.27 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 122.794 1.283 . . . . 0.0 111.119 168.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -91.3 123.78 35.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.018 -1.051 . . . . 0.0 109.614 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -132.95 115.83 15.69 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.011 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -112.56 146.17 39.01 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 120.256 1.389 . . . . 0.0 112.993 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.99 115.12 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.17 -64.42 1.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.771 0.829 . . . . 0.0 111.454 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -138.61 118.9 13.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.255 0.622 . . . . 0.0 111.177 -169.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.6 p -102.59 121.06 41.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.373 0.669 . . . . 0.0 111.412 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -103.89 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.495 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -77.27 38.09 0.22 Allowed 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 121.26 1.846 . . . . 0.0 115.816 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.0 -42.66 37.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -64.31 -27.9 69.35 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -78.99 -42.65 26.14 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -45.81 -51.21 13.22 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 161.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.2 mtp -66.88 -30.44 70.61 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.92 -49.57 76.31 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 165.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -57.03 -33.69 67.45 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 166.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.9 mtp -64.71 -50.66 66.08 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 165.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.97 67.72 0.27 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 119.029 0.831 . . . . 0.0 114.407 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.45 149.82 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.867 0.841 . . . . 0.0 110.789 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -79.73 159.95 26.43 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 10.8 tp -49.44 -47.35 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.73 -46.67 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -76.45 -37.78 56.42 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -49.57 -46.13 48.59 Favored 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 121.287 1.858 . . . . 0.0 115.355 161.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.27 -57.17 10.2 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -56.75 -35.05 68.17 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.78 97.8 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.74 93.34 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 164.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -93.17 42.02 1.09 Allowed 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -77.89 -23.88 48.6 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 60.71 47.06 8.46 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.79 108.07 4.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 111.826 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -99.5 108.2 20.58 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.347 0.659 . . . . 0.0 109.343 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.25 100.83 12.04 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.703 0.801 . . . . 0.0 109.07 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.0 m -93.98 98.04 10.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.9 mt -97.79 122.72 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -165.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -117.89 106.84 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.86 88.44 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.952 0.882 . . . . 0.0 111.264 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -80.12 46.21 0.79 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.6 83.3 0.49 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.732 -1.23 . . . . 0.0 114.719 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.317 24.7 m120 72.08 -40.4 0.47 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 -174.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -74.41 145.72 43.49 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.498 1.142 . . . . 0.0 113.081 164.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.03 109.95 13.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 0.0 108.595 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.8 m -89.51 99.97 12.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.32 104.12 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -85.6 104.37 15.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.613 -0.679 . . . . 0.0 109.779 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -93.7 99.24 11.69 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.943 0.897 . . . . 0.0 109.383 -173.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 t -104.7 114.03 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.1 0.56 . . . . 0.0 111.505 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -143.78 175.71 9.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -59.62 -33.12 71.09 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 163.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -85.56 -46.58 10.69 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -143.74 142.69 31.05 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.786 0.834 . . . . 0.0 111.875 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -126.48 92.4 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.73 144.46 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -164.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 112.25 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.913 -1.117 . . . . 0.0 112.065 171.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -99.15 105.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.22 115.21 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -135.78 146.9 48.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.702 -0.624 . . . . 0.0 112.504 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -99.51 151.95 20.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.136 0.969 . . . . 0.0 111.591 164.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.22 122.99 16.45 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.99 85.22 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.27 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.581 2.191 . . . . 0.0 110.637 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.7 p -75.04 106.81 6.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.584 -0.698 . . . . 0.0 111.122 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -140.17 161.61 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.643 0.735 . . . . 0.0 112.487 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.93 104.13 12.07 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 111.775 170.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -86.77 -177.36 6.09 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 122.06 0.933 . . . . 0.0 111.775 164.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.29 152.16 51.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.8 mt -85.9 160.74 19.33 Favored 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 146.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.11 63.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.96 -68.22 0.4 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 124.189 0.996 . . . . 0.0 113.514 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.35 87.59 0.07 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.1 m -148.77 110.65 4.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.073 -0.663 . . . . 0.0 109.685 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 93.41 4.33 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 125.947 1.699 . . . . 0.0 113.161 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt -100.4 99.53 10.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 112.328 -171.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -85.54 117.8 24.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.878 -1.139 . . . . 0.0 113.283 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.56 -171.25 44.35 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 116.969 1.548 . . . . 0.0 116.969 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -115.28 117.81 31.52 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 118.595 -0.716 . . . . 0.0 111.652 -170.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -74.53 107.14 6.47 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.155 0.889 . . . . 0.0 110.784 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -119.58 135.82 54.63 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.591 0.756 . . . . 0.0 111.324 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.59 107.46 18.16 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.801 -1.187 . . . . 0.0 111.691 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.44 80.42 2.23 Favored 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.602 1.161 . . . . 0.0 109.915 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.85 0.83 Allowed Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.511 -0.743 . . . . 0.0 113.772 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -88.05 -35.77 17.35 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -75.73 121.82 23.09 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.197 0.908 . . . . 0.0 112.409 -164.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mt -80.6 96.85 6.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.0 109.169 166.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.59 116.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.102 0.961 . . . . 0.0 109.491 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.0 100.48 1.58 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.667 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.4 86.71 7.24 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -109.47 112.96 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.237 0.615 . . . . 0.0 111.942 -164.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -89.37 130.97 35.66 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.195 -0.941 . . . . 0.0 111.293 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.89 114.3 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.975 . . . . 0.0 110.477 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.8 m -59.56 -49.97 75.71 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -162.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.295 3.4 t70 -72.76 -17.29 61.61 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.61 -58.79 3.02 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.691 1.587 . . . . 0.0 114.545 162.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.52 44.13 9.72 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 -146.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -142.94 139.48 30.72 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.175 1.487 . . . . 0.0 111.357 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.14 138.96 31.1 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.665 2.469 . . . . 0.0 117.665 -163.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.36 111.86 16.28 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.591 1.556 . . . . 0.0 108.253 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -100.35 115.97 31.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 110.987 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.4 p -109.83 115.19 29.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.594 0.758 . . . . 0.0 111.003 -169.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.73 116.9 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 119.467 1.03 . . . . 0.0 109.266 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -94.35 124.86 38.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.195 0.598 . . . . 0.0 110.908 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.48 42.08 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.508 0.671 . . . . 0.0 111.0 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.4 mm -95.92 109.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.691 -1.256 . . . . 0.0 108.571 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.258 10.3 tp -79.71 63.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 122.439 1.114 . . . . 0.0 112.904 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.04 -77.88 1.12 Allowed Glycine 0 N--CA 1.49 2.238 0 O-C-N 120.556 -1.34 . . . . 0.0 115.07 -170.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -97.14 -45.19 6.63 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -96.95 148.63 22.77 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 112.956 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.6 tp -85.56 114.71 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.901 -1.124 . . . . 0.0 110.411 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.3 m -87.8 123.93 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.784 . . . . 0.0 109.776 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -104.94 98.69 8.37 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 164.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.2 m -95.05 106.76 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -109.07 115.61 30.38 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.596 0.758 . . . . 0.0 110.273 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.18 110.06 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -98.5 105.98 18.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.942 1.246 . . . . 0.0 109.682 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 46.89 50.2 13.84 Favored 'General case' 0 CA--C 1.58 2.101 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.96 -40.49 2.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.16 116.34 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.48 2.14 . . . . 0.0 112.373 -170.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -92.32 138.68 31.31 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 121.729 0.776 . . . . 0.0 112.921 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.37 142.31 47.15 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.678 0.791 . . . . 0.0 111.609 164.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -123.43 101.94 7.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -83.06 117.65 22.99 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 166.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -104.82 123.09 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -108.8 127.64 54.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.965 0.906 . . . . 0.0 111.151 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -85.26 148.74 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.997 0.903 . . . . 0.0 112.899 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.89 123.95 31.81 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.196 0.598 . . . . 0.0 112.338 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 125.088 1.355 . . . . 0.0 112.592 174.121 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.594 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.353 82.2 m-85 69.79 -67.93 0.21 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.72 72.96 5.27 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 119.949 1.249 . . . . 0.0 113.269 -171.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.9 p -156.43 -178.01 7.02 Favored 'General case' 0 CA--C 1.573 1.856 0 C-N-CA 124.42 1.088 . . . . 0.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.26 128.75 34.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.94 -1.1 . . . . 0.0 110.915 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -129.39 114.55 16.31 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -101.86 141.37 34.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.286 -0.884 . . . . 0.0 112.394 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.69 93.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.873 -1.142 . . . . 0.0 113.916 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.88 -45.74 9.48 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -143.64 152.72 41.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 111.354 -167.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.5 m -159.65 150.77 19.62 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.362 -2.086 . . . . 0.0 112.994 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -123.76 0.06 Allowed 'General case' 0 CA--C 1.578 2.045 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.22 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.295 0.1 OUTLIER -77.22 49.8 0.72 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 122.448 2.385 . . . . 0.0 116.776 -174.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -47.72 83.58 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.449 1.5 . . . . 0.0 114.745 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.92 -36.84 84.49 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.72 -44.18 74.4 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 120.177 1.353 . . . . 0.0 114.496 170.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -46.8 -56.73 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.9 mtt -67.21 -28.63 68.24 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -59.09 -48.27 82.2 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.82 1.645 . . . . 0.0 115.145 161.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -62.53 -36.2 81.85 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 mtp -59.09 -59.38 5.57 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.29 69.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.5 0.591 . . . . 0.0 114.456 171.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.3 p -148.43 136.56 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.932 0 CA-C-O 121.92 0.867 . . . . 0.0 110.17 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -82.42 164.65 20.86 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 33.1 pt -55.59 -40.17 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -169.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -48.9 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -70.67 -36.03 73.13 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -65.45 -42.3 92.48 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 167.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -55.53 -39.74 70.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.01 -60.93 2.78 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.508 160.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.75 74.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -173.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.37 71.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 161.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -124.52 41.9 3.39 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 123.741 0.816 . . . . 0.0 112.903 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.12 11.31 4.26 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 20.0 m-80 56.1 49.63 15.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -168.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.93 113.97 14.03 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.252 1.025 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -112.82 118.61 35.42 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.683 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -101.6 97.45 7.88 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.9 m -95.01 115.02 26.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -110.36 127.09 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -164.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -140.07 116.52 10.7 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.585 -0.697 . . . . 0.0 111.139 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -71.54 114.55 9.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -90.75 86.47 6.35 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.447 0.642 . . . . 0.0 109.292 165.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.79 23.23 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 117.431 1.732 . . . . 0.0 117.431 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.346 33.1 m120 65.59 -0.5 1.22 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -164.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -95.7 107.56 19.78 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 120.484 1.493 . . . . 0.0 109.384 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.38 105.69 8.66 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.047 0.939 . . . . 0.0 111.515 -169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.0 m -79.86 95.51 6.08 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -95.14 112.38 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.62 74.58 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.731 -169.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -84.68 101.42 12.16 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.56 0.695 . . . . 0.0 109.665 -158.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.6 m -114.91 101.96 9.53 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.872 -156.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -137.13 176.06 9.05 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.6 t -66.98 -9.68 41.28 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 168.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.26 -55.71 4.18 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.589 1.541 . . . . 0.0 113.156 166.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -155.42 140.65 17.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 118.703 0.683 . . . . 0.0 110.662 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -108.51 93.28 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -116.83 115.6 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.249 0.547 . . . . 0.0 110.501 -163.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.69 90.2 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.13 116.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -166.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.03 92.83 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -104.58 134.07 48.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.02 153.0 41.07 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 112.435 166.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.7 mt -73.71 73.94 1.53 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 120.966 -1.084 . . . . 0.0 111.845 164.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.39 -63.18 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -167.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.36 146.06 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 p -83.1 106.2 14.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.4 -0.813 . . . . 0.0 110.925 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -129.87 154.98 46.75 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.466 0.706 . . . . 0.0 112.612 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -82.01 119.92 24.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 111.579 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -94.11 -40.62 9.95 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.266 5.6 m120 76.8 99.07 0.07 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 168.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -87.0 111.78 21.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.149 -0.969 . . . . 0.0 112.346 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.298 . . 46.13 -88.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 118.767 2.877 . . . . 0.0 118.767 161.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.79 -58.37 7.04 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 -34.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 120.352 2.901 . . . . 0.0 120.352 -166.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -67.69 108.98 3.12 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 120.778 2.289 . . . . 0.0 113.963 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.303 22.8 pt-20 -86.7 95.95 9.97 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-O 123.104 1.43 . . . . 0.0 112.371 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.92 111.94 8.5 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.73 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -94.37 122.18 36.66 Favored 'General case' 0 CA--C 1.559 1.32 0 O-C-N 121.951 -0.468 . . . . 0.0 111.625 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.83 -152.38 21.6 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 115.573 0.989 . . . . 0.0 115.573 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.3 p -130.52 115.57 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.741 -155.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -80.42 142.42 34.35 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.509 0.671 . . . . 0.0 110.456 157.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.7 m -153.05 146.31 24.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.58 -1.325 . . . . 0.0 110.826 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.7 tp -88.24 102.61 14.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.89 -1.131 . . . . 0.0 111.36 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.0 93.77 7.59 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.324 0.65 . . . . 0.0 109.455 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -100.99 0.76 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 121.368 -0.833 . . . . 0.0 113.668 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -89.95 -33.07 16.54 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 161.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -80.76 133.19 35.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.845 1.657 . . . . 0.0 112.554 -161.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.14 101.07 7.71 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.721 -1.237 . . . . 0.0 109.562 163.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.84 111.81 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.737 0.815 . . . . 0.0 109.866 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.89 98.18 2.12 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 123.924 0.773 . . . . 0.0 113.06 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.48 103.58 16.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -121.52 150.5 41.52 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.235 1.017 . . . . 0.0 112.409 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -118.37 140.27 50.1 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.642 0.777 . . . . 0.0 109.487 169.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -66.11 125.2 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.722 -1.236 . . . . 0.0 112.049 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 m -70.89 -43.31 68.6 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.46 -0.775 . . . . 0.0 113.022 171.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -51.05 -56.92 10.2 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 165.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.75 -40.23 9.46 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.62 -9.78 60.65 Favored Glycine 0 CA--C 1.556 2.595 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.79 150.07 28.07 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 119.689 1.744 . . . . 0.0 112.841 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -85.46 143.7 28.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -173.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -131.92 134.87 46.15 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.48 1.112 . . . . 0.0 110.179 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -119.5 109.16 15.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.68 120.33 41.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.627 -0.67 . . . . 0.0 112.119 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.43 110.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.266 -0.896 . . . . 0.0 109.002 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 mtm-85 -92.75 116.38 28.97 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 121.586 -0.696 . . . . 0.0 110.766 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -137.51 149.43 46.77 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.769 0.828 . . . . 0.0 111.601 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -99.76 115.14 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.79 -1.194 . . . . 0.0 108.391 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 pt -80.73 -27.96 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.31 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.11 34.88 2.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 159.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -145.15 128.87 17.21 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.114 0.966 . . . . 0.0 109.865 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.98 110.05 20.29 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.742 0.817 . . . . 0.0 109.641 170.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.17 114.08 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -109.45 91.64 3.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -93.98 98.38 10.99 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.403 0.681 . . . . 0.0 110.073 -166.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.12 98.78 11.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.732 0.813 . . . . 0.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.12 106.88 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -120.3 109.7 15.69 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 53.61 50.5 17.05 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.86 -27.8 4.25 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 -167.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.0 t -87.74 113.92 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.694 1.747 . . . . 0.0 109.524 -170.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -104.87 101.53 11.12 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.398 0.679 . . . . 0.0 111.978 -169.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.31 102.97 14.84 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 112.377 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -81.48 99.22 8.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.097 0.559 . . . . 0.0 110.226 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -99.71 109.87 22.31 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.93 120.1 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.673 -1.267 . . . . 0.0 108.768 -159.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.2 123.65 48.31 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.517 0.727 . . . . 0.0 110.014 -168.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.06 156.8 31.5 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.986 1.266 . . . . 0.0 113.526 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -64.49 99.98 0.34 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 123.845 0.858 . . . . 0.0 113.147 174.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 4.8 t0 . . . . . 0 C--O 1.256 1.399 0 C-N-CA 125.407 1.483 . . . . 0.0 114.355 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.317 0 CA-C-O 121.57 0.7 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.322 86.3 m-85 73.82 -54.86 0.68 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -71.24 92.49 1.02 Allowed 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.083 1.311 . . . . 0.0 113.522 -164.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -177.04 171.21 2.14 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 125.211 1.405 . . . . 0.0 110.877 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -90.02 126.83 35.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.941 -1.099 . . . . 0.0 110.7 171.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -128.62 109.32 11.25 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.123 0.569 . . . . 0.0 110.07 -173.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -104.18 143.72 32.55 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.233 0.924 . . . . 0.0 113.067 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.43 120.56 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' CG ' HH21 ' A' ' 10' ' ' ARG . 10.7 t0 -86.72 -66.08 0.94 Allowed 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 123.486 0.715 . . . . 0.0 110.683 170.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.402 HH21 ' CG ' ' A' ' 9' ' ' ASP . 3.1 ptp85 -137.14 117.98 14.14 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.936 0.494 . . . . 0.0 111.223 -168.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.1 p -93.1 100.13 12.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.704 -0.622 . . . . 0.0 110.176 166.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.74 -80.4 0.07 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -155.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -88.29 44.36 1.19 Allowed 'General case' 0 CA--C 1.579 2.081 0 CA-C-N 120.32 1.418 . . . . 0.0 113.451 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -80.33 -45.29 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.387 -1.446 . . . . 0.0 114.827 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.71 -21.16 65.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.36 -40.95 17.24 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 120.331 1.423 . . . . 0.0 114.799 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -47.43 -49.98 23.89 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.971 1.714 . . . . 0.0 115.534 158.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 165.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -54.17 -44.43 71.48 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -58.16 -40.63 81.89 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 165.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -40.17 95.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 169.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.35 65.37 0.63 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 119.055 0.843 . . . . 0.0 114.177 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -128.13 148.38 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 122.274 1.035 . . . . 0.0 112.511 -167.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.91 159.2 33.14 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 14.2 tt -53.3 -38.67 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.93 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.264 0.938 . . . . 0.0 113.198 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -56.27 -43.81 79.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -60.33 -38.63 84.35 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -67.95 -54.93 14.87 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 166.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.38 -36.04 77.13 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.73 74.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.68 81.36 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 163.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -97.92 49.47 1.02 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 119.288 0.949 . . . . 0.0 113.532 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -83.31 -12.25 56.84 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.34 36.06 25.27 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.91 122.94 20.88 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 122.288 1.042 . . . . 0.0 112.674 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -118.42 111.79 19.13 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.032 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.61 98.98 10.07 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 m -92.04 100.24 12.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.835 . . . . 0.0 109.007 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.56 122.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.1 p -130.48 109.73 10.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -94.69 102.68 14.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.825 -1.172 . . . . 0.0 110.918 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.1 pm0 -75.09 -34.87 61.8 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.54 81.42 0.05 OUTLIER Glycine 0 N--CA 1.486 2.003 0 CA-C-N 119.18 0.9 . . . . 0.0 111.83 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER 74.32 -56.41 0.64 Allowed 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -160.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -60.53 139.54 57.72 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.62 114.47 28.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.823 0.449 . . . . 0.0 109.855 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.0 m -88.55 96.75 10.75 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.03 112.04 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.35 102.31 11.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.47 -0.769 . . . . 0.0 109.069 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -97.05 101.18 12.7 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -174.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.1 t -116.11 115.51 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.072 0.549 . . . . 0.0 112.412 -165.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -150.04 179.03 8.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -166.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -62.45 -43.69 98.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 164.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.1 -42.1 69.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 172.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -149.16 130.02 14.25 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.415 1.007 . . . . 0.0 111.209 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -119.99 86.99 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.22 144.74 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.676 -0.64 . . . . 0.0 111.657 -158.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.68 116.03 28.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.706 -1.246 . . . . 0.0 111.902 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.34 99.59 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.67 95.73 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.88 130.18 53.07 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.268 0.556 . . . . 0.0 112.477 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -92.22 145.51 24.44 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-O 122.353 1.073 . . . . 0.0 111.062 166.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.23 128.05 32.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.163 -0.961 . . . . 0.0 112.234 -168.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 -8.66 59.25 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 119.161 2.424 . . . . 0.0 119.161 -167.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.21 137.14 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 119.904 1.852 . . . . 0.0 110.813 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 95.62 5.68 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 121.711 0.767 . . . . 0.0 111.77 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -120.9 165.18 15.56 Favored 'General case' 0 CA--C 1.573 1.852 0 C-N-CA 124.401 1.08 . . . . 0.0 111.851 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -82.06 125.68 31.11 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.863 -1.148 . . . . 0.0 113.011 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -139.69 72.12 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.819 -0.55 . . . . 0.0 110.763 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -77.75 146.45 35.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.938 . . . . 0.0 113.086 -172.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.8 mt -65.73 -30.25 70.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.317 . . 74.03 -46.36 0.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -166.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -66.98 -57.39 6.97 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 163.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.75 -62.87 0.68 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -163.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 t -149.81 165.94 30.97 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -164.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -94.14 120.21 34.07 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 125.19 1.396 . . . . 0.0 109.744 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.1 mt -127.88 131.14 49.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 112.164 -164.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -120.17 134.24 55.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.577 -0.702 . . . . 0.0 110.711 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.73 -178.62 43.81 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 118.944 2.337 . . . . 0.0 118.944 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.1 p -118.3 120.09 36.6 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.408 -1.396 . . . . 0.0 110.992 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.25 111.45 20.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -87.51 -38.37 16.1 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.267 39.3 tp 62.01 86.74 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.957 1.303 . . . . 0.0 113.586 -167.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -86.45 83.57 7.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.18 0.99 . . . . 0.0 109.956 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.98 -96.14 0.59 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -98.26 -9.43 25.55 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -108.7 122.31 46.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.13 1.786 . . . . 0.0 110.383 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -73.44 102.02 3.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.809 -1.182 . . . . 0.0 109.84 168.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -97.27 123.3 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-O 121.523 0.677 . . . . 0.0 109.761 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.98 102.22 0.67 Allowed Glycine 0 N--CA 1.481 1.655 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.11 -170.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -84.29 98.92 10.26 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.301 0.551 . . . . 0.0 110.301 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -107.09 105.91 16.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.157 0.98 . . . . 0.0 110.019 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -90.01 133.1 35.01 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 121.639 -0.663 . . . . 0.0 110.938 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -62.38 122.7 16.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.3 p -71.19 -26.6 63.03 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -64.98 -57.47 8.63 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 164.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -111.35 -46.77 3.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 38.71 6.14 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 118.562 2.185 . . . . 0.0 118.562 -165.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.82 -8.04 59.31 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.301 4.9 tt0 72.18 99.49 0.07 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 175.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 tt -99.86 114.88 28.38 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.871 0.868 . . . . 0.0 110.229 172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -99.71 113.33 25.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.0 m -103.42 122.4 44.79 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 122.832 0.453 . . . . 0.0 110.759 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.57 111.06 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -105.29 113.05 26.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.375 0.67 . . . . 0.0 109.739 171.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.91 158.38 44.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.442 -0.786 . . . . 0.0 112.634 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.98 111.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.993 -1.067 . . . . 0.0 108.261 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 10.9 tp -85.5 68.26 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 CA-C-O 122.341 1.067 . . . . 0.0 111.744 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.77 -84.55 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 120.795 -1.191 . . . . 0.0 114.698 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.35 -17.39 18.05 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -118.46 131.34 56.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.336 1.425 . . . . 0.0 111.334 -168.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.8 tp -79.63 109.88 14.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 110.209 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.4 114.04 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.57 99.29 9.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.0 109.231 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.581 ' HG1' ' NZ ' ' A' ' 125' ' ' LYS . 30.4 m -100.01 105.67 17.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -172.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -84.18 102.3 12.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.198 0.599 . . . . 0.0 110.561 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.83 112.12 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -128.89 107.03 9.31 Favored 'General case' 0 CA--C 1.564 1.497 0 O-C-N 121.779 -0.576 . . . . 0.0 110.818 -176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.406 15.4 pt-20 39.56 64.57 0.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.56 -33.13 4.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -168.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.61 117.81 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 119.341 1.57 . . . . 0.0 109.758 -162.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.21 144.95 25.97 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.84 144.29 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 161.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.581 ' NZ ' ' HG1' ' A' ' 116' ' ' THR . 60.7 mttm -122.98 104.01 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 109.226 -174.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -80.7 105.44 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 162.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.91 123.26 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -109.44 125.37 52.35 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.441 0.696 . . . . 0.0 110.218 -171.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -81.39 165.54 21.22 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.573 0.701 . . . . 0.0 112.248 169.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -71.54 100.45 2.25 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 120.869 -1.144 . . . . 0.0 112.09 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 7.3 t0 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 125.2 1.4 . . . . 0.0 114.012 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.292 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -106.63 66.06 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.349 0.977 . . . . 0.0 112.5 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -155.69 81.87 1.03 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.022 . . . . 0.0 109.884 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -167.74 171.19 10.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.126 -0.984 . . . . 0.0 112.052 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -71.84 117.29 13.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.92 . . . . 0.0 111.138 161.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -114.64 101.87 9.5 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.69 135.99 33.62 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.476 0.711 . . . . 0.0 112.685 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.22 117.58 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.57 -62.88 1.19 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.723 0.809 . . . . 0.0 111.302 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.73 129.59 47.36 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.02 0.914 . . . . 0.0 110.946 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m -113.27 115.32 28.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -87.71 -57.78 2.82 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.894 0.478 . . . . 0.0 112.27 -165.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -121.15 145.83 47.41 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -163.21 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.077 0.951 . . . . 0.0 111.305 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -35.48 80.65 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -67.29 -37.14 82.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 165.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.6 -52.09 63.27 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.6 mtp -58.54 -37.44 75.68 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.4 -43.9 75.68 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.55 -44.84 95.35 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 166.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.0 mtm -58.22 -44.1 88.04 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.508 2.04 . . . . 0.0 116.508 175.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.17 63.02 0.1 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.6 143.59 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-O 122.483 1.135 . . . . 0.0 111.139 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -82.05 163.11 22.3 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 120.853 -1.155 . . . . 0.0 113.742 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.8 tp -64.0 157.46 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 O-C-N 121.03 -1.044 . . . . 0.0 113.24 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.389 21.8 t 80.48 -61.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 124.346 1.058 . . . . 0.0 110.7 -162.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -56.2 -47.42 78.4 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 162.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -61.83 -16.6 51.45 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 164.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.67 -44.31 12.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.21 1.368 . . . . 0.0 113.462 164.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.96 -48.89 69.84 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 166.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.76 -18.66 62.11 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.09 -58.51 3.98 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.912 1.233 . . . . 0.0 113.019 158.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.1 49.39 1.79 Allowed 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' CG ' ' HG ' ' A' ' 53' ' ' SER . 31.0 t0 -79.78 -30.43 40.64 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 63.91 55.41 1.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.713 1.142 . . . . 0.0 112.547 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.3 tp -79.81 113.25 17.82 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.957 0.884 . . . . 0.0 111.658 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -107.15 101.36 10.77 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.048 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.34 93.85 8.81 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.4 m -90.37 94.34 9.7 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.59 0.709 . . . . 0.0 110.336 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mt -80.77 124.47 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.674 0.79 . . . . 0.0 109.389 -175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.5 p -133.12 104.54 6.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -92.24 115.87 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.65 -1.281 . . . . 0.0 112.274 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.92 -41.29 59.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.7 -84.09 0.05 OUTLIER Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.126 -0.984 . . . . 0.0 111.42 171.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -82.02 -49.73 9.91 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 157.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.87 119.71 11.17 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -85.58 115.95 23.58 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -95.86 99.44 11.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -96.53 103.89 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.32 100.38 8.36 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 123.297 0.639 . . . . 0.0 110.062 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -86.92 97.3 10.61 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.419 0.688 . . . . 0.0 109.433 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -107.03 113.11 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.075 0.55 . . . . 0.0 110.317 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HG ' ' CG ' ' A' ' 34' ' ' ASP . 4.1 p -145.49 -170.45 3.45 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.21 1.005 . . . . 0.0 113.292 -174.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -62.0 -47.31 85.38 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.901 -1.125 . . . . 0.0 113.441 165.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -63.17 -48.77 76.99 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -142.09 163.05 33.92 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -160.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -143.43 88.68 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.111 163.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 141.62 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.261 -0.9 . . . . 0.0 112.429 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -84.72 115.31 22.61 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 121.398 -0.814 . . . . 0.0 112.708 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.24 98.32 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -87.39 114.07 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -127.44 124.1 37.64 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.757 0.789 . . . . 0.0 112.824 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.29 148.44 29.42 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 121.683 0.754 . . . . 0.0 111.478 164.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.52 88.46 2.68 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.758 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.07 -47.38 0.69 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -160.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.9 t -75.7 136.88 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 118.716 1.258 . . . . 0.0 112.264 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.3 p -89.84 120.12 30.8 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.304 -0.872 . . . . 0.0 110.35 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.82 156.8 47.03 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 121.971 0.891 . . . . 0.0 112.737 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.26 97.78 10.97 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.519 0.676 . . . . 0.0 110.479 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -84.31 97.94 9.73 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.531 -0.731 . . . . 0.0 110.299 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.41 133.07 39.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.579 -0.7 . . . . 0.0 112.057 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.38 171.95 13.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.78 69.43 1.81 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.052 1.406 . . . . 0.0 113.407 168.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 t70 179.57 -93.66 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 -156.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.34 50.48 0.02 OUTLIER Glycine 0 CA--C 1.548 2.099 0 C-N-CA 124.643 1.116 . . . . 0.0 112.891 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.5 m -143.4 113.71 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -158.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.39 130.12 35.03 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.42 120.46 38.21 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.705 1.202 . . . . 0.0 108.876 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -113.4 108.79 17.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.389 -1.444 . . . . 0.0 111.1 -159.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.22 -149.19 18.97 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 -172.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.9 m -140.78 147.26 38.82 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.01 0.91 . . . . 0.0 112.314 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -92.45 117.61 30.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.014 163.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -111.74 144.34 41.18 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.375 0.67 . . . . 0.0 111.586 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.3 tp -87.77 103.36 15.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.732 -1.23 . . . . 0.0 110.861 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.92 84.86 4.99 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.966 0.888 . . . . 0.0 108.848 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.34 -97.05 0.44 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -95.28 -19.97 19.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -89.17 124.24 34.17 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.639 1.563 . . . . 0.0 111.19 -172.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -82.54 100.07 9.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.772 -1.205 . . . . 0.0 108.967 164.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -95.79 110.32 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-O 122.131 0.967 . . . . 0.0 109.893 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.7 93.15 1.85 Allowed Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.005 0.812 . . . . 0.0 112.363 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.41 94.65 9.44 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.41 131.18 56.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.277 0.631 . . . . 0.0 109.719 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -90.41 134.72 34.15 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.953 -1.092 . . . . 0.0 110.131 164.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.23 105.88 1.52 Allowed 'General case' 0 CA--C 1.566 1.573 0 O-C-N 120.824 -1.173 . . . . 0.0 110.653 169.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -42.93 -59.63 1.92 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -163.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.69 67.42 0.67 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 123.568 1.651 . . . . 0.0 107.497 -169.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.71 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.068 -162.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.27 45.37 5.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 116.182 1.233 . . . . 0.0 116.182 -171.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -139.81 126.3 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 117.843 0.821 . . . . 0.0 109.883 -166.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -76.74 127.12 32.16 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.91 109.58 21.51 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.557 0.743 . . . . 0.0 109.281 161.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -98.77 122.38 41.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.02 94.17 4.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.02 -0.425 . . . . 0.0 110.217 -159.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.94 105.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 119.764 -1.835 . . . . 0.0 108.99 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -102.89 113.34 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.834 0.743 . . . . 0.0 110.506 170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -135.2 154.03 51.75 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 123.946 0.899 . . . . 0.0 111.06 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -86.57 108.71 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.692 -1.255 . . . . 0.0 109.627 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.7 tp -88.68 72.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.997 0.903 . . . . 0.0 111.117 172.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.59 0.5 Allowed Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.06 -1.025 . . . . 0.0 115.122 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -91.15 -14.07 31.81 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -134.3 145.57 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 119.443 1.019 . . . . 0.0 112.283 -161.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.2 tp -82.4 105.97 13.9 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.722 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.1 p -87.5 108.15 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -0.778 . . . . 0.0 110.209 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -98.96 106.25 18.48 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.114 0.566 . . . . 0.0 110.278 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.7 m -98.1 110.73 23.26 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.83 0.852 . . . . 0.0 109.78 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -98.9 105.99 18.2 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.542 1.137 . . . . 0.0 108.373 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.92 110.12 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -139.23 127.08 22.11 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.543 0.737 . . . . 0.0 110.86 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 50.66 45.17 27.23 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.63 -15.5 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 119.688 2.635 . . . . 0.0 119.688 -166.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.87 119.46 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 CA-C-N 119.618 1.709 . . . . 0.0 108.958 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.96 120.89 33.04 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.32 0.648 . . . . 0.0 110.565 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.92 136.31 54.81 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.53 0.732 . . . . 0.0 112.306 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -126.53 117.99 23.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 109.912 -172.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -109.96 116.75 32.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.06 120.03 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -108.95 126.21 52.85 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.842 0.857 . . . . 0.0 110.172 -171.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -91.85 153.92 19.23 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.174 0.988 . . . . 0.0 113.125 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -63.34 112.93 2.93 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.289 5.3 m-20 . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 126.221 1.809 . . . . 0.0 108.436 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.317 73.9 m-85 73.12 -47.86 0.67 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.11 94.63 2.44 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 -170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 m -173.73 177.53 2.45 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.581 1.552 . . . . 0.0 110.532 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.6 m -92.96 129.07 39.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.915 -1.741 . . . . 0.0 111.05 168.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -124.18 104.76 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.236 0.614 . . . . 0.0 109.871 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -89.82 133.37 34.76 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.511 0.724 . . . . 0.0 111.238 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.34 111.91 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.382 -0.823 . . . . 0.0 112.444 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.64 -62.79 1.51 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.276 0.631 . . . . 0.0 111.747 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -143.52 116.29 8.74 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.75 0.786 . . . . 0.0 109.788 -168.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.3 m -99.57 127.65 45.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.271 0.628 . . . . 0.0 110.729 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.317 5.7 tm-20 -74.82 -93.59 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -167.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -96.82 39.25 1.18 Allowed 'General case' 0 CA--C 1.577 1.982 0 O-C-N 120.477 -1.389 . . . . 0.0 113.72 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.27 -36.99 58.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.91 -35.64 78.99 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 166.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -71.28 -40.07 71.15 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 167.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -47.44 -50.45 22.87 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 157.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.476 ' SD ' HG12 ' A' ' 23' ' ' VAL . 6.5 mmt -59.3 -42.39 91.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 169.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.09 -44.67 91.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 166.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -55.91 -43.89 77.73 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.9 mmt -58.51 -37.65 76.06 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 167.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.3 46.01 2.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.476 HG12 ' SD ' ' A' ' 18' ' ' MET . 7.1 p -108.73 142.76 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 C-N-CA 123.841 0.856 . . . . 0.0 110.518 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -69.76 165.56 21.15 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.299 12.5 tt -73.63 53.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.78 -67.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -67.67 -25.95 65.96 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -42.9 -42.47 3.7 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 153.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.42 -52.01 5.61 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.291 -0.862 . . . . 0.0 112.364 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -57.86 -40.11 79.36 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.53 -35.03 60.81 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.88 88.36 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 163.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -103.43 47.67 0.87 Allowed 'General case' 0 CA--C 1.577 1.994 0 C-N-CA 123.867 0.867 . . . . 0.0 112.895 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -83.78 -11.56 56.91 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 59.27 46.21 13.09 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.311 -1.493 . . . . 0.0 114.185 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tt -85.32 108.65 17.9 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 121.379 -0.825 . . . . 0.0 111.914 -166.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -94.82 111.19 22.99 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.448 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.82 101.67 13.77 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.369 0.668 . . . . 0.0 110.256 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -81.48 101.15 9.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.168 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.7 mt -90.38 119.58 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 p -128.79 108.68 10.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -88.44 84.58 6.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 111.527 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.41 76.25 5.92 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 121.92 0.866 . . . . 0.0 111.563 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.95 77.23 0.7 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 115.812 1.085 . . . . 0.0 115.812 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.292 18.1 t-20 70.9 -57.87 0.58 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.25 119.01 9.45 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -86.42 106.37 17.4 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.502 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.4 m -87.64 97.35 10.82 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -104.23 107.79 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -94.63 106.02 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -78.78 111.86 15.34 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.237 0.615 . . . . 0.0 110.801 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 t -113.02 106.07 14.24 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.047 0.539 . . . . 0.0 109.558 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -142.86 178.43 7.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -58.83 -39.63 81.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -60.65 -52.12 66.5 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 165.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -158.3 151.45 22.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -159.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -122.91 90.92 3.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.789 0.836 . . . . 0.0 109.675 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.29 148.8 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.233 -0.917 . . . . 0.0 112.785 -167.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.86 116.88 33.77 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.109 0.964 . . . . 0.0 112.609 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.01 104.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.45 114.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -123.12 124.57 43.36 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.86 145.87 29.21 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.818 0.818 . . . . 0.0 111.263 166.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.73 117.5 11.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.33 0.11 85.05 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 119.537 2.575 . . . . 0.0 119.537 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.7 t -95.95 137.1 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 120.526 2.163 . . . . 0.0 110.374 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.0 p -75.28 121.83 22.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.728 . . . . 0.0 112.651 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -137.97 158.6 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.644 -0.66 . . . . 0.0 112.455 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.51 107.28 18.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.71 -0.619 . . . . 0.0 110.304 173.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -95.46 110.13 22.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -75.18 126.8 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.631 -0.668 . . . . 0.0 110.62 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.8 mt -78.37 167.41 21.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.757 -1.214 . . . . 0.0 113.88 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.39 63.23 2.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -167.52 -83.69 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.023 1.329 . . . . 0.0 108.113 -172.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.93 61.05 0.04 OUTLIER Glycine 0 CA--C 1.548 2.116 0 C-N-CA 125.354 1.454 . . . . 0.0 111.12 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.1 m -143.62 119.62 10.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.24 101.35 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.3 115.49 24.74 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -98.08 109.6 22.33 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.621 0.769 . . . . 0.0 110.409 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.59 -176.52 46.54 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -120.94 119.56 32.95 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.093 -1.553 . . . . 0.0 110.565 -166.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -79.47 112.19 16.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.905 0.775 . . . . 0.0 110.202 159.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.2 m -106.62 138.09 43.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.278 0.631 . . . . 0.0 110.983 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 tp -88.43 108.44 19.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.782 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -67.72 -42.56 81.74 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 171.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.28 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -79.77 -22.07 43.62 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 157.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -105.97 134.42 49.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.284 1.402 . . . . 0.0 111.341 -167.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.5 mt -94.35 111.35 23.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 108.78 167.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -105.36 120.11 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.784 1.234 . . . . 0.0 109.184 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.02 111.83 2.48 Favored Glycine 0 N--CA 1.483 1.805 0 O-C-N 121.839 -0.538 . . . . 0.0 113.94 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -97.59 107.97 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.136 0.575 . . . . 0.0 109.556 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -127.14 107.25 9.86 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.399 0.618 . . . . 0.0 112.618 -164.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.72 124.71 31.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -61.24 150.53 34.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.829 -1.17 . . . . 0.0 113.875 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.6 m -80.67 68.23 6.82 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-O 123.508 1.623 . . . . 0.0 111.011 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -152.23 -85.04 0.07 Allowed 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -115.72 -22.87 8.94 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 50.81 2.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 -167.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -82.03 -30.78 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.383 10.7 tt0 74.99 97.83 0.07 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 126.001 1.72 . . . . 0.0 114.707 -168.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 tt -89.58 116.32 27.64 Favored 'General case' 0 CA--C 1.563 1.442 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.526 165.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -92.07 117.02 29.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.762 . . . . 0.0 110.764 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -114.02 112.97 24.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.825 0.85 . . . . 0.0 109.157 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.8 t -105.85 113.52 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -110.32 117.93 34.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.219 0.918 . . . . 0.0 109.566 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.16 144.53 38.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.998 0.904 . . . . 0.0 112.045 -169.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -91.31 108.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.68 -47.57 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.763 -0.585 . . . . 0.0 111.542 168.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.84 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.485 1.917 0 CA-C-N 119.185 0.902 . . . . 0.0 111.247 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.35 -30.02 47.82 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.08 144.2 34.1 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 122.425 1.107 . . . . 0.0 112.516 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 tp -95.13 115.2 27.12 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.756 0.822 . . . . 0.0 109.186 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.4 121.43 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.805 -0.559 . . . . 0.0 109.83 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.37 99.14 7.99 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.689 0.796 . . . . 0.0 109.85 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -98.17 111.01 23.49 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.725 0.81 . . . . 0.0 110.915 -169.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -100.91 112.08 24.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.928 0.891 . . . . 0.0 110.723 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.27 113.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -123.96 110.0 14.25 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 122.997 0.519 . . . . 0.0 112.209 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.275 43.6 mt-10 47.22 34.5 3.1 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 119.53 -44.26 1.43 Allowed Glycine 0 CA--C 1.553 2.418 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -162.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.74 121.76 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 119.304 1.552 . . . . 0.0 113.33 -163.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.02 133.74 34.65 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.841 -0.537 . . . . 0.0 111.689 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.69 117.33 9.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.436 0.694 . . . . 0.0 111.571 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.297 1.1 pptp? -114.64 126.22 54.64 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -105.23 115.33 30.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 110.365 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mt -98.78 120.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.89 130.28 55.63 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.342 0.657 . . . . 0.0 110.896 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.61 149.07 21.83 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.97 0.89 . . . . 0.0 112.053 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -84.89 113.03 21.08 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 112.689 -174.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.65 0 C-N-CA 124.802 1.241 . . . . 0.0 113.896 172.222 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.404 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.43 62.26 0.91 Allowed 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 119.686 1.13 . . . . 0.0 113.008 -171.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -141.74 91.11 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.367 -1.458 . . . . 0.0 107.746 166.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -174.87 167.5 3.63 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.54 1.162 . . . . 0.0 111.899 -171.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -101.3 141.78 33.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 111.662 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -141.84 121.81 13.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.477 -165.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -112.11 142.47 44.52 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 120.502 1.501 . . . . 0.0 112.52 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.279 7.7 p -80.5 91.09 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 122.769 1.271 . . . . 0.0 114.059 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.55 -36.26 29.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -122.52 145.7 48.08 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.082 -1.011 . . . . 0.0 112.189 -172.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 p -152.46 159.5 43.35 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.271 1.6 tm-20 -106.57 -137.28 0.36 Allowed 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.736 171.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.286 8.8 p30 -80.99 58.72 3.53 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 118.917 -2.364 . . . . 0.0 117.159 -167.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CE2' ' SD ' ' A' ' 18' ' ' MET . 31.6 t80 -61.14 -40.44 93.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.719 -1.863 . . . . 0.0 115.159 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.64 -43.05 68.45 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 165.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.91 -45.12 52.58 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.596 1.543 . . . . 0.0 115.024 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -45.55 -51.61 11.65 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 160.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.45 ' SD ' ' HA ' ' A' ' 28' ' ' ARG . 43.4 mtp -62.01 -45.4 93.77 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -43.04 72.21 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-N 120.373 1.442 . . . . 0.0 114.733 168.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -40.34 89.15 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 166.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.466 ' SD ' HG22 ' A' ' 76' ' ' THR . 72.9 mtm -62.98 -45.37 92.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 169.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.82 68.61 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 CA-C-N 118.841 0.746 . . . . 0.0 114.633 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.42 174.39 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.311 1.053 . . . . 0.0 113.267 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.16 159.8 21.97 Favored 'General case' 0 CA--C 1.577 2.009 0 O-C-N 120.712 -1.243 . . . . 0.0 113.338 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.264 14.7 tt -59.67 -44.49 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.66 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 CA-C-O 123.715 1.721 . . . . 0.0 112.088 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -149.77 -52.28 0.15 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 127.749 2.419 . . . . 0.0 106.169 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 12.0 mtm105 -42.95 -55.11 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 161.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -62.28 -41.44 98.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.09 -51.85 66.28 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.29 36.65 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.61 -56.07 25.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 119.674 -1.891 . . . . 0.0 113.162 156.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -86.28 48.56 1.64 Allowed 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -80.41 -16.13 55.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 58.69 21.24 8.61 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.27 1.3 pt? -77.2 145.53 37.57 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -157.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.03 119.07 34.69 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.396 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -99.19 109.76 22.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.559 0.744 . . . . 0.0 109.615 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 m -90.19 101.62 14.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.92 125.38 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.253 12.8 t -133.37 143.05 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.062 0.934 . . . . 0.0 111.705 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -110.1 110.36 21.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.866 0.866 . . . . 0.0 110.858 -172.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -88.8 77.17 7.87 Favored 'General case' 0 CA--C 1.57 1.73 0 CA-C-O 121.723 0.773 . . . . 0.0 110.149 165.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.46 -95.25 0.14 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -91.97 -8.47 46.11 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 168.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -113.38 118.55 34.88 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 121.121 1.782 . . . . 0.0 111.213 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.44 129.81 38.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.555 -0.716 . . . . 0.0 111.709 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -100.37 109.84 22.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 163.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.13 103.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -88.5 99.37 12.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.863 . . . . 0.0 109.734 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.26 100.08 12.2 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.287 0.635 . . . . 0.0 112.431 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.4 t -95.08 94.81 8.18 Favored 'General case' 0 CA--C 1.56 1.331 0 O-C-N 122.126 -0.359 . . . . 0.0 111.024 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.8 p -114.61 167.5 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.148 0.979 . . . . 0.0 113.361 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.6 m -56.96 -42.62 80.45 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 166.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -68.04 -49.33 62.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -148.95 145.76 27.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.498 1.044 . . . . 0.0 112.16 -169.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.06 102.11 8.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.646 . . . . 0.0 109.59 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -139.93 149.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.787 0.803 . . . . 0.0 112.145 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.87 105.54 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.491 -0.755 . . . . 0.0 110.416 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.65 99.03 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.2 t -96.83 123.43 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -144.33 146.83 32.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -99.66 143.3 30.05 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.023 0.916 . . . . 0.0 111.906 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.18 109.34 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.461 0.704 . . . . 0.0 112.898 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.92 -38.12 3.4 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.7 t -73.79 132.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 118.847 1.323 . . . . 0.0 110.329 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -98.21 102.99 14.89 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.315 1.055 . . . . 0.0 110.715 -171.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.41 163.73 14.92 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.973 1.309 . . . . 0.0 112.06 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -87.12 112.15 21.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.643 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -80.54 -65.93 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.536 -0.728 . . . . 0.0 112.135 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 73.03 122.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.386 1.074 . . . . 0.0 113.029 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.9 mt -74.4 159.61 32.11 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.15 -35.23 64.52 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -51.82 -78.82 0.02 OUTLIER 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 160.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.62 61.73 0.01 OUTLIER Glycine 0 N--CA 1.485 1.904 0 C-N-CA 123.85 0.738 . . . . 0.0 111.893 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.466 HG22 ' SD ' ' A' ' 21' ' ' MET . 91.7 m -127.18 116.24 20.33 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -172.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.75 117.33 20.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.766 -0.584 . . . . 0.0 111.703 -173.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.6 mt -141.02 117.81 11.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.974 0.91 . . . . 0.0 110.612 -164.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.264 2.6 ptm85 -131.89 138.84 48.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.33 -172.93 40.24 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.248 0.927 . . . . 0.0 112.189 -167.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -110.2 -179.08 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.888 -1.36 . . . . 0.0 112.72 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -122.67 107.23 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 p -85.17 128.96 34.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -0.975 . . . . 0.0 113.356 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 tp -85.31 104.49 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.298 0.639 . . . . 0.0 111.148 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.22 97.37 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.864 0.84 . . . . 0.0 109.201 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.5 -100.25 1.17 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.589 -0.694 . . . . 0.0 113.652 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -113.63 8.6 17.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 163.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -103.23 127.49 50.53 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.804 1.638 . . . . 0.0 110.528 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.62 99.02 11.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 151.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.21 114.17 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.789 0.804 . . . . 0.0 109.169 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.19 99.97 1.4 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 121.79 -0.569 . . . . 0.0 114.04 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -87.46 100.26 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.452 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.6 116.32 31.52 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.613 0.765 . . . . 0.0 109.435 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -76.36 124.63 27.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.137 -0.977 . . . . 0.0 111.726 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.1 100.36 12.59 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 -171.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.5 p -68.45 -21.68 64.63 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -56.74 -23.46 42.85 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 163.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.45 -49.54 0.36 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.428 1.091 . . . . 0.0 113.681 -157.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.92 60.36 0.93 Allowed Glycine 0 N--CA 1.49 2.246 0 CA-C-N 119.172 0.896 . . . . 0.0 115.051 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -144.0 141.63 30.25 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.465 0.706 . . . . 0.0 110.635 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.28 103.28 6.22 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.025 0.917 . . . . 0.0 111.575 167.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.98 123.58 25.97 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 121.796 -0.565 . . . . 0.0 109.804 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -107.59 100.17 9.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -108.02 118.7 37.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.357 0.663 . . . . 0.0 110.91 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.87 113.57 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -100.59 118.53 36.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.079 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.65 145.86 31.97 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 123.591 0.756 . . . . 0.0 110.809 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.31 110.89 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.535 -1.353 . . . . 0.0 108.006 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER -91.78 85.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.272 1.034 . . . . 0.0 109.005 171.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.46 -91.05 1.04 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 120.77 -1.206 . . . . 0.0 114.205 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -130.93 42.92 3.17 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.687 -0.89 . . . . 0.0 112.945 165.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -136.23 119.79 17.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.817 -1.177 . . . . 0.0 109.716 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.65 108.23 13.04 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.407 0.683 . . . . 0.0 110.614 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -89.9 71.63 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 123.318 0.647 . . . . 0.0 112.027 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -69.56 97.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.821 -1.174 . . . . 0.0 112.048 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -109.58 98.05 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -160.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.12 106.23 18.22 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.501 1.12 . . . . 0.0 111.942 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.14 123.1 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.54 -0.725 . . . . 0.0 109.308 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -136.32 124.02 22.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.102 0.561 . . . . 0.0 110.716 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.253 48.2 mt-10 46.62 54.72 8.48 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.78 24.63 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.3 t -114.45 129.33 70.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 120.294 2.047 . . . . 0.0 108.966 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -114.83 127.2 55.58 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.776 0.83 . . . . 0.0 111.525 -171.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.52 115.16 25.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.923 0.868 . . . . 0.0 112.54 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -87.46 122.79 31.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -104.88 102.71 12.23 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.41 107.4 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.99 123.92 42.22 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.856 0.462 . . . . 0.0 110.463 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -78.0 167.93 20.68 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.66 0.743 . . . . 0.0 112.025 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.77 103.89 1.88 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.88 -1.138 . . . . 0.0 113.028 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 125.623 1.569 . . . . 0.0 113.978 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.26 77.4 m-85 . . . . . 0 N--CA 1.508 2.463 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.23 105.62 1.46 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.946 1.298 . . . . 0.0 114.186 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 m 178.04 169.65 0.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 125.253 1.421 . . . . 0.0 111.412 -172.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.1 m -97.06 128.42 43.99 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.734 -1.229 . . . . 0.0 110.789 171.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -131.22 95.51 3.8 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.306 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -77.56 139.78 39.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -70.25 124.05 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 112.454 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.64 -57.58 3.07 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.278 163.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -136.2 156.82 48.12 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 122.294 1.045 . . . . 0.0 112.589 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.9 m -136.2 94.51 3.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.596 -1.315 . . . . 0.0 110.067 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -93.06 118.84 31.65 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.616 -159.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.274 51.5 t30 64.11 17.92 10.93 Favored 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.19 -33.16 74.81 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -50.52 71.98 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -63.86 -41.49 97.77 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -49.58 -51.11 39.43 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.751 1.759 . . . . 0.0 115.751 163.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.5 mtp -65.84 -32.29 73.72 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.04 -48.54 75.82 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 160.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.16 -32.86 74.59 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.9 mmt -58.09 -53.9 53.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.075 1.307 . . . . 0.0 114.202 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.36 52.94 0.12 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.79 167.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 118.457 1.128 . . . . 0.0 112.756 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -79.52 166.56 21.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.756 -1.215 . . . . 0.0 113.032 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.285 13.3 tt -75.63 59.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 123.534 1.635 . . . . 0.0 114.72 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.17 -65.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -60.15 -33.75 72.61 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -50.45 -52.12 40.76 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 162.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.59 -52.29 18.87 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.41 -50.25 68.34 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.53 58.04 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.46 94.01 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -110.1 39.24 2.2 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -80.0 0.29 32.26 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.253 62.3 m-80 62.18 52.28 3.25 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.0 tp -76.77 121.87 23.94 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-O 122.085 0.945 . . . . 0.0 113.096 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -109.92 122.21 47.01 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.682 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.18 103.01 14.46 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.898 0.479 . . . . 0.0 109.723 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -91.4 100.07 12.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.119 -0.988 . . . . 0.0 108.735 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.5 mt -90.15 124.68 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.1 p -135.03 115.84 13.95 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -99.26 105.4 17.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.626 -1.296 . . . . 0.0 111.39 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.92 -52.01 9.52 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.27 87.88 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.105 -0.997 . . . . 0.0 111.086 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.316 25.8 t30 69.55 -48.65 0.61 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -165.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.62 121.39 14.85 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -85.42 114.54 22.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.057 0.543 . . . . 0.0 110.321 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -90.44 102.57 15.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.7 t -105.36 101.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -79.86 105.06 10.86 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 123.362 0.665 . . . . 0.0 109.867 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.89 99.52 9.73 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.155 0.982 . . . . 0.0 109.146 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.0 t -111.77 109.16 18.86 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.815 0.446 . . . . 0.0 112.174 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -135.27 178.74 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.3 m -54.64 -37.45 65.68 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -69.74 -53.24 19.35 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -148.32 143.71 27.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.302 0.955 . . . . 0.0 112.842 -168.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -121.87 95.23 4.58 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.596 0.759 . . . . 0.0 109.425 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.08 152.89 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 123.317 0.647 . . . . 0.0 111.026 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.27 115.82 30.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.708 -1.245 . . . . 0.0 112.505 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -86.48 101.09 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.32 107.15 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -126.5 130.68 51.09 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -83.51 147.56 27.72 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.452 1.12 . . . . 0.0 111.478 161.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.57 111.08 4.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.64 -6.99 52.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 119.019 2.367 . . . . 0.0 119.019 -167.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.9 t -85.78 130.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.822 2.311 . . . . 0.0 110.511 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 107.54 10.68 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.559 0.744 . . . . 0.0 111.919 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -126.9 157.71 38.69 Favored 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.42 0.688 . . . . 0.0 112.426 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -82.95 113.93 20.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 111.844 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -92.44 116.76 29.27 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.503 0.721 . . . . 0.0 109.405 167.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -96.96 124.35 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.25 0.548 . . . . 0.0 111.155 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.449 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -110.28 142.97 41.15 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 122.368 1.08 . . . . 0.0 111.639 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.8 mt -114.58 116.22 28.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.736 0.814 . . . . 0.0 110.13 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -93.69 120.49 34.02 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 121.674 -0.641 . . . . 0.0 111.103 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.55 -161.67 35.12 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 117.651 1.82 . . . . 0.0 117.651 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.8 p -123.84 121.48 35.5 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.579 -160.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -79.25 114.15 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.938 0.79 . . . . 0.0 109.908 155.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -114.35 142.9 45.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.38 0.672 . . . . 0.0 110.973 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 tp -91.41 103.41 16.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.687 -1.258 . . . . 0.0 111.768 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -83.55 83.95 7.71 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.144 0.974 . . . . 0.0 110.127 166.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.57 -88.38 0.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -118.32 13.05 13.57 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.82 128.51 49.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.153 1.797 . . . . 0.0 109.473 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 mt -85.8 101.11 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.48 110.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-O 122.481 1.134 . . . . 0.0 109.335 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.87 103.12 3.01 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.731 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -90.06 90.47 8.14 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.23 161.16 19.39 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 122.844 1.306 . . . . 0.0 111.773 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -150.05 155.17 39.4 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.992 . . . . 0.0 110.724 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -68.21 131.78 45.98 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 113.858 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.3 p -55.46 -43.62 75.64 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 164.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -45.25 4.57 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.895 0.878 . . . . 0.0 111.698 -161.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -65.32 -42.74 92.67 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.73 -9.89 72.17 Favored Glycine 0 CA--C 1.558 2.732 0 N-CA-C 119.136 2.414 . . . . 0.0 119.136 -161.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -78.02 138.75 38.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.326 1.563 . . . . 0.0 112.894 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -73.45 148.06 43.58 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 tt -137.6 121.2 17.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.67 0.747 . . . . 0.0 110.227 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -93.59 120.18 33.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.982 -0.449 . . . . 0.0 110.112 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -125.02 124.8 42.75 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.668 0.387 . . . . 0.0 111.67 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.01 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -96.04 120.7 36.79 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.093 0.557 . . . . 0.0 110.458 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.87 153.79 31.68 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.523 0.729 . . . . 0.0 111.931 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.97 115.93 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.827 -1.17 . . . . 0.0 108.252 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tp -89.34 81.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.126 0.965 . . . . 0.0 110.67 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.0 -84.44 1.13 Allowed Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.905 -1.122 . . . . 0.0 114.976 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -128.8 26.01 5.59 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.66 125.79 31.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.901 -1.125 . . . . 0.0 109.906 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 tp -77.93 117.75 19.58 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.352 -0.843 . . . . 0.0 111.007 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -97.77 125.52 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.81 104.04 14.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 162.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -98.93 91.87 5.25 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.35 0.66 . . . . 0.0 109.248 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.27 113.44 25.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.96 0.904 . . . . 0.0 111.402 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.52 108.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -122.28 124.82 44.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.129 0.572 . . . . 0.0 110.872 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 57.1 37.68 28.7 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.12 26.39 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 119.801 2.68 . . . . 0.0 119.801 -163.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.28 107.26 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 119.942 1.871 . . . . 0.0 108.08 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 118.81 28.17 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.449 0.7 . . . . 0.0 111.948 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.88 125.12 53.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.222 0.609 . . . . 0.0 112.195 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.68 106.21 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.863 -0.523 . . . . 0.0 110.395 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -85.58 117.99 24.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.919 -1.113 . . . . 0.0 109.225 164.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.7 mt -115.02 117.42 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -164.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -116.55 117.47 29.97 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.34 0.656 . . . . 0.0 109.683 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.67 152.31 28.51 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 112.08 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -63.2 100.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.05 -1.031 . . . . 0.0 112.751 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.41 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -116.37 88.53 2.91 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 120.221 -1.549 . . . . 0.0 111.252 -150.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -164.77 -178.94 5.55 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.687 1.195 . . . . 0.0 110.88 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -92.22 106.99 18.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.614 -1.304 . . . . 0.0 109.192 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -109.54 100.5 9.55 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -168.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -95.94 139.06 32.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.199 -0.938 . . . . 0.0 112.754 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.64 115.57 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.61 -61.45 1.91 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.151 0.58 . . . . 0.0 111.395 164.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -140.13 146.54 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.197 0.999 . . . . 0.0 112.948 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 108.07 8.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.56 -49.85 24.24 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -162.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -138.66 41.29 2.18 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -84.39 48.66 1.53 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 119.469 -2.02 . . . . 0.0 114.513 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -149.02 -47.57 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.415 1.486 . . . . 0.0 111.682 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.89 -37.97 89.35 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.942 1.701 . . . . 0.0 114.834 160.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -49.4 -57.93 6.05 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 159.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -45.29 76.95 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 168.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -50.59 -49.35 56.66 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -62.8 -37.73 87.88 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.7 mtm -62.91 -52.25 63.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.05 70.53 0.09 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 145.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-O 122.708 1.242 . . . . 0.0 111.276 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -63.92 156.34 28.0 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.258 14.0 tt -56.66 -40.11 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.47 -53.14 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.34 0.973 . . . . 0.0 113.067 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.78 -30.03 67.5 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -52.3 -46.41 65.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 159.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -57.53 -48.38 79.44 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.17 -34.65 75.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.27 75.28 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.94 -50.83 30.33 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 162.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.46 58.56 4.93 Favored 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 119.807 1.185 . . . . 0.0 112.917 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -95.97 -28.04 14.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 65.31 49.88 1.85 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.625 1.17 . . . . 0.0 114.041 -168.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -77.08 124.67 28.14 Favored 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.765 -1.21 . . . . 0.0 113.741 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -120.94 111.65 17.77 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.828 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 mt -91.38 100.23 13.05 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -91.65 101.05 13.68 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.97 -1.081 . . . . 0.0 109.116 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.19 107.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -104.03 104.15 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -92.45 127.52 37.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.668 -0.645 . . . . 0.0 110.984 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -125.74 76.92 1.62 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.734 1.254 . . . . 0.0 111.265 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 -95.23 1.36 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.055 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -97.19 -23.37 16.22 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -91.15 155.31 18.71 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 120.182 1.355 . . . . 0.0 112.621 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -124.6 112.49 16.88 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.955 0.902 . . . . 0.0 109.449 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.4 m -96.41 94.28 7.32 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.82 107.17 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.83 94.31 9.27 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.08 97.86 10.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.621 0.769 . . . . 0.0 108.934 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -113.62 115.53 28.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.324 0.65 . . . . 0.0 111.507 -162.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -144.66 168.57 19.85 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 0.0 113.127 -170.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -58.9 -34.64 71.91 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 160.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -50.08 67.74 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.25 11.66 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.35 1.06 . . . . 0.0 111.839 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -118.19 101.21 8.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.42 120.17 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.633 -0.667 . . . . 0.0 110.799 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.88 102.81 14.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.941 -1.099 . . . . 0.0 111.46 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.5 97.4 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.01 111.0 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -138.58 142.49 39.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.79 150.42 25.06 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.15 0.976 . . . . 0.0 111.648 164.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.08 102.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.053 -1.029 . . . . 0.0 113.099 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.81 -4.01 36.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 118.931 2.333 . . . . 0.0 118.931 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.79 135.23 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 121.376 2.588 . . . . 0.0 112.263 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.8 p -84.22 96.69 9.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 110.75 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -122.96 154.98 37.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.407 0.683 . . . . 0.0 112.693 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -83.38 105.71 14.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.654 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -96.87 101.72 13.36 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.047 0.939 . . . . 0.0 110.638 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -87.35 109.33 19.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.056 -1.028 . . . . 0.0 111.061 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -166.557 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -68.28 140.12 55.97 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 25.2 mt -134.76 100.24 4.55 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.328 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -84.51 107.25 16.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.913 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -154.55 23.97 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.506 0.963 . . . . 0.0 115.506 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.2 p -124.33 122.35 37.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.773 -155.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -82.27 107.51 15.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 155.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.5 m -108.69 149.96 28.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.6 -0.687 . . . . 0.0 112.322 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 105.28 17.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.877 -1.139 . . . . 0.0 110.91 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.05 79.85 1.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.955 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.51 -92.83 0.89 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 121.128 -0.982 . . . . 0.0 114.04 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.69 52.37 1.93 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.401 0.62 . . . . 0.0 111.188 160.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -141.04 120.06 12.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -83.04 99.2 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.358 -1.464 . . . . 0.0 109.446 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 tp -90.17 111.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.693 0.797 . . . . 0.0 110.033 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.28 92.8 1.36 Allowed Glycine 0 N--CA 1.482 1.734 0 C-N-CA 123.793 0.711 . . . . 0.0 113.172 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.21 111.25 22.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -134.86 111.16 9.65 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -156.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -84.79 120.64 26.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.697 -1.252 . . . . 0.0 111.855 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -54.97 120.21 6.56 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.9 p -64.17 -43.07 96.26 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.25 -44.24 76.08 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.92 -47.66 8.4 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.48 54.66 3.06 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 -157.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -138.52 124.22 19.75 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.335 1.067 . . . . 0.0 110.24 -172.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -83.75 99.51 10.32 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.115 1.436 . . . . 0.0 113.774 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.5 132.46 34.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.715 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -106.71 110.19 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.734 -0.604 . . . . 0.0 110.192 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -111.05 112.34 24.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.799 -0.563 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.66 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.154 -0.966 . . . . 0.0 108.784 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 mtm-85 -90.46 116.08 28.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.847 168.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -144.39 159.45 42.7 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.656 0.782 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.3 mt -126.14 121.43 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.423 -1.423 . . . . 0.0 109.494 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.13 83.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.12 -80.59 0.96 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.89 -50.41 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -94.22 148.16 22.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 120.212 1.369 . . . . 0.0 114.329 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 tp -86.93 120.75 28.53 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.127 0.571 . . . . 0.0 111.411 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 m -106.77 121.38 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -107.97 103.18 12.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.54 -0.725 . . . . 0.0 109.751 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.4 m -97.8 100.49 11.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.584 0.753 . . . . 0.0 109.356 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -90.04 117.71 29.04 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.023 0.929 . . . . 0.0 111.424 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.92 115.64 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -110.84 107.56 17.09 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.67 0.668 . . . . 0.0 109.647 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER 54.64 32.4 17.1 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 175.349 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.01 -40.5 2.5 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -162.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.69 112.67 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 120.538 2.169 . . . . 0.0 112.361 -168.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.77 130.07 39.9 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.08 0.552 . . . . 0.0 112.342 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.69 112.46 13.68 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.846 0.858 . . . . 0.0 110.996 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -103.31 116.29 32.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -0.804 . . . . 0.0 110.679 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -106.14 114.07 27.98 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.041 0.448 . . . . 0.0 109.83 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.1 mt -101.23 121.19 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.97 124.87 51.61 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.326 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -82.65 142.35 31.78 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.887 0.851 . . . . 0.0 111.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -79.97 105.5 11.3 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 124.924 1.29 . . . . 0.0 113.669 174.485 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.277 87.8 m-85 . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 122.815 1.293 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.92 -36.15 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -137.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -122.82 -172.32 2.46 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 123.327 1.537 . . . . 0.0 112.918 -158.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.8 m -78.03 118.97 20.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.16 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -122.71 108.1 12.69 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -109.94 139.52 44.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.099 -1.001 . . . . 0.0 113.307 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.62 117.75 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -102.28 -56.97 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.691 0.797 . . . . 0.0 111.438 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 110.77 11.93 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.467 0.707 . . . . 0.0 112.032 -166.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.1 p -106.86 127.31 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 112.512 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -73.94 -46.65 42.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -147.03 45.59 1.17 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -83.9 52.44 2.29 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 119.332 -2.105 . . . . 0.0 113.955 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -152.26 -51.76 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.157 1.383 . . . . 0.0 110.349 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.95 -30.75 70.12 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 163.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -50.94 -40.47 57.46 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 154.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -70.39 -34.23 72.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -50.95 -52.68 39.96 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 121.009 1.731 . . . . 0.0 115.318 159.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.09 -34.14 74.46 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.28 -51.52 69.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 162.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 68.27 0.48 Allowed Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.015 0.825 . . . . 0.0 114.094 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.66 149.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.462 0.649 . . . . 0.0 112.489 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -78.89 153.03 30.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.769 -1.207 . . . . 0.0 113.68 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.311 10.7 tt -59.61 -39.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 118.483 2.771 . . . . 0.0 118.483 -170.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.6 m -59.11 -42.43 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -67.14 -35.18 79.15 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -55.72 -50.73 69.56 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.387 1.903 . . . . 0.0 114.151 164.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -56.38 -54.68 42.69 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.94 48.58 0.85 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.96 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.059 1.344 . . . . 0.0 111.963 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.28 93.85 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -83.97 67.75 9.75 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 122.283 1.04 . . . . 0.0 111.403 171.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -92.51 -33.55 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.84 50.58 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.521 1.129 . . . . 0.0 113.532 -166.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.88 124.19 26.91 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.493 1.14 . . . . 0.0 113.632 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -108.71 100.05 9.33 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.054 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.83 102.73 11.01 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.132 0.573 . . . . 0.0 109.491 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.1 m -99.51 105.59 17.52 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -107.22 118.23 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -161.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 p -123.96 126.53 46.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.72 -0.612 . . . . 0.0 110.492 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.17 119.95 37.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.631 -0.668 . . . . 0.0 110.933 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.08 -49.83 14.42 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.36 -91.42 0.08 OUTLIER Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -74.7 -24.6 58.79 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 157.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -87.62 129.5 35.1 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 119.894 1.225 . . . . 0.0 111.954 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -109.83 134.7 51.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.358 1.063 . . . . 0.0 110.581 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.5 m -107.59 111.93 24.42 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -104.76 105.63 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -80.88 110.02 16.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 110.335 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.16 82.52 4.16 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.175 0.59 . . . . 0.0 110.525 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 t -96.66 111.09 23.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.002 -1.061 . . . . 0.0 112.752 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 p -131.94 -169.72 2.26 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.376 0.671 . . . . 0.0 112.069 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -70.45 -1.59 11.25 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 159.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -126.91 -38.36 2.04 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.675 1.19 . . . . 0.0 114.008 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -90.4 -90.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 119.79 1.177 . . . . 0.0 111.781 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.287 70.4 m-80 60.96 60.28 1.87 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 pt -134.14 135.2 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 123.121 0.568 . . . . 0.0 110.595 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.79 103.05 14.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 111.868 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 t -88.13 98.28 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.0 113.61 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.99 140.64 45.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.689 0.757 . . . . 0.0 112.734 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.36 142.71 41.09 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 111.982 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 100.69 0.89 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 112.891 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.81 -12.42 24.94 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.103 2.401 . . . . 0.0 119.103 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.26 134.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 121.247 2.524 . . . . 0.0 112.61 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.6 t -82.08 92.8 6.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 111.984 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -119.15 170.27 9.22 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.956 0.902 . . . . 0.0 113.036 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -88.61 99.13 12.08 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 121.723 -0.611 . . . . 0.0 110.613 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -87.1 87.1 7.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.835 170.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -71.18 142.75 50.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 177.522 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 121.665 0.745 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -85.68 118.56 25.26 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 110.794 151.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -92.66 116.63 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.929 -1.107 . . . . 0.0 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -94.58 114.63 26.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.721 . . . . 0.0 110.649 -174.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.77 -153.7 24.98 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 p -119.86 140.77 50.31 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -160.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.16 109.64 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 108.913 155.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.3 m -104.58 139.19 39.81 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.181 0.592 . . . . 0.0 111.484 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.1 tp -88.17 107.47 18.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.118 -0.989 . . . . 0.0 109.959 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.85 -53.59 17.41 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.79 -71.07 0.28 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -162.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.15 -39.8 39.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 160.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.04 145.26 35.88 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.959 0.904 . . . . 0.0 112.882 -164.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.06 101.53 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 146.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.2 110.42 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.797 0.808 . . . . 0.0 109.485 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.76 94.68 2.02 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.8 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.02 95.61 9.89 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.534 0.683 . . . . 0.0 109.18 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.48 164.96 20.77 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 122.561 1.172 . . . . 0.0 111.835 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.79 155.01 46.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.849 -1.157 . . . . 0.0 112.072 165.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -67.84 139.02 56.53 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.8 m -77.91 -51.87 9.74 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.17 0.588 . . . . 0.0 112.062 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.97 -41.38 74.66 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -108.0 -31.63 7.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.15 38.56 29.48 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 118.556 2.182 . . . . 0.0 118.556 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -144.08 157.54 44.25 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.92 1.36 . . . . 0.0 111.916 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -80.54 129.68 34.66 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -159.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.79 124.08 51.77 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.029 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -107.24 107.22 18.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -107.27 99.32 8.86 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.58 119.91 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -103.62 124.49 48.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.748 0.704 . . . . 0.0 110.398 170.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.28 146.27 40.17 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.53 0.732 . . . . 0.0 111.114 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -89.71 115.16 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.322 -1.486 . . . . 0.0 108.676 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -99.74 88.93 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.31 -88.51 0.8 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.486 -0.759 . . . . 0.0 113.953 -174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -136.88 50.41 2.01 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 161.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -137.57 122.05 18.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.23 109.25 15.58 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 123.549 0.74 . . . . 0.0 110.786 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.69 98.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 109.951 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -84.59 96.26 9.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.033 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.2 m -96.34 92.6 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.524 0.73 . . . . 0.0 109.709 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.9 105.78 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.964 0.906 . . . . 0.0 111.438 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.6 t -109.48 109.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -127.18 119.46 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 110.078 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.8 OUTLIER 48.75 63.64 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.18 -31.72 2.58 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 119.211 2.444 . . . . 0.0 119.211 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.54 121.78 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.662 1.731 . . . . 0.0 110.698 -159.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.43 143.6 27.15 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 123.81 0.844 . . . . 0.0 112.953 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.29 109.39 6.1 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 121.56 -0.713 . . . . 0.0 110.689 164.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -101.16 96.98 7.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.257 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -87.46 111.41 21.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.259 0.624 . . . . 0.0 110.231 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.09 111.59 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -170.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -103.68 113.82 27.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.41 0.684 . . . . 0.0 109.602 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -77.11 162.75 27.22 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.35 110.25 4.01 Favored 'General case' 0 CA--C 1.57 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 112.361 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 C-N-CA 125.039 1.335 . . . . 0.0 112.38 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -69.13 94.42 0.67 Allowed 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -168.05 173.18 8.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.619 1.168 . . . . 0.0 110.999 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 m -88.97 117.79 28.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.001 . . . . 0.0 109.499 166.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -120.43 113.0 19.68 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.986 0.514 . . . . 0.0 109.876 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 142.45 27.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.267 -0.896 . . . . 0.0 112.754 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.72 115.94 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.573 -0.705 . . . . 0.0 111.923 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.21 -53.38 6.72 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.334 0.654 . . . . 0.0 112.074 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.12 143.23 25.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.667 0.746 . . . . 0.0 112.839 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -109.3 88.39 2.72 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.995 0.902 . . . . 0.0 110.446 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.31 118.89 25.13 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.632 0.773 . . . . 0.0 110.969 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.291 22.9 t30 67.25 11.71 8.53 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 118.105 2.631 . . . . 0.0 118.105 -173.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -64.77 -37.64 88.27 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -63.05 -42.84 99.82 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -71.39 -39.87 70.89 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -46.51 -55.88 6.85 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 158.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtp -63.17 -39.25 94.12 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.18 -43.87 95.52 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -38.02 66.26 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 163.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.4 mtt -59.56 -36.94 77.16 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.311 2.338 . . . . 0.0 117.311 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.6 63.12 0.89 Allowed Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.779 0.718 . . . . 0.0 114.147 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.91 -171.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.481 0.658 . . . . 0.0 112.479 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -65.36 173.41 2.62 Favored 'General case' 0 CA--C 1.583 2.231 0 O-C-N 119.899 -1.751 . . . . 0.0 113.976 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.4 tt -94.8 -45.39 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.333 -1.479 . . . . 0.0 114.381 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.2 -60.03 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.686 1.13 . . . . 0.0 112.239 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -55.08 -49.6 71.26 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -34.49 -51.37 0.47 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 118.668 2.84 . . . . 0.0 118.668 160.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -73.2 -39.67 65.37 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.53 95.99 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 168.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.04 -44.59 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -114.02 54.33 0.76 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 118.505 0.593 . . . . 0.0 112.086 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -83.63 -13.77 53.51 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 59.9 m-80 64.89 61.15 0.8 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.736 1.153 . . . . 0.0 113.136 -167.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 tp -83.32 120.86 26.38 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.607 1.194 . . . . 0.0 113.357 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -102.69 118.35 36.65 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.941 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.19 100.41 12.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 m -91.54 102.92 15.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.842 0.83 . . . . 0.0 108.878 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.21 124.04 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -117.98 107.75 14.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -87.22 91.17 8.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.51 0.671 . . . . 0.0 111.323 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -89.46 68.16 7.79 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.463 0.649 . . . . 0.0 112.158 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 78.66 0.15 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 116.86 1.504 . . . . 0.0 116.86 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.328 24.0 m120 72.27 -34.32 0.29 Allowed 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -166.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.79 148.98 34.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.477 1.035 . . . . 0.0 112.971 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -132.19 116.88 17.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.389 1.076 . . . . 0.0 108.116 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.9 m -102.38 100.64 10.81 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.9 t -105.87 104.57 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -83.32 104.47 13.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.27 96.39 8.46 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -115.09 114.53 25.46 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.573 0.749 . . . . 0.0 110.944 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 p -141.62 -177.64 5.27 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.301 1.048 . . . . 0.0 113.765 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 159.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -90.58 -48.51 7.04 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -130.32 152.14 50.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 119.997 1.271 . . . . 0.0 112.918 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.01 93.43 2.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.981 . . . . 0.0 109.799 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 pt -136.38 130.31 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.632 -0.668 . . . . 0.0 111.245 -172.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -88.32 105.81 17.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.379 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.72 101.46 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.61 121.7 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 123.385 0.674 . . . . 0.0 109.365 -171.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.55 148.96 23.42 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.396 0.679 . . . . 0.0 111.628 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.88 155.98 17.38 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 120.555 -1.341 . . . . 0.0 113.052 162.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.64 124.4 20.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.65 62.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.536 2.574 . . . . 0.0 119.536 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.86 141.94 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 120.488 2.144 . . . . 0.0 110.741 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 t -73.08 124.43 25.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -137.01 165.0 27.05 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 121.814 0.816 . . . . 0.0 111.246 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -91.39 110.04 21.33 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 110.424 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -84.61 -50.14 7.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.264 5.8 m120 75.65 133.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 122.593 1.187 . . . . 0.0 113.598 175.629 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 CA--C 1.573 1.862 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -94.09 126.49 39.34 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.053 1.406 . . . . 0.0 113.022 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.01 123.99 46.85 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.218 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -135.95 131.44 35.12 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.86 -148.06 16.55 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.477 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.7 p -120.51 123.04 41.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.026 -0.691 . . . . 0.0 112.104 -156.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -80.9 107.15 13.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.65 0.659 . . . . 0.0 109.734 153.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.6 m -95.39 172.34 8.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 111.24 162.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.41 116.79 14.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.409 -1.432 . . . . 0.0 109.978 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.3 88.04 5.01 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.007 0.908 . . . . 0.0 111.795 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.98 -84.17 0.59 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -126.81 32.45 5.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 170.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -141.11 123.66 15.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.482 -1.387 . . . . 0.0 109.096 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.48 127.61 33.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.16 124.18 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.685 0.755 . . . . 0.0 109.945 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.85 103.37 1.41 Allowed Glycine 0 N--CA 1.479 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 113.538 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -95.51 96.78 9.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.4 119.23 31.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.521 -170.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -87.4 139.58 30.4 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.533 1.159 . . . . 0.0 112.512 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -63.86 139.19 58.74 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 168.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -52.37 -43.25 64.59 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 152.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.96 -55.37 3.79 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.508 0.723 . . . . 0.0 111.876 -157.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.17 -32.39 13.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.45 90.04 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 119.042 2.377 . . . . 0.0 119.042 -163.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.09 -3.36 57.22 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -164.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.333 4.7 tt0 72.57 118.3 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 tt -90.34 137.68 32.15 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.137 0.975 . . . . 0.0 111.441 162.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.1 108.09 16.18 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.094 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.261 9.9 t -113.32 114.55 26.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 0.0 112.278 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.07 134.24 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -112.8 121.16 43.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 0.0 110.529 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.99 172.65 12.08 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 121.679 0.752 . . . . 0.0 111.766 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.59 108.36 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.053 . . . . 0.0 109.481 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.263 11.1 tp -96.98 88.09 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.812 0.815 . . . . 0.0 109.717 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.27 -90.31 1.01 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.121 -0.987 . . . . 0.0 114.125 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.83 52.48 1.94 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 165.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -132.87 121.99 23.73 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.181 0.992 . . . . 0.0 108.375 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.2 101.97 11.58 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.775 -0.578 . . . . 0.0 109.908 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.81 83.46 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.093 0.949 . . . . 0.0 110.476 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.39 100.05 10.45 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.238 1.018 . . . . 0.0 109.984 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.4 m -110.68 90.44 3.32 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.005 -151.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.42 114.02 24.61 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.978 0.911 . . . . 0.0 110.89 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -108.71 124.26 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -141.34 128.15 20.46 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 121.355 0.597 . . . . 0.0 111.649 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 3.9 mm-40 48.96 44.35 22.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -167.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.04 -25.3 1.87 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 119.31 2.484 . . . . 0.0 119.31 -165.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.3 t -82.85 117.31 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 120.317 2.058 . . . . 0.0 110.03 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -91.67 140.76 29.4 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.97 0.908 . . . . 0.0 112.659 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.59 32.58 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 165.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -103.32 106.19 16.65 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.959 -0.463 . . . . 0.0 110.388 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -83.8 102.59 12.44 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.22 115.16 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -106.96 115.62 30.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.241 0.543 . . . . 0.0 109.576 -173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -84.16 149.29 26.26 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.421 0.689 . . . . 0.0 111.924 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -62.17 112.1 2.24 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 125.235 1.414 . . . . 0.0 112.827 -173.658 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.252 5.5 p-10 -74.55 80.89 1.97 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 120.234 1.379 . . . . 0.0 114.205 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -146.93 -166.35 2.48 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.135 0.969 . . . . 0.0 111.573 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.5 m -94.55 127.56 40.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.654 -1.279 . . . . 0.0 109.985 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -136.63 105.53 5.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.966 -0.459 . . . . 0.0 110.509 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -98.97 137.39 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.212 0.915 . . . . 0.0 111.339 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.6 120.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.801 0.81 . . . . 0.0 112.693 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.17 -54.64 5.79 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.065 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -147.25 160.77 42.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 121.765 0.793 . . . . 0.0 112.677 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -136.54 118.27 15.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 111.445 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -70.46 -60.35 2.32 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -165.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -130.33 51.13 2.13 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.32 1.057 . . . . 0.0 112.944 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -74.89 -36.8 62.25 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.0 -50.56 72.34 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.13 -36.79 77.86 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.53 -52.44 38.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 160.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 mtp -61.22 -48.97 79.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -43.02 64.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -54.69 -30.14 54.93 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtm -70.98 -11.46 60.98 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.69 64.54 1.74 Allowed Glycine 0 N--CA 1.495 2.583 0 CA-C-N 122.265 2.302 . . . . 0.0 114.67 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -119.55 170.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 122.821 1.296 . . . . 0.0 113.092 -164.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.2 108.0 16.84 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 120.877 -1.139 . . . . 0.0 110.531 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.3 12.7 tt -49.25 -44.53 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 119.808 3.262 . . . . 0.0 119.808 -164.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.07 -46.94 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 170.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -68.66 -31.13 70.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -51.22 -45.58 61.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.91 -52.24 66.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.79 -36.29 82.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.89 91.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.12 75.18 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -92.47 62.48 3.95 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 163.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER -83.03 -17.36 43.56 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 60.28 50.88 5.85 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -84.22 149.62 26.01 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -111.59 114.48 27.57 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.771 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.11 103.28 11.61 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.2 m -91.73 99.0 11.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 168.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -99.94 124.22 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.9 p -129.76 119.45 23.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.649 -0.657 . . . . 0.0 109.921 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -88.72 119.2 28.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.901 0.773 . . . . 0.0 111.96 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.81 76.9 1.82 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 123.112 0.565 . . . . 0.0 109.856 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.54 80.49 0.1 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 20.0 m120 71.62 -50.4 0.69 Allowed 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -166.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -73.95 121.84 21.64 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.981 0.912 . . . . 0.0 112.929 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -99.69 134.78 42.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.56 -0.712 . . . . 0.0 111.481 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 m -102.27 111.06 23.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 161.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.04 105.49 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 70' ' ' TYR . 16.4 mt-10 -86.01 95.8 9.63 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.954 0.502 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.0 t -98.76 110.28 22.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.875 0.47 . . . . 0.0 110.336 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.83 170.35 15.91 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -68.82 -6.54 27.5 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -100.03 -46.03 5.47 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.499 1.045 . . . . 0.0 113.206 168.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.87 154.5 40.5 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.035 1.288 . . . . 0.0 112.205 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -112.58 105.94 14.25 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 161.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.2 pt -123.51 127.6 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.248 0.547 . . . . 0.0 111.3 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -99.71 100.67 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.759 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.17 98.11 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.0 109.582 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.19 128.9 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.194 0.598 . . . . 0.0 110.346 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -148.66 147.78 29.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.456 0.646 . . . . 0.0 112.729 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 157.06 16.47 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.318 1.056 . . . . 0.0 110.785 164.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.78 80.89 3.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 112.436 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.02 -38.3 1.83 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -162.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.53 121.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.072 1.436 . . . . 0.0 110.091 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -68.19 127.69 33.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.39 165.43 22.57 Favored 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 123.896 0.879 . . . . 0.0 111.579 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -96.26 108.16 20.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' OH ' ' OE2' ' A' ' 51' ' ' GLU . 6.5 t80 -92.15 97.62 11.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.489 -0.757 . . . . 0.0 110.135 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -75.67 115.24 15.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.778 -0.576 . . . . 0.0 112.409 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.563 1.454 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -172.751 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.19 114.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.366 0.603 . . . . 0.0 109.651 160.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.18 117.11 27.92 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.448 0.642 . . . . 0.0 110.494 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -91.27 109.45 20.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.39 0.676 . . . . 0.0 109.998 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.94 -149.84 14.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.8 p -138.92 142.65 38.47 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.076 0.551 . . . . 0.0 110.851 -170.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -85.32 89.18 7.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.998 -1.064 . . . . 0.0 108.319 153.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -76.69 138.06 39.77 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.984 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.97 105.74 13.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 110.857 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.24 -35.39 73.8 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.73 -79.21 0.2 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.91 -24.25 41.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 160.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -120.79 149.15 43.01 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.263 1.392 . . . . 0.0 111.921 -160.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -94.94 108.88 20.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.925 -1.11 . . . . 0.0 108.993 162.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.19 112.43 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 CA-C-O 122.317 1.056 . . . . 0.0 109.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.01 92.88 0.74 Allowed Glycine 0 N--CA 1.479 1.519 0 C-N-CA 124.265 0.936 . . . . 0.0 113.746 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.09 91.33 8.67 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.41 152.25 37.14 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.101 0.953 . . . . 0.0 112.386 -168.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -121.61 139.43 53.55 Favored 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.549 0.74 . . . . 0.0 110.023 169.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -63.38 131.16 47.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.862 -1.149 . . . . 0.0 113.607 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.7 m -66.59 -47.21 73.46 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 167.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.66 -51.87 37.21 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.72 -45.94 27.38 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.75 -8.34 79.66 Favored Glycine 0 CA--C 1.558 2.781 0 N-CA-C 118.543 2.177 . . . . 0.0 118.543 -153.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.53 152.12 24.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.648 1.724 . . . . 0.0 112.724 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -70.81 141.63 51.35 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.92 126.16 40.95 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -100.51 146.73 26.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 111.15 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 m -148.35 109.73 4.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.159 -1.588 . . . . 0.0 111.69 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.1 t -97.07 122.87 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.227 . . . . 0.0 109.966 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.41 127.62 44.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 111.198 163.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.61 146.01 27.08 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.337 0.655 . . . . 0.0 110.872 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.36 102.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.26 11.3 tp -98.68 75.19 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.039 0.923 . . . . 0.0 111.27 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.83 62.4 3.83 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 116.164 1.226 . . . . 0.0 116.164 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.317 9.1 t70 81.9 -41.1 0.13 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -167.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.74 107.75 7.04 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.97 0.908 . . . . 0.0 113.324 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.3 tp -76.07 102.42 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.655 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -91.72 82.5 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.111 0.482 . . . . 0.0 110.447 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -73.8 97.93 2.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.955 -1.091 . . . . 0.0 110.921 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.7 m -106.08 89.52 3.09 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 -157.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -81.96 137.96 35.04 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.146 0.978 . . . . 0.0 111.977 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.64 120.62 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -131.71 122.59 26.16 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 55.92 36.8 28.0 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.83 -17.15 17.16 Favored Glycine 0 CA--C 1.557 2.689 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 -163.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.37 116.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.009 1.904 . . . . 0.0 109.23 -172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.15 147.37 23.11 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.57 123.49 15.36 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.894 0.877 . . . . 0.0 111.681 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -110.72 98.4 7.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.061 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -86.69 108.83 18.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.2 mt -106.91 126.34 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -115.67 128.7 56.1 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.516 0.674 . . . . 0.0 111.447 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -80.79 155.03 26.86 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 121.672 0.749 . . . . 0.0 111.396 165.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -68.45 114.22 6.69 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.15 -0.969 . . . . 0.0 111.7 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 125.253 1.421 . . . . 0.0 112.531 -173.879 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -82.35 90.55 6.68 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 120.747 1.612 . . . . 0.0 113.466 -165.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -162.37 179.0 8.16 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 122.209 1.004 . . . . 0.0 112.188 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 m -83.04 125.2 31.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 110.222 163.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.91 106.39 9.28 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.183 0.593 . . . . 0.0 109.727 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -97.74 138.39 35.19 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.919 -1.113 . . . . 0.0 112.605 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.85 112.05 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 113.326 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.71 -59.52 2.22 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.087 0.555 . . . . 0.0 111.828 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -134.78 124.48 25.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.0 p -103.72 129.26 51.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.454 0.702 . . . . 0.0 112.034 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.332 0.1 OUTLIER -72.75 -72.81 0.23 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 177.026 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -121.48 39.5 3.83 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.804 1.184 . . . . 0.0 114.069 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.74 -40.83 75.93 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -64.54 -30.77 71.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -79.0 -40.12 32.34 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -48.27 -50.44 29.76 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 158.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.403 ' SD ' HG21 ' A' ' 23' ' ' VAL . 12.4 mmt -50.12 -50.8 47.34 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 163.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -52.66 -46.51 67.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -57.67 -41.83 82.36 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.61 -33.82 74.58 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.77 67.9 0.83 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-N 119.55 1.068 . . . . 0.0 113.904 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 ' SD ' ' A' ' 18' ' ' MET . 11.5 m -126.2 170.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.466 1.127 . . . . 0.0 112.51 -165.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -64.22 178.74 0.65 Allowed 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.4 tt -108.53 167.4 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 157.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.383 46.2 t 80.85 -68.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 120.392 -1.443 . . . . 0.0 111.691 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -65.87 -38.86 89.91 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 119.802 1.183 . . . . 0.0 113.811 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -44.23 -42.84 6.83 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 161.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -69.69 -51.23 36.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.179 -0.951 . . . . 0.0 113.538 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -55.51 -33.65 63.93 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.2 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.24 94.34 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 161.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -103.8 51.74 0.78 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.85 -7.58 59.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 7.3 m-80 67.07 49.29 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.787 1.235 . . . . 0.0 114.229 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.9 tp -72.36 117.25 13.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.08 103.64 10.08 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.713 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.98 100.75 13.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.46 0.704 . . . . 0.0 110.072 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -90.57 101.92 14.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.966 -1.084 . . . . 0.0 109.551 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -94.34 113.45 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.4 p -107.8 110.08 21.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.46 91.61 5.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.665 1.221 . . . . 0.0 111.281 -167.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.63 80.39 9.14 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.746 1.26 . . . . 0.0 113.817 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 -100.02 1.56 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.322 -0.861 . . . . 0.0 114.937 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.08 -4.47 56.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 162.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -114.27 162.83 16.08 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-O 122.224 1.011 . . . . 0.0 111.998 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.46 112.19 10.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.94 -1.1 . . . . 0.0 109.223 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.5 m -95.74 100.7 12.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 164.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -99.26 100.71 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -86.62 98.69 11.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.76 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.44 99.01 10.14 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -97.73 116.51 30.08 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -142.76 176.55 8.96 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.196 0.998 . . . . 0.0 113.394 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -55.09 -37.11 66.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 164.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.91 -46.8 14.64 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -147.02 144.27 29.02 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.539 1.518 . . . . 0.0 112.897 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -126.78 96.29 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 167.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.92 148.78 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.651 1.215 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.39 109.07 18.77 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.409 -0.807 . . . . 0.0 111.219 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.43 96.41 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.59 112.41 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -140.18 144.36 36.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.176 0.591 . . . . 0.0 111.925 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.69 153.2 18.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.365 1.079 . . . . 0.0 111.083 162.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.31 117.73 6.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.57 -9.68 68.96 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 -168.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -77.65 130.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 120.772 2.286 . . . . 0.0 110.691 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -80.15 122.31 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.658 -0.651 . . . . 0.0 112.341 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -148.44 165.98 29.52 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 121.552 0.692 . . . . 0.0 111.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.88 101.17 13.46 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 110.822 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -75.77 -55.69 5.4 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.446 ' H ' ' HB2' ' A' ' 78' ' ' LEU 0.262 9.3 m-20 73.12 137.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.872 1.269 . . . . 0.0 114.013 172.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.853 178.584 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.31 148.76 44.05 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 120.76 -1.212 . . . . 0.0 114.09 148.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.446 ' HB2' ' H ' ' A' ' 71' ' ' ASN . 31.1 mt -140.35 100.78 3.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.61 0.764 . . . . 0.0 111.676 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -86.53 121.43 29.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.576 1.15 . . . . 0.0 111.917 171.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.59 -163.11 34.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.9 p -120.05 125.06 47.39 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.081 0.553 . . . . 0.0 111.907 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -80.42 106.93 12.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.792 -0.568 . . . . 0.0 110.21 155.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -98.12 170.01 9.21 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.965 0.888 . . . . 0.0 111.711 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.3 117.48 29.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.916 -1.115 . . . . 0.0 108.803 172.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -71.85 -43.77 64.94 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.2 -81.83 0.06 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -78.65 -31.29 46.74 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 157.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -86.75 132.04 33.97 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.688 1.131 . . . . 0.0 112.239 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.21 120.56 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 157.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.03 111.21 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.876 0.846 . . . . 0.0 108.783 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -106.24 105.93 2.48 Favored Glycine 0 N--CA 1.482 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 113.02 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -100.56 98.13 8.75 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -124.15 118.91 27.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.274 0.629 . . . . 0.0 111.561 -165.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -95.68 148.18 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 111.967 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -66.68 138.94 57.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.424 -1.422 . . . . 0.0 113.179 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.269 32.2 p -70.55 -33.44 71.14 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.55 -71.22 0.07 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.83 -50.58 3.15 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.346 1.058 . . . . 0.0 113.768 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.36 51.95 0.42 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -95.54 134.09 38.8 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.34 1.07 . . . . 0.0 110.151 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.88 118.05 12.23 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -108.9 115.66 30.5 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.81 104.92 17.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 109.642 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.3 p -99.2 102.75 14.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.8 134.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.619 1.1 . . . . 0.0 108.42 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -134.06 138.21 45.16 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.84 157.68 38.24 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.47 1.128 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.58 119.22 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.956 -1.09 . . . . 0.0 110.075 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -89.79 66.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 121.121 -0.987 . . . . 0.0 111.817 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.95 -77.87 0.95 Allowed Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.742 -1.224 . . . . 0.0 114.858 -168.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.63 -49.29 4.05 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.05 153.46 20.55 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 120.186 1.357 . . . . 0.0 114.122 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.23 108.59 20.06 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.506 -0.746 . . . . 0.0 110.562 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.17 139.66 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 169.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -130.2 101.88 5.98 Favored 'General case' 0 CA--C 1.563 1.465 0 O-C-N 121.675 -0.64 . . . . 0.0 109.867 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 119.1 23.52 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.131 0.972 . . . . 0.0 109.733 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -106.81 109.08 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 164.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.74 132.47 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -127.62 113.4 16.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 163.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.46 62.39 2.65 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.7 -44.98 3.38 Favored Glycine 0 CA--C 1.552 2.352 0 N-CA-C 118.115 2.006 . . . . 0.0 118.115 -166.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.59 123.81 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.402 1.601 . . . . 0.0 113.834 -162.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -80.24 150.63 29.98 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.506 1.146 . . . . 0.0 113.298 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.26 118.37 19.4 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.57 152.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -107.1 104.14 13.72 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -169.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -102.58 115.89 31.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.7 mt -101.98 113.74 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -98.72 130.73 45.21 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.049 1.404 . . . . 0.0 110.173 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -97.26 153.06 18.27 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.18 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.66 121.56 14.77 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 112.936 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.386 2.6 p30 . . . . . 0 N--CA 1.488 1.466 0 C-N-CA 125.463 1.505 . . . . 0.0 114.667 -175.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -159.35 83.8 0.77 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.165 -0.959 . . . . 0.0 110.126 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -166.48 175.82 7.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.284 -0.885 . . . . 0.0 111.915 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.9 m -81.84 124.78 29.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.964 -1.085 . . . . 0.0 110.482 160.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -124.98 104.09 8.38 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.304 0.641 . . . . 0.0 109.937 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -86.03 137.66 32.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.123 -0.986 . . . . 0.0 112.623 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.84 120.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.121 -0.987 . . . . 0.0 113.012 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -105.86 -64.83 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.78 0.832 . . . . 0.0 110.725 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.79 149.85 37.88 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 122.229 1.014 . . . . 0.0 111.402 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.0 m -157.86 106.11 2.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.101 -1.624 . . . . 0.0 109.692 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.24 -76.6 0.2 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -149.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.35 52.91 2.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.547 -1.346 . . . . 0.0 113.137 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.01 64.29 8.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 119.776 -1.828 . . . . 0.0 113.245 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.99 -49.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.374 1.07 . . . . 0.0 112.961 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -69.91 -39.39 76.21 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -45.23 -54.11 7.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 155.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.3 mtp -67.2 -40.62 86.48 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.92 -45.05 82.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 165.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -64.13 -34.89 79.1 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.39 -52.08 65.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 121.017 1.735 . . . . 0.0 115.535 166.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.17 65.96 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.8 p -148.44 128.68 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -77.56 158.66 29.75 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.292 10.1 tp -50.6 -41.03 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 118.853 2.909 . . . . 0.0 118.853 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -55.73 -46.09 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.98 -34.12 61.95 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -61.39 -38.97 88.98 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 165.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.81 -51.13 64.47 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-N 120.401 1.455 . . . . 0.0 114.694 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.07 -42.48 85.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.82 70.25 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.15 -50.92 66.29 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 164.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -88.53 55.1 3.27 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 119.444 1.02 . . . . 0.0 113.203 171.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -94.14 -7.47 42.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -173.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 60.08 42.28 15.93 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 114.99 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -74.54 117.44 16.36 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 122.691 1.234 . . . . 0.0 112.051 -172.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -117.46 112.58 20.83 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.898 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -96.02 103.04 14.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.884 -0.51 . . . . 0.0 110.306 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.5 m -91.03 97.89 11.44 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.96 124.1 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -135.73 114.62 12.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.04 115.85 28.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 112.638 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -83.76 76.68 9.98 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.11 0.957 . . . . 0.0 110.877 171.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.68 -81.02 0.53 Allowed Glycine 0 N--CA 1.492 2.378 0 O-C-N 121.144 -0.973 . . . . 0.0 115.141 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -100.07 -38.1 8.7 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 165.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -85.51 118.68 25.19 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.291 1.405 . . . . 0.0 113.05 -163.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -86.38 115.56 23.97 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.461 0.704 . . . . 0.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.1 m -86.78 104.44 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 162.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 t -106.45 116.67 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -84.73 99.49 10.87 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -75.03 91.07 2.5 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t -106.76 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.646 0.779 . . . . 0.0 110.789 -168.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.7 p -148.95 172.81 14.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.1 m -60.02 -49.09 79.05 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.36 -43.73 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -154.46 139.24 17.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.747 1.158 . . . . 0.0 111.889 -165.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -125.76 92.03 3.52 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -132.68 124.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.058 0.456 . . . . 0.0 111.153 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.49 102.9 10.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 112.135 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.91 103.78 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.36 106.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -129.59 138.56 51.34 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.6 0.76 . . . . 0.0 111.823 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.34 159.22 15.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.644 1.212 . . . . 0.0 111.86 167.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.5 113.3 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.68 75.91 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.0 126.4 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 121.013 2.407 . . . . 0.0 110.767 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -82.21 106.25 13.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.142 0.577 . . . . 0.0 111.871 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.48 154.3 48.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.732 -0.605 . . . . 0.0 112.384 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.36 89.54 7.7 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 122.709 1.242 . . . . 0.0 112.013 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -75.53 163.46 27.35 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.704 1.202 . . . . 0.0 112.523 168.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER -159.01 140.07 12.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.055 -1.653 . . . . 0.0 112.036 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -168.817 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.04 132.36 37.21 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 121.721 0.772 . . . . 0.0 112.919 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -136.49 103.72 5.35 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.747 0.819 . . . . 0.0 111.629 -159.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 127.38 35.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.166 -1.584 . . . . 0.0 111.623 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.68 174.47 46.91 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.226 2.451 . . . . 0.0 119.226 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.9 p -118.19 108.61 15.37 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.989 -1.106 . . . . 0.0 112.203 -169.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.73 107.54 5.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.612 -1.305 . . . . 0.0 109.989 166.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.5 m -110.07 -29.67 8.11 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -156.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.277 35.7 tp 69.08 103.31 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.312 1.445 . . . . 0.0 114.159 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.52 129.19 55.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.24 -108.82 1.42 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -118.3 45.33 2.03 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 163.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -141.99 114.68 8.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.13 95.77 5.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.839 -1.163 . . . . 0.0 110.187 170.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.5 tp -83.24 113.99 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 123.366 0.666 . . . . 0.0 110.606 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.89 2.47 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 123.834 0.731 . . . . 0.0 112.649 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -84.39 93.0 8.17 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -103.87 103.94 13.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.912 -0.492 . . . . 0.0 112.072 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -87.4 137.22 32.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.077 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -66.43 141.41 57.93 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.4 p -67.11 -32.69 74.0 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -63.86 -67.07 0.46 Allowed 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -109.4 -23.6 11.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 46.84 7.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.04 -16.1 55.79 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.317 6.3 tt0 69.36 87.88 0.12 Allowed 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.07 100.6 11.49 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -88.96 110.07 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.534 -0.729 . . . . 0.0 111.177 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -104.85 107.28 18.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.17 100.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.943 -1.098 . . . . 0.0 108.231 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -83.24 116.29 22.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.854 -0.529 . . . . 0.0 110.309 167.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -135.13 141.78 46.05 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.141 0.976 . . . . 0.0 110.294 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 105.41 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.32 -1.488 . . . . 0.0 107.022 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.251 14.7 tt -87.82 71.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.338 1.066 . . . . 0.0 110.714 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.12 1.54 Allowed Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.046 -1.034 . . . . 0.0 114.691 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.422 ' OD2' ' OE2' ' A' ' 112' ' ' GLU . 7.5 p-10 -105.12 -53.56 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.422 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 2.7 mt-10 -86.73 148.75 25.29 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 122.09 0.948 . . . . 0.0 112.914 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.3 tp -79.24 110.33 14.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.549 -0.719 . . . . 0.0 109.638 167.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.55 118.62 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -96.68 100.9 12.43 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 165.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 128.36 39.52 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.443 0.697 . . . . 0.0 109.759 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -135.31 119.1 17.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.845 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -87.16 144.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.012 0.525 . . . . 0.0 111.595 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -136.3 108.24 7.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 156.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.257 3.3 tm-20 49.19 70.03 0.52 Allowed 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.08 -42.73 2.76 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -169.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.63 119.71 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.708 1.254 . . . . 0.0 109.932 -165.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -98.41 140.2 33.03 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.854 0.835 . . . . 0.0 112.484 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.46 168.04 19.66 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.352 1.072 . . . . 0.0 112.497 162.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.69 150.05 51.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 111.599 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -122.99 117.0 24.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 157.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.4 109.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.34 127.5 47.94 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.959 0.903 . . . . 0.0 110.762 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -78.44 150.74 32.98 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.889 0.852 . . . . 0.0 112.62 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.43 122.23 14.06 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 113.155 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.489 1.492 0 C-N-CA 125.318 1.447 . . . . 0.0 111.501 -176.231 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.33 90.86 7.21 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 120.153 -1.592 . . . . 0.0 114.532 -161.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.8 m -167.26 174.19 8.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.761 1.224 . . . . 0.0 111.336 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.87 130.79 34.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -136.02 112.44 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -103.7 138.49 40.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 120.099 1.318 . . . . 0.0 113.453 -175.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.26 116.91 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -173.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -110.14 -48.29 3.2 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 123.949 0.899 . . . . 0.0 112.495 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 93.87 3.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.524 -0.735 . . . . 0.0 111.155 172.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -84.7 95.59 8.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.556 -1.34 . . . . 0.0 112.483 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.1 127.04 37.43 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.699 0.761 . . . . 0.0 111.11 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.303 6.7 t30 64.6 17.76 11.05 Favored 'General case' 0 CA--C 1.584 2.281 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 -171.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.52 -45.48 79.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -52.13 -41.39 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -42.56 61.92 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -46.78 -54.39 9.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 161.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.5 mmt -60.83 -48.12 83.23 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -60.55 -34.69 74.51 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -61.31 -40.79 95.48 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.0 mtp -58.46 -22.26 54.06 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 119.501 3.149 . . . . 0.0 119.501 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.93 49.67 3.28 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-N 120.246 1.384 . . . . 0.0 116.429 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.22 -30.87 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 17.8 m120 79.08 152.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.1 1.36 . . . . 0.0 112.444 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.17 75.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 122.89 1.329 . . . . 0.0 110.109 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.14 -68.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.877 1.271 . . . . 0.0 107.682 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -75.27 -38.57 60.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -61.51 -22.81 65.45 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -61.19 -55.71 29.1 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.361 0.982 . . . . 0.0 113.313 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -56.93 -29.01 62.74 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.43 -54.93 13.81 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.865 1.666 . . . . 0.0 113.885 162.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.15 -43.52 61.25 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -99.81 55.06 0.94 Allowed 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 161.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -70.45 -35.12 73.15 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 60.99 45.01 9.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.336 1.054 . . . . 0.0 113.751 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 tp -72.65 128.84 36.76 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.913 0.863 . . . . 0.0 113.038 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -126.44 118.36 24.8 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.777 0.831 . . . . 0.0 109.972 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.53 100.55 12.13 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.448 0.699 . . . . 0.0 109.787 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -95.28 96.86 9.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 109.054 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.8 mt -86.59 124.3 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.908 0.883 . . . . 0.0 109.321 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.8 p -122.04 109.61 14.78 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -113.74 126.05 54.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 112.258 -165.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.86 132.71 19.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 122.848 0.459 . . . . 0.0 110.156 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.11 61.99 4.97 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.306 31.7 m120 69.51 -28.2 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -168.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.88 128.57 34.81 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.409 1.459 . . . . 0.0 112.572 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -102.93 108.24 19.36 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 163.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 m -95.27 98.33 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 t -108.59 113.21 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -169.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 99.25 7.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.648 -0.658 . . . . 0.0 109.589 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.01 97.97 10.01 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.1 t -107.5 124.21 49.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 112.389 -161.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.6 p -146.14 169.02 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.822 0.849 . . . . 0.0 112.889 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -58.86 -38.5 78.9 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 167.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -64.89 -54.51 29.75 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -151.81 140.91 21.24 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.598 1.09 . . . . 0.0 112.332 -162.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.98 103.48 9.97 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.0 pt -125.33 127.78 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.946 -0.471 . . . . 0.0 111.241 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 96.52 8.52 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.192 -0.942 . . . . 0.0 111.486 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.64 100.3 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.54 110.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -127.76 124.09 36.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.348 0.594 . . . . 0.0 112.075 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -81.26 140.11 35.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.531 0.682 . . . . 0.0 111.382 166.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.93 120.72 11.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.75 -0.09 86.93 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.6 t -95.14 139.21 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.295 2.047 . . . . 0.0 110.122 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -76.81 110.11 11.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 112.135 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -134.52 169.39 17.35 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 123.699 0.8 . . . . 0.0 111.513 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -97.62 121.95 40.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 112.539 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -93.0 -66.56 0.91 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.341 16.0 m-80 92.55 129.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 125.732 1.613 . . . . 0.0 113.285 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.7 mt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.306 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.62 128.25 35.27 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.597 0.713 . . . . 0.0 111.049 167.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.12 111.86 24.1 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.081 0.952 . . . . 0.0 111.656 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.55 113.59 25.26 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.36 1.064 . . . . 0.0 110.948 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.51 -152.69 21.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -125.47 124.16 40.78 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 122.939 0.496 . . . . 0.0 111.937 -158.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -84.64 106.05 15.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.181 -0.949 . . . . 0.0 109.582 158.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -105.11 131.39 52.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.04 0.536 . . . . 0.0 110.6 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -82.57 98.0 8.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.869 -1.144 . . . . 0.0 110.639 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.41 83.85 7.57 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.685 0.755 . . . . 0.0 109.514 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -78.83 0.3 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 115.494 0.958 . . . . 0.0 115.494 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -112.28 -29.0 7.7 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -97.02 136.96 36.83 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 121.533 1.97 . . . . 0.0 111.973 -169.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.81 101.61 11.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -92.1 110.98 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 CA-C-O 122.2 1.0 . . . . 0.0 109.858 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.04 96.75 2.24 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 124.381 0.991 . . . . 0.0 112.884 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -91.99 94.84 9.47 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -119.21 107.28 13.24 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.891 0.476 . . . . 0.0 111.814 -163.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -73.21 141.15 47.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.81 -1.181 . . . . 0.0 112.054 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -69.14 132.81 47.15 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.175 0.988 . . . . 0.0 112.321 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.9 p -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 164.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -61.65 -74.58 0.08 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -89.1 -31.1 18.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.44 3.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -130.48 139.81 50.53 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 118.027 0.913 . . . . 0.0 109.764 171.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -72.4 102.52 3.19 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 123.497 1.618 . . . . 0.0 114.036 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -78.63 121.05 24.18 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.348 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -96.5 120.46 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 122.088 -0.382 . . . . 0.0 110.427 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -119.51 109.39 15.67 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.966 0.507 . . . . 0.0 110.001 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.15 108.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 120.358 -1.464 . . . . 0.0 109.267 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -88.59 119.75 29.34 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.425 0.69 . . . . 0.0 109.739 166.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -141.12 139.45 33.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 0.0 110.807 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.37 120.41 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.818 -1.176 . . . . 0.0 110.073 170.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.4 mt -116.09 94.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.17 -101.23 1.11 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.459 -0.776 . . . . 0.0 114.638 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -123.66 43.28 3.01 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 165.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.25 125.2 27.28 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.343 1.057 . . . . 0.0 108.683 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -86.48 105.99 17.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 m -88.89 115.7 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 109.225 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -107.64 95.99 6.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.418 -0.801 . . . . 0.0 110.067 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 86.2 m -91.11 96.76 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.035 0.534 . . . . 0.0 110.86 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -81.61 129.7 34.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.91 0.884 . . . . 0.0 111.323 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -126.31 115.55 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -120.9 117.96 28.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 118.545 0.611 . . . . 0.0 111.875 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 55.14 26.58 8.44 Favored 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.17 -32.28 7.73 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 -160.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.39 130.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.651 2.225 . . . . 0.0 113.48 -166.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.1 142.45 28.68 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.94 123.23 14.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.06 -1.025 . . . . 0.0 111.232 153.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -110.03 87.39 2.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -70.02 99.21 1.41 Allowed 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 170.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.3 mt -101.07 115.99 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -108.27 111.82 23.97 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.402 0.681 . . . . 0.0 110.715 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -78.17 146.03 35.28 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 121.607 0.717 . . . . 0.0 112.285 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -66.3 128.91 38.0 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.257 11.4 t70 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.909 1.684 . . . . 0.0 110.34 -165.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -94.42 82.17 4.02 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 120.067 -1.646 . . . . 0.0 114.491 -163.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -152.42 178.61 9.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.917 -1.114 . . . . 0.0 112.824 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 m -82.83 101.52 11.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.0 -1.063 . . . . 0.0 110.123 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -100.21 97.49 8.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.431 0.692 . . . . 0.0 110.067 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -97.96 139.24 34.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.603 . . . . 0.0 111.711 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 8.5 p -70.89 115.23 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.46 -60.83 2.2 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.64 0.776 . . . . 0.0 111.985 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -134.5 158.95 42.63 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 122.567 1.175 . . . . 0.0 111.094 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -156.97 143.44 18.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 119.397 -2.064 . . . . 0.0 112.025 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.49 139.19 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.235 0.541 . . . . 0.0 111.526 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.305 57.0 t30 53.99 38.92 29.91 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -81.05 -47.3 13.76 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.98 -37.42 74.19 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -51.61 66.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.528 1.058 . . . . 0.0 113.771 170.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -48.8 -53.44 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.674 ' SD ' HG11 ' A' ' 23' ' ' VAL . 11.8 mmt -55.06 -43.33 73.75 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -43.67 98.44 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 165.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.3 mtm -60.39 -61.51 2.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.71 56.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.347 0 CA-C-N 118.832 0.742 . . . . 0.0 114.925 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.674 HG11 ' SD ' ' A' ' 18' ' ' MET . 8.2 p -129.96 127.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -76.71 163.16 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -50.88 -44.88 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -169.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 -46.94 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 119.795 1.18 . . . . 0.0 113.052 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -57.79 -39.67 78.08 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 mtm105 -60.39 -29.05 68.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 167.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 121.258 1.845 . . . . 0.0 114.524 164.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.68 -38.43 84.92 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 165.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.07 -58.54 7.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.58 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -89.69 52.39 2.31 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 118.881 0.764 . . . . 0.0 112.252 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -77.39 -51.58 10.57 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.375 -1.453 . . . . 0.0 113.743 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 37.4 m-80 66.19 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.179 0.992 . . . . 0.0 111.646 -163.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -72.28 120.66 18.2 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -119.16 114.25 22.16 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.373 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.08 101.01 11.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.839 0.456 . . . . 0.0 109.806 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -87.02 105.92 17.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.98 -1.075 . . . . 0.0 109.22 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.9 mt -102.61 130.36 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 C-N-CA 123.211 0.605 . . . . 0.0 109.417 -168.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -114.9 134.36 55.22 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.184 0.594 . . . . 0.0 109.678 160.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -96.24 96.93 9.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 109.852 155.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -83.56 78.47 9.67 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 122.69 1.234 . . . . 0.0 112.024 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.26 -96.17 2.04 Favored Glycine 0 N--CA 1.488 2.124 0 O-C-N 121.568 -0.708 . . . . 0.0 113.002 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -99.08 -47.57 5.18 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.22 134.24 56.79 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -172.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -97.04 108.51 21.25 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.011 0.924 . . . . 0.0 109.316 174.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.4 m -90.07 100.13 13.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 164.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -94.93 102.9 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -88.04 93.01 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.616 -0.677 . . . . 0.0 109.282 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.59 120.73 24.92 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.592 0.357 . . . . 0.0 111.527 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -122.63 116.83 24.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.479 0.712 . . . . 0.0 109.396 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -149.03 168.83 22.09 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 122.364 1.078 . . . . 0.0 112.76 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 m -60.16 -37.85 81.38 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.84 -43.88 62.09 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.65 153.56 31.54 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.74 1.154 . . . . 0.0 111.36 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.13 104.14 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.554 -0.716 . . . . 0.0 110.298 166.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.49 159.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.043 0.925 . . . . 0.0 112.07 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -99.75 110.4 22.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.605 -1.309 . . . . 0.0 110.064 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.04 100.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.69 126.34 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.25 0.62 . . . . 0.0 109.794 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.55 141.88 21.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.73 -0.606 . . . . 0.0 111.982 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -92.02 147.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 112.084 170.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.86 91.47 5.37 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.07 -47.6 1.0 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 116.261 1.264 . . . . 0.0 116.261 -160.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -85.25 127.14 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.008 1.404 . . . . 0.0 109.912 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 t -74.41 142.27 45.02 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -141.83 166.48 24.62 Favored 'General case' 0 CA--C 1.572 1.807 0 C-N-CA 123.815 0.846 . . . . 0.0 112.253 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.85 104.46 16.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.382 0.61 . . . . 0.0 110.516 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -89.08 83.13 6.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 112.01 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -86.12 132.6 33.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.915 -1.115 . . . . 0.0 112.669 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.789 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.562 1.41 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.14 84.68 4.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 111.346 -158.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.5 95.56 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.327 -0.858 . . . . 0.0 113.214 -162.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -78.81 116.11 18.94 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.463 0.705 . . . . 0.0 110.837 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.32 9.77 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 115.539 0.976 . . . . 0.0 115.539 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.1 m -160.72 144.97 13.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.874 -0.78 . . . . 0.0 110.39 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.17 102.72 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 162.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -97.75 140.51 32.02 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.355 0.662 . . . . 0.0 111.864 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.79 102.15 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.819 -1.176 . . . . 0.0 111.016 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.15 84.94 4.92 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.004 0.906 . . . . 0.0 110.203 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.69 -81.99 0.61 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -119.38 -5.26 10.37 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -114.11 137.86 51.19 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 121.087 1.767 . . . . 0.0 110.237 -171.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.5 mt -82.54 106.42 14.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.45 -1.406 . . . . 0.0 110.105 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 tt -92.25 111.55 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 CA-C-O 122.399 1.095 . . . . 0.0 109.752 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.39 94.09 1.96 Allowed Glycine 0 N--CA 1.478 1.475 0 C-N-CA 123.878 0.751 . . . . 0.0 113.232 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -90.29 109.84 20.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -133.84 145.64 49.89 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.896 0.855 . . . . 0.0 111.512 -168.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -124.76 132.8 53.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.421 -0.799 . . . . 0.0 109.503 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -64.25 127.4 31.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 112.44 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.32 0.4 OUTLIER -82.8 -27.39 30.97 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -57.39 -54.82 42.44 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 164.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -93.47 -39.77 10.7 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.32 -13.59 51.52 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -158.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -96.03 153.66 17.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.383 1.592 . . . . 0.0 113.669 -160.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.48 134.56 34.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -166.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -119.47 129.65 54.84 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.7 1.2 . . . . 0.0 110.435 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -118.73 108.87 15.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.685 . . . . 0.0 109.491 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -115.47 112.95 23.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.916 -0.49 . . . . 0.0 111.981 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.29 116.12 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.984 -1.072 . . . . 0.0 109.215 -173.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -91.58 117.36 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.765 -0.585 . . . . 0.0 109.66 166.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.55 149.71 37.82 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.112 0.958 . . . . 0.0 112.478 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -89.51 103.87 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.395 -0.816 . . . . 0.0 109.354 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.6 tt -95.6 72.26 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.05 0.928 . . . . 0.0 110.96 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.88 59.75 6.74 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.353 24.8 m-20 79.59 -34.37 0.14 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.92 130.77 42.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 120.01 1.277 . . . . 0.0 113.034 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 46.7 tp -87.72 105.48 17.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.887 -1.133 . . . . 0.0 110.101 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.81 109.71 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.903 0.859 . . . . 0.0 110.295 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.11 104.53 17.09 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -106.93 91.11 3.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.216 0.607 . . . . 0.0 110.046 -162.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -81.87 102.04 10.6 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.456 0.703 . . . . 0.0 112.083 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.2 t -98.94 107.03 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.403 ' OH ' ' OE2' ' A' ' 120' ' ' GLU . 33.7 t80 -122.16 114.58 21.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.83 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.403 ' OE2' ' OH ' ' A' ' 119' ' ' TYR . 47.5 mt-10 51.7 39.03 24.39 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 -32.86 5.89 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 118.673 2.229 . . . . 0.0 118.673 -165.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.15 110.27 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 120.578 2.189 . . . . 0.0 112.238 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -86.84 117.95 25.91 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.97 0.508 . . . . 0.0 111.662 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.11 118.44 32.85 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.537 0.684 . . . . 0.0 111.949 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -100.42 122.61 43.45 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.081 0.552 . . . . 0.0 110.815 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -108.39 111.91 24.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 167.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.91 112.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -105.55 135.62 46.62 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 121.383 0.611 . . . . 0.0 112.249 -170.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.44 146.81 25.02 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 122.003 0.906 . . . . 0.0 111.515 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -81.01 90.4 5.97 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 121.445 0.641 . . . . 0.0 112.637 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 5.3 t0 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.21 1.404 . . . . 0.0 113.821 172.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 . . . . . 0 CA--C 1.576 1.975 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.25 3.4 p-10 -95.83 88.32 4.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.93 -1.731 . . . . 0.0 114.171 -158.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 p -148.2 -170.81 3.69 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 122.292 1.044 . . . . 0.0 112.309 170.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -87.16 114.92 24.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.938 -1.101 . . . . 0.0 109.373 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -119.73 106.24 11.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.74 136.84 42.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.178 -0.951 . . . . 0.0 112.814 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.61 117.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 113.566 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -101.11 -55.84 2.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.1 0.56 . . . . 0.0 111.588 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -85.56 -78.66 0.26 Allowed 'General case' 0 CA--C 1.57 1.722 0 O-C-N 121.757 -0.589 . . . . 0.0 112.248 -162.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.268 16.1 m 57.66 95.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.287 13.5 tm-20 -87.12 -110.19 0.06 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.938 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -86.27 58.9 5.32 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-N 121.474 1.943 . . . . 0.0 115.136 -169.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -70.12 -31.82 69.54 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 165.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -48.61 -54.09 15.94 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 169.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.26 -31.93 68.11 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -55.88 -52.85 62.63 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 164.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.64 -46.55 73.96 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -55.72 -47.66 76.52 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.29 -44.25 75.54 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.3 mtt -65.78 -35.25 80.18 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.56 61.32 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 CA-C-N 119.703 1.138 . . . . 0.0 115.029 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.29 145.37 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.285 0.564 . . . . 0.0 111.447 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -80.83 156.57 26.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.594 -1.316 . . . . 0.0 114.126 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.273 14.8 tt -53.66 -42.22 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.44 -45.23 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -58.26 -46.35 86.18 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -52.12 -51.6 56.84 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.86 -49.09 77.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -58.5 -37.79 76.31 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.16 -38.45 31.36 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.3 -53.1 54.26 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 163.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -88.95 53.92 2.84 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 119.362 0.983 . . . . 0.0 113.181 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.11 -31.99 26.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 66.53 49.68 1.33 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 124.663 1.185 . . . . 0.0 113.383 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.9 121.54 23.58 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 122.682 1.229 . . . . 0.0 113.363 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -111.46 106.31 15.17 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.364 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.05 94.72 7.85 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.3 m -87.06 100.19 12.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 49' ' ' VAL . 60.6 mt -93.87 127.85 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 p -129.11 110.74 12.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -91.44 101.09 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.9 . . . . 0.0 109.951 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.52 -35.5 30.28 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.3 81.77 0.04 OUTLIER Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.336 -0.853 . . . . 0.0 111.292 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 6.7 t-20 70.18 -52.48 0.64 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -159.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -62.8 137.92 58.39 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -112.61 109.45 19.0 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -84.23 103.1 13.14 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.543 0.737 . . . . 0.0 109.107 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 40' ' ' ILE . 17.7 m -105.89 108.27 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.73 89.74 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.527 -0.733 . . . . 0.0 109.568 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.66 85.4 6.05 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.912 0.863 . . . . 0.0 111.872 -163.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.4 m -101.84 98.19 8.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.707 -0.621 . . . . 0.0 111.527 -154.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.7 p -127.44 171.03 11.92 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.65 0.78 . . . . 0.0 112.926 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -75.05 66.05 1.55 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.829 -1.169 . . . . 0.0 110.95 163.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.36 -62.18 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 123.949 0.899 . . . . 0.0 111.416 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.291 42.1 ptt85 -138.55 -62.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.268 30.8 t-20 66.0 91.07 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.42 1.463 . . . . 0.0 113.944 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.7 143.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.436 0.636 . . . . 0.0 110.762 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -80.92 101.4 9.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.476 0.655 . . . . 0.0 112.005 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.12 106.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.6 97.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -109.18 126.98 53.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.21 148.97 21.98 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.782 0.801 . . . . 0.0 111.7 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.49 119.77 15.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 113.813 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.63 1.46 89.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -91.77 132.81 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 120.144 1.972 . . . . 0.0 109.872 -173.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -78.28 110.74 13.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 112.155 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -132.75 159.64 39.12 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.636 0.731 . . . . 0.0 112.549 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.88 105.75 17.95 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.512 -0.742 . . . . 0.0 111.302 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -93.08 116.2 28.82 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.081 0.952 . . . . 0.0 110.559 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -89.91 131.0 36.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.009 -1.057 . . . . 0.0 111.558 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.498 1.935 0 O-C-N 120.646 -1.284 . . . . 0.0 114.242 176.685 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.7 m . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 122.014 0.912 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -117.54 124.94 49.93 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -155.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.96 109.42 8.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.836 -1.165 . . . . 0.0 112.09 -162.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.52 112.64 24.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.057 -1.027 . . . . 0.0 111.141 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.39 -149.91 15.81 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 117.209 1.644 . . . . 0.0 117.209 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -133.8 123.38 24.74 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.438 -152.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -82.53 116.23 21.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.942 -0.474 . . . . 0.0 110.233 158.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.2 m -113.63 134.63 54.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 111.248 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 tp -85.66 115.55 23.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 110.689 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.71 -93.41 0.1 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 123.089 0.555 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.49 -86.18 1.9 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 119.432 1.014 . . . . 0.0 111.49 169.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -110.95 47.01 1.02 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 117.047 0.424 . . . . 0.0 111.901 161.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -140.82 122.27 15.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.858 -1.151 . . . . 0.0 108.394 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.29 105.09 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.93 112.13 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.33 95.87 1.51 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -85.3 113.6 21.75 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -137.67 111.35 8.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.08 0.552 . . . . 0.0 111.053 -165.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -87.2 129.98 34.74 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 120.489 -1.382 . . . . 0.0 112.919 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -62.02 139.35 58.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 163.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.0 p -72.02 -51.22 22.82 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 -49.81 64.44 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -86.91 -36.95 18.08 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.03 12.08 79.16 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -173.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.41 -18.66 44.64 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.752 3.242 . . . . 0.0 119.752 -165.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.346 5.4 tt0 67.14 100.97 0.05 OUTLIER 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.95 132.29 41.31 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.735 0.814 . . . . 0.0 110.703 160.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -112.72 97.4 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 t -92.64 110.15 21.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.498 0.666 . . . . 0.0 110.177 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.56 117.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -103.05 119.32 38.64 Favored 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.663 0.785 . . . . 0.0 110.612 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -144.08 142.43 30.62 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.774 0.83 . . . . 0.0 110.477 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -84.43 111.69 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 108.155 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.26 98.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.25 -106.27 2.78 Favored Glycine 0 N--CA 1.488 2.116 0 O-C-N 121.847 -0.533 . . . . 0.0 112.927 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.4 ' OD1' ' OE2' ' A' ' 112' ' ' GLU . 3.3 p-10 -92.97 -30.31 15.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE2' ' OD1' ' A' ' 111' ' ' ASP . 3.9 mt-10 -102.19 141.33 35.2 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.149 0.975 . . . . 0.0 112.975 -160.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.59 104.8 5.42 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.003 164.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.34 103.82 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 95.13 5.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -105.61 111.1 23.66 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.751 0.421 . . . . 0.0 110.473 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.75 112.4 18.87 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.718 0.407 . . . . 0.0 110.284 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.83 114.72 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -139.43 108.1 5.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.204 0.602 . . . . 0.0 109.768 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 54.98 50.88 14.53 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.32 -27.75 4.5 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.939 2.335 . . . . 0.0 118.939 -166.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.72 130.06 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.722 1.761 . . . . 0.0 110.485 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -101.29 107.96 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.05 0.54 . . . . 0.0 109.968 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.21 98.75 9.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -93.84 87.83 5.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.732 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -90.99 104.42 17.02 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.69 121.32 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.721 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -109.32 119.37 39.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.601 0.76 . . . . 0.0 110.504 -166.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -76.27 147.88 37.97 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 122.152 0.977 . . . . 0.0 113.43 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -68.13 109.53 3.57 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 123.804 0.842 . . . . 0.0 112.829 175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 125.118 1.367 . . . . 0.0 112.569 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.36 174.09 5.16 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.392 37.0 p 86.83 -177.79 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.625 1.57 . . . . 0.0 114.075 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.9 m -96.92 129.07 44.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.654 -1.279 . . . . 0.0 111.405 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -122.26 102.73 8.3 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -100.53 144.66 29.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.54 0.686 . . . . 0.0 112.268 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.77 122.8 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.58 -68.05 0.78 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.795 163.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.17 128.17 44.29 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.556 0.693 . . . . 0.0 111.585 -172.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -109.44 120.48 42.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.654 0.782 . . . . 0.0 111.028 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.26 130.39 47.39 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.386 0.675 . . . . 0.0 110.538 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 18.7 t30 53.74 21.63 2.77 Favored 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 119.48 3.141 . . . . 0.0 119.48 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.44 -42.24 71.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -59.08 -38.91 80.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.75 -48.41 81.78 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 120.602 1.546 . . . . 0.0 114.837 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -48.13 -61.02 2.19 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 mtt -66.94 -35.75 80.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -63.83 -42.86 97.55 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 167.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -56.78 -42.98 80.4 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 164.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtp -51.34 -30.5 18.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 164.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.46 47.68 4.24 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 116.165 1.226 . . . . 0.0 116.165 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.43 163.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 122.197 0.998 . . . . 0.0 112.188 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -66.84 144.38 56.32 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.694 -1.254 . . . . 0.0 112.804 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.281 15.4 tt -56.89 -40.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.01 -44.68 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 119.554 1.07 . . . . 0.0 113.28 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -58.96 -40.99 86.38 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -35.35 79.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -67.11 -48.37 68.33 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 114.157 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -53.64 -24.92 15.67 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 165.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.76 -51.44 59.17 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 120.955 1.707 . . . . 0.0 114.602 164.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.74 -44.32 63.25 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -106.52 61.14 0.64 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 167.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.3 5.6 p30 -82.08 -35.5 28.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.304 -1.498 . . . . 0.0 114.698 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 54.95 44.44 28.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -76.3 122.08 23.9 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -111.28 133.77 53.37 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.551 0.74 . . . . 0.0 111.745 166.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.53 102.75 10.59 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -85.78 100.93 12.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.304 -0.872 . . . . 0.0 109.403 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -93.83 127.94 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -141.29 125.39 17.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.131 -0.981 . . . . 0.0 110.207 171.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -95.03 122.98 38.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.687 -0.633 . . . . 0.0 111.396 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -105.45 76.41 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.571 0.7 . . . . 0.0 109.895 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.13 78.05 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 115.994 1.157 . . . . 0.0 115.994 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 4.3 m-80 70.26 -50.27 0.65 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -167.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -73.64 120.74 19.65 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.017 0.927 . . . . 0.0 112.726 -172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -98.85 125.26 44.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.223 0.609 . . . . 0.0 111.919 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.6 m -94.78 108.13 20.14 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 165.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -105.29 101.47 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.16 104.87 17.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.16 145.03 35.88 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 121.936 0.874 . . . . 0.0 112.473 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -149.49 117.98 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.844 -1.16 . . . . 0.0 110.068 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 t -150.33 167.21 27.68 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 124.541 1.136 . . . . 0.0 111.26 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -51.9 -29.7 21.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -63.06 -53.86 47.15 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -171.78 171.29 5.26 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.226 1.01 . . . . 0.0 112.312 -162.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -133.26 119.58 19.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.731 -1.23 . . . . 0.0 111.129 161.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.4 pt -140.02 150.22 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-O 122.171 0.986 . . . . 0.0 111.521 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.12 106.63 18.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.7 t -95.59 93.61 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 t -93.91 120.77 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -135.51 139.48 44.02 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.145 0.974 . . . . 0.0 113.311 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.15 142.4 27.54 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 121.853 0.835 . . . . 0.0 110.858 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.22 92.79 1.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.397 -0.814 . . . . 0.0 112.84 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.37 -27.44 5.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.659 1.823 . . . . 0.0 117.659 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.08 127.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.036 1.918 . . . . 0.0 110.422 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -75.07 102.23 4.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.236 0.615 . . . . 0.0 111.309 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -112.27 150.6 30.73 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.754 0.822 . . . . 0.0 112.069 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -90.97 101.48 14.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.689 -0.632 . . . . 0.0 110.661 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.31 104.72 17.02 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.48 -0.762 . . . . 0.0 110.529 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -72.49 114.86 11.07 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.699 0.761 . . . . 0.0 111.769 168.22 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -75.65 107.19 7.65 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.586 0.707 . . . . 0.0 112.536 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.3 mt -84.24 104.36 14.21 Favored 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.427 -0.795 . . . . 0.0 110.536 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -87.17 110.35 20.09 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.448 1.099 . . . . 0.0 110.758 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.8 -157.87 30.39 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -128.37 136.18 50.57 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 122.903 0.481 . . . . 0.0 111.957 -165.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -91.56 114.93 27.59 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 153.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -107.19 136.9 46.25 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.084 0.554 . . . . 0.0 111.176 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.8 tp -89.31 104.39 16.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.972 -1.08 . . . . 0.0 110.987 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -78.09 -42.74 31.11 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.53 -92.27 0.08 OUTLIER Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -74.77 3.45 7.99 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 156.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -126.62 119.47 27.12 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.802 1.183 . . . . 0.0 108.772 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.07 102.34 13.76 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 160.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.88 113.55 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 C-N-CA 124.093 0.957 . . . . 0.0 109.25 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.8 104.1 3.01 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.044 0.83 . . . . 0.0 113.164 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.07 99.96 11.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.51 152.36 41.83 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.285 1.04 . . . . 0.0 112.121 -172.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -125.48 146.03 49.82 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.765 0.793 . . . . 0.0 110.056 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -65.41 129.57 40.23 Favored 'General case' 0 CA--C 1.565 1.556 0 O-C-N 120.827 -1.171 . . . . 0.0 112.11 170.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -85.63 38.17 0.73 Allowed 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 122.122 0.963 . . . . 0.0 112.298 158.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -160.74 45.35 0.2 Allowed 'General case' 0 CA--C 1.585 2.314 0 C-N-CA 124.845 1.258 . . . . 0.0 110.314 -157.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.38 51.6 p30 138.11 -50.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.763 2.425 . . . . 0.0 111.469 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.8 2.14 27.12 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -90.48 145.61 24.77 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.514 2.157 . . . . 0.0 112.649 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -70.49 151.06 45.51 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.87 113.89 12.02 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -104.61 132.19 51.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.618 -0.676 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -142.85 139.2 30.77 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.8 t -120.92 118.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -96.54 120.94 37.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 162.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -146.34 165.28 29.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.82 111.58 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.634 -1.291 . . . . 0.0 109.307 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.19 85.99 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.046 0.927 . . . . 0.0 110.204 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.95 -84.31 1.02 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.079 -1.013 . . . . 0.0 114.622 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -141.62 48.07 1.64 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 163.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -142.75 136.91 29.37 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -81.49 105.7 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.478 -1.389 . . . . 0.0 111.177 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.33 109.76 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.749 0.785 . . . . 0.0 110.442 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -98.13 104.43 16.46 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -91.47 142.6 27.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 123.257 0.623 . . . . 0.0 109.61 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -151.2 116.88 5.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.789 -1.194 . . . . 0.0 110.513 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.72 125.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.359 1.064 . . . . 0.0 108.505 -171.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 110.97 10.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.969 0.507 . . . . 0.0 109.791 173.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 68.02 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 175.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 -31.19 1.92 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.826 2.291 . . . . 0.0 118.826 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.98 102.72 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 119.311 1.556 . . . . 0.0 109.189 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.66 133.41 33.7 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.197 0.998 . . . . 0.0 111.104 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.24 156.25 47.86 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.108 0.956 . . . . 0.0 111.722 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -133.89 149.84 51.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.939 0.876 . . . . 0.0 111.855 -170.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -141.1 119.39 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.019 -1.051 . . . . 0.0 108.54 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt -101.52 108.02 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -94.3 123.23 37.56 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.629 0.772 . . . . 0.0 110.015 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -79.57 165.47 22.91 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.06 112.76 6.67 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.802 -1.186 . . . . 0.0 112.859 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 125.151 1.38 . . . . 0.0 113.372 178.361 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.12 101.61 2.29 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.232 1.378 . . . . 0.0 112.756 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.5 m 179.61 165.56 1.1 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.145 1.378 . . . . 0.0 110.518 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.1 m -96.33 111.98 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 167.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -108.8 114.25 27.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.776 -0.578 . . . . 0.0 110.509 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -92.74 135.29 34.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.105 -0.997 . . . . 0.0 112.559 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.3 129.22 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.885 -1.134 . . . . 0.0 113.61 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -119.0 -65.17 1.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.168 0.987 . . . . 0.0 110.998 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 75.46 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.345 0.658 . . . . 0.0 111.494 -165.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.411 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 13.4 p -85.89 139.59 31.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.341 2.5 tm-20 -94.06 -97.78 0.15 Allowed 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.542 -166.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.255 19.3 t30 -100.0 50.22 0.91 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.143 -1.598 . . . . 0.0 113.345 -167.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -76.84 -39.73 50.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.06 -40.55 98.04 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -67.19 -43.79 81.25 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -47.02 -54.97 9.06 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 161.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtp -65.32 -34.11 77.55 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -53.79 -46.36 71.0 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 163.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.66 -41.31 98.22 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.9 mmm -54.11 -48.95 70.19 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.06 65.72 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 123.536 0.589 . . . . 0.0 114.209 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.41 131.51 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.749 0.785 . . . . 0.0 110.701 -174.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.67 161.86 24.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.9 tt -58.23 158.03 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.384 42.3 t 82.14 -73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 C-N-CA 124.573 1.149 . . . . 0.0 109.267 -161.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -53.51 -50.68 64.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -64.07 -24.82 67.85 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -71.14 -48.54 51.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 121.67 2.032 . . . . 0.0 113.545 167.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.6 mt -56.0 -48.69 75.44 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 165.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.08 81.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -49.22 78.32 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.103 1.774 . . . . 0.0 115.355 165.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -92.3 59.95 3.57 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 121.79 -0.569 . . . . 0.0 111.439 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -74.3 -27.64 60.81 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.75 38.2 11.98 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.308 1.5 pt? -81.16 151.45 28.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -169.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -127.75 114.31 17.12 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.822 -173.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.8 mt -97.39 99.15 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.82 -1.175 . . . . 0.0 111.236 -170.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.2 m -85.71 95.02 9.25 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.886 0.851 . . . . 0.0 109.818 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.0 mt -95.71 121.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -133.6 69.57 1.47 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.606 0.639 . . . . 0.0 111.973 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -58.36 110.64 1.0 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -165.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.15 62.29 2.15 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.47 84.69 0.17 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.312 -0.867 . . . . 0.0 114.76 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.32 -66.21 0.29 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.546 1.173 . . . . 0.0 112.651 -160.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -67.93 123.69 21.29 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.347 1.059 . . . . 0.0 113.676 -161.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.21 107.9 19.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.265 -0.897 . . . . 0.0 110.825 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -90.9 101.99 14.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -112.11 102.36 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -85.42 97.34 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.04 93.29 9.33 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.734 0.778 . . . . 0.0 108.964 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.6 t -91.99 89.39 6.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.359 0.599 . . . . 0.0 111.8 -164.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.2 p -100.61 162.64 12.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -51.68 -36.63 47.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 163.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.09 -46.92 63.87 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -162.81 137.96 6.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.962 0.905 . . . . 0.0 111.342 -161.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -100.75 101.88 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 163.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 pt -103.89 113.45 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.107 0.563 . . . . 0.0 110.105 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -77.9 89.42 4.1 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.768 0.794 . . . . 0.0 112.024 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.88 106.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.95 104.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -117.85 132.28 56.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.925 -0.484 . . . . 0.0 112.255 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 157.45 24.66 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.778 1.275 . . . . 0.0 111.304 159.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.53 102.27 8.73 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.679 -1.263 . . . . 0.0 111.386 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.1 3.08 51.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 119.026 2.371 . . . . 0.0 119.026 -162.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.54 132.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 121.55 2.675 . . . . 0.0 112.222 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -82.99 102.9 12.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.283 -0.885 . . . . 0.0 110.768 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -139.13 157.58 45.71 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 112.997 -171.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.33 110.55 19.18 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.224 0.609 . . . . 0.0 111.533 173.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -100.61 113.66 26.68 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.122 0.969 . . . . 0.0 110.8 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.61 128.67 35.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 112.321 167.678 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.389 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.06 119.19 22.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-O 122.327 1.061 . . . . 0.0 111.322 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.38 111.32 23.58 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.689 0.796 . . . . 0.0 110.418 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -95.32 116.89 29.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 112.294 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.22 -150.58 18.59 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -133.48 116.63 16.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.274 -0.545 . . . . 0.0 112.278 -160.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.59 119.79 20.12 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.55 0.614 . . . . 0.0 111.036 158.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -132.21 150.81 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.701 0.8 . . . . 0.0 111.419 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -98.92 103.57 15.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.658 -1.276 . . . . 0.0 112.019 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -91.69 81.81 5.27 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.01 0.91 . . . . 0.0 110.083 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.9 -105.89 1.84 Allowed Glycine 0 N--CA 1.491 2.303 0 O-C-N 121.411 -0.806 . . . . 0.0 114.777 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.62 10.72 37.71 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -113.54 116.75 30.03 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.836 1.198 . . . . 0.0 110.005 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -77.25 96.75 4.63 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.971 -1.08 . . . . 0.0 109.22 163.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.58 111.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.994 0.918 . . . . 0.0 108.89 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.99 98.06 1.85 Allowed Glycine 0 N--CA 1.475 1.284 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -78.52 105.07 9.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.36 134.11 47.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 111.306 -165.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -106.29 140.59 38.99 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 111.257 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -66.71 122.95 18.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.566 -1.334 . . . . 0.0 112.366 167.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -63.45 -25.74 68.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 -44.98 94.97 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.95 -4.93 0.21 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -160.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.8 7.17 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 118.596 2.198 . . . . 0.0 118.596 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.87 -29.47 12.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -172.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.328 1.8 mt-10 71.46 112.98 0.06 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 124.73 1.212 . . . . 0.0 113.296 -160.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 114.78 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 164.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.68 134.7 35.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 111.522 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.2 p -131.3 116.37 17.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.962 -0.461 . . . . 0.0 110.654 -167.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -114.36 106.62 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 120.854 -1.154 . . . . 0.0 108.458 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -90.54 122.23 33.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.217 162.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.33 144.18 31.33 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.76 1.164 . . . . 0.0 113.882 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -96.56 104.61 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.85 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 174.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.11 -97.56 0.14 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -99.78 25.19 7.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.98 149.18 41.45 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.265 1.031 . . . . 0.0 110.213 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.7 tp -100.22 112.64 24.96 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 168.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.12 120.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -110.15 91.62 3.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.7 m -89.13 101.96 14.62 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.964 0.905 . . . . 0.0 109.413 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -103.25 116.07 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.827 -0.546 . . . . 0.0 110.162 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.92 123.95 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -126.06 111.81 15.13 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.36 0.664 . . . . 0.0 110.544 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.3 OUTLIER 52.79 53.98 11.26 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.14 -25.36 1.58 Allowed Glycine 0 CA--C 1.556 2.616 0 N-CA-C 119.292 2.477 . . . . 0.0 119.292 -165.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.47 109.48 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 119.362 1.581 . . . . 0.0 109.246 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -85.04 143.98 28.55 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.914 0.885 . . . . 0.0 112.807 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.36 121.17 17.51 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.472 -0.768 . . . . 0.0 110.813 162.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -100.44 110.01 22.18 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.411 ' HE ' ' HB3' ' A' ' 11' ' ' SER . 49.3 mmm-85 -90.23 109.57 20.64 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.4 mt -109.67 117.52 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.099 -1.0 . . . . 0.0 108.352 -167.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.64 144.77 42.36 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 121.692 0.758 . . . . 0.0 112.179 -167.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -114.34 138.86 49.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.942 0.897 . . . . 0.0 110.205 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -67.78 118.0 10.43 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -174.381 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.326 50.8 m-85 . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 116.288 1.959 . . . . 0.0 116.288 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -79.19 98.01 6.43 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.365 0.984 . . . . 0.0 112.471 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 m -168.65 -176.95 2.93 Favored 'General case' 0 CA--C 1.573 1.843 0 C-N-CA 124.95 1.3 . . . . 0.0 110.064 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.0 m -93.16 130.12 38.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.643 -1.286 . . . . 0.0 109.615 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -135.9 112.97 10.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.229 -0.919 . . . . 0.0 111.552 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -102.51 143.21 32.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 112.268 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.252 8.6 p -76.41 90.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.339 1.066 . . . . 0.0 113.319 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -46.17 18.45 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -141.35 79.51 1.69 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.92 1.236 . . . . 0.0 113.16 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -79.75 139.53 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.817 -1.177 . . . . 0.0 114.163 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.343 0.9 OUTLIER -86.87 -91.26 0.11 Allowed 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 123.989 0.916 . . . . 0.0 111.702 -177.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -107.0 43.7 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 121.116 1.78 . . . . 0.0 114.634 -166.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.79 -32.14 63.62 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.52 -44.56 80.91 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -69.1 -38.51 78.97 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.72 -54.09 38.59 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 162.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.535 ' SD ' HG11 ' A' ' 23' ' ' VAL . 8.1 mmt -48.06 -50.98 26.24 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 164.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -56.56 -45.92 81.02 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.2 -38.99 91.22 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.406 ' SD ' HG21 ' A' ' 76' ' ' THR . 71.8 mtm -62.16 -35.02 77.54 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.83 62.63 0.54 Allowed Glycine 0 N--CA 1.49 2.26 0 CA-C-N 119.046 0.839 . . . . 0.0 114.96 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG11 ' SD ' ' A' ' 18' ' ' MET . 16.1 m -118.91 145.6 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.395 0.616 . . . . 0.0 111.175 -170.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -66.7 156.29 35.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.881 -1.137 . . . . 0.0 113.673 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.07 -43.72 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -57.92 -51.64 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -59.95 -44.88 94.12 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -51.6 -48.24 63.29 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -70.56 -58.53 3.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 168.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.15 -32.84 69.43 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.91 65.57 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 121.598 1.999 . . . . 0.0 115.598 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.76 85.25 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 156.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -100.45 49.15 0.9 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -85.47 -7.22 59.02 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 58.87 38.26 24.57 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.288 1.3 pt? -74.28 139.23 44.12 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.698 1.237 . . . . 0.0 113.059 -172.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -136.9 89.1 2.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -155.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.1 mt -89.35 110.16 20.98 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.148 0.579 . . . . 0.0 110.985 -160.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.4 m -89.0 106.71 18.6 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 164.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.01 124.19 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 60.5 p -139.63 118.56 12.52 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.966 -0.459 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -77.5 96.7 4.79 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.646 0.778 . . . . 0.0 111.158 167.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.24 83.57 7.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.688 1.232 . . . . 0.0 111.116 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.51 1.57 Allowed Glycine 0 N--CA 1.489 2.19 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.704 -165.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -131.98 -22.44 2.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.36 115.46 12.74 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 120.282 1.401 . . . . 0.0 112.723 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -78.64 106.13 10.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.477 -0.764 . . . . 0.0 110.025 171.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -88.15 103.64 15.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -104.54 107.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.28 96.15 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.62 90.55 3.95 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -89.77 95.45 10.25 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -129.25 173.06 10.85 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 0.0 112.955 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -58.88 -40.32 84.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.24 -40.17 52.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 151.21 31.08 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 121.677 2.035 . . . . 0.0 113.456 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -111.02 96.15 5.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.83 132.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.591 -0.693 . . . . 0.0 112.443 -168.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.23 109.36 18.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.006 -1.059 . . . . 0.0 111.773 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -95.36 101.0 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.4 t -100.15 116.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -141.51 123.02 15.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -174.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.69 152.93 31.34 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 112.611 166.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.33 106.47 1.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 113.558 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 CA--C 1.552 2.385 0 N-CA-C 118.846 2.299 . . . . 0.0 118.846 -169.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.09 135.67 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 121.127 2.464 . . . . 0.0 112.654 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.7 p -84.42 105.16 15.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.315 -0.865 . . . . 0.0 110.925 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.27 163.04 31.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -100.33 110.11 22.33 Favored 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 123.155 0.582 . . . . 0.0 110.37 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -73.56 -61.7 1.74 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.261 39.2 m-80 77.91 100.95 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.778 1.172 . . . . 0.0 114.055 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 CA--C 1.577 2.011 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.608 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.406 HG21 ' SD ' ' A' ' 21' ' ' MET . 91.0 m . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.84 127.94 34.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.481 0.712 . . . . 0.0 109.912 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -137.05 97.97 3.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.765 -1.209 . . . . 0.0 111.806 -157.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.487 HH21 ' HZ1' ' A' ' 94' ' ' LYS . 32.3 ptt180 -91.37 115.63 28.19 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.415 0.686 . . . . 0.0 111.843 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.34 -154.07 23.12 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -127.48 145.58 50.79 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.37 116.36 29.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.131 -0.981 . . . . 0.0 108.995 150.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -106.67 174.7 5.77 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 121.158 0.504 . . . . 0.0 111.462 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -124.29 120.91 33.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.149 -1.594 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.43 83.46 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 109.972 169.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.86 -93.21 0.39 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.266 -0.896 . . . . 0.0 115.227 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -117.69 39.39 3.35 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 166.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.97 110.69 9.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.799 -1.188 . . . . 0.0 108.092 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -82.48 118.27 23.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 109.685 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -111.88 105.84 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.404 0.682 . . . . 0.0 110.219 -167.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.41 95.8 2.11 Favored Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 113.098 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -102.62 102.54 12.77 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.36 134.17 51.14 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.431 0.692 . . . . 0.0 110.911 -168.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HZ1' HH21 ' A' ' 79' ' ' ARG . 0.2 OUTLIER -104.42 127.65 52.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.14 115.23 13.39 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.388 -0.82 . . . . 0.0 112.835 -170.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -59.14 -44.84 92.08 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.96 -39.47 78.18 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -125.48 -28.15 3.35 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -161.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.46 65.95 1.49 Allowed Glycine 0 N--CA 1.492 2.37 0 CA-C-N 120.615 1.552 . . . . 0.0 114.777 -172.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -152.89 137.43 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 117.512 0.656 . . . . 0.0 111.869 -164.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -77.66 122.16 24.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 113.391 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.05 120.19 41.6 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.717 0.807 . . . . 0.0 109.602 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -113.01 108.05 16.81 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.259 15.3 t -115.94 102.26 9.51 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.175 0.59 . . . . 0.0 112.255 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.93 121.08 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.181 -0.949 . . . . 0.0 109.855 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -96.17 125.62 40.82 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.932 0.893 . . . . 0.0 111.423 170.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -149.83 159.77 44.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.989 0.899 . . . . 0.0 112.224 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.29 117.61 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.552 -1.342 . . . . 0.0 109.352 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.73 -51.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.57 77.37 0.08 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.48 0.0 OUTLIER 78.09 -45.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -159.289 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -78.44 143.73 36.46 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.03 116.94 29.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.91 0.884 . . . . 0.0 110.427 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.35 107.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.761 -0.587 . . . . 0.0 109.521 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.48 103.29 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.0 m -101.47 91.5 4.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.313 0.645 . . . . 0.0 109.993 -161.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.55 109.89 18.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.339 1.056 . . . . 0.0 112.892 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.15 119.12 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -124.48 113.25 17.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 50.36 55.33 9.64 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.03 -21.12 1.38 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.36 102.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.739 1.769 . . . . 0.0 108.946 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.84 141.36 28.71 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.71 0.804 . . . . 0.0 112.883 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.98 116.0 12.39 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.493 0.717 . . . . 0.0 111.403 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.35 101.94 13.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 0.0 108.632 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -82.91 101.86 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.7 mt -95.08 106.81 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.41 130.37 43.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.093 0.557 . . . . 0.0 110.945 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -85.47 148.16 26.11 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.459 0.647 . . . . 0.0 111.424 169.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -80.53 90.01 5.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 122.137 0.97 . . . . 0.0 112.035 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -174.03 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 116.728 2.122 . . . . 0.0 116.728 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.58 94.78 5.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.48 1.133 . . . . 0.0 112.244 -163.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -167.21 173.11 9.3 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.745 1.26 . . . . 0.0 111.346 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 m -84.8 129.6 34.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.056 . . . . 0.0 110.613 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -136.24 99.99 4.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.912 -0.493 . . . . 0.0 111.366 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -87.84 136.38 32.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.092 -1.005 . . . . 0.0 112.653 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -65.83 119.89 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.69 -62.75 1.2 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.643 0.777 . . . . 0.0 111.219 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -133.69 103.03 5.7 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.163 0.585 . . . . 0.0 110.985 -160.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -96.56 100.12 11.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.36 -0.837 . . . . 0.0 112.334 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.35 122.46 24.49 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.053 0.541 . . . . 0.0 110.849 -174.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.253 23.8 t30 64.09 12.5 7.05 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -65.76 -43.17 89.68 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.57 -35.95 77.3 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.93 -41.73 50.89 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -45.93 -52.1 12.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 158.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mtt -68.6 -28.94 67.37 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -55.75 -47.07 77.59 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-N 120.871 1.669 . . . . 0.0 114.825 158.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -59.47 -41.4 89.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 167.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.4 mtp -60.91 -39.02 87.76 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 167.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.03 65.29 0.64 Allowed Glycine 0 N--CA 1.486 2.01 0 CA-C-N 118.926 0.784 . . . . 0.0 114.186 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.79 131.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.353 0.596 . . . . 0.0 110.611 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -74.64 153.78 38.8 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 14.1 tt -48.16 -39.4 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -172.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.45 -59.45 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 120.29 1.405 . . . . 0.0 113.024 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -68.0 -37.84 81.92 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.17 -40.99 82.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -60.5 -44.56 95.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 163.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.44 -40.6 75.05 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.17 77.18 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 171.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.96 68.06 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 166.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -94.0 58.31 2.55 Favored 'General case' 0 CA--C 1.575 1.912 0 C-N-CA 123.832 0.853 . . . . 0.0 111.947 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.42 -23.04 18.55 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 61.01 52.33 4.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.693 1.197 . . . . 0.0 114.222 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.0 tp -82.24 114.06 20.48 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.401 -0.812 . . . . 0.0 112.639 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -100.16 105.05 16.61 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.05 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.34 102.32 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.2 m -92.45 105.42 17.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.405 HG12 HG12 ' A' ' 49' ' ' VAL . 60.1 mt -96.57 124.56 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -147.9 107.67 3.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.699 -0.625 . . . . 0.0 111.323 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.01 147.43 26.21 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 171.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.38 -48.53 12.79 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 164.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.84 -68.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.172 -0.955 . . . . 0.0 113.386 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -123.33 48.84 1.77 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.767 -0.843 . . . . 0.0 112.449 164.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -154.14 109.96 3.22 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.033 -1.042 . . . . 0.0 108.318 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -86.08 118.48 25.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.902 0.481 . . . . 0.0 111.752 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.5 m -84.67 102.99 13.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 165.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG12 HG12 ' A' ' 40' ' ' ILE . 31.8 m -100.25 108.63 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.35 99.5 12.3 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.69 74.53 3.69 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.885 -161.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 t -87.99 109.7 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.737 -1.227 . . . . 0.0 113.227 -166.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -139.71 163.55 32.31 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.936 1.294 . . . . 0.0 109.405 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 m -75.57 51.95 0.62 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 119.687 -1.883 . . . . 0.0 112.336 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -174.73 -53.84 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.809 0 C-N-CA 125.06 1.344 . . . . 0.0 111.78 -164.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -93.63 -91.58 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.189 1.359 . . . . 0.0 110.023 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.303 2.1 t30 51.71 57.74 6.22 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.0 pt -119.53 -35.61 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.273 35.0 mt-10 76.98 99.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.086 1.312 . . . . 0.0 112.135 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.66 113.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.15 97.35 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -106.93 136.43 46.78 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -86.4 149.71 24.82 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.201 1.001 . . . . 0.0 112.427 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -80.47 75.23 7.33 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 110.347 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.14 -60.23 0.26 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 -161.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.18 140.59 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 118.402 1.101 . . . . 0.0 112.287 -172.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 p -86.95 118.6 26.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.986 -1.071 . . . . 0.0 110.459 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -140.21 162.23 35.76 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.837 0.827 . . . . 0.0 112.643 -166.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.23 103.55 10.18 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 111.692 167.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -81.77 -48.16 11.97 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 168.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.255 15.4 m-20 69.19 168.05 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.872 1.269 . . . . 0.0 114.168 172.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.571 1.763 0 O-C-N 120.914 -1.117 . . . . 0.0 109.003 167.784 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -84.65 151.96 24.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -141.39 109.81 5.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.873 -0.517 . . . . 0.0 110.134 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -97.35 122.43 40.38 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.238 1.015 . . . . 0.0 110.817 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.61 -160.07 33.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.6 m -140.69 142.26 34.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.391 -0.476 . . . . 0.0 110.007 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -89.31 109.6 20.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 163.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -96.76 135.24 38.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.293 0.637 . . . . 0.0 111.17 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.45 105.35 17.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.858 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -78.71 -41.59 30.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.15 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -85.1 5.24 30.52 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 159.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -121.47 123.57 42.36 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.964 1.256 . . . . 0.0 109.508 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.58 100.9 12.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 159.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 tp -89.03 107.27 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-O 122.005 0.907 . . . . 0.0 109.289 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.53 100.89 1.87 Allowed Glycine 0 N--CA 1.475 1.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.334 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.08 96.06 10.57 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -113.63 154.47 27.16 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.991 . . . . 0.0 111.702 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -146.1 147.35 31.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.71 -1.244 . . . . 0.0 111.767 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -72.44 149.43 44.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p -72.92 -46.62 51.6 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.007 -1.058 . . . . 0.0 112.969 152.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -50.01 5.59 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -174.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.52 20.89 5.15 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.63 -16.18 3.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 120.434 2.934 . . . . 0.0 120.434 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -83.29 146.28 28.62 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 118.717 1.259 . . . . 0.0 113.982 -157.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -69.69 130.85 43.48 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.34 111.62 23.29 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.77 162.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -91.23 112.58 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 109.936 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -114.75 136.24 53.29 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.413 0.685 . . . . 0.0 111.135 -170.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.66 114.11 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.868 -1.145 . . . . 0.0 108.838 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -96.53 112.85 24.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.913 -1.117 . . . . 0.0 109.725 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.83 140.52 32.97 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-O 121.221 0.534 . . . . 0.0 112.322 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.9 120.16 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.45 -1.406 . . . . 0.0 109.594 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -97.88 75.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 123.93 0.892 . . . . 0.0 110.737 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.65 -89.51 1.24 Allowed Glycine 0 N--CA 1.492 2.41 0 O-C-N 120.523 -1.361 . . . . 0.0 114.453 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -126.1 36.2 4.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 170.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -136.09 121.33 19.09 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.299 1.039 . . . . 0.0 108.227 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -78.63 108.63 12.18 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.216 0.607 . . . . 0.0 109.423 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.4 m -90.69 114.07 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -95.38 99.31 11.24 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.2 m -92.17 96.75 10.49 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 -167.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -100.66 115.58 30.55 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.863 0.865 . . . . 0.0 110.834 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -113.99 115.78 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -118.46 117.93 30.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.725 -0.609 . . . . 0.0 109.445 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.1 OUTLIER 41.62 66.06 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.4 -35.25 2.43 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.1 118.49 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.294 1.547 . . . . 0.0 109.609 -164.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.71 146.04 24.32 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.223 1.011 . . . . 0.0 112.663 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.26 146.23 44.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.735 0.779 . . . . 0.0 111.663 156.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -118.86 101.99 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -82.71 102.81 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.7 mt -100.17 115.96 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -108.27 120.47 42.47 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.335 0.654 . . . . 0.0 110.044 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -81.48 156.5 25.29 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.954 0.883 . . . . 0.0 112.774 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -65.17 122.61 17.48 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 112.869 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.265 10.7 t70 . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 125.403 1.481 . . . . 0.0 110.529 -167.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.72 83.91 7.74 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -163.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 t -148.91 -173.11 4.27 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 122.794 1.283 . . . . 0.0 111.119 168.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -91.3 123.78 35.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.018 -1.051 . . . . 0.0 109.614 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -132.95 115.83 15.69 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.011 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -112.56 146.17 39.01 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 120.256 1.389 . . . . 0.0 112.993 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.99 115.12 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.17 -64.42 1.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.771 0.829 . . . . 0.0 111.454 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -138.61 118.9 13.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.255 0.622 . . . . 0.0 111.177 -169.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.6 p -102.59 121.06 41.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.373 0.669 . . . . 0.0 111.412 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -103.89 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.495 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -77.27 38.09 0.22 Allowed 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 121.26 1.846 . . . . 0.0 115.816 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.0 -42.66 37.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -64.31 -27.9 69.35 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -78.99 -42.65 26.14 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -45.81 -51.21 13.22 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 161.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.2 mtp -66.88 -30.44 70.61 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.92 -49.57 76.31 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 165.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -57.03 -33.69 67.45 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 166.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.9 mtp -64.71 -50.66 66.08 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 165.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.97 67.72 0.27 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 119.029 0.831 . . . . 0.0 114.407 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.45 149.82 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.867 0.841 . . . . 0.0 110.789 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -79.73 159.95 26.43 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 10.8 tp -49.44 -47.35 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.73 -46.67 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -76.45 -37.78 56.42 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -49.57 -46.13 48.59 Favored 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 121.287 1.858 . . . . 0.0 115.355 161.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.27 -57.17 10.2 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -56.75 -35.05 68.17 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.78 97.8 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.74 93.34 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 164.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -93.17 42.02 1.09 Allowed 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -77.89 -23.88 48.6 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 60.71 47.06 8.46 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.79 108.07 4.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 111.826 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -99.5 108.2 20.58 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.347 0.659 . . . . 0.0 109.343 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.25 100.83 12.04 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.703 0.801 . . . . 0.0 109.07 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.0 m -93.98 98.04 10.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.9 mt -97.79 122.72 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -165.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -117.89 106.84 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.86 88.44 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.952 0.882 . . . . 0.0 111.264 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -80.12 46.21 0.79 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.6 83.3 0.49 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.732 -1.23 . . . . 0.0 114.719 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.317 24.7 m120 72.08 -40.4 0.47 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 -174.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -74.41 145.72 43.49 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.498 1.142 . . . . 0.0 113.081 164.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.03 109.95 13.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 0.0 108.595 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.8 m -89.51 99.97 12.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.32 104.12 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -85.6 104.37 15.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.613 -0.679 . . . . 0.0 109.779 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -93.7 99.24 11.69 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.943 0.897 . . . . 0.0 109.383 -173.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 t -104.7 114.03 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.1 0.56 . . . . 0.0 111.505 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -143.78 175.71 9.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -59.62 -33.12 71.09 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 163.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -85.56 -46.58 10.69 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -143.74 142.69 31.05 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.786 0.834 . . . . 0.0 111.875 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -126.48 92.4 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.73 144.46 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -164.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 112.25 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.913 -1.117 . . . . 0.0 112.065 171.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -99.15 105.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.22 115.21 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -135.78 146.9 48.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.702 -0.624 . . . . 0.0 112.504 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -99.51 151.95 20.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.136 0.969 . . . . 0.0 111.591 164.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.22 122.99 16.45 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.99 85.22 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.27 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.581 2.191 . . . . 0.0 110.637 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.7 p -75.04 106.81 6.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.584 -0.698 . . . . 0.0 111.122 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -140.17 161.61 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.643 0.735 . . . . 0.0 112.487 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.93 104.13 12.07 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 111.775 170.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -86.77 -177.36 6.09 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 122.06 0.933 . . . . 0.0 111.775 164.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.29 152.16 51.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 CA--C 1.571 1.788 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 146.61 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 93.41 4.33 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 125.947 1.699 . . . . 0.0 113.161 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt -100.4 99.53 10.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 112.328 -171.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -85.54 117.8 24.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.878 -1.139 . . . . 0.0 113.283 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.56 -171.25 44.35 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 116.969 1.548 . . . . 0.0 116.969 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -115.28 117.81 31.52 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 118.595 -0.716 . . . . 0.0 111.652 -170.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -74.53 107.14 6.47 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.155 0.889 . . . . 0.0 110.784 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -119.58 135.82 54.63 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.591 0.756 . . . . 0.0 111.324 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.59 107.46 18.16 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.801 -1.187 . . . . 0.0 111.691 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.44 80.42 2.23 Favored 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.602 1.161 . . . . 0.0 109.915 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.85 0.83 Allowed Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.511 -0.743 . . . . 0.0 113.772 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -88.05 -35.77 17.35 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -75.73 121.82 23.09 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.197 0.908 . . . . 0.0 112.409 -164.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mt -80.6 96.85 6.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.0 109.169 166.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.59 116.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.102 0.961 . . . . 0.0 109.491 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.0 100.48 1.58 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.667 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.4 86.71 7.24 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -109.47 112.96 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.237 0.615 . . . . 0.0 111.942 -164.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -89.37 130.97 35.66 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.195 -0.941 . . . . 0.0 111.293 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.89 114.3 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.975 . . . . 0.0 110.477 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.8 m -59.56 -49.97 75.71 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -162.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.295 3.4 t70 -72.76 -17.29 61.61 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.61 -58.79 3.02 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.691 1.587 . . . . 0.0 114.545 162.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.52 44.13 9.72 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 -146.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -142.94 139.48 30.72 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.175 1.487 . . . . 0.0 111.357 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.14 138.96 31.1 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.665 2.469 . . . . 0.0 117.665 -163.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.36 111.86 16.28 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.591 1.556 . . . . 0.0 108.253 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -100.35 115.97 31.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 110.987 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.4 p -109.83 115.19 29.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.594 0.758 . . . . 0.0 111.003 -169.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.73 116.9 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 119.467 1.03 . . . . 0.0 109.266 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -94.35 124.86 38.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.195 0.598 . . . . 0.0 110.908 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.48 42.08 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.508 0.671 . . . . 0.0 111.0 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.4 mm -95.92 109.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.691 -1.256 . . . . 0.0 108.571 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.258 10.3 tp -79.71 63.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 122.439 1.114 . . . . 0.0 112.904 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.04 -77.88 1.12 Allowed Glycine 0 N--CA 1.49 2.238 0 O-C-N 120.556 -1.34 . . . . 0.0 115.07 -170.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -97.14 -45.19 6.63 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -96.95 148.63 22.77 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 112.956 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.6 tp -85.56 114.71 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.901 -1.124 . . . . 0.0 110.411 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.3 m -87.8 123.93 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.784 . . . . 0.0 109.776 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -104.94 98.69 8.37 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 164.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.2 m -95.05 106.76 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -109.07 115.61 30.38 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.596 0.758 . . . . 0.0 110.273 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.18 110.06 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -98.5 105.98 18.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.942 1.246 . . . . 0.0 109.682 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 46.89 50.2 13.84 Favored 'General case' 0 CA--C 1.58 2.101 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.96 -40.49 2.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.16 116.34 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.48 2.14 . . . . 0.0 112.373 -170.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -92.32 138.68 31.31 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 121.729 0.776 . . . . 0.0 112.921 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.37 142.31 47.15 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.678 0.791 . . . . 0.0 111.609 164.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -123.43 101.94 7.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -83.06 117.65 22.99 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 166.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -104.82 123.09 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -108.8 127.64 54.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.965 0.906 . . . . 0.0 111.151 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -85.26 148.74 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.997 0.903 . . . . 0.0 112.899 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.89 123.95 31.81 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.196 0.598 . . . . 0.0 112.338 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 125.088 1.355 . . . . 0.0 112.592 174.121 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.353 82.2 m-85 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.72 72.96 5.27 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 119.949 1.249 . . . . 0.0 113.269 -171.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.9 p -156.43 -178.01 7.02 Favored 'General case' 0 CA--C 1.573 1.856 0 C-N-CA 124.42 1.088 . . . . 0.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.26 128.75 34.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.94 -1.1 . . . . 0.0 110.915 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -129.39 114.55 16.31 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -101.86 141.37 34.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.286 -0.884 . . . . 0.0 112.394 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.69 93.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.873 -1.142 . . . . 0.0 113.916 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.88 -45.74 9.48 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -143.64 152.72 41.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 111.354 -167.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.5 m -159.65 150.77 19.62 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.362 -2.086 . . . . 0.0 112.994 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -123.76 0.06 Allowed 'General case' 0 CA--C 1.578 2.045 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.22 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.295 0.1 OUTLIER -77.22 49.8 0.72 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 122.448 2.385 . . . . 0.0 116.776 -174.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -47.72 83.58 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.449 1.5 . . . . 0.0 114.745 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.92 -36.84 84.49 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.72 -44.18 74.4 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 120.177 1.353 . . . . 0.0 114.496 170.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -46.8 -56.73 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.9 mtt -67.21 -28.63 68.24 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -59.09 -48.27 82.2 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.82 1.645 . . . . 0.0 115.145 161.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -62.53 -36.2 81.85 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 mtp -59.09 -59.38 5.57 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.29 69.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.5 0.591 . . . . 0.0 114.456 171.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG13 ' HG2' ' A' ' 28' ' ' ARG . 3.3 p -148.43 136.56 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.932 0 CA-C-O 121.92 0.867 . . . . 0.0 110.17 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -82.42 164.65 20.86 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 33.1 pt -55.59 -40.17 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -169.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -48.9 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -70.67 -36.03 73.13 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HG2' HG13 ' A' ' 23' ' ' VAL . 43.5 mtm-85 -65.45 -42.3 92.48 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 167.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -55.53 -39.74 70.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.01 -60.93 2.78 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.508 160.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.75 74.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -173.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.37 71.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 161.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -124.52 41.9 3.39 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 123.741 0.816 . . . . 0.0 112.903 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.12 11.31 4.26 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 20.0 m-80 56.1 49.63 15.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -168.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.93 113.97 14.03 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.252 1.025 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -112.82 118.61 35.42 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.683 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -101.6 97.45 7.88 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.9 m -95.01 115.02 26.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 49' ' ' VAL . 63.2 mt -110.36 127.09 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -164.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -140.07 116.52 10.7 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.585 -0.697 . . . . 0.0 111.139 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -71.54 114.55 9.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -90.75 86.47 6.35 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.447 0.642 . . . . 0.0 109.292 165.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.79 23.23 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 117.431 1.732 . . . . 0.0 117.431 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.346 33.1 m120 65.59 -0.5 1.22 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -164.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -95.7 107.56 19.78 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 120.484 1.493 . . . . 0.0 109.384 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.38 105.69 8.66 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.047 0.939 . . . . 0.0 111.515 -169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.0 m -79.86 95.51 6.08 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.415 HG12 HG12 ' A' ' 40' ' ' ILE . 35.8 m -95.14 112.38 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.62 74.58 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.731 -169.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -84.68 101.42 12.16 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.56 0.695 . . . . 0.0 109.665 -158.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.6 m -114.91 101.96 9.53 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.872 -156.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -137.13 176.06 9.05 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.6 t -66.98 -9.68 41.28 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 168.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.26 -55.71 4.18 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.589 1.541 . . . . 0.0 113.156 166.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -155.42 140.65 17.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 118.703 0.683 . . . . 0.0 110.662 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -108.51 93.28 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -116.83 115.6 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.249 0.547 . . . . 0.0 110.501 -163.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.69 90.2 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.13 116.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -166.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.03 92.83 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -104.58 134.07 48.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.02 153.0 41.07 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 112.435 166.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.7 mt -73.71 73.94 1.53 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 120.966 -1.084 . . . . 0.0 111.845 164.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.39 -63.18 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -167.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.36 146.06 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 p -83.1 106.2 14.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.4 -0.813 . . . . 0.0 110.925 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -129.87 154.98 46.75 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.466 0.706 . . . . 0.0 112.612 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -82.01 119.92 24.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 111.579 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -94.11 -40.62 9.95 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.266 5.6 m120 76.8 99.07 0.07 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 168.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.149 -0.969 . . . . 0.0 112.346 175.398 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.501 2.075 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.303 22.8 pt-20 -86.7 95.95 9.97 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-O 123.104 1.43 . . . . 0.0 112.371 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.92 111.94 8.5 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.73 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -94.37 122.18 36.66 Favored 'General case' 0 CA--C 1.559 1.32 0 O-C-N 121.951 -0.468 . . . . 0.0 111.625 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.83 -152.38 21.6 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 115.573 0.989 . . . . 0.0 115.573 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.3 p -130.52 115.57 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.741 -155.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -80.42 142.42 34.35 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.509 0.671 . . . . 0.0 110.456 157.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.7 m -153.05 146.31 24.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.58 -1.325 . . . . 0.0 110.826 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.7 tp -88.24 102.61 14.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.89 -1.131 . . . . 0.0 111.36 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.0 93.77 7.59 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.324 0.65 . . . . 0.0 109.455 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -100.99 0.76 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 121.368 -0.833 . . . . 0.0 113.668 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -89.95 -33.07 16.54 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 161.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -80.76 133.19 35.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.845 1.657 . . . . 0.0 112.554 -161.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.14 101.07 7.71 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.721 -1.237 . . . . 0.0 109.562 163.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.84 111.81 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.737 0.815 . . . . 0.0 109.866 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.89 98.18 2.12 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 123.924 0.773 . . . . 0.0 113.06 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.48 103.58 16.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -121.52 150.5 41.52 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.235 1.017 . . . . 0.0 112.409 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -118.37 140.27 50.1 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.642 0.777 . . . . 0.0 109.487 169.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -66.11 125.2 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.722 -1.236 . . . . 0.0 112.049 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 m -70.89 -43.31 68.6 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.46 -0.775 . . . . 0.0 113.022 171.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -51.05 -56.92 10.2 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 165.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.75 -40.23 9.46 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.62 -9.78 60.65 Favored Glycine 0 CA--C 1.556 2.595 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.79 150.07 28.07 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 119.689 1.744 . . . . 0.0 112.841 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -85.46 143.7 28.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -173.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -131.92 134.87 46.15 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.48 1.112 . . . . 0.0 110.179 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -119.5 109.16 15.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.68 120.33 41.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.627 -0.67 . . . . 0.0 112.119 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.43 110.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.266 -0.896 . . . . 0.0 109.002 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 mtm-85 -92.75 116.38 28.97 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 121.586 -0.696 . . . . 0.0 110.766 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -137.51 149.43 46.77 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.769 0.828 . . . . 0.0 111.601 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -99.76 115.14 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.79 -1.194 . . . . 0.0 108.391 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 pt -80.73 -27.96 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.31 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.11 34.88 2.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 159.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -145.15 128.87 17.21 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.114 0.966 . . . . 0.0 109.865 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.98 110.05 20.29 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.742 0.817 . . . . 0.0 109.641 170.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.17 114.08 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -109.45 91.64 3.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -93.98 98.38 10.99 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.403 0.681 . . . . 0.0 110.073 -166.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.12 98.78 11.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.732 0.813 . . . . 0.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.12 106.88 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -120.3 109.7 15.69 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 53.61 50.5 17.05 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.86 -27.8 4.25 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 -167.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.0 t -87.74 113.92 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.694 1.747 . . . . 0.0 109.524 -170.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -104.87 101.53 11.12 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.398 0.679 . . . . 0.0 111.978 -169.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.31 102.97 14.84 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 112.377 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -81.48 99.22 8.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.097 0.559 . . . . 0.0 110.226 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -99.71 109.87 22.31 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.93 120.1 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.673 -1.267 . . . . 0.0 108.768 -159.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.2 123.65 48.31 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.517 0.727 . . . . 0.0 110.014 -168.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.06 156.8 31.5 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.986 1.266 . . . . 0.0 113.526 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -64.49 99.98 0.34 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 123.845 0.858 . . . . 0.0 113.147 174.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 4.8 t0 . . . . . 0 C--O 1.256 1.399 0 C-N-CA 125.407 1.483 . . . . 0.0 114.355 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.322 86.3 m-85 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -71.24 92.49 1.02 Allowed 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.083 1.311 . . . . 0.0 113.522 -164.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -177.04 171.21 2.14 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 125.211 1.405 . . . . 0.0 110.877 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -90.02 126.83 35.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.941 -1.099 . . . . 0.0 110.7 171.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -128.62 109.32 11.25 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.123 0.569 . . . . 0.0 110.07 -173.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -104.18 143.72 32.55 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.233 0.924 . . . . 0.0 113.067 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.43 120.56 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.72 -66.08 0.94 Allowed 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 123.486 0.715 . . . . 0.0 110.683 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -137.14 117.98 14.14 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.936 0.494 . . . . 0.0 111.223 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.1 p -93.1 100.13 12.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.704 -0.622 . . . . 0.0 110.176 166.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.74 -80.4 0.07 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -155.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -88.29 44.36 1.19 Allowed 'General case' 0 CA--C 1.579 2.081 0 CA-C-N 120.32 1.418 . . . . 0.0 113.451 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -80.33 -45.29 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.387 -1.446 . . . . 0.0 114.827 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.71 -21.16 65.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.36 -40.95 17.24 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 120.331 1.423 . . . . 0.0 114.799 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -47.43 -49.98 23.89 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.971 1.714 . . . . 0.0 115.534 158.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.61 ' SD ' HG21 ' A' ' 23' ' ' VAL . 20.9 mmt -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 165.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -54.17 -44.43 71.48 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -58.16 -40.63 81.89 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 165.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -40.17 95.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 169.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.35 65.37 0.63 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 119.055 0.843 . . . . 0.0 114.177 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' A' ' 18' ' ' MET . 15.4 m -128.13 148.38 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 122.274 1.035 . . . . 0.0 112.511 -167.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.91 159.2 33.14 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 14.2 tt -53.3 -38.67 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.93 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.264 0.938 . . . . 0.0 113.198 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -56.27 -43.81 79.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -60.33 -38.63 84.35 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -67.95 -54.93 14.87 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 166.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.38 -36.04 77.13 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.73 74.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.68 81.36 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 163.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -97.92 49.47 1.02 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 119.288 0.949 . . . . 0.0 113.532 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -83.31 -12.25 56.84 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.34 36.06 25.27 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.91 122.94 20.88 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 122.288 1.042 . . . . 0.0 112.674 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -118.42 111.79 19.13 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.032 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.61 98.98 10.07 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 m -92.04 100.24 12.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.835 . . . . 0.0 109.007 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.56 122.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.1 p -130.48 109.73 10.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -94.69 102.68 14.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.825 -1.172 . . . . 0.0 110.918 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.1 pm0 -75.09 -34.87 61.8 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.54 81.42 0.05 OUTLIER Glycine 0 N--CA 1.486 2.003 0 CA-C-N 119.18 0.9 . . . . 0.0 111.83 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER 74.32 -56.41 0.64 Allowed 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -160.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -60.53 139.54 57.72 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.62 114.47 28.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.823 0.449 . . . . 0.0 109.855 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.0 m -88.55 96.75 10.75 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.494 HG11 HH22 ' A' ' 106' ' ' ARG . 25.7 t -101.03 112.04 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.35 102.31 11.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.47 -0.769 . . . . 0.0 109.069 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -97.05 101.18 12.7 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -174.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.1 t -116.11 115.51 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.072 0.549 . . . . 0.0 112.412 -165.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -150.04 179.03 8.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -166.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -62.45 -43.69 98.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 164.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.1 -42.1 69.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 172.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -149.16 130.02 14.25 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.415 1.007 . . . . 0.0 111.209 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -119.99 86.99 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.22 144.74 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.676 -0.64 . . . . 0.0 111.657 -158.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.68 116.03 28.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.706 -1.246 . . . . 0.0 111.902 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.34 99.59 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.67 95.73 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.88 130.18 53.07 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.268 0.556 . . . . 0.0 112.477 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -92.22 145.51 24.44 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-O 122.353 1.073 . . . . 0.0 111.062 166.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.23 128.05 32.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.163 -0.961 . . . . 0.0 112.234 -168.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 -8.66 59.25 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 119.161 2.424 . . . . 0.0 119.161 -167.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.21 137.14 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 119.904 1.852 . . . . 0.0 110.813 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 95.62 5.68 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 121.711 0.767 . . . . 0.0 111.77 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -120.9 165.18 15.56 Favored 'General case' 0 CA--C 1.573 1.852 0 C-N-CA 124.401 1.08 . . . . 0.0 111.851 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -82.06 125.68 31.11 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.863 -1.148 . . . . 0.0 113.011 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -139.69 72.12 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.819 -0.55 . . . . 0.0 110.763 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -77.75 146.45 35.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.938 . . . . 0.0 113.086 -172.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 CA--C 1.574 1.871 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 178.69 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.503 2.193 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -94.14 120.21 34.07 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 125.19 1.396 . . . . 0.0 109.744 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.1 mt -127.88 131.14 49.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 112.164 -164.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -120.17 134.24 55.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.577 -0.702 . . . . 0.0 110.711 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.73 -178.62 43.81 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 118.944 2.337 . . . . 0.0 118.944 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.1 p -118.3 120.09 36.6 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.408 -1.396 . . . . 0.0 110.992 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.25 111.45 20.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -87.51 -38.37 16.1 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.267 39.3 tp 62.01 86.74 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.957 1.303 . . . . 0.0 113.586 -167.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -86.45 83.57 7.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.18 0.99 . . . . 0.0 109.956 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.98 -96.14 0.59 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -98.26 -9.43 25.55 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -108.7 122.31 46.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.13 1.786 . . . . 0.0 110.383 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -73.44 102.02 3.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.809 -1.182 . . . . 0.0 109.84 168.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -97.27 123.3 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-O 121.523 0.677 . . . . 0.0 109.761 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.98 102.22 0.67 Allowed Glycine 0 N--CA 1.481 1.655 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.11 -170.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -84.29 98.92 10.26 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.301 0.551 . . . . 0.0 110.301 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -107.09 105.91 16.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.157 0.98 . . . . 0.0 110.019 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -90.01 133.1 35.01 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 121.639 -0.663 . . . . 0.0 110.938 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -62.38 122.7 16.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.3 p -71.19 -26.6 63.03 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -64.98 -57.47 8.63 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 164.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -111.35 -46.77 3.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 38.71 6.14 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 118.562 2.185 . . . . 0.0 118.562 -165.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.82 -8.04 59.31 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.301 4.9 tt0 72.18 99.49 0.07 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 175.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 tt -99.86 114.88 28.38 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.871 0.868 . . . . 0.0 110.229 172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -99.71 113.33 25.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.0 m -103.42 122.4 44.79 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 122.832 0.453 . . . . 0.0 110.759 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.57 111.06 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.494 HH22 HG11 ' A' ' 49' ' ' VAL . 27.7 mtp180 -105.29 113.05 26.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.375 0.67 . . . . 0.0 109.739 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.91 158.38 44.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.442 -0.786 . . . . 0.0 112.634 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.98 111.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.993 -1.067 . . . . 0.0 108.261 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 10.9 tp -85.5 68.26 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 CA-C-O 122.341 1.067 . . . . 0.0 111.744 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.77 -84.55 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 120.795 -1.191 . . . . 0.0 114.698 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.35 -17.39 18.05 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -118.46 131.34 56.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.336 1.425 . . . . 0.0 111.334 -168.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.8 tp -79.63 109.88 14.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 110.209 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.4 114.04 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.57 99.29 9.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.0 109.231 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -100.01 105.67 17.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -84.18 102.3 12.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.198 0.599 . . . . 0.0 110.561 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.83 112.12 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.403 ' OH ' ' OE2' ' A' ' 120' ' ' GLU . 16.6 t80 -128.89 107.03 9.31 Favored 'General case' 0 CA--C 1.564 1.497 0 O-C-N 121.779 -0.576 . . . . 0.0 110.818 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.403 ' OE2' ' OH ' ' A' ' 119' ' ' TYR 0.406 15.4 pt-20 39.56 64.57 0.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.56 -33.13 4.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -168.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.61 117.81 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 119.341 1.57 . . . . 0.0 109.758 -162.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.21 144.95 25.97 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.84 144.29 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 161.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -122.98 104.01 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 109.226 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -80.7 105.44 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 162.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.91 123.26 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -109.44 125.37 52.35 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.441 0.696 . . . . 0.0 110.218 -171.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -81.39 165.54 21.22 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.573 0.701 . . . . 0.0 112.248 169.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -71.54 100.45 2.25 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 120.869 -1.144 . . . . 0.0 112.09 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 7.3 t0 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 125.2 1.4 . . . . 0.0 114.012 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -155.69 81.87 1.03 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.022 . . . . 0.0 109.884 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -167.74 171.19 10.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.126 -0.984 . . . . 0.0 112.052 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -71.84 117.29 13.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.92 . . . . 0.0 111.138 161.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -114.64 101.87 9.5 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.69 135.99 33.62 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.476 0.711 . . . . 0.0 112.685 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.22 117.58 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.57 -62.88 1.19 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.723 0.809 . . . . 0.0 111.302 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.73 129.59 47.36 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.02 0.914 . . . . 0.0 110.946 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m -113.27 115.32 28.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -87.71 -57.78 2.82 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.894 0.478 . . . . 0.0 112.27 -165.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -121.15 145.83 47.41 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -163.21 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.077 0.951 . . . . 0.0 111.305 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -35.48 80.65 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -67.29 -37.14 82.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 165.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.6 -52.09 63.27 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.6 mtp -58.54 -37.44 75.68 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.4 -43.9 75.68 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.55 -44.84 95.35 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 166.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.0 mtm -58.22 -44.1 88.04 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.508 2.04 . . . . 0.0 116.508 175.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.17 63.02 0.1 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.6 143.59 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-O 122.483 1.135 . . . . 0.0 111.139 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -82.05 163.11 22.3 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 120.853 -1.155 . . . . 0.0 113.742 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.8 tp -64.0 157.46 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 O-C-N 121.03 -1.044 . . . . 0.0 113.24 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.389 21.8 t 80.48 -61.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 124.346 1.058 . . . . 0.0 110.7 -162.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -56.2 -47.42 78.4 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 162.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -61.83 -16.6 51.45 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 164.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.67 -44.31 12.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.21 1.368 . . . . 0.0 113.462 164.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.96 -48.89 69.84 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 166.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.76 -18.66 62.11 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.09 -58.51 3.98 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.912 1.233 . . . . 0.0 113.019 158.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.1 49.39 1.79 Allowed 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -79.78 -30.43 40.64 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 63.91 55.41 1.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.713 1.142 . . . . 0.0 112.547 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.3 tp -79.81 113.25 17.82 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.957 0.884 . . . . 0.0 111.658 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -107.15 101.36 10.77 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.048 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.34 93.85 8.81 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.4 m -90.37 94.34 9.7 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.59 0.709 . . . . 0.0 110.336 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.486 HD11 HH21 ' A' ' 106' ' ' ARG . 24.5 mt -80.77 124.47 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.674 0.79 . . . . 0.0 109.389 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.5 p -133.12 104.54 6.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -92.24 115.87 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.65 -1.281 . . . . 0.0 112.274 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.92 -41.29 59.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.7 -84.09 0.05 OUTLIER Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.126 -0.984 . . . . 0.0 111.42 171.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -82.02 -49.73 9.91 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 157.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.87 119.71 11.17 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -85.58 115.95 23.58 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -95.86 99.44 11.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -96.53 103.89 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.32 100.38 8.36 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 123.297 0.639 . . . . 0.0 110.062 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -86.92 97.3 10.61 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.419 0.688 . . . . 0.0 109.433 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -107.03 113.11 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.075 0.55 . . . . 0.0 110.317 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 p -145.49 -170.45 3.45 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.21 1.005 . . . . 0.0 113.292 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -62.0 -47.31 85.38 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.901 -1.125 . . . . 0.0 113.441 165.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -63.17 -48.77 76.99 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -142.09 163.05 33.92 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -160.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -143.43 88.68 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.111 163.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 141.62 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.261 -0.9 . . . . 0.0 112.429 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -84.72 115.31 22.61 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 121.398 -0.814 . . . . 0.0 112.708 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.24 98.32 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -87.39 114.07 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -127.44 124.1 37.64 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.757 0.789 . . . . 0.0 112.824 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.29 148.44 29.42 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 121.683 0.754 . . . . 0.0 111.478 164.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.52 88.46 2.68 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.758 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.07 -47.38 0.69 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -160.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.9 t -75.7 136.88 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 118.716 1.258 . . . . 0.0 112.264 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.3 p -89.84 120.12 30.8 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.304 -0.872 . . . . 0.0 110.35 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.82 156.8 47.03 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 121.971 0.891 . . . . 0.0 112.737 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.26 97.78 10.97 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.519 0.676 . . . . 0.0 110.479 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -84.31 97.94 9.73 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.531 -0.731 . . . . 0.0 110.299 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.41 133.07 39.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.579 -0.7 . . . . 0.0 112.057 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -174.643 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.39 130.12 35.03 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.42 120.46 38.21 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.705 1.202 . . . . 0.0 108.876 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -113.4 108.79 17.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.389 -1.444 . . . . 0.0 111.1 -159.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.22 -149.19 18.97 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 -172.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.9 m -140.78 147.26 38.82 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.01 0.91 . . . . 0.0 112.314 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -92.45 117.61 30.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.014 163.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -111.74 144.34 41.18 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.375 0.67 . . . . 0.0 111.586 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.3 tp -87.77 103.36 15.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.732 -1.23 . . . . 0.0 110.861 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.92 84.86 4.99 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.966 0.888 . . . . 0.0 108.848 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.34 -97.05 0.44 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -95.28 -19.97 19.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -89.17 124.24 34.17 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.639 1.563 . . . . 0.0 111.19 -172.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -82.54 100.07 9.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.772 -1.205 . . . . 0.0 108.967 164.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -95.79 110.32 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-O 122.131 0.967 . . . . 0.0 109.893 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.7 93.15 1.85 Allowed Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.005 0.812 . . . . 0.0 112.363 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.41 94.65 9.44 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.41 131.18 56.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.277 0.631 . . . . 0.0 109.719 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -90.41 134.72 34.15 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.953 -1.092 . . . . 0.0 110.131 164.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.23 105.88 1.52 Allowed 'General case' 0 CA--C 1.566 1.573 0 O-C-N 120.824 -1.173 . . . . 0.0 110.653 169.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -42.93 -59.63 1.92 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -163.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.69 67.42 0.67 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 123.568 1.651 . . . . 0.0 107.497 -169.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.71 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.068 -162.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.27 45.37 5.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 116.182 1.233 . . . . 0.0 116.182 -171.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -139.81 126.3 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 117.843 0.821 . . . . 0.0 109.883 -166.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -76.74 127.12 32.16 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.91 109.58 21.51 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.557 0.743 . . . . 0.0 109.281 161.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -98.77 122.38 41.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.02 94.17 4.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.02 -0.425 . . . . 0.0 110.217 -159.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.94 105.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 119.764 -1.835 . . . . 0.0 108.99 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.486 HH21 HD11 ' A' ' 40' ' ' ILE . 9.6 ptm180 -102.89 113.34 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.834 0.743 . . . . 0.0 110.506 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -135.2 154.03 51.75 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 123.946 0.899 . . . . 0.0 111.06 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -86.57 108.71 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.692 -1.255 . . . . 0.0 109.627 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.7 tp -88.68 72.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.997 0.903 . . . . 0.0 111.117 172.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.59 0.5 Allowed Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.06 -1.025 . . . . 0.0 115.122 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -91.15 -14.07 31.81 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -134.3 145.57 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 119.443 1.019 . . . . 0.0 112.283 -161.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.2 tp -82.4 105.97 13.9 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.722 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.1 p -87.5 108.15 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -0.778 . . . . 0.0 110.209 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -98.96 106.25 18.48 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.114 0.566 . . . . 0.0 110.278 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.7 m -98.1 110.73 23.26 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.83 0.852 . . . . 0.0 109.78 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -98.9 105.99 18.2 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.542 1.137 . . . . 0.0 108.373 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.92 110.12 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -139.23 127.08 22.11 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.543 0.737 . . . . 0.0 110.86 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 50.66 45.17 27.23 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.63 -15.5 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 119.688 2.635 . . . . 0.0 119.688 -166.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.87 119.46 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 CA-C-N 119.618 1.709 . . . . 0.0 108.958 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.96 120.89 33.04 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.32 0.648 . . . . 0.0 110.565 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.92 136.31 54.81 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.53 0.732 . . . . 0.0 112.306 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -126.53 117.99 23.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 109.912 -172.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -109.96 116.75 32.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.06 120.03 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -108.95 126.21 52.85 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.842 0.857 . . . . 0.0 110.172 -171.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -91.85 153.92 19.23 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.174 0.988 . . . . 0.0 113.125 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -63.34 112.93 2.93 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.289 5.3 m-20 . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 126.221 1.809 . . . . 0.0 108.436 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.317 73.9 m-85 . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.11 94.63 2.44 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 -170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 m -173.73 177.53 2.45 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.581 1.552 . . . . 0.0 110.532 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.6 m -92.96 129.07 39.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.915 -1.741 . . . . 0.0 111.05 168.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -124.18 104.76 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.236 0.614 . . . . 0.0 109.871 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -89.82 133.37 34.76 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.511 0.724 . . . . 0.0 111.238 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 36' ' ' LEU . 2.3 p -68.34 111.91 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.382 -0.823 . . . . 0.0 112.444 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.64 -62.79 1.51 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.276 0.631 . . . . 0.0 111.747 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -143.52 116.29 8.74 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.75 0.786 . . . . 0.0 109.788 -168.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.3 m -99.57 127.65 45.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.271 0.628 . . . . 0.0 110.729 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.317 5.7 tm-20 -74.82 -93.59 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -167.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -96.82 39.25 1.18 Allowed 'General case' 0 CA--C 1.577 1.982 0 O-C-N 120.477 -1.389 . . . . 0.0 113.72 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.27 -36.99 58.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.91 -35.64 78.99 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 166.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -71.28 -40.07 71.15 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 167.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -47.44 -50.45 22.87 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 157.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 mmt -59.3 -42.39 91.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.09 -44.67 91.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 166.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -55.91 -43.89 77.73 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.9 mmt -58.51 -37.65 76.06 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 167.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.3 46.01 2.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.73 142.76 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 C-N-CA 123.841 0.856 . . . . 0.0 110.518 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -69.76 165.56 21.15 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.299 12.5 tt -73.63 53.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.78 -67.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -67.67 -25.95 65.96 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -42.9 -42.47 3.7 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 153.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.42 -52.01 5.61 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.291 -0.862 . . . . 0.0 112.364 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -57.86 -40.11 79.36 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.53 -35.03 60.81 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.88 88.36 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 163.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -103.43 47.67 0.87 Allowed 'General case' 0 CA--C 1.577 1.994 0 C-N-CA 123.867 0.867 . . . . 0.0 112.895 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -83.78 -11.56 56.91 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 59.27 46.21 13.09 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.311 -1.493 . . . . 0.0 114.185 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.452 ' H ' HG12 ' A' ' 8' ' ' VAL . 2.8 tt -85.32 108.65 17.9 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 121.379 -0.825 . . . . 0.0 111.914 -166.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -94.82 111.19 22.99 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.448 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.82 101.67 13.77 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.369 0.668 . . . . 0.0 110.256 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -81.48 101.15 9.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.168 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.7 mt -90.38 119.58 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 p -128.79 108.68 10.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -88.44 84.58 6.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 111.527 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.41 76.25 5.92 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 121.92 0.866 . . . . 0.0 111.563 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.95 77.23 0.7 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 115.812 1.085 . . . . 0.0 115.812 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.292 18.1 t-20 70.9 -57.87 0.58 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.25 119.01 9.45 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -86.42 106.37 17.4 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.502 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.4 m -87.64 97.35 10.82 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -104.23 107.79 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -94.63 106.02 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -78.78 111.86 15.34 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.237 0.615 . . . . 0.0 110.801 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 t -113.02 106.07 14.24 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.047 0.539 . . . . 0.0 109.558 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -142.86 178.43 7.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -58.83 -39.63 81.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -60.65 -52.12 66.5 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 165.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -158.3 151.45 22.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -159.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -122.91 90.92 3.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.789 0.836 . . . . 0.0 109.675 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.29 148.8 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.233 -0.917 . . . . 0.0 112.785 -167.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.86 116.88 33.77 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.109 0.964 . . . . 0.0 112.609 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.01 104.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.45 114.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -123.12 124.57 43.36 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.86 145.87 29.21 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.818 0.818 . . . . 0.0 111.263 166.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.73 117.5 11.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.33 0.11 85.05 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 119.537 2.575 . . . . 0.0 119.537 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.7 t -95.95 137.1 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 120.526 2.163 . . . . 0.0 110.374 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.0 p -75.28 121.83 22.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.728 . . . . 0.0 112.651 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -137.97 158.6 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.644 -0.66 . . . . 0.0 112.455 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.51 107.28 18.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.71 -0.619 . . . . 0.0 110.304 173.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -95.46 110.13 22.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -75.18 126.8 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.631 -0.668 . . . . 0.0 110.62 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.498 1.941 0 O-C-N 120.757 -1.214 . . . . 0.0 113.88 172.189 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.24 101.35 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.3 115.49 24.74 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -98.08 109.6 22.33 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.621 0.769 . . . . 0.0 110.409 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.59 -176.52 46.54 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -120.94 119.56 32.95 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.093 -1.553 . . . . 0.0 110.565 -166.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -79.47 112.19 16.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.905 0.775 . . . . 0.0 110.202 159.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.2 m -106.62 138.09 43.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.278 0.631 . . . . 0.0 110.983 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 tp -88.43 108.44 19.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.782 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -67.72 -42.56 81.74 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 171.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.28 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -79.77 -22.07 43.62 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 157.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -105.97 134.42 49.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.284 1.402 . . . . 0.0 111.341 -167.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.5 mt -94.35 111.35 23.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 108.78 167.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -105.36 120.11 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.784 1.234 . . . . 0.0 109.184 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.02 111.83 2.48 Favored Glycine 0 N--CA 1.483 1.805 0 O-C-N 121.839 -0.538 . . . . 0.0 113.94 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -97.59 107.97 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.136 0.575 . . . . 0.0 109.556 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -127.14 107.25 9.86 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.399 0.618 . . . . 0.0 112.618 -164.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.72 124.71 31.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -61.24 150.53 34.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.829 -1.17 . . . . 0.0 113.875 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.6 m -80.67 68.23 6.82 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-O 123.508 1.623 . . . . 0.0 111.011 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -152.23 -85.04 0.07 Allowed 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -115.72 -22.87 8.94 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 50.81 2.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 -167.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -82.03 -30.78 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.383 10.7 tt0 74.99 97.83 0.07 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 126.001 1.72 . . . . 0.0 114.707 -168.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 tt -89.58 116.32 27.64 Favored 'General case' 0 CA--C 1.563 1.442 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.526 165.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -92.07 117.02 29.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.762 . . . . 0.0 110.764 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -114.02 112.97 24.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.825 0.85 . . . . 0.0 109.157 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.8 t -105.85 113.52 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -110.32 117.93 34.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.219 0.918 . . . . 0.0 109.566 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.16 144.53 38.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.998 0.904 . . . . 0.0 112.045 -169.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -91.31 108.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.68 -47.57 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.763 -0.585 . . . . 0.0 111.542 168.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.84 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.485 1.917 0 CA-C-N 119.185 0.902 . . . . 0.0 111.247 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.35 -30.02 47.82 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.08 144.2 34.1 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 122.425 1.107 . . . . 0.0 112.516 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 tp -95.13 115.2 27.12 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.756 0.822 . . . . 0.0 109.186 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.4 121.43 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.805 -0.559 . . . . 0.0 109.83 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.37 99.14 7.99 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.689 0.796 . . . . 0.0 109.85 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -98.17 111.01 23.49 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.725 0.81 . . . . 0.0 110.915 -169.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -100.91 112.08 24.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.928 0.891 . . . . 0.0 110.723 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.27 113.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -123.96 110.0 14.25 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 122.997 0.519 . . . . 0.0 112.209 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.275 43.6 mt-10 47.22 34.5 3.1 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 119.53 -44.26 1.43 Allowed Glycine 0 CA--C 1.553 2.418 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -162.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.74 121.76 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 119.304 1.552 . . . . 0.0 113.33 -163.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.02 133.74 34.65 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.841 -0.537 . . . . 0.0 111.689 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.69 117.33 9.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.436 0.694 . . . . 0.0 111.571 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.297 1.1 pptp? -114.64 126.22 54.64 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -105.23 115.33 30.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 110.365 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mt -98.78 120.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.89 130.28 55.63 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.342 0.657 . . . . 0.0 110.896 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.61 149.07 21.83 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.97 0.89 . . . . 0.0 112.053 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -84.89 113.03 21.08 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 112.689 -174.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.65 0 C-N-CA 124.802 1.241 . . . . 0.0 113.896 172.222 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.575 1.92 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -141.74 91.11 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.367 -1.458 . . . . 0.0 107.746 166.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -174.87 167.5 3.63 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.54 1.162 . . . . 0.0 111.899 -171.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -101.3 141.78 33.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 111.662 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -141.84 121.81 13.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.477 -165.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -112.11 142.47 44.52 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 120.502 1.501 . . . . 0.0 112.52 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.279 7.7 p -80.5 91.09 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 122.769 1.271 . . . . 0.0 114.059 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.55 -36.26 29.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -122.52 145.7 48.08 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.082 -1.011 . . . . 0.0 112.189 -172.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 p -152.46 159.5 43.35 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.271 1.6 tm-20 -106.57 -137.28 0.36 Allowed 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.736 171.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.286 8.8 p30 -80.99 58.72 3.53 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 118.917 -2.364 . . . . 0.0 117.159 -167.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CE2' ' SD ' ' A' ' 18' ' ' MET . 31.6 t80 -61.14 -40.44 93.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.719 -1.863 . . . . 0.0 115.159 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.64 -43.05 68.45 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 165.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.91 -45.12 52.58 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.596 1.543 . . . . 0.0 115.024 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -45.55 -51.61 11.65 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 160.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' A' ' 28' ' ' ARG . 43.4 mtp -62.01 -45.4 93.77 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -43.04 72.21 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-N 120.373 1.442 . . . . 0.0 114.733 168.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -40.34 89.15 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 166.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.548 ' SD ' HG21 ' A' ' 76' ' ' THR . 72.9 mtm -62.98 -45.37 92.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 169.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.82 68.61 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 CA-C-N 118.841 0.746 . . . . 0.0 114.633 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.42 174.39 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.311 1.053 . . . . 0.0 113.267 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.16 159.8 21.97 Favored 'General case' 0 CA--C 1.577 2.009 0 O-C-N 120.712 -1.243 . . . . 0.0 113.338 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.264 14.7 tt -59.67 -44.49 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.66 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 CA-C-O 123.715 1.721 . . . . 0.0 112.088 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -149.77 -52.28 0.15 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 127.749 2.419 . . . . 0.0 106.169 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 12.0 mtm105 -42.95 -55.11 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 161.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -62.28 -41.44 98.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.09 -51.85 66.28 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.29 36.65 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.61 -56.07 25.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 119.674 -1.891 . . . . 0.0 113.162 156.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -86.28 48.56 1.64 Allowed 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -80.41 -16.13 55.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 58.69 21.24 8.61 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.27 1.3 pt? -77.2 145.53 37.57 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -157.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.03 119.07 34.69 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.396 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -99.19 109.76 22.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.559 0.744 . . . . 0.0 109.615 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 m -90.19 101.62 14.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.92 125.38 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.253 12.8 t -133.37 143.05 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.062 0.934 . . . . 0.0 111.705 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -110.1 110.36 21.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.866 0.866 . . . . 0.0 110.858 -172.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -88.8 77.17 7.87 Favored 'General case' 0 CA--C 1.57 1.73 0 CA-C-O 121.723 0.773 . . . . 0.0 110.149 165.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.46 -95.25 0.14 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -91.97 -8.47 46.11 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 168.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -113.38 118.55 34.88 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 121.121 1.782 . . . . 0.0 111.213 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.44 129.81 38.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.555 -0.716 . . . . 0.0 111.709 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -100.37 109.84 22.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 163.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.13 103.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -88.5 99.37 12.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.863 . . . . 0.0 109.734 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.26 100.08 12.2 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.287 0.635 . . . . 0.0 112.431 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.4 t -95.08 94.81 8.18 Favored 'General case' 0 CA--C 1.56 1.331 0 O-C-N 122.126 -0.359 . . . . 0.0 111.024 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.8 p -114.61 167.5 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.148 0.979 . . . . 0.0 113.361 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.6 m -56.96 -42.62 80.45 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 166.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -68.04 -49.33 62.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -148.95 145.76 27.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.498 1.044 . . . . 0.0 112.16 -169.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.06 102.11 8.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.646 . . . . 0.0 109.59 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -139.93 149.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.787 0.803 . . . . 0.0 112.145 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.87 105.54 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.491 -0.755 . . . . 0.0 110.416 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.65 99.03 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.2 t -96.83 123.43 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -144.33 146.83 32.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -99.66 143.3 30.05 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.023 0.916 . . . . 0.0 111.906 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.18 109.34 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.461 0.704 . . . . 0.0 112.898 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.92 -38.12 3.4 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.7 t -73.79 132.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 118.847 1.323 . . . . 0.0 110.329 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -98.21 102.99 14.89 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.315 1.055 . . . . 0.0 110.715 -171.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.41 163.73 14.92 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.973 1.309 . . . . 0.0 112.06 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -87.12 112.15 21.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.643 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -80.54 -65.93 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.536 -0.728 . . . . 0.0 112.135 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 73.03 122.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.386 1.074 . . . . 0.0 113.029 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.9 mt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.943 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.548 HG21 ' SD ' ' A' ' 21' ' ' MET . 91.7 m . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.75 117.33 20.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.766 -0.584 . . . . 0.0 111.703 -173.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.6 mt -141.02 117.81 11.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.974 0.91 . . . . 0.0 110.612 -164.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.264 2.6 ptm85 -131.89 138.84 48.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.33 -172.93 40.24 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.248 0.927 . . . . 0.0 112.189 -167.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -110.2 -179.08 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.888 -1.36 . . . . 0.0 112.72 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -122.67 107.23 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 p -85.17 128.96 34.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -0.975 . . . . 0.0 113.356 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 tp -85.31 104.49 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.298 0.639 . . . . 0.0 111.148 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.22 97.37 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.864 0.84 . . . . 0.0 109.201 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.5 -100.25 1.17 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.589 -0.694 . . . . 0.0 113.652 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -113.63 8.6 17.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 163.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -103.23 127.49 50.53 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.804 1.638 . . . . 0.0 110.528 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.62 99.02 11.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 151.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.21 114.17 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.789 0.804 . . . . 0.0 109.169 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.19 99.97 1.4 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 121.79 -0.569 . . . . 0.0 114.04 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -87.46 100.26 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.452 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.6 116.32 31.52 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.613 0.765 . . . . 0.0 109.435 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -76.36 124.63 27.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.137 -0.977 . . . . 0.0 111.726 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.1 100.36 12.59 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 -171.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.5 p -68.45 -21.68 64.63 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -56.74 -23.46 42.85 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 163.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.45 -49.54 0.36 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.428 1.091 . . . . 0.0 113.681 -157.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.92 60.36 0.93 Allowed Glycine 0 N--CA 1.49 2.246 0 CA-C-N 119.172 0.896 . . . . 0.0 115.051 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -144.0 141.63 30.25 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.465 0.706 . . . . 0.0 110.635 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.28 103.28 6.22 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.025 0.917 . . . . 0.0 111.575 167.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.98 123.58 25.97 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 121.796 -0.565 . . . . 0.0 109.804 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -107.59 100.17 9.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -108.02 118.7 37.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.357 0.663 . . . . 0.0 110.91 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.87 113.57 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -100.59 118.53 36.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.079 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.65 145.86 31.97 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 123.591 0.756 . . . . 0.0 110.809 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.31 110.89 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.535 -1.353 . . . . 0.0 108.006 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER -91.78 85.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.272 1.034 . . . . 0.0 109.005 171.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.46 -91.05 1.04 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 120.77 -1.206 . . . . 0.0 114.205 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -130.93 42.92 3.17 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.687 -0.89 . . . . 0.0 112.945 165.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -136.23 119.79 17.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.817 -1.177 . . . . 0.0 109.716 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.65 108.23 13.04 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.407 0.683 . . . . 0.0 110.614 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -89.9 71.63 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 123.318 0.647 . . . . 0.0 112.027 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -69.56 97.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.821 -1.174 . . . . 0.0 112.048 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -109.58 98.05 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -160.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.12 106.23 18.22 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.501 1.12 . . . . 0.0 111.942 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.14 123.1 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.54 -0.725 . . . . 0.0 109.308 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -136.32 124.02 22.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.102 0.561 . . . . 0.0 110.716 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.253 48.2 mt-10 46.62 54.72 8.48 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.78 24.63 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.3 t -114.45 129.33 70.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 120.294 2.047 . . . . 0.0 108.966 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -114.83 127.2 55.58 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.776 0.83 . . . . 0.0 111.525 -171.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.52 115.16 25.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.923 0.868 . . . . 0.0 112.54 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -87.46 122.79 31.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -104.88 102.71 12.23 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.41 107.4 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.99 123.92 42.22 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.856 0.462 . . . . 0.0 110.463 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -78.0 167.93 20.68 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.66 0.743 . . . . 0.0 112.025 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.77 103.89 1.88 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.88 -1.138 . . . . 0.0 113.028 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 125.623 1.569 . . . . 0.0 113.978 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.301 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.26 77.4 m-85 69.86 -21.92 0.17 Allowed 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.23 105.62 1.46 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.946 1.298 . . . . 0.0 114.186 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 m 178.04 169.65 0.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 125.253 1.421 . . . . 0.0 111.412 -172.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.1 m -97.06 128.42 43.99 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.734 -1.229 . . . . 0.0 110.789 171.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -131.22 95.51 3.8 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.306 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -77.56 139.78 39.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -70.25 124.05 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 112.454 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.64 -57.58 3.07 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.278 163.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -136.2 156.82 48.12 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 122.294 1.045 . . . . 0.0 112.589 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.9 m -136.2 94.51 3.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.596 -1.315 . . . . 0.0 110.067 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -93.06 118.84 31.65 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.616 -159.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.274 51.5 t30 64.11 17.92 10.93 Favored 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.19 -33.16 74.81 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -50.52 71.98 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -63.86 -41.49 97.77 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -49.58 -51.11 39.43 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.751 1.759 . . . . 0.0 115.751 163.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.5 mtp -65.84 -32.29 73.72 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.04 -48.54 75.82 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 160.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.16 -32.86 74.59 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.9 mmt -58.09 -53.9 53.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.075 1.307 . . . . 0.0 114.202 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.36 52.94 0.12 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.79 167.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 118.457 1.128 . . . . 0.0 112.756 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -79.52 166.56 21.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.756 -1.215 . . . . 0.0 113.032 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.285 13.3 tt -75.63 59.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 123.534 1.635 . . . . 0.0 114.72 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.17 -65.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -60.15 -33.75 72.61 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -50.45 -52.12 40.76 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 162.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.59 -52.29 18.87 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.41 -50.25 68.34 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.53 58.04 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.46 94.01 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -110.1 39.24 2.2 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -80.0 0.29 32.26 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.253 62.3 m-80 62.18 52.28 3.25 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.0 tp -76.77 121.87 23.94 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-O 122.085 0.945 . . . . 0.0 113.096 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -109.92 122.21 47.01 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.682 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.18 103.01 14.46 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.898 0.479 . . . . 0.0 109.723 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -91.4 100.07 12.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.119 -0.988 . . . . 0.0 108.735 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.5 mt -90.15 124.68 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.1 p -135.03 115.84 13.95 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -99.26 105.4 17.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.626 -1.296 . . . . 0.0 111.39 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.92 -52.01 9.52 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.27 87.88 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.105 -0.997 . . . . 0.0 111.086 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.316 25.8 t30 69.55 -48.65 0.61 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -165.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.62 121.39 14.85 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -85.42 114.54 22.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.057 0.543 . . . . 0.0 110.321 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -90.44 102.57 15.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.7 t -105.36 101.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -79.86 105.06 10.86 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 123.362 0.665 . . . . 0.0 109.867 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.89 99.52 9.73 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.155 0.982 . . . . 0.0 109.146 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.0 t -111.77 109.16 18.86 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.815 0.446 . . . . 0.0 112.174 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -135.27 178.74 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.3 m -54.64 -37.45 65.68 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -69.74 -53.24 19.35 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -148.32 143.71 27.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.302 0.955 . . . . 0.0 112.842 -168.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -121.87 95.23 4.58 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.596 0.759 . . . . 0.0 109.425 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.08 152.89 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 123.317 0.647 . . . . 0.0 111.026 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.27 115.82 30.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.708 -1.245 . . . . 0.0 112.505 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -86.48 101.09 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.32 107.15 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -126.5 130.68 51.09 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -83.51 147.56 27.72 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.452 1.12 . . . . 0.0 111.478 161.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.57 111.08 4.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.64 -6.99 52.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 119.019 2.367 . . . . 0.0 119.019 -167.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.9 t -85.78 130.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.822 2.311 . . . . 0.0 110.511 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 107.54 10.68 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.559 0.744 . . . . 0.0 111.919 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -126.9 157.71 38.69 Favored 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.42 0.688 . . . . 0.0 112.426 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -82.95 113.93 20.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 111.844 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -92.44 116.76 29.27 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.503 0.721 . . . . 0.0 109.405 167.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -96.96 124.35 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.25 0.548 . . . . 0.0 111.155 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.77 -11.3 59.96 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.289 . . 68.6 61.68 0.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -174.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -172.57 -59.96 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 124.637 1.175 . . . . 0.0 110.474 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.57 58.87 0.01 OUTLIER Glycine 0 CA--C 1.549 2.156 0 C-N-CA 125.154 1.359 . . . . 0.0 110.899 -170.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -172.44 114.76 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -166.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -110.28 142.97 41.15 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 122.368 1.08 . . . . 0.0 111.639 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.8 mt -114.58 116.22 28.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.736 0.814 . . . . 0.0 110.13 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -93.69 120.49 34.02 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 121.674 -0.641 . . . . 0.0 111.103 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.55 -161.67 35.12 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 117.651 1.82 . . . . 0.0 117.651 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.8 p -123.84 121.48 35.5 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.579 -160.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -79.25 114.15 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.938 0.79 . . . . 0.0 109.908 155.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -114.35 142.9 45.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.38 0.672 . . . . 0.0 110.973 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 tp -91.41 103.41 16.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.687 -1.258 . . . . 0.0 111.768 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -83.55 83.95 7.71 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.144 0.974 . . . . 0.0 110.127 166.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.57 -88.38 0.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -118.32 13.05 13.57 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.82 128.51 49.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.153 1.797 . . . . 0.0 109.473 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 mt -85.8 101.11 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.48 110.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-O 122.481 1.134 . . . . 0.0 109.335 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.87 103.12 3.01 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.731 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -90.06 90.47 8.14 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.23 161.16 19.39 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 122.844 1.306 . . . . 0.0 111.773 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -150.05 155.17 39.4 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.992 . . . . 0.0 110.724 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -68.21 131.78 45.98 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 113.858 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.3 p -55.46 -43.62 75.64 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 164.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -45.25 4.57 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.895 0.878 . . . . 0.0 111.698 -161.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -65.32 -42.74 92.67 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.73 -9.89 72.17 Favored Glycine 0 CA--C 1.558 2.732 0 N-CA-C 119.136 2.414 . . . . 0.0 119.136 -161.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -78.02 138.75 38.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.326 1.563 . . . . 0.0 112.894 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -73.45 148.06 43.58 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 tt -137.6 121.2 17.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.67 0.747 . . . . 0.0 110.227 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -93.59 120.18 33.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.982 -0.449 . . . . 0.0 110.112 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -125.02 124.8 42.75 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.668 0.387 . . . . 0.0 111.67 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.01 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -96.04 120.7 36.79 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.093 0.557 . . . . 0.0 110.458 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.87 153.79 31.68 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.523 0.729 . . . . 0.0 111.931 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.97 115.93 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.827 -1.17 . . . . 0.0 108.252 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tp -89.34 81.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.126 0.965 . . . . 0.0 110.67 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.0 -84.44 1.13 Allowed Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.905 -1.122 . . . . 0.0 114.976 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -128.8 26.01 5.59 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.66 125.79 31.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.901 -1.125 . . . . 0.0 109.906 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 tp -77.93 117.75 19.58 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.352 -0.843 . . . . 0.0 111.007 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -97.77 125.52 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.81 104.04 14.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 162.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -98.93 91.87 5.25 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.35 0.66 . . . . 0.0 109.248 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.27 113.44 25.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.96 0.904 . . . . 0.0 111.402 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.52 108.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -122.28 124.82 44.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.129 0.572 . . . . 0.0 110.872 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 57.1 37.68 28.7 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.12 26.39 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 119.801 2.68 . . . . 0.0 119.801 -163.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.28 107.26 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 119.942 1.871 . . . . 0.0 108.08 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 118.81 28.17 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.449 0.7 . . . . 0.0 111.948 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.88 125.12 53.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.222 0.609 . . . . 0.0 112.195 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.68 106.21 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.863 -0.523 . . . . 0.0 110.395 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -85.58 117.99 24.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.919 -1.113 . . . . 0.0 109.225 164.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.7 mt -115.02 117.42 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -164.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -116.55 117.47 29.97 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.34 0.656 . . . . 0.0 109.683 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.67 152.31 28.51 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 112.08 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -63.2 100.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.05 -1.031 . . . . 0.0 112.751 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.41 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.245 0 CA-C-O 120.945 0.403 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.29 11.73 3.27 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -116.37 88.53 2.91 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 120.221 -1.549 . . . . 0.0 111.252 -150.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -164.77 -178.94 5.55 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.687 1.195 . . . . 0.0 110.88 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -92.22 106.99 18.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.614 -1.304 . . . . 0.0 109.192 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -109.54 100.5 9.55 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -168.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -95.94 139.06 32.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.199 -0.938 . . . . 0.0 112.754 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.64 115.57 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.61 -61.45 1.91 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.151 0.58 . . . . 0.0 111.395 164.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -140.13 146.54 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.197 0.999 . . . . 0.0 112.948 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 108.07 8.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.56 -49.85 24.24 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -162.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -138.66 41.29 2.18 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -84.39 48.66 1.53 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 119.469 -2.02 . . . . 0.0 114.513 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -149.02 -47.57 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.415 1.486 . . . . 0.0 111.682 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.89 -37.97 89.35 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.942 1.701 . . . . 0.0 114.834 160.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -49.4 -57.93 6.05 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 159.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -45.29 76.95 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 168.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -50.59 -49.35 56.66 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -62.8 -37.73 87.88 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.7 mtm -62.91 -52.25 63.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.05 70.53 0.09 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 145.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-O 122.708 1.242 . . . . 0.0 111.276 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -63.92 156.34 28.0 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.258 14.0 tt -56.66 -40.11 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.47 -53.14 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.34 0.973 . . . . 0.0 113.067 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.78 -30.03 67.5 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -52.3 -46.41 65.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 159.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -57.53 -48.38 79.44 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.17 -34.65 75.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.27 75.28 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.94 -50.83 30.33 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 162.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.46 58.56 4.93 Favored 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 119.807 1.185 . . . . 0.0 112.917 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -95.97 -28.04 14.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 65.31 49.88 1.85 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.625 1.17 . . . . 0.0 114.041 -168.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -77.08 124.67 28.14 Favored 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.765 -1.21 . . . . 0.0 113.741 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -120.94 111.65 17.77 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.828 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 mt -91.38 100.23 13.05 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -91.65 101.05 13.68 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.97 -1.081 . . . . 0.0 109.116 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.19 107.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -104.03 104.15 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -92.45 127.52 37.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.668 -0.645 . . . . 0.0 110.984 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -125.74 76.92 1.62 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.734 1.254 . . . . 0.0 111.265 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 -95.23 1.36 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.055 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -97.19 -23.37 16.22 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -91.15 155.31 18.71 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 120.182 1.355 . . . . 0.0 112.621 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -124.6 112.49 16.88 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.955 0.902 . . . . 0.0 109.449 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.4 m -96.41 94.28 7.32 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.82 107.17 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.83 94.31 9.27 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.08 97.86 10.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.621 0.769 . . . . 0.0 108.934 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -113.62 115.53 28.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.324 0.65 . . . . 0.0 111.507 -162.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -144.66 168.57 19.85 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 0.0 113.127 -170.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -58.9 -34.64 71.91 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 160.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -50.08 67.74 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.25 11.66 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.35 1.06 . . . . 0.0 111.839 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -118.19 101.21 8.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.42 120.17 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.633 -0.667 . . . . 0.0 110.799 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.88 102.81 14.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.941 -1.099 . . . . 0.0 111.46 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.5 97.4 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.01 111.0 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -138.58 142.49 39.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.79 150.42 25.06 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.15 0.976 . . . . 0.0 111.648 164.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.08 102.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.053 -1.029 . . . . 0.0 113.099 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.81 -4.01 36.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 118.931 2.333 . . . . 0.0 118.931 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.79 135.23 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 121.376 2.588 . . . . 0.0 112.263 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.8 p -84.22 96.69 9.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 110.75 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -122.96 154.98 37.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.407 0.683 . . . . 0.0 112.693 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -83.38 105.71 14.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.654 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -96.87 101.72 13.36 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.047 0.939 . . . . 0.0 110.638 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -87.35 109.33 19.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.056 -1.028 . . . . 0.0 111.061 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.94 -82.99 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -166.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.29 -74.68 0.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.909 1.231 . . . . 0.0 111.585 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -71.9 -56.3 5.95 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 119.793 1.178 . . . . 0.0 114.098 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.03 48.53 0.12 Allowed Glycine 0 N--CA 1.485 1.912 0 CA-C-O 119.34 -0.7 . . . . 0.0 114.082 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -109.51 97.25 6.85 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 118.72 1.26 . . . . 0.0 109.417 -167.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -68.28 140.12 55.97 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 25.2 mt -134.76 100.24 4.55 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.328 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -84.51 107.25 16.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.913 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -154.55 23.97 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.506 0.963 . . . . 0.0 115.506 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.2 p -124.33 122.35 37.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.773 -155.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -82.27 107.51 15.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 155.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.5 m -108.69 149.96 28.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.6 -0.687 . . . . 0.0 112.322 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 105.28 17.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.877 -1.139 . . . . 0.0 110.91 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.05 79.85 1.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.955 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.51 -92.83 0.89 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 121.128 -0.982 . . . . 0.0 114.04 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.69 52.37 1.93 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.401 0.62 . . . . 0.0 111.188 160.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -141.04 120.06 12.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -83.04 99.2 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.358 -1.464 . . . . 0.0 109.446 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 tp -90.17 111.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.693 0.797 . . . . 0.0 110.033 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.28 92.8 1.36 Allowed Glycine 0 N--CA 1.482 1.734 0 C-N-CA 123.793 0.711 . . . . 0.0 113.172 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.21 111.25 22.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -134.86 111.16 9.65 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -156.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -84.79 120.64 26.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.697 -1.252 . . . . 0.0 111.855 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -54.97 120.21 6.56 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.9 p -64.17 -43.07 96.26 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.25 -44.24 76.08 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.92 -47.66 8.4 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.48 54.66 3.06 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 -157.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -138.52 124.22 19.75 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.335 1.067 . . . . 0.0 110.24 -172.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -83.75 99.51 10.32 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.115 1.436 . . . . 0.0 113.774 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.5 132.46 34.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.715 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -106.71 110.19 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.734 -0.604 . . . . 0.0 110.192 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -111.05 112.34 24.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.799 -0.563 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.66 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.154 -0.966 . . . . 0.0 108.784 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 mtm-85 -90.46 116.08 28.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.847 168.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -144.39 159.45 42.7 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.656 0.782 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.3 mt -126.14 121.43 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.423 -1.423 . . . . 0.0 109.494 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.13 83.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.12 -80.59 0.96 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.89 -50.41 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -94.22 148.16 22.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 120.212 1.369 . . . . 0.0 114.329 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 tp -86.93 120.75 28.53 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.127 0.571 . . . . 0.0 111.411 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 m -106.77 121.38 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -107.97 103.18 12.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.54 -0.725 . . . . 0.0 109.751 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.4 m -97.8 100.49 11.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.584 0.753 . . . . 0.0 109.356 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -90.04 117.71 29.04 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.023 0.929 . . . . 0.0 111.424 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.92 115.64 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -110.84 107.56 17.09 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.67 0.668 . . . . 0.0 109.647 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER 54.64 32.4 17.1 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 175.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.01 -40.5 2.5 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -162.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.69 112.67 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 120.538 2.169 . . . . 0.0 112.361 -168.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.77 130.07 39.9 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.08 0.552 . . . . 0.0 112.342 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.69 112.46 13.68 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.846 0.858 . . . . 0.0 110.996 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -103.31 116.29 32.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -0.804 . . . . 0.0 110.679 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -106.14 114.07 27.98 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.041 0.448 . . . . 0.0 109.83 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.1 mt -101.23 121.19 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.97 124.87 51.61 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.326 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -82.65 142.35 31.78 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.887 0.851 . . . . 0.0 111.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -79.97 105.5 11.3 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 124.924 1.29 . . . . 0.0 113.669 174.485 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.277 87.8 m-85 76.96 78.52 0.08 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.815 1.293 . . . . 0.0 110.413 -176.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.92 -36.15 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -137.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -122.82 -172.32 2.46 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 123.327 1.537 . . . . 0.0 112.918 -158.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.8 m -78.03 118.97 20.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.16 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -122.71 108.1 12.69 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -109.94 139.52 44.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.099 -1.001 . . . . 0.0 113.307 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.62 117.75 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -102.28 -56.97 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.691 0.797 . . . . 0.0 111.438 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 110.77 11.93 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.467 0.707 . . . . 0.0 112.032 -166.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.1 p -106.86 127.31 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 112.512 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -73.94 -46.65 42.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -147.03 45.59 1.17 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -83.9 52.44 2.29 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 119.332 -2.105 . . . . 0.0 113.955 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -152.26 -51.76 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.157 1.383 . . . . 0.0 110.349 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.95 -30.75 70.12 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 163.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -50.94 -40.47 57.46 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 154.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -70.39 -34.23 72.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -50.95 -52.68 39.96 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 121.009 1.731 . . . . 0.0 115.318 159.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.09 -34.14 74.46 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.28 -51.52 69.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 162.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 68.27 0.48 Allowed Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.015 0.825 . . . . 0.0 114.094 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.66 149.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.462 0.649 . . . . 0.0 112.489 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -78.89 153.03 30.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.769 -1.207 . . . . 0.0 113.68 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.311 10.7 tt -59.61 -39.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 118.483 2.771 . . . . 0.0 118.483 -170.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.6 m -59.11 -42.43 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -67.14 -35.18 79.15 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -55.72 -50.73 69.56 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.387 1.903 . . . . 0.0 114.151 164.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -56.38 -54.68 42.69 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.94 48.58 0.85 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.96 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.059 1.344 . . . . 0.0 111.963 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.28 93.85 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -83.97 67.75 9.75 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 122.283 1.04 . . . . 0.0 111.403 171.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -92.51 -33.55 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.84 50.58 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.521 1.129 . . . . 0.0 113.532 -166.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.88 124.19 26.91 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.493 1.14 . . . . 0.0 113.632 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -108.71 100.05 9.33 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.054 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.83 102.73 11.01 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.132 0.573 . . . . 0.0 109.491 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.1 m -99.51 105.59 17.52 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -107.22 118.23 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -161.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 p -123.96 126.53 46.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.72 -0.612 . . . . 0.0 110.492 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.17 119.95 37.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.631 -0.668 . . . . 0.0 110.933 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.08 -49.83 14.42 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.36 -91.42 0.08 OUTLIER Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -74.7 -24.6 58.79 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 157.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -87.62 129.5 35.1 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 119.894 1.225 . . . . 0.0 111.954 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -109.83 134.7 51.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.358 1.063 . . . . 0.0 110.581 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.5 m -107.59 111.93 24.42 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -104.76 105.63 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -80.88 110.02 16.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 110.335 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.16 82.52 4.16 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.175 0.59 . . . . 0.0 110.525 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 t -96.66 111.09 23.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.002 -1.061 . . . . 0.0 112.752 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 p -131.94 -169.72 2.26 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.376 0.671 . . . . 0.0 112.069 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -70.45 -1.59 11.25 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 159.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -126.91 -38.36 2.04 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.675 1.19 . . . . 0.0 114.008 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -90.4 -90.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 119.79 1.177 . . . . 0.0 111.781 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.287 70.4 m-80 60.96 60.28 1.87 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 pt -134.14 135.2 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 123.121 0.568 . . . . 0.0 110.595 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.79 103.05 14.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 111.868 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 t -88.13 98.28 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.0 113.61 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.99 140.64 45.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.689 0.757 . . . . 0.0 112.734 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.36 142.71 41.09 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 111.982 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 100.69 0.89 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 112.891 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.81 -12.42 24.94 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.103 2.401 . . . . 0.0 119.103 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.26 134.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 121.247 2.524 . . . . 0.0 112.61 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.6 t -82.08 92.8 6.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 111.984 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -119.15 170.27 9.22 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.956 0.902 . . . . 0.0 113.036 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -88.61 99.13 12.08 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 121.723 -0.611 . . . . 0.0 110.613 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -87.1 87.1 7.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.835 170.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -71.18 142.75 50.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.58 5.68 50.88 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.352 . . 72.03 -79.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.278 1.399 . . . . 0.0 113.554 -170.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.89 -19.83 31.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.63 -64.08 1.39 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 117.028 1.571 . . . . 0.0 117.028 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -171.21 171.84 5.53 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 124.352 1.061 . . . . 0.0 111.472 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -85.68 118.56 25.26 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 110.794 151.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -92.66 116.63 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.929 -1.107 . . . . 0.0 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -94.58 114.63 26.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.721 . . . . 0.0 110.649 -174.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.77 -153.7 24.98 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 p -119.86 140.77 50.31 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -160.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.16 109.64 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 108.913 155.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.3 m -104.58 139.19 39.81 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.181 0.592 . . . . 0.0 111.484 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.1 tp -88.17 107.47 18.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.118 -0.989 . . . . 0.0 109.959 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.85 -53.59 17.41 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.79 -71.07 0.28 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -162.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.15 -39.8 39.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 160.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.04 145.26 35.88 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.959 0.904 . . . . 0.0 112.882 -164.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.06 101.53 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 146.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.2 110.42 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.797 0.808 . . . . 0.0 109.485 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.76 94.68 2.02 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.8 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.02 95.61 9.89 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.534 0.683 . . . . 0.0 109.18 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.48 164.96 20.77 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 122.561 1.172 . . . . 0.0 111.835 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.79 155.01 46.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.849 -1.157 . . . . 0.0 112.072 165.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -67.84 139.02 56.53 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.8 m -77.91 -51.87 9.74 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.17 0.588 . . . . 0.0 112.062 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.97 -41.38 74.66 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -108.0 -31.63 7.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.15 38.56 29.48 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 118.556 2.182 . . . . 0.0 118.556 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -144.08 157.54 44.25 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.92 1.36 . . . . 0.0 111.916 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -80.54 129.68 34.66 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -159.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.79 124.08 51.77 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.029 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -107.24 107.22 18.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -107.27 99.32 8.86 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.58 119.91 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -103.62 124.49 48.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.748 0.704 . . . . 0.0 110.398 170.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.28 146.27 40.17 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.53 0.732 . . . . 0.0 111.114 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -89.71 115.16 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.322 -1.486 . . . . 0.0 108.676 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -99.74 88.93 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.31 -88.51 0.8 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.486 -0.759 . . . . 0.0 113.953 -174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -136.88 50.41 2.01 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 161.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -137.57 122.05 18.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.23 109.25 15.58 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 123.549 0.74 . . . . 0.0 110.786 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.69 98.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 109.951 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -84.59 96.26 9.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.033 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.2 m -96.34 92.6 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.524 0.73 . . . . 0.0 109.709 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.9 105.78 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.964 0.906 . . . . 0.0 111.438 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.6 t -109.48 109.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -127.18 119.46 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 110.078 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.8 OUTLIER 48.75 63.64 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.18 -31.72 2.58 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 119.211 2.444 . . . . 0.0 119.211 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.54 121.78 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.662 1.731 . . . . 0.0 110.698 -159.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.43 143.6 27.15 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 123.81 0.844 . . . . 0.0 112.953 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.29 109.39 6.1 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 121.56 -0.713 . . . . 0.0 110.689 164.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -101.16 96.98 7.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.257 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -87.46 111.41 21.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.259 0.624 . . . . 0.0 110.231 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.09 111.59 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -170.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -103.68 113.82 27.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.41 0.684 . . . . 0.0 109.602 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -77.11 162.75 27.22 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.35 110.25 4.01 Favored 'General case' 0 CA--C 1.57 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 112.361 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 C-N-CA 125.039 1.335 . . . . 0.0 112.38 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.321 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -134.07 -48.76 0.8 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.843 1.201 . . . . 0.0 112.379 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -69.13 94.42 0.67 Allowed 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -168.05 173.18 8.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.619 1.168 . . . . 0.0 110.999 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 m -88.97 117.79 28.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.001 . . . . 0.0 109.499 166.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -120.43 113.0 19.68 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.986 0.514 . . . . 0.0 109.876 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 142.45 27.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.267 -0.896 . . . . 0.0 112.754 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.72 115.94 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.573 -0.705 . . . . 0.0 111.923 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.21 -53.38 6.72 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.334 0.654 . . . . 0.0 112.074 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.12 143.23 25.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.667 0.746 . . . . 0.0 112.839 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -109.3 88.39 2.72 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.995 0.902 . . . . 0.0 110.446 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.31 118.89 25.13 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.632 0.773 . . . . 0.0 110.969 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.291 22.9 t30 67.25 11.71 8.53 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 118.105 2.631 . . . . 0.0 118.105 -173.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -64.77 -37.64 88.27 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -63.05 -42.84 99.82 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -71.39 -39.87 70.89 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -46.51 -55.88 6.85 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 158.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtp -63.17 -39.25 94.12 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.18 -43.87 95.52 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -38.02 66.26 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 163.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.4 mtt -59.56 -36.94 77.16 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.311 2.338 . . . . 0.0 117.311 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.6 63.12 0.89 Allowed Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.779 0.718 . . . . 0.0 114.147 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.91 -171.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.481 0.658 . . . . 0.0 112.479 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -65.36 173.41 2.62 Favored 'General case' 0 CA--C 1.583 2.231 0 O-C-N 119.899 -1.751 . . . . 0.0 113.976 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.4 tt -94.8 -45.39 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.333 -1.479 . . . . 0.0 114.381 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.2 -60.03 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.686 1.13 . . . . 0.0 112.239 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -55.08 -49.6 71.26 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -34.49 -51.37 0.47 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 118.668 2.84 . . . . 0.0 118.668 160.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -73.2 -39.67 65.37 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.53 95.99 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 168.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.04 -44.59 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -114.02 54.33 0.76 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 118.505 0.593 . . . . 0.0 112.086 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -83.63 -13.77 53.51 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 59.9 m-80 64.89 61.15 0.8 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.736 1.153 . . . . 0.0 113.136 -167.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 tp -83.32 120.86 26.38 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.607 1.194 . . . . 0.0 113.357 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -102.69 118.35 36.65 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.941 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.19 100.41 12.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 m -91.54 102.92 15.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.842 0.83 . . . . 0.0 108.878 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.21 124.04 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -117.98 107.75 14.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -87.22 91.17 8.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.51 0.671 . . . . 0.0 111.323 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -89.46 68.16 7.79 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.463 0.649 . . . . 0.0 112.158 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 78.66 0.15 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 116.86 1.504 . . . . 0.0 116.86 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.328 24.0 m120 72.27 -34.32 0.29 Allowed 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -166.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.79 148.98 34.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.477 1.035 . . . . 0.0 112.971 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -132.19 116.88 17.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.389 1.076 . . . . 0.0 108.116 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.9 m -102.38 100.64 10.81 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.9 t -105.87 104.57 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -83.32 104.47 13.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.27 96.39 8.46 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -115.09 114.53 25.46 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.573 0.749 . . . . 0.0 110.944 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 p -141.62 -177.64 5.27 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.301 1.048 . . . . 0.0 113.765 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 159.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -90.58 -48.51 7.04 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -130.32 152.14 50.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 119.997 1.271 . . . . 0.0 112.918 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.01 93.43 2.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.981 . . . . 0.0 109.799 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 pt -136.38 130.31 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.632 -0.668 . . . . 0.0 111.245 -172.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -88.32 105.81 17.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.379 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.72 101.46 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.61 121.7 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 123.385 0.674 . . . . 0.0 109.365 -171.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.55 148.96 23.42 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.396 0.679 . . . . 0.0 111.628 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.88 155.98 17.38 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 120.555 -1.341 . . . . 0.0 113.052 162.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.64 124.4 20.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.65 62.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.536 2.574 . . . . 0.0 119.536 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.86 141.94 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 120.488 2.144 . . . . 0.0 110.741 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 t -73.08 124.43 25.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -137.01 165.0 27.05 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 121.814 0.816 . . . . 0.0 111.246 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -91.39 110.04 21.33 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 110.424 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -84.61 -50.14 7.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.264 5.8 m120 75.65 133.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -77.2 156.42 31.53 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.593 1.187 . . . . 0.0 113.598 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 66.05 8.53 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -168.45 -62.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.038 1.335 . . . . 0.0 108.606 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.66 -52.76 0.02 OUTLIER Glycine 0 CA--C 1.55 2.281 0 N-CA-C 115.649 1.02 . . . . 0.0 115.649 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -62.41 146.71 50.67 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -94.09 126.49 39.34 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.053 1.406 . . . . 0.0 113.022 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.01 123.99 46.85 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.218 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -135.95 131.44 35.12 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.86 -148.06 16.55 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.477 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.7 p -120.51 123.04 41.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.026 -0.691 . . . . 0.0 112.104 -156.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -80.9 107.15 13.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.65 0.659 . . . . 0.0 109.734 153.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.6 m -95.39 172.34 8.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 111.24 162.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.41 116.79 14.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.409 -1.432 . . . . 0.0 109.978 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.3 88.04 5.01 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.007 0.908 . . . . 0.0 111.795 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.98 -84.17 0.59 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -126.81 32.45 5.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 170.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -141.11 123.66 15.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.482 -1.387 . . . . 0.0 109.096 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.48 127.61 33.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.16 124.18 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.685 0.755 . . . . 0.0 109.945 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.85 103.37 1.41 Allowed Glycine 0 N--CA 1.479 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 113.538 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -95.51 96.78 9.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.4 119.23 31.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.521 -170.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -87.4 139.58 30.4 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.533 1.159 . . . . 0.0 112.512 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -63.86 139.19 58.74 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 168.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -52.37 -43.25 64.59 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 152.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.96 -55.37 3.79 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.508 0.723 . . . . 0.0 111.876 -157.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.17 -32.39 13.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.45 90.04 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 119.042 2.377 . . . . 0.0 119.042 -163.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.09 -3.36 57.22 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -164.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.333 4.7 tt0 72.57 118.3 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 tt -90.34 137.68 32.15 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.137 0.975 . . . . 0.0 111.441 162.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.1 108.09 16.18 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.094 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.261 9.9 t -113.32 114.55 26.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 0.0 112.278 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.07 134.24 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -112.8 121.16 43.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 0.0 110.529 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.99 172.65 12.08 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 121.679 0.752 . . . . 0.0 111.766 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.59 108.36 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.053 . . . . 0.0 109.481 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.263 11.1 tp -96.98 88.09 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.812 0.815 . . . . 0.0 109.717 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.27 -90.31 1.01 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.121 -0.987 . . . . 0.0 114.125 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.83 52.48 1.94 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 165.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -132.87 121.99 23.73 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.181 0.992 . . . . 0.0 108.375 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.2 101.97 11.58 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.775 -0.578 . . . . 0.0 109.908 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.81 83.46 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.093 0.949 . . . . 0.0 110.476 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.39 100.05 10.45 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.238 1.018 . . . . 0.0 109.984 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.4 m -110.68 90.44 3.32 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.005 -151.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.42 114.02 24.61 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.978 0.911 . . . . 0.0 110.89 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -108.71 124.26 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -141.34 128.15 20.46 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 121.355 0.597 . . . . 0.0 111.649 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 3.9 mm-40 48.96 44.35 22.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -167.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.04 -25.3 1.87 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 119.31 2.484 . . . . 0.0 119.31 -165.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.3 t -82.85 117.31 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 120.317 2.058 . . . . 0.0 110.03 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -91.67 140.76 29.4 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.97 0.908 . . . . 0.0 112.659 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.59 32.58 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 165.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -103.32 106.19 16.65 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.959 -0.463 . . . . 0.0 110.388 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -83.8 102.59 12.44 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.22 115.16 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -106.96 115.62 30.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.241 0.543 . . . . 0.0 109.576 -173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -84.16 149.29 26.26 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.421 0.689 . . . . 0.0 111.924 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -62.17 112.1 2.24 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 125.235 1.414 . . . . 0.0 112.827 -173.658 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.24 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -110.49 -47.99 3.21 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.252 5.5 p-10 -74.55 80.89 1.97 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 120.234 1.379 . . . . 0.0 114.205 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -146.93 -166.35 2.48 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.135 0.969 . . . . 0.0 111.573 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.5 m -94.55 127.56 40.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.654 -1.279 . . . . 0.0 109.985 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -136.63 105.53 5.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.966 -0.459 . . . . 0.0 110.509 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -98.97 137.39 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.212 0.915 . . . . 0.0 111.339 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.6 120.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.801 0.81 . . . . 0.0 112.693 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.17 -54.64 5.79 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.065 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -147.25 160.77 42.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 121.765 0.793 . . . . 0.0 112.677 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -136.54 118.27 15.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 111.445 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -70.46 -60.35 2.32 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -165.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -130.33 51.13 2.13 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.32 1.057 . . . . 0.0 112.944 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -74.89 -36.8 62.25 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.0 -50.56 72.34 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.13 -36.79 77.86 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.53 -52.44 38.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 160.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 mtp -61.22 -48.97 79.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -43.02 64.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -54.69 -30.14 54.93 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtm -70.98 -11.46 60.98 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.69 64.54 1.74 Allowed Glycine 0 N--CA 1.495 2.583 0 CA-C-N 122.265 2.302 . . . . 0.0 114.67 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -119.55 170.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 122.821 1.296 . . . . 0.0 113.092 -164.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.2 108.0 16.84 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 120.877 -1.139 . . . . 0.0 110.531 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.3 12.7 tt -49.25 -44.53 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 119.808 3.262 . . . . 0.0 119.808 -164.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.07 -46.94 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 170.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -68.66 -31.13 70.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -51.22 -45.58 61.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.91 -52.24 66.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.79 -36.29 82.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.89 91.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.12 75.18 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -92.47 62.48 3.95 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 163.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER -83.03 -17.36 43.56 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 60.28 50.88 5.85 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -84.22 149.62 26.01 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -111.59 114.48 27.57 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.771 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.11 103.28 11.61 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.2 m -91.73 99.0 11.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 168.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -99.94 124.22 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.9 p -129.76 119.45 23.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.649 -0.657 . . . . 0.0 109.921 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -88.72 119.2 28.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.901 0.773 . . . . 0.0 111.96 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.81 76.9 1.82 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 123.112 0.565 . . . . 0.0 109.856 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.54 80.49 0.1 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 20.0 m120 71.62 -50.4 0.69 Allowed 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -166.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -73.95 121.84 21.64 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.981 0.912 . . . . 0.0 112.929 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -99.69 134.78 42.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.56 -0.712 . . . . 0.0 111.481 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 m -102.27 111.06 23.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 161.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.04 105.49 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 70' ' ' TYR . 16.4 mt-10 -86.01 95.8 9.63 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.954 0.502 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.0 t -98.76 110.28 22.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.875 0.47 . . . . 0.0 110.336 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.83 170.35 15.91 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -68.82 -6.54 27.5 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -100.03 -46.03 5.47 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.499 1.045 . . . . 0.0 113.206 168.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.87 154.5 40.5 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.035 1.288 . . . . 0.0 112.205 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -112.58 105.94 14.25 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 161.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.2 pt -123.51 127.6 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.248 0.547 . . . . 0.0 111.3 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -99.71 100.67 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.759 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.17 98.11 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.0 109.582 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.19 128.9 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.194 0.598 . . . . 0.0 110.346 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -148.66 147.78 29.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.456 0.646 . . . . 0.0 112.729 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 157.06 16.47 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.318 1.056 . . . . 0.0 110.785 164.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.78 80.89 3.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 112.436 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.02 -38.3 1.83 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -162.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.53 121.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.072 1.436 . . . . 0.0 110.091 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -68.19 127.69 33.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.39 165.43 22.57 Favored 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 123.896 0.879 . . . . 0.0 111.579 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -96.26 108.16 20.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' OH ' ' OE2' ' A' ' 51' ' ' GLU . 6.5 t80 -92.15 97.62 11.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.489 -0.757 . . . . 0.0 110.135 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -75.67 115.24 15.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.778 -0.576 . . . . 0.0 112.409 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.0 -69.57 0.39 Allowed 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.37 -68.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.687 1.131 . . . . 0.0 111.263 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -66.73 -55.5 14.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.27 67.12 0.07 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.0 m -152.12 106.73 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.953 . . . . 0.0 109.298 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.19 114.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.366 0.603 . . . . 0.0 109.651 160.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.18 117.11 27.92 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.448 0.642 . . . . 0.0 110.494 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -91.27 109.45 20.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.39 0.676 . . . . 0.0 109.998 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.94 -149.84 14.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.8 p -138.92 142.65 38.47 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.076 0.551 . . . . 0.0 110.851 -170.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -85.32 89.18 7.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.998 -1.064 . . . . 0.0 108.319 153.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -76.69 138.06 39.77 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.984 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.97 105.74 13.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 110.857 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.24 -35.39 73.8 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.73 -79.21 0.2 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.91 -24.25 41.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 160.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -120.79 149.15 43.01 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.263 1.392 . . . . 0.0 111.921 -160.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -94.94 108.88 20.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.925 -1.11 . . . . 0.0 108.993 162.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.19 112.43 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 CA-C-O 122.317 1.056 . . . . 0.0 109.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.01 92.88 0.74 Allowed Glycine 0 N--CA 1.479 1.519 0 C-N-CA 124.265 0.936 . . . . 0.0 113.746 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.09 91.33 8.67 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.41 152.25 37.14 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.101 0.953 . . . . 0.0 112.386 -168.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -121.61 139.43 53.55 Favored 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.549 0.74 . . . . 0.0 110.023 169.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -63.38 131.16 47.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.862 -1.149 . . . . 0.0 113.607 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.7 m -66.59 -47.21 73.46 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 167.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.66 -51.87 37.21 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.72 -45.94 27.38 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.75 -8.34 79.66 Favored Glycine 0 CA--C 1.558 2.781 0 N-CA-C 118.543 2.177 . . . . 0.0 118.543 -153.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.53 152.12 24.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.648 1.724 . . . . 0.0 112.724 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -70.81 141.63 51.35 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.92 126.16 40.95 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -100.51 146.73 26.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 111.15 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 m -148.35 109.73 4.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.159 -1.588 . . . . 0.0 111.69 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.1 t -97.07 122.87 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.227 . . . . 0.0 109.966 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.41 127.62 44.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 111.198 163.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.61 146.01 27.08 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.337 0.655 . . . . 0.0 110.872 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.36 102.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.26 11.3 tp -98.68 75.19 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.039 0.923 . . . . 0.0 111.27 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.83 62.4 3.83 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 116.164 1.226 . . . . 0.0 116.164 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.317 9.1 t70 81.9 -41.1 0.13 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -167.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.74 107.75 7.04 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.97 0.908 . . . . 0.0 113.324 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.3 tp -76.07 102.42 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.655 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -91.72 82.5 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.111 0.482 . . . . 0.0 110.447 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -73.8 97.93 2.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.955 -1.091 . . . . 0.0 110.921 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.7 m -106.08 89.52 3.09 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 -157.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -81.96 137.96 35.04 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.146 0.978 . . . . 0.0 111.977 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.64 120.62 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -131.71 122.59 26.16 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 55.92 36.8 28.0 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.83 -17.15 17.16 Favored Glycine 0 CA--C 1.557 2.689 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 -163.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.37 116.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.009 1.904 . . . . 0.0 109.23 -172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.15 147.37 23.11 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.57 123.49 15.36 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.894 0.877 . . . . 0.0 111.681 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -110.72 98.4 7.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.061 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -86.69 108.83 18.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.2 mt -106.91 126.34 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -115.67 128.7 56.1 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.516 0.674 . . . . 0.0 111.447 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -80.79 155.03 26.86 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 121.672 0.749 . . . . 0.0 111.396 165.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -68.45 114.22 6.69 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.15 -0.969 . . . . 0.0 111.7 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 125.253 1.421 . . . . 0.0 112.531 -173.879 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -109.42 -1.96 18.05 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 -171.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -82.35 90.55 6.68 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 120.747 1.612 . . . . 0.0 113.466 -165.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -162.37 179.0 8.16 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 122.209 1.004 . . . . 0.0 112.188 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 m -83.04 125.2 31.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 110.222 163.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.91 106.39 9.28 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.183 0.593 . . . . 0.0 109.727 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -97.74 138.39 35.19 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.919 -1.113 . . . . 0.0 112.605 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.85 112.05 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 113.326 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.71 -59.52 2.22 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.087 0.555 . . . . 0.0 111.828 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -134.78 124.48 25.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.0 p -103.72 129.26 51.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.454 0.702 . . . . 0.0 112.034 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.332 0.1 OUTLIER -72.75 -72.81 0.23 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 177.026 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -121.48 39.5 3.83 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.804 1.184 . . . . 0.0 114.069 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.74 -40.83 75.93 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -64.54 -30.77 71.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -79.0 -40.12 32.34 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -48.27 -50.44 29.76 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 158.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.403 ' SD ' HG21 ' A' ' 23' ' ' VAL . 12.4 mmt -50.12 -50.8 47.34 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 163.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -52.66 -46.51 67.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -57.67 -41.83 82.36 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.61 -33.82 74.58 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.77 67.9 0.83 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-N 119.55 1.068 . . . . 0.0 113.904 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 ' SD ' ' A' ' 18' ' ' MET . 11.5 m -126.2 170.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.466 1.127 . . . . 0.0 112.51 -165.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -64.22 178.74 0.65 Allowed 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.4 tt -108.53 167.4 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 157.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.383 46.2 t 80.85 -68.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 120.392 -1.443 . . . . 0.0 111.691 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -65.87 -38.86 89.91 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 119.802 1.183 . . . . 0.0 113.811 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -44.23 -42.84 6.83 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 161.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -69.69 -51.23 36.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.179 -0.951 . . . . 0.0 113.538 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -55.51 -33.65 63.93 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.2 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.24 94.34 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 161.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -103.8 51.74 0.78 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.85 -7.58 59.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 7.3 m-80 67.07 49.29 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.787 1.235 . . . . 0.0 114.229 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.9 tp -72.36 117.25 13.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.08 103.64 10.08 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.713 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.98 100.75 13.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.46 0.704 . . . . 0.0 110.072 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -90.57 101.92 14.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.966 -1.084 . . . . 0.0 109.551 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -94.34 113.45 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.4 p -107.8 110.08 21.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.46 91.61 5.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.665 1.221 . . . . 0.0 111.281 -167.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.63 80.39 9.14 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.746 1.26 . . . . 0.0 113.817 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 -100.02 1.56 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.322 -0.861 . . . . 0.0 114.937 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.08 -4.47 56.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 162.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -114.27 162.83 16.08 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-O 122.224 1.011 . . . . 0.0 111.998 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.46 112.19 10.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.94 -1.1 . . . . 0.0 109.223 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.5 m -95.74 100.7 12.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 164.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -99.26 100.71 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -86.62 98.69 11.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.76 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.44 99.01 10.14 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -97.73 116.51 30.08 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -142.76 176.55 8.96 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.196 0.998 . . . . 0.0 113.394 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -55.09 -37.11 66.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 164.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.91 -46.8 14.64 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -147.02 144.27 29.02 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.539 1.518 . . . . 0.0 112.897 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -126.78 96.29 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 167.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.92 148.78 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.651 1.215 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.39 109.07 18.77 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.409 -0.807 . . . . 0.0 111.219 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.43 96.41 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.59 112.41 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -140.18 144.36 36.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.176 0.591 . . . . 0.0 111.925 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.69 153.2 18.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.365 1.079 . . . . 0.0 111.083 162.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.31 117.73 6.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.57 -9.68 68.96 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 -168.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -77.65 130.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 120.772 2.286 . . . . 0.0 110.691 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -80.15 122.31 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.658 -0.651 . . . . 0.0 112.341 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -148.44 165.98 29.52 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 121.552 0.692 . . . . 0.0 111.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.88 101.17 13.46 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 110.822 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -75.77 -55.69 5.4 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.446 ' H ' ' HB2' ' A' ' 78' ' ' LEU 0.262 9.3 m-20 73.12 137.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.872 1.269 . . . . 0.0 114.013 172.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.3 mt -110.97 127.48 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.853 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.35 124.58 21.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.283 38.1 m-20 71.97 -29.91 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -160.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.19 -66.29 1.58 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 116.991 1.557 . . . . 0.0 116.991 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -174.89 156.44 2.23 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.0 110.345 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.31 148.76 44.05 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 120.76 -1.212 . . . . 0.0 114.09 148.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.446 ' HB2' ' H ' ' A' ' 71' ' ' ASN . 31.1 mt -140.35 100.78 3.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.61 0.764 . . . . 0.0 111.676 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -86.53 121.43 29.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.576 1.15 . . . . 0.0 111.917 171.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.59 -163.11 34.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.9 p -120.05 125.06 47.39 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.081 0.553 . . . . 0.0 111.907 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -80.42 106.93 12.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.792 -0.568 . . . . 0.0 110.21 155.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -98.12 170.01 9.21 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.965 0.888 . . . . 0.0 111.711 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.3 117.48 29.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.916 -1.115 . . . . 0.0 108.803 172.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -71.85 -43.77 64.94 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.2 -81.83 0.06 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -78.65 -31.29 46.74 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 157.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -86.75 132.04 33.97 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.688 1.131 . . . . 0.0 112.239 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.21 120.56 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 157.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.03 111.21 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.876 0.846 . . . . 0.0 108.783 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -106.24 105.93 2.48 Favored Glycine 0 N--CA 1.482 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 113.02 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -100.56 98.13 8.75 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -124.15 118.91 27.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.274 0.629 . . . . 0.0 111.561 -165.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -95.68 148.18 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 111.967 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -66.68 138.94 57.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.424 -1.422 . . . . 0.0 113.179 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.269 32.2 p -70.55 -33.44 71.14 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.55 -71.22 0.07 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.83 -50.58 3.15 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.346 1.058 . . . . 0.0 113.768 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.36 51.95 0.42 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -95.54 134.09 38.8 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.34 1.07 . . . . 0.0 110.151 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.88 118.05 12.23 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -108.9 115.66 30.5 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.81 104.92 17.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 109.642 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.3 p -99.2 102.75 14.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.8 134.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.619 1.1 . . . . 0.0 108.42 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -134.06 138.21 45.16 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.84 157.68 38.24 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.47 1.128 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.58 119.22 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.956 -1.09 . . . . 0.0 110.075 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -89.79 66.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 121.121 -0.987 . . . . 0.0 111.817 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.95 -77.87 0.95 Allowed Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.742 -1.224 . . . . 0.0 114.858 -168.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.63 -49.29 4.05 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.05 153.46 20.55 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 120.186 1.357 . . . . 0.0 114.122 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.23 108.59 20.06 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.506 -0.746 . . . . 0.0 110.562 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.17 139.66 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 169.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -130.2 101.88 5.98 Favored 'General case' 0 CA--C 1.563 1.465 0 O-C-N 121.675 -0.64 . . . . 0.0 109.867 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 119.1 23.52 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.131 0.972 . . . . 0.0 109.733 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -106.81 109.08 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 164.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.74 132.47 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -127.62 113.4 16.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 163.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.46 62.39 2.65 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.7 -44.98 3.38 Favored Glycine 0 CA--C 1.552 2.352 0 N-CA-C 118.115 2.006 . . . . 0.0 118.115 -166.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.59 123.81 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.402 1.601 . . . . 0.0 113.834 -162.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -80.24 150.63 29.98 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.506 1.146 . . . . 0.0 113.298 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.26 118.37 19.4 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.57 152.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -107.1 104.14 13.72 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -169.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -102.58 115.89 31.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.7 mt -101.98 113.74 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -98.72 130.73 45.21 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.049 1.404 . . . . 0.0 110.173 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -97.26 153.06 18.27 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.18 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.66 121.56 14.77 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 112.936 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.386 2.6 p30 . . . . . 0 N--CA 1.488 1.466 0 C-N-CA 125.463 1.505 . . . . 0.0 114.667 -175.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.437 0 CA-C-O 121.833 0.825 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -97.49 68.48 2.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.243 -0.911 . . . . 0.0 112.73 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -159.35 83.8 0.77 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.165 -0.959 . . . . 0.0 110.126 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -166.48 175.82 7.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.284 -0.885 . . . . 0.0 111.915 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.9 m -81.84 124.78 29.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.964 -1.085 . . . . 0.0 110.482 160.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -124.98 104.09 8.38 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.304 0.641 . . . . 0.0 109.937 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -86.03 137.66 32.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.123 -0.986 . . . . 0.0 112.623 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.84 120.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.121 -0.987 . . . . 0.0 113.012 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -105.86 -64.83 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.78 0.832 . . . . 0.0 110.725 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.79 149.85 37.88 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 122.229 1.014 . . . . 0.0 111.402 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.0 m -157.86 106.11 2.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.101 -1.624 . . . . 0.0 109.692 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.24 -76.6 0.2 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -149.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.35 52.91 2.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.547 -1.346 . . . . 0.0 113.137 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.01 64.29 8.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 119.776 -1.828 . . . . 0.0 113.245 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.99 -49.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.374 1.07 . . . . 0.0 112.961 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -69.91 -39.39 76.21 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -45.23 -54.11 7.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 155.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.3 mtp -67.2 -40.62 86.48 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.92 -45.05 82.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 165.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -64.13 -34.89 79.1 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.39 -52.08 65.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 121.017 1.735 . . . . 0.0 115.535 166.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.17 65.96 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.8 p -148.44 128.68 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -77.56 158.66 29.75 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.292 10.1 tp -50.6 -41.03 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 118.853 2.909 . . . . 0.0 118.853 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -55.73 -46.09 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.98 -34.12 61.95 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -61.39 -38.97 88.98 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 165.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.81 -51.13 64.47 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-N 120.401 1.455 . . . . 0.0 114.694 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.07 -42.48 85.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.82 70.25 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.15 -50.92 66.29 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 164.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -88.53 55.1 3.27 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 119.444 1.02 . . . . 0.0 113.203 171.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -94.14 -7.47 42.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -173.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 60.08 42.28 15.93 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 114.99 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -74.54 117.44 16.36 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 122.691 1.234 . . . . 0.0 112.051 -172.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -117.46 112.58 20.83 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.898 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -96.02 103.04 14.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.884 -0.51 . . . . 0.0 110.306 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.5 m -91.03 97.89 11.44 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.96 124.1 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -135.73 114.62 12.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.04 115.85 28.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 112.638 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -83.76 76.68 9.98 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.11 0.957 . . . . 0.0 110.877 171.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.68 -81.02 0.53 Allowed Glycine 0 N--CA 1.492 2.378 0 O-C-N 121.144 -0.973 . . . . 0.0 115.141 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -100.07 -38.1 8.7 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 165.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -85.51 118.68 25.19 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.291 1.405 . . . . 0.0 113.05 -163.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -86.38 115.56 23.97 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.461 0.704 . . . . 0.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.1 m -86.78 104.44 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 162.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 t -106.45 116.67 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -84.73 99.49 10.87 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -75.03 91.07 2.5 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t -106.76 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.646 0.779 . . . . 0.0 110.789 -168.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.7 p -148.95 172.81 14.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.1 m -60.02 -49.09 79.05 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.36 -43.73 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -154.46 139.24 17.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.747 1.158 . . . . 0.0 111.889 -165.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -125.76 92.03 3.52 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -132.68 124.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.058 0.456 . . . . 0.0 111.153 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.49 102.9 10.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 112.135 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.91 103.78 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.36 106.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -129.59 138.56 51.34 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.6 0.76 . . . . 0.0 111.823 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.34 159.22 15.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.644 1.212 . . . . 0.0 111.86 167.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.5 113.3 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.68 75.91 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.0 126.4 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 121.013 2.407 . . . . 0.0 110.767 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -82.21 106.25 13.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.142 0.577 . . . . 0.0 111.871 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.48 154.3 48.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.732 -0.605 . . . . 0.0 112.384 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.36 89.54 7.7 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 122.709 1.242 . . . . 0.0 112.013 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -75.53 163.46 27.35 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.704 1.202 . . . . 0.0 112.523 168.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER -159.01 140.07 12.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.055 -1.653 . . . . 0.0 112.036 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.6 mt -93.9 176.56 6.3 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.71 65.27 0.49 Allowed 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -173.01 -55.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.46 1.104 . . . . 0.0 111.823 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.13 2.45 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 117.093 1.597 . . . . 0.0 117.093 -159.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -70.22 114.88 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 119.729 1.765 . . . . 0.0 112.232 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.04 132.36 37.21 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 121.721 0.772 . . . . 0.0 112.919 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -136.49 103.72 5.35 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.747 0.819 . . . . 0.0 111.629 -159.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 127.38 35.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.166 -1.584 . . . . 0.0 111.623 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.68 174.47 46.91 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.226 2.451 . . . . 0.0 119.226 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.9 p -118.19 108.61 15.37 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.989 -1.106 . . . . 0.0 112.203 -169.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.73 107.54 5.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.612 -1.305 . . . . 0.0 109.989 166.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.5 m -110.07 -29.67 8.11 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -156.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.277 35.7 tp 69.08 103.31 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.312 1.445 . . . . 0.0 114.159 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.52 129.19 55.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.24 -108.82 1.42 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -118.3 45.33 2.03 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 163.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -141.99 114.68 8.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.13 95.77 5.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.839 -1.163 . . . . 0.0 110.187 170.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.5 tp -83.24 113.99 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 123.366 0.666 . . . . 0.0 110.606 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.89 2.47 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 123.834 0.731 . . . . 0.0 112.649 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -84.39 93.0 8.17 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -103.87 103.94 13.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.912 -0.492 . . . . 0.0 112.072 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -87.4 137.22 32.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.077 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -66.43 141.41 57.93 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.4 p -67.11 -32.69 74.0 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -63.86 -67.07 0.46 Allowed 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -109.4 -23.6 11.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 46.84 7.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.04 -16.1 55.79 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.317 6.3 tt0 69.36 87.88 0.12 Allowed 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.07 100.6 11.49 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -88.96 110.07 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.534 -0.729 . . . . 0.0 111.177 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -104.85 107.28 18.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.17 100.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.943 -1.098 . . . . 0.0 108.231 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -83.24 116.29 22.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.854 -0.529 . . . . 0.0 110.309 167.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -135.13 141.78 46.05 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.141 0.976 . . . . 0.0 110.294 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 105.41 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.32 -1.488 . . . . 0.0 107.022 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.251 14.7 tt -87.82 71.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.338 1.066 . . . . 0.0 110.714 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.12 1.54 Allowed Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.046 -1.034 . . . . 0.0 114.691 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.422 ' OD2' ' OE2' ' A' ' 112' ' ' GLU . 7.5 p-10 -105.12 -53.56 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.422 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 2.7 mt-10 -86.73 148.75 25.29 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 122.09 0.948 . . . . 0.0 112.914 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.3 tp -79.24 110.33 14.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.549 -0.719 . . . . 0.0 109.638 167.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.55 118.62 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -96.68 100.9 12.43 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 165.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 128.36 39.52 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.443 0.697 . . . . 0.0 109.759 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -135.31 119.1 17.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.845 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -87.16 144.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.012 0.525 . . . . 0.0 111.595 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -136.3 108.24 7.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 156.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.257 3.3 tm-20 49.19 70.03 0.52 Allowed 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.08 -42.73 2.76 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -169.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.63 119.71 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.708 1.254 . . . . 0.0 109.932 -165.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -98.41 140.2 33.03 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.854 0.835 . . . . 0.0 112.484 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.46 168.04 19.66 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.352 1.072 . . . . 0.0 112.497 162.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.69 150.05 51.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 111.599 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -122.99 117.0 24.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 157.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.4 109.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.34 127.5 47.94 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.959 0.903 . . . . 0.0 110.762 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -78.44 150.74 32.98 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.889 0.852 . . . . 0.0 112.62 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.43 122.23 14.06 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 113.155 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.489 1.492 0 C-N-CA 125.318 1.447 . . . . 0.0 111.501 -176.231 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.359 0 CA-C-O 121.152 0.501 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -112.83 48.65 1.0 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.508 -0.745 . . . . 0.0 112.458 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.33 90.86 7.21 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 120.153 -1.592 . . . . 0.0 114.532 -161.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.8 m -167.26 174.19 8.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.761 1.224 . . . . 0.0 111.336 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.87 130.79 34.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -136.02 112.44 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -103.7 138.49 40.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 120.099 1.318 . . . . 0.0 113.453 -175.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.26 116.91 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -173.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -110.14 -48.29 3.2 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 123.949 0.899 . . . . 0.0 112.495 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 93.87 3.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.524 -0.735 . . . . 0.0 111.155 172.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -84.7 95.59 8.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.556 -1.34 . . . . 0.0 112.483 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.1 127.04 37.43 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.699 0.761 . . . . 0.0 111.11 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.303 6.7 t30 64.6 17.76 11.05 Favored 'General case' 0 CA--C 1.584 2.281 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 -171.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.52 -45.48 79.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -52.13 -41.39 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -42.56 61.92 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -46.78 -54.39 9.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 161.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.5 mmt -60.83 -48.12 83.23 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -60.55 -34.69 74.51 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -61.31 -40.79 95.48 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.0 mtp -58.46 -22.26 54.06 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 119.501 3.149 . . . . 0.0 119.501 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.93 49.67 3.28 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-N 120.246 1.384 . . . . 0.0 116.429 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.22 -30.87 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 17.8 m120 79.08 152.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.1 1.36 . . . . 0.0 112.444 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.17 75.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 122.89 1.329 . . . . 0.0 110.109 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.14 -68.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.877 1.271 . . . . 0.0 107.682 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -75.27 -38.57 60.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -61.51 -22.81 65.45 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -61.19 -55.71 29.1 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.361 0.982 . . . . 0.0 113.313 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -56.93 -29.01 62.74 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.43 -54.93 13.81 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.865 1.666 . . . . 0.0 113.885 162.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.15 -43.52 61.25 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -99.81 55.06 0.94 Allowed 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 161.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -70.45 -35.12 73.15 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 60.99 45.01 9.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.336 1.054 . . . . 0.0 113.751 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 tp -72.65 128.84 36.76 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.913 0.863 . . . . 0.0 113.038 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -126.44 118.36 24.8 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.777 0.831 . . . . 0.0 109.972 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.53 100.55 12.13 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.448 0.699 . . . . 0.0 109.787 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -95.28 96.86 9.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 109.054 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.8 mt -86.59 124.3 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.908 0.883 . . . . 0.0 109.321 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.8 p -122.04 109.61 14.78 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -113.74 126.05 54.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 112.258 -165.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.86 132.71 19.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 122.848 0.459 . . . . 0.0 110.156 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.11 61.99 4.97 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.306 31.7 m120 69.51 -28.2 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -168.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.88 128.57 34.81 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.409 1.459 . . . . 0.0 112.572 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -102.93 108.24 19.36 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 163.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 m -95.27 98.33 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 t -108.59 113.21 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -169.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 99.25 7.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.648 -0.658 . . . . 0.0 109.589 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.01 97.97 10.01 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.1 t -107.5 124.21 49.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 112.389 -161.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.6 p -146.14 169.02 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.822 0.849 . . . . 0.0 112.889 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -58.86 -38.5 78.9 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 167.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -64.89 -54.51 29.75 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -151.81 140.91 21.24 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.598 1.09 . . . . 0.0 112.332 -162.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.98 103.48 9.97 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.0 pt -125.33 127.78 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.946 -0.471 . . . . 0.0 111.241 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 96.52 8.52 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.192 -0.942 . . . . 0.0 111.486 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.64 100.3 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.54 110.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -127.76 124.09 36.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.348 0.594 . . . . 0.0 112.075 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -81.26 140.11 35.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.531 0.682 . . . . 0.0 111.382 166.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.93 120.72 11.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.75 -0.09 86.93 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.6 t -95.14 139.21 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.295 2.047 . . . . 0.0 110.122 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -76.81 110.11 11.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 112.135 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -134.52 169.39 17.35 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 123.699 0.8 . . . . 0.0 111.513 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -97.62 121.95 40.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 112.539 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -93.0 -66.56 0.91 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.341 16.0 m-80 92.55 129.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 125.732 1.613 . . . . 0.0 113.285 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.7 mt -74.12 -67.06 0.65 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 179.23 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 125.493 1.517 . . . . 0.0 109.359 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -66.6 -47.01 74.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.99 70.31 0.1 OUTLIER Glycine 0 N--CA 1.484 1.878 0 CA-C-N 118.744 0.702 . . . . 0.0 114.079 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 m -163.08 116.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.719 -0.871 . . . . 0.0 108.931 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.62 128.25 35.27 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.597 0.713 . . . . 0.0 111.049 167.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.12 111.86 24.1 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.081 0.952 . . . . 0.0 111.656 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.55 113.59 25.26 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.36 1.064 . . . . 0.0 110.948 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.51 -152.69 21.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -125.47 124.16 40.78 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 122.939 0.496 . . . . 0.0 111.937 -158.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -84.64 106.05 15.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.181 -0.949 . . . . 0.0 109.582 158.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -105.11 131.39 52.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.04 0.536 . . . . 0.0 110.6 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -82.57 98.0 8.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.869 -1.144 . . . . 0.0 110.639 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.41 83.85 7.57 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.685 0.755 . . . . 0.0 109.514 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -78.83 0.3 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 115.494 0.958 . . . . 0.0 115.494 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -112.28 -29.0 7.7 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -97.02 136.96 36.83 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 121.533 1.97 . . . . 0.0 111.973 -169.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.81 101.61 11.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -92.1 110.98 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 CA-C-O 122.2 1.0 . . . . 0.0 109.858 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.04 96.75 2.24 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 124.381 0.991 . . . . 0.0 112.884 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -91.99 94.84 9.47 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -119.21 107.28 13.24 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.891 0.476 . . . . 0.0 111.814 -163.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -73.21 141.15 47.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.81 -1.181 . . . . 0.0 112.054 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -69.14 132.81 47.15 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.175 0.988 . . . . 0.0 112.321 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.9 p -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 164.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -61.65 -74.58 0.08 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -89.1 -31.1 18.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.44 3.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -130.48 139.81 50.53 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 118.027 0.913 . . . . 0.0 109.764 171.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -72.4 102.52 3.19 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 123.497 1.618 . . . . 0.0 114.036 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -78.63 121.05 24.18 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.348 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -96.5 120.46 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 122.088 -0.382 . . . . 0.0 110.427 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -119.51 109.39 15.67 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.966 0.507 . . . . 0.0 110.001 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.15 108.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 120.358 -1.464 . . . . 0.0 109.267 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -88.59 119.75 29.34 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.425 0.69 . . . . 0.0 109.739 166.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -141.12 139.45 33.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 0.0 110.807 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.37 120.41 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.818 -1.176 . . . . 0.0 110.073 170.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.4 mt -116.09 94.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.17 -101.23 1.11 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.459 -0.776 . . . . 0.0 114.638 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -123.66 43.28 3.01 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 165.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.25 125.2 27.28 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.343 1.057 . . . . 0.0 108.683 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -86.48 105.99 17.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 m -88.89 115.7 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 109.225 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -107.64 95.99 6.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.418 -0.801 . . . . 0.0 110.067 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 86.2 m -91.11 96.76 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.035 0.534 . . . . 0.0 110.86 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -81.61 129.7 34.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.91 0.884 . . . . 0.0 111.323 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -126.31 115.55 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -120.9 117.96 28.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 118.545 0.611 . . . . 0.0 111.875 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 55.14 26.58 8.44 Favored 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.17 -32.28 7.73 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 -160.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.39 130.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.651 2.225 . . . . 0.0 113.48 -166.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.1 142.45 28.68 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.94 123.23 14.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.06 -1.025 . . . . 0.0 111.232 153.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -110.03 87.39 2.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -70.02 99.21 1.41 Allowed 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 170.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.3 mt -101.07 115.99 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -108.27 111.82 23.97 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.402 0.681 . . . . 0.0 110.715 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -78.17 146.03 35.28 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 121.607 0.717 . . . . 0.0 112.285 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -66.3 128.91 38.0 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.257 11.4 t70 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.909 1.684 . . . . 0.0 110.34 -165.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.42 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.69 55.1 1.04 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 119.403 1.002 . . . . 0.0 111.71 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -94.42 82.17 4.02 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 120.067 -1.646 . . . . 0.0 114.491 -163.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -152.42 178.61 9.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.917 -1.114 . . . . 0.0 112.824 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 m -82.83 101.52 11.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.0 -1.063 . . . . 0.0 110.123 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -100.21 97.49 8.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.431 0.692 . . . . 0.0 110.067 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -97.96 139.24 34.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.603 . . . . 0.0 111.711 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 8.5 p -70.89 115.23 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.46 -60.83 2.2 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.64 0.776 . . . . 0.0 111.985 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -134.5 158.95 42.63 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 122.567 1.175 . . . . 0.0 111.094 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -156.97 143.44 18.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 119.397 -2.064 . . . . 0.0 112.025 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.49 139.19 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.235 0.541 . . . . 0.0 111.526 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.305 57.0 t30 53.99 38.92 29.91 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -81.05 -47.3 13.76 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.98 -37.42 74.19 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -51.61 66.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.528 1.058 . . . . 0.0 113.771 170.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -48.8 -53.44 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.674 ' SD ' HG11 ' A' ' 23' ' ' VAL . 11.8 mmt -55.06 -43.33 73.75 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -43.67 98.44 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 165.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.3 mtm -60.39 -61.51 2.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.71 56.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.347 0 CA-C-N 118.832 0.742 . . . . 0.0 114.925 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.674 HG11 ' SD ' ' A' ' 18' ' ' MET . 8.2 p -129.96 127.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -76.71 163.16 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -50.88 -44.88 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -169.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 -46.94 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 119.795 1.18 . . . . 0.0 113.052 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -57.79 -39.67 78.08 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 mtm105 -60.39 -29.05 68.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 167.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 121.258 1.845 . . . . 0.0 114.524 164.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.68 -38.43 84.92 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 165.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.07 -58.54 7.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.58 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -89.69 52.39 2.31 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 118.881 0.764 . . . . 0.0 112.252 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -77.39 -51.58 10.57 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.375 -1.453 . . . . 0.0 113.743 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 37.4 m-80 66.19 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.179 0.992 . . . . 0.0 111.646 -163.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -72.28 120.66 18.2 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -119.16 114.25 22.16 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.373 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.08 101.01 11.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.839 0.456 . . . . 0.0 109.806 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -87.02 105.92 17.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.98 -1.075 . . . . 0.0 109.22 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.9 mt -102.61 130.36 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 C-N-CA 123.211 0.605 . . . . 0.0 109.417 -168.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -114.9 134.36 55.22 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.184 0.594 . . . . 0.0 109.678 160.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -96.24 96.93 9.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 109.852 155.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -83.56 78.47 9.67 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 122.69 1.234 . . . . 0.0 112.024 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.26 -96.17 2.04 Favored Glycine 0 N--CA 1.488 2.124 0 O-C-N 121.568 -0.708 . . . . 0.0 113.002 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -99.08 -47.57 5.18 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.22 134.24 56.79 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -172.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -97.04 108.51 21.25 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.011 0.924 . . . . 0.0 109.316 174.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.4 m -90.07 100.13 13.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 164.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -94.93 102.9 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -88.04 93.01 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.616 -0.677 . . . . 0.0 109.282 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.59 120.73 24.92 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.592 0.357 . . . . 0.0 111.527 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -122.63 116.83 24.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.479 0.712 . . . . 0.0 109.396 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -149.03 168.83 22.09 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 122.364 1.078 . . . . 0.0 112.76 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 m -60.16 -37.85 81.38 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.84 -43.88 62.09 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.65 153.56 31.54 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.74 1.154 . . . . 0.0 111.36 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.13 104.14 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.554 -0.716 . . . . 0.0 110.298 166.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.49 159.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.043 0.925 . . . . 0.0 112.07 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -99.75 110.4 22.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.605 -1.309 . . . . 0.0 110.064 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.04 100.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.69 126.34 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.25 0.62 . . . . 0.0 109.794 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.55 141.88 21.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.73 -0.606 . . . . 0.0 111.982 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -92.02 147.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 112.084 170.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.86 91.47 5.37 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.07 -47.6 1.0 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 116.261 1.264 . . . . 0.0 116.261 -160.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -85.25 127.14 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.008 1.404 . . . . 0.0 109.912 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 t -74.41 142.27 45.02 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -141.83 166.48 24.62 Favored 'General case' 0 CA--C 1.572 1.807 0 C-N-CA 123.815 0.846 . . . . 0.0 112.253 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.85 104.46 16.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.382 0.61 . . . . 0.0 110.516 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -89.08 83.13 6.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 112.01 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -86.12 132.6 33.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.915 -1.115 . . . . 0.0 112.669 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.27 -69.72 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -166.06 -57.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 119.57 1.077 . . . . 0.0 111.722 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -45.24 -71.5 0.07 Allowed 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 165.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.98 45.61 0.02 OUTLIER Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.887 1.232 . . . . 0.0 112.872 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 m -99.84 103.54 15.16 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.14 84.68 4.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 111.346 -158.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.5 95.56 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.327 -0.858 . . . . 0.0 113.214 -162.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -78.81 116.11 18.94 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.463 0.705 . . . . 0.0 110.837 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.32 9.77 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 115.539 0.976 . . . . 0.0 115.539 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.1 m -160.72 144.97 13.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.874 -0.78 . . . . 0.0 110.39 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.17 102.72 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 162.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -97.75 140.51 32.02 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.355 0.662 . . . . 0.0 111.864 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.79 102.15 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.819 -1.176 . . . . 0.0 111.016 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.15 84.94 4.92 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.004 0.906 . . . . 0.0 110.203 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.69 -81.99 0.61 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -119.38 -5.26 10.37 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -114.11 137.86 51.19 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 121.087 1.767 . . . . 0.0 110.237 -171.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.5 mt -82.54 106.42 14.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.45 -1.406 . . . . 0.0 110.105 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 tt -92.25 111.55 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 CA-C-O 122.399 1.095 . . . . 0.0 109.752 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.39 94.09 1.96 Allowed Glycine 0 N--CA 1.478 1.475 0 C-N-CA 123.878 0.751 . . . . 0.0 113.232 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -90.29 109.84 20.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -133.84 145.64 49.89 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.896 0.855 . . . . 0.0 111.512 -168.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -124.76 132.8 53.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.421 -0.799 . . . . 0.0 109.503 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -64.25 127.4 31.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 112.44 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.32 0.4 OUTLIER -82.8 -27.39 30.97 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -57.39 -54.82 42.44 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 164.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -93.47 -39.77 10.7 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.32 -13.59 51.52 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -158.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -96.03 153.66 17.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.383 1.592 . . . . 0.0 113.669 -160.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.48 134.56 34.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -166.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -119.47 129.65 54.84 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.7 1.2 . . . . 0.0 110.435 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -118.73 108.87 15.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.685 . . . . 0.0 109.491 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -115.47 112.95 23.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.916 -0.49 . . . . 0.0 111.981 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.29 116.12 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.984 -1.072 . . . . 0.0 109.215 -173.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -91.58 117.36 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.765 -0.585 . . . . 0.0 109.66 166.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.55 149.71 37.82 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.112 0.958 . . . . 0.0 112.478 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -89.51 103.87 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.395 -0.816 . . . . 0.0 109.354 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.6 tt -95.6 72.26 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.05 0.928 . . . . 0.0 110.96 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.88 59.75 6.74 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.353 24.8 m-20 79.59 -34.37 0.14 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.92 130.77 42.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 120.01 1.277 . . . . 0.0 113.034 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 46.7 tp -87.72 105.48 17.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.887 -1.133 . . . . 0.0 110.101 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.81 109.71 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.903 0.859 . . . . 0.0 110.295 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.11 104.53 17.09 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -106.93 91.11 3.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.216 0.607 . . . . 0.0 110.046 -162.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -81.87 102.04 10.6 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.456 0.703 . . . . 0.0 112.083 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.2 t -98.94 107.03 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.403 ' OH ' ' OE2' ' A' ' 120' ' ' GLU . 33.7 t80 -122.16 114.58 21.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.83 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.403 ' OE2' ' OH ' ' A' ' 119' ' ' TYR . 47.5 mt-10 51.7 39.03 24.39 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 -32.86 5.89 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 118.673 2.229 . . . . 0.0 118.673 -165.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.15 110.27 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 120.578 2.189 . . . . 0.0 112.238 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -86.84 117.95 25.91 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.97 0.508 . . . . 0.0 111.662 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.11 118.44 32.85 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.537 0.684 . . . . 0.0 111.949 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -100.42 122.61 43.45 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.081 0.552 . . . . 0.0 110.815 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -108.39 111.91 24.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 167.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.91 112.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -105.55 135.62 46.62 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 121.383 0.611 . . . . 0.0 112.249 -170.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.44 146.81 25.02 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 122.003 0.906 . . . . 0.0 111.515 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -81.01 90.4 5.97 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 121.445 0.641 . . . . 0.0 112.637 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 5.3 t0 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.21 1.404 . . . . 0.0 113.821 172.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 122.118 0.961 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -105.13 40.52 1.5 Allowed 'General case' 0 CA--C 1.576 1.975 0 O-C-N 121.565 -0.709 . . . . 0.0 112.273 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.25 3.4 p-10 -95.83 88.32 4.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.93 -1.731 . . . . 0.0 114.171 -158.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 p -148.2 -170.81 3.69 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 122.292 1.044 . . . . 0.0 112.309 170.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -87.16 114.92 24.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.938 -1.101 . . . . 0.0 109.373 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -119.73 106.24 11.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.74 136.84 42.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.178 -0.951 . . . . 0.0 112.814 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.61 117.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 113.566 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -101.11 -55.84 2.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.1 0.56 . . . . 0.0 111.588 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -85.56 -78.66 0.26 Allowed 'General case' 0 CA--C 1.57 1.722 0 O-C-N 121.757 -0.589 . . . . 0.0 112.248 -162.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.268 16.1 m 57.66 95.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.287 13.5 tm-20 -87.12 -110.19 0.06 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.938 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -86.27 58.9 5.32 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-N 121.474 1.943 . . . . 0.0 115.136 -169.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -70.12 -31.82 69.54 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 165.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -48.61 -54.09 15.94 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 169.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.26 -31.93 68.11 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -55.88 -52.85 62.63 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 164.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.64 -46.55 73.96 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -55.72 -47.66 76.52 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.29 -44.25 75.54 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.3 mtt -65.78 -35.25 80.18 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.56 61.32 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 CA-C-N 119.703 1.138 . . . . 0.0 115.029 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.29 145.37 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.285 0.564 . . . . 0.0 111.447 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -80.83 156.57 26.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.594 -1.316 . . . . 0.0 114.126 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.273 14.8 tt -53.66 -42.22 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.44 -45.23 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -58.26 -46.35 86.18 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -52.12 -51.6 56.84 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.86 -49.09 77.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -58.5 -37.79 76.31 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.16 -38.45 31.36 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.3 -53.1 54.26 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 163.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -88.95 53.92 2.84 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 119.362 0.983 . . . . 0.0 113.181 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.11 -31.99 26.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 66.53 49.68 1.33 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 124.663 1.185 . . . . 0.0 113.383 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.9 121.54 23.58 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 122.682 1.229 . . . . 0.0 113.363 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -111.46 106.31 15.17 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.364 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.05 94.72 7.85 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.3 m -87.06 100.19 12.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 49' ' ' VAL . 60.6 mt -93.87 127.85 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 p -129.11 110.74 12.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -91.44 101.09 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.9 . . . . 0.0 109.951 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.52 -35.5 30.28 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.3 81.77 0.04 OUTLIER Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.336 -0.853 . . . . 0.0 111.292 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 6.7 t-20 70.18 -52.48 0.64 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -159.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -62.8 137.92 58.39 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -112.61 109.45 19.0 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -84.23 103.1 13.14 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.543 0.737 . . . . 0.0 109.107 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 40' ' ' ILE . 17.7 m -105.89 108.27 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.73 89.74 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.527 -0.733 . . . . 0.0 109.568 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.66 85.4 6.05 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.912 0.863 . . . . 0.0 111.872 -163.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.4 m -101.84 98.19 8.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.707 -0.621 . . . . 0.0 111.527 -154.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.7 p -127.44 171.03 11.92 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.65 0.78 . . . . 0.0 112.926 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -75.05 66.05 1.55 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.829 -1.169 . . . . 0.0 110.95 163.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.36 -62.18 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 123.949 0.899 . . . . 0.0 111.416 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.291 42.1 ptt85 -138.55 -62.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.268 30.8 t-20 66.0 91.07 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.42 1.463 . . . . 0.0 113.944 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.7 143.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.436 0.636 . . . . 0.0 110.762 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -80.92 101.4 9.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.476 0.655 . . . . 0.0 112.005 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.12 106.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.6 97.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -109.18 126.98 53.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.21 148.97 21.98 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.782 0.801 . . . . 0.0 111.7 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.49 119.77 15.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 113.813 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.63 1.46 89.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -91.77 132.81 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 120.144 1.972 . . . . 0.0 109.872 -173.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -78.28 110.74 13.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 112.155 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -132.75 159.64 39.12 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.636 0.731 . . . . 0.0 112.549 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.88 105.75 17.95 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.512 -0.742 . . . . 0.0 111.302 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -93.08 116.2 28.82 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.081 0.952 . . . . 0.0 110.559 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -89.91 131.0 36.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.009 -1.057 . . . . 0.0 111.558 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt -73.75 -177.22 2.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.646 -1.284 . . . . 0.0 114.242 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -58.5 4.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.244 -1.535 . . . . 0.0 113.566 167.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -41.19 -44.64 2.64 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.28 71.37 0.39 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 123.914 0.768 . . . . 0.0 111.429 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.7 m -157.34 141.32 16.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.59 -0.947 . . . . 0.0 109.846 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -117.54 124.94 49.93 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -155.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.96 109.42 8.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.836 -1.165 . . . . 0.0 112.09 -162.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.52 112.64 24.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.057 -1.027 . . . . 0.0 111.141 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.39 -149.91 15.81 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 117.209 1.644 . . . . 0.0 117.209 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -133.8 123.38 24.74 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.438 -152.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -82.53 116.23 21.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.942 -0.474 . . . . 0.0 110.233 158.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.2 m -113.63 134.63 54.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 111.248 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 tp -85.66 115.55 23.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 110.689 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.71 -93.41 0.1 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 123.089 0.555 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.49 -86.18 1.9 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 119.432 1.014 . . . . 0.0 111.49 169.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -110.95 47.01 1.02 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 117.047 0.424 . . . . 0.0 111.901 161.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -140.82 122.27 15.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.858 -1.151 . . . . 0.0 108.394 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.29 105.09 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.93 112.13 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.33 95.87 1.51 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -85.3 113.6 21.75 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -137.67 111.35 8.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.08 0.552 . . . . 0.0 111.053 -165.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -87.2 129.98 34.74 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 120.489 -1.382 . . . . 0.0 112.919 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -62.02 139.35 58.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 163.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.0 p -72.02 -51.22 22.82 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 -49.81 64.44 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -86.91 -36.95 18.08 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.03 12.08 79.16 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -173.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.41 -18.66 44.64 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.752 3.242 . . . . 0.0 119.752 -165.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.346 5.4 tt0 67.14 100.97 0.05 OUTLIER 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.95 132.29 41.31 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.735 0.814 . . . . 0.0 110.703 160.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -112.72 97.4 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 t -92.64 110.15 21.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.498 0.666 . . . . 0.0 110.177 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.56 117.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -103.05 119.32 38.64 Favored 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.663 0.785 . . . . 0.0 110.612 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -144.08 142.43 30.62 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.774 0.83 . . . . 0.0 110.477 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -84.43 111.69 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 108.155 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.26 98.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.25 -106.27 2.78 Favored Glycine 0 N--CA 1.488 2.116 0 O-C-N 121.847 -0.533 . . . . 0.0 112.927 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.4 ' OD1' ' OE2' ' A' ' 112' ' ' GLU . 3.3 p-10 -92.97 -30.31 15.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE2' ' OD1' ' A' ' 111' ' ' ASP . 3.9 mt-10 -102.19 141.33 35.2 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.149 0.975 . . . . 0.0 112.975 -160.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.59 104.8 5.42 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.003 164.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.34 103.82 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 95.13 5.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -105.61 111.1 23.66 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.751 0.421 . . . . 0.0 110.473 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.75 112.4 18.87 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.718 0.407 . . . . 0.0 110.284 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.83 114.72 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -139.43 108.1 5.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.204 0.602 . . . . 0.0 109.768 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 54.98 50.88 14.53 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.32 -27.75 4.5 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.939 2.335 . . . . 0.0 118.939 -166.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.72 130.06 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.722 1.761 . . . . 0.0 110.485 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -101.29 107.96 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.05 0.54 . . . . 0.0 109.968 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.21 98.75 9.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -93.84 87.83 5.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.732 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -90.99 104.42 17.02 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.69 121.32 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.721 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -109.32 119.37 39.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.601 0.76 . . . . 0.0 110.504 -166.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -76.27 147.88 37.97 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 122.152 0.977 . . . . 0.0 113.43 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -68.13 109.53 3.57 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 123.804 0.842 . . . . 0.0 112.829 175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 125.118 1.367 . . . . 0.0 112.569 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.49 -26.99 22.92 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -165.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.36 174.09 5.16 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.392 37.0 p 86.83 -177.79 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.625 1.57 . . . . 0.0 114.075 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.9 m -96.92 129.07 44.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.654 -1.279 . . . . 0.0 111.405 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -122.26 102.73 8.3 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -100.53 144.66 29.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.54 0.686 . . . . 0.0 112.268 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.77 122.8 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.58 -68.05 0.78 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.795 163.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.17 128.17 44.29 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.556 0.693 . . . . 0.0 111.585 -172.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -109.44 120.48 42.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.654 0.782 . . . . 0.0 111.028 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.26 130.39 47.39 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.386 0.675 . . . . 0.0 110.538 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 18.7 t30 53.74 21.63 2.77 Favored 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 119.48 3.141 . . . . 0.0 119.48 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.44 -42.24 71.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -59.08 -38.91 80.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.75 -48.41 81.78 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 120.602 1.546 . . . . 0.0 114.837 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -48.13 -61.02 2.19 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 mtt -66.94 -35.75 80.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -63.83 -42.86 97.55 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 167.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -56.78 -42.98 80.4 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 164.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtp -51.34 -30.5 18.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 164.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.46 47.68 4.24 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 116.165 1.226 . . . . 0.0 116.165 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.43 163.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 122.197 0.998 . . . . 0.0 112.188 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -66.84 144.38 56.32 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.694 -1.254 . . . . 0.0 112.804 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.281 15.4 tt -56.89 -40.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.01 -44.68 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 119.554 1.07 . . . . 0.0 113.28 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -58.96 -40.99 86.38 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -35.35 79.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -67.11 -48.37 68.33 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 114.157 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -53.64 -24.92 15.67 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 165.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.76 -51.44 59.17 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 120.955 1.707 . . . . 0.0 114.602 164.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.74 -44.32 63.25 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -106.52 61.14 0.64 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 167.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.3 5.6 p30 -82.08 -35.5 28.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.304 -1.498 . . . . 0.0 114.698 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 54.95 44.44 28.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -76.3 122.08 23.9 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -111.28 133.77 53.37 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.551 0.74 . . . . 0.0 111.745 166.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.53 102.75 10.59 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -85.78 100.93 12.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.304 -0.872 . . . . 0.0 109.403 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -93.83 127.94 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -141.29 125.39 17.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.131 -0.981 . . . . 0.0 110.207 171.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -95.03 122.98 38.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.687 -0.633 . . . . 0.0 111.396 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -105.45 76.41 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.571 0.7 . . . . 0.0 109.895 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.13 78.05 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 115.994 1.157 . . . . 0.0 115.994 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 4.3 m-80 70.26 -50.27 0.65 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -167.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -73.64 120.74 19.65 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.017 0.927 . . . . 0.0 112.726 -172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -98.85 125.26 44.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.223 0.609 . . . . 0.0 111.919 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.6 m -94.78 108.13 20.14 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 165.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -105.29 101.47 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.16 104.87 17.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.16 145.03 35.88 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 121.936 0.874 . . . . 0.0 112.473 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -149.49 117.98 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.844 -1.16 . . . . 0.0 110.068 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 t -150.33 167.21 27.68 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 124.541 1.136 . . . . 0.0 111.26 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -51.9 -29.7 21.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -63.06 -53.86 47.15 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -171.78 171.29 5.26 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.226 1.01 . . . . 0.0 112.312 -162.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -133.26 119.58 19.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.731 -1.23 . . . . 0.0 111.129 161.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.4 pt -140.02 150.22 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-O 122.171 0.986 . . . . 0.0 111.521 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.12 106.63 18.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.7 t -95.59 93.61 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 t -93.91 120.77 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -135.51 139.48 44.02 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.145 0.974 . . . . 0.0 113.311 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.15 142.4 27.54 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 121.853 0.835 . . . . 0.0 110.858 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.22 92.79 1.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.397 -0.814 . . . . 0.0 112.84 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.37 -27.44 5.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.659 1.823 . . . . 0.0 117.659 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.08 127.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.036 1.918 . . . . 0.0 110.422 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -75.07 102.23 4.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.236 0.615 . . . . 0.0 111.309 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -112.27 150.6 30.73 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.754 0.822 . . . . 0.0 112.069 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -90.97 101.48 14.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.689 -0.632 . . . . 0.0 110.661 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.31 104.72 17.02 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.48 -0.762 . . . . 0.0 110.529 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -72.49 114.86 11.07 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.65 150.33 39.62 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.699 0.761 . . . . 0.0 111.769 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.39 0.03 7.35 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 121.683 3.957 . . . . 0.0 121.683 -160.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.05 -79.68 0.19 Allowed 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.3 1.409 . . . . 0.0 109.474 157.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.71 63.88 0.15 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 119.108 0.867 . . . . 0.0 115.163 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.8 m -134.39 103.33 5.67 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 117.561 0.68 . . . . 0.0 109.657 -172.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -75.65 107.19 7.65 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.586 0.707 . . . . 0.0 112.536 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.3 mt -84.24 104.36 14.21 Favored 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.427 -0.795 . . . . 0.0 110.536 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -87.17 110.35 20.09 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.448 1.099 . . . . 0.0 110.758 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.8 -157.87 30.39 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -128.37 136.18 50.57 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 122.903 0.481 . . . . 0.0 111.957 -165.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -91.56 114.93 27.59 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 153.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -107.19 136.9 46.25 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.084 0.554 . . . . 0.0 111.176 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.8 tp -89.31 104.39 16.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.972 -1.08 . . . . 0.0 110.987 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -78.09 -42.74 31.11 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.53 -92.27 0.08 OUTLIER Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -74.77 3.45 7.99 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 156.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -126.62 119.47 27.12 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.802 1.183 . . . . 0.0 108.772 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.07 102.34 13.76 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 160.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.88 113.55 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 C-N-CA 124.093 0.957 . . . . 0.0 109.25 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.8 104.1 3.01 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.044 0.83 . . . . 0.0 113.164 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.07 99.96 11.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.51 152.36 41.83 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.285 1.04 . . . . 0.0 112.121 -172.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -125.48 146.03 49.82 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.765 0.793 . . . . 0.0 110.056 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -65.41 129.57 40.23 Favored 'General case' 0 CA--C 1.565 1.556 0 O-C-N 120.827 -1.171 . . . . 0.0 112.11 170.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -85.63 38.17 0.73 Allowed 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 122.122 0.963 . . . . 0.0 112.298 158.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -160.74 45.35 0.2 Allowed 'General case' 0 CA--C 1.585 2.314 0 C-N-CA 124.845 1.258 . . . . 0.0 110.314 -157.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.38 51.6 p30 138.11 -50.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.763 2.425 . . . . 0.0 111.469 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.8 2.14 27.12 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -90.48 145.61 24.77 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.514 2.157 . . . . 0.0 112.649 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -70.49 151.06 45.51 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.87 113.89 12.02 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -104.61 132.19 51.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.618 -0.676 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -142.85 139.2 30.77 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.8 t -120.92 118.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -96.54 120.94 37.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 162.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -146.34 165.28 29.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.82 111.58 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.634 -1.291 . . . . 0.0 109.307 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.19 85.99 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.046 0.927 . . . . 0.0 110.204 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.95 -84.31 1.02 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.079 -1.013 . . . . 0.0 114.622 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -141.62 48.07 1.64 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 163.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -142.75 136.91 29.37 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -81.49 105.7 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.478 -1.389 . . . . 0.0 111.177 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.33 109.76 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.749 0.785 . . . . 0.0 110.442 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -98.13 104.43 16.46 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -91.47 142.6 27.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 123.257 0.623 . . . . 0.0 109.61 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -151.2 116.88 5.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.789 -1.194 . . . . 0.0 110.513 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.72 125.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.359 1.064 . . . . 0.0 108.505 -171.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 110.97 10.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.969 0.507 . . . . 0.0 109.791 173.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 68.02 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 175.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 -31.19 1.92 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.826 2.291 . . . . 0.0 118.826 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.98 102.72 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 119.311 1.556 . . . . 0.0 109.189 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.66 133.41 33.7 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.197 0.998 . . . . 0.0 111.104 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.24 156.25 47.86 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.108 0.956 . . . . 0.0 111.722 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -133.89 149.84 51.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.939 0.876 . . . . 0.0 111.855 -170.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -141.1 119.39 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.019 -1.051 . . . . 0.0 108.54 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt -101.52 108.02 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -94.3 123.23 37.56 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.629 0.772 . . . . 0.0 110.015 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -79.57 165.47 22.91 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.06 112.76 6.67 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.802 -1.186 . . . . 0.0 112.859 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 125.151 1.38 . . . . 0.0 113.372 178.361 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.306 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 67.61 -1.75 1.53 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.12 101.61 2.29 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.232 1.378 . . . . 0.0 112.756 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.5 m 179.61 165.56 1.1 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.145 1.378 . . . . 0.0 110.518 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.1 m -96.33 111.98 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 167.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -108.8 114.25 27.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.776 -0.578 . . . . 0.0 110.509 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -92.74 135.29 34.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.105 -0.997 . . . . 0.0 112.559 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.3 129.22 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.885 -1.134 . . . . 0.0 113.61 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -119.0 -65.17 1.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.168 0.987 . . . . 0.0 110.998 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 75.46 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.345 0.658 . . . . 0.0 111.494 -165.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.411 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 13.4 p -85.89 139.59 31.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.341 2.5 tm-20 -94.06 -97.78 0.15 Allowed 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.542 -166.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.255 19.3 t30 -100.0 50.22 0.91 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.143 -1.598 . . . . 0.0 113.345 -167.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -76.84 -39.73 50.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.06 -40.55 98.04 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -67.19 -43.79 81.25 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -47.02 -54.97 9.06 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 161.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtp -65.32 -34.11 77.55 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -53.79 -46.36 71.0 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 163.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.66 -41.31 98.22 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.9 mmm -54.11 -48.95 70.19 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.06 65.72 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 123.536 0.589 . . . . 0.0 114.209 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.41 131.51 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.749 0.785 . . . . 0.0 110.701 -174.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.67 161.86 24.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.9 tt -58.23 158.03 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.384 42.3 t 82.14 -73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 C-N-CA 124.573 1.149 . . . . 0.0 109.267 -161.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -53.51 -50.68 64.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -64.07 -24.82 67.85 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -71.14 -48.54 51.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 121.67 2.032 . . . . 0.0 113.545 167.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.6 mt -56.0 -48.69 75.44 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 165.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.08 81.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -49.22 78.32 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.103 1.774 . . . . 0.0 115.355 165.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -92.3 59.95 3.57 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 121.79 -0.569 . . . . 0.0 111.439 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -74.3 -27.64 60.81 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.75 38.2 11.98 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.308 1.5 pt? -81.16 151.45 28.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -169.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -127.75 114.31 17.12 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.822 -173.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.8 mt -97.39 99.15 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.82 -1.175 . . . . 0.0 111.236 -170.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.2 m -85.71 95.02 9.25 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.886 0.851 . . . . 0.0 109.818 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.0 mt -95.71 121.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -133.6 69.57 1.47 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.606 0.639 . . . . 0.0 111.973 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -58.36 110.64 1.0 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -165.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.15 62.29 2.15 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.47 84.69 0.17 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.312 -0.867 . . . . 0.0 114.76 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.32 -66.21 0.29 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.546 1.173 . . . . 0.0 112.651 -160.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -67.93 123.69 21.29 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.347 1.059 . . . . 0.0 113.676 -161.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.21 107.9 19.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.265 -0.897 . . . . 0.0 110.825 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -90.9 101.99 14.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -112.11 102.36 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -85.42 97.34 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.04 93.29 9.33 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.734 0.778 . . . . 0.0 108.964 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.6 t -91.99 89.39 6.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.359 0.599 . . . . 0.0 111.8 -164.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.2 p -100.61 162.64 12.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -51.68 -36.63 47.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 163.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.09 -46.92 63.87 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -162.81 137.96 6.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.962 0.905 . . . . 0.0 111.342 -161.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -100.75 101.88 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 163.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 pt -103.89 113.45 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.107 0.563 . . . . 0.0 110.105 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -77.9 89.42 4.1 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.768 0.794 . . . . 0.0 112.024 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.88 106.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.95 104.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -117.85 132.28 56.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.925 -0.484 . . . . 0.0 112.255 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 157.45 24.66 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.778 1.275 . . . . 0.0 111.304 159.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.53 102.27 8.73 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.679 -1.263 . . . . 0.0 111.386 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.1 3.08 51.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 119.026 2.371 . . . . 0.0 119.026 -162.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.54 132.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 121.55 2.675 . . . . 0.0 112.222 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -82.99 102.9 12.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.283 -0.885 . . . . 0.0 110.768 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -139.13 157.58 45.71 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 112.997 -171.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.33 110.55 19.18 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.224 0.609 . . . . 0.0 111.533 173.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -100.61 113.66 26.68 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.122 0.969 . . . . 0.0 110.8 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.61 128.67 35.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 mt -84.8 165.97 17.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 112.321 167.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.16 -73.51 0.05 Allowed 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -114.43 59.13 0.69 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 120.397 1.453 . . . . 0.0 111.096 158.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.5 41.68 0.66 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.389 0.6 OUTLIER 75.91 163.67 0.25 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 163.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.06 119.19 22.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-O 122.327 1.061 . . . . 0.0 111.322 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.38 111.32 23.58 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.689 0.796 . . . . 0.0 110.418 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -95.32 116.89 29.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 112.294 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.22 -150.58 18.59 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -133.48 116.63 16.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.274 -0.545 . . . . 0.0 112.278 -160.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.59 119.79 20.12 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.55 0.614 . . . . 0.0 111.036 158.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -132.21 150.81 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.701 0.8 . . . . 0.0 111.419 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -98.92 103.57 15.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.658 -1.276 . . . . 0.0 112.019 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -91.69 81.81 5.27 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.01 0.91 . . . . 0.0 110.083 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.9 -105.89 1.84 Allowed Glycine 0 N--CA 1.491 2.303 0 O-C-N 121.411 -0.806 . . . . 0.0 114.777 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.62 10.72 37.71 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -113.54 116.75 30.03 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.836 1.198 . . . . 0.0 110.005 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -77.25 96.75 4.63 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.971 -1.08 . . . . 0.0 109.22 163.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.58 111.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.994 0.918 . . . . 0.0 108.89 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.99 98.06 1.85 Allowed Glycine 0 N--CA 1.475 1.284 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -78.52 105.07 9.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.36 134.11 47.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 111.306 -165.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -106.29 140.59 38.99 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 111.257 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -66.71 122.95 18.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.566 -1.334 . . . . 0.0 112.366 167.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -63.45 -25.74 68.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 -44.98 94.97 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.95 -4.93 0.21 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -160.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.8 7.17 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 118.596 2.198 . . . . 0.0 118.596 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.87 -29.47 12.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -172.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.328 1.8 mt-10 71.46 112.98 0.06 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 124.73 1.212 . . . . 0.0 113.296 -160.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 114.78 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 164.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.68 134.7 35.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 111.522 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.2 p -131.3 116.37 17.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.962 -0.461 . . . . 0.0 110.654 -167.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -114.36 106.62 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 120.854 -1.154 . . . . 0.0 108.458 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -90.54 122.23 33.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.217 162.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.33 144.18 31.33 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.76 1.164 . . . . 0.0 113.882 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -96.56 104.61 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.85 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 174.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.11 -97.56 0.14 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -99.78 25.19 7.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.98 149.18 41.45 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.265 1.031 . . . . 0.0 110.213 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.7 tp -100.22 112.64 24.96 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 168.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.12 120.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -110.15 91.62 3.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.7 m -89.13 101.96 14.62 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.964 0.905 . . . . 0.0 109.413 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -103.25 116.07 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.827 -0.546 . . . . 0.0 110.162 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.92 123.95 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -126.06 111.81 15.13 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.36 0.664 . . . . 0.0 110.544 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.3 OUTLIER 52.79 53.98 11.26 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.14 -25.36 1.58 Allowed Glycine 0 CA--C 1.556 2.616 0 N-CA-C 119.292 2.477 . . . . 0.0 119.292 -165.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.47 109.48 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 119.362 1.581 . . . . 0.0 109.246 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -85.04 143.98 28.55 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.914 0.885 . . . . 0.0 112.807 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.36 121.17 17.51 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.472 -0.768 . . . . 0.0 110.813 162.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -100.44 110.01 22.18 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.411 ' HE ' ' HB3' ' A' ' 11' ' ' SER . 49.3 mmm-85 -90.23 109.57 20.64 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.4 mt -109.67 117.52 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.099 -1.0 . . . . 0.0 108.352 -167.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.64 144.77 42.36 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 121.692 0.758 . . . . 0.0 112.179 -167.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -114.34 138.86 49.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.942 0.897 . . . . 0.0 110.205 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -67.78 118.0 10.43 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -174.381 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.304 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.326 50.8 m-85 74.96 -53.15 0.67 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.288 1.959 . . . . 0.0 116.288 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -79.19 98.01 6.43 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.365 0.984 . . . . 0.0 112.471 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 m -168.65 -176.95 2.93 Favored 'General case' 0 CA--C 1.573 1.843 0 C-N-CA 124.95 1.3 . . . . 0.0 110.064 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.0 m -93.16 130.12 38.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.643 -1.286 . . . . 0.0 109.615 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -135.9 112.97 10.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.229 -0.919 . . . . 0.0 111.552 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -102.51 143.21 32.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 112.268 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.252 8.6 p -76.41 90.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.339 1.066 . . . . 0.0 113.319 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -46.17 18.45 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -141.35 79.51 1.69 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.92 1.236 . . . . 0.0 113.16 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -79.75 139.53 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.817 -1.177 . . . . 0.0 114.163 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.343 0.9 OUTLIER -86.87 -91.26 0.11 Allowed 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 123.989 0.916 . . . . 0.0 111.702 -177.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -107.0 43.7 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 121.116 1.78 . . . . 0.0 114.634 -166.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.79 -32.14 63.62 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.52 -44.56 80.91 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -69.1 -38.51 78.97 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.72 -54.09 38.59 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 162.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.535 ' SD ' HG11 ' A' ' 23' ' ' VAL . 8.1 mmt -48.06 -50.98 26.24 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 164.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -56.56 -45.92 81.02 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.2 -38.99 91.22 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.406 ' SD ' HG21 ' A' ' 76' ' ' THR . 71.8 mtm -62.16 -35.02 77.54 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.83 62.63 0.54 Allowed Glycine 0 N--CA 1.49 2.26 0 CA-C-N 119.046 0.839 . . . . 0.0 114.96 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG11 ' SD ' ' A' ' 18' ' ' MET . 16.1 m -118.91 145.6 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.395 0.616 . . . . 0.0 111.175 -170.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -66.7 156.29 35.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.881 -1.137 . . . . 0.0 113.673 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.07 -43.72 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -57.92 -51.64 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -59.95 -44.88 94.12 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -51.6 -48.24 63.29 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -70.56 -58.53 3.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 168.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.15 -32.84 69.43 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.91 65.57 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 121.598 1.999 . . . . 0.0 115.598 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.76 85.25 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 156.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -100.45 49.15 0.9 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -85.47 -7.22 59.02 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 58.87 38.26 24.57 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.288 1.3 pt? -74.28 139.23 44.12 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.698 1.237 . . . . 0.0 113.059 -172.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -136.9 89.1 2.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -155.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.1 mt -89.35 110.16 20.98 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.148 0.579 . . . . 0.0 110.985 -160.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.4 m -89.0 106.71 18.6 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 164.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.01 124.19 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 60.5 p -139.63 118.56 12.52 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.966 -0.459 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -77.5 96.7 4.79 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.646 0.778 . . . . 0.0 111.158 167.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.24 83.57 7.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.688 1.232 . . . . 0.0 111.116 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.51 1.57 Allowed Glycine 0 N--CA 1.489 2.19 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.704 -165.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -131.98 -22.44 2.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.36 115.46 12.74 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 120.282 1.401 . . . . 0.0 112.723 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -78.64 106.13 10.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.477 -0.764 . . . . 0.0 110.025 171.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -88.15 103.64 15.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -104.54 107.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.28 96.15 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.62 90.55 3.95 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -89.77 95.45 10.25 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -129.25 173.06 10.85 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 0.0 112.955 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -58.88 -40.32 84.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.24 -40.17 52.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 151.21 31.08 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 121.677 2.035 . . . . 0.0 113.456 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -111.02 96.15 5.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.83 132.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.591 -0.693 . . . . 0.0 112.443 -168.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.23 109.36 18.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.006 -1.059 . . . . 0.0 111.773 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -95.36 101.0 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.4 t -100.15 116.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -141.51 123.02 15.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -174.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.69 152.93 31.34 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 112.611 166.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.33 106.47 1.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 113.558 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 CA--C 1.552 2.385 0 N-CA-C 118.846 2.299 . . . . 0.0 118.846 -169.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.09 135.67 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 121.127 2.464 . . . . 0.0 112.654 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.7 p -84.42 105.16 15.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.315 -0.865 . . . . 0.0 110.925 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.27 163.04 31.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -100.33 110.11 22.33 Favored 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 123.155 0.582 . . . . 0.0 110.37 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -73.56 -61.7 1.74 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.261 39.2 m-80 77.91 100.95 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.778 1.172 . . . . 0.0 114.055 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.75 176.83 9.17 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.27 68.5 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -72.89 -58.64 3.18 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 171.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.0 58.42 0.04 OUTLIER Glycine 0 CA--C 1.546 2.007 0 C-N-CA 124.288 0.947 . . . . 0.0 110.965 -161.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.406 HG21 ' SD ' ' A' ' 21' ' ' MET . 91.0 m -130.79 96.45 4.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.84 127.94 34.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.481 0.712 . . . . 0.0 109.912 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -137.05 97.97 3.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.765 -1.209 . . . . 0.0 111.806 -157.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.487 HH21 ' HZ1' ' A' ' 94' ' ' LYS . 32.3 ptt180 -91.37 115.63 28.19 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.415 0.686 . . . . 0.0 111.843 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.34 -154.07 23.12 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -127.48 145.58 50.79 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.37 116.36 29.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.131 -0.981 . . . . 0.0 108.995 150.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -106.67 174.7 5.77 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 121.158 0.504 . . . . 0.0 111.462 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -124.29 120.91 33.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.149 -1.594 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.43 83.46 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 109.972 169.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.86 -93.21 0.39 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.266 -0.896 . . . . 0.0 115.227 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -117.69 39.39 3.35 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 166.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.97 110.69 9.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.799 -1.188 . . . . 0.0 108.092 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -82.48 118.27 23.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 109.685 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -111.88 105.84 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.404 0.682 . . . . 0.0 110.219 -167.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.41 95.8 2.11 Favored Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 113.098 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -102.62 102.54 12.77 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.36 134.17 51.14 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.431 0.692 . . . . 0.0 110.911 -168.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HZ1' HH21 ' A' ' 79' ' ' ARG . 0.2 OUTLIER -104.42 127.65 52.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.14 115.23 13.39 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.388 -0.82 . . . . 0.0 112.835 -170.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -59.14 -44.84 92.08 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.96 -39.47 78.18 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -125.48 -28.15 3.35 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -161.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.46 65.95 1.49 Allowed Glycine 0 N--CA 1.492 2.37 0 CA-C-N 120.615 1.552 . . . . 0.0 114.777 -172.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -152.89 137.43 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 117.512 0.656 . . . . 0.0 111.869 -164.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -77.66 122.16 24.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 113.391 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.05 120.19 41.6 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.717 0.807 . . . . 0.0 109.602 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -113.01 108.05 16.81 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.259 15.3 t -115.94 102.26 9.51 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.175 0.59 . . . . 0.0 112.255 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.93 121.08 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.181 -0.949 . . . . 0.0 109.855 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -96.17 125.62 40.82 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.932 0.893 . . . . 0.0 111.423 170.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -149.83 159.77 44.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.989 0.899 . . . . 0.0 112.224 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.29 117.61 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.552 -1.342 . . . . 0.0 109.352 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.73 -51.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.57 77.37 0.08 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.48 0.0 OUTLIER 78.09 -45.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -159.289 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -78.44 143.73 36.46 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.03 116.94 29.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.91 0.884 . . . . 0.0 110.427 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.35 107.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.761 -0.587 . . . . 0.0 109.521 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.48 103.29 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.0 m -101.47 91.5 4.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.313 0.645 . . . . 0.0 109.993 -161.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.55 109.89 18.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.339 1.056 . . . . 0.0 112.892 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.15 119.12 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -124.48 113.25 17.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 50.36 55.33 9.64 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.03 -21.12 1.38 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.36 102.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.739 1.769 . . . . 0.0 108.946 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.84 141.36 28.71 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.71 0.804 . . . . 0.0 112.883 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.98 116.0 12.39 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.493 0.717 . . . . 0.0 111.403 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.35 101.94 13.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 0.0 108.632 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -82.91 101.86 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.7 mt -95.08 106.81 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.41 130.37 43.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.093 0.557 . . . . 0.0 110.945 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -85.47 148.16 26.11 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.459 0.647 . . . . 0.0 111.424 169.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -80.53 90.01 5.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 122.137 0.97 . . . . 0.0 112.035 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -174.03 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 121.443 0.64 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.6 -47.31 14.33 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.728 2.122 . . . . 0.0 116.728 -170.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.58 94.78 5.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.48 1.133 . . . . 0.0 112.244 -163.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -167.21 173.11 9.3 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.745 1.26 . . . . 0.0 111.346 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 m -84.8 129.6 34.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.056 . . . . 0.0 110.613 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -136.24 99.99 4.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.912 -0.493 . . . . 0.0 111.366 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -87.84 136.38 32.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.092 -1.005 . . . . 0.0 112.653 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -65.83 119.89 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.69 -62.75 1.2 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.643 0.777 . . . . 0.0 111.219 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -133.69 103.03 5.7 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.163 0.585 . . . . 0.0 110.985 -160.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -96.56 100.12 11.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.36 -0.837 . . . . 0.0 112.334 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.35 122.46 24.49 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.053 0.541 . . . . 0.0 110.849 -174.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.253 23.8 t30 64.09 12.5 7.05 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -65.76 -43.17 89.68 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.57 -35.95 77.3 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.93 -41.73 50.89 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -45.93 -52.1 12.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 158.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mtt -68.6 -28.94 67.37 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -55.75 -47.07 77.59 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-N 120.871 1.669 . . . . 0.0 114.825 158.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -59.47 -41.4 89.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 167.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.4 mtp -60.91 -39.02 87.76 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 167.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.03 65.29 0.64 Allowed Glycine 0 N--CA 1.486 2.01 0 CA-C-N 118.926 0.784 . . . . 0.0 114.186 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.79 131.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.353 0.596 . . . . 0.0 110.611 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -74.64 153.78 38.8 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 14.1 tt -48.16 -39.4 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -172.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.45 -59.45 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 120.29 1.405 . . . . 0.0 113.024 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -68.0 -37.84 81.92 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.17 -40.99 82.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -60.5 -44.56 95.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 163.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.44 -40.6 75.05 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.17 77.18 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 171.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.96 68.06 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 166.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -94.0 58.31 2.55 Favored 'General case' 0 CA--C 1.575 1.912 0 C-N-CA 123.832 0.853 . . . . 0.0 111.947 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.42 -23.04 18.55 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 61.01 52.33 4.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.693 1.197 . . . . 0.0 114.222 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.0 tp -82.24 114.06 20.48 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.401 -0.812 . . . . 0.0 112.639 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -100.16 105.05 16.61 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.05 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.34 102.32 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.2 m -92.45 105.42 17.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.405 HG12 HG12 ' A' ' 49' ' ' VAL . 60.1 mt -96.57 124.56 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -147.9 107.67 3.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.699 -0.625 . . . . 0.0 111.323 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.01 147.43 26.21 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 171.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.38 -48.53 12.79 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 164.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.84 -68.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.172 -0.955 . . . . 0.0 113.386 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -123.33 48.84 1.77 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.767 -0.843 . . . . 0.0 112.449 164.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -154.14 109.96 3.22 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.033 -1.042 . . . . 0.0 108.318 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -86.08 118.48 25.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.902 0.481 . . . . 0.0 111.752 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.5 m -84.67 102.99 13.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 165.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG12 HG12 ' A' ' 40' ' ' ILE . 31.8 m -100.25 108.63 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.35 99.5 12.3 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.69 74.53 3.69 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.885 -161.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 t -87.99 109.7 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.737 -1.227 . . . . 0.0 113.227 -166.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -139.71 163.55 32.31 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.936 1.294 . . . . 0.0 109.405 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 m -75.57 51.95 0.62 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 119.687 -1.883 . . . . 0.0 112.336 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -174.73 -53.84 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.809 0 C-N-CA 125.06 1.344 . . . . 0.0 111.78 -164.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -93.63 -91.58 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.189 1.359 . . . . 0.0 110.023 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.303 2.1 t30 51.71 57.74 6.22 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.0 pt -119.53 -35.61 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.273 35.0 mt-10 76.98 99.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.086 1.312 . . . . 0.0 112.135 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.66 113.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.15 97.35 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -106.93 136.43 46.78 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -86.4 149.71 24.82 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.201 1.001 . . . . 0.0 112.427 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -80.47 75.23 7.33 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 110.347 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.14 -60.23 0.26 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 -161.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.18 140.59 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 118.402 1.101 . . . . 0.0 112.287 -172.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 p -86.95 118.6 26.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.986 -1.071 . . . . 0.0 110.459 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -140.21 162.23 35.76 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.837 0.827 . . . . 0.0 112.643 -166.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.23 103.55 10.18 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 111.692 167.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -81.77 -48.16 11.97 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 168.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.255 15.4 m-20 69.19 168.05 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.872 1.269 . . . . 0.0 114.168 172.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -101.14 -130.07 0.23 Allowed 'General case' 0 CA--C 1.571 1.763 0 O-C-N 120.914 -1.117 . . . . 0.0 109.003 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.29 -29.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -47.97 83.38 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 168.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.48 71.29 0.01 OUTLIER Glycine 0 CA--C 1.543 1.796 0 C-N-CA 124.306 0.955 . . . . 0.0 110.761 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 m -162.21 119.61 2.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -84.65 151.96 24.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -141.39 109.81 5.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.873 -0.517 . . . . 0.0 110.134 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -97.35 122.43 40.38 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.238 1.015 . . . . 0.0 110.817 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.61 -160.07 33.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.6 m -140.69 142.26 34.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.391 -0.476 . . . . 0.0 110.007 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -89.31 109.6 20.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 163.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -96.76 135.24 38.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.293 0.637 . . . . 0.0 111.17 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.45 105.35 17.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.858 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -78.71 -41.59 30.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.15 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -85.1 5.24 30.52 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 159.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -121.47 123.57 42.36 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.964 1.256 . . . . 0.0 109.508 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.58 100.9 12.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 159.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 tp -89.03 107.27 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-O 122.005 0.907 . . . . 0.0 109.289 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.53 100.89 1.87 Allowed Glycine 0 N--CA 1.475 1.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.334 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.08 96.06 10.57 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -113.63 154.47 27.16 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.991 . . . . 0.0 111.702 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -146.1 147.35 31.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.71 -1.244 . . . . 0.0 111.767 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -72.44 149.43 44.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p -72.92 -46.62 51.6 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.007 -1.058 . . . . 0.0 112.969 152.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -50.01 5.59 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -174.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.52 20.89 5.15 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.63 -16.18 3.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 120.434 2.934 . . . . 0.0 120.434 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -83.29 146.28 28.62 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 118.717 1.259 . . . . 0.0 113.982 -157.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -69.69 130.85 43.48 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.34 111.62 23.29 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.77 162.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -91.23 112.58 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 109.936 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -114.75 136.24 53.29 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.413 0.685 . . . . 0.0 111.135 -170.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.66 114.11 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.868 -1.145 . . . . 0.0 108.838 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -96.53 112.85 24.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.913 -1.117 . . . . 0.0 109.725 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.83 140.52 32.97 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-O 121.221 0.534 . . . . 0.0 112.322 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.9 120.16 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.45 -1.406 . . . . 0.0 109.594 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -97.88 75.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 123.93 0.892 . . . . 0.0 110.737 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.65 -89.51 1.24 Allowed Glycine 0 N--CA 1.492 2.41 0 O-C-N 120.523 -1.361 . . . . 0.0 114.453 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -126.1 36.2 4.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 170.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -136.09 121.33 19.09 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.299 1.039 . . . . 0.0 108.227 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -78.63 108.63 12.18 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.216 0.607 . . . . 0.0 109.423 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.4 m -90.69 114.07 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -95.38 99.31 11.24 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.2 m -92.17 96.75 10.49 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 -167.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -100.66 115.58 30.55 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.863 0.865 . . . . 0.0 110.834 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -113.99 115.78 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -118.46 117.93 30.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.725 -0.609 . . . . 0.0 109.445 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.1 OUTLIER 41.62 66.06 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.4 -35.25 2.43 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.1 118.49 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.294 1.547 . . . . 0.0 109.609 -164.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.71 146.04 24.32 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.223 1.011 . . . . 0.0 112.663 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.26 146.23 44.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.735 0.779 . . . . 0.0 111.663 156.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -118.86 101.99 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -82.71 102.81 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.7 mt -100.17 115.96 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -108.27 120.47 42.47 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.335 0.654 . . . . 0.0 110.044 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -81.48 156.5 25.29 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.954 0.883 . . . . 0.0 112.774 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -65.17 122.61 17.48 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 112.869 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.265 10.7 t70 . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 125.403 1.481 . . . . 0.0 110.529 -167.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 121.65 0.738 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.88 12.65 7.3 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.72 83.91 7.74 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -163.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 t -148.91 -173.11 4.27 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 122.794 1.283 . . . . 0.0 111.119 168.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -91.3 123.78 35.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.018 -1.051 . . . . 0.0 109.614 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -132.95 115.83 15.69 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.011 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -112.56 146.17 39.01 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 120.256 1.389 . . . . 0.0 112.993 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.99 115.12 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.17 -64.42 1.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.771 0.829 . . . . 0.0 111.454 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -138.61 118.9 13.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.255 0.622 . . . . 0.0 111.177 -169.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.6 p -102.59 121.06 41.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.373 0.669 . . . . 0.0 111.412 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -103.89 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.495 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -77.27 38.09 0.22 Allowed 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 121.26 1.846 . . . . 0.0 115.816 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.0 -42.66 37.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -64.31 -27.9 69.35 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -78.99 -42.65 26.14 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -45.81 -51.21 13.22 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 161.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.2 mtp -66.88 -30.44 70.61 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.92 -49.57 76.31 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 165.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -57.03 -33.69 67.45 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 166.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.9 mtp -64.71 -50.66 66.08 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 165.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.97 67.72 0.27 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 119.029 0.831 . . . . 0.0 114.407 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.45 149.82 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.867 0.841 . . . . 0.0 110.789 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -79.73 159.95 26.43 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 10.8 tp -49.44 -47.35 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.73 -46.67 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -76.45 -37.78 56.42 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -49.57 -46.13 48.59 Favored 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 121.287 1.858 . . . . 0.0 115.355 161.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.27 -57.17 10.2 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -56.75 -35.05 68.17 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.78 97.8 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.74 93.34 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 164.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -93.17 42.02 1.09 Allowed 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -77.89 -23.88 48.6 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 60.71 47.06 8.46 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.79 108.07 4.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 111.826 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -99.5 108.2 20.58 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.347 0.659 . . . . 0.0 109.343 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.25 100.83 12.04 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.703 0.801 . . . . 0.0 109.07 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.0 m -93.98 98.04 10.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.9 mt -97.79 122.72 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -165.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -117.89 106.84 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.86 88.44 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.952 0.882 . . . . 0.0 111.264 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -80.12 46.21 0.79 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.6 83.3 0.49 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.732 -1.23 . . . . 0.0 114.719 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.317 24.7 m120 72.08 -40.4 0.47 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 -174.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -74.41 145.72 43.49 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.498 1.142 . . . . 0.0 113.081 164.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.03 109.95 13.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 0.0 108.595 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.8 m -89.51 99.97 12.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.32 104.12 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -85.6 104.37 15.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.613 -0.679 . . . . 0.0 109.779 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -93.7 99.24 11.69 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.943 0.897 . . . . 0.0 109.383 -173.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 t -104.7 114.03 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.1 0.56 . . . . 0.0 111.505 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -143.78 175.71 9.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -59.62 -33.12 71.09 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 163.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -85.56 -46.58 10.69 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -143.74 142.69 31.05 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.786 0.834 . . . . 0.0 111.875 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -126.48 92.4 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.73 144.46 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -164.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 112.25 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.913 -1.117 . . . . 0.0 112.065 171.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -99.15 105.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.22 115.21 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -135.78 146.9 48.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.702 -0.624 . . . . 0.0 112.504 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -99.51 151.95 20.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.136 0.969 . . . . 0.0 111.591 164.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.22 122.99 16.45 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.99 85.22 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.27 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.581 2.191 . . . . 0.0 110.637 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.7 p -75.04 106.81 6.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.584 -0.698 . . . . 0.0 111.122 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -140.17 161.61 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.643 0.735 . . . . 0.0 112.487 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.93 104.13 12.07 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 111.775 170.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -86.77 -177.36 6.09 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 122.06 0.933 . . . . 0.0 111.775 164.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.29 152.16 51.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.8 mt -85.9 160.74 19.33 Favored 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 146.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.11 63.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.96 -68.22 0.4 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 124.189 0.996 . . . . 0.0 113.514 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.35 87.59 0.07 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.1 m -148.77 110.65 4.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.073 -0.663 . . . . 0.0 109.685 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 93.41 4.33 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 125.947 1.699 . . . . 0.0 113.161 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt -100.4 99.53 10.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 112.328 -171.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -85.54 117.8 24.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.878 -1.139 . . . . 0.0 113.283 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.56 -171.25 44.35 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 116.969 1.548 . . . . 0.0 116.969 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -115.28 117.81 31.52 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 118.595 -0.716 . . . . 0.0 111.652 -170.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -74.53 107.14 6.47 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.155 0.889 . . . . 0.0 110.784 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -119.58 135.82 54.63 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.591 0.756 . . . . 0.0 111.324 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.59 107.46 18.16 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.801 -1.187 . . . . 0.0 111.691 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.44 80.42 2.23 Favored 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.602 1.161 . . . . 0.0 109.915 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.85 0.83 Allowed Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.511 -0.743 . . . . 0.0 113.772 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -88.05 -35.77 17.35 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -75.73 121.82 23.09 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.197 0.908 . . . . 0.0 112.409 -164.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mt -80.6 96.85 6.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.0 109.169 166.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.59 116.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.102 0.961 . . . . 0.0 109.491 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.0 100.48 1.58 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.667 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.4 86.71 7.24 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -109.47 112.96 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.237 0.615 . . . . 0.0 111.942 -164.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -89.37 130.97 35.66 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.195 -0.941 . . . . 0.0 111.293 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.89 114.3 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.975 . . . . 0.0 110.477 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.8 m -59.56 -49.97 75.71 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -162.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.295 3.4 t70 -72.76 -17.29 61.61 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.61 -58.79 3.02 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.691 1.587 . . . . 0.0 114.545 162.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.52 44.13 9.72 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 -146.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -142.94 139.48 30.72 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.175 1.487 . . . . 0.0 111.357 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.14 138.96 31.1 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.665 2.469 . . . . 0.0 117.665 -163.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.36 111.86 16.28 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.591 1.556 . . . . 0.0 108.253 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -100.35 115.97 31.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 110.987 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.4 p -109.83 115.19 29.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.594 0.758 . . . . 0.0 111.003 -169.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.73 116.9 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 119.467 1.03 . . . . 0.0 109.266 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -94.35 124.86 38.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.195 0.598 . . . . 0.0 110.908 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.48 42.08 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.508 0.671 . . . . 0.0 111.0 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.4 mm -95.92 109.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.691 -1.256 . . . . 0.0 108.571 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.258 10.3 tp -79.71 63.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 122.439 1.114 . . . . 0.0 112.904 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.04 -77.88 1.12 Allowed Glycine 0 N--CA 1.49 2.238 0 O-C-N 120.556 -1.34 . . . . 0.0 115.07 -170.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -97.14 -45.19 6.63 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -96.95 148.63 22.77 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 112.956 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.6 tp -85.56 114.71 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.901 -1.124 . . . . 0.0 110.411 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.3 m -87.8 123.93 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.784 . . . . 0.0 109.776 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -104.94 98.69 8.37 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 164.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.2 m -95.05 106.76 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -109.07 115.61 30.38 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.596 0.758 . . . . 0.0 110.273 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.18 110.06 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -98.5 105.98 18.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.942 1.246 . . . . 0.0 109.682 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 46.89 50.2 13.84 Favored 'General case' 0 CA--C 1.58 2.101 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.96 -40.49 2.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.16 116.34 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.48 2.14 . . . . 0.0 112.373 -170.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -92.32 138.68 31.31 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 121.729 0.776 . . . . 0.0 112.921 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.37 142.31 47.15 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.678 0.791 . . . . 0.0 111.609 164.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -123.43 101.94 7.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -83.06 117.65 22.99 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 166.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -104.82 123.09 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -108.8 127.64 54.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.965 0.906 . . . . 0.0 111.151 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -85.26 148.74 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.997 0.903 . . . . 0.0 112.899 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.89 123.95 31.81 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.196 0.598 . . . . 0.0 112.338 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 125.088 1.355 . . . . 0.0 112.592 174.121 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.594 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.353 82.2 m-85 69.79 -67.93 0.21 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.72 72.96 5.27 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 119.949 1.249 . . . . 0.0 113.269 -171.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.9 p -156.43 -178.01 7.02 Favored 'General case' 0 CA--C 1.573 1.856 0 C-N-CA 124.42 1.088 . . . . 0.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.26 128.75 34.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.94 -1.1 . . . . 0.0 110.915 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -129.39 114.55 16.31 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -101.86 141.37 34.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.286 -0.884 . . . . 0.0 112.394 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.69 93.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.873 -1.142 . . . . 0.0 113.916 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.88 -45.74 9.48 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -143.64 152.72 41.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 111.354 -167.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.5 m -159.65 150.77 19.62 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.362 -2.086 . . . . 0.0 112.994 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -123.76 0.06 Allowed 'General case' 0 CA--C 1.578 2.045 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.22 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.295 0.1 OUTLIER -77.22 49.8 0.72 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 122.448 2.385 . . . . 0.0 116.776 -174.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -47.72 83.58 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.449 1.5 . . . . 0.0 114.745 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.92 -36.84 84.49 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.72 -44.18 74.4 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 120.177 1.353 . . . . 0.0 114.496 170.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -46.8 -56.73 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.9 mtt -67.21 -28.63 68.24 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -59.09 -48.27 82.2 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.82 1.645 . . . . 0.0 115.145 161.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -62.53 -36.2 81.85 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 mtp -59.09 -59.38 5.57 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.29 69.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.5 0.591 . . . . 0.0 114.456 171.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG13 ' HG2' ' A' ' 28' ' ' ARG . 3.3 p -148.43 136.56 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.932 0 CA-C-O 121.92 0.867 . . . . 0.0 110.17 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -82.42 164.65 20.86 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 33.1 pt -55.59 -40.17 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -169.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -48.9 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -70.67 -36.03 73.13 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HG2' HG13 ' A' ' 23' ' ' VAL . 43.5 mtm-85 -65.45 -42.3 92.48 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 167.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -55.53 -39.74 70.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.01 -60.93 2.78 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.508 160.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.75 74.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -173.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.37 71.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 161.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -124.52 41.9 3.39 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 123.741 0.816 . . . . 0.0 112.903 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.12 11.31 4.26 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 20.0 m-80 56.1 49.63 15.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -168.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.93 113.97 14.03 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.252 1.025 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -112.82 118.61 35.42 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.683 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -101.6 97.45 7.88 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.9 m -95.01 115.02 26.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 49' ' ' VAL . 63.2 mt -110.36 127.09 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -164.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -140.07 116.52 10.7 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.585 -0.697 . . . . 0.0 111.139 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -71.54 114.55 9.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -90.75 86.47 6.35 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.447 0.642 . . . . 0.0 109.292 165.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.79 23.23 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 117.431 1.732 . . . . 0.0 117.431 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.346 33.1 m120 65.59 -0.5 1.22 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -164.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -95.7 107.56 19.78 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 120.484 1.493 . . . . 0.0 109.384 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.38 105.69 8.66 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.047 0.939 . . . . 0.0 111.515 -169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.0 m -79.86 95.51 6.08 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.415 HG12 HG12 ' A' ' 40' ' ' ILE . 35.8 m -95.14 112.38 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.62 74.58 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.731 -169.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -84.68 101.42 12.16 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.56 0.695 . . . . 0.0 109.665 -158.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.6 m -114.91 101.96 9.53 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.872 -156.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -137.13 176.06 9.05 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.6 t -66.98 -9.68 41.28 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 168.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.26 -55.71 4.18 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.589 1.541 . . . . 0.0 113.156 166.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -155.42 140.65 17.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 118.703 0.683 . . . . 0.0 110.662 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -108.51 93.28 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -116.83 115.6 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.249 0.547 . . . . 0.0 110.501 -163.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.69 90.2 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.13 116.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -166.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.03 92.83 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -104.58 134.07 48.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.02 153.0 41.07 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 112.435 166.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.7 mt -73.71 73.94 1.53 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 120.966 -1.084 . . . . 0.0 111.845 164.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.39 -63.18 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -167.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.36 146.06 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 p -83.1 106.2 14.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.4 -0.813 . . . . 0.0 110.925 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -129.87 154.98 46.75 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.466 0.706 . . . . 0.0 112.612 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -82.01 119.92 24.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 111.579 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -94.11 -40.62 9.95 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.266 5.6 m120 76.8 99.07 0.07 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 168.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -87.0 111.78 21.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.149 -0.969 . . . . 0.0 112.346 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.298 . . 46.13 -88.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 118.767 2.877 . . . . 0.0 118.767 161.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.79 -58.37 7.04 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 -34.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 120.352 2.901 . . . . 0.0 120.352 -166.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -67.69 108.98 3.12 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 120.778 2.289 . . . . 0.0 113.963 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.303 22.8 pt-20 -86.7 95.95 9.97 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-O 123.104 1.43 . . . . 0.0 112.371 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.92 111.94 8.5 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.73 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -94.37 122.18 36.66 Favored 'General case' 0 CA--C 1.559 1.32 0 O-C-N 121.951 -0.468 . . . . 0.0 111.625 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.83 -152.38 21.6 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 115.573 0.989 . . . . 0.0 115.573 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.3 p -130.52 115.57 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.741 -155.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -80.42 142.42 34.35 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.509 0.671 . . . . 0.0 110.456 157.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.7 m -153.05 146.31 24.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.58 -1.325 . . . . 0.0 110.826 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.7 tp -88.24 102.61 14.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.89 -1.131 . . . . 0.0 111.36 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.0 93.77 7.59 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.324 0.65 . . . . 0.0 109.455 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -100.99 0.76 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 121.368 -0.833 . . . . 0.0 113.668 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -89.95 -33.07 16.54 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 161.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -80.76 133.19 35.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.845 1.657 . . . . 0.0 112.554 -161.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.14 101.07 7.71 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.721 -1.237 . . . . 0.0 109.562 163.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.84 111.81 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.737 0.815 . . . . 0.0 109.866 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.89 98.18 2.12 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 123.924 0.773 . . . . 0.0 113.06 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.48 103.58 16.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -121.52 150.5 41.52 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.235 1.017 . . . . 0.0 112.409 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -118.37 140.27 50.1 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.642 0.777 . . . . 0.0 109.487 169.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -66.11 125.2 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.722 -1.236 . . . . 0.0 112.049 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 m -70.89 -43.31 68.6 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.46 -0.775 . . . . 0.0 113.022 171.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -51.05 -56.92 10.2 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 165.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.75 -40.23 9.46 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.62 -9.78 60.65 Favored Glycine 0 CA--C 1.556 2.595 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.79 150.07 28.07 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 119.689 1.744 . . . . 0.0 112.841 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -85.46 143.7 28.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -173.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -131.92 134.87 46.15 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.48 1.112 . . . . 0.0 110.179 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -119.5 109.16 15.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.68 120.33 41.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.627 -0.67 . . . . 0.0 112.119 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.43 110.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.266 -0.896 . . . . 0.0 109.002 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 mtm-85 -92.75 116.38 28.97 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 121.586 -0.696 . . . . 0.0 110.766 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -137.51 149.43 46.77 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.769 0.828 . . . . 0.0 111.601 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -99.76 115.14 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.79 -1.194 . . . . 0.0 108.391 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 pt -80.73 -27.96 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.31 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.11 34.88 2.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 159.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -145.15 128.87 17.21 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.114 0.966 . . . . 0.0 109.865 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.98 110.05 20.29 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.742 0.817 . . . . 0.0 109.641 170.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.17 114.08 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -109.45 91.64 3.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -93.98 98.38 10.99 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.403 0.681 . . . . 0.0 110.073 -166.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.12 98.78 11.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.732 0.813 . . . . 0.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.12 106.88 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -120.3 109.7 15.69 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 53.61 50.5 17.05 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.86 -27.8 4.25 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 -167.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.0 t -87.74 113.92 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.694 1.747 . . . . 0.0 109.524 -170.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -104.87 101.53 11.12 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.398 0.679 . . . . 0.0 111.978 -169.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.31 102.97 14.84 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 112.377 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -81.48 99.22 8.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.097 0.559 . . . . 0.0 110.226 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -99.71 109.87 22.31 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.93 120.1 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.673 -1.267 . . . . 0.0 108.768 -159.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.2 123.65 48.31 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.517 0.727 . . . . 0.0 110.014 -168.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.06 156.8 31.5 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.986 1.266 . . . . 0.0 113.526 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -64.49 99.98 0.34 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 123.845 0.858 . . . . 0.0 113.147 174.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 4.8 t0 . . . . . 0 C--O 1.256 1.399 0 C-N-CA 125.407 1.483 . . . . 0.0 114.355 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.317 0 CA-C-O 121.57 0.7 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.322 86.3 m-85 73.82 -54.86 0.68 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -71.24 92.49 1.02 Allowed 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.083 1.311 . . . . 0.0 113.522 -164.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -177.04 171.21 2.14 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 125.211 1.405 . . . . 0.0 110.877 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -90.02 126.83 35.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.941 -1.099 . . . . 0.0 110.7 171.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -128.62 109.32 11.25 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.123 0.569 . . . . 0.0 110.07 -173.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -104.18 143.72 32.55 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.233 0.924 . . . . 0.0 113.067 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.43 120.56 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.72 -66.08 0.94 Allowed 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 123.486 0.715 . . . . 0.0 110.683 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -137.14 117.98 14.14 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.936 0.494 . . . . 0.0 111.223 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.1 p -93.1 100.13 12.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.704 -0.622 . . . . 0.0 110.176 166.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.74 -80.4 0.07 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -155.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -88.29 44.36 1.19 Allowed 'General case' 0 CA--C 1.579 2.081 0 CA-C-N 120.32 1.418 . . . . 0.0 113.451 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -80.33 -45.29 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.387 -1.446 . . . . 0.0 114.827 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.71 -21.16 65.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.36 -40.95 17.24 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 120.331 1.423 . . . . 0.0 114.799 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -47.43 -49.98 23.89 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.971 1.714 . . . . 0.0 115.534 158.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.61 ' SD ' HG21 ' A' ' 23' ' ' VAL . 20.9 mmt -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 165.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -54.17 -44.43 71.48 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -58.16 -40.63 81.89 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 165.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -40.17 95.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 169.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.35 65.37 0.63 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 119.055 0.843 . . . . 0.0 114.177 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' A' ' 18' ' ' MET . 15.4 m -128.13 148.38 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 122.274 1.035 . . . . 0.0 112.511 -167.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.91 159.2 33.14 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 14.2 tt -53.3 -38.67 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.93 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.264 0.938 . . . . 0.0 113.198 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -56.27 -43.81 79.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -60.33 -38.63 84.35 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -67.95 -54.93 14.87 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 166.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.38 -36.04 77.13 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.73 74.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.68 81.36 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 163.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -97.92 49.47 1.02 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 119.288 0.949 . . . . 0.0 113.532 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -83.31 -12.25 56.84 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.34 36.06 25.27 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.91 122.94 20.88 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 122.288 1.042 . . . . 0.0 112.674 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -118.42 111.79 19.13 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.032 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.61 98.98 10.07 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 m -92.04 100.24 12.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.835 . . . . 0.0 109.007 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.56 122.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.1 p -130.48 109.73 10.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -94.69 102.68 14.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.825 -1.172 . . . . 0.0 110.918 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.1 pm0 -75.09 -34.87 61.8 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.54 81.42 0.05 OUTLIER Glycine 0 N--CA 1.486 2.003 0 CA-C-N 119.18 0.9 . . . . 0.0 111.83 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER 74.32 -56.41 0.64 Allowed 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -160.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -60.53 139.54 57.72 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.62 114.47 28.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.823 0.449 . . . . 0.0 109.855 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.0 m -88.55 96.75 10.75 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.494 HG11 HH22 ' A' ' 106' ' ' ARG . 25.7 t -101.03 112.04 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.35 102.31 11.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.47 -0.769 . . . . 0.0 109.069 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -97.05 101.18 12.7 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -174.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.1 t -116.11 115.51 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.072 0.549 . . . . 0.0 112.412 -165.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -150.04 179.03 8.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -166.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -62.45 -43.69 98.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 164.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.1 -42.1 69.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 172.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -149.16 130.02 14.25 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.415 1.007 . . . . 0.0 111.209 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -119.99 86.99 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.22 144.74 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.676 -0.64 . . . . 0.0 111.657 -158.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.68 116.03 28.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.706 -1.246 . . . . 0.0 111.902 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.34 99.59 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.67 95.73 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.88 130.18 53.07 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.268 0.556 . . . . 0.0 112.477 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -92.22 145.51 24.44 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-O 122.353 1.073 . . . . 0.0 111.062 166.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.23 128.05 32.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.163 -0.961 . . . . 0.0 112.234 -168.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 -8.66 59.25 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 119.161 2.424 . . . . 0.0 119.161 -167.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.21 137.14 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 119.904 1.852 . . . . 0.0 110.813 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 95.62 5.68 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 121.711 0.767 . . . . 0.0 111.77 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -120.9 165.18 15.56 Favored 'General case' 0 CA--C 1.573 1.852 0 C-N-CA 124.401 1.08 . . . . 0.0 111.851 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -82.06 125.68 31.11 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.863 -1.148 . . . . 0.0 113.011 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -139.69 72.12 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.819 -0.55 . . . . 0.0 110.763 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -77.75 146.45 35.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.938 . . . . 0.0 113.086 -172.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.8 mt -65.73 -30.25 70.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.317 . . 74.03 -46.36 0.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -166.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -66.98 -57.39 6.97 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 163.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.75 -62.87 0.68 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -163.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 t -149.81 165.94 30.97 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -164.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -94.14 120.21 34.07 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 125.19 1.396 . . . . 0.0 109.744 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.1 mt -127.88 131.14 49.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 112.164 -164.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -120.17 134.24 55.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.577 -0.702 . . . . 0.0 110.711 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.73 -178.62 43.81 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 118.944 2.337 . . . . 0.0 118.944 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.1 p -118.3 120.09 36.6 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.408 -1.396 . . . . 0.0 110.992 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.25 111.45 20.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -87.51 -38.37 16.1 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.267 39.3 tp 62.01 86.74 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.957 1.303 . . . . 0.0 113.586 -167.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -86.45 83.57 7.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.18 0.99 . . . . 0.0 109.956 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.98 -96.14 0.59 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -98.26 -9.43 25.55 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -108.7 122.31 46.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.13 1.786 . . . . 0.0 110.383 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -73.44 102.02 3.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.809 -1.182 . . . . 0.0 109.84 168.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -97.27 123.3 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-O 121.523 0.677 . . . . 0.0 109.761 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.98 102.22 0.67 Allowed Glycine 0 N--CA 1.481 1.655 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.11 -170.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -84.29 98.92 10.26 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.301 0.551 . . . . 0.0 110.301 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -107.09 105.91 16.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.157 0.98 . . . . 0.0 110.019 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -90.01 133.1 35.01 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 121.639 -0.663 . . . . 0.0 110.938 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -62.38 122.7 16.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.3 p -71.19 -26.6 63.03 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -64.98 -57.47 8.63 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 164.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -111.35 -46.77 3.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 38.71 6.14 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 118.562 2.185 . . . . 0.0 118.562 -165.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.82 -8.04 59.31 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.301 4.9 tt0 72.18 99.49 0.07 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 175.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 tt -99.86 114.88 28.38 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.871 0.868 . . . . 0.0 110.229 172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -99.71 113.33 25.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.0 m -103.42 122.4 44.79 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 122.832 0.453 . . . . 0.0 110.759 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.57 111.06 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.494 HH22 HG11 ' A' ' 49' ' ' VAL . 27.7 mtp180 -105.29 113.05 26.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.375 0.67 . . . . 0.0 109.739 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.91 158.38 44.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.442 -0.786 . . . . 0.0 112.634 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.98 111.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.993 -1.067 . . . . 0.0 108.261 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 10.9 tp -85.5 68.26 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 CA-C-O 122.341 1.067 . . . . 0.0 111.744 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.77 -84.55 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 120.795 -1.191 . . . . 0.0 114.698 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.35 -17.39 18.05 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -118.46 131.34 56.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.336 1.425 . . . . 0.0 111.334 -168.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.8 tp -79.63 109.88 14.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 110.209 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.4 114.04 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.57 99.29 9.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.0 109.231 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -100.01 105.67 17.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -84.18 102.3 12.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.198 0.599 . . . . 0.0 110.561 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.83 112.12 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.403 ' OH ' ' OE2' ' A' ' 120' ' ' GLU . 16.6 t80 -128.89 107.03 9.31 Favored 'General case' 0 CA--C 1.564 1.497 0 O-C-N 121.779 -0.576 . . . . 0.0 110.818 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.403 ' OE2' ' OH ' ' A' ' 119' ' ' TYR 0.406 15.4 pt-20 39.56 64.57 0.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.56 -33.13 4.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -168.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.61 117.81 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 119.341 1.57 . . . . 0.0 109.758 -162.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.21 144.95 25.97 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.84 144.29 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 161.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -122.98 104.01 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 109.226 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -80.7 105.44 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 162.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.91 123.26 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -109.44 125.37 52.35 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.441 0.696 . . . . 0.0 110.218 -171.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -81.39 165.54 21.22 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.573 0.701 . . . . 0.0 112.248 169.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -71.54 100.45 2.25 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 120.869 -1.144 . . . . 0.0 112.09 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 7.3 t0 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 125.2 1.4 . . . . 0.0 114.012 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.292 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -106.63 66.06 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.349 0.977 . . . . 0.0 112.5 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -155.69 81.87 1.03 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.022 . . . . 0.0 109.884 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -167.74 171.19 10.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.126 -0.984 . . . . 0.0 112.052 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -71.84 117.29 13.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.92 . . . . 0.0 111.138 161.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -114.64 101.87 9.5 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.69 135.99 33.62 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.476 0.711 . . . . 0.0 112.685 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.22 117.58 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.57 -62.88 1.19 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.723 0.809 . . . . 0.0 111.302 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.73 129.59 47.36 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.02 0.914 . . . . 0.0 110.946 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m -113.27 115.32 28.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -87.71 -57.78 2.82 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.894 0.478 . . . . 0.0 112.27 -165.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -121.15 145.83 47.41 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -163.21 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.077 0.951 . . . . 0.0 111.305 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -35.48 80.65 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -67.29 -37.14 82.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 165.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.6 -52.09 63.27 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.6 mtp -58.54 -37.44 75.68 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.4 -43.9 75.68 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.55 -44.84 95.35 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 166.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.0 mtm -58.22 -44.1 88.04 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.508 2.04 . . . . 0.0 116.508 175.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.17 63.02 0.1 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.6 143.59 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-O 122.483 1.135 . . . . 0.0 111.139 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -82.05 163.11 22.3 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 120.853 -1.155 . . . . 0.0 113.742 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.8 tp -64.0 157.46 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 O-C-N 121.03 -1.044 . . . . 0.0 113.24 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.389 21.8 t 80.48 -61.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 124.346 1.058 . . . . 0.0 110.7 -162.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -56.2 -47.42 78.4 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 162.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -61.83 -16.6 51.45 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 164.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.67 -44.31 12.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.21 1.368 . . . . 0.0 113.462 164.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.96 -48.89 69.84 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 166.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.76 -18.66 62.11 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.09 -58.51 3.98 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.912 1.233 . . . . 0.0 113.019 158.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.1 49.39 1.79 Allowed 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -79.78 -30.43 40.64 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 63.91 55.41 1.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.713 1.142 . . . . 0.0 112.547 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.3 tp -79.81 113.25 17.82 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.957 0.884 . . . . 0.0 111.658 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -107.15 101.36 10.77 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.048 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.34 93.85 8.81 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.4 m -90.37 94.34 9.7 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.59 0.709 . . . . 0.0 110.336 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.486 HD11 HH21 ' A' ' 106' ' ' ARG . 24.5 mt -80.77 124.47 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.674 0.79 . . . . 0.0 109.389 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.5 p -133.12 104.54 6.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -92.24 115.87 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.65 -1.281 . . . . 0.0 112.274 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.92 -41.29 59.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.7 -84.09 0.05 OUTLIER Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.126 -0.984 . . . . 0.0 111.42 171.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -82.02 -49.73 9.91 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 157.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.87 119.71 11.17 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -85.58 115.95 23.58 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -95.86 99.44 11.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -96.53 103.89 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.32 100.38 8.36 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 123.297 0.639 . . . . 0.0 110.062 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -86.92 97.3 10.61 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.419 0.688 . . . . 0.0 109.433 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -107.03 113.11 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.075 0.55 . . . . 0.0 110.317 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 p -145.49 -170.45 3.45 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.21 1.005 . . . . 0.0 113.292 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -62.0 -47.31 85.38 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.901 -1.125 . . . . 0.0 113.441 165.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -63.17 -48.77 76.99 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -142.09 163.05 33.92 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -160.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -143.43 88.68 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.111 163.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 141.62 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.261 -0.9 . . . . 0.0 112.429 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -84.72 115.31 22.61 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 121.398 -0.814 . . . . 0.0 112.708 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.24 98.32 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -87.39 114.07 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -127.44 124.1 37.64 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.757 0.789 . . . . 0.0 112.824 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.29 148.44 29.42 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 121.683 0.754 . . . . 0.0 111.478 164.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.52 88.46 2.68 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.758 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.07 -47.38 0.69 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -160.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.9 t -75.7 136.88 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 118.716 1.258 . . . . 0.0 112.264 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.3 p -89.84 120.12 30.8 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.304 -0.872 . . . . 0.0 110.35 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.82 156.8 47.03 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 121.971 0.891 . . . . 0.0 112.737 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.26 97.78 10.97 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.519 0.676 . . . . 0.0 110.479 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -84.31 97.94 9.73 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.531 -0.731 . . . . 0.0 110.299 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.41 133.07 39.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.579 -0.7 . . . . 0.0 112.057 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.38 171.95 13.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.78 69.43 1.81 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.052 1.406 . . . . 0.0 113.407 168.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 t70 179.57 -93.66 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 -156.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.34 50.48 0.02 OUTLIER Glycine 0 CA--C 1.548 2.099 0 C-N-CA 124.643 1.116 . . . . 0.0 112.891 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.5 m -143.4 113.71 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -158.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.39 130.12 35.03 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.42 120.46 38.21 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.705 1.202 . . . . 0.0 108.876 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -113.4 108.79 17.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.389 -1.444 . . . . 0.0 111.1 -159.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.22 -149.19 18.97 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 -172.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.9 m -140.78 147.26 38.82 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.01 0.91 . . . . 0.0 112.314 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -92.45 117.61 30.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.014 163.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -111.74 144.34 41.18 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.375 0.67 . . . . 0.0 111.586 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.3 tp -87.77 103.36 15.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.732 -1.23 . . . . 0.0 110.861 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.92 84.86 4.99 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.966 0.888 . . . . 0.0 108.848 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.34 -97.05 0.44 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -95.28 -19.97 19.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -89.17 124.24 34.17 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.639 1.563 . . . . 0.0 111.19 -172.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -82.54 100.07 9.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.772 -1.205 . . . . 0.0 108.967 164.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -95.79 110.32 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-O 122.131 0.967 . . . . 0.0 109.893 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.7 93.15 1.85 Allowed Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.005 0.812 . . . . 0.0 112.363 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.41 94.65 9.44 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.41 131.18 56.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.277 0.631 . . . . 0.0 109.719 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -90.41 134.72 34.15 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.953 -1.092 . . . . 0.0 110.131 164.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.23 105.88 1.52 Allowed 'General case' 0 CA--C 1.566 1.573 0 O-C-N 120.824 -1.173 . . . . 0.0 110.653 169.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -42.93 -59.63 1.92 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -163.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.69 67.42 0.67 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 123.568 1.651 . . . . 0.0 107.497 -169.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.71 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.068 -162.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.27 45.37 5.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 116.182 1.233 . . . . 0.0 116.182 -171.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -139.81 126.3 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 117.843 0.821 . . . . 0.0 109.883 -166.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -76.74 127.12 32.16 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.91 109.58 21.51 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.557 0.743 . . . . 0.0 109.281 161.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -98.77 122.38 41.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.02 94.17 4.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.02 -0.425 . . . . 0.0 110.217 -159.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.94 105.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 119.764 -1.835 . . . . 0.0 108.99 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.486 HH21 HD11 ' A' ' 40' ' ' ILE . 9.6 ptm180 -102.89 113.34 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.834 0.743 . . . . 0.0 110.506 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -135.2 154.03 51.75 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 123.946 0.899 . . . . 0.0 111.06 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -86.57 108.71 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.692 -1.255 . . . . 0.0 109.627 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.7 tp -88.68 72.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.997 0.903 . . . . 0.0 111.117 172.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.59 0.5 Allowed Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.06 -1.025 . . . . 0.0 115.122 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -91.15 -14.07 31.81 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -134.3 145.57 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 119.443 1.019 . . . . 0.0 112.283 -161.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.2 tp -82.4 105.97 13.9 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.722 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.1 p -87.5 108.15 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -0.778 . . . . 0.0 110.209 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -98.96 106.25 18.48 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.114 0.566 . . . . 0.0 110.278 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.7 m -98.1 110.73 23.26 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.83 0.852 . . . . 0.0 109.78 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -98.9 105.99 18.2 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.542 1.137 . . . . 0.0 108.373 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.92 110.12 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -139.23 127.08 22.11 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.543 0.737 . . . . 0.0 110.86 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 50.66 45.17 27.23 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.63 -15.5 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 119.688 2.635 . . . . 0.0 119.688 -166.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.87 119.46 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 CA-C-N 119.618 1.709 . . . . 0.0 108.958 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.96 120.89 33.04 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.32 0.648 . . . . 0.0 110.565 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.92 136.31 54.81 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.53 0.732 . . . . 0.0 112.306 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -126.53 117.99 23.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 109.912 -172.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -109.96 116.75 32.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.06 120.03 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -108.95 126.21 52.85 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.842 0.857 . . . . 0.0 110.172 -171.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -91.85 153.92 19.23 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.174 0.988 . . . . 0.0 113.125 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -63.34 112.93 2.93 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.289 5.3 m-20 . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 126.221 1.809 . . . . 0.0 108.436 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.317 73.9 m-85 73.12 -47.86 0.67 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.11 94.63 2.44 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 -170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 m -173.73 177.53 2.45 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.581 1.552 . . . . 0.0 110.532 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.6 m -92.96 129.07 39.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.915 -1.741 . . . . 0.0 111.05 168.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -124.18 104.76 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.236 0.614 . . . . 0.0 109.871 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -89.82 133.37 34.76 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.511 0.724 . . . . 0.0 111.238 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 36' ' ' LEU . 2.3 p -68.34 111.91 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.382 -0.823 . . . . 0.0 112.444 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.64 -62.79 1.51 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.276 0.631 . . . . 0.0 111.747 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -143.52 116.29 8.74 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.75 0.786 . . . . 0.0 109.788 -168.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.3 m -99.57 127.65 45.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.271 0.628 . . . . 0.0 110.729 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.317 5.7 tm-20 -74.82 -93.59 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -167.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -96.82 39.25 1.18 Allowed 'General case' 0 CA--C 1.577 1.982 0 O-C-N 120.477 -1.389 . . . . 0.0 113.72 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.27 -36.99 58.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.91 -35.64 78.99 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 166.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -71.28 -40.07 71.15 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 167.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -47.44 -50.45 22.87 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 157.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 mmt -59.3 -42.39 91.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.09 -44.67 91.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 166.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -55.91 -43.89 77.73 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.9 mmt -58.51 -37.65 76.06 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 167.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.3 46.01 2.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.73 142.76 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 C-N-CA 123.841 0.856 . . . . 0.0 110.518 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -69.76 165.56 21.15 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.299 12.5 tt -73.63 53.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.78 -67.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -67.67 -25.95 65.96 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -42.9 -42.47 3.7 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 153.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.42 -52.01 5.61 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.291 -0.862 . . . . 0.0 112.364 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -57.86 -40.11 79.36 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.53 -35.03 60.81 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.88 88.36 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 163.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -103.43 47.67 0.87 Allowed 'General case' 0 CA--C 1.577 1.994 0 C-N-CA 123.867 0.867 . . . . 0.0 112.895 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -83.78 -11.56 56.91 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 59.27 46.21 13.09 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.311 -1.493 . . . . 0.0 114.185 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.452 ' H ' HG12 ' A' ' 8' ' ' VAL . 2.8 tt -85.32 108.65 17.9 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 121.379 -0.825 . . . . 0.0 111.914 -166.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -94.82 111.19 22.99 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.448 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.82 101.67 13.77 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.369 0.668 . . . . 0.0 110.256 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -81.48 101.15 9.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.168 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.7 mt -90.38 119.58 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 p -128.79 108.68 10.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -88.44 84.58 6.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 111.527 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.41 76.25 5.92 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 121.92 0.866 . . . . 0.0 111.563 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.95 77.23 0.7 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 115.812 1.085 . . . . 0.0 115.812 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.292 18.1 t-20 70.9 -57.87 0.58 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.25 119.01 9.45 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -86.42 106.37 17.4 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.502 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.4 m -87.64 97.35 10.82 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -104.23 107.79 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -94.63 106.02 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -78.78 111.86 15.34 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.237 0.615 . . . . 0.0 110.801 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 t -113.02 106.07 14.24 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.047 0.539 . . . . 0.0 109.558 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -142.86 178.43 7.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -58.83 -39.63 81.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -60.65 -52.12 66.5 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 165.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -158.3 151.45 22.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -159.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -122.91 90.92 3.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.789 0.836 . . . . 0.0 109.675 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.29 148.8 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.233 -0.917 . . . . 0.0 112.785 -167.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.86 116.88 33.77 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.109 0.964 . . . . 0.0 112.609 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.01 104.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.45 114.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -123.12 124.57 43.36 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.86 145.87 29.21 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.818 0.818 . . . . 0.0 111.263 166.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.73 117.5 11.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.33 0.11 85.05 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 119.537 2.575 . . . . 0.0 119.537 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.7 t -95.95 137.1 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 120.526 2.163 . . . . 0.0 110.374 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.0 p -75.28 121.83 22.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.728 . . . . 0.0 112.651 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -137.97 158.6 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.644 -0.66 . . . . 0.0 112.455 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.51 107.28 18.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.71 -0.619 . . . . 0.0 110.304 173.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -95.46 110.13 22.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -75.18 126.8 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.631 -0.668 . . . . 0.0 110.62 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.8 mt -78.37 167.41 21.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.757 -1.214 . . . . 0.0 113.88 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.39 63.23 2.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -167.52 -83.69 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.023 1.329 . . . . 0.0 108.113 -172.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.93 61.05 0.04 OUTLIER Glycine 0 CA--C 1.548 2.116 0 C-N-CA 125.354 1.454 . . . . 0.0 111.12 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.1 m -143.62 119.62 10.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.24 101.35 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.3 115.49 24.74 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -98.08 109.6 22.33 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.621 0.769 . . . . 0.0 110.409 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.59 -176.52 46.54 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -120.94 119.56 32.95 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.093 -1.553 . . . . 0.0 110.565 -166.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -79.47 112.19 16.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.905 0.775 . . . . 0.0 110.202 159.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.2 m -106.62 138.09 43.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.278 0.631 . . . . 0.0 110.983 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 tp -88.43 108.44 19.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.782 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -67.72 -42.56 81.74 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 171.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.28 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -79.77 -22.07 43.62 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 157.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -105.97 134.42 49.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.284 1.402 . . . . 0.0 111.341 -167.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.5 mt -94.35 111.35 23.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 108.78 167.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -105.36 120.11 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.784 1.234 . . . . 0.0 109.184 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.02 111.83 2.48 Favored Glycine 0 N--CA 1.483 1.805 0 O-C-N 121.839 -0.538 . . . . 0.0 113.94 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -97.59 107.97 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.136 0.575 . . . . 0.0 109.556 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -127.14 107.25 9.86 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.399 0.618 . . . . 0.0 112.618 -164.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.72 124.71 31.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -61.24 150.53 34.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.829 -1.17 . . . . 0.0 113.875 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.6 m -80.67 68.23 6.82 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-O 123.508 1.623 . . . . 0.0 111.011 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -152.23 -85.04 0.07 Allowed 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -115.72 -22.87 8.94 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 50.81 2.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 -167.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -82.03 -30.78 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.383 10.7 tt0 74.99 97.83 0.07 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 126.001 1.72 . . . . 0.0 114.707 -168.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 tt -89.58 116.32 27.64 Favored 'General case' 0 CA--C 1.563 1.442 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.526 165.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -92.07 117.02 29.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.762 . . . . 0.0 110.764 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -114.02 112.97 24.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.825 0.85 . . . . 0.0 109.157 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.8 t -105.85 113.52 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -110.32 117.93 34.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.219 0.918 . . . . 0.0 109.566 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.16 144.53 38.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.998 0.904 . . . . 0.0 112.045 -169.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -91.31 108.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.68 -47.57 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.763 -0.585 . . . . 0.0 111.542 168.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.84 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.485 1.917 0 CA-C-N 119.185 0.902 . . . . 0.0 111.247 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.35 -30.02 47.82 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.08 144.2 34.1 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 122.425 1.107 . . . . 0.0 112.516 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 tp -95.13 115.2 27.12 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.756 0.822 . . . . 0.0 109.186 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.4 121.43 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.805 -0.559 . . . . 0.0 109.83 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.37 99.14 7.99 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.689 0.796 . . . . 0.0 109.85 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -98.17 111.01 23.49 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.725 0.81 . . . . 0.0 110.915 -169.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -100.91 112.08 24.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.928 0.891 . . . . 0.0 110.723 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.27 113.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -123.96 110.0 14.25 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 122.997 0.519 . . . . 0.0 112.209 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.275 43.6 mt-10 47.22 34.5 3.1 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 119.53 -44.26 1.43 Allowed Glycine 0 CA--C 1.553 2.418 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -162.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.74 121.76 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 119.304 1.552 . . . . 0.0 113.33 -163.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.02 133.74 34.65 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.841 -0.537 . . . . 0.0 111.689 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.69 117.33 9.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.436 0.694 . . . . 0.0 111.571 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.297 1.1 pptp? -114.64 126.22 54.64 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -105.23 115.33 30.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 110.365 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mt -98.78 120.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.89 130.28 55.63 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.342 0.657 . . . . 0.0 110.896 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.61 149.07 21.83 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.97 0.89 . . . . 0.0 112.053 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -84.89 113.03 21.08 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 112.689 -174.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.65 0 C-N-CA 124.802 1.241 . . . . 0.0 113.896 172.222 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.404 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.43 62.26 0.91 Allowed 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 119.686 1.13 . . . . 0.0 113.008 -171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -141.74 91.11 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.367 -1.458 . . . . 0.0 107.746 166.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -174.87 167.5 3.63 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.54 1.162 . . . . 0.0 111.899 -171.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -101.3 141.78 33.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 111.662 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -141.84 121.81 13.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.477 -165.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -112.11 142.47 44.52 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 120.502 1.501 . . . . 0.0 112.52 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.279 7.7 p -80.5 91.09 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 122.769 1.271 . . . . 0.0 114.059 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.55 -36.26 29.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -122.52 145.7 48.08 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.082 -1.011 . . . . 0.0 112.189 -172.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 p -152.46 159.5 43.35 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.271 1.6 tm-20 -106.57 -137.28 0.36 Allowed 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.736 171.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.286 8.8 p30 -80.99 58.72 3.53 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 118.917 -2.364 . . . . 0.0 117.159 -167.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CE2' ' SD ' ' A' ' 18' ' ' MET . 31.6 t80 -61.14 -40.44 93.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.719 -1.863 . . . . 0.0 115.159 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.64 -43.05 68.45 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 165.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.91 -45.12 52.58 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.596 1.543 . . . . 0.0 115.024 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -45.55 -51.61 11.65 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 160.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' A' ' 28' ' ' ARG . 43.4 mtp -62.01 -45.4 93.77 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -43.04 72.21 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-N 120.373 1.442 . . . . 0.0 114.733 168.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -40.34 89.15 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 166.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.548 ' SD ' HG21 ' A' ' 76' ' ' THR . 72.9 mtm -62.98 -45.37 92.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 169.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.82 68.61 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 CA-C-N 118.841 0.746 . . . . 0.0 114.633 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.42 174.39 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.311 1.053 . . . . 0.0 113.267 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.16 159.8 21.97 Favored 'General case' 0 CA--C 1.577 2.009 0 O-C-N 120.712 -1.243 . . . . 0.0 113.338 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.264 14.7 tt -59.67 -44.49 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.66 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 CA-C-O 123.715 1.721 . . . . 0.0 112.088 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -149.77 -52.28 0.15 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 127.749 2.419 . . . . 0.0 106.169 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 12.0 mtm105 -42.95 -55.11 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 161.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -62.28 -41.44 98.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.09 -51.85 66.28 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.29 36.65 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.61 -56.07 25.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 119.674 -1.891 . . . . 0.0 113.162 156.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -86.28 48.56 1.64 Allowed 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -80.41 -16.13 55.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 58.69 21.24 8.61 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.27 1.3 pt? -77.2 145.53 37.57 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -157.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.03 119.07 34.69 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.396 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -99.19 109.76 22.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.559 0.744 . . . . 0.0 109.615 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 m -90.19 101.62 14.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.92 125.38 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.253 12.8 t -133.37 143.05 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.062 0.934 . . . . 0.0 111.705 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -110.1 110.36 21.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.866 0.866 . . . . 0.0 110.858 -172.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -88.8 77.17 7.87 Favored 'General case' 0 CA--C 1.57 1.73 0 CA-C-O 121.723 0.773 . . . . 0.0 110.149 165.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.46 -95.25 0.14 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -91.97 -8.47 46.11 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 168.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -113.38 118.55 34.88 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 121.121 1.782 . . . . 0.0 111.213 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.44 129.81 38.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.555 -0.716 . . . . 0.0 111.709 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -100.37 109.84 22.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 163.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.13 103.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -88.5 99.37 12.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.863 . . . . 0.0 109.734 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.26 100.08 12.2 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.287 0.635 . . . . 0.0 112.431 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.4 t -95.08 94.81 8.18 Favored 'General case' 0 CA--C 1.56 1.331 0 O-C-N 122.126 -0.359 . . . . 0.0 111.024 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.8 p -114.61 167.5 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.148 0.979 . . . . 0.0 113.361 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.6 m -56.96 -42.62 80.45 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 166.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -68.04 -49.33 62.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -148.95 145.76 27.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.498 1.044 . . . . 0.0 112.16 -169.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.06 102.11 8.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.646 . . . . 0.0 109.59 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -139.93 149.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.787 0.803 . . . . 0.0 112.145 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.87 105.54 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.491 -0.755 . . . . 0.0 110.416 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.65 99.03 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.2 t -96.83 123.43 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -144.33 146.83 32.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -99.66 143.3 30.05 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.023 0.916 . . . . 0.0 111.906 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.18 109.34 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.461 0.704 . . . . 0.0 112.898 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.92 -38.12 3.4 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.7 t -73.79 132.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 118.847 1.323 . . . . 0.0 110.329 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -98.21 102.99 14.89 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.315 1.055 . . . . 0.0 110.715 -171.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.41 163.73 14.92 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.973 1.309 . . . . 0.0 112.06 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -87.12 112.15 21.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.643 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -80.54 -65.93 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.536 -0.728 . . . . 0.0 112.135 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 73.03 122.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.386 1.074 . . . . 0.0 113.029 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.9 mt -74.4 159.61 32.11 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.15 -35.23 64.52 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -51.82 -78.82 0.02 OUTLIER 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 160.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.62 61.73 0.01 OUTLIER Glycine 0 N--CA 1.485 1.904 0 C-N-CA 123.85 0.738 . . . . 0.0 111.893 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.548 HG21 ' SD ' ' A' ' 21' ' ' MET . 91.7 m -127.18 116.24 20.33 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -172.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.75 117.33 20.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.766 -0.584 . . . . 0.0 111.703 -173.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.6 mt -141.02 117.81 11.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.974 0.91 . . . . 0.0 110.612 -164.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.264 2.6 ptm85 -131.89 138.84 48.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.33 -172.93 40.24 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.248 0.927 . . . . 0.0 112.189 -167.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -110.2 -179.08 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.888 -1.36 . . . . 0.0 112.72 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -122.67 107.23 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 p -85.17 128.96 34.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -0.975 . . . . 0.0 113.356 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 tp -85.31 104.49 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.298 0.639 . . . . 0.0 111.148 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.22 97.37 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.864 0.84 . . . . 0.0 109.201 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.5 -100.25 1.17 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.589 -0.694 . . . . 0.0 113.652 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -113.63 8.6 17.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 163.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -103.23 127.49 50.53 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.804 1.638 . . . . 0.0 110.528 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.62 99.02 11.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 151.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.21 114.17 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.789 0.804 . . . . 0.0 109.169 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.19 99.97 1.4 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 121.79 -0.569 . . . . 0.0 114.04 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -87.46 100.26 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.452 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.6 116.32 31.52 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.613 0.765 . . . . 0.0 109.435 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -76.36 124.63 27.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.137 -0.977 . . . . 0.0 111.726 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.1 100.36 12.59 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 -171.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.5 p -68.45 -21.68 64.63 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -56.74 -23.46 42.85 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 163.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.45 -49.54 0.36 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.428 1.091 . . . . 0.0 113.681 -157.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.92 60.36 0.93 Allowed Glycine 0 N--CA 1.49 2.246 0 CA-C-N 119.172 0.896 . . . . 0.0 115.051 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -144.0 141.63 30.25 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.465 0.706 . . . . 0.0 110.635 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.28 103.28 6.22 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.025 0.917 . . . . 0.0 111.575 167.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.98 123.58 25.97 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 121.796 -0.565 . . . . 0.0 109.804 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -107.59 100.17 9.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -108.02 118.7 37.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.357 0.663 . . . . 0.0 110.91 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.87 113.57 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -100.59 118.53 36.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.079 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.65 145.86 31.97 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 123.591 0.756 . . . . 0.0 110.809 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.31 110.89 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.535 -1.353 . . . . 0.0 108.006 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER -91.78 85.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.272 1.034 . . . . 0.0 109.005 171.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.46 -91.05 1.04 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 120.77 -1.206 . . . . 0.0 114.205 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -130.93 42.92 3.17 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.687 -0.89 . . . . 0.0 112.945 165.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -136.23 119.79 17.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.817 -1.177 . . . . 0.0 109.716 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.65 108.23 13.04 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.407 0.683 . . . . 0.0 110.614 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -89.9 71.63 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 123.318 0.647 . . . . 0.0 112.027 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -69.56 97.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.821 -1.174 . . . . 0.0 112.048 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -109.58 98.05 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -160.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.12 106.23 18.22 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.501 1.12 . . . . 0.0 111.942 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.14 123.1 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.54 -0.725 . . . . 0.0 109.308 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -136.32 124.02 22.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.102 0.561 . . . . 0.0 110.716 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.253 48.2 mt-10 46.62 54.72 8.48 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.78 24.63 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.3 t -114.45 129.33 70.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 120.294 2.047 . . . . 0.0 108.966 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -114.83 127.2 55.58 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.776 0.83 . . . . 0.0 111.525 -171.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.52 115.16 25.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.923 0.868 . . . . 0.0 112.54 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -87.46 122.79 31.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -104.88 102.71 12.23 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.41 107.4 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.99 123.92 42.22 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.856 0.462 . . . . 0.0 110.463 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -78.0 167.93 20.68 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.66 0.743 . . . . 0.0 112.025 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.77 103.89 1.88 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.88 -1.138 . . . . 0.0 113.028 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 125.623 1.569 . . . . 0.0 113.978 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.26 77.4 m-85 . . . . . 0 N--CA 1.508 2.463 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.23 105.62 1.46 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.946 1.298 . . . . 0.0 114.186 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 m 178.04 169.65 0.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 125.253 1.421 . . . . 0.0 111.412 -172.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.1 m -97.06 128.42 43.99 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.734 -1.229 . . . . 0.0 110.789 171.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -131.22 95.51 3.8 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.306 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -77.56 139.78 39.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -70.25 124.05 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 112.454 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.64 -57.58 3.07 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.278 163.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -136.2 156.82 48.12 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 122.294 1.045 . . . . 0.0 112.589 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.9 m -136.2 94.51 3.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.596 -1.315 . . . . 0.0 110.067 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -93.06 118.84 31.65 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.616 -159.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.274 51.5 t30 64.11 17.92 10.93 Favored 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.19 -33.16 74.81 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -50.52 71.98 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -63.86 -41.49 97.77 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -49.58 -51.11 39.43 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.751 1.759 . . . . 0.0 115.751 163.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.5 mtp -65.84 -32.29 73.72 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.04 -48.54 75.82 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 160.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.16 -32.86 74.59 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.9 mmt -58.09 -53.9 53.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.075 1.307 . . . . 0.0 114.202 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.36 52.94 0.12 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.79 167.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 118.457 1.128 . . . . 0.0 112.756 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -79.52 166.56 21.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.756 -1.215 . . . . 0.0 113.032 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.285 13.3 tt -75.63 59.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 123.534 1.635 . . . . 0.0 114.72 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.17 -65.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -60.15 -33.75 72.61 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -50.45 -52.12 40.76 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 162.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.59 -52.29 18.87 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.41 -50.25 68.34 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.53 58.04 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.46 94.01 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -110.1 39.24 2.2 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -80.0 0.29 32.26 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.253 62.3 m-80 62.18 52.28 3.25 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.0 tp -76.77 121.87 23.94 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-O 122.085 0.945 . . . . 0.0 113.096 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -109.92 122.21 47.01 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.682 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.18 103.01 14.46 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.898 0.479 . . . . 0.0 109.723 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -91.4 100.07 12.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.119 -0.988 . . . . 0.0 108.735 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.5 mt -90.15 124.68 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.1 p -135.03 115.84 13.95 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -99.26 105.4 17.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.626 -1.296 . . . . 0.0 111.39 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.92 -52.01 9.52 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.27 87.88 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.105 -0.997 . . . . 0.0 111.086 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.316 25.8 t30 69.55 -48.65 0.61 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -165.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.62 121.39 14.85 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -85.42 114.54 22.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.057 0.543 . . . . 0.0 110.321 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -90.44 102.57 15.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.7 t -105.36 101.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -79.86 105.06 10.86 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 123.362 0.665 . . . . 0.0 109.867 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.89 99.52 9.73 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.155 0.982 . . . . 0.0 109.146 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.0 t -111.77 109.16 18.86 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.815 0.446 . . . . 0.0 112.174 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -135.27 178.74 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.3 m -54.64 -37.45 65.68 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -69.74 -53.24 19.35 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -148.32 143.71 27.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.302 0.955 . . . . 0.0 112.842 -168.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -121.87 95.23 4.58 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.596 0.759 . . . . 0.0 109.425 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.08 152.89 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 123.317 0.647 . . . . 0.0 111.026 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.27 115.82 30.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.708 -1.245 . . . . 0.0 112.505 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -86.48 101.09 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.32 107.15 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -126.5 130.68 51.09 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -83.51 147.56 27.72 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.452 1.12 . . . . 0.0 111.478 161.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.57 111.08 4.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.64 -6.99 52.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 119.019 2.367 . . . . 0.0 119.019 -167.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.9 t -85.78 130.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.822 2.311 . . . . 0.0 110.511 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 107.54 10.68 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.559 0.744 . . . . 0.0 111.919 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -126.9 157.71 38.69 Favored 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.42 0.688 . . . . 0.0 112.426 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -82.95 113.93 20.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 111.844 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -92.44 116.76 29.27 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.503 0.721 . . . . 0.0 109.405 167.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -96.96 124.35 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.25 0.548 . . . . 0.0 111.155 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.449 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -110.28 142.97 41.15 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 122.368 1.08 . . . . 0.0 111.639 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.8 mt -114.58 116.22 28.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.736 0.814 . . . . 0.0 110.13 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -93.69 120.49 34.02 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 121.674 -0.641 . . . . 0.0 111.103 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.55 -161.67 35.12 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 117.651 1.82 . . . . 0.0 117.651 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.8 p -123.84 121.48 35.5 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.579 -160.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -79.25 114.15 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.938 0.79 . . . . 0.0 109.908 155.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -114.35 142.9 45.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.38 0.672 . . . . 0.0 110.973 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 tp -91.41 103.41 16.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.687 -1.258 . . . . 0.0 111.768 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -83.55 83.95 7.71 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.144 0.974 . . . . 0.0 110.127 166.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.57 -88.38 0.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -118.32 13.05 13.57 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.82 128.51 49.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.153 1.797 . . . . 0.0 109.473 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 mt -85.8 101.11 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.48 110.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-O 122.481 1.134 . . . . 0.0 109.335 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.87 103.12 3.01 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.731 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -90.06 90.47 8.14 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.23 161.16 19.39 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 122.844 1.306 . . . . 0.0 111.773 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -150.05 155.17 39.4 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.992 . . . . 0.0 110.724 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -68.21 131.78 45.98 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 113.858 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.3 p -55.46 -43.62 75.64 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 164.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -45.25 4.57 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.895 0.878 . . . . 0.0 111.698 -161.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -65.32 -42.74 92.67 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.73 -9.89 72.17 Favored Glycine 0 CA--C 1.558 2.732 0 N-CA-C 119.136 2.414 . . . . 0.0 119.136 -161.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -78.02 138.75 38.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.326 1.563 . . . . 0.0 112.894 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -73.45 148.06 43.58 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 tt -137.6 121.2 17.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.67 0.747 . . . . 0.0 110.227 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -93.59 120.18 33.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.982 -0.449 . . . . 0.0 110.112 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -125.02 124.8 42.75 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.668 0.387 . . . . 0.0 111.67 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.01 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -96.04 120.7 36.79 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.093 0.557 . . . . 0.0 110.458 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.87 153.79 31.68 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.523 0.729 . . . . 0.0 111.931 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.97 115.93 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.827 -1.17 . . . . 0.0 108.252 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tp -89.34 81.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.126 0.965 . . . . 0.0 110.67 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.0 -84.44 1.13 Allowed Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.905 -1.122 . . . . 0.0 114.976 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -128.8 26.01 5.59 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.66 125.79 31.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.901 -1.125 . . . . 0.0 109.906 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 tp -77.93 117.75 19.58 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.352 -0.843 . . . . 0.0 111.007 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -97.77 125.52 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.81 104.04 14.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 162.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -98.93 91.87 5.25 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.35 0.66 . . . . 0.0 109.248 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.27 113.44 25.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.96 0.904 . . . . 0.0 111.402 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.52 108.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -122.28 124.82 44.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.129 0.572 . . . . 0.0 110.872 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 57.1 37.68 28.7 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.12 26.39 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 119.801 2.68 . . . . 0.0 119.801 -163.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.28 107.26 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 119.942 1.871 . . . . 0.0 108.08 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 118.81 28.17 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.449 0.7 . . . . 0.0 111.948 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.88 125.12 53.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.222 0.609 . . . . 0.0 112.195 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.68 106.21 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.863 -0.523 . . . . 0.0 110.395 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -85.58 117.99 24.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.919 -1.113 . . . . 0.0 109.225 164.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.7 mt -115.02 117.42 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -164.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -116.55 117.47 29.97 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.34 0.656 . . . . 0.0 109.683 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.67 152.31 28.51 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 112.08 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -63.2 100.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.05 -1.031 . . . . 0.0 112.751 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.41 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -116.37 88.53 2.91 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 120.221 -1.549 . . . . 0.0 111.252 -150.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -164.77 -178.94 5.55 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.687 1.195 . . . . 0.0 110.88 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -92.22 106.99 18.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.614 -1.304 . . . . 0.0 109.192 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -109.54 100.5 9.55 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -168.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -95.94 139.06 32.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.199 -0.938 . . . . 0.0 112.754 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.64 115.57 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.61 -61.45 1.91 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.151 0.58 . . . . 0.0 111.395 164.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -140.13 146.54 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.197 0.999 . . . . 0.0 112.948 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 108.07 8.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.56 -49.85 24.24 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -162.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -138.66 41.29 2.18 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -84.39 48.66 1.53 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 119.469 -2.02 . . . . 0.0 114.513 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -149.02 -47.57 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.415 1.486 . . . . 0.0 111.682 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.89 -37.97 89.35 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.942 1.701 . . . . 0.0 114.834 160.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -49.4 -57.93 6.05 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 159.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -45.29 76.95 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 168.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -50.59 -49.35 56.66 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -62.8 -37.73 87.88 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.7 mtm -62.91 -52.25 63.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.05 70.53 0.09 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 145.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-O 122.708 1.242 . . . . 0.0 111.276 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -63.92 156.34 28.0 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.258 14.0 tt -56.66 -40.11 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.47 -53.14 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.34 0.973 . . . . 0.0 113.067 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.78 -30.03 67.5 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -52.3 -46.41 65.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 159.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -57.53 -48.38 79.44 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.17 -34.65 75.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.27 75.28 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.94 -50.83 30.33 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 162.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.46 58.56 4.93 Favored 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 119.807 1.185 . . . . 0.0 112.917 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -95.97 -28.04 14.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 65.31 49.88 1.85 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.625 1.17 . . . . 0.0 114.041 -168.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -77.08 124.67 28.14 Favored 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.765 -1.21 . . . . 0.0 113.741 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -120.94 111.65 17.77 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.828 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 mt -91.38 100.23 13.05 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -91.65 101.05 13.68 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.97 -1.081 . . . . 0.0 109.116 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.19 107.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -104.03 104.15 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -92.45 127.52 37.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.668 -0.645 . . . . 0.0 110.984 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -125.74 76.92 1.62 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.734 1.254 . . . . 0.0 111.265 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 -95.23 1.36 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.055 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -97.19 -23.37 16.22 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -91.15 155.31 18.71 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 120.182 1.355 . . . . 0.0 112.621 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -124.6 112.49 16.88 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.955 0.902 . . . . 0.0 109.449 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.4 m -96.41 94.28 7.32 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.82 107.17 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.83 94.31 9.27 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.08 97.86 10.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.621 0.769 . . . . 0.0 108.934 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -113.62 115.53 28.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.324 0.65 . . . . 0.0 111.507 -162.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -144.66 168.57 19.85 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 0.0 113.127 -170.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -58.9 -34.64 71.91 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 160.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -50.08 67.74 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.25 11.66 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.35 1.06 . . . . 0.0 111.839 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -118.19 101.21 8.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.42 120.17 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.633 -0.667 . . . . 0.0 110.799 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.88 102.81 14.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.941 -1.099 . . . . 0.0 111.46 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.5 97.4 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.01 111.0 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -138.58 142.49 39.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.79 150.42 25.06 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.15 0.976 . . . . 0.0 111.648 164.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.08 102.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.053 -1.029 . . . . 0.0 113.099 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.81 -4.01 36.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 118.931 2.333 . . . . 0.0 118.931 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.79 135.23 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 121.376 2.588 . . . . 0.0 112.263 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.8 p -84.22 96.69 9.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 110.75 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -122.96 154.98 37.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.407 0.683 . . . . 0.0 112.693 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -83.38 105.71 14.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.654 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -96.87 101.72 13.36 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.047 0.939 . . . . 0.0 110.638 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -87.35 109.33 19.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.056 -1.028 . . . . 0.0 111.061 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -166.557 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -68.28 140.12 55.97 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 25.2 mt -134.76 100.24 4.55 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.328 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -84.51 107.25 16.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.913 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -154.55 23.97 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.506 0.963 . . . . 0.0 115.506 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.2 p -124.33 122.35 37.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.773 -155.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -82.27 107.51 15.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 155.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.5 m -108.69 149.96 28.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.6 -0.687 . . . . 0.0 112.322 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 105.28 17.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.877 -1.139 . . . . 0.0 110.91 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.05 79.85 1.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.955 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.51 -92.83 0.89 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 121.128 -0.982 . . . . 0.0 114.04 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.69 52.37 1.93 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.401 0.62 . . . . 0.0 111.188 160.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -141.04 120.06 12.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -83.04 99.2 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.358 -1.464 . . . . 0.0 109.446 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 tp -90.17 111.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.693 0.797 . . . . 0.0 110.033 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.28 92.8 1.36 Allowed Glycine 0 N--CA 1.482 1.734 0 C-N-CA 123.793 0.711 . . . . 0.0 113.172 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.21 111.25 22.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -134.86 111.16 9.65 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -156.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -84.79 120.64 26.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.697 -1.252 . . . . 0.0 111.855 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -54.97 120.21 6.56 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.9 p -64.17 -43.07 96.26 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.25 -44.24 76.08 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.92 -47.66 8.4 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.48 54.66 3.06 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 -157.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -138.52 124.22 19.75 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.335 1.067 . . . . 0.0 110.24 -172.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -83.75 99.51 10.32 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.115 1.436 . . . . 0.0 113.774 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.5 132.46 34.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.715 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -106.71 110.19 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.734 -0.604 . . . . 0.0 110.192 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -111.05 112.34 24.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.799 -0.563 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.66 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.154 -0.966 . . . . 0.0 108.784 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 mtm-85 -90.46 116.08 28.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.847 168.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -144.39 159.45 42.7 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.656 0.782 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.3 mt -126.14 121.43 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.423 -1.423 . . . . 0.0 109.494 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.13 83.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.12 -80.59 0.96 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.89 -50.41 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -94.22 148.16 22.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 120.212 1.369 . . . . 0.0 114.329 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 tp -86.93 120.75 28.53 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.127 0.571 . . . . 0.0 111.411 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 m -106.77 121.38 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -107.97 103.18 12.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.54 -0.725 . . . . 0.0 109.751 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.4 m -97.8 100.49 11.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.584 0.753 . . . . 0.0 109.356 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -90.04 117.71 29.04 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.023 0.929 . . . . 0.0 111.424 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.92 115.64 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -110.84 107.56 17.09 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.67 0.668 . . . . 0.0 109.647 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER 54.64 32.4 17.1 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 175.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.01 -40.5 2.5 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -162.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.69 112.67 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 120.538 2.169 . . . . 0.0 112.361 -168.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.77 130.07 39.9 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.08 0.552 . . . . 0.0 112.342 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.69 112.46 13.68 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.846 0.858 . . . . 0.0 110.996 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -103.31 116.29 32.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -0.804 . . . . 0.0 110.679 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -106.14 114.07 27.98 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.041 0.448 . . . . 0.0 109.83 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.1 mt -101.23 121.19 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.97 124.87 51.61 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.326 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -82.65 142.35 31.78 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.887 0.851 . . . . 0.0 111.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -79.97 105.5 11.3 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 124.924 1.29 . . . . 0.0 113.669 174.485 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.277 87.8 m-85 . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 122.815 1.293 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.92 -36.15 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -137.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -122.82 -172.32 2.46 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 123.327 1.537 . . . . 0.0 112.918 -158.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.8 m -78.03 118.97 20.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.16 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -122.71 108.1 12.69 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -109.94 139.52 44.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.099 -1.001 . . . . 0.0 113.307 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.62 117.75 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -102.28 -56.97 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.691 0.797 . . . . 0.0 111.438 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 110.77 11.93 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.467 0.707 . . . . 0.0 112.032 -166.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.1 p -106.86 127.31 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 112.512 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -73.94 -46.65 42.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -147.03 45.59 1.17 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -83.9 52.44 2.29 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 119.332 -2.105 . . . . 0.0 113.955 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -152.26 -51.76 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.157 1.383 . . . . 0.0 110.349 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.95 -30.75 70.12 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 163.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -50.94 -40.47 57.46 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 154.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -70.39 -34.23 72.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -50.95 -52.68 39.96 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 121.009 1.731 . . . . 0.0 115.318 159.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.09 -34.14 74.46 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.28 -51.52 69.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 162.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 68.27 0.48 Allowed Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.015 0.825 . . . . 0.0 114.094 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.66 149.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.462 0.649 . . . . 0.0 112.489 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -78.89 153.03 30.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.769 -1.207 . . . . 0.0 113.68 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.311 10.7 tt -59.61 -39.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 118.483 2.771 . . . . 0.0 118.483 -170.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.6 m -59.11 -42.43 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -67.14 -35.18 79.15 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -55.72 -50.73 69.56 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.387 1.903 . . . . 0.0 114.151 164.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -56.38 -54.68 42.69 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.94 48.58 0.85 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.96 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.059 1.344 . . . . 0.0 111.963 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.28 93.85 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -83.97 67.75 9.75 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 122.283 1.04 . . . . 0.0 111.403 171.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -92.51 -33.55 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.84 50.58 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.521 1.129 . . . . 0.0 113.532 -166.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.88 124.19 26.91 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.493 1.14 . . . . 0.0 113.632 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -108.71 100.05 9.33 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.054 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.83 102.73 11.01 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.132 0.573 . . . . 0.0 109.491 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.1 m -99.51 105.59 17.52 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -107.22 118.23 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -161.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 p -123.96 126.53 46.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.72 -0.612 . . . . 0.0 110.492 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.17 119.95 37.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.631 -0.668 . . . . 0.0 110.933 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.08 -49.83 14.42 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.36 -91.42 0.08 OUTLIER Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -74.7 -24.6 58.79 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 157.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -87.62 129.5 35.1 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 119.894 1.225 . . . . 0.0 111.954 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -109.83 134.7 51.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.358 1.063 . . . . 0.0 110.581 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.5 m -107.59 111.93 24.42 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -104.76 105.63 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -80.88 110.02 16.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 110.335 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.16 82.52 4.16 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.175 0.59 . . . . 0.0 110.525 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 t -96.66 111.09 23.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.002 -1.061 . . . . 0.0 112.752 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 p -131.94 -169.72 2.26 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.376 0.671 . . . . 0.0 112.069 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -70.45 -1.59 11.25 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 159.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -126.91 -38.36 2.04 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.675 1.19 . . . . 0.0 114.008 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -90.4 -90.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 119.79 1.177 . . . . 0.0 111.781 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.287 70.4 m-80 60.96 60.28 1.87 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 pt -134.14 135.2 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 123.121 0.568 . . . . 0.0 110.595 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.79 103.05 14.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 111.868 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 t -88.13 98.28 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.0 113.61 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.99 140.64 45.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.689 0.757 . . . . 0.0 112.734 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.36 142.71 41.09 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 111.982 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 100.69 0.89 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 112.891 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.81 -12.42 24.94 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.103 2.401 . . . . 0.0 119.103 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.26 134.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 121.247 2.524 . . . . 0.0 112.61 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.6 t -82.08 92.8 6.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 111.984 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -119.15 170.27 9.22 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.956 0.902 . . . . 0.0 113.036 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -88.61 99.13 12.08 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 121.723 -0.611 . . . . 0.0 110.613 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -87.1 87.1 7.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.835 170.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -71.18 142.75 50.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 177.522 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 121.665 0.745 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -85.68 118.56 25.26 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 110.794 151.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -92.66 116.63 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.929 -1.107 . . . . 0.0 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -94.58 114.63 26.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.721 . . . . 0.0 110.649 -174.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.77 -153.7 24.98 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 p -119.86 140.77 50.31 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -160.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.16 109.64 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 108.913 155.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.3 m -104.58 139.19 39.81 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.181 0.592 . . . . 0.0 111.484 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.1 tp -88.17 107.47 18.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.118 -0.989 . . . . 0.0 109.959 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.85 -53.59 17.41 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.79 -71.07 0.28 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -162.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.15 -39.8 39.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 160.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.04 145.26 35.88 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.959 0.904 . . . . 0.0 112.882 -164.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.06 101.53 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 146.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.2 110.42 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.797 0.808 . . . . 0.0 109.485 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.76 94.68 2.02 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.8 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.02 95.61 9.89 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.534 0.683 . . . . 0.0 109.18 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.48 164.96 20.77 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 122.561 1.172 . . . . 0.0 111.835 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.79 155.01 46.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.849 -1.157 . . . . 0.0 112.072 165.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -67.84 139.02 56.53 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.8 m -77.91 -51.87 9.74 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.17 0.588 . . . . 0.0 112.062 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.97 -41.38 74.66 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.0 -31.63 7.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.15 38.56 29.48 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 118.556 2.182 . . . . 0.0 118.556 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -144.08 157.54 44.25 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.92 1.36 . . . . 0.0 111.916 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -80.54 129.68 34.66 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -159.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.79 124.08 51.77 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.029 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -107.24 107.22 18.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -107.27 99.32 8.86 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.58 119.91 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -103.62 124.49 48.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.748 0.704 . . . . 0.0 110.398 170.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.28 146.27 40.17 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.53 0.732 . . . . 0.0 111.114 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -89.71 115.16 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.322 -1.486 . . . . 0.0 108.676 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -99.74 88.93 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.31 -88.51 0.8 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.486 -0.759 . . . . 0.0 113.953 -174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -136.88 50.41 2.01 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 161.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -137.57 122.05 18.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.23 109.25 15.58 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 123.549 0.74 . . . . 0.0 110.786 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.69 98.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 109.951 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -84.59 96.26 9.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.033 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.2 m -96.34 92.6 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.524 0.73 . . . . 0.0 109.709 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.9 105.78 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.964 0.906 . . . . 0.0 111.438 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.6 t -109.48 109.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -127.18 119.46 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 110.078 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.8 OUTLIER 48.75 63.64 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.18 -31.72 2.58 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 119.211 2.444 . . . . 0.0 119.211 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.54 121.78 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.662 1.731 . . . . 0.0 110.698 -159.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.43 143.6 27.15 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 123.81 0.844 . . . . 0.0 112.953 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.29 109.39 6.1 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 121.56 -0.713 . . . . 0.0 110.689 164.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -101.16 96.98 7.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.257 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -87.46 111.41 21.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.259 0.624 . . . . 0.0 110.231 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.09 111.59 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -170.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -103.68 113.82 27.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.41 0.684 . . . . 0.0 109.602 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -77.11 162.75 27.22 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.35 110.25 4.01 Favored 'General case' 0 CA--C 1.57 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 112.361 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 C-N-CA 125.039 1.335 . . . . 0.0 112.38 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -69.13 94.42 0.67 Allowed 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -168.05 173.18 8.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.619 1.168 . . . . 0.0 110.999 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 m -88.97 117.79 28.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.001 . . . . 0.0 109.499 166.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -120.43 113.0 19.68 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.986 0.514 . . . . 0.0 109.876 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 142.45 27.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.267 -0.896 . . . . 0.0 112.754 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.72 115.94 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.573 -0.705 . . . . 0.0 111.923 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.21 -53.38 6.72 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.334 0.654 . . . . 0.0 112.074 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.12 143.23 25.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.667 0.746 . . . . 0.0 112.839 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -109.3 88.39 2.72 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.995 0.902 . . . . 0.0 110.446 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.31 118.89 25.13 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.632 0.773 . . . . 0.0 110.969 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.291 22.9 t30 67.25 11.71 8.53 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 118.105 2.631 . . . . 0.0 118.105 -173.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -64.77 -37.64 88.27 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -63.05 -42.84 99.82 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -71.39 -39.87 70.89 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -46.51 -55.88 6.85 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 158.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtp -63.17 -39.25 94.12 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.18 -43.87 95.52 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -38.02 66.26 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 163.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.4 mtt -59.56 -36.94 77.16 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.311 2.338 . . . . 0.0 117.311 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.6 63.12 0.89 Allowed Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.779 0.718 . . . . 0.0 114.147 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.91 -171.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.481 0.658 . . . . 0.0 112.479 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -65.36 173.41 2.62 Favored 'General case' 0 CA--C 1.583 2.231 0 O-C-N 119.899 -1.751 . . . . 0.0 113.976 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.4 tt -94.8 -45.39 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.333 -1.479 . . . . 0.0 114.381 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.2 -60.03 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.686 1.13 . . . . 0.0 112.239 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -55.08 -49.6 71.26 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -34.49 -51.37 0.47 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 118.668 2.84 . . . . 0.0 118.668 160.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -73.2 -39.67 65.37 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.53 95.99 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 168.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.04 -44.59 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -114.02 54.33 0.76 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 118.505 0.593 . . . . 0.0 112.086 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -83.63 -13.77 53.51 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 59.9 m-80 64.89 61.15 0.8 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.736 1.153 . . . . 0.0 113.136 -167.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 tp -83.32 120.86 26.38 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.607 1.194 . . . . 0.0 113.357 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -102.69 118.35 36.65 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.941 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.19 100.41 12.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 m -91.54 102.92 15.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.842 0.83 . . . . 0.0 108.878 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.21 124.04 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -117.98 107.75 14.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -87.22 91.17 8.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.51 0.671 . . . . 0.0 111.323 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -89.46 68.16 7.79 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.463 0.649 . . . . 0.0 112.158 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 78.66 0.15 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 116.86 1.504 . . . . 0.0 116.86 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.328 24.0 m120 72.27 -34.32 0.29 Allowed 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -166.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.79 148.98 34.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.477 1.035 . . . . 0.0 112.971 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -132.19 116.88 17.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.389 1.076 . . . . 0.0 108.116 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.9 m -102.38 100.64 10.81 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.9 t -105.87 104.57 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -83.32 104.47 13.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.27 96.39 8.46 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -115.09 114.53 25.46 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.573 0.749 . . . . 0.0 110.944 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 p -141.62 -177.64 5.27 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.301 1.048 . . . . 0.0 113.765 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 159.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -90.58 -48.51 7.04 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -130.32 152.14 50.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 119.997 1.271 . . . . 0.0 112.918 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.01 93.43 2.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.981 . . . . 0.0 109.799 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 pt -136.38 130.31 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.632 -0.668 . . . . 0.0 111.245 -172.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -88.32 105.81 17.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.379 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.72 101.46 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.61 121.7 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 123.385 0.674 . . . . 0.0 109.365 -171.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.55 148.96 23.42 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.396 0.679 . . . . 0.0 111.628 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.88 155.98 17.38 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 120.555 -1.341 . . . . 0.0 113.052 162.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.64 124.4 20.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.65 62.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.536 2.574 . . . . 0.0 119.536 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.86 141.94 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 120.488 2.144 . . . . 0.0 110.741 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 t -73.08 124.43 25.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -137.01 165.0 27.05 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 121.814 0.816 . . . . 0.0 111.246 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -91.39 110.04 21.33 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 110.424 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -84.61 -50.14 7.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.264 5.8 m120 75.65 133.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 122.593 1.187 . . . . 0.0 113.598 175.629 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 CA--C 1.573 1.862 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -94.09 126.49 39.34 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.053 1.406 . . . . 0.0 113.022 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.01 123.99 46.85 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.218 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -135.95 131.44 35.12 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.86 -148.06 16.55 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.477 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.7 p -120.51 123.04 41.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.026 -0.691 . . . . 0.0 112.104 -156.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -80.9 107.15 13.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.65 0.659 . . . . 0.0 109.734 153.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.6 m -95.39 172.34 8.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 111.24 162.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.41 116.79 14.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.409 -1.432 . . . . 0.0 109.978 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.3 88.04 5.01 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.007 0.908 . . . . 0.0 111.795 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.98 -84.17 0.59 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -126.81 32.45 5.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 170.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -141.11 123.66 15.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.482 -1.387 . . . . 0.0 109.096 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.48 127.61 33.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.16 124.18 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.685 0.755 . . . . 0.0 109.945 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.85 103.37 1.41 Allowed Glycine 0 N--CA 1.479 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 113.538 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -95.51 96.78 9.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.4 119.23 31.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.521 -170.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -87.4 139.58 30.4 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.533 1.159 . . . . 0.0 112.512 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -63.86 139.19 58.74 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 168.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -52.37 -43.25 64.59 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 152.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.96 -55.37 3.79 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.508 0.723 . . . . 0.0 111.876 -157.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.17 -32.39 13.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.45 90.04 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 119.042 2.377 . . . . 0.0 119.042 -163.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.09 -3.36 57.22 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -164.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.333 4.7 tt0 72.57 118.3 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 tt -90.34 137.68 32.15 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.137 0.975 . . . . 0.0 111.441 162.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.1 108.09 16.18 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.094 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.261 9.9 t -113.32 114.55 26.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 0.0 112.278 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.07 134.24 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -112.8 121.16 43.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 0.0 110.529 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.99 172.65 12.08 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 121.679 0.752 . . . . 0.0 111.766 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.59 108.36 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.053 . . . . 0.0 109.481 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.263 11.1 tp -96.98 88.09 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.812 0.815 . . . . 0.0 109.717 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.27 -90.31 1.01 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.121 -0.987 . . . . 0.0 114.125 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.83 52.48 1.94 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 165.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -132.87 121.99 23.73 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.181 0.992 . . . . 0.0 108.375 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.2 101.97 11.58 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.775 -0.578 . . . . 0.0 109.908 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.81 83.46 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.093 0.949 . . . . 0.0 110.476 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.39 100.05 10.45 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.238 1.018 . . . . 0.0 109.984 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.4 m -110.68 90.44 3.32 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.005 -151.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.42 114.02 24.61 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.978 0.911 . . . . 0.0 110.89 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -108.71 124.26 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -141.34 128.15 20.46 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 121.355 0.597 . . . . 0.0 111.649 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 3.9 mm-40 48.96 44.35 22.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -167.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.04 -25.3 1.87 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 119.31 2.484 . . . . 0.0 119.31 -165.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.3 t -82.85 117.31 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 120.317 2.058 . . . . 0.0 110.03 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -91.67 140.76 29.4 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.97 0.908 . . . . 0.0 112.659 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.59 32.58 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 165.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -103.32 106.19 16.65 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.959 -0.463 . . . . 0.0 110.388 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -83.8 102.59 12.44 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.22 115.16 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -106.96 115.62 30.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.241 0.543 . . . . 0.0 109.576 -173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -84.16 149.29 26.26 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.421 0.689 . . . . 0.0 111.924 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -62.17 112.1 2.24 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 125.235 1.414 . . . . 0.0 112.827 -173.658 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.252 5.5 p-10 -74.55 80.89 1.97 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 120.234 1.379 . . . . 0.0 114.205 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -146.93 -166.35 2.48 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.135 0.969 . . . . 0.0 111.573 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.5 m -94.55 127.56 40.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.654 -1.279 . . . . 0.0 109.985 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -136.63 105.53 5.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.966 -0.459 . . . . 0.0 110.509 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -98.97 137.39 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.212 0.915 . . . . 0.0 111.339 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.6 120.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.801 0.81 . . . . 0.0 112.693 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.17 -54.64 5.79 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.065 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -147.25 160.77 42.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 121.765 0.793 . . . . 0.0 112.677 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -136.54 118.27 15.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 111.445 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -70.46 -60.35 2.32 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -165.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -130.33 51.13 2.13 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.32 1.057 . . . . 0.0 112.944 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -74.89 -36.8 62.25 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.0 -50.56 72.34 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.13 -36.79 77.86 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.53 -52.44 38.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 160.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 mtp -61.22 -48.97 79.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -43.02 64.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -54.69 -30.14 54.93 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtm -70.98 -11.46 60.98 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.69 64.54 1.74 Allowed Glycine 0 N--CA 1.495 2.583 0 CA-C-N 122.265 2.302 . . . . 0.0 114.67 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -119.55 170.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 122.821 1.296 . . . . 0.0 113.092 -164.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.2 108.0 16.84 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 120.877 -1.139 . . . . 0.0 110.531 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.3 12.7 tt -49.25 -44.53 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 119.808 3.262 . . . . 0.0 119.808 -164.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.07 -46.94 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 170.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -68.66 -31.13 70.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -51.22 -45.58 61.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.91 -52.24 66.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.79 -36.29 82.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.89 91.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.12 75.18 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -92.47 62.48 3.95 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 163.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER -83.03 -17.36 43.56 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 60.28 50.88 5.85 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -84.22 149.62 26.01 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -111.59 114.48 27.57 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.771 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.11 103.28 11.61 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.2 m -91.73 99.0 11.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 168.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -99.94 124.22 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.9 p -129.76 119.45 23.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.649 -0.657 . . . . 0.0 109.921 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -88.72 119.2 28.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.901 0.773 . . . . 0.0 111.96 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.81 76.9 1.82 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 123.112 0.565 . . . . 0.0 109.856 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.54 80.49 0.1 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 20.0 m120 71.62 -50.4 0.69 Allowed 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -166.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -73.95 121.84 21.64 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.981 0.912 . . . . 0.0 112.929 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -99.69 134.78 42.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.56 -0.712 . . . . 0.0 111.481 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 m -102.27 111.06 23.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 161.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.04 105.49 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 70' ' ' TYR . 16.4 mt-10 -86.01 95.8 9.63 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.954 0.502 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.0 t -98.76 110.28 22.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.875 0.47 . . . . 0.0 110.336 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.83 170.35 15.91 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -68.82 -6.54 27.5 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -100.03 -46.03 5.47 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.499 1.045 . . . . 0.0 113.206 168.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.87 154.5 40.5 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.035 1.288 . . . . 0.0 112.205 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -112.58 105.94 14.25 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 161.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.2 pt -123.51 127.6 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.248 0.547 . . . . 0.0 111.3 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -99.71 100.67 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.759 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.17 98.11 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.0 109.582 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.19 128.9 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.194 0.598 . . . . 0.0 110.346 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -148.66 147.78 29.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.456 0.646 . . . . 0.0 112.729 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 157.06 16.47 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.318 1.056 . . . . 0.0 110.785 164.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.78 80.89 3.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 112.436 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.02 -38.3 1.83 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -162.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.53 121.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.072 1.436 . . . . 0.0 110.091 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -68.19 127.69 33.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.39 165.43 22.57 Favored 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 123.896 0.879 . . . . 0.0 111.579 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -96.26 108.16 20.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' OH ' ' OE2' ' A' ' 51' ' ' GLU . 6.5 t80 -92.15 97.62 11.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.489 -0.757 . . . . 0.0 110.135 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -75.67 115.24 15.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.778 -0.576 . . . . 0.0 112.409 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.563 1.454 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -172.751 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.19 114.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.366 0.603 . . . . 0.0 109.651 160.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.18 117.11 27.92 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.448 0.642 . . . . 0.0 110.494 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -91.27 109.45 20.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.39 0.676 . . . . 0.0 109.998 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.94 -149.84 14.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.8 p -138.92 142.65 38.47 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.076 0.551 . . . . 0.0 110.851 -170.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -85.32 89.18 7.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.998 -1.064 . . . . 0.0 108.319 153.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -76.69 138.06 39.77 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.984 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.97 105.74 13.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 110.857 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.24 -35.39 73.8 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.73 -79.21 0.2 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.91 -24.25 41.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 160.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -120.79 149.15 43.01 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.263 1.392 . . . . 0.0 111.921 -160.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -94.94 108.88 20.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.925 -1.11 . . . . 0.0 108.993 162.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.19 112.43 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 CA-C-O 122.317 1.056 . . . . 0.0 109.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.01 92.88 0.74 Allowed Glycine 0 N--CA 1.479 1.519 0 C-N-CA 124.265 0.936 . . . . 0.0 113.746 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.09 91.33 8.67 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.41 152.25 37.14 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.101 0.953 . . . . 0.0 112.386 -168.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -121.61 139.43 53.55 Favored 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.549 0.74 . . . . 0.0 110.023 169.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -63.38 131.16 47.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.862 -1.149 . . . . 0.0 113.607 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.7 m -66.59 -47.21 73.46 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 167.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.66 -51.87 37.21 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.72 -45.94 27.38 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.75 -8.34 79.66 Favored Glycine 0 CA--C 1.558 2.781 0 N-CA-C 118.543 2.177 . . . . 0.0 118.543 -153.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.53 152.12 24.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.648 1.724 . . . . 0.0 112.724 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -70.81 141.63 51.35 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.92 126.16 40.95 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -100.51 146.73 26.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 111.15 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 m -148.35 109.73 4.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.159 -1.588 . . . . 0.0 111.69 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.1 t -97.07 122.87 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.227 . . . . 0.0 109.966 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.41 127.62 44.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 111.198 163.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.61 146.01 27.08 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.337 0.655 . . . . 0.0 110.872 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.36 102.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.26 11.3 tp -98.68 75.19 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.039 0.923 . . . . 0.0 111.27 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.83 62.4 3.83 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 116.164 1.226 . . . . 0.0 116.164 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.317 9.1 t70 81.9 -41.1 0.13 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -167.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.74 107.75 7.04 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.97 0.908 . . . . 0.0 113.324 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.3 tp -76.07 102.42 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.655 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -91.72 82.5 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.111 0.482 . . . . 0.0 110.447 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -73.8 97.93 2.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.955 -1.091 . . . . 0.0 110.921 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.7 m -106.08 89.52 3.09 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 -157.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -81.96 137.96 35.04 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.146 0.978 . . . . 0.0 111.977 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.64 120.62 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -131.71 122.59 26.16 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 55.92 36.8 28.0 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.83 -17.15 17.16 Favored Glycine 0 CA--C 1.557 2.689 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 -163.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.37 116.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.009 1.904 . . . . 0.0 109.23 -172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.15 147.37 23.11 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.57 123.49 15.36 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.894 0.877 . . . . 0.0 111.681 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -110.72 98.4 7.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.061 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -86.69 108.83 18.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.2 mt -106.91 126.34 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -115.67 128.7 56.1 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.516 0.674 . . . . 0.0 111.447 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -80.79 155.03 26.86 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 121.672 0.749 . . . . 0.0 111.396 165.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -68.45 114.22 6.69 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.15 -0.969 . . . . 0.0 111.7 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 125.253 1.421 . . . . 0.0 112.531 -173.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -82.35 90.55 6.68 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 120.747 1.612 . . . . 0.0 113.466 -165.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -162.37 179.0 8.16 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 122.209 1.004 . . . . 0.0 112.188 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 m -83.04 125.2 31.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 110.222 163.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.91 106.39 9.28 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.183 0.593 . . . . 0.0 109.727 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -97.74 138.39 35.19 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.919 -1.113 . . . . 0.0 112.605 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.85 112.05 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 113.326 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.71 -59.52 2.22 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.087 0.555 . . . . 0.0 111.828 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -134.78 124.48 25.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.0 p -103.72 129.26 51.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.454 0.702 . . . . 0.0 112.034 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.332 0.1 OUTLIER -72.75 -72.81 0.23 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 177.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -121.48 39.5 3.83 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.804 1.184 . . . . 0.0 114.069 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.74 -40.83 75.93 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -64.54 -30.77 71.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -79.0 -40.12 32.34 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -48.27 -50.44 29.76 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 158.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.403 ' SD ' HG21 ' A' ' 23' ' ' VAL . 12.4 mmt -50.12 -50.8 47.34 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 163.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -52.66 -46.51 67.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -57.67 -41.83 82.36 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.61 -33.82 74.58 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.77 67.9 0.83 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-N 119.55 1.068 . . . . 0.0 113.904 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 ' SD ' ' A' ' 18' ' ' MET . 11.5 m -126.2 170.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.466 1.127 . . . . 0.0 112.51 -165.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -64.22 178.74 0.65 Allowed 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.4 tt -108.53 167.4 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 157.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.383 46.2 t 80.85 -68.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 120.392 -1.443 . . . . 0.0 111.691 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -65.87 -38.86 89.91 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 119.802 1.183 . . . . 0.0 113.811 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -44.23 -42.84 6.83 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 161.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -69.69 -51.23 36.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.179 -0.951 . . . . 0.0 113.538 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -55.51 -33.65 63.93 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.2 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.24 94.34 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 161.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -103.8 51.74 0.78 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.85 -7.58 59.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 7.3 m-80 67.07 49.29 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.787 1.235 . . . . 0.0 114.229 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.9 tp -72.36 117.25 13.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.08 103.64 10.08 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.713 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.98 100.75 13.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.46 0.704 . . . . 0.0 110.072 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -90.57 101.92 14.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.966 -1.084 . . . . 0.0 109.551 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -94.34 113.45 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.4 p -107.8 110.08 21.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.46 91.61 5.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.665 1.221 . . . . 0.0 111.281 -167.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.63 80.39 9.14 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.746 1.26 . . . . 0.0 113.817 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 -100.02 1.56 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.322 -0.861 . . . . 0.0 114.937 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.08 -4.47 56.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 162.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -114.27 162.83 16.08 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-O 122.224 1.011 . . . . 0.0 111.998 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.46 112.19 10.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.94 -1.1 . . . . 0.0 109.223 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.5 m -95.74 100.7 12.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 164.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -99.26 100.71 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -86.62 98.69 11.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.76 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.44 99.01 10.14 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -97.73 116.51 30.08 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -142.76 176.55 8.96 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.196 0.998 . . . . 0.0 113.394 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -55.09 -37.11 66.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 164.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.91 -46.8 14.64 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -147.02 144.27 29.02 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.539 1.518 . . . . 0.0 112.897 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -126.78 96.29 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 167.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.92 148.78 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.651 1.215 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.39 109.07 18.77 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.409 -0.807 . . . . 0.0 111.219 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.43 96.41 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.59 112.41 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -140.18 144.36 36.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.176 0.591 . . . . 0.0 111.925 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.69 153.2 18.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.365 1.079 . . . . 0.0 111.083 162.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.31 117.73 6.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.57 -9.68 68.96 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 -168.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -77.65 130.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 120.772 2.286 . . . . 0.0 110.691 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -80.15 122.31 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.658 -0.651 . . . . 0.0 112.341 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -148.44 165.98 29.52 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 121.552 0.692 . . . . 0.0 111.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.88 101.17 13.46 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 110.822 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -75.77 -55.69 5.4 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.446 ' H ' ' HB2' ' A' ' 78' ' ' LEU 0.262 9.3 m-20 73.12 137.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.872 1.269 . . . . 0.0 114.013 172.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.853 178.584 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.31 148.76 44.05 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 120.76 -1.212 . . . . 0.0 114.09 148.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.446 ' HB2' ' H ' ' A' ' 71' ' ' ASN . 31.1 mt -140.35 100.78 3.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.61 0.764 . . . . 0.0 111.676 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -86.53 121.43 29.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.576 1.15 . . . . 0.0 111.917 171.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.59 -163.11 34.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.9 p -120.05 125.06 47.39 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.081 0.553 . . . . 0.0 111.907 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -80.42 106.93 12.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.792 -0.568 . . . . 0.0 110.21 155.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -98.12 170.01 9.21 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.965 0.888 . . . . 0.0 111.711 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.3 117.48 29.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.916 -1.115 . . . . 0.0 108.803 172.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -71.85 -43.77 64.94 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.2 -81.83 0.06 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -78.65 -31.29 46.74 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 157.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -86.75 132.04 33.97 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.688 1.131 . . . . 0.0 112.239 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.21 120.56 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 157.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.03 111.21 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.876 0.846 . . . . 0.0 108.783 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -106.24 105.93 2.48 Favored Glycine 0 N--CA 1.482 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 113.02 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -100.56 98.13 8.75 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -124.15 118.91 27.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.274 0.629 . . . . 0.0 111.561 -165.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -95.68 148.18 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 111.967 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -66.68 138.94 57.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.424 -1.422 . . . . 0.0 113.179 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.269 32.2 p -70.55 -33.44 71.14 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.55 -71.22 0.07 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.83 -50.58 3.15 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.346 1.058 . . . . 0.0 113.768 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.36 51.95 0.42 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -95.54 134.09 38.8 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.34 1.07 . . . . 0.0 110.151 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.88 118.05 12.23 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -108.9 115.66 30.5 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.81 104.92 17.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 109.642 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.3 p -99.2 102.75 14.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.8 134.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.619 1.1 . . . . 0.0 108.42 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -134.06 138.21 45.16 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.84 157.68 38.24 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.47 1.128 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.58 119.22 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.956 -1.09 . . . . 0.0 110.075 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -89.79 66.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 121.121 -0.987 . . . . 0.0 111.817 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.95 -77.87 0.95 Allowed Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.742 -1.224 . . . . 0.0 114.858 -168.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.63 -49.29 4.05 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.05 153.46 20.55 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 120.186 1.357 . . . . 0.0 114.122 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.23 108.59 20.06 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.506 -0.746 . . . . 0.0 110.562 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.17 139.66 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 169.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -130.2 101.88 5.98 Favored 'General case' 0 CA--C 1.563 1.465 0 O-C-N 121.675 -0.64 . . . . 0.0 109.867 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 119.1 23.52 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.131 0.972 . . . . 0.0 109.733 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -106.81 109.08 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 164.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.74 132.47 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -127.62 113.4 16.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 163.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.46 62.39 2.65 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.7 -44.98 3.38 Favored Glycine 0 CA--C 1.552 2.352 0 N-CA-C 118.115 2.006 . . . . 0.0 118.115 -166.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.59 123.81 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.402 1.601 . . . . 0.0 113.834 -162.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -80.24 150.63 29.98 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.506 1.146 . . . . 0.0 113.298 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.26 118.37 19.4 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.57 152.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -107.1 104.14 13.72 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -169.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -102.58 115.89 31.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.7 mt -101.98 113.74 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -98.72 130.73 45.21 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.049 1.404 . . . . 0.0 110.173 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -97.26 153.06 18.27 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.18 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.66 121.56 14.77 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 112.936 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.386 2.6 p30 . . . . . 0 N--CA 1.488 1.466 0 C-N-CA 125.463 1.505 . . . . 0.0 114.667 -175.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -159.35 83.8 0.77 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.165 -0.959 . . . . 0.0 110.126 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -166.48 175.82 7.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.284 -0.885 . . . . 0.0 111.915 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.9 m -81.84 124.78 29.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.964 -1.085 . . . . 0.0 110.482 160.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -124.98 104.09 8.38 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.304 0.641 . . . . 0.0 109.937 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -86.03 137.66 32.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.123 -0.986 . . . . 0.0 112.623 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.84 120.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.121 -0.987 . . . . 0.0 113.012 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -105.86 -64.83 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.78 0.832 . . . . 0.0 110.725 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.79 149.85 37.88 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 122.229 1.014 . . . . 0.0 111.402 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.0 m -157.86 106.11 2.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.101 -1.624 . . . . 0.0 109.692 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.24 -76.6 0.2 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -149.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.35 52.91 2.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.547 -1.346 . . . . 0.0 113.137 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.01 64.29 8.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 119.776 -1.828 . . . . 0.0 113.245 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.99 -49.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.374 1.07 . . . . 0.0 112.961 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -69.91 -39.39 76.21 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -45.23 -54.11 7.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 155.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.3 mtp -67.2 -40.62 86.48 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.92 -45.05 82.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 165.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -64.13 -34.89 79.1 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.39 -52.08 65.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 121.017 1.735 . . . . 0.0 115.535 166.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.17 65.96 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.8 p -148.44 128.68 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -77.56 158.66 29.75 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.292 10.1 tp -50.6 -41.03 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 118.853 2.909 . . . . 0.0 118.853 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -55.73 -46.09 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.98 -34.12 61.95 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -61.39 -38.97 88.98 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 165.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.81 -51.13 64.47 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-N 120.401 1.455 . . . . 0.0 114.694 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.07 -42.48 85.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.82 70.25 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.15 -50.92 66.29 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 164.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -88.53 55.1 3.27 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 119.444 1.02 . . . . 0.0 113.203 171.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -94.14 -7.47 42.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -173.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 60.08 42.28 15.93 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 114.99 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -74.54 117.44 16.36 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 122.691 1.234 . . . . 0.0 112.051 -172.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -117.46 112.58 20.83 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.898 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -96.02 103.04 14.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.884 -0.51 . . . . 0.0 110.306 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.5 m -91.03 97.89 11.44 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.96 124.1 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -135.73 114.62 12.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.04 115.85 28.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 112.638 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -83.76 76.68 9.98 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.11 0.957 . . . . 0.0 110.877 171.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.68 -81.02 0.53 Allowed Glycine 0 N--CA 1.492 2.378 0 O-C-N 121.144 -0.973 . . . . 0.0 115.141 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -100.07 -38.1 8.7 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 165.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -85.51 118.68 25.19 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.291 1.405 . . . . 0.0 113.05 -163.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -86.38 115.56 23.97 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.461 0.704 . . . . 0.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.1 m -86.78 104.44 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 162.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 t -106.45 116.67 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -84.73 99.49 10.87 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -75.03 91.07 2.5 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t -106.76 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.646 0.779 . . . . 0.0 110.789 -168.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.7 p -148.95 172.81 14.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.1 m -60.02 -49.09 79.05 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.36 -43.73 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -154.46 139.24 17.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.747 1.158 . . . . 0.0 111.889 -165.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -125.76 92.03 3.52 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -132.68 124.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.058 0.456 . . . . 0.0 111.153 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.49 102.9 10.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 112.135 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.91 103.78 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.36 106.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -129.59 138.56 51.34 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.6 0.76 . . . . 0.0 111.823 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.34 159.22 15.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.644 1.212 . . . . 0.0 111.86 167.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.5 113.3 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.68 75.91 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.0 126.4 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 121.013 2.407 . . . . 0.0 110.767 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -82.21 106.25 13.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.142 0.577 . . . . 0.0 111.871 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.48 154.3 48.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.732 -0.605 . . . . 0.0 112.384 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.36 89.54 7.7 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 122.709 1.242 . . . . 0.0 112.013 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -75.53 163.46 27.35 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.704 1.202 . . . . 0.0 112.523 168.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER -159.01 140.07 12.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.055 -1.653 . . . . 0.0 112.036 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -168.817 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.04 132.36 37.21 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 121.721 0.772 . . . . 0.0 112.919 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -136.49 103.72 5.35 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.747 0.819 . . . . 0.0 111.629 -159.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 127.38 35.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.166 -1.584 . . . . 0.0 111.623 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.68 174.47 46.91 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.226 2.451 . . . . 0.0 119.226 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.9 p -118.19 108.61 15.37 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.989 -1.106 . . . . 0.0 112.203 -169.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.73 107.54 5.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.612 -1.305 . . . . 0.0 109.989 166.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.5 m -110.07 -29.67 8.11 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -156.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.277 35.7 tp 69.08 103.31 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.312 1.445 . . . . 0.0 114.159 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.52 129.19 55.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.24 -108.82 1.42 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -118.3 45.33 2.03 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 163.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -141.99 114.68 8.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.13 95.77 5.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.839 -1.163 . . . . 0.0 110.187 170.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.5 tp -83.24 113.99 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 123.366 0.666 . . . . 0.0 110.606 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.89 2.47 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 123.834 0.731 . . . . 0.0 112.649 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -84.39 93.0 8.17 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -103.87 103.94 13.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.912 -0.492 . . . . 0.0 112.072 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -87.4 137.22 32.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.077 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -66.43 141.41 57.93 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.4 p -67.11 -32.69 74.0 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -63.86 -67.07 0.46 Allowed 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -109.4 -23.6 11.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 46.84 7.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.04 -16.1 55.79 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.317 6.3 tt0 69.36 87.88 0.12 Allowed 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.07 100.6 11.49 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -88.96 110.07 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.534 -0.729 . . . . 0.0 111.177 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -104.85 107.28 18.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.17 100.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.943 -1.098 . . . . 0.0 108.231 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -83.24 116.29 22.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.854 -0.529 . . . . 0.0 110.309 167.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -135.13 141.78 46.05 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.141 0.976 . . . . 0.0 110.294 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 105.41 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.32 -1.488 . . . . 0.0 107.022 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.251 14.7 tt -87.82 71.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.338 1.066 . . . . 0.0 110.714 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.12 1.54 Allowed Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.046 -1.034 . . . . 0.0 114.691 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.422 ' OD2' ' OE2' ' A' ' 112' ' ' GLU . 7.5 p-10 -105.12 -53.56 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.422 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 2.7 mt-10 -86.73 148.75 25.29 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 122.09 0.948 . . . . 0.0 112.914 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.3 tp -79.24 110.33 14.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.549 -0.719 . . . . 0.0 109.638 167.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.55 118.62 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -96.68 100.9 12.43 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 165.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 128.36 39.52 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.443 0.697 . . . . 0.0 109.759 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -135.31 119.1 17.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.845 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -87.16 144.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.012 0.525 . . . . 0.0 111.595 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -136.3 108.24 7.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 156.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.257 3.3 tm-20 49.19 70.03 0.52 Allowed 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.08 -42.73 2.76 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -169.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.63 119.71 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.708 1.254 . . . . 0.0 109.932 -165.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -98.41 140.2 33.03 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.854 0.835 . . . . 0.0 112.484 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.46 168.04 19.66 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.352 1.072 . . . . 0.0 112.497 162.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.69 150.05 51.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 111.599 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -122.99 117.0 24.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 157.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.4 109.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.34 127.5 47.94 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.959 0.903 . . . . 0.0 110.762 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -78.44 150.74 32.98 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.889 0.852 . . . . 0.0 112.62 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.43 122.23 14.06 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 113.155 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.489 1.492 0 C-N-CA 125.318 1.447 . . . . 0.0 111.501 -176.231 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.33 90.86 7.21 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 120.153 -1.592 . . . . 0.0 114.532 -161.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.8 m -167.26 174.19 8.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.761 1.224 . . . . 0.0 111.336 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.87 130.79 34.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -136.02 112.44 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -103.7 138.49 40.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 120.099 1.318 . . . . 0.0 113.453 -175.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.26 116.91 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -173.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -110.14 -48.29 3.2 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 123.949 0.899 . . . . 0.0 112.495 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 93.87 3.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.524 -0.735 . . . . 0.0 111.155 172.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -84.7 95.59 8.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.556 -1.34 . . . . 0.0 112.483 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.1 127.04 37.43 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.699 0.761 . . . . 0.0 111.11 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.303 6.7 t30 64.6 17.76 11.05 Favored 'General case' 0 CA--C 1.584 2.281 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 -171.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.52 -45.48 79.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -52.13 -41.39 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -42.56 61.92 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -46.78 -54.39 9.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 161.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.5 mmt -60.83 -48.12 83.23 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -60.55 -34.69 74.51 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -61.31 -40.79 95.48 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.0 mtp -58.46 -22.26 54.06 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 119.501 3.149 . . . . 0.0 119.501 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.93 49.67 3.28 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-N 120.246 1.384 . . . . 0.0 116.429 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.22 -30.87 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 17.8 m120 79.08 152.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.1 1.36 . . . . 0.0 112.444 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.17 75.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 122.89 1.329 . . . . 0.0 110.109 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.14 -68.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.877 1.271 . . . . 0.0 107.682 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -75.27 -38.57 60.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -61.51 -22.81 65.45 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -61.19 -55.71 29.1 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.361 0.982 . . . . 0.0 113.313 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -56.93 -29.01 62.74 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.43 -54.93 13.81 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.865 1.666 . . . . 0.0 113.885 162.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.15 -43.52 61.25 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -99.81 55.06 0.94 Allowed 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 161.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -70.45 -35.12 73.15 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 60.99 45.01 9.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.336 1.054 . . . . 0.0 113.751 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 tp -72.65 128.84 36.76 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.913 0.863 . . . . 0.0 113.038 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -126.44 118.36 24.8 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.777 0.831 . . . . 0.0 109.972 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.53 100.55 12.13 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.448 0.699 . . . . 0.0 109.787 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -95.28 96.86 9.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 109.054 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.8 mt -86.59 124.3 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.908 0.883 . . . . 0.0 109.321 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.8 p -122.04 109.61 14.78 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -113.74 126.05 54.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 112.258 -165.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.86 132.71 19.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 122.848 0.459 . . . . 0.0 110.156 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.11 61.99 4.97 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.306 31.7 m120 69.51 -28.2 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -168.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.88 128.57 34.81 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.409 1.459 . . . . 0.0 112.572 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -102.93 108.24 19.36 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 163.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 m -95.27 98.33 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 t -108.59 113.21 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -169.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 99.25 7.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.648 -0.658 . . . . 0.0 109.589 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.01 97.97 10.01 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.1 t -107.5 124.21 49.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 112.389 -161.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.6 p -146.14 169.02 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.822 0.849 . . . . 0.0 112.889 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -58.86 -38.5 78.9 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 167.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -64.89 -54.51 29.75 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -151.81 140.91 21.24 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.598 1.09 . . . . 0.0 112.332 -162.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.98 103.48 9.97 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.0 pt -125.33 127.78 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.946 -0.471 . . . . 0.0 111.241 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 96.52 8.52 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.192 -0.942 . . . . 0.0 111.486 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.64 100.3 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.54 110.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -127.76 124.09 36.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.348 0.594 . . . . 0.0 112.075 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -81.26 140.11 35.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.531 0.682 . . . . 0.0 111.382 166.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.93 120.72 11.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.75 -0.09 86.93 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.6 t -95.14 139.21 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.295 2.047 . . . . 0.0 110.122 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -76.81 110.11 11.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 112.135 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -134.52 169.39 17.35 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 123.699 0.8 . . . . 0.0 111.513 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -97.62 121.95 40.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 112.539 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -93.0 -66.56 0.91 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.341 16.0 m-80 92.55 129.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 125.732 1.613 . . . . 0.0 113.285 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.7 mt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.306 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.62 128.25 35.27 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.597 0.713 . . . . 0.0 111.049 167.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.12 111.86 24.1 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.081 0.952 . . . . 0.0 111.656 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.55 113.59 25.26 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.36 1.064 . . . . 0.0 110.948 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.51 -152.69 21.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -125.47 124.16 40.78 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 122.939 0.496 . . . . 0.0 111.937 -158.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -84.64 106.05 15.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.181 -0.949 . . . . 0.0 109.582 158.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -105.11 131.39 52.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.04 0.536 . . . . 0.0 110.6 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -82.57 98.0 8.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.869 -1.144 . . . . 0.0 110.639 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.41 83.85 7.57 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.685 0.755 . . . . 0.0 109.514 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -78.83 0.3 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 115.494 0.958 . . . . 0.0 115.494 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -112.28 -29.0 7.7 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -97.02 136.96 36.83 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 121.533 1.97 . . . . 0.0 111.973 -169.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.81 101.61 11.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -92.1 110.98 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 CA-C-O 122.2 1.0 . . . . 0.0 109.858 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.04 96.75 2.24 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 124.381 0.991 . . . . 0.0 112.884 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -91.99 94.84 9.47 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -119.21 107.28 13.24 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.891 0.476 . . . . 0.0 111.814 -163.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -73.21 141.15 47.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.81 -1.181 . . . . 0.0 112.054 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -69.14 132.81 47.15 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.175 0.988 . . . . 0.0 112.321 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.9 p -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 164.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -61.65 -74.58 0.08 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -89.1 -31.1 18.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.44 3.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -130.48 139.81 50.53 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 118.027 0.913 . . . . 0.0 109.764 171.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -72.4 102.52 3.19 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 123.497 1.618 . . . . 0.0 114.036 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -78.63 121.05 24.18 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.348 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -96.5 120.46 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 122.088 -0.382 . . . . 0.0 110.427 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -119.51 109.39 15.67 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.966 0.507 . . . . 0.0 110.001 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.15 108.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 120.358 -1.464 . . . . 0.0 109.267 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -88.59 119.75 29.34 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.425 0.69 . . . . 0.0 109.739 166.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -141.12 139.45 33.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 0.0 110.807 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.37 120.41 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.818 -1.176 . . . . 0.0 110.073 170.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.4 mt -116.09 94.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.17 -101.23 1.11 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.459 -0.776 . . . . 0.0 114.638 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -123.66 43.28 3.01 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 165.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.25 125.2 27.28 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.343 1.057 . . . . 0.0 108.683 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -86.48 105.99 17.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 m -88.89 115.7 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 109.225 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -107.64 95.99 6.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.418 -0.801 . . . . 0.0 110.067 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 86.2 m -91.11 96.76 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.035 0.534 . . . . 0.0 110.86 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -81.61 129.7 34.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.91 0.884 . . . . 0.0 111.323 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -126.31 115.55 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -120.9 117.96 28.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 118.545 0.611 . . . . 0.0 111.875 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 55.14 26.58 8.44 Favored 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.17 -32.28 7.73 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 -160.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.39 130.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.651 2.225 . . . . 0.0 113.48 -166.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.1 142.45 28.68 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.94 123.23 14.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.06 -1.025 . . . . 0.0 111.232 153.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -110.03 87.39 2.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -70.02 99.21 1.41 Allowed 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 170.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.3 mt -101.07 115.99 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -108.27 111.82 23.97 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.402 0.681 . . . . 0.0 110.715 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -78.17 146.03 35.28 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 121.607 0.717 . . . . 0.0 112.285 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -66.3 128.91 38.0 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.257 11.4 t70 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.909 1.684 . . . . 0.0 110.34 -165.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -94.42 82.17 4.02 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 120.067 -1.646 . . . . 0.0 114.491 -163.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -152.42 178.61 9.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.917 -1.114 . . . . 0.0 112.824 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 m -82.83 101.52 11.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.0 -1.063 . . . . 0.0 110.123 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -100.21 97.49 8.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.431 0.692 . . . . 0.0 110.067 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -97.96 139.24 34.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.603 . . . . 0.0 111.711 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 8.5 p -70.89 115.23 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.46 -60.83 2.2 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.64 0.776 . . . . 0.0 111.985 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -134.5 158.95 42.63 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 122.567 1.175 . . . . 0.0 111.094 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -156.97 143.44 18.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 119.397 -2.064 . . . . 0.0 112.025 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.49 139.19 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.235 0.541 . . . . 0.0 111.526 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.305 57.0 t30 53.99 38.92 29.91 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -81.05 -47.3 13.76 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.98 -37.42 74.19 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -51.61 66.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.528 1.058 . . . . 0.0 113.771 170.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -48.8 -53.44 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.674 ' SD ' HG11 ' A' ' 23' ' ' VAL . 11.8 mmt -55.06 -43.33 73.75 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -43.67 98.44 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 165.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.3 mtm -60.39 -61.51 2.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.71 56.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.347 0 CA-C-N 118.832 0.742 . . . . 0.0 114.925 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.674 HG11 ' SD ' ' A' ' 18' ' ' MET . 8.2 p -129.96 127.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -76.71 163.16 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -50.88 -44.88 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -169.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 -46.94 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 119.795 1.18 . . . . 0.0 113.052 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -57.79 -39.67 78.08 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 mtm105 -60.39 -29.05 68.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 167.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 121.258 1.845 . . . . 0.0 114.524 164.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.68 -38.43 84.92 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 165.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.07 -58.54 7.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.58 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -89.69 52.39 2.31 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 118.881 0.764 . . . . 0.0 112.252 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -77.39 -51.58 10.57 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.375 -1.453 . . . . 0.0 113.743 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 37.4 m-80 66.19 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.179 0.992 . . . . 0.0 111.646 -163.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -72.28 120.66 18.2 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -119.16 114.25 22.16 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.373 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.08 101.01 11.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.839 0.456 . . . . 0.0 109.806 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -87.02 105.92 17.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.98 -1.075 . . . . 0.0 109.22 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.9 mt -102.61 130.36 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 C-N-CA 123.211 0.605 . . . . 0.0 109.417 -168.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -114.9 134.36 55.22 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.184 0.594 . . . . 0.0 109.678 160.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -96.24 96.93 9.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 109.852 155.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -83.56 78.47 9.67 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 122.69 1.234 . . . . 0.0 112.024 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.26 -96.17 2.04 Favored Glycine 0 N--CA 1.488 2.124 0 O-C-N 121.568 -0.708 . . . . 0.0 113.002 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -99.08 -47.57 5.18 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.22 134.24 56.79 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -172.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -97.04 108.51 21.25 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.011 0.924 . . . . 0.0 109.316 174.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.4 m -90.07 100.13 13.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 164.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -94.93 102.9 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -88.04 93.01 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.616 -0.677 . . . . 0.0 109.282 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.59 120.73 24.92 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.592 0.357 . . . . 0.0 111.527 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -122.63 116.83 24.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.479 0.712 . . . . 0.0 109.396 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -149.03 168.83 22.09 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 122.364 1.078 . . . . 0.0 112.76 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 m -60.16 -37.85 81.38 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.84 -43.88 62.09 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.65 153.56 31.54 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.74 1.154 . . . . 0.0 111.36 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.13 104.14 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.554 -0.716 . . . . 0.0 110.298 166.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.49 159.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.043 0.925 . . . . 0.0 112.07 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -99.75 110.4 22.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.605 -1.309 . . . . 0.0 110.064 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.04 100.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.69 126.34 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.25 0.62 . . . . 0.0 109.794 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.55 141.88 21.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.73 -0.606 . . . . 0.0 111.982 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -92.02 147.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 112.084 170.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.86 91.47 5.37 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.07 -47.6 1.0 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 116.261 1.264 . . . . 0.0 116.261 -160.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -85.25 127.14 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.008 1.404 . . . . 0.0 109.912 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 t -74.41 142.27 45.02 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -141.83 166.48 24.62 Favored 'General case' 0 CA--C 1.572 1.807 0 C-N-CA 123.815 0.846 . . . . 0.0 112.253 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.85 104.46 16.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.382 0.61 . . . . 0.0 110.516 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -89.08 83.13 6.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 112.01 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -86.12 132.6 33.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.915 -1.115 . . . . 0.0 112.669 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.789 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.562 1.41 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.14 84.68 4.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 111.346 -158.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.5 95.56 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.327 -0.858 . . . . 0.0 113.214 -162.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -78.81 116.11 18.94 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.463 0.705 . . . . 0.0 110.837 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.32 9.77 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 115.539 0.976 . . . . 0.0 115.539 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.1 m -160.72 144.97 13.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.874 -0.78 . . . . 0.0 110.39 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.17 102.72 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 162.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -97.75 140.51 32.02 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.355 0.662 . . . . 0.0 111.864 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.79 102.15 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.819 -1.176 . . . . 0.0 111.016 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.15 84.94 4.92 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.004 0.906 . . . . 0.0 110.203 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.69 -81.99 0.61 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -119.38 -5.26 10.37 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -114.11 137.86 51.19 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 121.087 1.767 . . . . 0.0 110.237 -171.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.5 mt -82.54 106.42 14.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.45 -1.406 . . . . 0.0 110.105 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 tt -92.25 111.55 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 CA-C-O 122.399 1.095 . . . . 0.0 109.752 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.39 94.09 1.96 Allowed Glycine 0 N--CA 1.478 1.475 0 C-N-CA 123.878 0.751 . . . . 0.0 113.232 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -90.29 109.84 20.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -133.84 145.64 49.89 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.896 0.855 . . . . 0.0 111.512 -168.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -124.76 132.8 53.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.421 -0.799 . . . . 0.0 109.503 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -64.25 127.4 31.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 112.44 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.32 0.4 OUTLIER -82.8 -27.39 30.97 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -57.39 -54.82 42.44 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 164.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -93.47 -39.77 10.7 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.32 -13.59 51.52 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -158.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -96.03 153.66 17.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.383 1.592 . . . . 0.0 113.669 -160.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.48 134.56 34.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -166.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -119.47 129.65 54.84 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.7 1.2 . . . . 0.0 110.435 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -118.73 108.87 15.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.685 . . . . 0.0 109.491 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -115.47 112.95 23.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.916 -0.49 . . . . 0.0 111.981 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.29 116.12 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.984 -1.072 . . . . 0.0 109.215 -173.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -91.58 117.36 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.765 -0.585 . . . . 0.0 109.66 166.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.55 149.71 37.82 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.112 0.958 . . . . 0.0 112.478 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -89.51 103.87 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.395 -0.816 . . . . 0.0 109.354 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.6 tt -95.6 72.26 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.05 0.928 . . . . 0.0 110.96 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.88 59.75 6.74 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.353 24.8 m-20 79.59 -34.37 0.14 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.92 130.77 42.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 120.01 1.277 . . . . 0.0 113.034 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 46.7 tp -87.72 105.48 17.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.887 -1.133 . . . . 0.0 110.101 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.81 109.71 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.903 0.859 . . . . 0.0 110.295 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.11 104.53 17.09 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -106.93 91.11 3.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.216 0.607 . . . . 0.0 110.046 -162.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -81.87 102.04 10.6 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.456 0.703 . . . . 0.0 112.083 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.2 t -98.94 107.03 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.403 ' OH ' ' OE2' ' A' ' 120' ' ' GLU . 33.7 t80 -122.16 114.58 21.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.83 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.403 ' OE2' ' OH ' ' A' ' 119' ' ' TYR . 47.5 mt-10 51.7 39.03 24.39 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 -32.86 5.89 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 118.673 2.229 . . . . 0.0 118.673 -165.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.15 110.27 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 120.578 2.189 . . . . 0.0 112.238 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -86.84 117.95 25.91 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.97 0.508 . . . . 0.0 111.662 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.11 118.44 32.85 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.537 0.684 . . . . 0.0 111.949 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -100.42 122.61 43.45 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.081 0.552 . . . . 0.0 110.815 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -108.39 111.91 24.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 167.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.91 112.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -105.55 135.62 46.62 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 121.383 0.611 . . . . 0.0 112.249 -170.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.44 146.81 25.02 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 122.003 0.906 . . . . 0.0 111.515 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -81.01 90.4 5.97 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 121.445 0.641 . . . . 0.0 112.637 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 5.3 t0 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.21 1.404 . . . . 0.0 113.821 172.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 . . . . . 0 CA--C 1.576 1.975 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.25 3.4 p-10 -95.83 88.32 4.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.93 -1.731 . . . . 0.0 114.171 -158.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 p -148.2 -170.81 3.69 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 122.292 1.044 . . . . 0.0 112.309 170.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -87.16 114.92 24.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.938 -1.101 . . . . 0.0 109.373 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -119.73 106.24 11.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.74 136.84 42.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.178 -0.951 . . . . 0.0 112.814 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.61 117.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 113.566 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -101.11 -55.84 2.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.1 0.56 . . . . 0.0 111.588 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -85.56 -78.66 0.26 Allowed 'General case' 0 CA--C 1.57 1.722 0 O-C-N 121.757 -0.589 . . . . 0.0 112.248 -162.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.268 16.1 m 57.66 95.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.287 13.5 tm-20 -87.12 -110.19 0.06 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.938 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -86.27 58.9 5.32 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-N 121.474 1.943 . . . . 0.0 115.136 -169.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -70.12 -31.82 69.54 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 165.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -48.61 -54.09 15.94 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 169.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.26 -31.93 68.11 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -55.88 -52.85 62.63 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 164.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.64 -46.55 73.96 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -55.72 -47.66 76.52 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.29 -44.25 75.54 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.3 mtt -65.78 -35.25 80.18 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.56 61.32 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 CA-C-N 119.703 1.138 . . . . 0.0 115.029 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.29 145.37 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.285 0.564 . . . . 0.0 111.447 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -80.83 156.57 26.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.594 -1.316 . . . . 0.0 114.126 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.273 14.8 tt -53.66 -42.22 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.44 -45.23 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -58.26 -46.35 86.18 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -52.12 -51.6 56.84 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.86 -49.09 77.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -58.5 -37.79 76.31 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.16 -38.45 31.36 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.3 -53.1 54.26 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 163.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -88.95 53.92 2.84 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 119.362 0.983 . . . . 0.0 113.181 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.11 -31.99 26.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 66.53 49.68 1.33 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 124.663 1.185 . . . . 0.0 113.383 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.9 121.54 23.58 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 122.682 1.229 . . . . 0.0 113.363 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -111.46 106.31 15.17 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.364 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.05 94.72 7.85 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.3 m -87.06 100.19 12.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 49' ' ' VAL . 60.6 mt -93.87 127.85 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 p -129.11 110.74 12.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -91.44 101.09 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.9 . . . . 0.0 109.951 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.52 -35.5 30.28 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.3 81.77 0.04 OUTLIER Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.336 -0.853 . . . . 0.0 111.292 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 6.7 t-20 70.18 -52.48 0.64 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -159.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -62.8 137.92 58.39 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -112.61 109.45 19.0 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -84.23 103.1 13.14 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.543 0.737 . . . . 0.0 109.107 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 40' ' ' ILE . 17.7 m -105.89 108.27 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.73 89.74 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.527 -0.733 . . . . 0.0 109.568 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.66 85.4 6.05 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.912 0.863 . . . . 0.0 111.872 -163.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.4 m -101.84 98.19 8.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.707 -0.621 . . . . 0.0 111.527 -154.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.7 p -127.44 171.03 11.92 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.65 0.78 . . . . 0.0 112.926 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -75.05 66.05 1.55 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.829 -1.169 . . . . 0.0 110.95 163.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.36 -62.18 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 123.949 0.899 . . . . 0.0 111.416 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.291 42.1 ptt85 -138.55 -62.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.268 30.8 t-20 66.0 91.07 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.42 1.463 . . . . 0.0 113.944 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.7 143.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.436 0.636 . . . . 0.0 110.762 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -80.92 101.4 9.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.476 0.655 . . . . 0.0 112.005 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.12 106.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.6 97.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -109.18 126.98 53.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.21 148.97 21.98 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.782 0.801 . . . . 0.0 111.7 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.49 119.77 15.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 113.813 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.63 1.46 89.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -91.77 132.81 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 120.144 1.972 . . . . 0.0 109.872 -173.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -78.28 110.74 13.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 112.155 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -132.75 159.64 39.12 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.636 0.731 . . . . 0.0 112.549 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.88 105.75 17.95 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.512 -0.742 . . . . 0.0 111.302 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -93.08 116.2 28.82 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.081 0.952 . . . . 0.0 110.559 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -89.91 131.0 36.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.009 -1.057 . . . . 0.0 111.558 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.498 1.935 0 O-C-N 120.646 -1.284 . . . . 0.0 114.242 176.685 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.7 m . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 122.014 0.912 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -117.54 124.94 49.93 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -155.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.96 109.42 8.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.836 -1.165 . . . . 0.0 112.09 -162.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.52 112.64 24.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.057 -1.027 . . . . 0.0 111.141 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.39 -149.91 15.81 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 117.209 1.644 . . . . 0.0 117.209 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -133.8 123.38 24.74 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.438 -152.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -82.53 116.23 21.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.942 -0.474 . . . . 0.0 110.233 158.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.2 m -113.63 134.63 54.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 111.248 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 tp -85.66 115.55 23.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 110.689 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.71 -93.41 0.1 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 123.089 0.555 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.49 -86.18 1.9 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 119.432 1.014 . . . . 0.0 111.49 169.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -110.95 47.01 1.02 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 117.047 0.424 . . . . 0.0 111.901 161.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -140.82 122.27 15.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.858 -1.151 . . . . 0.0 108.394 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.29 105.09 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.93 112.13 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.33 95.87 1.51 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -85.3 113.6 21.75 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -137.67 111.35 8.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.08 0.552 . . . . 0.0 111.053 -165.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -87.2 129.98 34.74 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 120.489 -1.382 . . . . 0.0 112.919 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -62.02 139.35 58.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 163.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.0 p -72.02 -51.22 22.82 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 -49.81 64.44 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -86.91 -36.95 18.08 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.03 12.08 79.16 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -173.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.41 -18.66 44.64 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.752 3.242 . . . . 0.0 119.752 -165.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.346 5.4 tt0 67.14 100.97 0.05 OUTLIER 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.95 132.29 41.31 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.735 0.814 . . . . 0.0 110.703 160.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -112.72 97.4 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 t -92.64 110.15 21.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.498 0.666 . . . . 0.0 110.177 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.56 117.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -103.05 119.32 38.64 Favored 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.663 0.785 . . . . 0.0 110.612 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -144.08 142.43 30.62 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.774 0.83 . . . . 0.0 110.477 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -84.43 111.69 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 108.155 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.26 98.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.25 -106.27 2.78 Favored Glycine 0 N--CA 1.488 2.116 0 O-C-N 121.847 -0.533 . . . . 0.0 112.927 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.4 ' OD1' ' OE2' ' A' ' 112' ' ' GLU . 3.3 p-10 -92.97 -30.31 15.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE2' ' OD1' ' A' ' 111' ' ' ASP . 3.9 mt-10 -102.19 141.33 35.2 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.149 0.975 . . . . 0.0 112.975 -160.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.59 104.8 5.42 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.003 164.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.34 103.82 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 95.13 5.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -105.61 111.1 23.66 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.751 0.421 . . . . 0.0 110.473 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.75 112.4 18.87 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.718 0.407 . . . . 0.0 110.284 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.83 114.72 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -139.43 108.1 5.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.204 0.602 . . . . 0.0 109.768 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 54.98 50.88 14.53 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.32 -27.75 4.5 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.939 2.335 . . . . 0.0 118.939 -166.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.72 130.06 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.722 1.761 . . . . 0.0 110.485 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -101.29 107.96 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.05 0.54 . . . . 0.0 109.968 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.21 98.75 9.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -93.84 87.83 5.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.732 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -90.99 104.42 17.02 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.69 121.32 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.721 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -109.32 119.37 39.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.601 0.76 . . . . 0.0 110.504 -166.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -76.27 147.88 37.97 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 122.152 0.977 . . . . 0.0 113.43 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -68.13 109.53 3.57 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 123.804 0.842 . . . . 0.0 112.829 175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 125.118 1.367 . . . . 0.0 112.569 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.36 174.09 5.16 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.392 37.0 p 86.83 -177.79 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.625 1.57 . . . . 0.0 114.075 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.9 m -96.92 129.07 44.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.654 -1.279 . . . . 0.0 111.405 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -122.26 102.73 8.3 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -100.53 144.66 29.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.54 0.686 . . . . 0.0 112.268 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.77 122.8 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.58 -68.05 0.78 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.795 163.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.17 128.17 44.29 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.556 0.693 . . . . 0.0 111.585 -172.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -109.44 120.48 42.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.654 0.782 . . . . 0.0 111.028 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.26 130.39 47.39 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.386 0.675 . . . . 0.0 110.538 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 18.7 t30 53.74 21.63 2.77 Favored 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 119.48 3.141 . . . . 0.0 119.48 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.44 -42.24 71.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -59.08 -38.91 80.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.75 -48.41 81.78 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 120.602 1.546 . . . . 0.0 114.837 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -48.13 -61.02 2.19 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 mtt -66.94 -35.75 80.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -63.83 -42.86 97.55 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 167.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -56.78 -42.98 80.4 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 164.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtp -51.34 -30.5 18.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 164.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.46 47.68 4.24 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 116.165 1.226 . . . . 0.0 116.165 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.43 163.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 122.197 0.998 . . . . 0.0 112.188 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -66.84 144.38 56.32 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.694 -1.254 . . . . 0.0 112.804 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.281 15.4 tt -56.89 -40.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.01 -44.68 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 119.554 1.07 . . . . 0.0 113.28 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -58.96 -40.99 86.38 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -35.35 79.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -67.11 -48.37 68.33 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 114.157 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -53.64 -24.92 15.67 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 165.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.76 -51.44 59.17 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 120.955 1.707 . . . . 0.0 114.602 164.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.74 -44.32 63.25 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -106.52 61.14 0.64 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 167.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.3 5.6 p30 -82.08 -35.5 28.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.304 -1.498 . . . . 0.0 114.698 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 54.95 44.44 28.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -76.3 122.08 23.9 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -111.28 133.77 53.37 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.551 0.74 . . . . 0.0 111.745 166.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.53 102.75 10.59 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -85.78 100.93 12.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.304 -0.872 . . . . 0.0 109.403 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -93.83 127.94 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -141.29 125.39 17.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.131 -0.981 . . . . 0.0 110.207 171.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -95.03 122.98 38.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.687 -0.633 . . . . 0.0 111.396 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -105.45 76.41 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.571 0.7 . . . . 0.0 109.895 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.13 78.05 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 115.994 1.157 . . . . 0.0 115.994 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 4.3 m-80 70.26 -50.27 0.65 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -167.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -73.64 120.74 19.65 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.017 0.927 . . . . 0.0 112.726 -172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -98.85 125.26 44.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.223 0.609 . . . . 0.0 111.919 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.6 m -94.78 108.13 20.14 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 165.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -105.29 101.47 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.16 104.87 17.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.16 145.03 35.88 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 121.936 0.874 . . . . 0.0 112.473 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -149.49 117.98 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.844 -1.16 . . . . 0.0 110.068 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 t -150.33 167.21 27.68 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 124.541 1.136 . . . . 0.0 111.26 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -51.9 -29.7 21.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -63.06 -53.86 47.15 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -171.78 171.29 5.26 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.226 1.01 . . . . 0.0 112.312 -162.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -133.26 119.58 19.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.731 -1.23 . . . . 0.0 111.129 161.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.4 pt -140.02 150.22 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-O 122.171 0.986 . . . . 0.0 111.521 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.12 106.63 18.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.7 t -95.59 93.61 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 t -93.91 120.77 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -135.51 139.48 44.02 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.145 0.974 . . . . 0.0 113.311 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.15 142.4 27.54 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 121.853 0.835 . . . . 0.0 110.858 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.22 92.79 1.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.397 -0.814 . . . . 0.0 112.84 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.37 -27.44 5.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.659 1.823 . . . . 0.0 117.659 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.08 127.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.036 1.918 . . . . 0.0 110.422 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -75.07 102.23 4.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.236 0.615 . . . . 0.0 111.309 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -112.27 150.6 30.73 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.754 0.822 . . . . 0.0 112.069 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -90.97 101.48 14.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.689 -0.632 . . . . 0.0 110.661 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.31 104.72 17.02 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.48 -0.762 . . . . 0.0 110.529 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -72.49 114.86 11.07 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.699 0.761 . . . . 0.0 111.769 168.22 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -75.65 107.19 7.65 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.586 0.707 . . . . 0.0 112.536 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.3 mt -84.24 104.36 14.21 Favored 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.427 -0.795 . . . . 0.0 110.536 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -87.17 110.35 20.09 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.448 1.099 . . . . 0.0 110.758 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.8 -157.87 30.39 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -128.37 136.18 50.57 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 122.903 0.481 . . . . 0.0 111.957 -165.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -91.56 114.93 27.59 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 153.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -107.19 136.9 46.25 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.084 0.554 . . . . 0.0 111.176 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.8 tp -89.31 104.39 16.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.972 -1.08 . . . . 0.0 110.987 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -78.09 -42.74 31.11 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.53 -92.27 0.08 OUTLIER Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -74.77 3.45 7.99 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 156.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -126.62 119.47 27.12 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.802 1.183 . . . . 0.0 108.772 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.07 102.34 13.76 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 160.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.88 113.55 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 C-N-CA 124.093 0.957 . . . . 0.0 109.25 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.8 104.1 3.01 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.044 0.83 . . . . 0.0 113.164 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.07 99.96 11.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.51 152.36 41.83 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.285 1.04 . . . . 0.0 112.121 -172.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -125.48 146.03 49.82 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.765 0.793 . . . . 0.0 110.056 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -65.41 129.57 40.23 Favored 'General case' 0 CA--C 1.565 1.556 0 O-C-N 120.827 -1.171 . . . . 0.0 112.11 170.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -85.63 38.17 0.73 Allowed 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 122.122 0.963 . . . . 0.0 112.298 158.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -160.74 45.35 0.2 Allowed 'General case' 0 CA--C 1.585 2.314 0 C-N-CA 124.845 1.258 . . . . 0.0 110.314 -157.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.38 51.6 p30 138.11 -50.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.763 2.425 . . . . 0.0 111.469 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.8 2.14 27.12 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -90.48 145.61 24.77 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.514 2.157 . . . . 0.0 112.649 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -70.49 151.06 45.51 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.87 113.89 12.02 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -104.61 132.19 51.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.618 -0.676 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -142.85 139.2 30.77 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.8 t -120.92 118.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -96.54 120.94 37.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 162.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -146.34 165.28 29.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.82 111.58 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.634 -1.291 . . . . 0.0 109.307 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.19 85.99 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.046 0.927 . . . . 0.0 110.204 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.95 -84.31 1.02 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.079 -1.013 . . . . 0.0 114.622 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -141.62 48.07 1.64 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 163.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -142.75 136.91 29.37 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -81.49 105.7 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.478 -1.389 . . . . 0.0 111.177 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.33 109.76 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.749 0.785 . . . . 0.0 110.442 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -98.13 104.43 16.46 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -91.47 142.6 27.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 123.257 0.623 . . . . 0.0 109.61 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -151.2 116.88 5.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.789 -1.194 . . . . 0.0 110.513 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.72 125.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.359 1.064 . . . . 0.0 108.505 -171.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 110.97 10.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.969 0.507 . . . . 0.0 109.791 173.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 68.02 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 175.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 -31.19 1.92 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.826 2.291 . . . . 0.0 118.826 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.98 102.72 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 119.311 1.556 . . . . 0.0 109.189 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.66 133.41 33.7 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.197 0.998 . . . . 0.0 111.104 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.24 156.25 47.86 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.108 0.956 . . . . 0.0 111.722 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -133.89 149.84 51.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.939 0.876 . . . . 0.0 111.855 -170.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -141.1 119.39 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.019 -1.051 . . . . 0.0 108.54 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt -101.52 108.02 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -94.3 123.23 37.56 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.629 0.772 . . . . 0.0 110.015 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -79.57 165.47 22.91 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.06 112.76 6.67 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.802 -1.186 . . . . 0.0 112.859 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 125.151 1.38 . . . . 0.0 113.372 178.361 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.12 101.61 2.29 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.232 1.378 . . . . 0.0 112.756 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.5 m 179.61 165.56 1.1 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.145 1.378 . . . . 0.0 110.518 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.1 m -96.33 111.98 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 167.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -108.8 114.25 27.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.776 -0.578 . . . . 0.0 110.509 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -92.74 135.29 34.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.105 -0.997 . . . . 0.0 112.559 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.3 129.22 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.885 -1.134 . . . . 0.0 113.61 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -119.0 -65.17 1.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.168 0.987 . . . . 0.0 110.998 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 75.46 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.345 0.658 . . . . 0.0 111.494 -165.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.411 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 13.4 p -85.89 139.59 31.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.341 2.5 tm-20 -94.06 -97.78 0.15 Allowed 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.542 -166.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.255 19.3 t30 -100.0 50.22 0.91 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.143 -1.598 . . . . 0.0 113.345 -167.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -76.84 -39.73 50.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.06 -40.55 98.04 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -67.19 -43.79 81.25 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -47.02 -54.97 9.06 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 161.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtp -65.32 -34.11 77.55 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -53.79 -46.36 71.0 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 163.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.66 -41.31 98.22 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.9 mmm -54.11 -48.95 70.19 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.06 65.72 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 123.536 0.589 . . . . 0.0 114.209 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.41 131.51 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.749 0.785 . . . . 0.0 110.701 -174.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.67 161.86 24.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.9 tt -58.23 158.03 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.384 42.3 t 82.14 -73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 C-N-CA 124.573 1.149 . . . . 0.0 109.267 -161.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -53.51 -50.68 64.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -64.07 -24.82 67.85 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -71.14 -48.54 51.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 121.67 2.032 . . . . 0.0 113.545 167.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.6 mt -56.0 -48.69 75.44 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 165.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.08 81.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -49.22 78.32 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.103 1.774 . . . . 0.0 115.355 165.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -92.3 59.95 3.57 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 121.79 -0.569 . . . . 0.0 111.439 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -74.3 -27.64 60.81 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.75 38.2 11.98 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.308 1.5 pt? -81.16 151.45 28.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -169.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -127.75 114.31 17.12 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.822 -173.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.8 mt -97.39 99.15 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.82 -1.175 . . . . 0.0 111.236 -170.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.2 m -85.71 95.02 9.25 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.886 0.851 . . . . 0.0 109.818 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.0 mt -95.71 121.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -133.6 69.57 1.47 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.606 0.639 . . . . 0.0 111.973 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -58.36 110.64 1.0 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -165.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.15 62.29 2.15 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.47 84.69 0.17 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.312 -0.867 . . . . 0.0 114.76 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.32 -66.21 0.29 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.546 1.173 . . . . 0.0 112.651 -160.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -67.93 123.69 21.29 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.347 1.059 . . . . 0.0 113.676 -161.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.21 107.9 19.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.265 -0.897 . . . . 0.0 110.825 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -90.9 101.99 14.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -112.11 102.36 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -85.42 97.34 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.04 93.29 9.33 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.734 0.778 . . . . 0.0 108.964 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.6 t -91.99 89.39 6.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.359 0.599 . . . . 0.0 111.8 -164.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.2 p -100.61 162.64 12.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -51.68 -36.63 47.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 163.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.09 -46.92 63.87 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -162.81 137.96 6.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.962 0.905 . . . . 0.0 111.342 -161.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -100.75 101.88 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 163.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 pt -103.89 113.45 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.107 0.563 . . . . 0.0 110.105 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -77.9 89.42 4.1 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.768 0.794 . . . . 0.0 112.024 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.88 106.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.95 104.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -117.85 132.28 56.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.925 -0.484 . . . . 0.0 112.255 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 157.45 24.66 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.778 1.275 . . . . 0.0 111.304 159.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.53 102.27 8.73 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.679 -1.263 . . . . 0.0 111.386 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.1 3.08 51.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 119.026 2.371 . . . . 0.0 119.026 -162.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.54 132.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 121.55 2.675 . . . . 0.0 112.222 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -82.99 102.9 12.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.283 -0.885 . . . . 0.0 110.768 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -139.13 157.58 45.71 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 112.997 -171.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.33 110.55 19.18 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.224 0.609 . . . . 0.0 111.533 173.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -100.61 113.66 26.68 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.122 0.969 . . . . 0.0 110.8 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.61 128.67 35.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 112.321 167.678 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.389 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.06 119.19 22.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-O 122.327 1.061 . . . . 0.0 111.322 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.38 111.32 23.58 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.689 0.796 . . . . 0.0 110.418 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -95.32 116.89 29.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 112.294 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.22 -150.58 18.59 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -133.48 116.63 16.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.274 -0.545 . . . . 0.0 112.278 -160.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.59 119.79 20.12 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.55 0.614 . . . . 0.0 111.036 158.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -132.21 150.81 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.701 0.8 . . . . 0.0 111.419 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -98.92 103.57 15.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.658 -1.276 . . . . 0.0 112.019 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -91.69 81.81 5.27 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.01 0.91 . . . . 0.0 110.083 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.9 -105.89 1.84 Allowed Glycine 0 N--CA 1.491 2.303 0 O-C-N 121.411 -0.806 . . . . 0.0 114.777 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.62 10.72 37.71 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -113.54 116.75 30.03 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.836 1.198 . . . . 0.0 110.005 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -77.25 96.75 4.63 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.971 -1.08 . . . . 0.0 109.22 163.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.58 111.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.994 0.918 . . . . 0.0 108.89 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.99 98.06 1.85 Allowed Glycine 0 N--CA 1.475 1.284 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -78.52 105.07 9.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.36 134.11 47.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 111.306 -165.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -106.29 140.59 38.99 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 111.257 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -66.71 122.95 18.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.566 -1.334 . . . . 0.0 112.366 167.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -63.45 -25.74 68.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 -44.98 94.97 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.95 -4.93 0.21 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -160.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.8 7.17 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 118.596 2.198 . . . . 0.0 118.596 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.87 -29.47 12.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -172.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.328 1.8 mt-10 71.46 112.98 0.06 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 124.73 1.212 . . . . 0.0 113.296 -160.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 114.78 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 164.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.68 134.7 35.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 111.522 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.2 p -131.3 116.37 17.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.962 -0.461 . . . . 0.0 110.654 -167.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -114.36 106.62 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 120.854 -1.154 . . . . 0.0 108.458 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -90.54 122.23 33.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.217 162.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.33 144.18 31.33 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.76 1.164 . . . . 0.0 113.882 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -96.56 104.61 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.85 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 174.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.11 -97.56 0.14 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -99.78 25.19 7.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.98 149.18 41.45 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.265 1.031 . . . . 0.0 110.213 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.7 tp -100.22 112.64 24.96 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 168.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.12 120.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -110.15 91.62 3.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.7 m -89.13 101.96 14.62 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.964 0.905 . . . . 0.0 109.413 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -103.25 116.07 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.827 -0.546 . . . . 0.0 110.162 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.92 123.95 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -126.06 111.81 15.13 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.36 0.664 . . . . 0.0 110.544 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.3 OUTLIER 52.79 53.98 11.26 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.14 -25.36 1.58 Allowed Glycine 0 CA--C 1.556 2.616 0 N-CA-C 119.292 2.477 . . . . 0.0 119.292 -165.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.47 109.48 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 119.362 1.581 . . . . 0.0 109.246 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -85.04 143.98 28.55 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.914 0.885 . . . . 0.0 112.807 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.36 121.17 17.51 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.472 -0.768 . . . . 0.0 110.813 162.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -100.44 110.01 22.18 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.411 ' HE ' ' HB3' ' A' ' 11' ' ' SER . 49.3 mmm-85 -90.23 109.57 20.64 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.4 mt -109.67 117.52 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.099 -1.0 . . . . 0.0 108.352 -167.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.64 144.77 42.36 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 121.692 0.758 . . . . 0.0 112.179 -167.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -114.34 138.86 49.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.942 0.897 . . . . 0.0 110.205 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -67.78 118.0 10.43 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -174.381 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.326 50.8 m-85 . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 116.288 1.959 . . . . 0.0 116.288 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -79.19 98.01 6.43 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.365 0.984 . . . . 0.0 112.471 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 m -168.65 -176.95 2.93 Favored 'General case' 0 CA--C 1.573 1.843 0 C-N-CA 124.95 1.3 . . . . 0.0 110.064 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.0 m -93.16 130.12 38.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.643 -1.286 . . . . 0.0 109.615 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -135.9 112.97 10.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.229 -0.919 . . . . 0.0 111.552 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -102.51 143.21 32.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 112.268 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.252 8.6 p -76.41 90.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.339 1.066 . . . . 0.0 113.319 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -46.17 18.45 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -141.35 79.51 1.69 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.92 1.236 . . . . 0.0 113.16 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -79.75 139.53 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.817 -1.177 . . . . 0.0 114.163 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.343 0.9 OUTLIER -86.87 -91.26 0.11 Allowed 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 123.989 0.916 . . . . 0.0 111.702 -177.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -107.0 43.7 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 121.116 1.78 . . . . 0.0 114.634 -166.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.79 -32.14 63.62 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.52 -44.56 80.91 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -69.1 -38.51 78.97 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.72 -54.09 38.59 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 162.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.535 ' SD ' HG11 ' A' ' 23' ' ' VAL . 8.1 mmt -48.06 -50.98 26.24 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 164.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -56.56 -45.92 81.02 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.2 -38.99 91.22 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.406 ' SD ' HG21 ' A' ' 76' ' ' THR . 71.8 mtm -62.16 -35.02 77.54 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.83 62.63 0.54 Allowed Glycine 0 N--CA 1.49 2.26 0 CA-C-N 119.046 0.839 . . . . 0.0 114.96 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG11 ' SD ' ' A' ' 18' ' ' MET . 16.1 m -118.91 145.6 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.395 0.616 . . . . 0.0 111.175 -170.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -66.7 156.29 35.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.881 -1.137 . . . . 0.0 113.673 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.07 -43.72 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -57.92 -51.64 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -59.95 -44.88 94.12 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -51.6 -48.24 63.29 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -70.56 -58.53 3.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 168.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.15 -32.84 69.43 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.91 65.57 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 121.598 1.999 . . . . 0.0 115.598 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.76 85.25 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 156.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -100.45 49.15 0.9 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -85.47 -7.22 59.02 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 58.87 38.26 24.57 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.288 1.3 pt? -74.28 139.23 44.12 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.698 1.237 . . . . 0.0 113.059 -172.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -136.9 89.1 2.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -155.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.1 mt -89.35 110.16 20.98 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.148 0.579 . . . . 0.0 110.985 -160.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.4 m -89.0 106.71 18.6 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 164.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.01 124.19 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 60.5 p -139.63 118.56 12.52 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.966 -0.459 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -77.5 96.7 4.79 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.646 0.778 . . . . 0.0 111.158 167.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.24 83.57 7.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.688 1.232 . . . . 0.0 111.116 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.51 1.57 Allowed Glycine 0 N--CA 1.489 2.19 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.704 -165.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -131.98 -22.44 2.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.36 115.46 12.74 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 120.282 1.401 . . . . 0.0 112.723 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -78.64 106.13 10.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.477 -0.764 . . . . 0.0 110.025 171.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -88.15 103.64 15.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -104.54 107.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.28 96.15 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.62 90.55 3.95 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -89.77 95.45 10.25 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -129.25 173.06 10.85 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 0.0 112.955 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -58.88 -40.32 84.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.24 -40.17 52.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 151.21 31.08 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 121.677 2.035 . . . . 0.0 113.456 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -111.02 96.15 5.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.83 132.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.591 -0.693 . . . . 0.0 112.443 -168.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.23 109.36 18.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.006 -1.059 . . . . 0.0 111.773 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -95.36 101.0 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.4 t -100.15 116.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -141.51 123.02 15.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -174.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.69 152.93 31.34 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 112.611 166.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.33 106.47 1.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 113.558 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 CA--C 1.552 2.385 0 N-CA-C 118.846 2.299 . . . . 0.0 118.846 -169.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.09 135.67 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 121.127 2.464 . . . . 0.0 112.654 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.7 p -84.42 105.16 15.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.315 -0.865 . . . . 0.0 110.925 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.27 163.04 31.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -100.33 110.11 22.33 Favored 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 123.155 0.582 . . . . 0.0 110.37 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -73.56 -61.7 1.74 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.261 39.2 m-80 77.91 100.95 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.778 1.172 . . . . 0.0 114.055 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 CA--C 1.577 2.011 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.608 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.406 HG21 ' SD ' ' A' ' 21' ' ' MET . 91.0 m . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.84 127.94 34.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.481 0.712 . . . . 0.0 109.912 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -137.05 97.97 3.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.765 -1.209 . . . . 0.0 111.806 -157.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.487 HH21 ' HZ1' ' A' ' 94' ' ' LYS . 32.3 ptt180 -91.37 115.63 28.19 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.415 0.686 . . . . 0.0 111.843 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.34 -154.07 23.12 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -127.48 145.58 50.79 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.37 116.36 29.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.131 -0.981 . . . . 0.0 108.995 150.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -106.67 174.7 5.77 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 121.158 0.504 . . . . 0.0 111.462 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -124.29 120.91 33.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.149 -1.594 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.43 83.46 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 109.972 169.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.86 -93.21 0.39 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.266 -0.896 . . . . 0.0 115.227 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -117.69 39.39 3.35 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 166.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.97 110.69 9.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.799 -1.188 . . . . 0.0 108.092 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -82.48 118.27 23.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 109.685 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -111.88 105.84 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.404 0.682 . . . . 0.0 110.219 -167.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.41 95.8 2.11 Favored Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 113.098 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -102.62 102.54 12.77 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.36 134.17 51.14 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.431 0.692 . . . . 0.0 110.911 -168.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HZ1' HH21 ' A' ' 79' ' ' ARG . 0.2 OUTLIER -104.42 127.65 52.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.14 115.23 13.39 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.388 -0.82 . . . . 0.0 112.835 -170.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -59.14 -44.84 92.08 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.96 -39.47 78.18 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -125.48 -28.15 3.35 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -161.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.46 65.95 1.49 Allowed Glycine 0 N--CA 1.492 2.37 0 CA-C-N 120.615 1.552 . . . . 0.0 114.777 -172.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -152.89 137.43 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 117.512 0.656 . . . . 0.0 111.869 -164.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -77.66 122.16 24.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 113.391 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.05 120.19 41.6 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.717 0.807 . . . . 0.0 109.602 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -113.01 108.05 16.81 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.259 15.3 t -115.94 102.26 9.51 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.175 0.59 . . . . 0.0 112.255 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.93 121.08 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.181 -0.949 . . . . 0.0 109.855 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -96.17 125.62 40.82 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.932 0.893 . . . . 0.0 111.423 170.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -149.83 159.77 44.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.989 0.899 . . . . 0.0 112.224 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.29 117.61 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.552 -1.342 . . . . 0.0 109.352 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.73 -51.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.57 77.37 0.08 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.48 0.0 OUTLIER 78.09 -45.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -159.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -78.44 143.73 36.46 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.03 116.94 29.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.91 0.884 . . . . 0.0 110.427 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.35 107.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.761 -0.587 . . . . 0.0 109.521 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.48 103.29 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.0 m -101.47 91.5 4.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.313 0.645 . . . . 0.0 109.993 -161.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.55 109.89 18.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.339 1.056 . . . . 0.0 112.892 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.15 119.12 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -124.48 113.25 17.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 50.36 55.33 9.64 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.03 -21.12 1.38 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.36 102.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.739 1.769 . . . . 0.0 108.946 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.84 141.36 28.71 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.71 0.804 . . . . 0.0 112.883 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.98 116.0 12.39 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.493 0.717 . . . . 0.0 111.403 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.35 101.94 13.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 0.0 108.632 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -82.91 101.86 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.7 mt -95.08 106.81 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.41 130.37 43.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.093 0.557 . . . . 0.0 110.945 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -85.47 148.16 26.11 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.459 0.647 . . . . 0.0 111.424 169.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -80.53 90.01 5.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 122.137 0.97 . . . . 0.0 112.035 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -174.03 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 116.728 2.122 . . . . 0.0 116.728 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.58 94.78 5.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.48 1.133 . . . . 0.0 112.244 -163.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -167.21 173.11 9.3 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.745 1.26 . . . . 0.0 111.346 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 m -84.8 129.6 34.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.056 . . . . 0.0 110.613 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -136.24 99.99 4.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.912 -0.493 . . . . 0.0 111.366 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -87.84 136.38 32.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.092 -1.005 . . . . 0.0 112.653 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -65.83 119.89 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.69 -62.75 1.2 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.643 0.777 . . . . 0.0 111.219 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -133.69 103.03 5.7 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.163 0.585 . . . . 0.0 110.985 -160.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -96.56 100.12 11.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.36 -0.837 . . . . 0.0 112.334 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.35 122.46 24.49 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.053 0.541 . . . . 0.0 110.849 -174.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.253 23.8 t30 64.09 12.5 7.05 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -65.76 -43.17 89.68 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.57 -35.95 77.3 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.93 -41.73 50.89 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -45.93 -52.1 12.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 158.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mtt -68.6 -28.94 67.37 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -55.75 -47.07 77.59 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-N 120.871 1.669 . . . . 0.0 114.825 158.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -59.47 -41.4 89.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 167.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.4 mtp -60.91 -39.02 87.76 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 167.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.03 65.29 0.64 Allowed Glycine 0 N--CA 1.486 2.01 0 CA-C-N 118.926 0.784 . . . . 0.0 114.186 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.79 131.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.353 0.596 . . . . 0.0 110.611 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -74.64 153.78 38.8 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 14.1 tt -48.16 -39.4 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -172.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.45 -59.45 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 120.29 1.405 . . . . 0.0 113.024 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -68.0 -37.84 81.92 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.17 -40.99 82.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -60.5 -44.56 95.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 163.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.44 -40.6 75.05 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.17 77.18 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 171.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.96 68.06 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 166.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -94.0 58.31 2.55 Favored 'General case' 0 CA--C 1.575 1.912 0 C-N-CA 123.832 0.853 . . . . 0.0 111.947 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.42 -23.04 18.55 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 61.01 52.33 4.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.693 1.197 . . . . 0.0 114.222 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.0 tp -82.24 114.06 20.48 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.401 -0.812 . . . . 0.0 112.639 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -100.16 105.05 16.61 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.05 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.34 102.32 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.2 m -92.45 105.42 17.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.405 HG12 HG12 ' A' ' 49' ' ' VAL . 60.1 mt -96.57 124.56 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -147.9 107.67 3.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.699 -0.625 . . . . 0.0 111.323 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.01 147.43 26.21 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 171.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.38 -48.53 12.79 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 164.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.84 -68.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.172 -0.955 . . . . 0.0 113.386 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -123.33 48.84 1.77 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.767 -0.843 . . . . 0.0 112.449 164.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -154.14 109.96 3.22 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.033 -1.042 . . . . 0.0 108.318 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -86.08 118.48 25.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.902 0.481 . . . . 0.0 111.752 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.5 m -84.67 102.99 13.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 165.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG12 HG12 ' A' ' 40' ' ' ILE . 31.8 m -100.25 108.63 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.35 99.5 12.3 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.69 74.53 3.69 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.885 -161.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 t -87.99 109.7 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.737 -1.227 . . . . 0.0 113.227 -166.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -139.71 163.55 32.31 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.936 1.294 . . . . 0.0 109.405 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 m -75.57 51.95 0.62 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 119.687 -1.883 . . . . 0.0 112.336 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -174.73 -53.84 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.809 0 C-N-CA 125.06 1.344 . . . . 0.0 111.78 -164.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -93.63 -91.58 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.189 1.359 . . . . 0.0 110.023 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.303 2.1 t30 51.71 57.74 6.22 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.0 pt -119.53 -35.61 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.273 35.0 mt-10 76.98 99.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.086 1.312 . . . . 0.0 112.135 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.66 113.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.15 97.35 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -106.93 136.43 46.78 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -86.4 149.71 24.82 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.201 1.001 . . . . 0.0 112.427 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -80.47 75.23 7.33 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 110.347 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.14 -60.23 0.26 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 -161.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.18 140.59 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 118.402 1.101 . . . . 0.0 112.287 -172.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 p -86.95 118.6 26.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.986 -1.071 . . . . 0.0 110.459 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -140.21 162.23 35.76 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.837 0.827 . . . . 0.0 112.643 -166.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.23 103.55 10.18 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 111.692 167.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -81.77 -48.16 11.97 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 168.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.255 15.4 m-20 69.19 168.05 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.872 1.269 . . . . 0.0 114.168 172.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.571 1.763 0 O-C-N 120.914 -1.117 . . . . 0.0 109.003 167.784 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -84.65 151.96 24.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -141.39 109.81 5.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.873 -0.517 . . . . 0.0 110.134 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -97.35 122.43 40.38 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.238 1.015 . . . . 0.0 110.817 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.61 -160.07 33.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.6 m -140.69 142.26 34.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.391 -0.476 . . . . 0.0 110.007 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -89.31 109.6 20.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 163.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -96.76 135.24 38.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.293 0.637 . . . . 0.0 111.17 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.45 105.35 17.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.858 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -78.71 -41.59 30.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.15 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -85.1 5.24 30.52 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 159.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -121.47 123.57 42.36 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.964 1.256 . . . . 0.0 109.508 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.58 100.9 12.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 159.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 tp -89.03 107.27 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-O 122.005 0.907 . . . . 0.0 109.289 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.53 100.89 1.87 Allowed Glycine 0 N--CA 1.475 1.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.334 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.08 96.06 10.57 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -113.63 154.47 27.16 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.991 . . . . 0.0 111.702 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -146.1 147.35 31.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.71 -1.244 . . . . 0.0 111.767 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -72.44 149.43 44.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p -72.92 -46.62 51.6 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.007 -1.058 . . . . 0.0 112.969 152.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -50.01 5.59 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -174.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.52 20.89 5.15 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.63 -16.18 3.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 120.434 2.934 . . . . 0.0 120.434 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -83.29 146.28 28.62 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 118.717 1.259 . . . . 0.0 113.982 -157.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -69.69 130.85 43.48 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.34 111.62 23.29 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.77 162.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -91.23 112.58 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 109.936 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -114.75 136.24 53.29 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.413 0.685 . . . . 0.0 111.135 -170.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.66 114.11 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.868 -1.145 . . . . 0.0 108.838 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -96.53 112.85 24.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.913 -1.117 . . . . 0.0 109.725 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.83 140.52 32.97 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-O 121.221 0.534 . . . . 0.0 112.322 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.9 120.16 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.45 -1.406 . . . . 0.0 109.594 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -97.88 75.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 123.93 0.892 . . . . 0.0 110.737 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.65 -89.51 1.24 Allowed Glycine 0 N--CA 1.492 2.41 0 O-C-N 120.523 -1.361 . . . . 0.0 114.453 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -126.1 36.2 4.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 170.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -136.09 121.33 19.09 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.299 1.039 . . . . 0.0 108.227 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -78.63 108.63 12.18 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.216 0.607 . . . . 0.0 109.423 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.4 m -90.69 114.07 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -95.38 99.31 11.24 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.2 m -92.17 96.75 10.49 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 -167.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -100.66 115.58 30.55 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.863 0.865 . . . . 0.0 110.834 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -113.99 115.78 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -118.46 117.93 30.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.725 -0.609 . . . . 0.0 109.445 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.1 OUTLIER 41.62 66.06 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.4 -35.25 2.43 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.1 118.49 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.294 1.547 . . . . 0.0 109.609 -164.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.71 146.04 24.32 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.223 1.011 . . . . 0.0 112.663 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.26 146.23 44.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.735 0.779 . . . . 0.0 111.663 156.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -118.86 101.99 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -82.71 102.81 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.7 mt -100.17 115.96 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -108.27 120.47 42.47 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.335 0.654 . . . . 0.0 110.044 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -81.48 156.5 25.29 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.954 0.883 . . . . 0.0 112.774 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -65.17 122.61 17.48 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 112.869 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.265 10.7 t70 . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 125.403 1.481 . . . . 0.0 110.529 -167.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.72 83.91 7.74 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -163.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 t -148.91 -173.11 4.27 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 122.794 1.283 . . . . 0.0 111.119 168.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -91.3 123.78 35.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.018 -1.051 . . . . 0.0 109.614 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -132.95 115.83 15.69 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.011 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -112.56 146.17 39.01 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 120.256 1.389 . . . . 0.0 112.993 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.99 115.12 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.17 -64.42 1.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.771 0.829 . . . . 0.0 111.454 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -138.61 118.9 13.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.255 0.622 . . . . 0.0 111.177 -169.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.6 p -102.59 121.06 41.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.373 0.669 . . . . 0.0 111.412 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -103.89 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.495 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -77.27 38.09 0.22 Allowed 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 121.26 1.846 . . . . 0.0 115.816 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.0 -42.66 37.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -64.31 -27.9 69.35 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -78.99 -42.65 26.14 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -45.81 -51.21 13.22 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 161.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.2 mtp -66.88 -30.44 70.61 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.92 -49.57 76.31 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 165.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -57.03 -33.69 67.45 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 166.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.9 mtp -64.71 -50.66 66.08 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 165.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.97 67.72 0.27 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 119.029 0.831 . . . . 0.0 114.407 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.45 149.82 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.867 0.841 . . . . 0.0 110.789 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -79.73 159.95 26.43 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 10.8 tp -49.44 -47.35 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.73 -46.67 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -76.45 -37.78 56.42 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -49.57 -46.13 48.59 Favored 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 121.287 1.858 . . . . 0.0 115.355 161.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.27 -57.17 10.2 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -56.75 -35.05 68.17 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.78 97.8 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.74 93.34 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 164.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -93.17 42.02 1.09 Allowed 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -77.89 -23.88 48.6 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 60.71 47.06 8.46 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.79 108.07 4.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 111.826 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -99.5 108.2 20.58 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.347 0.659 . . . . 0.0 109.343 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.25 100.83 12.04 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.703 0.801 . . . . 0.0 109.07 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.0 m -93.98 98.04 10.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.9 mt -97.79 122.72 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -165.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -117.89 106.84 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.86 88.44 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.952 0.882 . . . . 0.0 111.264 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -80.12 46.21 0.79 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.6 83.3 0.49 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.732 -1.23 . . . . 0.0 114.719 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.317 24.7 m120 72.08 -40.4 0.47 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 -174.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -74.41 145.72 43.49 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.498 1.142 . . . . 0.0 113.081 164.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.03 109.95 13.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 0.0 108.595 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.8 m -89.51 99.97 12.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.32 104.12 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -85.6 104.37 15.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.613 -0.679 . . . . 0.0 109.779 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -93.7 99.24 11.69 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.943 0.897 . . . . 0.0 109.383 -173.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 t -104.7 114.03 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.1 0.56 . . . . 0.0 111.505 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -143.78 175.71 9.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -59.62 -33.12 71.09 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 163.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -85.56 -46.58 10.69 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -143.74 142.69 31.05 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.786 0.834 . . . . 0.0 111.875 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -126.48 92.4 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.73 144.46 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -164.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 112.25 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.913 -1.117 . . . . 0.0 112.065 171.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -99.15 105.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.22 115.21 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -135.78 146.9 48.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.702 -0.624 . . . . 0.0 112.504 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -99.51 151.95 20.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.136 0.969 . . . . 0.0 111.591 164.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.22 122.99 16.45 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.99 85.22 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.27 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.581 2.191 . . . . 0.0 110.637 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.7 p -75.04 106.81 6.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.584 -0.698 . . . . 0.0 111.122 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -140.17 161.61 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.643 0.735 . . . . 0.0 112.487 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.93 104.13 12.07 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 111.775 170.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -86.77 -177.36 6.09 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 122.06 0.933 . . . . 0.0 111.775 164.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.29 152.16 51.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 CA--C 1.571 1.788 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 146.61 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 93.41 4.33 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 125.947 1.699 . . . . 0.0 113.161 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt -100.4 99.53 10.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 112.328 -171.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -85.54 117.8 24.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.878 -1.139 . . . . 0.0 113.283 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.56 -171.25 44.35 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 116.969 1.548 . . . . 0.0 116.969 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -115.28 117.81 31.52 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 118.595 -0.716 . . . . 0.0 111.652 -170.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -74.53 107.14 6.47 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.155 0.889 . . . . 0.0 110.784 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -119.58 135.82 54.63 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.591 0.756 . . . . 0.0 111.324 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.59 107.46 18.16 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.801 -1.187 . . . . 0.0 111.691 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.44 80.42 2.23 Favored 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.602 1.161 . . . . 0.0 109.915 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.85 0.83 Allowed Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.511 -0.743 . . . . 0.0 113.772 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -88.05 -35.77 17.35 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -75.73 121.82 23.09 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.197 0.908 . . . . 0.0 112.409 -164.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mt -80.6 96.85 6.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.0 109.169 166.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.59 116.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.102 0.961 . . . . 0.0 109.491 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.0 100.48 1.58 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.667 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.4 86.71 7.24 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -109.47 112.96 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.237 0.615 . . . . 0.0 111.942 -164.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -89.37 130.97 35.66 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.195 -0.941 . . . . 0.0 111.293 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.89 114.3 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.975 . . . . 0.0 110.477 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.8 m -59.56 -49.97 75.71 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -162.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.295 3.4 t70 -72.76 -17.29 61.61 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.61 -58.79 3.02 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.691 1.587 . . . . 0.0 114.545 162.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.52 44.13 9.72 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 -146.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -142.94 139.48 30.72 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.175 1.487 . . . . 0.0 111.357 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.14 138.96 31.1 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.665 2.469 . . . . 0.0 117.665 -163.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.36 111.86 16.28 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.591 1.556 . . . . 0.0 108.253 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -100.35 115.97 31.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 110.987 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.4 p -109.83 115.19 29.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.594 0.758 . . . . 0.0 111.003 -169.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.73 116.9 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 119.467 1.03 . . . . 0.0 109.266 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -94.35 124.86 38.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.195 0.598 . . . . 0.0 110.908 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.48 42.08 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.508 0.671 . . . . 0.0 111.0 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.4 mm -95.92 109.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.691 -1.256 . . . . 0.0 108.571 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.258 10.3 tp -79.71 63.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 122.439 1.114 . . . . 0.0 112.904 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.04 -77.88 1.12 Allowed Glycine 0 N--CA 1.49 2.238 0 O-C-N 120.556 -1.34 . . . . 0.0 115.07 -170.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -97.14 -45.19 6.63 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -96.95 148.63 22.77 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 112.956 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.6 tp -85.56 114.71 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.901 -1.124 . . . . 0.0 110.411 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.3 m -87.8 123.93 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.784 . . . . 0.0 109.776 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -104.94 98.69 8.37 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 164.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.2 m -95.05 106.76 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -109.07 115.61 30.38 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.596 0.758 . . . . 0.0 110.273 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.18 110.06 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -98.5 105.98 18.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.942 1.246 . . . . 0.0 109.682 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 46.89 50.2 13.84 Favored 'General case' 0 CA--C 1.58 2.101 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.96 -40.49 2.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.16 116.34 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.48 2.14 . . . . 0.0 112.373 -170.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -92.32 138.68 31.31 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 121.729 0.776 . . . . 0.0 112.921 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.37 142.31 47.15 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.678 0.791 . . . . 0.0 111.609 164.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -123.43 101.94 7.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -83.06 117.65 22.99 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 166.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -104.82 123.09 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -108.8 127.64 54.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.965 0.906 . . . . 0.0 111.151 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -85.26 148.74 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.997 0.903 . . . . 0.0 112.899 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.89 123.95 31.81 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.196 0.598 . . . . 0.0 112.338 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 125.088 1.355 . . . . 0.0 112.592 174.121 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.353 82.2 m-85 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.72 72.96 5.27 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 119.949 1.249 . . . . 0.0 113.269 -171.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.9 p -156.43 -178.01 7.02 Favored 'General case' 0 CA--C 1.573 1.856 0 C-N-CA 124.42 1.088 . . . . 0.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.26 128.75 34.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.94 -1.1 . . . . 0.0 110.915 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -129.39 114.55 16.31 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -101.86 141.37 34.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.286 -0.884 . . . . 0.0 112.394 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.69 93.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.873 -1.142 . . . . 0.0 113.916 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.88 -45.74 9.48 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -143.64 152.72 41.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 111.354 -167.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.5 m -159.65 150.77 19.62 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.362 -2.086 . . . . 0.0 112.994 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -123.76 0.06 Allowed 'General case' 0 CA--C 1.578 2.045 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.22 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.295 0.1 OUTLIER -77.22 49.8 0.72 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 122.448 2.385 . . . . 0.0 116.776 -174.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -47.72 83.58 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.449 1.5 . . . . 0.0 114.745 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.92 -36.84 84.49 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.72 -44.18 74.4 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 120.177 1.353 . . . . 0.0 114.496 170.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -46.8 -56.73 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.9 mtt -67.21 -28.63 68.24 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -59.09 -48.27 82.2 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.82 1.645 . . . . 0.0 115.145 161.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -62.53 -36.2 81.85 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 mtp -59.09 -59.38 5.57 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.29 69.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.5 0.591 . . . . 0.0 114.456 171.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG13 ' HG2' ' A' ' 28' ' ' ARG . 3.3 p -148.43 136.56 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.932 0 CA-C-O 121.92 0.867 . . . . 0.0 110.17 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -82.42 164.65 20.86 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 33.1 pt -55.59 -40.17 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -169.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -48.9 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -70.67 -36.03 73.13 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HG2' HG13 ' A' ' 23' ' ' VAL . 43.5 mtm-85 -65.45 -42.3 92.48 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 167.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -55.53 -39.74 70.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.01 -60.93 2.78 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.508 160.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.75 74.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -173.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.37 71.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 161.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -124.52 41.9 3.39 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 123.741 0.816 . . . . 0.0 112.903 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.12 11.31 4.26 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 20.0 m-80 56.1 49.63 15.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -168.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.93 113.97 14.03 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.252 1.025 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -112.82 118.61 35.42 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.683 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -101.6 97.45 7.88 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.9 m -95.01 115.02 26.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 49' ' ' VAL . 63.2 mt -110.36 127.09 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -164.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -140.07 116.52 10.7 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.585 -0.697 . . . . 0.0 111.139 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -71.54 114.55 9.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -90.75 86.47 6.35 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.447 0.642 . . . . 0.0 109.292 165.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.79 23.23 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 117.431 1.732 . . . . 0.0 117.431 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.346 33.1 m120 65.59 -0.5 1.22 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -164.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -95.7 107.56 19.78 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 120.484 1.493 . . . . 0.0 109.384 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.38 105.69 8.66 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.047 0.939 . . . . 0.0 111.515 -169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.0 m -79.86 95.51 6.08 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.415 HG12 HG12 ' A' ' 40' ' ' ILE . 35.8 m -95.14 112.38 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.62 74.58 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.731 -169.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -84.68 101.42 12.16 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.56 0.695 . . . . 0.0 109.665 -158.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.6 m -114.91 101.96 9.53 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.872 -156.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -137.13 176.06 9.05 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.6 t -66.98 -9.68 41.28 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 168.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.26 -55.71 4.18 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.589 1.541 . . . . 0.0 113.156 166.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -155.42 140.65 17.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 118.703 0.683 . . . . 0.0 110.662 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -108.51 93.28 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -116.83 115.6 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.249 0.547 . . . . 0.0 110.501 -163.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.69 90.2 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.13 116.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -166.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.03 92.83 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -104.58 134.07 48.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.02 153.0 41.07 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 112.435 166.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.7 mt -73.71 73.94 1.53 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 120.966 -1.084 . . . . 0.0 111.845 164.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.39 -63.18 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -167.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.36 146.06 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 p -83.1 106.2 14.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.4 -0.813 . . . . 0.0 110.925 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -129.87 154.98 46.75 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.466 0.706 . . . . 0.0 112.612 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -82.01 119.92 24.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 111.579 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -94.11 -40.62 9.95 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.266 5.6 m120 76.8 99.07 0.07 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 168.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.149 -0.969 . . . . 0.0 112.346 175.398 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.501 2.075 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.303 22.8 pt-20 -86.7 95.95 9.97 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-O 123.104 1.43 . . . . 0.0 112.371 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.92 111.94 8.5 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.73 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -94.37 122.18 36.66 Favored 'General case' 0 CA--C 1.559 1.32 0 O-C-N 121.951 -0.468 . . . . 0.0 111.625 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.83 -152.38 21.6 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 115.573 0.989 . . . . 0.0 115.573 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.3 p -130.52 115.57 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.741 -155.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -80.42 142.42 34.35 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.509 0.671 . . . . 0.0 110.456 157.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.7 m -153.05 146.31 24.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.58 -1.325 . . . . 0.0 110.826 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.7 tp -88.24 102.61 14.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.89 -1.131 . . . . 0.0 111.36 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.0 93.77 7.59 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.324 0.65 . . . . 0.0 109.455 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -100.99 0.76 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 121.368 -0.833 . . . . 0.0 113.668 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -89.95 -33.07 16.54 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 161.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -80.76 133.19 35.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.845 1.657 . . . . 0.0 112.554 -161.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.14 101.07 7.71 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.721 -1.237 . . . . 0.0 109.562 163.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.84 111.81 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.737 0.815 . . . . 0.0 109.866 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.89 98.18 2.12 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 123.924 0.773 . . . . 0.0 113.06 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.48 103.58 16.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -121.52 150.5 41.52 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.235 1.017 . . . . 0.0 112.409 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -118.37 140.27 50.1 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.642 0.777 . . . . 0.0 109.487 169.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -66.11 125.2 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.722 -1.236 . . . . 0.0 112.049 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 m -70.89 -43.31 68.6 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.46 -0.775 . . . . 0.0 113.022 171.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -51.05 -56.92 10.2 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 165.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.75 -40.23 9.46 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.62 -9.78 60.65 Favored Glycine 0 CA--C 1.556 2.595 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.79 150.07 28.07 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 119.689 1.744 . . . . 0.0 112.841 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -85.46 143.7 28.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -173.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -131.92 134.87 46.15 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.48 1.112 . . . . 0.0 110.179 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -119.5 109.16 15.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.68 120.33 41.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.627 -0.67 . . . . 0.0 112.119 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.43 110.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.266 -0.896 . . . . 0.0 109.002 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 mtm-85 -92.75 116.38 28.97 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 121.586 -0.696 . . . . 0.0 110.766 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -137.51 149.43 46.77 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.769 0.828 . . . . 0.0 111.601 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -99.76 115.14 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.79 -1.194 . . . . 0.0 108.391 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 pt -80.73 -27.96 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.31 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.11 34.88 2.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 159.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -145.15 128.87 17.21 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.114 0.966 . . . . 0.0 109.865 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.98 110.05 20.29 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.742 0.817 . . . . 0.0 109.641 170.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.17 114.08 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -109.45 91.64 3.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -93.98 98.38 10.99 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.403 0.681 . . . . 0.0 110.073 -166.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.12 98.78 11.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.732 0.813 . . . . 0.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.12 106.88 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -120.3 109.7 15.69 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 53.61 50.5 17.05 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.86 -27.8 4.25 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 -167.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.0 t -87.74 113.92 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.694 1.747 . . . . 0.0 109.524 -170.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -104.87 101.53 11.12 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.398 0.679 . . . . 0.0 111.978 -169.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.31 102.97 14.84 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 112.377 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -81.48 99.22 8.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.097 0.559 . . . . 0.0 110.226 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -99.71 109.87 22.31 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.93 120.1 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.673 -1.267 . . . . 0.0 108.768 -159.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.2 123.65 48.31 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.517 0.727 . . . . 0.0 110.014 -168.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.06 156.8 31.5 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.986 1.266 . . . . 0.0 113.526 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -64.49 99.98 0.34 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 123.845 0.858 . . . . 0.0 113.147 174.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 4.8 t0 . . . . . 0 C--O 1.256 1.399 0 C-N-CA 125.407 1.483 . . . . 0.0 114.355 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.322 86.3 m-85 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -71.24 92.49 1.02 Allowed 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.083 1.311 . . . . 0.0 113.522 -164.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -177.04 171.21 2.14 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 125.211 1.405 . . . . 0.0 110.877 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -90.02 126.83 35.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.941 -1.099 . . . . 0.0 110.7 171.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -128.62 109.32 11.25 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.123 0.569 . . . . 0.0 110.07 -173.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -104.18 143.72 32.55 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.233 0.924 . . . . 0.0 113.067 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.43 120.56 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.72 -66.08 0.94 Allowed 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 123.486 0.715 . . . . 0.0 110.683 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -137.14 117.98 14.14 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.936 0.494 . . . . 0.0 111.223 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.1 p -93.1 100.13 12.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.704 -0.622 . . . . 0.0 110.176 166.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.74 -80.4 0.07 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -155.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -88.29 44.36 1.19 Allowed 'General case' 0 CA--C 1.579 2.081 0 CA-C-N 120.32 1.418 . . . . 0.0 113.451 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -80.33 -45.29 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.387 -1.446 . . . . 0.0 114.827 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.71 -21.16 65.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.36 -40.95 17.24 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 120.331 1.423 . . . . 0.0 114.799 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -47.43 -49.98 23.89 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.971 1.714 . . . . 0.0 115.534 158.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.61 ' SD ' HG21 ' A' ' 23' ' ' VAL . 20.9 mmt -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 165.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -54.17 -44.43 71.48 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -58.16 -40.63 81.89 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 165.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -40.17 95.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 169.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.35 65.37 0.63 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 119.055 0.843 . . . . 0.0 114.177 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' A' ' 18' ' ' MET . 15.4 m -128.13 148.38 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 122.274 1.035 . . . . 0.0 112.511 -167.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.91 159.2 33.14 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 14.2 tt -53.3 -38.67 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.93 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.264 0.938 . . . . 0.0 113.198 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -56.27 -43.81 79.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -60.33 -38.63 84.35 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -67.95 -54.93 14.87 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 166.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.38 -36.04 77.13 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.73 74.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.68 81.36 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 163.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -97.92 49.47 1.02 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 119.288 0.949 . . . . 0.0 113.532 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -83.31 -12.25 56.84 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.34 36.06 25.27 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.91 122.94 20.88 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 122.288 1.042 . . . . 0.0 112.674 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -118.42 111.79 19.13 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.032 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.61 98.98 10.07 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 m -92.04 100.24 12.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.835 . . . . 0.0 109.007 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.56 122.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.1 p -130.48 109.73 10.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -94.69 102.68 14.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.825 -1.172 . . . . 0.0 110.918 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.1 pm0 -75.09 -34.87 61.8 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.54 81.42 0.05 OUTLIER Glycine 0 N--CA 1.486 2.003 0 CA-C-N 119.18 0.9 . . . . 0.0 111.83 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER 74.32 -56.41 0.64 Allowed 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -160.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -60.53 139.54 57.72 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.62 114.47 28.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.823 0.449 . . . . 0.0 109.855 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.0 m -88.55 96.75 10.75 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.494 HG11 HH22 ' A' ' 106' ' ' ARG . 25.7 t -101.03 112.04 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.35 102.31 11.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.47 -0.769 . . . . 0.0 109.069 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -97.05 101.18 12.7 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -174.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.1 t -116.11 115.51 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.072 0.549 . . . . 0.0 112.412 -165.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -150.04 179.03 8.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -166.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -62.45 -43.69 98.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 164.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.1 -42.1 69.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 172.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -149.16 130.02 14.25 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.415 1.007 . . . . 0.0 111.209 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -119.99 86.99 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.22 144.74 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.676 -0.64 . . . . 0.0 111.657 -158.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.68 116.03 28.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.706 -1.246 . . . . 0.0 111.902 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.34 99.59 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.67 95.73 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.88 130.18 53.07 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.268 0.556 . . . . 0.0 112.477 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -92.22 145.51 24.44 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-O 122.353 1.073 . . . . 0.0 111.062 166.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.23 128.05 32.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.163 -0.961 . . . . 0.0 112.234 -168.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 -8.66 59.25 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 119.161 2.424 . . . . 0.0 119.161 -167.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.21 137.14 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 119.904 1.852 . . . . 0.0 110.813 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 95.62 5.68 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 121.711 0.767 . . . . 0.0 111.77 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -120.9 165.18 15.56 Favored 'General case' 0 CA--C 1.573 1.852 0 C-N-CA 124.401 1.08 . . . . 0.0 111.851 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -82.06 125.68 31.11 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.863 -1.148 . . . . 0.0 113.011 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -139.69 72.12 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.819 -0.55 . . . . 0.0 110.763 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -77.75 146.45 35.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.938 . . . . 0.0 113.086 -172.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 CA--C 1.574 1.871 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 178.69 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.503 2.193 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -94.14 120.21 34.07 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 125.19 1.396 . . . . 0.0 109.744 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.1 mt -127.88 131.14 49.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 112.164 -164.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -120.17 134.24 55.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.577 -0.702 . . . . 0.0 110.711 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.73 -178.62 43.81 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 118.944 2.337 . . . . 0.0 118.944 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.1 p -118.3 120.09 36.6 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.408 -1.396 . . . . 0.0 110.992 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.25 111.45 20.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -87.51 -38.37 16.1 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.267 39.3 tp 62.01 86.74 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.957 1.303 . . . . 0.0 113.586 -167.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -86.45 83.57 7.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.18 0.99 . . . . 0.0 109.956 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.98 -96.14 0.59 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -98.26 -9.43 25.55 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -108.7 122.31 46.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.13 1.786 . . . . 0.0 110.383 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -73.44 102.02 3.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.809 -1.182 . . . . 0.0 109.84 168.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -97.27 123.3 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-O 121.523 0.677 . . . . 0.0 109.761 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.98 102.22 0.67 Allowed Glycine 0 N--CA 1.481 1.655 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.11 -170.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -84.29 98.92 10.26 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.301 0.551 . . . . 0.0 110.301 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -107.09 105.91 16.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.157 0.98 . . . . 0.0 110.019 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -90.01 133.1 35.01 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 121.639 -0.663 . . . . 0.0 110.938 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -62.38 122.7 16.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.3 p -71.19 -26.6 63.03 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -64.98 -57.47 8.63 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 164.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -111.35 -46.77 3.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 38.71 6.14 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 118.562 2.185 . . . . 0.0 118.562 -165.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.82 -8.04 59.31 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.301 4.9 tt0 72.18 99.49 0.07 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 175.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 tt -99.86 114.88 28.38 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.871 0.868 . . . . 0.0 110.229 172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -99.71 113.33 25.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.0 m -103.42 122.4 44.79 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 122.832 0.453 . . . . 0.0 110.759 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.57 111.06 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.494 HH22 HG11 ' A' ' 49' ' ' VAL . 27.7 mtp180 -105.29 113.05 26.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.375 0.67 . . . . 0.0 109.739 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.91 158.38 44.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.442 -0.786 . . . . 0.0 112.634 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.98 111.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.993 -1.067 . . . . 0.0 108.261 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 10.9 tp -85.5 68.26 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 CA-C-O 122.341 1.067 . . . . 0.0 111.744 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.77 -84.55 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 120.795 -1.191 . . . . 0.0 114.698 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.35 -17.39 18.05 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -118.46 131.34 56.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.336 1.425 . . . . 0.0 111.334 -168.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.8 tp -79.63 109.88 14.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 110.209 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.4 114.04 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.57 99.29 9.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.0 109.231 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -100.01 105.67 17.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -84.18 102.3 12.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.198 0.599 . . . . 0.0 110.561 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.83 112.12 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.403 ' OH ' ' OE2' ' A' ' 120' ' ' GLU . 16.6 t80 -128.89 107.03 9.31 Favored 'General case' 0 CA--C 1.564 1.497 0 O-C-N 121.779 -0.576 . . . . 0.0 110.818 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.403 ' OE2' ' OH ' ' A' ' 119' ' ' TYR 0.406 15.4 pt-20 39.56 64.57 0.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.56 -33.13 4.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -168.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.61 117.81 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 119.341 1.57 . . . . 0.0 109.758 -162.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.21 144.95 25.97 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.84 144.29 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 161.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -122.98 104.01 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 109.226 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -80.7 105.44 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 162.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.91 123.26 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -109.44 125.37 52.35 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.441 0.696 . . . . 0.0 110.218 -171.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -81.39 165.54 21.22 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.573 0.701 . . . . 0.0 112.248 169.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -71.54 100.45 2.25 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 120.869 -1.144 . . . . 0.0 112.09 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 7.3 t0 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 125.2 1.4 . . . . 0.0 114.012 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -155.69 81.87 1.03 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.022 . . . . 0.0 109.884 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -167.74 171.19 10.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.126 -0.984 . . . . 0.0 112.052 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -71.84 117.29 13.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.92 . . . . 0.0 111.138 161.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -114.64 101.87 9.5 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.69 135.99 33.62 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.476 0.711 . . . . 0.0 112.685 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.22 117.58 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.57 -62.88 1.19 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.723 0.809 . . . . 0.0 111.302 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.73 129.59 47.36 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.02 0.914 . . . . 0.0 110.946 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m -113.27 115.32 28.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -87.71 -57.78 2.82 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.894 0.478 . . . . 0.0 112.27 -165.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -121.15 145.83 47.41 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -163.21 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.077 0.951 . . . . 0.0 111.305 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -35.48 80.65 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -67.29 -37.14 82.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 165.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.6 -52.09 63.27 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.6 mtp -58.54 -37.44 75.68 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.4 -43.9 75.68 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.55 -44.84 95.35 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 166.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.0 mtm -58.22 -44.1 88.04 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.508 2.04 . . . . 0.0 116.508 175.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.17 63.02 0.1 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.6 143.59 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-O 122.483 1.135 . . . . 0.0 111.139 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -82.05 163.11 22.3 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 120.853 -1.155 . . . . 0.0 113.742 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.8 tp -64.0 157.46 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 O-C-N 121.03 -1.044 . . . . 0.0 113.24 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.389 21.8 t 80.48 -61.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 124.346 1.058 . . . . 0.0 110.7 -162.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -56.2 -47.42 78.4 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 162.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -61.83 -16.6 51.45 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 164.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.67 -44.31 12.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.21 1.368 . . . . 0.0 113.462 164.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.96 -48.89 69.84 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 166.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.76 -18.66 62.11 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.09 -58.51 3.98 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.912 1.233 . . . . 0.0 113.019 158.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.1 49.39 1.79 Allowed 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -79.78 -30.43 40.64 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 63.91 55.41 1.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.713 1.142 . . . . 0.0 112.547 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.3 tp -79.81 113.25 17.82 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.957 0.884 . . . . 0.0 111.658 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -107.15 101.36 10.77 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.048 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.34 93.85 8.81 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.4 m -90.37 94.34 9.7 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.59 0.709 . . . . 0.0 110.336 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.486 HD11 HH21 ' A' ' 106' ' ' ARG . 24.5 mt -80.77 124.47 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.674 0.79 . . . . 0.0 109.389 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.5 p -133.12 104.54 6.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -92.24 115.87 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.65 -1.281 . . . . 0.0 112.274 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.92 -41.29 59.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.7 -84.09 0.05 OUTLIER Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.126 -0.984 . . . . 0.0 111.42 171.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -82.02 -49.73 9.91 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 157.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.87 119.71 11.17 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -85.58 115.95 23.58 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -95.86 99.44 11.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -96.53 103.89 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.32 100.38 8.36 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 123.297 0.639 . . . . 0.0 110.062 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -86.92 97.3 10.61 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.419 0.688 . . . . 0.0 109.433 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -107.03 113.11 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.075 0.55 . . . . 0.0 110.317 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 p -145.49 -170.45 3.45 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.21 1.005 . . . . 0.0 113.292 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -62.0 -47.31 85.38 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.901 -1.125 . . . . 0.0 113.441 165.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -63.17 -48.77 76.99 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -142.09 163.05 33.92 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -160.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -143.43 88.68 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.111 163.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 141.62 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.261 -0.9 . . . . 0.0 112.429 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -84.72 115.31 22.61 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 121.398 -0.814 . . . . 0.0 112.708 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.24 98.32 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -87.39 114.07 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -127.44 124.1 37.64 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.757 0.789 . . . . 0.0 112.824 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.29 148.44 29.42 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 121.683 0.754 . . . . 0.0 111.478 164.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.52 88.46 2.68 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.758 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.07 -47.38 0.69 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -160.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.9 t -75.7 136.88 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 118.716 1.258 . . . . 0.0 112.264 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.3 p -89.84 120.12 30.8 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.304 -0.872 . . . . 0.0 110.35 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.82 156.8 47.03 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 121.971 0.891 . . . . 0.0 112.737 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.26 97.78 10.97 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.519 0.676 . . . . 0.0 110.479 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -84.31 97.94 9.73 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.531 -0.731 . . . . 0.0 110.299 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.41 133.07 39.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.579 -0.7 . . . . 0.0 112.057 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -174.643 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.39 130.12 35.03 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.42 120.46 38.21 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.705 1.202 . . . . 0.0 108.876 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -113.4 108.79 17.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.389 -1.444 . . . . 0.0 111.1 -159.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.22 -149.19 18.97 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 -172.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.9 m -140.78 147.26 38.82 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.01 0.91 . . . . 0.0 112.314 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -92.45 117.61 30.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.014 163.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -111.74 144.34 41.18 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.375 0.67 . . . . 0.0 111.586 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.3 tp -87.77 103.36 15.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.732 -1.23 . . . . 0.0 110.861 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.92 84.86 4.99 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.966 0.888 . . . . 0.0 108.848 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.34 -97.05 0.44 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -95.28 -19.97 19.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -89.17 124.24 34.17 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.639 1.563 . . . . 0.0 111.19 -172.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -82.54 100.07 9.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.772 -1.205 . . . . 0.0 108.967 164.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -95.79 110.32 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-O 122.131 0.967 . . . . 0.0 109.893 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.7 93.15 1.85 Allowed Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.005 0.812 . . . . 0.0 112.363 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.41 94.65 9.44 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.41 131.18 56.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.277 0.631 . . . . 0.0 109.719 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -90.41 134.72 34.15 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.953 -1.092 . . . . 0.0 110.131 164.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.23 105.88 1.52 Allowed 'General case' 0 CA--C 1.566 1.573 0 O-C-N 120.824 -1.173 . . . . 0.0 110.653 169.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -42.93 -59.63 1.92 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -163.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.69 67.42 0.67 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 123.568 1.651 . . . . 0.0 107.497 -169.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.71 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.068 -162.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.27 45.37 5.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 116.182 1.233 . . . . 0.0 116.182 -171.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -139.81 126.3 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 117.843 0.821 . . . . 0.0 109.883 -166.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -76.74 127.12 32.16 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.91 109.58 21.51 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.557 0.743 . . . . 0.0 109.281 161.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -98.77 122.38 41.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.02 94.17 4.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.02 -0.425 . . . . 0.0 110.217 -159.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.94 105.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 119.764 -1.835 . . . . 0.0 108.99 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.486 HH21 HD11 ' A' ' 40' ' ' ILE . 9.6 ptm180 -102.89 113.34 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.834 0.743 . . . . 0.0 110.506 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -135.2 154.03 51.75 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 123.946 0.899 . . . . 0.0 111.06 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -86.57 108.71 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.692 -1.255 . . . . 0.0 109.627 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.7 tp -88.68 72.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.997 0.903 . . . . 0.0 111.117 172.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.59 0.5 Allowed Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.06 -1.025 . . . . 0.0 115.122 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -91.15 -14.07 31.81 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -134.3 145.57 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 119.443 1.019 . . . . 0.0 112.283 -161.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.2 tp -82.4 105.97 13.9 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.722 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.1 p -87.5 108.15 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -0.778 . . . . 0.0 110.209 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -98.96 106.25 18.48 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.114 0.566 . . . . 0.0 110.278 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.7 m -98.1 110.73 23.26 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.83 0.852 . . . . 0.0 109.78 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -98.9 105.99 18.2 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.542 1.137 . . . . 0.0 108.373 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.92 110.12 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -139.23 127.08 22.11 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.543 0.737 . . . . 0.0 110.86 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 50.66 45.17 27.23 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.63 -15.5 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 119.688 2.635 . . . . 0.0 119.688 -166.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.87 119.46 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 CA-C-N 119.618 1.709 . . . . 0.0 108.958 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.96 120.89 33.04 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.32 0.648 . . . . 0.0 110.565 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.92 136.31 54.81 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.53 0.732 . . . . 0.0 112.306 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -126.53 117.99 23.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 109.912 -172.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -109.96 116.75 32.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.06 120.03 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -108.95 126.21 52.85 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.842 0.857 . . . . 0.0 110.172 -171.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -91.85 153.92 19.23 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.174 0.988 . . . . 0.0 113.125 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -63.34 112.93 2.93 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.289 5.3 m-20 . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 126.221 1.809 . . . . 0.0 108.436 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.317 73.9 m-85 . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.11 94.63 2.44 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 -170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 m -173.73 177.53 2.45 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.581 1.552 . . . . 0.0 110.532 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.6 m -92.96 129.07 39.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.915 -1.741 . . . . 0.0 111.05 168.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -124.18 104.76 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.236 0.614 . . . . 0.0 109.871 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -89.82 133.37 34.76 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.511 0.724 . . . . 0.0 111.238 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 36' ' ' LEU . 2.3 p -68.34 111.91 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.382 -0.823 . . . . 0.0 112.444 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.64 -62.79 1.51 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.276 0.631 . . . . 0.0 111.747 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -143.52 116.29 8.74 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.75 0.786 . . . . 0.0 109.788 -168.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.3 m -99.57 127.65 45.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.271 0.628 . . . . 0.0 110.729 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.317 5.7 tm-20 -74.82 -93.59 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -167.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -96.82 39.25 1.18 Allowed 'General case' 0 CA--C 1.577 1.982 0 O-C-N 120.477 -1.389 . . . . 0.0 113.72 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.27 -36.99 58.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.91 -35.64 78.99 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 166.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -71.28 -40.07 71.15 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 167.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -47.44 -50.45 22.87 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 157.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 mmt -59.3 -42.39 91.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.09 -44.67 91.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 166.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -55.91 -43.89 77.73 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.9 mmt -58.51 -37.65 76.06 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 167.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.3 46.01 2.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.73 142.76 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 C-N-CA 123.841 0.856 . . . . 0.0 110.518 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -69.76 165.56 21.15 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.299 12.5 tt -73.63 53.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.78 -67.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -67.67 -25.95 65.96 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -42.9 -42.47 3.7 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 153.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.42 -52.01 5.61 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.291 -0.862 . . . . 0.0 112.364 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -57.86 -40.11 79.36 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.53 -35.03 60.81 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.88 88.36 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 163.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -103.43 47.67 0.87 Allowed 'General case' 0 CA--C 1.577 1.994 0 C-N-CA 123.867 0.867 . . . . 0.0 112.895 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -83.78 -11.56 56.91 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 59.27 46.21 13.09 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.311 -1.493 . . . . 0.0 114.185 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.452 ' H ' HG12 ' A' ' 8' ' ' VAL . 2.8 tt -85.32 108.65 17.9 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 121.379 -0.825 . . . . 0.0 111.914 -166.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -94.82 111.19 22.99 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.448 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.82 101.67 13.77 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.369 0.668 . . . . 0.0 110.256 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -81.48 101.15 9.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.168 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.7 mt -90.38 119.58 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 p -128.79 108.68 10.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -88.44 84.58 6.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 111.527 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.41 76.25 5.92 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 121.92 0.866 . . . . 0.0 111.563 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.95 77.23 0.7 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 115.812 1.085 . . . . 0.0 115.812 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.292 18.1 t-20 70.9 -57.87 0.58 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.25 119.01 9.45 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -86.42 106.37 17.4 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.502 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.4 m -87.64 97.35 10.82 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -104.23 107.79 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -94.63 106.02 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -78.78 111.86 15.34 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.237 0.615 . . . . 0.0 110.801 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 t -113.02 106.07 14.24 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.047 0.539 . . . . 0.0 109.558 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -142.86 178.43 7.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -58.83 -39.63 81.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -60.65 -52.12 66.5 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 165.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -158.3 151.45 22.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -159.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -122.91 90.92 3.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.789 0.836 . . . . 0.0 109.675 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.29 148.8 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.233 -0.917 . . . . 0.0 112.785 -167.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.86 116.88 33.77 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.109 0.964 . . . . 0.0 112.609 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.01 104.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.45 114.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -123.12 124.57 43.36 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.86 145.87 29.21 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.818 0.818 . . . . 0.0 111.263 166.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.73 117.5 11.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.33 0.11 85.05 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 119.537 2.575 . . . . 0.0 119.537 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.7 t -95.95 137.1 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 120.526 2.163 . . . . 0.0 110.374 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.0 p -75.28 121.83 22.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.728 . . . . 0.0 112.651 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -137.97 158.6 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.644 -0.66 . . . . 0.0 112.455 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.51 107.28 18.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.71 -0.619 . . . . 0.0 110.304 173.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -95.46 110.13 22.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -75.18 126.8 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.631 -0.668 . . . . 0.0 110.62 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.498 1.941 0 O-C-N 120.757 -1.214 . . . . 0.0 113.88 172.189 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.24 101.35 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.3 115.49 24.74 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -98.08 109.6 22.33 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.621 0.769 . . . . 0.0 110.409 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.59 -176.52 46.54 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -120.94 119.56 32.95 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.093 -1.553 . . . . 0.0 110.565 -166.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -79.47 112.19 16.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.905 0.775 . . . . 0.0 110.202 159.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.2 m -106.62 138.09 43.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.278 0.631 . . . . 0.0 110.983 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 tp -88.43 108.44 19.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.782 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -67.72 -42.56 81.74 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 171.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.28 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -79.77 -22.07 43.62 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 157.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -105.97 134.42 49.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.284 1.402 . . . . 0.0 111.341 -167.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.5 mt -94.35 111.35 23.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 108.78 167.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -105.36 120.11 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.784 1.234 . . . . 0.0 109.184 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.02 111.83 2.48 Favored Glycine 0 N--CA 1.483 1.805 0 O-C-N 121.839 -0.538 . . . . 0.0 113.94 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -97.59 107.97 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.136 0.575 . . . . 0.0 109.556 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -127.14 107.25 9.86 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.399 0.618 . . . . 0.0 112.618 -164.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.72 124.71 31.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -61.24 150.53 34.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.829 -1.17 . . . . 0.0 113.875 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.6 m -80.67 68.23 6.82 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-O 123.508 1.623 . . . . 0.0 111.011 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -152.23 -85.04 0.07 Allowed 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -115.72 -22.87 8.94 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 50.81 2.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 -167.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -82.03 -30.78 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.383 10.7 tt0 74.99 97.83 0.07 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 126.001 1.72 . . . . 0.0 114.707 -168.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 tt -89.58 116.32 27.64 Favored 'General case' 0 CA--C 1.563 1.442 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.526 165.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -92.07 117.02 29.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.762 . . . . 0.0 110.764 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -114.02 112.97 24.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.825 0.85 . . . . 0.0 109.157 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.8 t -105.85 113.52 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -110.32 117.93 34.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.219 0.918 . . . . 0.0 109.566 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.16 144.53 38.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.998 0.904 . . . . 0.0 112.045 -169.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -91.31 108.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.68 -47.57 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.763 -0.585 . . . . 0.0 111.542 168.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.84 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.485 1.917 0 CA-C-N 119.185 0.902 . . . . 0.0 111.247 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.35 -30.02 47.82 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.08 144.2 34.1 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 122.425 1.107 . . . . 0.0 112.516 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 tp -95.13 115.2 27.12 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.756 0.822 . . . . 0.0 109.186 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.4 121.43 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.805 -0.559 . . . . 0.0 109.83 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.37 99.14 7.99 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.689 0.796 . . . . 0.0 109.85 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -98.17 111.01 23.49 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.725 0.81 . . . . 0.0 110.915 -169.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -100.91 112.08 24.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.928 0.891 . . . . 0.0 110.723 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.27 113.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -123.96 110.0 14.25 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 122.997 0.519 . . . . 0.0 112.209 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.275 43.6 mt-10 47.22 34.5 3.1 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 119.53 -44.26 1.43 Allowed Glycine 0 CA--C 1.553 2.418 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -162.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.74 121.76 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 119.304 1.552 . . . . 0.0 113.33 -163.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.02 133.74 34.65 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.841 -0.537 . . . . 0.0 111.689 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.69 117.33 9.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.436 0.694 . . . . 0.0 111.571 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.297 1.1 pptp? -114.64 126.22 54.64 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -105.23 115.33 30.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 110.365 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mt -98.78 120.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.89 130.28 55.63 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.342 0.657 . . . . 0.0 110.896 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.61 149.07 21.83 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.97 0.89 . . . . 0.0 112.053 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -84.89 113.03 21.08 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 112.689 -174.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.65 0 C-N-CA 124.802 1.241 . . . . 0.0 113.896 172.222 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.575 1.92 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -141.74 91.11 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.367 -1.458 . . . . 0.0 107.746 166.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -174.87 167.5 3.63 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.54 1.162 . . . . 0.0 111.899 -171.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -101.3 141.78 33.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 111.662 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -141.84 121.81 13.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.477 -165.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -112.11 142.47 44.52 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 120.502 1.501 . . . . 0.0 112.52 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.279 7.7 p -80.5 91.09 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 122.769 1.271 . . . . 0.0 114.059 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.55 -36.26 29.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -122.52 145.7 48.08 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.082 -1.011 . . . . 0.0 112.189 -172.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 p -152.46 159.5 43.35 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.271 1.6 tm-20 -106.57 -137.28 0.36 Allowed 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.736 171.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.286 8.8 p30 -80.99 58.72 3.53 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 118.917 -2.364 . . . . 0.0 117.159 -167.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CE2' ' SD ' ' A' ' 18' ' ' MET . 31.6 t80 -61.14 -40.44 93.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.719 -1.863 . . . . 0.0 115.159 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.64 -43.05 68.45 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 165.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.91 -45.12 52.58 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.596 1.543 . . . . 0.0 115.024 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -45.55 -51.61 11.65 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 160.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' A' ' 28' ' ' ARG . 43.4 mtp -62.01 -45.4 93.77 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -43.04 72.21 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-N 120.373 1.442 . . . . 0.0 114.733 168.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -40.34 89.15 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 166.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.548 ' SD ' HG21 ' A' ' 76' ' ' THR . 72.9 mtm -62.98 -45.37 92.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 169.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.82 68.61 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 CA-C-N 118.841 0.746 . . . . 0.0 114.633 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.42 174.39 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.311 1.053 . . . . 0.0 113.267 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.16 159.8 21.97 Favored 'General case' 0 CA--C 1.577 2.009 0 O-C-N 120.712 -1.243 . . . . 0.0 113.338 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.264 14.7 tt -59.67 -44.49 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.66 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 CA-C-O 123.715 1.721 . . . . 0.0 112.088 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -149.77 -52.28 0.15 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 127.749 2.419 . . . . 0.0 106.169 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 12.0 mtm105 -42.95 -55.11 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 161.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -62.28 -41.44 98.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.09 -51.85 66.28 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.29 36.65 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.61 -56.07 25.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 119.674 -1.891 . . . . 0.0 113.162 156.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -86.28 48.56 1.64 Allowed 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -80.41 -16.13 55.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 58.69 21.24 8.61 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.27 1.3 pt? -77.2 145.53 37.57 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -157.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.03 119.07 34.69 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.396 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -99.19 109.76 22.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.559 0.744 . . . . 0.0 109.615 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 m -90.19 101.62 14.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.92 125.38 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.253 12.8 t -133.37 143.05 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.062 0.934 . . . . 0.0 111.705 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -110.1 110.36 21.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.866 0.866 . . . . 0.0 110.858 -172.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -88.8 77.17 7.87 Favored 'General case' 0 CA--C 1.57 1.73 0 CA-C-O 121.723 0.773 . . . . 0.0 110.149 165.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.46 -95.25 0.14 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -91.97 -8.47 46.11 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 168.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -113.38 118.55 34.88 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 121.121 1.782 . . . . 0.0 111.213 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.44 129.81 38.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.555 -0.716 . . . . 0.0 111.709 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -100.37 109.84 22.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 163.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.13 103.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -88.5 99.37 12.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.863 . . . . 0.0 109.734 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.26 100.08 12.2 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.287 0.635 . . . . 0.0 112.431 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.4 t -95.08 94.81 8.18 Favored 'General case' 0 CA--C 1.56 1.331 0 O-C-N 122.126 -0.359 . . . . 0.0 111.024 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.8 p -114.61 167.5 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.148 0.979 . . . . 0.0 113.361 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.6 m -56.96 -42.62 80.45 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 166.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -68.04 -49.33 62.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -148.95 145.76 27.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.498 1.044 . . . . 0.0 112.16 -169.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.06 102.11 8.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.646 . . . . 0.0 109.59 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -139.93 149.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.787 0.803 . . . . 0.0 112.145 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.87 105.54 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.491 -0.755 . . . . 0.0 110.416 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.65 99.03 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.2 t -96.83 123.43 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -144.33 146.83 32.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -99.66 143.3 30.05 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.023 0.916 . . . . 0.0 111.906 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.18 109.34 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.461 0.704 . . . . 0.0 112.898 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.92 -38.12 3.4 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.7 t -73.79 132.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 118.847 1.323 . . . . 0.0 110.329 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -98.21 102.99 14.89 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.315 1.055 . . . . 0.0 110.715 -171.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.41 163.73 14.92 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.973 1.309 . . . . 0.0 112.06 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -87.12 112.15 21.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.643 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -80.54 -65.93 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.536 -0.728 . . . . 0.0 112.135 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 73.03 122.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.386 1.074 . . . . 0.0 113.029 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.9 mt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.548 HG21 ' SD ' ' A' ' 21' ' ' MET . 91.7 m . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.75 117.33 20.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.766 -0.584 . . . . 0.0 111.703 -173.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.6 mt -141.02 117.81 11.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.974 0.91 . . . . 0.0 110.612 -164.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.264 2.6 ptm85 -131.89 138.84 48.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.33 -172.93 40.24 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.248 0.927 . . . . 0.0 112.189 -167.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -110.2 -179.08 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.888 -1.36 . . . . 0.0 112.72 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -122.67 107.23 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 p -85.17 128.96 34.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -0.975 . . . . 0.0 113.356 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 tp -85.31 104.49 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.298 0.639 . . . . 0.0 111.148 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.22 97.37 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.864 0.84 . . . . 0.0 109.201 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.5 -100.25 1.17 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.589 -0.694 . . . . 0.0 113.652 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -113.63 8.6 17.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 163.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -103.23 127.49 50.53 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.804 1.638 . . . . 0.0 110.528 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.62 99.02 11.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 151.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.21 114.17 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.789 0.804 . . . . 0.0 109.169 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.19 99.97 1.4 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 121.79 -0.569 . . . . 0.0 114.04 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -87.46 100.26 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.452 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.6 116.32 31.52 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.613 0.765 . . . . 0.0 109.435 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -76.36 124.63 27.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.137 -0.977 . . . . 0.0 111.726 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.1 100.36 12.59 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 -171.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.5 p -68.45 -21.68 64.63 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -56.74 -23.46 42.85 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 163.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.45 -49.54 0.36 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.428 1.091 . . . . 0.0 113.681 -157.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.92 60.36 0.93 Allowed Glycine 0 N--CA 1.49 2.246 0 CA-C-N 119.172 0.896 . . . . 0.0 115.051 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -144.0 141.63 30.25 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.465 0.706 . . . . 0.0 110.635 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.28 103.28 6.22 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.025 0.917 . . . . 0.0 111.575 167.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.98 123.58 25.97 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 121.796 -0.565 . . . . 0.0 109.804 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -107.59 100.17 9.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -108.02 118.7 37.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.357 0.663 . . . . 0.0 110.91 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.87 113.57 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -100.59 118.53 36.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.079 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.65 145.86 31.97 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 123.591 0.756 . . . . 0.0 110.809 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.31 110.89 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.535 -1.353 . . . . 0.0 108.006 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER -91.78 85.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.272 1.034 . . . . 0.0 109.005 171.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.46 -91.05 1.04 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 120.77 -1.206 . . . . 0.0 114.205 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -130.93 42.92 3.17 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.687 -0.89 . . . . 0.0 112.945 165.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -136.23 119.79 17.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.817 -1.177 . . . . 0.0 109.716 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.65 108.23 13.04 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.407 0.683 . . . . 0.0 110.614 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -89.9 71.63 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 123.318 0.647 . . . . 0.0 112.027 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -69.56 97.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.821 -1.174 . . . . 0.0 112.048 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -109.58 98.05 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -160.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.12 106.23 18.22 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.501 1.12 . . . . 0.0 111.942 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.14 123.1 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.54 -0.725 . . . . 0.0 109.308 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -136.32 124.02 22.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.102 0.561 . . . . 0.0 110.716 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.253 48.2 mt-10 46.62 54.72 8.48 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.78 24.63 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.3 t -114.45 129.33 70.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 120.294 2.047 . . . . 0.0 108.966 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -114.83 127.2 55.58 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.776 0.83 . . . . 0.0 111.525 -171.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.52 115.16 25.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.923 0.868 . . . . 0.0 112.54 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -87.46 122.79 31.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -104.88 102.71 12.23 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.41 107.4 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.99 123.92 42.22 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.856 0.462 . . . . 0.0 110.463 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -78.0 167.93 20.68 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.66 0.743 . . . . 0.0 112.025 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.77 103.89 1.88 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.88 -1.138 . . . . 0.0 113.028 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 125.623 1.569 . . . . 0.0 113.978 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.301 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.26 77.4 m-85 69.86 -21.92 0.17 Allowed 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.23 105.62 1.46 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.946 1.298 . . . . 0.0 114.186 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 m 178.04 169.65 0.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 125.253 1.421 . . . . 0.0 111.412 -172.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.1 m -97.06 128.42 43.99 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.734 -1.229 . . . . 0.0 110.789 171.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -131.22 95.51 3.8 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.306 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -77.56 139.78 39.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 p -70.25 124.05 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.3 -0.875 . . . . 0.0 112.454 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.64 -57.58 3.07 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.278 163.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -136.2 156.82 48.12 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 122.294 1.045 . . . . 0.0 112.589 -171.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.9 m -136.2 94.51 3.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.596 -1.315 . . . . 0.0 110.067 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -93.06 118.84 31.65 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.616 -159.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.274 51.5 t30 64.11 17.92 10.93 Favored 'General case' 0 CA--C 1.584 2.282 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.19 -33.16 74.81 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.73 -50.52 71.98 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -63.86 -41.49 97.77 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -49.58 -51.11 39.43 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.751 1.759 . . . . 0.0 115.751 163.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.5 mtp -65.84 -32.29 73.72 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -56.04 -48.54 75.82 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 160.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.16 -32.86 74.59 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.9 mmt -58.09 -53.9 53.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 120.075 1.307 . . . . 0.0 114.202 160.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.36 52.94 0.12 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.79 167.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 118.457 1.128 . . . . 0.0 112.756 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -79.52 166.56 21.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.756 -1.215 . . . . 0.0 113.032 168.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.285 13.3 tt -75.63 59.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 CA-C-O 123.534 1.635 . . . . 0.0 114.72 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -141.17 -65.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -60.15 -33.75 72.61 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -50.45 -52.12 40.76 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 162.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.59 -52.29 18.87 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.41 -50.25 68.34 Favored 'General case' 0 CA--C 1.564 1.481 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.53 58.04 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.46 94.01 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 159.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -110.1 39.24 2.2 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -80.0 0.29 32.26 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 118.013 2.598 . . . . 0.0 118.013 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.253 62.3 m-80 62.18 52.28 3.25 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.0 tp -76.77 121.87 23.94 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-O 122.085 0.945 . . . . 0.0 113.096 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -109.92 122.21 47.01 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.682 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.18 103.01 14.46 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.898 0.479 . . . . 0.0 109.723 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -91.4 100.07 12.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.119 -0.988 . . . . 0.0 108.735 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.5 mt -90.15 124.68 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.1 p -135.03 115.84 13.95 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -99.26 105.4 17.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.626 -1.296 . . . . 0.0 111.39 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.92 -52.01 9.52 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.27 87.88 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 121.105 -0.997 . . . . 0.0 111.086 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.316 25.8 t30 69.55 -48.65 0.61 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -165.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.62 121.39 14.85 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -85.42 114.54 22.55 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.057 0.543 . . . . 0.0 110.321 169.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -90.44 102.57 15.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.7 t -105.36 101.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -79.86 105.06 10.86 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 123.362 0.665 . . . . 0.0 109.867 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.89 99.52 9.73 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.155 0.982 . . . . 0.0 109.146 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.0 t -111.77 109.16 18.86 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.815 0.446 . . . . 0.0 112.174 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -135.27 178.74 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.3 m -54.64 -37.45 65.68 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.834 1.791 . . . . 0.0 115.834 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -69.74 -53.24 19.35 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 169.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -148.32 143.71 27.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.302 0.955 . . . . 0.0 112.842 -168.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -121.87 95.23 4.58 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.596 0.759 . . . . 0.0 109.425 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 pp -138.08 152.89 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 123.317 0.647 . . . . 0.0 111.026 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.27 115.82 30.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.708 -1.245 . . . . 0.0 112.505 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.7 t -86.48 101.09 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.32 107.15 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -126.5 130.68 51.09 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.957 0.503 . . . . 0.0 112.091 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -83.51 147.56 27.72 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.452 1.12 . . . . 0.0 111.478 161.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.57 111.08 4.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.64 -6.99 52.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 119.019 2.367 . . . . 0.0 119.019 -167.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.9 t -85.78 130.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.822 2.311 . . . . 0.0 110.511 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 107.54 10.68 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.559 0.744 . . . . 0.0 111.919 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -126.9 157.71 38.69 Favored 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.42 0.688 . . . . 0.0 112.426 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -82.95 113.93 20.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 111.844 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -92.44 116.76 29.27 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.503 0.721 . . . . 0.0 109.405 167.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -96.96 124.35 40.91 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.25 0.548 . . . . 0.0 111.155 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.77 -11.3 59.96 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.289 . . 68.6 61.68 0.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -174.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -172.57 -59.96 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 124.637 1.175 . . . . 0.0 110.474 -167.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.57 58.87 0.01 OUTLIER Glycine 0 CA--C 1.549 2.156 0 C-N-CA 125.154 1.359 . . . . 0.0 110.899 -170.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -172.44 114.76 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -166.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -110.28 142.97 41.15 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 122.368 1.08 . . . . 0.0 111.639 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.8 mt -114.58 116.22 28.42 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.736 0.814 . . . . 0.0 110.13 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -93.69 120.49 34.02 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 121.674 -0.641 . . . . 0.0 111.103 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.55 -161.67 35.12 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 117.651 1.82 . . . . 0.0 117.651 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.8 p -123.84 121.48 35.5 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.579 -160.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -79.25 114.15 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 118.938 0.79 . . . . 0.0 109.908 155.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -114.35 142.9 45.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.38 0.672 . . . . 0.0 110.973 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 tp -91.41 103.41 16.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.687 -1.258 . . . . 0.0 111.768 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -83.55 83.95 7.71 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 122.144 0.974 . . . . 0.0 110.127 166.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.57 -88.38 0.35 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -118.32 13.05 13.57 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.82 128.51 49.63 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.153 1.797 . . . . 0.0 109.473 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 mt -85.8 101.11 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 tp -83.48 110.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-O 122.481 1.134 . . . . 0.0 109.335 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.87 103.12 3.01 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.731 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -90.06 90.47 8.14 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.23 161.16 19.39 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 122.844 1.306 . . . . 0.0 111.773 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -150.05 155.17 39.4 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.992 . . . . 0.0 110.724 170.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -68.21 131.78 45.98 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 113.858 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.3 p -55.46 -43.62 75.64 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 164.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.11 -45.25 4.57 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.895 0.878 . . . . 0.0 111.698 -161.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -65.32 -42.74 92.67 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.73 -9.89 72.17 Favored Glycine 0 CA--C 1.558 2.732 0 N-CA-C 119.136 2.414 . . . . 0.0 119.136 -161.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -78.02 138.75 38.97 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.326 1.563 . . . . 0.0 112.894 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -73.45 148.06 43.58 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 tt -137.6 121.2 17.3 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.67 0.747 . . . . 0.0 110.227 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -93.59 120.18 33.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.982 -0.449 . . . . 0.0 110.112 172.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.1 t -125.02 124.8 42.75 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.668 0.387 . . . . 0.0 111.67 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.01 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -96.04 120.7 36.79 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.093 0.557 . . . . 0.0 110.458 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.87 153.79 31.68 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.523 0.729 . . . . 0.0 111.931 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.97 115.93 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.827 -1.17 . . . . 0.0 108.252 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tp -89.34 81.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.126 0.965 . . . . 0.0 110.67 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.0 -84.44 1.13 Allowed Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.905 -1.122 . . . . 0.0 114.976 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -128.8 26.01 5.59 Favored 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.66 125.79 31.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.901 -1.125 . . . . 0.0 109.906 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 tp -77.93 117.75 19.58 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.352 -0.843 . . . . 0.0 111.007 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -97.77 125.52 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.81 104.04 14.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 162.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -98.93 91.87 5.25 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.35 0.66 . . . . 0.0 109.248 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.27 113.44 25.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.96 0.904 . . . . 0.0 111.402 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.52 108.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -122.28 124.82 44.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.129 0.572 . . . . 0.0 110.872 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 57.1 37.68 28.7 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.88 -5.12 26.39 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 119.801 2.68 . . . . 0.0 119.801 -163.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t -98.28 107.26 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 119.942 1.871 . . . . 0.0 108.08 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 118.81 28.17 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 123.449 0.7 . . . . 0.0 111.948 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.88 125.12 53.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.222 0.609 . . . . 0.0 112.195 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.68 106.21 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.863 -0.523 . . . . 0.0 110.395 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -85.58 117.99 24.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.919 -1.113 . . . . 0.0 109.225 164.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.7 mt -115.02 117.42 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -164.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -116.55 117.47 29.97 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.34 0.656 . . . . 0.0 109.683 -168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.67 152.31 28.51 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 112.08 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -63.2 100.64 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.05 -1.031 . . . . 0.0 112.751 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.256 1.41 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.245 0 CA-C-O 120.945 0.403 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.29 11.73 3.27 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.169 1.915 . . . . 0.0 116.169 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -116.37 88.53 2.91 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 120.221 -1.549 . . . . 0.0 111.252 -150.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -164.77 -178.94 5.55 Favored 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.687 1.195 . . . . 0.0 110.88 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -92.22 106.99 18.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.614 -1.304 . . . . 0.0 109.192 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -109.54 100.5 9.55 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -168.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -95.94 139.06 32.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.199 -0.938 . . . . 0.0 112.754 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.64 115.57 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -172.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.61 -61.45 1.91 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.151 0.58 . . . . 0.0 111.395 164.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -140.13 146.54 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.197 0.999 . . . . 0.0 112.948 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.9 m -132.29 108.07 8.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.56 -49.85 24.24 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -162.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -138.66 41.29 2.18 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -84.39 48.66 1.53 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 119.469 -2.02 . . . . 0.0 114.513 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -149.02 -47.57 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.415 1.486 . . . . 0.0 111.682 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.89 -37.97 89.35 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.942 1.701 . . . . 0.0 114.834 160.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -49.4 -57.93 6.05 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 159.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -45.29 76.95 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 168.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -50.59 -49.35 56.66 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -62.8 -37.73 87.88 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 70.7 mtm -62.91 -52.25 63.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 168.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.05 70.53 0.09 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 145.39 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-O 122.708 1.242 . . . . 0.0 111.276 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -63.92 156.34 28.0 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.258 14.0 tt -56.66 -40.11 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.47 -53.14 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 119.34 0.973 . . . . 0.0 113.067 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -69.78 -30.03 67.5 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -52.3 -46.41 65.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 159.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -57.53 -48.38 79.44 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.17 -34.65 75.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.27 75.28 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.94 -50.83 30.33 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 162.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.46 58.56 4.93 Favored 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 119.807 1.185 . . . . 0.0 112.917 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -95.97 -28.04 14.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 65.31 49.88 1.85 Allowed 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.625 1.17 . . . . 0.0 114.041 -168.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -77.08 124.67 28.14 Favored 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.765 -1.21 . . . . 0.0 113.741 -173.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -120.94 111.65 17.77 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.828 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.5 mt -91.38 100.23 13.05 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -91.65 101.05 13.68 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.97 -1.081 . . . . 0.0 109.116 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.19 107.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -104.03 104.15 14.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -92.45 127.52 37.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.668 -0.645 . . . . 0.0 110.984 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -125.74 76.92 1.62 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.734 1.254 . . . . 0.0 111.265 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 -95.23 1.36 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.055 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -97.19 -23.37 16.22 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -91.15 155.31 18.71 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 120.182 1.355 . . . . 0.0 112.621 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -124.6 112.49 16.88 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.955 0.902 . . . . 0.0 109.449 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.4 m -96.41 94.28 7.32 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -97.82 107.17 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.83 94.31 9.27 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.08 97.86 10.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.621 0.769 . . . . 0.0 108.934 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.5 m -113.62 115.53 28.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.324 0.65 . . . . 0.0 111.507 -162.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.5 p -144.66 168.57 19.85 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.82 0.819 . . . . 0.0 113.127 -170.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -58.9 -34.64 71.91 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 160.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.98 -50.08 67.74 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.36 149.25 11.66 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.35 1.06 . . . . 0.0 111.839 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -118.19 101.21 8.04 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.42 120.17 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.633 -0.667 . . . . 0.0 110.799 -171.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.88 102.81 14.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.941 -1.099 . . . . 0.0 111.46 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.5 97.4 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.01 111.0 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -138.58 142.49 39.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.79 150.42 25.06 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.15 0.976 . . . . 0.0 111.648 164.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.08 102.64 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.053 -1.029 . . . . 0.0 113.099 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.81 -4.01 36.31 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 118.931 2.333 . . . . 0.0 118.931 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.79 135.23 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 121.376 2.588 . . . . 0.0 112.263 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.8 p -84.22 96.69 9.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.313 -0.867 . . . . 0.0 110.75 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -122.96 154.98 37.68 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.407 0.683 . . . . 0.0 112.693 -173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -83.38 105.71 14.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 111.654 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -96.87 101.72 13.36 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.047 0.939 . . . . 0.0 110.638 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -87.35 109.33 19.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.056 -1.028 . . . . 0.0 111.061 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.94 -82.99 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -166.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.29 -74.68 0.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.909 1.231 . . . . 0.0 111.585 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -71.9 -56.3 5.95 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 119.793 1.178 . . . . 0.0 114.098 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.03 48.53 0.12 Allowed Glycine 0 N--CA 1.485 1.912 0 CA-C-O 119.34 -0.7 . . . . 0.0 114.082 173.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.2 m -109.51 97.25 6.85 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 118.72 1.26 . . . . 0.0 109.417 -167.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -68.28 140.12 55.97 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 25.2 mt -134.76 100.24 4.55 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.328 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -84.51 107.25 16.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.278 -0.889 . . . . 0.0 111.913 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.41 -154.55 23.97 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.506 0.963 . . . . 0.0 115.506 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.2 p -124.33 122.35 37.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.773 -155.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -82.27 107.51 15.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 155.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.5 m -108.69 149.96 28.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.6 -0.687 . . . . 0.0 112.322 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 105.28 17.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.877 -1.139 . . . . 0.0 110.91 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.05 79.85 1.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.955 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.51 -92.83 0.89 Allowed Glycine 0 N--CA 1.492 2.408 0 O-C-N 121.128 -0.982 . . . . 0.0 114.04 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.69 52.37 1.93 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.401 0.62 . . . . 0.0 111.188 160.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -141.04 120.06 12.78 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -83.04 99.2 9.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.358 -1.464 . . . . 0.0 109.446 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 tp -90.17 111.22 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.693 0.797 . . . . 0.0 110.033 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.28 92.8 1.36 Allowed Glycine 0 N--CA 1.482 1.734 0 C-N-CA 123.793 0.711 . . . . 0.0 113.172 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.21 111.25 22.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -134.86 111.16 9.65 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -156.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -84.79 120.64 26.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.697 -1.252 . . . . 0.0 111.855 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -54.97 120.21 6.56 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.9 p -64.17 -43.07 96.26 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.25 -44.24 76.08 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.92 -47.66 8.4 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.48 54.66 3.06 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 -157.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -138.52 124.22 19.75 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 118.335 1.067 . . . . 0.0 110.24 -172.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -83.75 99.51 10.32 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 123.115 1.436 . . . . 0.0 113.774 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.5 132.46 34.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.715 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -106.71 110.19 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.734 -0.604 . . . . 0.0 110.192 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -111.05 112.34 24.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.799 -0.563 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.66 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.154 -0.966 . . . . 0.0 108.784 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.3 mtm-85 -90.46 116.08 28.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 109.847 168.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -144.39 159.45 42.7 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 123.656 0.782 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.3 mt -126.14 121.43 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.423 -1.423 . . . . 0.0 109.494 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.13 83.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.12 -80.59 0.96 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.89 -50.41 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -94.22 148.16 22.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 120.212 1.369 . . . . 0.0 114.329 -168.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 tp -86.93 120.75 28.53 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.127 0.571 . . . . 0.0 111.411 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 m -106.77 121.38 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -107.97 103.18 12.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.54 -0.725 . . . . 0.0 109.751 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.4 m -97.8 100.49 11.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.584 0.753 . . . . 0.0 109.356 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -90.04 117.71 29.04 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.023 0.929 . . . . 0.0 111.424 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.92 115.64 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -110.84 107.56 17.09 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 118.67 0.668 . . . . 0.0 109.647 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER 54.64 32.4 17.1 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 175.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.01 -40.5 2.5 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -162.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.69 112.67 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 120.538 2.169 . . . . 0.0 112.361 -168.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.77 130.07 39.9 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.08 0.552 . . . . 0.0 112.342 -174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -129.69 112.46 13.68 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.846 0.858 . . . . 0.0 110.996 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -103.31 116.29 32.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -0.804 . . . . 0.0 110.679 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -106.14 114.07 27.98 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.041 0.448 . . . . 0.0 109.83 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.1 mt -101.23 121.19 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -115.97 124.87 51.61 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.326 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -82.65 142.35 31.78 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.887 0.851 . . . . 0.0 111.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -79.97 105.5 11.3 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 124.924 1.29 . . . . 0.0 113.669 174.485 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.277 87.8 m-85 76.96 78.52 0.08 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.815 1.293 . . . . 0.0 110.413 -176.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.92 -36.15 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -137.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -122.82 -172.32 2.46 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 123.327 1.537 . . . . 0.0 112.918 -158.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.8 m -78.03 118.97 20.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.873 . . . . 0.0 110.16 163.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -122.71 108.1 12.69 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -109.94 139.52 44.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.099 -1.001 . . . . 0.0 113.307 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.62 117.75 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -102.28 -56.97 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.691 0.797 . . . . 0.0 111.438 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 110.77 11.93 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.467 0.707 . . . . 0.0 112.032 -166.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 84.1 p -106.86 127.31 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 0.0 112.512 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -73.94 -46.65 42.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -147.03 45.59 1.17 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -83.9 52.44 2.29 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 119.332 -2.105 . . . . 0.0 113.955 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -152.26 -51.76 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.157 1.383 . . . . 0.0 110.349 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.95 -30.75 70.12 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 163.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -50.94 -40.47 57.46 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 154.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -70.39 -34.23 72.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -50.95 -52.68 39.96 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 121.009 1.731 . . . . 0.0 115.318 159.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -61.09 -34.14 74.46 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.28 -51.52 69.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 162.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.21 68.27 0.48 Allowed Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.015 0.825 . . . . 0.0 114.094 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.66 149.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.462 0.649 . . . . 0.0 112.489 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -78.89 153.03 30.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.769 -1.207 . . . . 0.0 113.68 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.311 10.7 tt -59.61 -39.51 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 118.483 2.771 . . . . 0.0 118.483 -170.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.6 m -59.11 -42.43 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -67.14 -35.18 79.15 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -55.72 -50.73 69.56 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.387 1.903 . . . . 0.0 114.151 164.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -56.38 -54.68 42.69 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.94 48.58 0.85 Allowed 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.96 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.059 1.344 . . . . 0.0 111.963 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.28 93.85 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -83.97 67.75 9.75 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-O 122.283 1.04 . . . . 0.0 111.403 171.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -92.51 -33.55 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.84 50.58 1.09 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.521 1.129 . . . . 0.0 113.532 -166.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.88 124.19 26.91 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.493 1.14 . . . . 0.0 113.632 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -108.71 100.05 9.33 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.054 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.83 102.73 11.01 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.132 0.573 . . . . 0.0 109.491 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.1 m -99.51 105.59 17.52 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -107.22 118.23 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -161.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.0 p -123.96 126.53 46.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.72 -0.612 . . . . 0.0 110.492 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.17 119.95 37.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.631 -0.668 . . . . 0.0 110.933 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.08 -49.83 14.42 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.36 -91.42 0.08 OUTLIER Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -74.7 -24.6 58.79 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 157.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -87.62 129.5 35.1 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 119.894 1.225 . . . . 0.0 111.954 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -109.83 134.7 51.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.358 1.063 . . . . 0.0 110.581 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 85.5 m -107.59 111.93 24.42 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -104.76 105.63 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -80.88 110.02 16.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 110.335 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.16 82.52 4.16 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 123.175 0.59 . . . . 0.0 110.525 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 t -96.66 111.09 23.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.002 -1.061 . . . . 0.0 112.752 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 p -131.94 -169.72 2.26 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.376 0.671 . . . . 0.0 112.069 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -70.45 -1.59 11.25 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 159.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -126.91 -38.36 2.04 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.675 1.19 . . . . 0.0 114.008 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -90.4 -90.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 119.79 1.177 . . . . 0.0 111.781 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.287 70.4 m-80 60.96 60.28 1.87 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 pt -134.14 135.2 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 123.121 0.568 . . . . 0.0 110.595 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.79 103.05 14.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 111.868 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.9 t -88.13 98.28 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.0 113.61 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.99 140.64 45.84 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.689 0.757 . . . . 0.0 112.734 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.36 142.71 41.09 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 111.982 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 100.69 0.89 Allowed 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 112.891 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.81 -12.42 24.94 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.103 2.401 . . . . 0.0 119.103 -171.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 p -75.26 134.19 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-N 121.247 2.524 . . . . 0.0 112.61 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.6 t -82.08 92.8 6.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.54 -0.725 . . . . 0.0 111.984 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -119.15 170.27 9.22 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.956 0.902 . . . . 0.0 113.036 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -88.61 99.13 12.08 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 121.723 -0.611 . . . . 0.0 110.613 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -87.1 87.1 7.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.835 170.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -71.18 142.75 50.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.58 5.68 50.88 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.352 . . 72.03 -79.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.278 1.399 . . . . 0.0 113.554 -170.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.89 -19.83 31.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.63 -64.08 1.39 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 117.028 1.571 . . . . 0.0 117.028 -173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -171.21 171.84 5.53 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 124.352 1.061 . . . . 0.0 111.472 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -85.68 118.56 25.26 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 110.794 151.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.1 mt -92.66 116.63 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.929 -1.107 . . . . 0.0 111.467 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -94.58 114.63 26.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.546 -0.721 . . . . 0.0 110.649 -174.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.77 -153.7 24.98 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.5 p -119.86 140.77 50.31 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -160.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.16 109.64 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.163 -0.961 . . . . 0.0 108.913 155.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.3 m -104.58 139.19 39.81 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.181 0.592 . . . . 0.0 111.484 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.1 tp -88.17 107.47 18.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.118 -0.989 . . . . 0.0 109.959 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -69.85 -53.59 17.41 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.79 -71.07 0.28 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -162.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.15 -39.8 39.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 160.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.04 145.26 35.88 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.959 0.904 . . . . 0.0 112.882 -164.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.06 101.53 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 146.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.2 110.42 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.797 0.808 . . . . 0.0 109.485 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.76 94.68 2.02 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.8 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.02 95.61 9.89 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.534 0.683 . . . . 0.0 109.18 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.48 164.96 20.77 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 122.561 1.172 . . . . 0.0 111.835 -169.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.79 155.01 46.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.849 -1.157 . . . . 0.0 112.072 165.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -67.84 139.02 56.53 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.8 m -77.91 -51.87 9.74 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.17 0.588 . . . . 0.0 112.062 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.97 -41.38 74.66 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.0 -31.63 7.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -172.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.15 38.56 29.48 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 118.556 2.182 . . . . 0.0 118.556 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -144.08 157.54 44.25 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.92 1.36 . . . . 0.0 111.916 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -80.54 129.68 34.66 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -159.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 tt -112.79 124.08 51.77 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.029 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -107.24 107.22 18.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.573 -0.704 . . . . 0.0 109.4 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -107.27 99.32 8.86 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.58 119.91 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -103.62 124.49 48.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.748 0.704 . . . . 0.0 110.398 170.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.28 146.27 40.17 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.53 0.732 . . . . 0.0 111.114 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -89.71 115.16 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.322 -1.486 . . . . 0.0 108.676 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.7 mm -99.74 88.93 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.31 -88.51 0.8 Allowed Glycine 0 N--CA 1.492 2.393 0 O-C-N 121.486 -0.759 . . . . 0.0 113.953 -174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -136.88 50.41 2.01 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 161.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -137.57 122.05 18.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.23 109.25 15.58 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 123.549 0.74 . . . . 0.0 110.786 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.69 98.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 109.951 -174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -84.59 96.26 9.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.033 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.2 m -96.34 92.6 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.524 0.73 . . . . 0.0 109.709 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.9 105.78 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.964 0.906 . . . . 0.0 111.438 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.6 t -109.48 109.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -127.18 119.46 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 110.078 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.8 OUTLIER 48.75 63.64 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.18 -31.72 2.58 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 119.211 2.444 . . . . 0.0 119.211 -167.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.54 121.78 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.662 1.731 . . . . 0.0 110.698 -159.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.43 143.6 27.15 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 123.81 0.844 . . . . 0.0 112.953 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.29 109.39 6.1 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 121.56 -0.713 . . . . 0.0 110.689 164.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -101.16 96.98 7.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.257 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -87.46 111.41 21.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.259 0.624 . . . . 0.0 110.231 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.09 111.59 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -170.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -103.68 113.82 27.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.41 0.684 . . . . 0.0 109.602 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -77.11 162.75 27.22 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.35 110.25 4.01 Favored 'General case' 0 CA--C 1.57 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 112.361 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 C-N-CA 125.039 1.335 . . . . 0.0 112.38 -175.572 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.321 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -134.07 -48.76 0.8 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.843 1.201 . . . . 0.0 112.379 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -69.13 94.42 0.67 Allowed 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -168.05 173.18 8.23 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.619 1.168 . . . . 0.0 110.999 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 m -88.97 117.79 28.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.099 -1.001 . . . . 0.0 109.499 166.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -120.43 113.0 19.68 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.986 0.514 . . . . 0.0 109.876 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 142.45 27.83 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.267 -0.896 . . . . 0.0 112.754 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.72 115.94 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.573 -0.705 . . . . 0.0 111.923 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.21 -53.38 6.72 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.334 0.654 . . . . 0.0 112.074 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.12 143.23 25.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.667 0.746 . . . . 0.0 112.839 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -109.3 88.39 2.72 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.995 0.902 . . . . 0.0 110.446 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.31 118.89 25.13 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.632 0.773 . . . . 0.0 110.969 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.291 22.9 t30 67.25 11.71 8.53 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 118.105 2.631 . . . . 0.0 118.105 -173.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -64.77 -37.64 88.27 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -63.05 -42.84 99.82 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -71.39 -39.87 70.89 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -46.51 -55.88 6.85 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 158.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtp -63.17 -39.25 94.12 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.18 -43.87 95.52 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.6 -38.02 66.26 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 163.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.4 mtt -59.56 -36.94 77.16 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 117.311 2.338 . . . . 0.0 117.311 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.6 63.12 0.89 Allowed Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.779 0.718 . . . . 0.0 114.147 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.91 -171.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.481 0.658 . . . . 0.0 112.479 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -65.36 173.41 2.62 Favored 'General case' 0 CA--C 1.583 2.231 0 O-C-N 119.899 -1.751 . . . . 0.0 113.976 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 12.4 tt -94.8 -45.39 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.333 -1.479 . . . . 0.0 114.381 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.2 -60.03 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.686 1.13 . . . . 0.0 112.239 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -55.08 -49.6 71.26 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -34.49 -51.37 0.47 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 118.668 2.84 . . . . 0.0 118.668 160.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -73.2 -39.67 65.37 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.19 -43.07 87.38 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 167.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.53 95.99 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 168.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.04 -44.59 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -114.02 54.33 0.76 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 118.505 0.593 . . . . 0.0 112.086 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -83.63 -13.77 53.51 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 59.9 m-80 64.89 61.15 0.8 Allowed 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 119.736 1.153 . . . . 0.0 113.136 -167.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 tp -83.32 120.86 26.38 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.607 1.194 . . . . 0.0 113.357 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -102.69 118.35 36.65 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.941 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.19 100.41 12.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 m -91.54 102.92 15.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.842 0.83 . . . . 0.0 108.878 171.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.21 124.04 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -117.98 107.75 14.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -87.22 91.17 8.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.51 0.671 . . . . 0.0 111.323 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -89.46 68.16 7.79 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.463 0.649 . . . . 0.0 112.158 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 78.66 0.15 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 116.86 1.504 . . . . 0.0 116.86 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.328 24.0 m120 72.27 -34.32 0.29 Allowed 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 -166.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.79 148.98 34.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.477 1.035 . . . . 0.0 112.971 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -132.19 116.88 17.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.389 1.076 . . . . 0.0 108.116 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.9 m -102.38 100.64 10.81 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.9 t -105.87 104.57 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -83.32 104.47 13.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.27 96.39 8.46 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.0 t -115.09 114.53 25.46 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.573 0.749 . . . . 0.0 110.944 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 p -141.62 -177.64 5.27 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.301 1.048 . . . . 0.0 113.765 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 159.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -90.58 -48.51 7.04 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -130.32 152.14 50.06 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 119.997 1.271 . . . . 0.0 112.918 -175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -138.01 93.43 2.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.981 . . . . 0.0 109.799 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 pt -136.38 130.31 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.632 -0.668 . . . . 0.0 111.245 -172.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -88.32 105.81 17.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.379 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.72 101.46 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.61 121.7 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 123.385 0.674 . . . . 0.0 109.365 -171.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.55 148.96 23.42 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.396 0.679 . . . . 0.0 111.628 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.88 155.98 17.38 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 120.555 -1.341 . . . . 0.0 113.052 162.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.64 124.4 20.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.99 -14.65 62.85 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.536 2.574 . . . . 0.0 119.536 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.86 141.94 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 120.488 2.144 . . . . 0.0 110.741 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 t -73.08 124.43 25.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -137.01 165.0 27.05 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 121.814 0.816 . . . . 0.0 111.246 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -91.39 110.04 21.33 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 110.424 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -84.61 -50.14 7.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.264 5.8 m120 75.65 133.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -77.2 156.42 31.53 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.593 1.187 . . . . 0.0 113.598 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 66.05 8.53 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -168.45 -62.49 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.038 1.335 . . . . 0.0 108.606 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.66 -52.76 0.02 OUTLIER Glycine 0 CA--C 1.55 2.281 0 N-CA-C 115.649 1.02 . . . . 0.0 115.649 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -62.41 146.71 50.67 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -94.09 126.49 39.34 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.053 1.406 . . . . 0.0 113.022 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.01 123.99 46.85 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.218 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -135.95 131.44 35.12 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.86 -148.06 16.55 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.477 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.7 p -120.51 123.04 41.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.026 -0.691 . . . . 0.0 112.104 -156.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -80.9 107.15 13.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.65 0.659 . . . . 0.0 109.734 153.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.6 m -95.39 172.34 8.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.727 -0.608 . . . . 0.0 111.24 162.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.41 116.79 14.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.409 -1.432 . . . . 0.0 109.978 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.3 88.04 5.01 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.007 0.908 . . . . 0.0 111.795 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.98 -84.17 0.59 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -126.81 32.45 5.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 170.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -141.11 123.66 15.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.482 -1.387 . . . . 0.0 109.096 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.48 127.61 33.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.16 124.18 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.685 0.755 . . . . 0.0 109.945 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.85 103.37 1.41 Allowed Glycine 0 N--CA 1.479 1.563 0 O-C-N 121.587 -0.695 . . . . 0.0 113.538 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -95.51 96.78 9.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.4 119.23 31.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.521 -170.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -87.4 139.58 30.4 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.533 1.159 . . . . 0.0 112.512 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -63.86 139.19 58.74 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 168.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -52.37 -43.25 64.59 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 152.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.96 -55.37 3.79 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.508 0.723 . . . . 0.0 111.876 -157.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.17 -32.39 13.74 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.82 5.45 90.04 Favored Glycine 0 CA--C 1.558 2.749 0 N-CA-C 119.042 2.377 . . . . 0.0 119.042 -163.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -83.09 -3.36 57.22 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -164.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.333 4.7 tt0 72.57 118.3 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 tt -90.34 137.68 32.15 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.137 0.975 . . . . 0.0 111.441 162.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.1 108.09 16.18 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.094 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.261 9.9 t -113.32 114.55 26.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 0.0 112.278 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.07 134.24 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -112.8 121.16 43.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 0.0 110.529 167.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.99 172.65 12.08 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 121.679 0.752 . . . . 0.0 111.766 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -115.59 108.36 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.053 . . . . 0.0 109.481 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.263 11.1 tp -96.98 88.09 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.812 0.815 . . . . 0.0 109.717 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.27 -90.31 1.01 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.121 -0.987 . . . . 0.0 114.125 -174.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -136.83 52.48 1.94 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 165.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -132.87 121.99 23.73 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.181 0.992 . . . . 0.0 108.375 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.2 101.97 11.58 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.775 -0.578 . . . . 0.0 109.908 173.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.81 83.46 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 122.093 0.949 . . . . 0.0 110.476 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.39 100.05 10.45 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.238 1.018 . . . . 0.0 109.984 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.4 m -110.68 90.44 3.32 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.005 -151.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.42 114.02 24.61 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.978 0.911 . . . . 0.0 110.89 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -108.71 124.26 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -141.34 128.15 20.46 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 121.355 0.597 . . . . 0.0 111.649 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 3.9 mm-40 48.96 44.35 22.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -167.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.04 -25.3 1.87 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 119.31 2.484 . . . . 0.0 119.31 -165.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.3 t -82.85 117.31 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 120.317 2.058 . . . . 0.0 110.03 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -91.67 140.76 29.4 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.97 0.908 . . . . 0.0 112.659 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.59 32.58 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 165.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -103.32 106.19 16.65 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.959 -0.463 . . . . 0.0 110.388 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -83.8 102.59 12.44 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.22 115.16 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -106.96 115.62 30.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.241 0.543 . . . . 0.0 109.576 -173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -84.16 149.29 26.26 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.421 0.689 . . . . 0.0 111.924 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -62.17 112.1 2.24 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.486 1.36 0 C-N-CA 125.235 1.414 . . . . 0.0 112.827 -173.658 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.24 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -110.49 -47.99 3.21 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.252 5.5 p-10 -74.55 80.89 1.97 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 120.234 1.379 . . . . 0.0 114.205 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -146.93 -166.35 2.48 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.135 0.969 . . . . 0.0 111.573 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.5 m -94.55 127.56 40.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.654 -1.279 . . . . 0.0 109.985 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -136.63 105.53 5.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.966 -0.459 . . . . 0.0 110.509 -169.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -98.97 137.39 37.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.212 0.915 . . . . 0.0 111.339 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.6 120.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.801 0.81 . . . . 0.0 112.693 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.17 -54.64 5.79 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.065 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -147.25 160.77 42.1 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 121.765 0.793 . . . . 0.0 112.677 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -136.54 118.27 15.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 111.445 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -70.46 -60.35 2.32 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -165.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -130.33 51.13 2.13 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.32 1.057 . . . . 0.0 112.944 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -74.89 -36.8 62.25 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.0 -50.56 72.34 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.13 -36.79 77.86 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.53 -52.44 38.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 160.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 35.9 mtp -61.22 -48.97 79.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -43.02 64.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -54.69 -30.14 54.93 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 166.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtm -70.98 -11.46 60.98 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.69 64.54 1.74 Allowed Glycine 0 N--CA 1.495 2.583 0 CA-C-N 122.265 2.302 . . . . 0.0 114.67 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -119.55 170.24 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 122.821 1.296 . . . . 0.0 113.092 -164.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.2 108.0 16.84 Favored 'General case' 0 CA--C 1.566 1.588 0 O-C-N 120.877 -1.139 . . . . 0.0 110.531 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.3 12.7 tt -49.25 -44.53 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 119.808 3.262 . . . . 0.0 119.808 -164.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.07 -46.94 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.367 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 170.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -68.66 -31.13 70.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -51.22 -45.58 61.95 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.91 -52.24 66.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.9 mt -62.79 -36.29 82.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.89 91.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.12 75.18 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -92.47 62.48 3.95 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 163.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER -83.03 -17.36 43.56 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 60.28 50.88 5.85 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -84.22 149.62 26.01 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -111.59 114.48 27.57 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.771 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.11 103.28 11.61 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.2 m -91.73 99.0 11.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 168.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.7 mt -99.94 124.22 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.9 p -129.76 119.45 23.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.649 -0.657 . . . . 0.0 109.921 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -88.72 119.2 28.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.901 0.773 . . . . 0.0 111.96 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.81 76.9 1.82 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 123.112 0.565 . . . . 0.0 109.856 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.54 80.49 0.1 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 116.419 1.328 . . . . 0.0 116.419 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 20.0 m120 71.62 -50.4 0.69 Allowed 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -166.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -73.95 121.84 21.64 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.981 0.912 . . . . 0.0 112.929 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -99.69 134.78 42.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.56 -0.712 . . . . 0.0 111.481 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 m -102.27 111.06 23.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 161.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.04 105.49 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 70' ' ' TYR . 16.4 mt-10 -86.01 95.8 9.63 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.954 0.502 . . . . 0.0 110.218 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.0 t -98.76 110.28 22.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.875 0.47 . . . . 0.0 110.336 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.83 170.35 15.91 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -172.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -68.82 -6.54 27.5 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -100.03 -46.03 5.47 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.499 1.045 . . . . 0.0 113.206 168.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.87 154.5 40.5 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.035 1.288 . . . . 0.0 112.205 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -112.58 105.94 14.25 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 161.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.2 pt -123.51 127.6 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.248 0.547 . . . . 0.0 111.3 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -99.71 100.67 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.759 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.17 98.11 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.0 109.582 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.19 128.9 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 123.194 0.598 . . . . 0.0 110.346 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -148.66 147.78 29.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.456 0.646 . . . . 0.0 112.729 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 157.06 16.47 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.318 1.056 . . . . 0.0 110.785 164.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.78 80.89 3.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 0.0 112.436 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.02 -38.3 1.83 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 116.832 1.493 . . . . 0.0 116.832 -162.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.53 121.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.072 1.436 . . . . 0.0 110.091 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 t -68.19 127.69 33.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.39 165.43 22.57 Favored 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 123.896 0.879 . . . . 0.0 111.579 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -96.26 108.16 20.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' OH ' ' OE2' ' A' ' 51' ' ' GLU . 6.5 t80 -92.15 97.62 11.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.489 -0.757 . . . . 0.0 110.135 175.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -75.67 115.24 15.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.778 -0.576 . . . . 0.0 112.409 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.0 -69.57 0.39 Allowed 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -164.37 -68.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.687 1.131 . . . . 0.0 111.263 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -66.73 -55.5 14.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.27 67.12 0.07 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 111.996 -0.442 . . . . 0.0 111.996 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.0 m -152.12 106.73 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.953 . . . . 0.0 109.298 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.19 114.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.366 0.603 . . . . 0.0 109.651 160.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.18 117.11 27.92 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.448 0.642 . . . . 0.0 110.494 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -91.27 109.45 20.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.39 0.676 . . . . 0.0 109.998 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.94 -149.84 14.55 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.8 p -138.92 142.65 38.47 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.076 0.551 . . . . 0.0 110.851 -170.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -85.32 89.18 7.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.998 -1.064 . . . . 0.0 108.319 153.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -76.69 138.06 39.77 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.984 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.97 105.74 13.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 110.857 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.24 -35.39 73.8 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.73 -79.21 0.2 Allowed Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.91 -24.25 41.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 160.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -120.79 149.15 43.01 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 120.263 1.392 . . . . 0.0 111.921 -160.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -94.94 108.88 20.94 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.925 -1.11 . . . . 0.0 108.993 162.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.19 112.43 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 CA-C-O 122.317 1.056 . . . . 0.0 109.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.01 92.88 0.74 Allowed Glycine 0 N--CA 1.479 1.519 0 C-N-CA 124.265 0.936 . . . . 0.0 113.746 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.09 91.33 8.67 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -119.41 152.25 37.14 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.101 0.953 . . . . 0.0 112.386 -168.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -121.61 139.43 53.55 Favored 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 123.549 0.74 . . . . 0.0 110.023 169.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -63.38 131.16 47.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.862 -1.149 . . . . 0.0 113.607 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.7 m -66.59 -47.21 73.46 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 167.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.66 -51.87 37.21 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.72 -45.94 27.38 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.75 -8.34 79.66 Favored Glycine 0 CA--C 1.558 2.781 0 N-CA-C 118.543 2.177 . . . . 0.0 118.543 -153.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.53 152.12 24.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.648 1.724 . . . . 0.0 112.724 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -70.81 141.63 51.35 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 tt -127.92 126.16 40.95 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -100.51 146.73 26.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 0.0 111.15 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 m -148.35 109.73 4.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.159 -1.588 . . . . 0.0 111.69 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 80.1 t -97.07 122.87 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.227 . . . . 0.0 109.966 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -98.41 127.62 44.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 111.198 163.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -149.61 146.01 27.08 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.337 0.655 . . . . 0.0 110.872 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.36 102.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.26 11.3 tp -98.68 75.19 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.039 0.923 . . . . 0.0 111.27 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.83 62.4 3.83 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 116.164 1.226 . . . . 0.0 116.164 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.317 9.1 t70 81.9 -41.1 0.13 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -167.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -74.74 107.75 7.04 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.97 0.908 . . . . 0.0 113.324 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.3 tp -76.07 102.42 5.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.655 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.9 m -91.72 82.5 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.111 0.482 . . . . 0.0 110.447 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -73.8 97.93 2.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.955 -1.091 . . . . 0.0 110.921 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.7 m -106.08 89.52 3.09 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 -157.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -81.96 137.96 35.04 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.146 0.978 . . . . 0.0 111.977 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.64 120.62 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -131.71 122.59 26.16 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 55.92 36.8 28.0 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.83 -17.15 17.16 Favored Glycine 0 CA--C 1.557 2.689 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 -163.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.37 116.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.009 1.904 . . . . 0.0 109.23 -172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -91.15 147.37 23.11 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.57 123.49 15.36 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.894 0.877 . . . . 0.0 111.681 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -110.72 98.4 7.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.061 -173.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -86.69 108.83 18.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.2 mt -106.91 126.34 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -115.67 128.7 56.1 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.516 0.674 . . . . 0.0 111.447 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -80.79 155.03 26.86 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 121.672 0.749 . . . . 0.0 111.396 165.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -68.45 114.22 6.69 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 121.15 -0.969 . . . . 0.0 111.7 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 125.253 1.421 . . . . 0.0 112.531 -173.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -109.42 -1.96 18.05 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 -171.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -82.35 90.55 6.68 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 120.747 1.612 . . . . 0.0 113.466 -165.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -162.37 179.0 8.16 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 122.209 1.004 . . . . 0.0 112.188 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 m -83.04 125.2 31.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 110.222 163.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.91 106.39 9.28 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.183 0.593 . . . . 0.0 109.727 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -97.74 138.39 35.19 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.919 -1.113 . . . . 0.0 112.605 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.85 112.05 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.282 -0.886 . . . . 0.0 113.326 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.71 -59.52 2.22 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.087 0.555 . . . . 0.0 111.828 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -134.78 124.48 25.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.0 p -103.72 129.26 51.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.454 0.702 . . . . 0.0 112.034 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.332 0.1 OUTLIER -72.75 -72.81 0.23 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 177.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -121.48 39.5 3.83 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.804 1.184 . . . . 0.0 114.069 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.74 -40.83 75.93 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -64.54 -30.77 71.8 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -79.0 -40.12 32.34 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -48.27 -50.44 29.76 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 158.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.403 ' SD ' HG21 ' A' ' 23' ' ' VAL . 12.4 mmt -50.12 -50.8 47.34 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 163.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -52.66 -46.51 67.22 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -57.67 -41.83 82.36 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.61 -33.82 74.58 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.77 67.9 0.83 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-N 119.55 1.068 . . . . 0.0 113.904 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 ' SD ' ' A' ' 18' ' ' MET . 11.5 m -126.2 170.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 122.466 1.127 . . . . 0.0 112.51 -165.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -64.22 178.74 0.65 Allowed 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 174.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.4 tt -108.53 167.4 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 157.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.383 46.2 t 80.85 -68.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 120.392 -1.443 . . . . 0.0 111.691 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -65.87 -38.86 89.91 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 119.802 1.183 . . . . 0.0 113.811 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -44.23 -42.84 6.83 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 161.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -69.69 -51.23 36.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.179 -0.951 . . . . 0.0 113.538 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -55.51 -33.65 63.93 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.2 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.24 94.34 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 161.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -103.8 51.74 0.78 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.85 -7.58 59.65 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 7.3 m-80 67.07 49.29 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.787 1.235 . . . . 0.0 114.229 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.9 tp -72.36 117.25 13.77 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.08 103.64 10.08 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.713 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.98 100.75 13.15 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.46 0.704 . . . . 0.0 110.072 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -90.57 101.92 14.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.966 -1.084 . . . . 0.0 109.551 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.9 mt -94.34 113.45 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.4 p -107.8 110.08 21.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.46 91.61 5.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.665 1.221 . . . . 0.0 111.281 -167.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.63 80.39 9.14 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 122.746 1.26 . . . . 0.0 113.817 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 -100.02 1.56 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.322 -0.861 . . . . 0.0 114.937 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.08 -4.47 56.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 162.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -114.27 162.83 16.08 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-O 122.224 1.011 . . . . 0.0 111.998 -164.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.46 112.19 10.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.94 -1.1 . . . . 0.0 109.223 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.5 m -95.74 100.7 12.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 164.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -99.26 100.71 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -86.62 98.69 11.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.76 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -98.44 99.01 10.14 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.0 t -97.73 116.51 30.08 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -142.76 176.55 8.96 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.196 0.998 . . . . 0.0 113.394 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.8 m -55.09 -37.11 66.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 164.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.91 -46.8 14.64 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -147.02 144.27 29.02 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.539 1.518 . . . . 0.0 112.897 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -126.78 96.29 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 167.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.92 148.78 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.651 1.215 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.39 109.07 18.77 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.409 -0.807 . . . . 0.0 111.219 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.43 96.41 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.59 112.41 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -140.18 144.36 36.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.176 0.591 . . . . 0.0 111.925 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.69 153.2 18.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.365 1.079 . . . . 0.0 111.083 162.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.31 117.73 6.51 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.57 -9.68 68.96 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 -168.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -77.65 130.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 120.772 2.286 . . . . 0.0 110.691 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -80.15 122.31 26.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.658 -0.651 . . . . 0.0 112.341 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -148.44 165.98 29.52 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 121.552 0.692 . . . . 0.0 111.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.88 101.17 13.46 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 110.822 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -75.77 -55.69 5.4 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.446 ' H ' ' HB2' ' A' ' 78' ' ' LEU 0.262 9.3 m-20 73.12 137.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.872 1.269 . . . . 0.0 114.013 172.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.3 mt -110.97 127.48 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.853 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.35 124.58 21.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.283 38.1 m-20 71.97 -29.91 0.2 Allowed 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -160.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.19 -66.29 1.58 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 116.991 1.557 . . . . 0.0 116.991 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -174.89 156.44 2.23 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.0 110.345 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.31 148.76 44.05 Favored 'General case' 0 CA--C 1.572 1.797 0 O-C-N 120.76 -1.212 . . . . 0.0 114.09 148.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.446 ' HB2' ' H ' ' A' ' 71' ' ' ASN . 31.1 mt -140.35 100.78 3.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.61 0.764 . . . . 0.0 111.676 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -86.53 121.43 29.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.576 1.15 . . . . 0.0 111.917 171.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.59 -163.11 34.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.9 p -120.05 125.06 47.39 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.081 0.553 . . . . 0.0 111.907 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -80.42 106.93 12.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.792 -0.568 . . . . 0.0 110.21 155.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.9 m -98.12 170.01 9.21 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.965 0.888 . . . . 0.0 111.711 165.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.1 tp -117.3 117.48 29.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.916 -1.115 . . . . 0.0 108.803 172.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -71.85 -43.77 64.94 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.2 -81.83 0.06 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -78.65 -31.29 46.74 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 157.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -86.75 132.04 33.97 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.688 1.131 . . . . 0.0 112.239 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.21 120.56 23.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 157.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.03 111.21 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.876 0.846 . . . . 0.0 108.783 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -106.24 105.93 2.48 Favored Glycine 0 N--CA 1.482 1.73 0 O-C-N 121.442 -0.786 . . . . 0.0 113.02 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -100.56 98.13 8.75 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -124.15 118.91 27.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.274 0.629 . . . . 0.0 111.561 -165.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -95.68 148.18 22.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 111.967 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -66.68 138.94 57.78 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.424 -1.422 . . . . 0.0 113.179 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.269 32.2 p -70.55 -33.44 71.14 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.55 -71.22 0.07 Allowed 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.83 -50.58 3.15 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.346 1.058 . . . . 0.0 113.768 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.36 51.95 0.42 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 -169.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -95.54 134.09 38.8 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.34 1.07 . . . . 0.0 110.151 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.88 118.05 12.23 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -108.9 115.66 30.5 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.81 104.92 17.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 109.642 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.3 p -99.2 102.75 14.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.8 134.52 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 119.619 1.1 . . . . 0.0 108.42 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -134.06 138.21 45.16 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.84 157.68 38.24 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.47 1.128 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.58 119.22 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.956 -1.09 . . . . 0.0 110.075 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 pt -89.79 66.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 O-C-N 121.121 -0.987 . . . . 0.0 111.817 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.95 -77.87 0.95 Allowed Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.742 -1.224 . . . . 0.0 114.858 -168.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.63 -49.29 4.05 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.05 153.46 20.55 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 120.186 1.357 . . . . 0.0 114.122 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.23 108.59 20.06 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.506 -0.746 . . . . 0.0 110.562 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.17 139.66 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 169.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -130.2 101.88 5.98 Favored 'General case' 0 CA--C 1.563 1.465 0 O-C-N 121.675 -0.64 . . . . 0.0 109.867 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -81.91 119.1 23.52 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.131 0.972 . . . . 0.0 109.733 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -106.81 109.08 20.88 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 164.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.74 132.47 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -127.62 113.4 16.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 163.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.46 62.39 2.65 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.7 -44.98 3.38 Favored Glycine 0 CA--C 1.552 2.352 0 N-CA-C 118.115 2.006 . . . . 0.0 118.115 -166.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.59 123.81 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.402 1.601 . . . . 0.0 113.834 -162.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -80.24 150.63 29.98 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.506 1.146 . . . . 0.0 113.298 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.26 118.37 19.4 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.57 152.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -107.1 104.14 13.72 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -169.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -102.58 115.89 31.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 37.7 mt -101.98 113.74 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -98.72 130.73 45.21 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 123.049 1.404 . . . . 0.0 110.173 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -97.26 153.06 18.27 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.108 -1.406 . . . . 0.0 111.18 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -64.66 121.56 14.77 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 112.936 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.386 2.6 p30 . . . . . 0 N--CA 1.488 1.466 0 C-N-CA 125.463 1.505 . . . . 0.0 114.667 -175.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.437 0 CA-C-O 121.833 0.825 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -97.49 68.48 2.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.243 -0.911 . . . . 0.0 112.73 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -159.35 83.8 0.77 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.165 -0.959 . . . . 0.0 110.126 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -166.48 175.82 7.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.284 -0.885 . . . . 0.0 111.915 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.9 m -81.84 124.78 29.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.964 -1.085 . . . . 0.0 110.482 160.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -124.98 104.09 8.38 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.304 0.641 . . . . 0.0 109.937 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -86.03 137.66 32.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.123 -0.986 . . . . 0.0 112.623 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.84 120.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.121 -0.987 . . . . 0.0 113.012 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -105.86 -64.83 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.78 0.832 . . . . 0.0 110.725 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.79 149.85 37.88 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 122.229 1.014 . . . . 0.0 111.402 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.0 m -157.86 106.11 2.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.101 -1.624 . . . . 0.0 109.692 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.24 -76.6 0.2 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -149.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -88.35 52.91 2.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.547 -1.346 . . . . 0.0 113.137 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -86.01 64.29 8.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 119.776 -1.828 . . . . 0.0 113.245 -171.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.99 -49.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.374 1.07 . . . . 0.0 112.961 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -69.91 -39.39 76.21 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -45.23 -54.11 7.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 155.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.3 mtp -67.2 -40.62 86.48 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.92 -45.05 82.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 165.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -64.13 -34.89 79.1 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.1 mtm -62.39 -52.08 65.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 121.017 1.735 . . . . 0.0 115.535 166.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.17 65.96 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.8 p -148.44 128.68 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -77.56 158.66 29.75 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.292 10.1 tp -50.6 -41.03 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 118.853 2.909 . . . . 0.0 118.853 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -55.73 -46.09 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.98 -34.12 61.95 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 114.6 1.334 . . . . 0.0 114.6 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -61.39 -38.97 88.98 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 165.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.81 -51.13 64.47 Favored 'General case' 0 CA--C 1.571 1.779 0 CA-C-N 120.401 1.455 . . . . 0.0 114.694 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.07 -42.48 85.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 165.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.82 70.25 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.15 -50.92 66.29 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 164.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -88.53 55.1 3.27 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 119.444 1.02 . . . . 0.0 113.203 171.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -94.14 -7.47 42.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -173.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 60.08 42.28 15.93 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 114.99 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -74.54 117.44 16.36 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 122.691 1.234 . . . . 0.0 112.051 -172.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -117.46 112.58 20.83 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.898 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -96.02 103.04 14.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.884 -0.51 . . . . 0.0 110.306 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.5 m -91.03 97.89 11.44 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.96 124.1 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -135.73 114.62 12.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.04 115.85 28.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 112.638 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -83.76 76.68 9.98 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.11 0.957 . . . . 0.0 110.877 171.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.68 -81.02 0.53 Allowed Glycine 0 N--CA 1.492 2.378 0 O-C-N 121.144 -0.973 . . . . 0.0 115.141 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -100.07 -38.1 8.7 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 165.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -85.51 118.68 25.19 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.291 1.405 . . . . 0.0 113.05 -163.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -86.38 115.56 23.97 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.461 0.704 . . . . 0.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.1 m -86.78 104.44 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 162.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 t -106.45 116.67 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -84.73 99.49 10.87 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -75.03 91.07 2.5 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 168.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t -106.76 109.55 21.49 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.646 0.779 . . . . 0.0 110.789 -168.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.7 p -148.95 172.81 14.11 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.1 m -60.02 -49.09 79.05 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 168.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.36 -43.73 98.14 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -154.46 139.24 17.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.747 1.158 . . . . 0.0 111.889 -165.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -125.76 92.03 3.52 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -132.68 124.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.058 0.456 . . . . 0.0 111.153 -165.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.49 102.9 10.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 112.135 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.91 103.78 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.36 106.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -129.59 138.56 51.34 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.6 0.76 . . . . 0.0 111.823 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -94.34 159.22 15.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.644 1.212 . . . . 0.0 111.86 167.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.5 113.3 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.52 2.68 75.91 Favored Glycine 0 CA--C 1.555 2.537 0 N-CA-C 119.704 2.642 . . . . 0.0 119.704 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.0 126.4 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 121.013 2.407 . . . . 0.0 110.767 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -82.21 106.25 13.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.142 0.577 . . . . 0.0 111.871 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.48 154.3 48.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.732 -0.605 . . . . 0.0 112.384 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.36 89.54 7.7 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-O 122.709 1.242 . . . . 0.0 112.013 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -75.53 163.46 27.35 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.704 1.202 . . . . 0.0 112.523 168.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER -159.01 140.07 12.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.055 -1.653 . . . . 0.0 112.036 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.6 mt -93.9 176.56 6.3 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.71 65.27 0.49 Allowed 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -173.01 -55.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.46 1.104 . . . . 0.0 111.823 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.17 -21.13 2.45 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 117.093 1.597 . . . . 0.0 117.093 -159.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.4 m -70.22 114.88 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 119.729 1.765 . . . . 0.0 112.232 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.04 132.36 37.21 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 121.721 0.772 . . . . 0.0 112.919 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 75.8 mt -136.49 103.72 5.35 Favored 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.747 0.819 . . . . 0.0 111.629 -159.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 127.38 35.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.166 -1.584 . . . . 0.0 111.623 173.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.68 174.47 46.91 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.226 2.451 . . . . 0.0 119.226 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.9 p -118.19 108.61 15.37 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 113.989 -1.106 . . . . 0.0 112.203 -169.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.73 107.54 5.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.612 -1.305 . . . . 0.0 109.989 166.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.5 m -110.07 -29.67 8.11 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -156.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.277 35.7 tp 69.08 103.31 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.312 1.445 . . . . 0.0 114.159 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.52 129.19 55.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.24 -108.82 1.42 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -118.3 45.33 2.03 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 163.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -141.99 114.68 8.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.13 95.77 5.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.839 -1.163 . . . . 0.0 110.187 170.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.5 tp -83.24 113.99 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 123.366 0.666 . . . . 0.0 110.606 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.97 103.89 2.47 Favored Glycine 0 N--CA 1.481 1.686 0 C-N-CA 123.834 0.731 . . . . 0.0 112.649 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -84.39 93.0 8.17 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -103.87 103.94 13.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.912 -0.492 . . . . 0.0 112.072 -171.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -87.4 137.22 32.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.077 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -66.43 141.41 57.93 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.4 p -67.11 -32.69 74.0 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -63.86 -67.07 0.46 Allowed 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -109.4 -23.6 11.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 46.84 7.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 117.276 1.671 . . . . 0.0 117.276 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.04 -16.1 55.79 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.317 6.3 tt0 69.36 87.88 0.12 Allowed 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -173.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.07 100.6 11.49 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -88.96 110.07 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.534 -0.729 . . . . 0.0 111.177 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -104.85 107.28 18.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.736 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.8 t -101.17 100.14 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.943 -1.098 . . . . 0.0 108.231 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -83.24 116.29 22.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.854 -0.529 . . . . 0.0 110.309 167.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -135.13 141.78 46.05 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.141 0.976 . . . . 0.0 110.294 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 105.41 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.32 -1.488 . . . . 0.0 107.022 164.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.251 14.7 tt -87.82 71.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.338 1.066 . . . . 0.0 110.714 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.12 1.54 Allowed Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.046 -1.034 . . . . 0.0 114.691 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.422 ' OD2' ' OE2' ' A' ' 112' ' ' GLU . 7.5 p-10 -105.12 -53.56 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.422 ' OE2' ' OD2' ' A' ' 111' ' ' ASP . 2.7 mt-10 -86.73 148.75 25.29 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 122.09 0.948 . . . . 0.0 112.914 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.3 tp -79.24 110.33 14.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.549 -0.719 . . . . 0.0 109.638 167.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.55 118.62 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.471 -0.768 . . . . 0.0 109.854 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -96.68 100.9 12.43 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 165.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 128.36 39.52 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 123.443 0.697 . . . . 0.0 109.759 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -135.31 119.1 17.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.845 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -87.16 144.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.012 0.525 . . . . 0.0 111.595 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -136.3 108.24 7.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 156.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.257 3.3 tm-20 49.19 70.03 0.52 Allowed 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.08 -42.73 2.76 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 118.285 2.074 . . . . 0.0 118.285 -169.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.63 119.71 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.708 1.254 . . . . 0.0 109.932 -165.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -98.41 140.2 33.03 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.854 0.835 . . . . 0.0 112.484 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.46 168.04 19.66 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 122.352 1.072 . . . . 0.0 112.497 162.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -133.69 150.05 51.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 111.599 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -122.99 117.0 24.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 157.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.4 109.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -101.34 127.5 47.94 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 123.959 0.903 . . . . 0.0 110.762 -171.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -78.44 150.74 32.98 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.889 0.852 . . . . 0.0 112.62 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -60.43 122.23 14.06 Favored 'General case' 0 CA--C 1.571 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 113.155 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.489 1.492 0 C-N-CA 125.318 1.447 . . . . 0.0 111.501 -176.231 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.359 0 CA-C-O 121.152 0.501 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -112.83 48.65 1.0 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.508 -0.745 . . . . 0.0 112.458 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.33 90.86 7.21 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 120.153 -1.592 . . . . 0.0 114.532 -161.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.8 m -167.26 174.19 8.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.761 1.224 . . . . 0.0 111.336 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.87 130.79 34.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -136.02 112.44 9.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -103.7 138.49 40.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 120.099 1.318 . . . . 0.0 113.453 -175.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.26 116.91 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -173.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -110.14 -48.29 3.2 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 123.949 0.899 . . . . 0.0 112.495 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 93.87 3.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.524 -0.735 . . . . 0.0 111.155 172.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.9 p -84.7 95.59 8.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.556 -1.34 . . . . 0.0 112.483 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -92.1 127.04 37.43 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.699 0.761 . . . . 0.0 111.11 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.303 6.7 t30 64.6 17.76 11.05 Favored 'General case' 0 CA--C 1.584 2.281 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 -171.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.52 -45.48 79.36 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -52.13 -41.39 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -42.56 61.92 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -46.78 -54.39 9.88 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 161.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.5 mmt -60.83 -48.12 83.23 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 170.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -60.55 -34.69 74.51 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -61.31 -40.79 95.48 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.0 mtp -58.46 -22.26 54.06 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 119.501 3.149 . . . . 0.0 119.501 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.93 49.67 3.28 Favored Glycine 0 N--CA 1.495 2.618 0 CA-C-N 120.246 1.384 . . . . 0.0 116.429 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.22 -30.87 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 17.8 m120 79.08 152.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.1 1.36 . . . . 0.0 112.444 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.17 75.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 122.89 1.329 . . . . 0.0 110.109 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.14 -68.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.877 1.271 . . . . 0.0 107.682 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -75.27 -38.57 60.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -61.51 -22.81 65.45 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -61.19 -55.71 29.1 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.361 0.982 . . . . 0.0 113.313 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.7 mt -56.93 -29.01 62.74 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.43 -54.93 13.81 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 120.865 1.666 . . . . 0.0 113.885 162.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.15 -43.52 61.25 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -99.81 55.06 0.94 Allowed 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 161.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -70.45 -35.12 73.15 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 60.99 45.01 9.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.336 1.054 . . . . 0.0 113.751 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 tp -72.65 128.84 36.76 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.913 0.863 . . . . 0.0 113.038 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -126.44 118.36 24.8 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.777 0.831 . . . . 0.0 109.972 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.53 100.55 12.13 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.448 0.699 . . . . 0.0 109.787 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 51.7 m -95.28 96.86 9.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 109.054 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.8 mt -86.59 124.3 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.908 0.883 . . . . 0.0 109.321 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.8 p -122.04 109.61 14.78 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -113.74 126.05 54.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 112.258 -165.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.86 132.71 19.03 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 122.848 0.459 . . . . 0.0 110.156 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.11 61.99 4.97 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.306 31.7 m120 69.51 -28.2 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -168.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.88 128.57 34.81 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.409 1.459 . . . . 0.0 112.572 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -102.93 108.24 19.36 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 163.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 m -95.27 98.33 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 t -108.59 113.21 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -169.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.63 99.25 7.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.648 -0.658 . . . . 0.0 109.589 170.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.01 97.97 10.01 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.1 t -107.5 124.21 49.56 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 112.389 -161.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.6 p -146.14 169.02 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.822 0.849 . . . . 0.0 112.889 -173.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -58.86 -38.5 78.9 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 167.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -64.89 -54.51 29.75 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -151.81 140.91 21.24 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.598 1.09 . . . . 0.0 112.332 -162.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.98 103.48 9.97 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.0 pt -125.33 127.78 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.946 -0.471 . . . . 0.0 111.241 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.3 96.52 8.52 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.192 -0.942 . . . . 0.0 111.486 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.64 100.3 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.54 110.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -127.76 124.09 36.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.348 0.594 . . . . 0.0 112.075 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -81.26 140.11 35.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.531 0.682 . . . . 0.0 111.382 166.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.93 120.72 11.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.75 -0.09 86.93 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.6 t -95.14 139.21 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.295 2.047 . . . . 0.0 110.122 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -76.81 110.11 11.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 112.135 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -134.52 169.39 17.35 Favored 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 123.699 0.8 . . . . 0.0 111.513 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -97.62 121.95 40.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.947 -1.096 . . . . 0.0 112.539 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -93.0 -66.56 0.91 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.341 16.0 m-80 92.55 129.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 125.732 1.613 . . . . 0.0 113.285 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.7 mt -74.12 -67.06 0.65 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 179.23 -73.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 125.493 1.517 . . . . 0.0 109.359 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -66.6 -47.01 74.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.99 70.31 0.1 OUTLIER Glycine 0 N--CA 1.484 1.878 0 CA-C-N 118.744 0.702 . . . . 0.0 114.079 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 m -163.08 116.64 1.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.719 -0.871 . . . . 0.0 108.931 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.62 128.25 35.27 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 121.597 0.713 . . . . 0.0 111.049 167.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.4 mt -108.12 111.86 24.1 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.081 0.952 . . . . 0.0 111.656 -174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.55 113.59 25.26 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.36 1.064 . . . . 0.0 110.948 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.51 -152.69 21.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -125.47 124.16 40.78 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 122.939 0.496 . . . . 0.0 111.937 -158.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -84.64 106.05 15.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.181 -0.949 . . . . 0.0 109.582 158.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.8 m -105.11 131.39 52.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.04 0.536 . . . . 0.0 110.6 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -82.57 98.0 8.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.869 -1.144 . . . . 0.0 110.639 174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.41 83.85 7.57 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.685 0.755 . . . . 0.0 109.514 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -78.83 0.3 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 115.494 0.958 . . . . 0.0 115.494 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -112.28 -29.0 7.7 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -97.02 136.96 36.83 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 121.533 1.97 . . . . 0.0 111.973 -169.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.81 101.61 11.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 tt -92.1 110.98 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 CA-C-O 122.2 1.0 . . . . 0.0 109.858 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.04 96.75 2.24 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 124.381 0.991 . . . . 0.0 112.884 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -91.99 94.84 9.47 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -119.21 107.28 13.24 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.891 0.476 . . . . 0.0 111.814 -163.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -73.21 141.15 47.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.81 -1.181 . . . . 0.0 112.054 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -69.14 132.81 47.15 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.175 0.988 . . . . 0.0 112.321 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.9 p -61.8 -43.36 99.01 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 164.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -61.65 -74.58 0.08 Allowed 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -89.1 -31.1 18.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.44 3.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -130.48 139.81 50.53 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 118.027 0.913 . . . . 0.0 109.764 171.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -72.4 102.52 3.19 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 123.497 1.618 . . . . 0.0 114.036 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -78.63 121.05 24.18 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.348 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -96.5 120.46 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 122.088 -0.382 . . . . 0.0 110.427 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -119.51 109.39 15.67 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.966 0.507 . . . . 0.0 110.001 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.15 108.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 120.358 -1.464 . . . . 0.0 109.267 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -88.59 119.75 29.34 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.425 0.69 . . . . 0.0 109.739 166.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -141.12 139.45 33.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 0.0 110.807 -175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.37 120.41 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 120.818 -1.176 . . . . 0.0 110.073 170.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.4 mt -116.09 94.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.17 -101.23 1.11 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.459 -0.776 . . . . 0.0 114.638 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -123.66 43.28 3.01 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 165.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -134.25 125.2 27.28 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.343 1.057 . . . . 0.0 108.683 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 tp -86.48 105.99 17.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.621 -0.674 . . . . 0.0 109.393 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 m -88.89 115.7 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 109.225 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -107.64 95.99 6.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.418 -0.801 . . . . 0.0 110.067 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 86.2 m -91.11 96.76 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.035 0.534 . . . . 0.0 110.86 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -81.61 129.7 34.78 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.91 0.884 . . . . 0.0 111.323 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -126.31 115.55 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -120.9 117.96 28.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 118.545 0.611 . . . . 0.0 111.875 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 55.14 26.58 8.44 Favored 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.17 -32.28 7.73 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 118.448 2.139 . . . . 0.0 118.448 -160.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.39 130.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.651 2.225 . . . . 0.0 113.48 -166.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.1 142.45 28.68 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.94 123.23 14.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.06 -1.025 . . . . 0.0 111.232 153.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -110.03 87.39 2.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -70.02 99.21 1.41 Allowed 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 170.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.3 mt -101.07 115.99 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -108.27 111.82 23.97 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.402 0.681 . . . . 0.0 110.715 -167.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -78.17 146.03 35.28 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 121.607 0.717 . . . . 0.0 112.285 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -66.3 128.91 38.0 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.257 11.4 t70 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 125.909 1.684 . . . . 0.0 110.34 -165.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.42 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.69 55.1 1.04 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 119.403 1.002 . . . . 0.0 111.71 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -94.42 82.17 4.02 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 120.067 -1.646 . . . . 0.0 114.491 -163.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 p -152.42 178.61 9.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.917 -1.114 . . . . 0.0 112.824 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 m -82.83 101.52 11.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.0 -1.063 . . . . 0.0 110.123 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -100.21 97.49 8.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.431 0.692 . . . . 0.0 110.067 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -97.96 139.24 34.08 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.603 . . . . 0.0 111.711 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.251 8.5 p -70.89 115.23 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -170.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.46 -60.83 2.2 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.64 0.776 . . . . 0.0 111.985 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -134.5 158.95 42.63 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 122.567 1.175 . . . . 0.0 111.094 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -156.97 143.44 18.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 119.397 -2.064 . . . . 0.0 112.025 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.49 139.19 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.235 0.541 . . . . 0.0 111.526 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.305 57.0 t30 53.99 38.92 29.91 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -81.05 -47.3 13.76 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.98 -37.42 74.19 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -51.61 66.97 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.528 1.058 . . . . 0.0 113.771 170.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -48.8 -53.44 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.674 ' SD ' HG11 ' A' ' 23' ' ' VAL . 11.8 mmt -55.06 -43.33 73.75 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -43.67 98.44 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 165.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.3 mtm -60.39 -61.51 2.55 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.71 56.88 0.05 OUTLIER Glycine 0 N--CA 1.491 2.347 0 CA-C-N 118.832 0.742 . . . . 0.0 114.925 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.674 HG11 ' SD ' ' A' ' 18' ' ' MET . 8.2 p -129.96 127.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -76.71 163.16 27.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.291 13.0 tt -50.88 -44.88 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -169.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.56 -46.94 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 CA-C-N 119.795 1.18 . . . . 0.0 113.052 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -57.79 -39.67 78.08 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 165.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 mtm105 -60.39 -29.05 68.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 167.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 121.258 1.845 . . . . 0.0 114.524 164.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.68 -38.43 84.92 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 165.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.07 -58.54 7.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.58 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -89.69 52.39 2.31 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 118.881 0.764 . . . . 0.0 112.252 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -77.39 -51.58 10.57 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.375 -1.453 . . . . 0.0 113.743 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 37.4 m-80 66.19 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.179 0.992 . . . . 0.0 111.646 -163.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -72.28 120.66 18.2 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -119.16 114.25 22.16 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.373 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.08 101.01 11.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.839 0.456 . . . . 0.0 109.806 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -87.02 105.92 17.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.98 -1.075 . . . . 0.0 109.22 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.9 mt -102.61 130.36 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 C-N-CA 123.211 0.605 . . . . 0.0 109.417 -168.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -114.9 134.36 55.22 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.184 0.594 . . . . 0.0 109.678 160.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -96.24 96.93 9.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.313 -0.867 . . . . 0.0 109.852 155.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -83.56 78.47 9.67 Favored 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 122.69 1.234 . . . . 0.0 112.024 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.26 -96.17 2.04 Favored Glycine 0 N--CA 1.488 2.124 0 O-C-N 121.568 -0.708 . . . . 0.0 113.002 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -99.08 -47.57 5.18 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -61.22 134.24 56.79 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -172.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -97.04 108.51 21.25 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.011 0.924 . . . . 0.0 109.316 174.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.4 m -90.07 100.13 13.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 164.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -94.93 102.9 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -88.04 93.01 9.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.616 -0.677 . . . . 0.0 109.282 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.59 120.73 24.92 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.592 0.357 . . . . 0.0 111.527 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -122.63 116.83 24.49 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.479 0.712 . . . . 0.0 109.396 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -149.03 168.83 22.09 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 122.364 1.078 . . . . 0.0 112.76 -177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 m -60.16 -37.85 81.38 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.84 -43.88 62.09 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -154.65 153.56 31.54 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.74 1.154 . . . . 0.0 111.36 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.13 104.14 7.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.554 -0.716 . . . . 0.0 110.298 166.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 pt -141.49 159.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.043 0.925 . . . . 0.0 112.07 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -99.75 110.4 22.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.605 -1.309 . . . . 0.0 110.064 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.04 100.66 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.69 126.34 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.25 0.62 . . . . 0.0 109.794 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.55 141.88 21.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.73 -0.606 . . . . 0.0 111.982 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -92.02 147.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 112.084 170.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.86 91.47 5.37 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.07 -47.6 1.0 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 116.261 1.264 . . . . 0.0 116.261 -160.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -85.25 127.14 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.008 1.404 . . . . 0.0 109.912 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 t -74.41 142.27 45.02 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -141.83 166.48 24.62 Favored 'General case' 0 CA--C 1.572 1.807 0 C-N-CA 123.815 0.846 . . . . 0.0 112.253 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -98.85 104.46 16.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.382 0.61 . . . . 0.0 110.516 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -89.08 83.13 6.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 112.01 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -86.12 132.6 33.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.915 -1.115 . . . . 0.0 112.669 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.27 -69.72 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -166.06 -57.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 119.57 1.077 . . . . 0.0 111.722 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -45.24 -71.5 0.07 Allowed 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 165.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.98 45.61 0.02 OUTLIER Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.887 1.232 . . . . 0.0 112.872 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.1 m -99.84 103.54 15.16 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.14 84.68 4.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 111.346 -158.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.5 95.56 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.327 -0.858 . . . . 0.0 113.214 -162.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -78.81 116.11 18.94 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.463 0.705 . . . . 0.0 110.837 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.32 9.77 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 115.539 0.976 . . . . 0.0 115.539 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.1 m -160.72 144.97 13.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.874 -0.78 . . . . 0.0 110.39 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.17 102.72 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 162.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -97.75 140.51 32.02 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.355 0.662 . . . . 0.0 111.864 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.79 102.15 11.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.819 -1.176 . . . . 0.0 111.016 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.15 84.94 4.92 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.004 0.906 . . . . 0.0 110.203 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.69 -81.99 0.61 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -119.38 -5.26 10.37 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 169.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -114.11 137.86 51.19 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 121.087 1.767 . . . . 0.0 110.237 -171.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.5 mt -82.54 106.42 14.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.45 -1.406 . . . . 0.0 110.105 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 tt -92.25 111.55 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 CA-C-O 122.399 1.095 . . . . 0.0 109.752 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.39 94.09 1.96 Allowed Glycine 0 N--CA 1.478 1.475 0 C-N-CA 123.878 0.751 . . . . 0.0 113.232 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -90.29 109.84 20.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -133.84 145.64 49.89 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.896 0.855 . . . . 0.0 111.512 -168.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -124.76 132.8 53.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.421 -0.799 . . . . 0.0 109.503 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -64.25 127.4 31.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 112.44 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.32 0.4 OUTLIER -82.8 -27.39 30.97 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -57.39 -54.82 42.44 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 164.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -93.47 -39.77 10.7 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.32 -13.59 51.52 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -158.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -96.03 153.66 17.66 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.383 1.592 . . . . 0.0 113.669 -160.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.48 134.56 34.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -166.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -119.47 129.65 54.84 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.7 1.2 . . . . 0.0 110.435 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -118.73 108.87 15.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.685 . . . . 0.0 109.491 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -115.47 112.95 23.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.916 -0.49 . . . . 0.0 111.981 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.29 116.12 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.984 -1.072 . . . . 0.0 109.215 -173.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -91.58 117.36 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.765 -0.585 . . . . 0.0 109.66 166.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.55 149.71 37.82 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.112 0.958 . . . . 0.0 112.478 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -89.51 103.87 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.395 -0.816 . . . . 0.0 109.354 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.6 tt -95.6 72.26 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.05 0.928 . . . . 0.0 110.96 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.88 59.75 6.74 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.353 24.8 m-20 79.59 -34.37 0.14 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.92 130.77 42.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 120.01 1.277 . . . . 0.0 113.034 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 46.7 tp -87.72 105.48 17.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.887 -1.133 . . . . 0.0 110.101 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -91.81 109.71 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.903 0.859 . . . . 0.0 110.295 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -91.11 104.53 17.09 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.21 1.004 . . . . 0.0 109.499 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -106.93 91.11 3.53 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.216 0.607 . . . . 0.0 110.046 -162.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -81.87 102.04 10.6 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.456 0.703 . . . . 0.0 112.083 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.2 t -98.94 107.03 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.403 ' OH ' ' OE2' ' A' ' 120' ' ' GLU . 33.7 t80 -122.16 114.58 21.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.469 -0.769 . . . . 0.0 109.83 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.403 ' OE2' ' OH ' ' A' ' 119' ' ' TYR . 47.5 mt-10 51.7 39.03 24.39 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 -32.86 5.89 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 118.673 2.229 . . . . 0.0 118.673 -165.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.15 110.27 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 120.578 2.189 . . . . 0.0 112.238 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -86.84 117.95 25.91 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.97 0.508 . . . . 0.0 111.662 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.11 118.44 32.85 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.537 0.684 . . . . 0.0 111.949 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -100.42 122.61 43.45 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.081 0.552 . . . . 0.0 110.815 -176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -108.39 111.91 24.06 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 167.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 27.7 mt -108.91 112.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -167.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -105.55 135.62 46.62 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 121.383 0.611 . . . . 0.0 112.249 -170.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -88.44 146.81 25.02 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 122.003 0.906 . . . . 0.0 111.515 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -81.01 90.4 5.97 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-O 121.445 0.641 . . . . 0.0 112.637 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 5.3 t0 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.21 1.404 . . . . 0.0 113.821 172.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 122.118 0.961 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -105.13 40.52 1.5 Allowed 'General case' 0 CA--C 1.576 1.975 0 O-C-N 121.565 -0.709 . . . . 0.0 112.273 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.25 3.4 p-10 -95.83 88.32 4.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.93 -1.731 . . . . 0.0 114.171 -158.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 p -148.2 -170.81 3.69 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-O 122.292 1.044 . . . . 0.0 112.309 170.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.1 m -87.16 114.92 24.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.938 -1.101 . . . . 0.0 109.373 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -119.73 106.24 11.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -173.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.74 136.84 42.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.178 -0.951 . . . . 0.0 112.814 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.61 117.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 113.566 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -101.11 -55.84 2.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.1 0.56 . . . . 0.0 111.588 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -85.56 -78.66 0.26 Allowed 'General case' 0 CA--C 1.57 1.722 0 O-C-N 121.757 -0.589 . . . . 0.0 112.248 -162.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . 0.268 16.1 m 57.66 95.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.287 13.5 tm-20 -87.12 -110.19 0.06 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 118.835 -0.602 . . . . 0.0 109.938 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -86.27 58.9 5.32 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-N 121.474 1.943 . . . . 0.0 115.136 -169.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -70.12 -31.82 69.54 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 165.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -48.61 -54.09 15.94 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 169.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.26 -31.93 68.11 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -55.88 -52.85 62.63 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 164.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.64 -46.55 73.96 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -55.72 -47.66 76.52 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -55.29 -44.25 75.54 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 165.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.3 mtt -65.78 -35.25 80.18 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 174.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.56 61.32 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 CA-C-N 119.703 1.138 . . . . 0.0 115.029 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.29 145.37 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.285 0.564 . . . . 0.0 111.447 -170.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -80.83 156.57 26.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.594 -1.316 . . . . 0.0 114.126 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.273 14.8 tt -53.66 -42.22 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 118.339 2.718 . . . . 0.0 118.339 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.44 -45.23 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -58.26 -46.35 86.18 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -52.12 -51.6 56.84 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.86 -49.09 77.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.0 mt -58.5 -37.79 76.31 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.16 -38.45 31.36 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.3 -53.1 54.26 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 163.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -88.95 53.92 2.84 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 119.362 0.983 . . . . 0.0 113.181 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -83.11 -31.99 26.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 66.53 49.68 1.33 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 124.663 1.185 . . . . 0.0 113.383 -169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -76.9 121.54 23.58 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 122.682 1.229 . . . . 0.0 113.363 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -111.46 106.31 15.17 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.364 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.05 94.72 7.85 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.3 m -87.06 100.19 12.45 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 49' ' ' VAL . 60.6 mt -93.87 127.85 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.5 p -129.11 110.74 12.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? -91.44 101.09 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.9 . . . . 0.0 109.951 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.52 -35.5 30.28 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.3 81.77 0.04 OUTLIER Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.336 -0.853 . . . . 0.0 111.292 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 6.7 t-20 70.18 -52.48 0.64 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -159.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -62.8 137.92 58.39 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -112.61 109.45 19.0 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -84.23 103.1 13.14 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.543 0.737 . . . . 0.0 109.107 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 40' ' ' ILE . 17.7 m -105.89 108.27 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.73 89.74 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.527 -0.733 . . . . 0.0 109.568 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.66 85.4 6.05 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.912 0.863 . . . . 0.0 111.872 -163.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.4 m -101.84 98.19 8.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.707 -0.621 . . . . 0.0 111.527 -154.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.7 p -127.44 171.03 11.92 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.65 0.78 . . . . 0.0 112.926 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.3 m -75.05 66.05 1.55 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.829 -1.169 . . . . 0.0 110.95 163.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.36 -62.18 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 123.949 0.899 . . . . 0.0 111.416 -169.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.291 42.1 ptt85 -138.55 -62.37 0.57 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.268 30.8 t-20 66.0 91.07 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.42 1.463 . . . . 0.0 113.944 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.7 143.36 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.436 0.636 . . . . 0.0 110.762 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -80.92 101.4 9.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.476 0.655 . . . . 0.0 112.005 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.12 106.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.6 97.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -109.18 126.98 53.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -91.21 148.97 21.98 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 121.782 0.801 . . . . 0.0 111.7 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.49 119.77 15.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 113.813 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.63 1.46 89.07 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -91.77 132.81 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 120.144 1.972 . . . . 0.0 109.872 -173.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -78.28 110.74 13.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.596 -0.69 . . . . 0.0 112.155 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -132.75 159.64 39.12 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.636 0.731 . . . . 0.0 112.549 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.88 105.75 17.95 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.512 -0.742 . . . . 0.0 111.302 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -93.08 116.2 28.82 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.081 0.952 . . . . 0.0 110.559 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -89.91 131.0 36.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.009 -1.057 . . . . 0.0 111.558 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt -73.75 -177.22 2.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.646 -1.284 . . . . 0.0 114.242 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -58.5 4.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.244 -1.535 . . . . 0.0 113.566 167.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -41.19 -44.64 2.64 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.28 71.37 0.39 Allowed Glycine 0 N--CA 1.485 1.934 0 C-N-CA 123.914 0.768 . . . . 0.0 111.429 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.7 m -157.34 141.32 16.09 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.59 -0.947 . . . . 0.0 109.846 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -117.54 124.94 49.93 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 124.642 1.177 . . . . 0.0 112.417 -155.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt -134.96 109.42 8.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.836 -1.165 . . . . 0.0 112.09 -162.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.52 112.64 24.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.057 -1.027 . . . . 0.0 111.141 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.39 -149.91 15.81 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 117.209 1.644 . . . . 0.0 117.209 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.5 p -133.8 123.38 24.74 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.438 -152.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -82.53 116.23 21.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.942 -0.474 . . . . 0.0 110.233 158.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.2 m -113.63 134.63 54.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.836 -0.54 . . . . 0.0 111.248 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 tp -85.66 115.55 23.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 110.689 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.71 -93.41 0.1 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 123.089 0.555 . . . . 0.0 110.692 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.49 -86.18 1.9 Allowed Glycine 0 N--CA 1.491 2.309 0 CA-C-N 119.432 1.014 . . . . 0.0 111.49 169.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -110.95 47.01 1.02 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 117.047 0.424 . . . . 0.0 111.901 161.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -140.82 122.27 15.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.858 -1.151 . . . . 0.0 108.394 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.29 105.09 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.93 112.13 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.33 95.87 1.51 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -85.3 113.6 21.75 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -137.67 111.35 8.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.08 0.552 . . . . 0.0 111.053 -165.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -87.2 129.98 34.74 Favored 'General case' 0 CA--C 1.566 1.575 0 O-C-N 120.489 -1.382 . . . . 0.0 112.919 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -62.02 139.35 58.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 163.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.0 p -72.02 -51.22 22.82 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 -49.81 64.44 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -86.91 -36.95 18.08 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.03 12.08 79.16 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -173.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -81.41 -18.66 44.64 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.752 3.242 . . . . 0.0 119.752 -165.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.346 5.4 tt0 67.14 100.97 0.05 OUTLIER 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 tt -74.95 132.29 41.31 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.735 0.814 . . . . 0.0 110.703 160.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -112.72 97.4 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 t -92.64 110.15 21.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.498 0.666 . . . . 0.0 110.177 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.56 117.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -103.05 119.32 38.64 Favored 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.663 0.785 . . . . 0.0 110.612 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -144.08 142.43 30.62 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 123.774 0.83 . . . . 0.0 110.477 173.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -84.43 111.69 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.588 -1.32 . . . . 0.0 108.155 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.26 98.6 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.25 -106.27 2.78 Favored Glycine 0 N--CA 1.488 2.116 0 O-C-N 121.847 -0.533 . . . . 0.0 112.927 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.4 ' OD1' ' OE2' ' A' ' 112' ' ' GLU . 3.3 p-10 -92.97 -30.31 15.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE2' ' OD1' ' A' ' 111' ' ' ASP . 3.9 mt-10 -102.19 141.33 35.2 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.149 0.975 . . . . 0.0 112.975 -160.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.59 104.8 5.42 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.003 164.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.34 103.82 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 95.13 5.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -105.61 111.1 23.66 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 122.751 0.421 . . . . 0.0 110.473 -171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.75 112.4 18.87 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.718 0.407 . . . . 0.0 110.284 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.83 114.72 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -139.43 108.1 5.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.204 0.602 . . . . 0.0 109.768 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 54.98 50.88 14.53 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.32 -27.75 4.5 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.939 2.335 . . . . 0.0 118.939 -166.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.72 130.06 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 119.722 1.761 . . . . 0.0 110.485 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -101.29 107.96 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.05 0.54 . . . . 0.0 109.968 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.21 98.75 9.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 111.166 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -93.84 87.83 5.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.732 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -90.99 104.42 17.02 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.69 121.32 60.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.721 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -109.32 119.37 39.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.601 0.76 . . . . 0.0 110.504 -166.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -76.27 147.88 37.97 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 122.152 0.977 . . . . 0.0 113.43 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -68.13 109.53 3.57 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 123.804 0.842 . . . . 0.0 112.829 175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 125.118 1.367 . . . . 0.0 112.569 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.49 -26.99 22.92 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -165.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.36 174.09 5.16 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.392 37.0 p 86.83 -177.79 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.625 1.57 . . . . 0.0 114.075 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.9 m -96.92 129.07 44.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.654 -1.279 . . . . 0.0 111.405 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -122.26 102.73 8.3 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -100.53 144.66 29.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.54 0.686 . . . . 0.0 112.268 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.77 122.8 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.58 -68.05 0.78 Allowed 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.795 163.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.17 128.17 44.29 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 121.556 0.693 . . . . 0.0 111.585 -172.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -109.44 120.48 42.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.654 0.782 . . . . 0.0 111.028 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.26 130.39 47.39 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.386 0.675 . . . . 0.0 110.538 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.285 18.7 t30 53.74 21.63 2.77 Favored 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 119.48 3.141 . . . . 0.0 119.48 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -70.44 -42.24 71.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -59.08 -38.91 80.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.75 -48.41 81.78 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 120.602 1.546 . . . . 0.0 114.837 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -48.13 -61.02 2.19 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 mtt -66.94 -35.75 80.69 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -63.83 -42.86 97.55 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 167.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -56.78 -42.98 80.4 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 164.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 74.7 mtp -51.34 -30.5 18.75 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 164.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.46 47.68 4.24 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 116.165 1.226 . . . . 0.0 116.165 -174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.43 163.73 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 122.197 0.998 . . . . 0.0 112.188 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -66.84 144.38 56.32 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.694 -1.254 . . . . 0.0 112.804 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.281 15.4 tt -56.89 -40.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 -176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.01 -44.68 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-N 119.554 1.07 . . . . 0.0 113.28 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -58.96 -40.99 86.38 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -35.35 79.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -67.11 -48.37 68.33 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 114.157 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -53.64 -24.92 15.67 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 165.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.76 -51.44 59.17 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 120.955 1.707 . . . . 0.0 114.602 164.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.74 -44.32 63.25 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -106.52 61.14 0.64 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 167.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.3 5.6 p30 -82.08 -35.5 28.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.304 -1.498 . . . . 0.0 114.698 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 54.95 44.44 28.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -76.3 122.08 23.9 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -111.28 133.77 53.37 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.551 0.74 . . . . 0.0 111.745 166.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.7 mt -113.53 102.75 10.59 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -85.78 100.93 12.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.304 -0.872 . . . . 0.0 109.403 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -93.83 127.94 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.8 t -141.29 125.39 17.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.131 -0.981 . . . . 0.0 110.207 171.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -95.03 122.98 38.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.687 -0.633 . . . . 0.0 111.396 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -105.45 76.41 1.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.571 0.7 . . . . 0.0 109.895 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.13 78.05 0.32 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 115.994 1.157 . . . . 0.0 115.994 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.291 4.3 m-80 70.26 -50.27 0.65 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -167.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -73.64 120.74 19.65 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.017 0.927 . . . . 0.0 112.726 -172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -98.85 125.26 44.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.223 0.609 . . . . 0.0 111.919 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.6 m -94.78 108.13 20.14 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 165.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.9 t -105.29 101.47 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.16 104.87 17.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.16 145.03 35.88 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-O 121.936 0.874 . . . . 0.0 112.473 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -149.49 117.98 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.844 -1.16 . . . . 0.0 110.068 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.1 t -150.33 167.21 27.68 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 124.541 1.136 . . . . 0.0 111.26 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -51.9 -29.7 21.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 165.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -63.06 -53.86 47.15 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -171.78 171.29 5.26 Favored 'General case' 0 CA--C 1.574 1.891 0 C-N-CA 124.226 1.01 . . . . 0.0 112.312 -162.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -133.26 119.58 19.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.731 -1.23 . . . . 0.0 111.129 161.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.4 pt -140.02 150.22 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-O 122.171 0.986 . . . . 0.0 111.521 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.12 106.63 18.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.7 t -95.59 93.61 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.7 t -93.91 120.77 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -135.51 139.48 44.02 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.145 0.974 . . . . 0.0 113.311 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.15 142.4 27.54 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 121.853 0.835 . . . . 0.0 110.858 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.6 mt -73.22 92.79 1.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.397 -0.814 . . . . 0.0 112.84 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.37 -27.44 5.01 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.659 1.823 . . . . 0.0 117.659 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.08 127.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 120.036 1.918 . . . . 0.0 110.422 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.1 p -75.07 102.23 4.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.236 0.615 . . . . 0.0 111.309 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -112.27 150.6 30.73 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.754 0.822 . . . . 0.0 112.069 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -90.97 101.48 14.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.689 -0.632 . . . . 0.0 110.661 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.31 104.72 17.02 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.48 -0.762 . . . . 0.0 110.529 171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -72.49 114.86 11.07 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.65 150.33 39.62 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.699 0.761 . . . . 0.0 111.769 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.39 0.03 7.35 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 121.683 3.957 . . . . 0.0 121.683 -160.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.05 -79.68 0.19 Allowed 'General case' 0 CA--C 1.573 1.838 0 CA-C-N 120.3 1.409 . . . . 0.0 109.474 157.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.71 63.88 0.15 Allowed Glycine 0 N--CA 1.486 2.033 0 CA-C-N 119.108 0.867 . . . . 0.0 115.163 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.8 m -134.39 103.33 5.67 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 117.561 0.68 . . . . 0.0 109.657 -172.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -75.65 107.19 7.65 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.586 0.707 . . . . 0.0 112.536 173.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.3 mt -84.24 104.36 14.21 Favored 'General case' 0 CA--C 1.558 1.288 0 O-C-N 121.427 -0.795 . . . . 0.0 110.536 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -87.17 110.35 20.09 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.448 1.099 . . . . 0.0 110.758 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.8 -157.87 30.39 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 116.997 1.559 . . . . 0.0 116.997 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -128.37 136.18 50.57 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 122.903 0.481 . . . . 0.0 111.957 -165.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -91.56 114.93 27.59 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 153.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -107.19 136.9 46.25 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.084 0.554 . . . . 0.0 111.176 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.8 tp -89.31 104.39 16.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.972 -1.08 . . . . 0.0 110.987 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -78.09 -42.74 31.11 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.53 -92.27 0.08 OUTLIER Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -74.77 3.45 7.99 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 156.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -126.62 119.47 27.12 Favored 'General case' 0 CA--C 1.562 1.433 0 CA-C-N 119.802 1.183 . . . . 0.0 108.772 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.07 102.34 13.76 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 160.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.88 113.55 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 C-N-CA 124.093 0.957 . . . . 0.0 109.25 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.8 104.1 3.01 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.044 0.83 . . . . 0.0 113.164 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.07 99.96 11.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -123.51 152.36 41.83 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.285 1.04 . . . . 0.0 112.121 -172.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -125.48 146.03 49.82 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.765 0.793 . . . . 0.0 110.056 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -65.41 129.57 40.23 Favored 'General case' 0 CA--C 1.565 1.556 0 O-C-N 120.827 -1.171 . . . . 0.0 112.11 170.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 m -85.63 38.17 0.73 Allowed 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 122.122 0.963 . . . . 0.0 112.298 158.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -160.74 45.35 0.2 Allowed 'General case' 0 CA--C 1.585 2.314 0 C-N-CA 124.845 1.258 . . . . 0.0 110.314 -157.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.38 51.6 p30 138.11 -50.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 127.763 2.425 . . . . 0.0 111.469 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.8 2.14 27.12 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -90.48 145.61 24.77 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.514 2.157 . . . . 0.0 112.649 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -70.49 151.06 45.51 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.87 113.89 12.02 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -104.61 132.19 51.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.618 -0.676 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -142.85 139.2 30.77 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.8 t -120.92 118.63 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -96.54 120.94 37.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 162.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -146.34 165.28 29.78 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.82 111.58 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.634 -1.291 . . . . 0.0 109.307 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 tp -88.19 85.99 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.046 0.927 . . . . 0.0 110.204 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.95 -84.31 1.02 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.079 -1.013 . . . . 0.0 114.622 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -141.62 48.07 1.64 Allowed 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 163.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -142.75 136.91 29.37 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -81.49 105.7 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.478 -1.389 . . . . 0.0 111.177 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.33 109.76 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.749 0.785 . . . . 0.0 110.442 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -98.13 104.43 16.46 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -91.47 142.6 27.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 123.257 0.623 . . . . 0.0 109.61 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -151.2 116.88 5.44 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.789 -1.194 . . . . 0.0 110.513 -171.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.72 125.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.359 1.064 . . . . 0.0 108.505 -171.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 110.97 10.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.969 0.507 . . . . 0.0 109.791 173.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 68.02 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 175.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 -31.19 1.92 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.826 2.291 . . . . 0.0 118.826 -168.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.98 102.72 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 119.311 1.556 . . . . 0.0 109.189 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.66 133.41 33.7 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.197 0.998 . . . . 0.0 111.104 168.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -138.24 156.25 47.86 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 122.108 0.956 . . . . 0.0 111.722 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -133.89 149.84 51.33 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.939 0.876 . . . . 0.0 111.855 -170.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -141.1 119.39 12.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.019 -1.051 . . . . 0.0 108.54 169.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.3 mt -101.52 108.02 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -94.3 123.23 37.56 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.629 0.772 . . . . 0.0 110.015 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -79.57 165.47 22.91 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.06 112.76 6.67 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.802 -1.186 . . . . 0.0 112.859 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 125.151 1.38 . . . . 0.0 113.372 178.361 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.306 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 67.61 -1.75 1.53 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 118.497 2.776 . . . . 0.0 118.497 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.12 101.61 2.29 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.232 1.378 . . . . 0.0 112.756 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.5 m 179.61 165.56 1.1 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.145 1.378 . . . . 0.0 110.518 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.1 m -96.33 111.98 23.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 167.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -108.8 114.25 27.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.776 -0.578 . . . . 0.0 110.509 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -92.74 135.29 34.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.105 -0.997 . . . . 0.0 112.559 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.3 129.22 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.885 -1.134 . . . . 0.0 113.61 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -119.0 -65.17 1.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.168 0.987 . . . . 0.0 110.998 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 75.46 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.345 0.658 . . . . 0.0 111.494 -165.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.411 ' HB3' ' HE ' ' A' ' 126' ' ' ARG . 13.4 p -85.89 139.59 31.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.341 2.5 tm-20 -94.06 -97.78 0.15 Allowed 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.542 -166.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.255 19.3 t30 -100.0 50.22 0.91 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.143 -1.598 . . . . 0.0 113.345 -167.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -76.84 -39.73 50.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -170.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.06 -40.55 98.04 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -67.19 -43.79 81.25 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -47.02 -54.97 9.06 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 161.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mtp -65.32 -34.11 77.55 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -53.79 -46.36 71.0 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 163.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.66 -41.31 98.22 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.9 mmm -54.11 -48.95 70.19 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.06 65.72 0.18 Allowed Glycine 0 N--CA 1.489 2.197 0 C-N-CA 123.536 0.589 . . . . 0.0 114.209 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.41 131.51 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.749 0.785 . . . . 0.0 110.701 -174.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -80.67 161.86 24.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.9 tt -58.23 158.03 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.384 42.3 t 82.14 -73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 C-N-CA 124.573 1.149 . . . . 0.0 109.267 -161.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -53.51 -50.68 64.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -64.07 -24.82 67.85 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -71.14 -48.54 51.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 121.67 2.032 . . . . 0.0 113.545 167.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.6 mt -56.0 -48.69 75.44 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 165.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.74 -37.08 81.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -49.22 78.32 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 121.103 1.774 . . . . 0.0 115.355 165.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -92.3 59.95 3.57 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 121.79 -0.569 . . . . 0.0 111.439 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -74.3 -27.64 60.81 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 62.75 38.2 11.98 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.308 1.5 pt? -81.16 151.45 28.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -169.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -127.75 114.31 17.12 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.822 -173.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.8 mt -97.39 99.15 10.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.82 -1.175 . . . . 0.0 111.236 -170.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.2 m -85.71 95.02 9.25 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.886 0.851 . . . . 0.0 109.818 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.0 mt -95.71 121.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -133.6 69.57 1.47 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.606 0.639 . . . . 0.0 111.973 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -58.36 110.64 1.0 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -165.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.15 62.29 2.15 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.47 84.69 0.17 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.312 -0.867 . . . . 0.0 114.76 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.32 -66.21 0.29 Allowed 'General case' 0 N--CA 1.506 2.346 0 CA-C-N 118.546 1.173 . . . . 0.0 112.651 -160.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -67.93 123.69 21.29 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.347 1.059 . . . . 0.0 113.676 -161.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -91.21 107.9 19.52 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.265 -0.897 . . . . 0.0 110.825 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.5 m -90.9 101.99 14.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.1 m -112.11 102.36 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -85.42 97.34 9.95 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.04 93.29 9.33 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.734 0.778 . . . . 0.0 108.964 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.6 t -91.99 89.39 6.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.359 0.599 . . . . 0.0 111.8 -164.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.2 p -100.61 162.64 12.79 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -51.68 -36.63 47.3 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 163.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.09 -46.92 63.87 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -162.81 137.96 6.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.962 0.905 . . . . 0.0 111.342 -161.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -100.75 101.88 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 163.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 pt -103.89 113.45 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.107 0.563 . . . . 0.0 110.105 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pm0 -77.9 89.42 4.1 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.768 0.794 . . . . 0.0 112.024 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.88 106.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.95 104.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -117.85 132.28 56.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.925 -0.484 . . . . 0.0 112.255 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 157.45 24.66 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.778 1.275 . . . . 0.0 111.304 159.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.53 102.27 8.73 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 120.679 -1.263 . . . . 0.0 111.386 -169.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.1 3.08 51.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 119.026 2.371 . . . . 0.0 119.026 -162.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.54 132.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 121.55 2.675 . . . . 0.0 112.222 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.6 p -82.99 102.9 12.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.283 -0.885 . . . . 0.0 110.768 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -139.13 157.58 45.71 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 112.997 -171.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.33 110.55 19.18 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.224 0.609 . . . . 0.0 111.533 173.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -100.61 113.66 26.68 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.122 0.969 . . . . 0.0 110.8 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.61 128.67 35.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 mt -84.8 165.97 17.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.693 -0.629 . . . . 0.0 112.321 167.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.16 -73.51 0.05 Allowed 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -114.43 59.13 0.69 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 120.397 1.453 . . . . 0.0 111.096 158.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.5 41.68 0.66 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.389 0.6 OUTLIER 75.91 163.67 0.25 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 163.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -80.06 119.19 22.53 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-O 122.327 1.061 . . . . 0.0 111.322 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.38 111.32 23.58 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.689 0.796 . . . . 0.0 110.418 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -95.32 116.89 29.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 112.294 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.22 -150.58 18.59 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 114.712 0.645 . . . . 0.0 114.712 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 p -133.48 116.63 16.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.274 -0.545 . . . . 0.0 112.278 -160.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.59 119.79 20.12 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.55 0.614 . . . . 0.0 111.036 158.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -132.21 150.81 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.701 0.8 . . . . 0.0 111.419 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 tp -98.92 103.57 15.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.658 -1.276 . . . . 0.0 112.019 -171.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -91.69 81.81 5.27 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.01 0.91 . . . . 0.0 110.083 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.9 -105.89 1.84 Allowed Glycine 0 N--CA 1.491 2.303 0 O-C-N 121.411 -0.806 . . . . 0.0 114.777 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.62 10.72 37.71 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 166.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -113.54 116.75 30.03 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.836 1.198 . . . . 0.0 110.005 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt -77.25 96.75 4.63 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.971 -1.08 . . . . 0.0 109.22 163.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.58 111.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.994 0.918 . . . . 0.0 108.89 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.99 98.06 1.85 Allowed Glycine 0 N--CA 1.475 1.284 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -78.52 105.07 9.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -129.36 134.11 47.73 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 111.306 -165.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -106.29 140.59 38.99 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 111.257 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -66.71 122.95 18.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.566 -1.334 . . . . 0.0 112.366 167.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -63.45 -25.74 68.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 -44.98 94.97 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.95 -4.93 0.21 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -160.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.8 7.17 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 118.596 2.198 . . . . 0.0 118.596 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.87 -29.47 12.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -172.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.328 1.8 mt-10 71.46 112.98 0.06 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 124.73 1.212 . . . . 0.0 113.296 -160.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 114.78 26.41 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 164.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -93.68 134.7 35.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 111.522 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.2 p -131.3 116.37 17.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.962 -0.461 . . . . 0.0 110.654 -167.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.4 t -114.36 106.62 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 120.854 -1.154 . . . . 0.0 108.458 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -90.54 122.23 33.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.344 -0.848 . . . . 0.0 110.217 162.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.33 144.18 31.33 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 119.76 1.164 . . . . 0.0 113.882 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -96.56 104.61 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.85 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 174.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.11 -97.56 0.14 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -99.78 25.19 7.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.98 149.18 41.45 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.265 1.031 . . . . 0.0 110.213 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.7 tp -100.22 112.64 24.96 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 168.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.12 120.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -110.15 91.62 3.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.7 m -89.13 101.96 14.62 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.964 0.905 . . . . 0.0 109.413 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -103.25 116.07 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.827 -0.546 . . . . 0.0 110.162 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.7 t -110.92 123.95 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -126.06 111.81 15.13 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.36 0.664 . . . . 0.0 110.544 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.258 0.3 OUTLIER 52.79 53.98 11.26 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.14 -25.36 1.58 Allowed Glycine 0 CA--C 1.556 2.616 0 N-CA-C 119.292 2.477 . . . . 0.0 119.292 -165.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.47 109.48 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 119.362 1.581 . . . . 0.0 109.246 -170.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -85.04 143.98 28.55 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.914 0.885 . . . . 0.0 112.807 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.36 121.17 17.51 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.472 -0.768 . . . . 0.0 110.813 162.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -100.44 110.01 22.18 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.411 ' HE ' ' HB3' ' A' ' 11' ' ' SER . 49.3 mmm-85 -90.23 109.57 20.64 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.4 mt -109.67 117.52 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.099 -1.0 . . . . 0.0 108.352 -167.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.64 144.77 42.36 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 121.692 0.758 . . . . 0.0 112.179 -167.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -114.34 138.86 49.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.942 0.897 . . . . 0.0 110.205 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -67.78 118.0 10.43 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.253 1.257 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -174.381 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.304 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.326 50.8 m-85 74.96 -53.15 0.67 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.288 1.959 . . . . 0.0 116.288 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -79.19 98.01 6.43 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.365 0.984 . . . . 0.0 112.471 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 m -168.65 -176.95 2.93 Favored 'General case' 0 CA--C 1.573 1.843 0 C-N-CA 124.95 1.3 . . . . 0.0 110.064 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.0 m -93.16 130.12 38.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.643 -1.286 . . . . 0.0 109.615 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -135.9 112.97 10.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.229 -0.919 . . . . 0.0 111.552 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -102.51 143.21 32.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 112.268 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.252 8.6 p -76.41 90.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.339 1.066 . . . . 0.0 113.319 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -46.17 18.45 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -141.35 79.51 1.69 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 119.92 1.236 . . . . 0.0 113.16 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -79.75 139.53 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.817 -1.177 . . . . 0.0 114.163 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.343 0.9 OUTLIER -86.87 -91.26 0.11 Allowed 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 123.989 0.916 . . . . 0.0 111.702 -177.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -107.0 43.7 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 121.116 1.78 . . . . 0.0 114.634 -166.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.79 -32.14 63.62 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.52 -44.56 80.91 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -69.1 -38.51 78.97 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.72 -54.09 38.59 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 162.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.535 ' SD ' HG11 ' A' ' 23' ' ' VAL . 8.1 mmt -48.06 -50.98 26.24 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 164.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -56.56 -45.92 81.02 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.2 -38.99 91.22 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.406 ' SD ' HG21 ' A' ' 76' ' ' THR . 71.8 mtm -62.16 -35.02 77.54 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.83 62.63 0.54 Allowed Glycine 0 N--CA 1.49 2.26 0 CA-C-N 119.046 0.839 . . . . 0.0 114.96 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG11 ' SD ' ' A' ' 18' ' ' MET . 16.1 m -118.91 145.6 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.395 0.616 . . . . 0.0 111.175 -170.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -66.7 156.29 35.69 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.881 -1.137 . . . . 0.0 113.673 171.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.07 -43.72 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -57.92 -51.64 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -59.95 -44.88 94.12 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -51.6 -48.24 63.29 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -70.56 -58.53 3.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 168.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.15 -32.84 69.43 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.24 -33.91 65.57 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 121.598 1.999 . . . . 0.0 115.598 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.76 85.25 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 156.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -100.45 49.15 0.9 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -85.47 -7.22 59.02 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 58.87 38.26 24.57 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.288 1.3 pt? -74.28 139.23 44.12 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 122.698 1.237 . . . . 0.0 113.059 -172.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -136.9 89.1 2.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -155.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.1 mt -89.35 110.16 20.98 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.148 0.579 . . . . 0.0 110.985 -160.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.4 m -89.0 106.71 18.6 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 164.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.01 124.19 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 60.5 p -139.63 118.56 12.52 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.966 -0.459 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -77.5 96.7 4.79 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.646 0.778 . . . . 0.0 111.158 167.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.24 83.57 7.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.688 1.232 . . . . 0.0 111.116 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.84 -79.51 1.57 Allowed Glycine 0 N--CA 1.489 2.19 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.704 -165.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -131.98 -22.44 2.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -73.36 115.46 12.74 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 120.282 1.401 . . . . 0.0 112.723 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -78.64 106.13 10.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.477 -0.764 . . . . 0.0 110.025 171.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.4 m -88.15 103.64 15.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -104.54 107.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.28 96.15 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -77.62 90.55 3.95 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -89.77 95.45 10.25 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -129.25 173.06 10.85 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.771 0.796 . . . . 0.0 112.955 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -58.88 -40.32 84.03 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.24 -40.17 52.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 151.21 31.08 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 121.677 2.035 . . . . 0.0 113.456 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -111.02 96.15 5.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.83 132.99 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.591 -0.693 . . . . 0.0 112.443 -168.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.23 109.36 18.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.006 -1.059 . . . . 0.0 111.773 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -95.36 101.0 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 50.4 t -100.15 116.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -141.51 123.02 15.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -174.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.69 152.93 31.34 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 112.611 166.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.33 106.47 1.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 113.558 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 CA--C 1.552 2.385 0 N-CA-C 118.846 2.299 . . . . 0.0 118.846 -169.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 p -79.09 135.67 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 121.127 2.464 . . . . 0.0 112.654 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.7 p -84.42 105.16 15.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.315 -0.865 . . . . 0.0 110.925 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.27 163.04 31.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -100.33 110.11 22.33 Favored 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 123.155 0.582 . . . . 0.0 110.37 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -73.56 -61.7 1.74 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -167.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.261 39.2 m-80 77.91 100.95 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.778 1.172 . . . . 0.0 114.055 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.75 176.83 9.17 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.27 68.5 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 119.03 2.974 . . . . 0.0 119.03 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -72.89 -58.64 3.18 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 171.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.0 58.42 0.04 OUTLIER Glycine 0 CA--C 1.546 2.007 0 C-N-CA 124.288 0.947 . . . . 0.0 110.965 -161.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.406 HG21 ' SD ' ' A' ' 21' ' ' MET . 91.0 m -130.79 96.45 4.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.84 127.94 34.7 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.481 0.712 . . . . 0.0 109.912 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -137.05 97.97 3.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.765 -1.209 . . . . 0.0 111.806 -157.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.487 HH21 ' HZ1' ' A' ' 94' ' ' LYS . 32.3 ptt180 -91.37 115.63 28.19 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.415 0.686 . . . . 0.0 111.843 -176.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.34 -154.07 23.12 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.7 p -127.48 145.58 50.79 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -97.37 116.36 29.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.131 -0.981 . . . . 0.0 108.995 150.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -106.67 174.7 5.77 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 121.158 0.504 . . . . 0.0 111.462 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -124.29 120.91 33.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.149 -1.594 . . . . 0.0 110.844 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.43 83.46 2.63 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 109.972 169.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.86 -93.21 0.39 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 121.266 -0.896 . . . . 0.0 115.227 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -117.69 39.39 3.35 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 166.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -134.97 110.69 9.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.799 -1.188 . . . . 0.0 108.092 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -82.48 118.27 23.11 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 109.685 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -111.88 105.84 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.404 0.682 . . . . 0.0 110.219 -167.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -91.41 95.8 2.11 Favored Glycine 0 N--CA 1.483 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 113.098 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -102.62 102.54 12.77 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -126.36 134.17 51.14 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.431 0.692 . . . . 0.0 110.911 -168.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HZ1' HH21 ' A' ' 79' ' ' ARG . 0.2 OUTLIER -104.42 127.65 52.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.14 115.23 13.39 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.388 -0.82 . . . . 0.0 112.835 -170.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -59.14 -44.84 92.08 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.96 -39.47 78.18 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -125.48 -28.15 3.35 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -161.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.46 65.95 1.49 Allowed Glycine 0 N--CA 1.492 2.37 0 CA-C-N 120.615 1.552 . . . . 0.0 114.777 -172.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -152.89 137.43 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 117.512 0.656 . . . . 0.0 111.869 -164.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -77.66 122.16 24.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 113.391 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.05 120.19 41.6 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.717 0.807 . . . . 0.0 109.602 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -113.01 108.05 16.81 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.259 15.3 t -115.94 102.26 9.51 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.175 0.59 . . . . 0.0 112.255 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.0 t -100.93 121.08 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.181 -0.949 . . . . 0.0 109.855 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -96.17 125.62 40.82 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.932 0.893 . . . . 0.0 111.423 170.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -149.83 159.77 44.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.989 0.899 . . . . 0.0 112.224 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.29 117.61 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.552 -1.342 . . . . 0.0 109.352 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tp -82.73 -51.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 114.339 1.236 . . . . 0.0 114.339 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.57 77.37 0.08 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 0.48 0.0 OUTLIER 78.09 -45.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -159.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -78.44 143.73 36.46 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -95.03 116.94 29.34 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.91 0.884 . . . . 0.0 110.427 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.35 107.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.761 -0.587 . . . . 0.0 109.521 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -96.48 103.29 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.0 m -101.47 91.5 4.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.313 0.645 . . . . 0.0 109.993 -161.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.55 109.89 18.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.339 1.056 . . . . 0.0 112.892 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.15 119.12 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -124.48 113.25 17.88 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 50.36 55.33 9.64 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.03 -21.12 1.38 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.36 102.4 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.739 1.769 . . . . 0.0 108.946 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.84 141.36 28.71 Favored 'General case' 0 CA--C 1.563 1.444 0 C-N-CA 123.71 0.804 . . . . 0.0 112.883 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -136.98 116.0 12.39 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.493 0.717 . . . . 0.0 111.403 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.35 101.94 13.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.294 -0.879 . . . . 0.0 108.632 -174.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -82.91 101.86 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.7 mt -95.08 106.81 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.41 130.37 43.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.093 0.557 . . . . 0.0 110.945 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -85.47 148.16 26.11 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.459 0.647 . . . . 0.0 111.424 169.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -80.53 90.01 5.68 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 122.137 0.97 . . . . 0.0 112.035 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -174.03 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 121.443 0.64 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -80.6 -47.31 14.33 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.728 2.122 . . . . 0.0 116.728 -170.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.58 94.78 5.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.48 1.133 . . . . 0.0 112.244 -163.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -167.21 173.11 9.3 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.745 1.26 . . . . 0.0 111.346 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.0 m -84.8 129.6 34.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.056 . . . . 0.0 110.613 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -136.24 99.99 4.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.912 -0.493 . . . . 0.0 111.366 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -87.84 136.38 32.99 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.092 -1.005 . . . . 0.0 112.653 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -65.83 119.89 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.69 -62.75 1.2 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.643 0.777 . . . . 0.0 111.219 173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -133.69 103.03 5.7 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.163 0.585 . . . . 0.0 110.985 -160.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -96.56 100.12 11.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.36 -0.837 . . . . 0.0 112.334 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.35 122.46 24.49 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.053 0.541 . . . . 0.0 110.849 -174.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.253 23.8 t30 64.09 12.5 7.05 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -65.76 -43.17 89.68 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.57 -35.95 77.3 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.93 -41.73 50.89 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -45.93 -52.1 12.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 158.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mtt -68.6 -28.94 67.37 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -55.75 -47.07 77.59 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-N 120.871 1.669 . . . . 0.0 114.825 158.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -59.47 -41.4 89.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 167.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.4 mtp -60.91 -39.02 87.76 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 167.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.03 65.29 0.64 Allowed Glycine 0 N--CA 1.486 2.01 0 CA-C-N 118.926 0.784 . . . . 0.0 114.186 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.79 131.29 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.353 0.596 . . . . 0.0 110.611 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -74.64 153.78 38.8 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.286 14.1 tt -48.16 -39.4 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 119.1 3.0 . . . . 0.0 119.1 -172.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.45 -59.45 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 120.29 1.405 . . . . 0.0 113.024 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -68.0 -37.84 81.92 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -58.17 -40.99 82.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 173.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -60.5 -44.56 95.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 163.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.44 -40.6 75.05 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.17 77.18 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 171.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.96 68.06 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 166.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -94.0 58.31 2.55 Favored 'General case' 0 CA--C 1.575 1.912 0 C-N-CA 123.832 0.853 . . . . 0.0 111.947 175.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.42 -23.04 18.55 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 61.01 52.33 4.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.693 1.197 . . . . 0.0 114.222 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.0 tp -82.24 114.06 20.48 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.401 -0.812 . . . . 0.0 112.639 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -100.16 105.05 16.61 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.05 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.34 102.32 12.63 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.2 m -92.45 105.42 17.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.405 HG12 HG12 ' A' ' 49' ' ' VAL . 60.1 mt -96.57 124.56 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -147.9 107.67 3.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.699 -0.625 . . . . 0.0 111.323 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.01 147.43 26.21 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 171.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.38 -48.53 12.79 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 164.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.84 -68.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.172 -0.955 . . . . 0.0 113.386 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -123.33 48.84 1.77 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.767 -0.843 . . . . 0.0 112.449 164.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -154.14 109.96 3.22 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.033 -1.042 . . . . 0.0 108.318 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -86.08 118.48 25.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.902 0.481 . . . . 0.0 111.752 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.5 m -84.67 102.99 13.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 165.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG12 HG12 ' A' ' 40' ' ' ILE . 31.8 m -100.25 108.63 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.35 99.5 12.3 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -94.69 74.53 3.69 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.885 -161.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.0 t -87.99 109.7 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.737 -1.227 . . . . 0.0 113.227 -166.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -139.71 163.55 32.31 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.936 1.294 . . . . 0.0 109.405 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 m -75.57 51.95 0.62 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 119.687 -1.883 . . . . 0.0 112.336 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -174.73 -53.84 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.809 0 C-N-CA 125.06 1.344 . . . . 0.0 111.78 -164.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -93.63 -91.58 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 120.189 1.359 . . . . 0.0 110.023 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.303 2.1 t30 51.71 57.74 6.22 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.0 pt -119.53 -35.61 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.273 35.0 mt-10 76.98 99.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 120.086 1.312 . . . . 0.0 112.135 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.66 113.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.15 97.35 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -106.93 136.43 46.78 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -86.4 149.71 24.82 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-O 122.201 1.001 . . . . 0.0 112.427 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -80.47 75.23 7.33 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 110.347 167.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.14 -60.23 0.26 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 -161.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.18 140.59 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 118.402 1.101 . . . . 0.0 112.287 -172.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 p -86.95 118.6 26.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.986 -1.071 . . . . 0.0 110.459 171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -140.21 162.23 35.76 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.837 0.827 . . . . 0.0 112.643 -166.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.23 103.55 10.18 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 111.692 167.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -81.77 -48.16 11.97 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 168.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.255 15.4 m-20 69.19 168.05 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.872 1.269 . . . . 0.0 114.168 172.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -101.14 -130.07 0.23 Allowed 'General case' 0 CA--C 1.571 1.763 0 O-C-N 120.914 -1.117 . . . . 0.0 109.003 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.29 -29.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -47.97 83.38 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 168.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.48 71.29 0.01 OUTLIER Glycine 0 CA--C 1.543 1.796 0 C-N-CA 124.306 0.955 . . . . 0.0 110.761 -171.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.1 m -162.21 119.61 2.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -84.65 151.96 24.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.9 mt -141.39 109.81 5.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.873 -0.517 . . . . 0.0 110.134 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -97.35 122.43 40.38 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.238 1.015 . . . . 0.0 110.817 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.61 -160.07 33.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.62 1.008 . . . . 0.0 115.62 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.6 m -140.69 142.26 34.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.391 -0.476 . . . . 0.0 110.007 -176.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -89.31 109.6 20.48 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 163.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -96.76 135.24 38.98 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.293 0.637 . . . . 0.0 111.17 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.45 105.35 17.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 110.858 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -78.71 -41.59 30.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.15 -91.3 0.08 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -85.1 5.24 30.52 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 159.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -121.47 123.57 42.36 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.964 1.256 . . . . 0.0 109.508 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 mt -86.58 100.9 12.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 159.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 tp -89.03 107.27 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-O 122.005 0.907 . . . . 0.0 109.289 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.53 100.89 1.87 Allowed Glycine 0 N--CA 1.475 1.299 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.334 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.08 96.06 10.57 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -113.63 154.47 27.16 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.182 0.991 . . . . 0.0 111.702 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -146.1 147.35 31.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.71 -1.244 . . . . 0.0 111.767 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -72.44 149.43 44.23 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p -72.92 -46.62 51.6 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.007 -1.058 . . . . 0.0 112.969 152.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -50.01 5.59 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -174.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.52 20.89 5.15 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.63 -16.18 3.29 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 120.434 2.934 . . . . 0.0 120.434 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -83.29 146.28 28.62 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 118.717 1.259 . . . . 0.0 113.982 -157.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -69.69 130.85 43.48 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.34 111.62 23.29 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.77 162.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -91.23 112.58 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 109.936 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -114.75 136.24 53.29 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.413 0.685 . . . . 0.0 111.135 -170.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.66 114.11 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 120.868 -1.145 . . . . 0.0 108.838 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -96.53 112.85 24.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.913 -1.117 . . . . 0.0 109.725 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.83 140.52 32.97 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-O 121.221 0.534 . . . . 0.0 112.322 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.9 120.16 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.45 -1.406 . . . . 0.0 109.594 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -97.88 75.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 123.93 0.892 . . . . 0.0 110.737 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.65 -89.51 1.24 Allowed Glycine 0 N--CA 1.492 2.41 0 O-C-N 120.523 -1.361 . . . . 0.0 114.453 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -126.1 36.2 4.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 170.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -136.09 121.33 19.09 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.299 1.039 . . . . 0.0 108.227 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -78.63 108.63 12.18 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.216 0.607 . . . . 0.0 109.423 167.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.4 m -90.69 114.07 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -95.38 99.31 11.24 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.2 m -92.17 96.75 10.49 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 -167.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -100.66 115.58 30.55 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.863 0.865 . . . . 0.0 110.834 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -113.99 115.78 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -118.46 117.93 30.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.725 -0.609 . . . . 0.0 109.445 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.259 0.1 OUTLIER 41.62 66.06 0.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.4 -35.25 2.43 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.1 118.49 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.294 1.547 . . . . 0.0 109.609 -164.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.71 146.04 24.32 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.223 1.011 . . . . 0.0 112.663 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.26 146.23 44.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.735 0.779 . . . . 0.0 111.663 156.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -118.86 101.99 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -82.71 102.81 11.76 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.7 mt -100.17 115.96 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -167.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -108.27 120.47 42.47 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.335 0.654 . . . . 0.0 110.044 -175.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -81.48 156.5 25.29 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.954 0.883 . . . . 0.0 112.774 175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -65.17 122.61 17.48 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.464 -0.773 . . . . 0.0 112.869 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.265 10.7 t70 . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 125.403 1.481 . . . . 0.0 110.529 -167.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 121.65 0.738 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.88 12.65 7.3 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.72 83.91 7.74 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -163.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 t -148.91 -173.11 4.27 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 122.794 1.283 . . . . 0.0 111.119 168.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.8 m -91.3 123.78 35.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.018 -1.051 . . . . 0.0 109.614 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -132.95 115.83 15.69 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.011 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -112.56 146.17 39.01 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 120.256 1.389 . . . . 0.0 112.993 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.99 115.12 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.17 -64.42 1.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.771 0.829 . . . . 0.0 111.454 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -138.61 118.9 13.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.255 0.622 . . . . 0.0 111.177 -169.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.6 p -102.59 121.06 41.63 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.373 0.669 . . . . 0.0 111.412 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -103.89 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.495 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -77.27 38.09 0.22 Allowed 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 121.26 1.846 . . . . 0.0 115.816 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.0 -42.66 37.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -171.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.7 p30 -64.31 -27.9 69.35 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -78.99 -42.65 26.14 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -45.81 -51.21 13.22 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 161.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.2 mtp -66.88 -30.44 70.61 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.92 -49.57 76.31 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 165.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -57.03 -33.69 67.45 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 166.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 44.9 mtp -64.71 -50.66 66.08 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 165.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.97 67.72 0.27 Allowed Glycine 0 N--CA 1.489 2.231 0 CA-C-N 119.029 0.831 . . . . 0.0 114.407 177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.45 149.82 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.867 0.841 . . . . 0.0 110.789 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -79.73 159.95 26.43 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -171.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.305 10.8 tp -49.44 -47.35 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.73 -46.67 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -76.45 -37.78 56.42 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -49.57 -46.13 48.59 Favored 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 121.287 1.858 . . . . 0.0 115.355 161.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -64.27 -57.17 10.2 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -56.75 -35.05 68.17 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.78 97.8 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.74 93.34 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 164.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -93.17 42.02 1.09 Allowed 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -77.89 -23.88 48.6 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 60.71 47.06 8.46 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -170.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.79 108.07 4.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 111.826 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -99.5 108.2 20.58 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.347 0.659 . . . . 0.0 109.343 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.25 100.83 12.04 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.703 0.801 . . . . 0.0 109.07 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.0 m -93.98 98.04 10.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.9 mt -97.79 122.72 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -165.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -117.89 106.84 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.86 88.44 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.952 0.882 . . . . 0.0 111.264 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -80.12 46.21 0.79 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.6 83.3 0.49 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.732 -1.23 . . . . 0.0 114.719 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.317 24.7 m120 72.08 -40.4 0.47 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 -174.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -74.41 145.72 43.49 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.498 1.142 . . . . 0.0 113.081 164.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.03 109.95 13.57 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 0.0 108.595 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.8 m -89.51 99.97 12.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.32 104.12 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -85.6 104.37 15.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.613 -0.679 . . . . 0.0 109.779 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -93.7 99.24 11.69 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.943 0.897 . . . . 0.0 109.383 -173.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 t -104.7 114.03 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.1 0.56 . . . . 0.0 111.505 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -143.78 175.71 9.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -59.62 -33.12 71.09 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 163.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -85.56 -46.58 10.69 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -143.74 142.69 31.05 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.786 0.834 . . . . 0.0 111.875 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -126.48 92.4 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.73 144.46 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -164.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 112.25 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.913 -1.117 . . . . 0.0 112.065 171.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -99.15 105.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.22 115.21 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -135.78 146.9 48.09 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.702 -0.624 . . . . 0.0 112.504 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -99.51 151.95 20.56 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.136 0.969 . . . . 0.0 111.591 164.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.22 122.99 16.45 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 -3.99 85.22 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.27 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.581 2.191 . . . . 0.0 110.637 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.7 p -75.04 106.81 6.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.584 -0.698 . . . . 0.0 111.122 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -140.17 161.61 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.643 0.735 . . . . 0.0 112.487 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.93 104.13 12.07 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 111.775 170.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -86.77 -177.36 6.09 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 122.06 0.933 . . . . 0.0 111.775 164.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.29 152.16 51.24 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.8 mt -85.9 160.74 19.33 Favored 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 121.372 0.606 . . . . 0.0 110.506 146.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.47 -46.11 63.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.96 -68.22 0.4 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 124.189 0.996 . . . . 0.0 113.514 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.35 87.59 0.07 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.1 m -148.77 110.65 4.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.073 -0.663 . . . . 0.0 109.685 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 93.41 4.33 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 125.947 1.699 . . . . 0.0 113.161 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.8 mt -100.4 99.53 10.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 112.328 -171.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -85.54 117.8 24.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.878 -1.139 . . . . 0.0 113.283 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.56 -171.25 44.35 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 116.969 1.548 . . . . 0.0 116.969 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -115.28 117.81 31.52 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 118.595 -0.716 . . . . 0.0 111.652 -170.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -74.53 107.14 6.47 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.155 0.889 . . . . 0.0 110.784 160.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -119.58 135.82 54.63 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.591 0.756 . . . . 0.0 111.324 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -86.59 107.46 18.16 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.801 -1.187 . . . . 0.0 111.691 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.44 80.42 2.23 Favored 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.602 1.161 . . . . 0.0 109.915 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.15 -98.85 0.83 Allowed Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.511 -0.743 . . . . 0.0 113.772 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -88.05 -35.77 17.35 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 161.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -75.73 121.82 23.09 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.197 0.908 . . . . 0.0 112.409 -164.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mt -80.6 96.85 6.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.0 109.169 166.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 tp -90.59 116.73 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.102 0.961 . . . . 0.0 109.491 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.0 100.48 1.58 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.667 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.4 86.71 7.24 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -109.47 112.96 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.237 0.615 . . . . 0.0 111.942 -164.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -89.37 130.97 35.66 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.195 -0.941 . . . . 0.0 111.293 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.89 114.3 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.975 . . . . 0.0 110.477 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.8 m -59.56 -49.97 75.71 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -162.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.295 3.4 t70 -72.76 -17.29 61.61 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.61 -58.79 3.02 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.691 1.587 . . . . 0.0 114.545 162.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.52 44.13 9.72 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 -146.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -142.94 139.48 30.72 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 119.175 1.487 . . . . 0.0 111.357 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.14 138.96 31.1 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.665 2.469 . . . . 0.0 117.665 -163.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.36 111.86 16.28 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.591 1.556 . . . . 0.0 108.253 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -100.35 115.97 31.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 110.987 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.4 p -109.83 115.19 29.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.594 0.758 . . . . 0.0 111.003 -169.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.73 116.9 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 119.467 1.03 . . . . 0.0 109.266 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -94.35 124.86 38.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.195 0.598 . . . . 0.0 110.908 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.48 42.08 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.508 0.671 . . . . 0.0 111.0 174.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.4 mm -95.92 109.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.691 -1.256 . . . . 0.0 108.571 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.258 10.3 tp -79.71 63.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 122.439 1.114 . . . . 0.0 112.904 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.04 -77.88 1.12 Allowed Glycine 0 N--CA 1.49 2.238 0 O-C-N 120.556 -1.34 . . . . 0.0 115.07 -170.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -97.14 -45.19 6.63 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -96.95 148.63 22.77 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.971 0.908 . . . . 0.0 112.956 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.6 tp -85.56 114.71 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.901 -1.124 . . . . 0.0 110.411 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.3 m -87.8 123.93 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.784 . . . . 0.0 109.776 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -104.94 98.69 8.37 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 164.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.2 m -95.05 106.76 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -109.07 115.61 30.38 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.596 0.758 . . . . 0.0 110.273 -171.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.18 110.06 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -98.5 105.98 18.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 119.942 1.246 . . . . 0.0 109.682 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 46.89 50.2 13.84 Favored 'General case' 0 CA--C 1.58 2.101 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.96 -40.49 2.42 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.16 116.34 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-N 120.48 2.14 . . . . 0.0 112.373 -170.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -92.32 138.68 31.31 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-O 121.729 0.776 . . . . 0.0 112.921 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.37 142.31 47.15 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.678 0.791 . . . . 0.0 111.609 164.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -123.43 101.94 7.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -83.06 117.65 22.99 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 166.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -104.82 123.09 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -108.8 127.64 54.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.965 0.906 . . . . 0.0 111.151 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -85.26 148.74 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.997 0.903 . . . . 0.0 112.899 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.89 123.95 31.81 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.196 0.598 . . . . 0.0 112.338 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.491 1.597 0 C-N-CA 125.088 1.355 . . . . 0.0 112.592 174.121 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.594 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.353 82.2 m-85 69.79 -67.93 0.21 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.72 72.96 5.27 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 119.949 1.249 . . . . 0.0 113.269 -171.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.9 p -156.43 -178.01 7.02 Favored 'General case' 0 CA--C 1.573 1.856 0 C-N-CA 124.42 1.088 . . . . 0.0 111.818 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.1 m -84.26 128.75 34.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.94 -1.1 . . . . 0.0 110.915 169.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -129.39 114.55 16.31 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -101.86 141.37 34.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.286 -0.884 . . . . 0.0 112.394 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.69 93.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.873 -1.142 . . . . 0.0 113.916 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.88 -45.74 9.48 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -143.64 152.72 41.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 111.354 -167.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.5 m -159.65 150.77 19.62 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.362 -2.086 . . . . 0.0 112.994 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -89.89 -123.76 0.06 Allowed 'General case' 0 CA--C 1.578 2.045 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.22 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.295 0.1 OUTLIER -77.22 49.8 0.72 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 122.448 2.385 . . . . 0.0 116.776 -174.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -47.72 83.58 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.449 1.5 . . . . 0.0 114.745 176.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -65.92 -36.84 84.49 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.72 -44.18 74.4 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 120.177 1.353 . . . . 0.0 114.496 170.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -46.8 -56.73 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.9 mtt -67.21 -28.63 68.24 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -59.09 -48.27 82.2 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.82 1.645 . . . . 0.0 115.145 161.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -62.53 -36.2 81.85 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 mtp -59.09 -59.38 5.57 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.29 69.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.5 0.591 . . . . 0.0 114.456 171.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG13 ' HG2' ' A' ' 28' ' ' ARG . 3.3 p -148.43 136.56 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.932 0 CA-C-O 121.92 0.867 . . . . 0.0 110.17 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -82.42 164.65 20.86 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.27 33.1 pt -55.59 -40.17 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 -169.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.41 -48.9 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -70.67 -36.03 73.13 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HG2' HG13 ' A' ' 23' ' ' VAL . 43.5 mtm-85 -65.45 -42.3 92.48 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 167.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -55.53 -39.74 70.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.01 -60.93 2.78 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.508 160.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.75 74.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -173.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.37 71.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 161.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -124.52 41.9 3.39 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 123.741 0.816 . . . . 0.0 112.903 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.12 11.31 4.26 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -170.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.264 20.0 m-80 56.1 49.63 15.2 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -168.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.93 113.97 14.03 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 122.252 1.025 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -112.82 118.61 35.42 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.683 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.3 mt -101.6 97.45 7.88 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.9 m -95.01 115.02 26.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 49' ' ' VAL . 63.2 mt -110.36 127.09 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -164.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -140.07 116.52 10.7 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.585 -0.697 . . . . 0.0 111.139 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -71.54 114.55 9.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -90.75 86.47 6.35 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.447 0.642 . . . . 0.0 109.292 165.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.79 23.23 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 117.431 1.732 . . . . 0.0 117.431 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.346 33.1 m120 65.59 -0.5 1.22 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 119.121 3.008 . . . . 0.0 119.121 -164.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -95.7 107.56 19.78 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 120.484 1.493 . . . . 0.0 109.384 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.38 105.69 8.66 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.047 0.939 . . . . 0.0 111.515 -169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 79.0 m -79.86 95.51 6.08 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.415 HG12 HG12 ' A' ' 40' ' ' ILE . 35.8 m -95.14 112.38 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.62 74.58 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.731 -169.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -84.68 101.42 12.16 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.56 0.695 . . . . 0.0 109.665 -158.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.6 m -114.91 101.96 9.53 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.872 -156.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 p -137.13 176.06 9.05 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.6 t -66.98 -9.68 41.28 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 168.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.26 -55.71 4.18 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 120.589 1.541 . . . . 0.0 113.156 166.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -155.42 140.65 17.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 118.703 0.683 . . . . 0.0 110.662 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -108.51 93.28 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.2 pt -116.83 115.6 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.249 0.547 . . . . 0.0 110.501 -163.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.69 90.2 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.13 116.11 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -166.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.03 92.83 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -104.58 134.07 48.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.02 153.0 41.07 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 112.435 166.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.7 mt -73.71 73.94 1.53 Allowed 'General case' 0 CA--C 1.577 2.002 0 O-C-N 120.966 -1.084 . . . . 0.0 111.845 164.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.39 -63.18 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -167.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -57.36 146.06 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -171.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 p -83.1 106.2 14.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.4 -0.813 . . . . 0.0 110.925 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -129.87 154.98 46.75 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 123.466 0.706 . . . . 0.0 112.612 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -82.01 119.92 24.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 111.579 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -94.11 -40.62 9.95 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . 0.266 5.6 m120 76.8 99.07 0.07 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 168.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -87.0 111.78 21.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.149 -0.969 . . . . 0.0 112.346 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.298 . . 46.13 -88.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 118.767 2.877 . . . . 0.0 118.767 161.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.79 -58.37 7.04 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 -34.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 120.352 2.901 . . . . 0.0 120.352 -166.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -67.69 108.98 3.12 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-N 120.778 2.289 . . . . 0.0 113.963 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.303 22.8 pt-20 -86.7 95.95 9.97 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-O 123.104 1.43 . . . . 0.0 112.371 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.92 111.94 8.5 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.73 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -94.37 122.18 36.66 Favored 'General case' 0 CA--C 1.559 1.32 0 O-C-N 121.951 -0.468 . . . . 0.0 111.625 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.83 -152.38 21.6 Favored Glycine 0 N--CA 1.483 1.799 0 N-CA-C 115.573 0.989 . . . . 0.0 115.573 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.3 p -130.52 115.57 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.741 -155.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -80.42 142.42 34.35 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.509 0.671 . . . . 0.0 110.456 157.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.7 m -153.05 146.31 24.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.58 -1.325 . . . . 0.0 110.826 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.7 tp -88.24 102.61 14.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.89 -1.131 . . . . 0.0 111.36 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.0 93.77 7.59 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.324 0.65 . . . . 0.0 109.455 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.17 -100.99 0.76 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 121.368 -0.833 . . . . 0.0 113.668 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -89.95 -33.07 16.54 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 161.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -80.76 133.19 35.61 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.845 1.657 . . . . 0.0 112.554 -161.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.14 101.07 7.71 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 120.721 -1.237 . . . . 0.0 109.562 163.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.7 tp -89.84 111.81 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.737 0.815 . . . . 0.0 109.866 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.89 98.18 2.12 Favored Glycine 0 N--CA 1.48 1.582 0 C-N-CA 123.924 0.773 . . . . 0.0 113.06 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.48 103.58 16.25 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -121.52 150.5 41.52 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.235 1.017 . . . . 0.0 112.409 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -118.37 140.27 50.1 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 123.642 0.777 . . . . 0.0 109.487 169.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -66.11 125.2 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.722 -1.236 . . . . 0.0 112.049 169.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.2 m -70.89 -43.31 68.6 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.46 -0.775 . . . . 0.0 113.022 171.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -51.05 -56.92 10.2 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 165.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.75 -40.23 9.46 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.62 -9.78 60.65 Favored Glycine 0 CA--C 1.556 2.595 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.79 150.07 28.07 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 119.689 1.744 . . . . 0.0 112.841 -172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -85.46 143.7 28.41 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -173.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -131.92 134.87 46.15 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 124.48 1.112 . . . . 0.0 110.179 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -119.5 109.16 15.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.68 120.33 41.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.627 -0.67 . . . . 0.0 112.119 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.43 110.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.266 -0.896 . . . . 0.0 109.002 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 mtm-85 -92.75 116.38 28.97 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 121.586 -0.696 . . . . 0.0 110.766 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -137.51 149.43 46.77 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.769 0.828 . . . . 0.0 111.601 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -99.76 115.14 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.79 -1.194 . . . . 0.0 108.391 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.0 pt -80.73 -27.96 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.31 -93.58 0.09 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.11 34.88 2.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 159.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -145.15 128.87 17.21 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.114 0.966 . . . . 0.0 109.865 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.98 110.05 20.29 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.742 0.817 . . . . 0.0 109.641 170.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.17 114.08 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -109.45 91.64 3.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.5 m -93.98 98.38 10.99 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.403 0.681 . . . . 0.0 110.073 -166.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -86.12 98.78 11.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.732 0.813 . . . . 0.0 111.542 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.12 106.88 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -120.3 109.7 15.69 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 53.61 50.5 17.05 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.86 -27.8 4.25 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 -167.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.0 t -87.74 113.92 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.694 1.747 . . . . 0.0 109.524 -170.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -104.87 101.53 11.12 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.398 0.679 . . . . 0.0 111.978 -169.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.31 102.97 14.84 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 112.377 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -81.48 99.22 8.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.097 0.559 . . . . 0.0 110.226 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -99.71 109.87 22.31 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.93 120.1 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.673 -1.267 . . . . 0.0 108.768 -159.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -116.2 123.65 48.31 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.517 0.727 . . . . 0.0 110.014 -168.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.06 156.8 31.5 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 119.986 1.266 . . . . 0.0 113.526 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -64.49 99.98 0.34 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 123.845 0.858 . . . . 0.0 113.147 174.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 4.8 t0 . . . . . 0 C--O 1.256 1.399 0 C-N-CA 125.407 1.483 . . . . 0.0 114.355 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.317 0 CA-C-O 121.57 0.7 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.322 86.3 m-85 73.82 -54.86 0.68 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -71.24 92.49 1.02 Allowed 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 120.083 1.311 . . . . 0.0 113.522 -164.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -177.04 171.21 2.14 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 125.211 1.405 . . . . 0.0 110.877 -171.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.4 m -90.02 126.83 35.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.941 -1.099 . . . . 0.0 110.7 171.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -128.62 109.32 11.25 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.123 0.569 . . . . 0.0 110.07 -173.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -104.18 143.72 32.55 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.233 0.924 . . . . 0.0 113.067 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.43 120.56 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.72 -66.08 0.94 Allowed 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 123.486 0.715 . . . . 0.0 110.683 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -137.14 117.98 14.14 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.936 0.494 . . . . 0.0 111.223 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.1 p -93.1 100.13 12.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.704 -0.622 . . . . 0.0 110.176 166.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.74 -80.4 0.07 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -155.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -88.29 44.36 1.19 Allowed 'General case' 0 CA--C 1.579 2.081 0 CA-C-N 120.32 1.418 . . . . 0.0 113.451 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -80.33 -45.29 18.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.387 -1.446 . . . . 0.0 114.827 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.71 -21.16 65.56 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.36 -40.95 17.24 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 120.331 1.423 . . . . 0.0 114.799 165.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -47.43 -49.98 23.89 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 120.971 1.714 . . . . 0.0 115.534 158.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.61 ' SD ' HG21 ' A' ' 23' ' ' VAL . 20.9 mmt -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 165.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -54.17 -44.43 71.48 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -58.16 -40.63 81.89 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 165.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -40.17 95.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 169.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.35 65.37 0.63 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 119.055 0.843 . . . . 0.0 114.177 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' A' ' 18' ' ' MET . 15.4 m -128.13 148.38 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 122.274 1.035 . . . . 0.0 112.511 -167.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.91 159.2 33.14 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.275 14.2 tt -53.3 -38.67 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.93 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.264 0.938 . . . . 0.0 113.198 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -56.27 -43.81 79.16 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -60.33 -38.63 84.35 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -67.95 -54.93 14.87 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 166.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.38 -36.04 77.13 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.45 -39.73 74.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.68 81.36 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 163.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -97.92 49.47 1.02 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 119.288 0.949 . . . . 0.0 113.532 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -83.31 -12.25 56.84 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 58.34 36.06 25.27 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.91 122.94 20.88 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 122.288 1.042 . . . . 0.0 112.674 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -118.42 111.79 19.13 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.032 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.61 98.98 10.07 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 m -92.04 100.24 12.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.835 . . . . 0.0 109.007 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.0 mt -87.56 122.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.1 p -130.48 109.73 10.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -94.69 102.68 14.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.825 -1.172 . . . . 0.0 110.918 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.1 pm0 -75.09 -34.87 61.8 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.54 81.42 0.05 OUTLIER Glycine 0 N--CA 1.486 2.003 0 CA-C-N 119.18 0.9 . . . . 0.0 111.83 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER 74.32 -56.41 0.64 Allowed 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -160.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -60.53 139.54 57.72 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -104.62 114.47 28.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.823 0.449 . . . . 0.0 109.855 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.0 m -88.55 96.75 10.75 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.494 HG11 HH22 ' A' ' 106' ' ' ARG . 25.7 t -101.03 112.04 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -83.35 102.31 11.92 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.47 -0.769 . . . . 0.0 109.069 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -97.05 101.18 12.7 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -174.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.1 t -116.11 115.51 26.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.072 0.549 . . . . 0.0 112.412 -165.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -150.04 179.03 8.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -166.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -62.45 -43.69 98.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 164.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -71.1 -42.1 69.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 172.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -149.16 130.02 14.25 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.415 1.007 . . . . 0.0 111.209 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -119.99 86.99 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.22 144.74 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.676 -0.64 . . . . 0.0 111.657 -158.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.68 116.03 28.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.706 -1.246 . . . . 0.0 111.902 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.34 99.59 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.67 95.73 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.88 130.18 53.07 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.268 0.556 . . . . 0.0 112.477 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -92.22 145.51 24.44 Favored 'General case' 0 CA--C 1.568 1.672 0 CA-C-O 122.353 1.073 . . . . 0.0 111.062 166.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.23 128.05 32.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.163 -0.961 . . . . 0.0 112.234 -168.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 -8.66 59.25 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 119.161 2.424 . . . . 0.0 119.161 -167.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.21 137.14 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 119.904 1.852 . . . . 0.0 110.813 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 95.62 5.68 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 121.711 0.767 . . . . 0.0 111.77 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -120.9 165.18 15.56 Favored 'General case' 0 CA--C 1.573 1.852 0 C-N-CA 124.401 1.08 . . . . 0.0 111.851 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -82.06 125.68 31.11 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.863 -1.148 . . . . 0.0 113.011 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -139.69 72.12 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.819 -0.55 . . . . 0.0 110.763 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -77.75 146.45 35.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.938 . . . . 0.0 113.086 -172.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.8 mt -65.73 -30.25 70.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.317 . . 74.03 -46.36 0.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -166.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -66.98 -57.39 6.97 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 163.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.75 -62.87 0.68 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 118.239 2.055 . . . . 0.0 118.239 -163.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 t -149.81 165.94 30.97 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -164.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -94.14 120.21 34.07 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 125.19 1.396 . . . . 0.0 109.744 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.1 mt -127.88 131.14 49.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 112.164 -164.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -120.17 134.24 55.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.577 -0.702 . . . . 0.0 110.711 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.73 -178.62 43.81 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 118.944 2.337 . . . . 0.0 118.944 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.1 p -118.3 120.09 36.6 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.408 -1.396 . . . . 0.0 110.992 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.25 111.45 20.43 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 163.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 m -87.51 -38.37 16.1 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . 0.267 39.3 tp 62.01 86.74 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.957 1.303 . . . . 0.0 113.586 -167.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -86.45 83.57 7.62 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.18 0.99 . . . . 0.0 109.956 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.98 -96.14 0.59 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -98.26 -9.43 25.55 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -108.7 122.31 46.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.13 1.786 . . . . 0.0 110.383 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -73.44 102.02 3.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.809 -1.182 . . . . 0.0 109.84 168.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -97.27 123.3 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-O 121.523 0.677 . . . . 0.0 109.761 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.98 102.22 0.67 Allowed Glycine 0 N--CA 1.481 1.655 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.11 -170.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -84.29 98.92 10.26 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.301 0.551 . . . . 0.0 110.301 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -107.09 105.91 16.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.157 0.98 . . . . 0.0 110.019 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -90.01 133.1 35.01 Favored 'General case' 0 CA--C 1.561 1.391 0 O-C-N 121.639 -0.663 . . . . 0.0 110.938 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -62.38 122.7 16.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.3 p -71.19 -26.6 63.03 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -64.98 -57.47 8.63 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 164.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -111.35 -46.77 3.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 38.71 6.14 Favored Glycine 0 CA--C 1.555 2.532 0 N-CA-C 118.562 2.185 . . . . 0.0 118.562 -165.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -83.82 -8.04 59.31 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.301 4.9 tt0 72.18 99.49 0.07 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 175.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.5 tt -99.86 114.88 28.38 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.871 0.868 . . . . 0.0 110.229 172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -99.71 113.33 25.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.0 m -103.42 122.4 44.79 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 122.832 0.453 . . . . 0.0 110.759 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.57 111.06 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.494 HH22 HG11 ' A' ' 49' ' ' VAL . 27.7 mtp180 -105.29 113.05 26.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.375 0.67 . . . . 0.0 109.739 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.91 158.38 44.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.442 -0.786 . . . . 0.0 112.634 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.98 111.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.993 -1.067 . . . . 0.0 108.261 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.253 10.9 tp -85.5 68.26 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 CA-C-O 122.341 1.067 . . . . 0.0 111.744 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.77 -84.55 1.0 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 120.795 -1.191 . . . . 0.0 114.698 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.35 -17.39 18.05 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -118.46 131.34 56.26 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.336 1.425 . . . . 0.0 111.334 -168.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.8 tp -79.63 109.88 14.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 110.209 169.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.4 114.04 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.57 99.29 9.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.459 -0.776 . . . . 0.0 109.231 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.4 m -100.01 105.67 17.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -84.18 102.3 12.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.198 0.599 . . . . 0.0 110.561 170.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.83 112.12 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.403 ' OH ' ' OE2' ' A' ' 120' ' ' GLU . 16.6 t80 -128.89 107.03 9.31 Favored 'General case' 0 CA--C 1.564 1.497 0 O-C-N 121.779 -0.576 . . . . 0.0 110.818 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.403 ' OE2' ' OH ' ' A' ' 119' ' ' TYR 0.406 15.4 pt-20 39.56 64.57 0.83 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.56 -33.13 4.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -168.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.61 117.81 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 119.341 1.57 . . . . 0.0 109.758 -162.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.21 144.95 25.97 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.84 144.29 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 161.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -122.98 104.01 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.48 -0.762 . . . . 0.0 109.226 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -80.7 105.44 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 162.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.9 mt -97.91 123.26 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -109.44 125.37 52.35 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.441 0.696 . . . . 0.0 110.218 -171.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -81.39 165.54 21.22 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.573 0.701 . . . . 0.0 112.248 169.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -71.54 100.45 2.25 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 120.869 -1.144 . . . . 0.0 112.09 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 7.3 t0 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 125.2 1.4 . . . . 0.0 114.012 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.292 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -106.63 66.06 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.349 0.977 . . . . 0.0 112.5 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -155.69 81.87 1.03 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.022 . . . . 0.0 109.884 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -167.74 171.19 10.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.126 -0.984 . . . . 0.0 112.052 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.1 m -71.84 117.29 13.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.92 . . . . 0.0 111.138 161.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -114.64 101.87 9.5 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -92.69 135.99 33.62 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.476 0.711 . . . . 0.0 112.685 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.22 117.58 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -100.57 -62.88 1.19 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.723 0.809 . . . . 0.0 111.302 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.73 129.59 47.36 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.02 0.914 . . . . 0.0 110.946 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m -113.27 115.32 28.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -87.71 -57.78 2.82 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.894 0.478 . . . . 0.0 112.27 -165.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -121.15 145.83 47.41 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -163.21 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.077 0.951 . . . . 0.0 111.305 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -35.48 80.65 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.714 2.116 . . . . 0.0 116.714 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -67.29 -37.14 82.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 165.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.6 -52.09 63.27 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 163.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.6 mtp -58.54 -37.44 75.68 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.4 -43.9 75.68 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -62.55 -44.84 95.35 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 166.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.0 mtm -58.22 -44.1 88.04 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.508 2.04 . . . . 0.0 116.508 175.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.17 63.02 0.1 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.6 143.59 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-O 122.483 1.135 . . . . 0.0 111.139 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -82.05 163.11 22.3 Favored 'General case' 0 CA--C 1.573 1.835 0 O-C-N 120.853 -1.155 . . . . 0.0 113.742 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.8 tp -64.0 157.46 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 O-C-N 121.03 -1.044 . . . . 0.0 113.24 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.389 21.8 t 80.48 -61.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 C-N-CA 124.346 1.058 . . . . 0.0 110.7 -162.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -56.2 -47.42 78.4 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 162.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -61.83 -16.6 51.45 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 164.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -85.67 -44.31 12.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.21 1.368 . . . . 0.0 113.462 164.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.96 -48.89 69.84 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 166.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.76 -18.66 62.11 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.09 -58.51 3.98 Favored 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 119.912 1.233 . . . . 0.0 113.019 158.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -88.1 49.39 1.79 Allowed 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -79.78 -30.43 40.64 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 63.91 55.41 1.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 119.713 1.142 . . . . 0.0 112.547 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.3 tp -79.81 113.25 17.82 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.957 0.884 . . . . 0.0 111.658 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -107.15 101.36 10.77 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.048 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.34 93.85 8.81 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.4 m -90.37 94.34 9.7 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.59 0.709 . . . . 0.0 110.336 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.486 HD11 HH21 ' A' ' 106' ' ' ARG . 24.5 mt -80.77 124.47 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.674 0.79 . . . . 0.0 109.389 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.5 p -133.12 104.54 6.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -92.24 115.87 28.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.65 -1.281 . . . . 0.0 112.274 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -74.92 -41.29 59.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.7 -84.09 0.05 OUTLIER Glycine 0 N--CA 1.489 2.208 0 O-C-N 121.126 -0.984 . . . . 0.0 111.42 171.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -82.02 -49.73 9.91 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 157.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -64.87 119.71 11.17 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -85.58 115.95 23.58 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.1 m -95.86 99.44 11.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.1 t -96.53 103.89 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.32 100.38 8.36 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 123.297 0.639 . . . . 0.0 110.062 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -86.92 97.3 10.61 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 123.419 0.688 . . . . 0.0 109.433 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -107.03 113.11 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.075 0.55 . . . . 0.0 110.317 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 p -145.49 -170.45 3.45 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.21 1.005 . . . . 0.0 113.292 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.2 m -62.0 -47.31 85.38 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.901 -1.125 . . . . 0.0 113.441 165.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -63.17 -48.77 76.99 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -142.09 163.05 33.92 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -160.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -143.43 88.68 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.111 163.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 141.62 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.261 -0.9 . . . . 0.0 112.429 -173.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -84.72 115.31 22.61 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 121.398 -0.814 . . . . 0.0 112.708 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.24 98.32 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -87.39 114.07 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -127.44 124.1 37.64 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.757 0.789 . . . . 0.0 112.824 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.29 148.44 29.42 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-O 121.683 0.754 . . . . 0.0 111.478 164.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.52 88.46 2.68 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.758 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.07 -47.38 0.69 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -160.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.9 t -75.7 136.88 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 118.716 1.258 . . . . 0.0 112.264 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.3 p -89.84 120.12 30.8 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.304 -0.872 . . . . 0.0 110.35 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.82 156.8 47.03 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 121.971 0.891 . . . . 0.0 112.737 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.26 97.78 10.97 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.519 0.676 . . . . 0.0 110.479 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -84.31 97.94 9.73 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 121.531 -0.731 . . . . 0.0 110.299 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.41 133.07 39.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.579 -0.7 . . . . 0.0 112.057 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.38 171.95 13.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.78 69.43 1.81 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 123.052 1.406 . . . . 0.0 113.407 168.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 t70 179.57 -93.66 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 -156.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.34 50.48 0.02 OUTLIER Glycine 0 CA--C 1.548 2.099 0 C-N-CA 124.643 1.116 . . . . 0.0 112.891 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.5 m -143.4 113.71 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -158.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.39 130.12 35.03 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.42 120.46 38.21 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.705 1.202 . . . . 0.0 108.876 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -113.4 108.79 17.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.389 -1.444 . . . . 0.0 111.1 -159.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.22 -149.19 18.97 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 115.096 0.798 . . . . 0.0 115.096 -172.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.9 m -140.78 147.26 38.82 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.01 0.91 . . . . 0.0 112.314 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -92.45 117.61 30.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.014 163.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -111.74 144.34 41.18 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.375 0.67 . . . . 0.0 111.586 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.3 tp -87.77 103.36 15.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.732 -1.23 . . . . 0.0 110.861 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.92 84.86 4.99 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.966 0.888 . . . . 0.0 108.848 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.34 -97.05 0.44 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -95.28 -19.97 19.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -89.17 124.24 34.17 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.639 1.563 . . . . 0.0 111.19 -172.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -82.54 100.07 9.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.772 -1.205 . . . . 0.0 108.967 164.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.1 tt -95.79 110.32 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-O 122.131 0.967 . . . . 0.0 109.893 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.7 93.15 1.85 Allowed Glycine 0 N--CA 1.481 1.645 0 C-N-CA 124.005 0.812 . . . . 0.0 112.363 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -86.41 94.65 9.44 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -118.41 131.18 56.29 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.277 0.631 . . . . 0.0 109.719 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -90.41 134.72 34.15 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.953 -1.092 . . . . 0.0 110.131 164.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.23 105.88 1.52 Allowed 'General case' 0 CA--C 1.566 1.573 0 O-C-N 120.824 -1.173 . . . . 0.0 110.653 169.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -42.93 -59.63 1.92 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -163.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.69 67.42 0.67 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 123.568 1.651 . . . . 0.0 107.497 -169.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -58.53 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.71 0 CA-C-N 112.898 -1.955 . . . . 0.0 108.068 -162.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.27 45.37 5.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 116.182 1.233 . . . . 0.0 116.182 -171.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -139.81 126.3 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 117.843 0.821 . . . . 0.0 109.883 -166.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -76.74 127.12 32.16 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.91 109.58 21.51 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.557 0.743 . . . . 0.0 109.281 161.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -98.77 122.38 41.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.723 -0.611 . . . . 0.0 110.438 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.02 94.17 4.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.02 -0.425 . . . . 0.0 110.217 -159.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.94 105.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 119.764 -1.835 . . . . 0.0 108.99 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.486 HH21 HD11 ' A' ' 40' ' ' ILE . 9.6 ptm180 -102.89 113.34 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 118.834 0.743 . . . . 0.0 110.506 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -135.2 154.03 51.75 Favored 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 123.946 0.899 . . . . 0.0 111.06 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -86.57 108.71 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.692 -1.255 . . . . 0.0 109.627 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.7 tp -88.68 72.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 121.997 0.903 . . . . 0.0 111.117 172.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.59 0.5 Allowed Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.06 -1.025 . . . . 0.0 115.122 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -91.15 -14.07 31.81 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -134.3 145.57 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 119.443 1.019 . . . . 0.0 112.283 -161.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.2 tp -82.4 105.97 13.9 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.722 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.1 p -87.5 108.15 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -0.778 . . . . 0.0 110.209 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -98.96 106.25 18.48 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.114 0.566 . . . . 0.0 110.278 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.7 m -98.1 110.73 23.26 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.83 0.852 . . . . 0.0 109.78 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -98.9 105.99 18.2 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.542 1.137 . . . . 0.0 108.373 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.2 t -98.92 110.12 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -139.23 127.08 22.11 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.543 0.737 . . . . 0.0 110.86 -175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 50.66 45.17 27.23 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.63 -15.5 7.61 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 119.688 2.635 . . . . 0.0 119.688 -166.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.87 119.46 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.631 0 CA-C-N 119.618 1.709 . . . . 0.0 108.958 -169.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.96 120.89 33.04 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.32 0.648 . . . . 0.0 110.565 172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.92 136.31 54.81 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.53 0.732 . . . . 0.0 112.306 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -126.53 117.99 23.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 109.912 -172.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -109.96 116.75 32.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.06 120.03 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -108.95 126.21 52.85 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 123.842 0.857 . . . . 0.0 110.172 -171.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -91.85 153.92 19.23 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.174 0.988 . . . . 0.0 113.125 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -63.34 112.93 2.93 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.289 5.3 m-20 . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 126.221 1.809 . . . . 0.0 108.436 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . 0.317 73.9 m-85 73.12 -47.86 0.67 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.11 94.63 2.44 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 -170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 m -173.73 177.53 2.45 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.581 1.552 . . . . 0.0 110.532 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.6 m -92.96 129.07 39.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 119.915 -1.741 . . . . 0.0 111.05 168.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -124.18 104.76 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.236 0.614 . . . . 0.0 109.871 -168.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -89.82 133.37 34.76 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.511 0.724 . . . . 0.0 111.238 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 36' ' ' LEU . 2.3 p -68.34 111.91 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.382 -0.823 . . . . 0.0 112.444 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.64 -62.79 1.51 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.276 0.631 . . . . 0.0 111.747 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -143.52 116.29 8.74 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 121.75 0.786 . . . . 0.0 109.788 -168.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.3 m -99.57 127.65 45.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.271 0.628 . . . . 0.0 110.729 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.317 5.7 tm-20 -74.82 -93.59 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -167.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -96.82 39.25 1.18 Allowed 'General case' 0 CA--C 1.577 1.982 0 O-C-N 120.477 -1.389 . . . . 0.0 113.72 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.27 -36.99 58.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.91 -35.64 78.99 Favored 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 166.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -71.28 -40.07 71.15 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 167.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -47.44 -50.45 22.87 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 157.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.5 mmt -59.3 -42.39 91.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -59.09 -44.67 91.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 166.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -55.91 -43.89 77.73 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.9 mmt -58.51 -37.65 76.06 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 167.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.3 46.01 2.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.73 142.76 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 C-N-CA 123.841 0.856 . . . . 0.0 110.518 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -69.76 165.56 21.15 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.299 12.5 tt -73.63 53.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.78 -67.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -67.67 -25.95 65.96 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -42.9 -42.47 3.7 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 153.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.42 -52.01 5.61 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.291 -0.862 . . . . 0.0 112.364 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -57.86 -40.11 79.36 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.53 -35.03 60.81 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.88 88.36 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 163.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -103.43 47.67 0.87 Allowed 'General case' 0 CA--C 1.577 1.994 0 C-N-CA 123.867 0.867 . . . . 0.0 112.895 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -83.78 -11.56 56.91 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 59.27 46.21 13.09 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.311 -1.493 . . . . 0.0 114.185 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.452 ' H ' HG12 ' A' ' 8' ' ' VAL . 2.8 tt -85.32 108.65 17.9 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 121.379 -0.825 . . . . 0.0 111.914 -166.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -94.82 111.19 22.99 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.448 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.82 101.67 13.77 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.369 0.668 . . . . 0.0 110.256 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -81.48 101.15 9.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.168 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.7 mt -90.38 119.58 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 p -128.79 108.68 10.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -88.44 84.58 6.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 111.527 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.41 76.25 5.92 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 121.92 0.866 . . . . 0.0 111.563 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.95 77.23 0.7 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 115.812 1.085 . . . . 0.0 115.812 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.292 18.1 t-20 70.9 -57.87 0.58 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -64.25 119.01 9.45 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -86.42 106.37 17.4 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.502 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.4 m -87.64 97.35 10.82 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -104.23 107.79 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -94.63 106.02 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -78.78 111.86 15.34 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.237 0.615 . . . . 0.0 110.801 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.4 t -113.02 106.07 14.24 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.047 0.539 . . . . 0.0 109.558 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -142.86 178.43 7.66 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -58.83 -39.63 81.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -60.65 -52.12 66.5 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 165.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -158.3 151.45 22.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -159.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -122.91 90.92 3.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.789 0.836 . . . . 0.0 109.675 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.29 148.8 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.233 -0.917 . . . . 0.0 112.785 -167.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.86 116.88 33.77 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.109 0.964 . . . . 0.0 112.609 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.01 104.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.45 114.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -123.12 124.57 43.36 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -82.86 145.87 29.21 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.818 0.818 . . . . 0.0 111.263 166.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.73 117.5 11.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.33 0.11 85.05 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 119.537 2.575 . . . . 0.0 119.537 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.7 t -95.95 137.1 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 120.526 2.163 . . . . 0.0 110.374 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.0 p -75.28 121.83 22.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.728 . . . . 0.0 112.651 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -137.97 158.6 44.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.644 -0.66 . . . . 0.0 112.455 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.51 107.28 18.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.71 -0.619 . . . . 0.0 110.304 173.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -95.46 110.13 22.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -75.18 126.8 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.631 -0.668 . . . . 0.0 110.62 175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.8 mt -78.37 167.41 21.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.757 -1.214 . . . . 0.0 113.88 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.39 63.23 2.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 169.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -167.52 -83.69 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.023 1.329 . . . . 0.0 108.113 -172.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.93 61.05 0.04 OUTLIER Glycine 0 CA--C 1.548 2.116 0 C-N-CA 125.354 1.454 . . . . 0.0 111.12 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.1 m -143.62 119.62 10.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.24 101.35 12.02 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.5 mt -87.3 115.49 24.74 Favored 'General case' 0 CA--C 1.561 1.378 0 O-C-N 121.153 -0.967 . . . . 0.0 111.482 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -98.08 109.6 22.33 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.621 0.769 . . . . 0.0 110.409 -175.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.59 -176.52 46.54 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -171.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -120.94 119.56 32.95 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.093 -1.553 . . . . 0.0 110.565 -166.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -79.47 112.19 16.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 118.905 0.775 . . . . 0.0 110.202 159.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.2 m -106.62 138.09 43.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.278 0.631 . . . . 0.0 110.983 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 tp -88.43 108.44 19.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.359 -0.838 . . . . 0.0 109.782 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -67.72 -42.56 81.74 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 171.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.28 -81.29 0.07 OUTLIER Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -79.77 -22.07 43.62 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 157.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -105.97 134.42 49.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.284 1.402 . . . . 0.0 111.341 -167.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.5 mt -94.35 111.35 23.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 108.78 167.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.5 tp -105.36 120.11 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 124.784 1.234 . . . . 0.0 109.184 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.02 111.83 2.48 Favored Glycine 0 N--CA 1.483 1.805 0 O-C-N 121.839 -0.538 . . . . 0.0 113.94 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -97.59 107.97 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.136 0.575 . . . . 0.0 109.556 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -127.14 107.25 9.86 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.399 0.618 . . . . 0.0 112.618 -164.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -83.72 124.71 31.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.764 -1.21 . . . . 0.0 110.954 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -61.24 150.53 34.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.829 -1.17 . . . . 0.0 113.875 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.6 m -80.67 68.23 6.82 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-O 123.508 1.623 . . . . 0.0 111.011 170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -152.23 -85.04 0.07 Allowed 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -115.72 -22.87 8.94 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 50.81 2.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.248 1.259 . . . . 0.0 116.248 -167.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -82.03 -30.78 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 119.038 2.977 . . . . 0.0 119.038 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . 0.383 10.7 tt0 74.99 97.83 0.07 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 126.001 1.72 . . . . 0.0 114.707 -168.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 tt -89.58 116.32 27.64 Favored 'General case' 0 CA--C 1.563 1.442 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.526 165.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -92.07 117.02 29.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.762 . . . . 0.0 110.764 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -114.02 112.97 24.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.825 0.85 . . . . 0.0 109.157 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.8 t -105.85 113.52 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -110.32 117.93 34.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.219 0.918 . . . . 0.0 109.566 170.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.16 144.53 38.64 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.998 0.904 . . . . 0.0 112.045 -169.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -91.31 108.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.9 mt -76.68 -47.57 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.763 -0.585 . . . . 0.0 111.542 168.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.84 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.485 1.917 0 CA-C-N 119.185 0.902 . . . . 0.0 111.247 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.35 -30.02 47.82 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.08 144.2 34.1 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 122.425 1.107 . . . . 0.0 112.516 -173.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 tp -95.13 115.2 27.12 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.756 0.822 . . . . 0.0 109.186 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.4 121.43 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.805 -0.559 . . . . 0.0 109.83 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.37 99.14 7.99 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.689 0.796 . . . . 0.0 109.85 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -98.17 111.01 23.49 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.725 0.81 . . . . 0.0 110.915 -169.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -100.91 112.08 24.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.928 0.891 . . . . 0.0 110.723 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.27 113.6 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -123.96 110.0 14.25 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 122.997 0.519 . . . . 0.0 112.209 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.275 43.6 mt-10 47.22 34.5 3.1 Favored 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 119.53 -44.26 1.43 Allowed Glycine 0 CA--C 1.553 2.418 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -162.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.74 121.76 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 119.304 1.552 . . . . 0.0 113.33 -163.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.02 133.74 34.65 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.841 -0.537 . . . . 0.0 111.689 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.69 117.33 9.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.436 0.694 . . . . 0.0 111.571 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.297 1.1 pptp? -114.64 126.22 54.64 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -105.23 115.33 30.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 110.365 -172.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mt -98.78 120.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.89 130.28 55.63 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.342 0.657 . . . . 0.0 110.896 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -91.61 149.07 21.83 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.97 0.89 . . . . 0.0 112.053 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -84.89 113.03 21.08 Favored 'General case' 0 CA--C 1.566 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 112.689 -174.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.492 1.65 0 C-N-CA 124.802 1.241 . . . . 0.0 113.896 172.222 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.404 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.43 62.26 0.91 Allowed 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 119.686 1.13 . . . . 0.0 113.008 -171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -141.74 91.11 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.367 -1.458 . . . . 0.0 107.746 166.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -174.87 167.5 3.63 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.54 1.162 . . . . 0.0 111.899 -171.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -101.3 141.78 33.67 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 111.662 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -141.84 121.81 13.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.477 -165.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -112.11 142.47 44.52 Favored 'General case' 0 N--CA 1.505 2.308 0 CA-C-N 120.502 1.501 . . . . 0.0 112.52 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.279 7.7 p -80.5 91.09 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 122.769 1.271 . . . . 0.0 114.059 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.55 -36.26 29.31 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -122.52 145.7 48.08 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.082 -1.011 . . . . 0.0 112.189 -172.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.5 p -152.46 159.5 43.35 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.271 1.6 tm-20 -106.57 -137.28 0.36 Allowed 'General case' 0 CA--C 1.582 2.174 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.736 171.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.286 8.8 p30 -80.99 58.72 3.53 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 118.917 -2.364 . . . . 0.0 117.159 -167.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CE2' ' SD ' ' A' ' 18' ' ' MET . 31.6 t80 -61.14 -40.44 93.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.719 -1.863 . . . . 0.0 115.159 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.64 -43.05 68.45 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 165.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.91 -45.12 52.58 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 120.596 1.543 . . . . 0.0 115.024 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -45.55 -51.61 11.65 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 160.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' A' ' 28' ' ' ARG . 43.4 mtp -62.01 -45.4 93.77 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 172.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -43.04 72.21 Favored 'General case' 0 CA--C 1.579 2.085 0 CA-C-N 120.373 1.442 . . . . 0.0 114.733 168.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -40.34 89.15 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 166.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.548 ' SD ' HG21 ' A' ' 76' ' ' THR . 72.9 mtm -62.98 -45.37 92.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 169.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.82 68.61 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 CA-C-N 118.841 0.746 . . . . 0.0 114.633 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.42 174.39 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.311 1.053 . . . . 0.0 113.267 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.16 159.8 21.97 Favored 'General case' 0 CA--C 1.577 2.009 0 O-C-N 120.712 -1.243 . . . . 0.0 113.338 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.264 14.7 tt -59.67 -44.49 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 167.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.66 49.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 CA-C-O 123.715 1.721 . . . . 0.0 112.088 167.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -149.77 -52.28 0.15 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 127.749 2.419 . . . . 0.0 106.169 172.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 12.0 mtm105 -42.95 -55.11 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 161.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -62.28 -41.44 98.49 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.09 -51.85 66.28 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.29 36.65 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.61 -56.07 25.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 119.674 -1.891 . . . . 0.0 113.162 156.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -86.28 48.56 1.64 Allowed 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -80.41 -16.13 55.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 58.69 21.24 8.61 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.27 1.3 pt? -77.2 145.53 37.57 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -157.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.03 119.07 34.69 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.396 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -99.19 109.76 22.4 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.559 0.744 . . . . 0.0 109.615 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.5 m -90.19 101.62 14.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -92.92 125.38 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.253 12.8 t -133.37 143.05 48.7 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.062 0.934 . . . . 0.0 111.705 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -110.1 110.36 21.22 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.866 0.866 . . . . 0.0 110.858 -172.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -88.8 77.17 7.87 Favored 'General case' 0 CA--C 1.57 1.73 0 CA-C-O 121.723 0.773 . . . . 0.0 110.149 165.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.46 -95.25 0.14 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -91.97 -8.47 46.11 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 168.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -113.38 118.55 34.88 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 121.121 1.782 . . . . 0.0 111.213 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.44 129.81 38.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.555 -0.716 . . . . 0.0 111.709 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -100.37 109.84 22.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 163.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -106.13 103.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -88.5 99.37 12.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.863 . . . . 0.0 109.734 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.26 100.08 12.2 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.287 0.635 . . . . 0.0 112.431 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.4 t -95.08 94.81 8.18 Favored 'General case' 0 CA--C 1.56 1.331 0 O-C-N 122.126 -0.359 . . . . 0.0 111.024 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.8 p -114.61 167.5 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.148 0.979 . . . . 0.0 113.361 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.6 m -56.96 -42.62 80.45 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 166.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -68.04 -49.33 62.07 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -148.95 145.76 27.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.498 1.044 . . . . 0.0 112.16 -169.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.06 102.11 8.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.646 . . . . 0.0 109.59 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.5 pt -139.93 149.04 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.787 0.803 . . . . 0.0 112.145 -171.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -87.87 105.54 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.491 -0.755 . . . . 0.0 110.416 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.65 99.03 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.2 t -96.83 123.43 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -144.33 146.83 32.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -99.66 143.3 30.05 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.023 0.916 . . . . 0.0 111.906 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.18 109.34 2.59 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.461 0.704 . . . . 0.0 112.898 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.92 -38.12 3.4 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.7 t -73.79 132.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 118.847 1.323 . . . . 0.0 110.329 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -98.21 102.99 14.89 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.315 1.055 . . . . 0.0 110.715 -171.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -114.41 163.73 14.92 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 124.973 1.309 . . . . 0.0 112.06 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -87.12 112.15 21.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 109.643 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -80.54 -65.93 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.536 -0.728 . . . . 0.0 112.135 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 73.03 122.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.386 1.074 . . . . 0.0 113.029 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.9 mt -74.4 159.61 32.11 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.15 -35.23 64.52 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -51.82 -78.82 0.02 OUTLIER 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 160.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.62 61.73 0.01 OUTLIER Glycine 0 N--CA 1.485 1.904 0 C-N-CA 123.85 0.738 . . . . 0.0 111.893 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.548 HG21 ' SD ' ' A' ' 21' ' ' MET . 91.7 m -127.18 116.24 20.33 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -172.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.75 117.33 20.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.766 -0.584 . . . . 0.0 111.703 -173.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.6 mt -141.02 117.81 11.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.974 0.91 . . . . 0.0 110.612 -164.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.264 2.6 ptm85 -131.89 138.84 48.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.33 -172.93 40.24 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.248 0.927 . . . . 0.0 112.189 -167.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -110.2 -179.08 3.68 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.888 -1.36 . . . . 0.0 112.72 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -122.67 107.23 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 p -85.17 128.96 34.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -0.975 . . . . 0.0 113.356 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 tp -85.31 104.49 15.19 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.298 0.639 . . . . 0.0 111.148 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.22 97.37 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.864 0.84 . . . . 0.0 109.201 -168.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.5 -100.25 1.17 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.589 -0.694 . . . . 0.0 113.652 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -113.63 8.6 17.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 163.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -103.23 127.49 50.53 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.804 1.638 . . . . 0.0 110.528 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.62 99.02 11.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 151.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.21 114.17 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.789 0.804 . . . . 0.0 109.169 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.19 99.97 1.4 Allowed Glycine 0 N--CA 1.478 1.45 0 O-C-N 121.79 -0.569 . . . . 0.0 114.04 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -87.46 100.26 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.452 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.6 116.32 31.52 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.613 0.765 . . . . 0.0 109.435 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -76.36 124.63 27.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.137 -0.977 . . . . 0.0 111.726 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.1 100.36 12.59 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 -171.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.5 p -68.45 -21.68 64.63 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -171.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -56.74 -23.46 42.85 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 163.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.45 -49.54 0.36 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.428 1.091 . . . . 0.0 113.681 -157.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.92 60.36 0.93 Allowed Glycine 0 N--CA 1.49 2.246 0 CA-C-N 119.172 0.896 . . . . 0.0 115.051 -170.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -144.0 141.63 30.25 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.465 0.706 . . . . 0.0 110.635 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.28 103.28 6.22 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.025 0.917 . . . . 0.0 111.575 167.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.98 123.58 25.97 Favored 'General case' 0 CA--C 1.562 1.421 0 O-C-N 121.796 -0.565 . . . . 0.0 109.804 166.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -107.59 100.17 9.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -108.02 118.7 37.45 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.357 0.663 . . . . 0.0 110.91 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.87 113.57 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -100.59 118.53 36.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.079 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.65 145.86 31.97 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 123.591 0.756 . . . . 0.0 110.809 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.31 110.89 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.535 -1.353 . . . . 0.0 108.006 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER -91.78 85.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 122.272 1.034 . . . . 0.0 109.005 171.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.46 -91.05 1.04 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 120.77 -1.206 . . . . 0.0 114.205 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -130.93 42.92 3.17 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.687 -0.89 . . . . 0.0 112.945 165.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -136.23 119.79 17.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.817 -1.177 . . . . 0.0 109.716 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.65 108.23 13.04 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.407 0.683 . . . . 0.0 110.614 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -89.9 71.63 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 123.318 0.647 . . . . 0.0 112.027 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -69.56 97.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.821 -1.174 . . . . 0.0 112.048 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -109.58 98.05 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -160.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.12 106.23 18.22 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.501 1.12 . . . . 0.0 111.942 -170.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.14 123.1 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.54 -0.725 . . . . 0.0 109.308 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -136.32 124.02 22.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.102 0.561 . . . . 0.0 110.716 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.253 48.2 mt-10 46.62 54.72 8.48 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 175.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.78 24.63 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.3 t -114.45 129.33 70.69 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 120.294 2.047 . . . . 0.0 108.966 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -114.83 127.2 55.58 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.776 0.83 . . . . 0.0 111.525 -171.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.52 115.16 25.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.923 0.868 . . . . 0.0 112.54 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -87.46 122.79 31.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -104.88 102.71 12.23 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.41 107.4 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -172.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.99 123.92 42.22 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.856 0.462 . . . . 0.0 110.463 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -78.0 167.93 20.68 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.66 0.743 . . . . 0.0 112.025 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.77 103.89 1.88 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.88 -1.138 . . . . 0.0 113.028 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 6.8 t0 . . . . . 0 N--CA 1.488 1.448 0 C-N-CA 125.623 1.569 . . . . 0.0 113.978 -179.069 . . . . . . . . 1 1 . 1 stop_ save_